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Governance
The Laboratory is governed by a Board of Trustees of up to 35 members that meets three or four
times a year. Authority to act for the Board of Trustees between meetings is vested in the Executive
Committee of the Board of Trustees. The Executive Committee is composed of the Officers of the
Board and any other members who may be elected to the Executive Committee by the Board of
Trustees. Additional standing and ad hoc committees are appointed by the Board of Trustees to pro-
vide guidance and advice in specific areas of the Laboratory's operations.
Representation on the Board of Trustees itself is divided between business and community lead-
ers and scientists from major educational and research institutions.
The Laboratory is chartered as an educational and research institution by the Board of Regents
of the Education Department of the State of New York. It is authorized to operate a graduate pro-
gram under the name “Cold Spring Harbor Laboratory, Watson School of Biological Sciences” and
thereat to confer the degrees of Doctor of Philosophy (Ph.D.), Master of Science (M.S.), and Doc-
tor of Science (Sc.D.), Honorary.
It is designated as a “public charity” under Section 501(c)(3) of the Internal Revenue Code.
frontmatter_Layout 1  7/8/11  1:25 PM  Page vi
Committees of the Board
vii
Audit
Leo A. Guthart, Chair
Louise M. Parent
Alan C. Stephenson, Esq.
Commercial Relations
James M. Stone, Ph.D., Chair
W. Dillaway Ayres, Jr.
David Botstein, Ph.D.
John P. Maroney, Esq.
Robert Martienssen, Ph.D.
Alan C. Stephenson, Esq.
Bruce Stillman, Ph.D.
Jerome Swartz, Ph.D.
Executive Committee
Eduardo G. Mestre, Chair 
W. Dillaway Ayres, Jr.
Timothy Broadbent
Leo Guthart
Jamie C. Nicholls (Chair as of 11/10)
Marilyn Simons, Ph.D.
Bruce Stillman, Ph.D.
James Stone, Ph.D.
Paul Taubman
Edward Travaglianti
Roy J. Zuckerberg
Finance
Jamie C. Nicholls, Chair
W. Dillaway Ayres, Jr.
Lola N. Grace
Leo Guthart (Chair as of 11/10)
Robert D. Lindsay
John C. Phelan
William S. Robertson
Lari C. Russo
Marilyn Simons, Ph.D.
Edward Travaglianti
Investment
John C. Phelan, Chair
W. Dillaway Ayres, Jr.
Thomas D. Lehrman
Stephen M. Lessing
Jamie C. Nicholls
William S. Robertson
Paul Taubman
Edward Travaglianti
Nominating
Robert D. Lindsay, Chair
W. Dillaway Ayres, Jr.
Kristina Perkin Davison
Eduardo G. Mestre
Jamie C. Nicholls
David M. Rubenstein
Bruce Stillman, Ph.D.
Roy J. Zuckerberg
Robertson Research Fund
W. Dillaway Ayres, Jr.
Walter Goldschmidts, Ph.D.
Leo Guthart
Eduardo G. Mestre
Jamie C. Nicholls
Bruce Stillman, Ph.D.
Family Representatives
Katherine Ernst
William Gridley
John Linnartz
Walter Meier, M.D.
William S. Robertson
Other Committees
Building
Joan Axinn
Arthur Brings
Helen Ann Dolan
Mary Beth Donohue
Sandra Lessing
Mary D. Lindsay
Terry Lindsay
Nancy Abeles Marks
Peter Quick
Elizabeth Watson
Planning and Development
Leo Guthart
Thomas Lehrman
Howard Morgan
Charles L. Sawyers, M.D.
Marilyn Simons, Ph.D.
Bruce Stillman, Ph.D.
Paul Taubman
Roy J. Zuckerberg
Education
Laurie J. Landeau, V.M.D., Chair
W. Dillaway Ayres, Jr.
Edward A. Chernoff
Maria de Lesseps
Lola N. Grace
Lori Homer
Suzanne Kleinknecht
Suzanne Leeds
David A. Micklos
Peter Quick
Lawrence Scherr, M.D.
Adele Smithers
Arthur Spiro
Bruce Stillman, Ph.D.
Peter Tilles
Edward Travaglianti
Marianne Dolan Weber
frontmatter_Layout 1  7/8/11  1:25 PM  Page vii
viii
George W. Cutting, Jr.
(1932–2010)
George W. Cutting, Jr., known long to all as “Butch,” was born on July 13, 1932, the son of George
W. Cutting and Mary Converse Cutting of  Warrentown, Virginia. A graduate of the Rensselaer and
Brooks Schools, he entered Yale College where he graduated in 1955 as a political science major.
After his 1958 marriage to Lucy Pulling at the Chapel of the Millbrook School (Dutchess County,
New York), which her father Edward Pulling had founded and long directed, they lived in New
York City where Butch was a stockbroker and portfolio manager at Fahnestock and Company. In
1958, he and Lucy moved to Oyster Bay Cove, Long Island, occupying a house that they built off
Yellow Cote Road estate land earlier owned by her grandfather, the illustrious banker, Russell Lef-
fingwell. Amidst the idyllic splendor of his estate’s meadows and fields, Butch and Lucy raised their
four children—George, Jr., Lucy, Cynthia, and Susie.
Liz and I first met Butch and Lucy during the first year of our marriage when Ed and Lucy
Pulling invited us down from Harvard for a February weekend to meet members of the Long Island
Biological Association (LIBA). Ed was then its President, having  taken over the reins from Neville
Ford, several years after he and his wife moved to Long Island following his retirement as head-
master of Millbrook. Then, he and his wife moved into Redcote, the wooden-shingled main house
of the Leffingwell estate. Later, Liz and I began to interact much with the Cuttings at the East
Woods School, immediately across Yellow Cote Road from the Leffingwell land. Butch and Lucy
also sent their children there to be educated. 
From the moment of my arrival in February 1968 as the Lab’s new Director, I had the good for-
tune to be able to devote almost all of my time to direct its science. All of our fund-raising efforts
aimed at private sources in effect were handled by Edward Pulling. He had no use for a develop-
ment office as long as he was available to make known the Laboratory’s needs. At a late-1970s lun-
cheon at the Piping Rock Club, Ed introduced us to Oliver and Lorraine Grace, who several years
before had moved nearby into a gracious, old waterfront home on Cove Neck. Oliver, long inter-
ested in cancer research, joined the Lab’s Board of Trustees in 1983, and his major gift made possi-
ble the 1986 opening of our Charles Moore–designed Oliver and Lorraine Grace Auditorium. By
then, Ed Pulling, at age 86, thought the time had come to retire as President, telling me that he had
found the perfect person to succeed him—Butch. 
Here, Ed made the perfect choice. He knew that Butch, then in his mid 50s, had the time, vi-
sion, and energy to attract even more community support for the Lab’s ever-growing research and
educational programs. Butch, as LIBA’s President, also became in 1986 a member of our Board of
Trustees, having an essential role in the Lab’s Second Century Campaign (1989–1992), serving as
cochairman of its steering body and directing the special gifts committee that focused on the mem-
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bers of LIBA. By the conclusion of the Second Century Campaign, more than $50 million were
raised, allowing construction of the Neuroscience Center to commence in 1992. From the mo-
ment he took over the LIBA presidency, he sensed the need to have its name much more directly
relate to the Lab. In 1991, LIBA became the Cold Spring Harbor Laboratory Association (CSHLA). 
As President, Butch always displayed his unqualified enthusiasm for the Lab, believing that the
Lab had to stop being Long Island’s best-kept secret. Joyously, he designed the Lab’s first tie. He soon
correctly sensed that the Association’s long-term future would be best served by a succession of
qualified individuals serving as its President. So, in 1993, he turned over the presidency to Mary
Lindsay. Upon his concurrent retirement from our Board of Trustees in 1993, he was elected an
Honorary Trustee, continuing to regularly attend its meetings for many years. 
Although no longer CSHLA President, Butch for many years continued to have an indispens-
able role in our community fund-raising efforts. Particularly important were his convincing his
longtime friend, Skip Hargraves, to head our Planned Giving activities and his temporarily running
our ever-growing Development Office after Susan Cooper’s move, in 1997, to the Trudeau Insti-
tute in Saranac Lake, New York. By then, Butch and Lucy were spending even longer intervals in
their summer house in Homer, on the Kenai Peninsula to the southwest of Anchorage. Frozen fish
always accompanied them home from their summers of much fishing, allowing them to hold each
year much appreciated, salmon-dominated parties for their still many close friends at the Lab.
Butch’s last years were greatly diminished by failure of his kidneys. Lucy valiantly held any fur-
ther decline at bay through skillful overnight dialysis procedures that she watched over while Butch
was asleep. To give her father more normalcy, their daughter Lucy heroically donated to her father
one of her kidneys. Happily, it was immunologically accepted, raising hope that Butch would have
many more years of meaningful life. This, however, was not to be, with a serious heart attack all too
soon putting him back in New York Hospital. Following unsuccessful surgical intervention, he
died on May 13, 2010. Today, his name remains a permanent fixture through our George W. and
Lucy Cutting Lectureship in the Watson School and our renaming as “Cutting House” the early
19th-century whaling home on Harbor Road that now serves to house students in the Watson
School of Biological Sciences.
Butch’s enthusiastic love for all things Lab and his warm kindness to all are sorely missed.
James D. Watson
George W. Cutting, Jr.      ix
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xCharles E. Harris III
(1943–2010)
Charlie Harris was remarkable both in how he lived his life and how he died. He and his wife Susan
have made invaluable contributions to Cold Spring Harbor Laboratory during the past 20 years that
will yield results well into the future. 
Charlie was raised in Jacksonville, Florida and attended public school until his parents recognized
the need to remove him from the rather dysfunctional public school system. He attended the Hill
School in Pottsdown, Pennsylvania for the final 2 years of high school before entering Princeton Uni-
versity. Later, Charlie graduated from Columbia Business School and successfully pursued a career
in the securities industry and as an innovative venture capitalist. He founded Harris & Harris
Group, a venture capital firm, in 1983 and subsequently brought the firm public. This was an un-
usual path for a venture fund, but then again, Charlie was unique. 
For the last decade of his career at Harris & Harris, Charlie became one of the most informed
and enthusiastic supporters of the emerging field of nanotechnology, in which he was recognized
as an astute investor. There was something about the merging of an exciting new science and the
opportunity to build new companies that attracted Charlie to this field. It enabled him to interact
with and advise many of the top nanotechnology scientists in academia. He was always encourag-
ing me to integrate nanotechnology into the research programs at Cold Spring Harbor Laboratory,
and he was way ahead of us in this respect. 
I know Charlie would have enjoyed this year’s President’s Council fall event, “Tiny Treatments:
The Science of Nanotechnology.” He died just the day before the weekend retreat, but he had e-
mailed me earlier to say how pleased he was with the agenda. It was Charlie who helped found the
President’s Council in 1994 as a vehicle to support CSHL Fellows. As a venture capitalist, I believe
Charlie looked at the opportunity to support early-career scientists as a smart investment in the fu-
ture. Investing in the best and the brightest young investigators is a hallmark of our institution,
and I view Charlie and Susan’s dedication to the CSHL Fellows program as perhaps one of the
strongest endorsements of our institutional strategy. The returns on investment from this program
are sizable, measurable in terms of scientific advancement and reflected by the grandest of prizes—
the Nobel Prize, which in 2009 went to former CSHL Fellow Carol Greider.
Charlie was also an avid thoroughbred horse owner who raced his horses at many prominent
tracks, including Belmont and Saratoga. He was often conflicted in time among the alternative ca-
reers of family man and father of two, horse owner, businessman, and philanthropist. I remember
the Saturday afternoon of one President’s Council chaired by Charlie that included a trip to Shel-
ter Island on the east end of Long Island. The drive there required a well-planned stop at a sports
bar to watch the Preakness Stakes in Maryland, before we all proceeded to a bird-watching event
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with some of the country’s top birders. Somehow, Charlie always managed to balance a rather busy
schedule and many interests without appearing to be busy.
In 2000, CSHL received endowment funds for The Susan T. and Charles E. Harris Visiting Lec-
tureship, providing students of the Watson School of Biological Sciences the opportunity to inter-
act with the world’s leading scientists. Again, I have to believe that with this gift, Charlie and Susan
made a strategic investment in the next generation of biomedical research by enhancing the edu-
cational experience of some of the brightest doctoral students in the country.
Charlie was elected to the Board of Trustees in 1998 and displayed the same enthusiasm for our
science as he did for nanotechnology. He served on many committees including Finance and In-
vestment, Compensation, Development, Audit, and Research. He helped to recruit some of our cur-
rent trustees and he expanded our network of contacts in both business and academia. We greatly
appreciated his sharp intellect and gentle manner. 
More recently, we were privileged to see his strengths in a much more personal and profound way.
Once diagnosed with cancer in the spring of 2009, Charlie began writing and posting a blog chron-
icling his treatment, progression, and personal approach and thoughts about dealing with terminal
illness. Although he was not trained as a writer, his chronicle became a compelling account of the
final chapter of a remarkable life, with deep insights into what it was to live and to face death.
At a memorial service for Charlie on November 3, 2010 in New York, I was touched by the
words of so many of Charlie and Susan’s friends. The comments of Dr. Andrew W. Lo, Harris &
Harris Professor at MIT, brilliantly captured Charlie. “As an academic,” said Andrew, “I’m sur-
rounded by colleagues who make it their business to think critically, objectively, and rationally. But
I don’t think I’ve ever met a clearer-thinking individual than Charles. He never engaged in the lux-
ury of self-pity, but methodically researched and pursued every avenue of cure that made sense
from an overall cost-benefit perspective. Now this may sound cold and calculating, but on the con-
trary, it was not the cost and benefit to him that Charles was weighing but rather the impact on his
family and friends.”
On June 3, when Charlie decided to stop chemotherapy completely, he began sharing with us
all through blog postings his experiences in dealing with his decision and the progress of his can-
cer. At the urging of his many friends and colleagues, Charlie was persuaded to turn these postings
into a book—a project that he worked on up to the end of his life. Entitled “Incurable: Life After
Diagnosis,” the book was published by the Cold Spring Harbor Laboratory Press in 2011. Charlie
not only made arrangements to cover the costs of publishing, but stipulated that any profits from
the book be dedicated to support research at Cold Spring Harbor Laboratory.
When Charlie was unable to continue writing his blog himself, Susan took over and encouraged
us all to meet Charlie’s bravery with our own. She and Charlie did not allow us to miss the oppor-
tunity to embrace Charlie and celebrate his life while he was still living. Again, I must echo Andrew
Lo’s beautiful remembrance of Charlie and the gift that he and Susan gave us. We were able to be
present in his last months and by allowing us the access to life before death, Susan and Charlie
taught us all a lesson on how to live and how to die. 
Bruce Stillman
Charles E. Harris III      xi
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In his State of the Union address in 1971, President Richard Nixon called upon Congress “to launch
an intensive campaign to find a cure for cancer.” Later that year, the National Cancer Act became
law, the first salvo in what since has been referred to as “the war on cancer.” 
After 40 years, where do we stand? This past year, cancers killed more than 550,000 Americans.
More than three times that number were newly diagnosed. These figures make clear that a “cure” is
nowhere in sight. Yet, four decades ago, it seemed plausible to imagine that we were on the trail of
a single killer. Today, we possess the sobering knowledge that our quarry is actually hundreds of dif-
ferent illnesses and that it is unlikely that a single magic bullet will bring cancer’s carnage to a halt.
Cancer is so very much more complicated than we understood it to be in 1971. Over four
decades, a major national investment in basic biological research—performed at Cold Spring Harbor
Laboratory and academic and clinical centers of excellence across the nation and around the world—
has yielded increasingly detailed knowledge of cancer at the genetic, cellular, and tissue levels. That
knowledge has brought us the first effective targeted therapies for certain cancer subtypes. These
point the way to a much more encouraging future. 
I would like to recognize in this report a few of the landmark discoveries in which Cold Spring
Harbor Laboratory scientists have had important roles, as prelude to describing a new Cancer Ther-
apeutics Initiative. Grounded in such outstanding basic science, I am optimistic that the powerful
approach we are taking at the Laboratory will contribute in the coming years to turning many major
cancer types into manageable chronic illnesses or even cures. 
Forty years is an eternity in biomedical science. It is important to remember that when a patient
went to a clinic in 1971, there was very little that an oncologist could determine except for the fact
that a cancer was present. Pathology on the tumor could help determine prognosis, but the ability
to characterize tumors beyond gross pathology was rather limited. There were plenty of chemother-
apies available, but responses to them were essentially hit or miss. 
Forty years ago, we knew that the genetics of individual cancers was important. We knew that
cancer cells had abnormal chromosomes compared to those of normal cells. But the concept that
specific genes caused cancer had not yet been clearly formulated. Our initial focus, beginning in
1968 when Jim Watson became director of Cold Spring Harbor Laboratory and trained his sights
on cancer, was on cancer-causing viruses because they carried genes that could promote cancer.
The notion that cancer could have a viral origin dates to the early 20th century and the work of
Peyton Rous at The Rockefeller University, who discovered a virus in a type of chicken tumor that
could be transferred via injection to baby chicks, which were subsequently observed to develop tu-
mors. In the mid 1970s, J. Michael Bishop and Harold Varmus at UCSF found a gene in healthy
chickens called c-src that was nearly identical to the cancer-causing gene in Rous sarcoma virus.
They concluded that the oncogene in the virus did not represent a true virus gene but instead was
a version of the normal cellular gene that the virus had acquired during replication in the host cell
and thereafter carried along.
In 1981, Michael Wigler here at Cold Spring Harbor Laboratory was one of three researchers in
the United States who independently discovered the first human oncogene, called RAS. It belongs
to a family of genes critical in signaling networks that regulate cell growth and division. Soon there-
after, CSHL scientist Earl Ruley and MIT’s Robert Weinberg began to reveal some of the mecha-
nisms through which oncogenes promote cancer. Their work shed light on the phenomenon of
cooperating oncogenes, instances in which the progression of cancer depends on the products of
two or more cancer-promoting genes, none of which is sufficient to cause cancer. 
PRESIDENT’S REPORT
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This notion dovetailed with the multiple-hit theory of oncogenesis, which led to the idea that
cells in our body had to acquire mutations in multiple oncogenes. Following pioneering research
by Alfred Knudsen at the Fox Chase Cancer Center, whose studies linked inherited cancer with
spontaneous mutations in adult cells and predicted the existence of tumor suppressor genes, Ed
Harlow at CSHL demonstrated that oncogenes could inactivate tumor suppressors, thereby pro-
viding another view of genetic cooperation to produce tumors. Thus, cancers could result not simply
from the actions of cancer-promoting oncogenes—which encoded proteins that accelerated growth
within the cell—but also from the simultaneous absence of action on the part of genes called tumor
suppressors, whose normal function was to prevent cellular growth from running amok. 
These early studies identified the kinds of malfunctioning or mutated genes that were at work in
oncogenesis, and what mechanisms and pathways they undermined to permit uncontrolled cell pro-
liferation and prevention of cell death, both of which were required for tumor progression. In parallel
with the genetics of cancer was basic research on cell proliferation control in which many labs at
CSHL had a major role and which proved important for understanding cancer. From the mid 1980s
to early 1990s, CSHL scientists helped piece together an increasingly comprehensive molecular pic-
ture of replication of the genetic material in the cell nucleus and the workings of the cell division
cycle that governed how cells proliferate. Defects in the control of cell proliferation are the main
drivers of cancer progression, causing increasingly complex mutations in cancer cells that further
promote tumor growth, loss of normal controls on cells within a tissue, and eventually metastasis.
In the mid 1970s, CSHL alumni Philip Sharp at MIT, Richard Roberts and Louise Chow at
CSHL, and their colleagues made the brilliant discovery of “split genes,” Nobel Prize–winning re-
search that enabled us to see how the RNA messages of genes could be spliced together in multiple
ways, to generate different proteins from a single gene. As Adrian Krainer has shown in recent years,
2 President’s Report
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this alternate splicing contributes to the emergence of cancer in humans. Most interestingly, Adrian
has shown, together with Harvard’s Lew Cantley, that the switching by RNA splicing from one
form of a gene to another form can endow cells with completely different metabolic outcomes, mak-
ing cancer cells very different from normal cells. These metabolic changes will likely provide new
therapeutic opportunities that exploit basic differences between cancer and normal cells.
With the realization that cancer is fundamentally a genetic disease, it became imperative that we
understand the entire human genome. The 1990s marked the beginning of the effort to sequence
the human genome and the genomic era in cancer research, and CSHL was among the leaders and
innovators. The essence of genomics is captured beautifully in work first performed by Mike Wigler
and colleagues around this time. They devised ingenious technical means with which to compare
thousands of genes at a time in tumor samples and a patient’s corresponding healthy tissue. This
immediately led to the discovery of the PTEN tumor suppressor gene, mutated in many human
cancers. Since 2003, Mike and his collaborators have also called our attention to areas of deletion
and amplification across entire genomes, revealing, respectively, a vast array of tumor suppressor
genes and oncogenes. This research has introduced a new dimension to the search for the genetic
culprits of cancer—phenomena such as gene copy-number variations—not known to exist at this
scale before the advent of technologies that study the entire genome. 
Amplified and deleted genomic segments in our genome are commonplace. We all have them,
and they are often harmless. But when they occur in certain parts of our DNA, the impact can be
devastating. Alea Mills of our faculty has provided an excellent example in the context of cancer.
Following up on knowledge that a large region of human chromosome 1 was very often deleted in
human cancers, Alea was able to determine that the region contained a novel tumor suppressor
gene, CHD5, that proves to be a master control switch regulating other tumor suppressor genes.
The pace of our insights has grown along with our technological capabilities. It has proven possible
to “mine” comparative genomic data obtained from tumor samples to identify, for instance, all over-
expressed genes in a particular cancer and then to overexpress the corresponding genes in laboratory
mice. It has also been possible to use designer short hairpin RNAs, members of a class of naturally
occurring small RNA molecules studied in Greg Hannon’s laboratory, to identify many new tumor
suppressor genes or to screen for new therapeutic targets in human cancers.
Building upon human genetics research from Mike Wigler, Jim Hicks, and their clinical colleagues
Scott Powers and quantitative biologist Alex Krasnitz have identified many genomic regions in human
cancer tissue that are either amplified or deleted, enabling insights gleaned from patients to be incor-
porated into the development of animal models of many cancer types, including liver, colon, prostate,
pancreas, and breast cancers, as well as various types of leukemia. In recent years, Scott Lowe and
others have made great strides with “mosaic” mouse models, genetic hybrids that use tissue-specific
stem cells to introduce quickly into mouse cells the same genetic mutations found in human tumors.
These mosaic mice have tumors that mimic the course of human cancers, enabling assessment of why
chemotherapy works in some patients and not in others, and validation of whether new therapeutic
targets will work on cancers that are resistant to current treatment.
We have learned that the underlying genetics of a tumor determines its response to therapy and
can therefore be exploited for both diagnosis and prognosis of tumor subtypes. Carrying this analysis
further, Mike Wigler and Jim Hicks developed a method to study genomic heterogeneity within a
patient’s breast tumor, allowing them to identify cellular subpopulations as well as map their spatial
organization. This analysis was used to advance our understanding of how a tumor evolves over
time, driven by genetic changes that are not visible if the entire tumor is considered to be uniform. 
Using powerful RNA-based tools developed at CSHL, we are learning how to identify new targets
for cancer therapy and to probe why an existing targeted drug works brilliantly for one patient and
fails utterly with another. Previously, both might superficially have appeared to have the same kind
of cancer, but now genetic analysis can separate tumor responses into subgroups, even within a par-
ticular tumor tissue type. RNA-based technology and cancer genetic techniques are also enabling
001-026_Pres_High_Annual Report_2009 template  7/12/11  9:59 AM  Page 3
CSHL scientists to study closely the perplexing phenomenon of resistance to existing drugs. It is
now very clear that new, targeted therapies have to be developed for each genetic subtype of tumor. 
Targeted therapies made a huge impact with the development of Gleevec, designed specifically
to block an oncoprotein produced by a mutant gene in the so-called Philadelphia chromosome, a
misshapen chromosome discovered at the University of Pennsylvania and Fox Chase Cancer Center
in 1960 and now understood to be the result of a translocation—a fragment of chromosome 9 fused
to a fragment of chromosome 22. Gleevec helps only those patients who have this uncommon mu-
tation, which is the cause of most cases of an acute blood cancer called chronic myelogenous
leukemia, or CML. 
Similarly, Tarceva is a drug that very specifically blocks the product of a mutant version of a gene
called EGFR (epidermal growth factor receptor), present in a subset of lung cancer cases. Like
Gleevec, Tarceva is not an indiscriminate killer of cells, both cancerous and healthy, like old-line
chemotherapies. Rather, it works well in many patients who have a specific EGFR mutation, but it
does not help those whose lung cancers have other genetic drivers. However, Tarceva, when effective,
typically holds the cancer at bay only for a year or two and then drug resistance emerges. Raffaella
Sordella’s lab at CSHL recently has found a new mechanism by which responsive lung cancers de-
velop resistance to the drug. 
The problem of resistance suggests the difficulty of the task before us and leads me to caution
against undue optimism that “a cure” is just around the bend. There are 50-odd major types of
human cancers based on tissue type alone, and there are probably six or seven important subtypes
within each tissue type (and maybe more), each one of which needs to be treated with what I an-
ticipate will be a cocktail of targeted drugs rather than a single one. Only then will the resistance
that cancers naturally develop be avoided. In the not-distant future, therefore, major cancers will
be treated in the manner that we now treat HIV infections, with multiple drugs that minimize the
development of resistance. For now, therefore, chronic management of cancer is a more realistic
prospect than its eradication, and this will be a major advance if the targeted drugs do not cause
major side effects, as in the case of Gleevec.
Our Cancer Therapeutics Initiative brings together many of the innovative elements I have dis-
cussed here. Beginning, importantly, from human tumor samples—which we obtain through our
collaborations with leading clinical centers—we use our state-of-the-art sequencing and genome
analysis capabilities to generate tumor profiles. Working with subsets of genes that emerge for genetic
analysis of human tumors, RNA interference (RNAi) technologies can rapidly identify the Achilles’
heel of the cancers and suggest new therapeutic targets. Validation of these targets in mouse models
of human cancer will most likely increase the success rate of drugs that eventually enter into the
clinic. We have learned the hard way that there is no substitute for observing the molecular mech-
anisms of cancer and their response to therapies within the incredibly complex living environment
in which actual cancers emerge, grow, and spread.
The net impact of our initiative—which I estimate will cost $100 million over a period of years—
will be the ability to systematically discover and rapidly validate new targets for cancer drugs. Such
an initiative will require constant interactions with the pharmaceutical industry to bring the validated
targets to human clinical studies. This will require seamless interactions among scientists in industry
and academia. Academic scientists lack the resources to develop drugs, and given well-validated tar-
gets, industry has proven to be very effective at developing drugs that work. The problem is that in-
dustry has not been good at discovery of targets with a high probability of clinical success. This is
where I expect academia will excel. 
While the Cancer Therapeutics Initiative is needed, CSHL will continue vigorously to pursue
basic research on small RNAs, genome structure and organization, cellular signaling pathways and
networks, and other aspects of fundamental biology, work that will lead us to other new technical
capabilities and understanding. It is possible that research performed on our campus will help solve
the technical problems that currently prevent us from using RNAi to directly shut down cancer genes
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in human patients. Other areas of basic research, notably on the immune system, tumor metabolism,
and tumor microenvironment, are likely to be of increasing importance in the years just ahead.
There is one additional element in our fight against cancer that I would like to mention, and it
concerns the current state of our clinical trials system. If we and others are successful in identifying
novel, very specific drug targets in subtypes of the major cancer killers, it is vitally important that
drugs developed against these targets not get bogged down in regulatory delays. A drug recently de-
veloped against a comparatively rare genetic mutation in lung cancer gene called ALK provides a
case in point. A recent early-stage clinical trial of an experimental drug called crizotinib was notably
successful in patients with non-small-cell-lung cancer (NSCLC) who harbored the ALK mutation,
with tumor shrinkage and stabilization in the range of 85%. Strikingly, about three-quarters of the
patients remained on the drug after the clinical trial met its endpoint. Under the current system,
the FDA will require the drug developer to randomize treatment in a phase III trial, splitting a
group of ALK-positive patients into two groups, only one of which will receive the drug. The desired
endpoint would be to demonstrate a survival advantage, a process that takes years to play out. 
Proceeding in this manner I would argue is unethical and costly. In some cases, such as this one,
phase III trials could be bypassed. A drug showing overwhelming responses in multicenter, early-
stage trials in a cancer type with poor prognosis should promptly be granted temporary approval. It
should be placed directly into broad clinical use in appropriate genetically screened patients who
wish to be treated with it, including early-stage cancer patients. The drug’s developer, meantime,
should be required to report the full course of all patients, irrespective of outcome. Hospitals and
clinics performing these trials should be protected from patient litigation if the therapies do not
work, allowing multicenter trials to proceed unhindered by legal complications. For a period of
years, all adverse side effects and outcomes should be reported and the drug’s temporary approval
rescinded if previously unnoticed safety issues emerge or if the drug proves not to have the desired
effect when a larger group of patients have been treated. Short of this, however, I believe humani-
tarian and cost considerations demand that a new drug found to have overwhelming initial success
in a genetically defined subpopulation of patients with otherwise poor prognosis should be made
available while further data on efficacy and side effects are being collected. 
If we are serious as a society about advancing the state of cancer treatment, we should rethink
the clinical trials process, particularly as we use new methods of discovery made possible by decades
of remarkable basic scientific and clinical research to find the next generation of targeted therapies.
These, if used in combination treatments, promise to make cancer a disease that millions of Amer-
icans will be able to live with, while enjoying a decent quality of life. It is not an easy goal, but one
that should be among the nation’s highest priorities.
Bruce Stillman, Ph.D., F.R.S.
President
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Research
Research at Cold Spring Harbor Laboratory (CSHL) has a major impact in the areas on which our
principal investigators focus: cancer, neuroscience, plant biology, and quantitative biology. It has
often been noted that our influence is especially remarkable for an institution of CSHL’s compar-
atively small size. A recent survey by the respected science publisher Thompson Reuters in fact
placed CSHL first in a group of 20 “heavy hitters” in molecular biology and genetics, selected from
among 42,000 research institutions worldwide. During the first decade of the 21st century, research
papers based on work conducted in CSHL laboratories had more impact—as measured by their
frequency of citation by peers—than papers originating in any other institution, including the Mas-
sachusetts Institute of Technology, the Salk Institute for Biological Studies, Memorial Sloan-Ket-
tering Cancer Center, The Rockefeller University, and Harvard University.
This survey is not the only measure of our worth or that of any institution, but it does suggest
the power of the work being performed at CSHL and its relevance, as measured by those who use
it—our colleagues at laboratories throughout the nation and across the globe. Together, we are en-
gaged in a vital enterprise, in which we bring all of our intellectual skills and technical ingenuity to
bear on fundamental questions of biology and generate knowledge that forms the basis for biomed-
icine to move forward in its mission to relieve the major causes of human suffering. Below, we sum-
marize just a few of the many fascinating and important findings made by CSHL’s dedicated team
of investigators during 2010.
Antisense Therapy Reverses Spinal Muscular Atrophy in Mice
Professor Adrian Krainer achieved a milestone this past year in his continuing
effort to understand spinal muscular atrophy (SMA), the leading genetic cause
of death in infants. SMA is the result of mutations in the survival of motor
neuron 1 (SMN1) gene. These lead to abnormally low levels of SMN protein
in motor nerve cells of the spinal cord and to the degeneration of those cells.
Last year, Adrian and colleagues identified a compound that stimulates SMN
production by altering RNA splicing. This year, they carried the work an im-
portant step further: By introducing chemically modified pieces of RNA called
antisense oligonucleotides (ASOs) into the spinal cords of mice, they succeeded
in reversing symptoms of Type III SMA. This result exemplifies how superb
basic science—in this case, work in the Krainer lab on the cell’s splicing ma-
chinery—can be fertile ground for value-added science, the kind of research activity that adds commercial
value to fundamental discoveries. Krainer’s team has collaborated with scientists at Isis Pharmaceuticals
in designing and synthesizing ASOs, which can be designed to bind to any piece of RNA. The team ze-
roed in on an ASO that optimally enhanced the inclusion of an exon that in people with SMA is
“skipped” by cellular machinery that cuts and pastes bits of RNA “message” together to form a template
for protein manufacture. A particularly encouraging aspect of the team’s progress this year was learning
how to overcome barriers to delivering ASOs directly into the fluid that surrounds the brain and spinal
cord. The treatment’s therapeutic effect in mice persisted for half a year after it was discontinued, indi-
cating that the ASO is very stable. In addition, the team reported no inflammation or toxicity.
Reversing Alzheimer’s-like Memory Loss in Drosophila
Work published this year by Professor Yi Zhong’s team demonstrated a means of reversing memory
loss in fruit flies caused by brain plaques similar to those implicated in Alzheimer’s disease. Modeling
a complex human illness such as Alzheimer’s is an important goal of basic science, and the fly pro-
A. Krainer
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vides us with a suitably simple starting point. The fly brain should not be underestimated,
for in it we see significant conservation of DNA sequence found in human genes known
to affect the structure and function of neural networks. Protein fragments of the β-amyloid
molecule associated with Alzheimer’s are known to alter many cell-signaling proteins such
as phosphoinositol-3 kinase (PI3K), causing a wide range of neuronal dysfunctions. In
flies engineered to produce the human β-amyloid protein in their brains, Yi’s team set out
to better comprehend the molecular basis of memory loss. This yielded a finding that went
against received wisdom that attributed a protective role to the kinase. Yi’s team instead
found that the increased PI3K activity caused a type of neurotransmission that is patho-
logically enhanced when β amyloid is present in the fly brain. Injection of chemicals that
block the kinase’s action and separate efforts to turn off the gene that encodes it both had
the effect of restoring normal signals in the fly brain. This research also intriguingly suggests that
brains affected by Alzheimer’s might become insulin resistant because of elevated PI3K activity.
Thus, the kinase becomes a potential target for novel therapeutics.
A Possible Inflammatory Component in Resistance to a Targeted
Lung Cancer Drug
A critical question about cancer concerns the molecular mechanisms involved in resistance to
chemotherapy. Particularly vexing is the phenomenon of resistance to the best drugs developed to
date, so-called targeted therapies. Assistant Professor Raffaella Sordella’s lab this year shed new light
on resistance to Tarceva (erlotinib), a targeted therapy approved in 2004 for a subset of patients
with non-small-cell lung cancer (NSCLC) and for some patients with pancreatic cancer.
Tarceva’s molecular target is known—the cell membrane receptor called epidermal growth
factor receptor (EGFR)—as are processes that lead to about half of observed cases of re-
sistance. But what about the other 50%? Raffaella and colleagues from Weill Cornell Med-
ical College and the Boltzmann Institute in Vienna discovered a subpopulation of NSCLC
cells that are intrinsically resistant to Tarceva. These tumor cells were observed to secrete
elevated amounts of a growth factor called transforming growth factor-β (TGF-β), which
in turn increases secretion of interleukin-6 (IL-6), an immune signaling molecule. Signif-
icantly, these effects were independent of the EGFR pathway. The team therefore hypoth-
esizes that inflammation is one of the factors that can render a tumor cell resistant to
treatment with Tarceva.
A Protein Linked to Leukemia “Bookmarks” Highly Active
Genes in Dividing Cells
When CSHL Fellow Christopher Vakoc and colleagues demonstrated this year how so-called epi-
genetic instructions are stably transferred from one generation of cells to the next, they provided a
compelling explanation of how a protein called MLL (mixed lineage leukemia) may be
involved in triggering leukemia. During cell division, gene activity is normally shut down
temporarily. The dividing cell’s chromosomes condense and expel most of the proteins
that cling to them, which are called epigenetic marks. These marks at other times in the
cell cycle help to determine which genes are accessible to the cellular machinery and can
be expressed and which genes are inaccessible and cannot be expressed. Unlike most other
chromosome-bound epigenetic marks, Chris’ team found that the MLL protein stays teth-
ered to the genetic material during cell division. It acts as a “bookmark,” preserving a bit
of vital gene expression information. But as the cell divides, sometimes the MLL proteins
shift to new locations on the chromosome. Interestingly, they seem to attach to genes that
are the most active before cell division shuts down all gene activity. This, in turn, can draw
Y. Zhong
R. Sordella
C. Vakoc
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other proteins to the same area, with the net effect of jump-starting gene expression. Chris is now
studying how MLL mutations might promote the abnormal proliferation of cells in leukemia.
A Potential Way to Reverse Cancer Cell Metabolism and Tumor Growth
Eighty years ago, Nobel laureate Otto Warburg observed the altered metabolic state of cancer cells
and tried to connect it, biochemically, with processes that give rise to the rapid proliferation that
characterizes cancer. In particular, cancer cells are distinct in the way in which they metabolize glu-
cose. They also produce large quantities of a by-product called lactate. A protein called PK-M2 is a
key mediator of glucose metabolism in cancer cells, and this year, Professor Adrian Krainer led a
group including researchers at Harvard Medical School and The Broad Institute that discovered
three molecular factors contributing to high levels of PK-M2 in cancer cells. PK-M2 is one of two
isoforms, or slightly varying versions, of an enzyme called pyruvate kinase. A single gene called PK-
M gives rise to both, via alternative splicing. Adrian’s expertise in splicing helped the team to un-
derstand how the benign isoform of the enzyme, PK-M1, is switched off and the dangerous M2
isoform is switched on in cancer cells. By manipulating three known splicing factors, the team was
able to halt M2 production and separately to restore production of the benign M1 isoform. This
sheds light on the so-called Warburg Effect and points to possible new targets for drugs that might
reverse the pathological metabolism of cancer cells. 
How Blood Stem Cells Are Maintained in the Bone Marrow Niche
Hematopoietic stem cells (HSCs) have unique abilities that are prized by medical re-
searchers. They can self-renew and develop, or differentiate, into any kind of blood cell,
which enables them to replenish the body’s entire blood and immune system. Researchers
have understood that these qualities are traceable to a distinct locale or niche within the
bone marrow that HSCs target, but the identity and function of the niche-forming con-
stituents had not been clearly defined until this past year, when Associate Professor Grigori
Enikolopov and colleagues from the medical schools at Harvard, Albert Einstein, and
Mount Sinai published a report in the journal Nature. HSCs retain their unique features,
they observed, in response to signals from another stem cell population, called mesenchy-
mal stem cells (MSCs), that create a supportive bone marrow niche for the HSCs. It was
the first demonstration that one type of stem cell could regulate another type of stem cell.
In a series of experiments, Grisha and the team discovered that genetic factors essential for HSC
maintenance are highly concentrated within neighboring MSCs. They speculate that if we can con-
trol the niche, we can also manipulate the HSC population within it. This raises the prospect of de-
veloping a drug to target the niche in order to enhance stem cell production. This would be useful
in regeneration therapies or could help to prevent the development of certain leukemias and other
illnesses related to unregulated stem cell proliferation.
Next-Generation Sequencing Enables Team to Find
Cause of Devastating Rare Illness
Professor Gregory Hannon and his talented graduate student Yaniv Erlich—who in 2010
received his Watson School doctorate as well as a prestigious appointment as a Fellow at
the Whitehead Institute—were part of an international team that discovered a genetic
mutation that causes Joubert syndrome, a rare inherited neurological disease found most
often among Ashkenazi Jews. Children whose parents both carry a copy of the mutated
gene, and who inherit a copy from each, develop devastating pathologies including mal-
formation of the brain, developmental delay, and muscular and visual impairment. The
CSHL contribution to the discovery of the mutation’s precise location involved a tech-
nological insight. Rather than sequence the entire genome of patients in search of the ge-
netic culprit, which would be time-consuming and very costly, the team could use a
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powerful genome fractionation method devised by Greg’s team to sequence only those portions of
the genome that encode proteins. This is called the exome, and it consists of less than 2% of the
entire human genetic sequence. This was one of the very first instances in which next-generation
sequencing was used to find the genetic cause of a rare disease and demonstrates that similar methods
can be used to find the causes of other uncommon illnesses that otherwise might not get the atten-
tion that their sufferers so desperately need.
Identifying the (Few) Protein Differences between Neanderthals
and Modern Humans
A closely related sequencing technology enabled Professor Hannon, postdoctoral researcher Emily
Hodges, and others in Greg’s lab to play an important part in a story that Science called one of
2010’s most important. After years of effort, a team led by Svante Pääbo at the Max-Planck Institute
in Germany succeeded in piecing together a draft of the full genome of our Neanderthal predeces-
sors. This was notable in part because the bone fragments from which the DNA was sampled were
so old—approaching 40,000 years. But it was also remarkable because the fragments were highly
corrupted, some containing as little as two tenths of 1% of Neanderthal DNA. One challenge was
how to sift such a tiny portion from the corrupted remainder. This was where the Hannon lab’s
technique called array-capture resequencing proved to be especially useful. They used it to sequence
14,000 genes known to be different in humans and our closest relatives on the tree of life—chim-
panzees. Although about three-fourths of the proteins encoded by those genes are different in hu-
mans and chimps, Greg’s team showed that stunningly few of them differed in humans and
Neanderthals. In fact, they found only 88 amino acid differences, correlating with 83 proteins. In
that register, at least, we are scarcely different from the “cave men.” 
A Gene Variant Is Found to Dramatically Boost Tomato Yields
and Sweetness
Superb basic science gives rise to perspective-altering discoveries such as the one just de-
scribed, but it also leads to insights that have immense practical value. An example can be
found in the work of Assistant Professor Zachary Lippman, who in collaboration with
scientists at Hebrew University in Israel identified a gene that pushes hybrid tomato plants
to increase their yield by as much as 60%. Not only is the yield-boosting power of the
gene—which works when plants make flowers—active in different species of tomatoes
and under a range of environmental conditions, it also can help to boost the yields of
many other flowering crops. The team made the discovery while hunting for genes that
boost hybrid vigor, a property first noted by Charles Darwin and then rediscovered at
CSHL by George Shull a century ago. Hybrid vigor, or heterosis, can be seen when the
breeding of two plant varieties gives rise to a new generation with higher yield than either
of the parental lines. The key to the spectacularly high yields in Zach’s plants was a mutation that
leaves only one active copy (instead of the normal two) of the florigen gene, whose function is to
instruct plants to cease making leaves and begin making flowers, which in turn produce fruit. Zach
tells us, incidentally, that the super-high-yield tomatoes are surprisingly sweet because the florigen
mutation also boost plants’ sugar production.
An Asexual Path to Limitless Food Plant Yield?
A very different approach to boosting yield in food crops is to bypass sexual reproduction altogether.
Indeed, this has been a fantasy of plant breeders for many years. When male and female gametes—
sperm and egg—combine randomly to generate a unique seed during sexual reproduction, valuable
parental traits that have been selected by breeders are erased. A subset of plants does reproduce asex-
ually, however, through a process called apomixis. The offspring of the common dandelion, for in-
stance, are clones of the parent. In 2010, Professor Rob Martienssen collaborated with scientists in
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Mexico to try to coax a flowering plant, the mustard plant Arabidopsis thaliana, to repro-
duce via apomixis. Key to the experiment was shutting down the activity of a protein called
Argonaute 9. By doing this, the team tricked an Arabidopsis ovule into manufacturing
multiple gametes, rather than one. These gametes carried the full complement of genetic
material for the next generation, then, and not half, as is the case when the plant reproduces
sexually. The offspring were, in this sense, clones. Intrigued by the observation that mobile
genetic elements, or transposons, seemed to promote sexual reproduction, it seemed logical
to Rob and colleagues to find a molecule that could silence transposons—Argonaute 9 is
one—and determine whether it inhibited sexual reproduction. They succeeded. The trick
now will be to detect whether this approach works in other plants that reproduce sexually
and then specifically in the subset on which we rely for food. 
A Protein Critical for Activating DNA Replication
My own research group discovered how a protein called DDK, an essential activator of DNA repli-
cation, actually triggers DNA replication in cells. DDK (for Ddf4-dependent protein kinase) is an
enzyme that attaches phosphate molecules to other proteins to modify their activity. We found that
it performs this operation, called phosphorylation, on a protein called Mcm4, specifically within a
domain that acts as a built-in brake to prevent the DNA double helix from being unwound. The
phosphorylation by DDK releases this brake, thus initiating the replication of unwound DNA
strands. Because DDK is often deregulated in human cancers, this new understanding of its role in
DNA replication may help to shape the development of new cancer therapies. Indeed, anti-DDK
drugs have recently been introduced into the clinic. The discovery of this self-inhibitory activity
within Mcm4 and the finding that DDK is required to overcome it were a surprise. It leads us to
ask, why such complexity? We suspect that it might have evolved in response to the importance of
precision and accuracy in DNA replication. This fits with the broad picture that we have assembled
over the years of how replication is coordinated and controlled by kinase proteins. 
Cold Spring Harbor Laboratory Board of Trustees
The Board of Trustees, which includes up to 35 members, meets in full, executive, and other com-
mittee sessions numerous times throughout each year to perform its duties as the governing body
of the institution. Many significant developments related to board leadership occurred this year and
deserve mention.
On behalf of the board, I would like to thank Eduardo G. Mestre, who served on the board since
2001 and was Chairman from 2004 to 2010. With Eduardo’s leadership during the first decade of
the 21st century, CSHL achieved unprecedented growth and expansion in infrastructure and pro-
grams. Serving on committees ranging from Capital Campaign, Executive, Nominating, Research,
and Robertson Research Fund, he challenged fellow trustees and the
leadership of the Laboratory to think strategically. As a result, we were
able to prevail in the face of significant external challenges that threat-
ened support for basic research across the country. I am pleased that
he will remain associated with CSHL as an honorary trustee.
On November 6, 2010, the board elected a new Chairman, Jamie
C. Nicholls, and new slate of officers: Vice Chairs Robert D. Lindsay,
comanaging partner Lindsay Goldberg, and Marilyn Simons, President
of The Simons Foundation; Treasurer Leo Guthart, CEO of Topspin
Partners; and Secretary Ed Travaglianti, President of TD Bank, Long
Island. I look forward to working closely with Jamie, who, as CSHL
Treasurer since 2009, has demonstrated her unique ability to translate
her business expertise to the nonprofit, academic world. 
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Four new trustees were elected to the CSHL Board of Trustees this year: Tania Baker, Howard
Hughes Medical Institute Investigator, E.C. Whitehead Professor, and Codirector of the biology
graduate program at Massachusetts Institute of Technology; David Boies, Chairman of the law firm
Boies, Schiller and Flexner LLP; Howard Morgan, President of Arca Group Inc. and Director of
Idealab; and Dinakar Singh, founding partner of TPG-Axon Capital.
Thank you Lola N. Grace, Vice Chairman from 2004 to 2010, for your enduring commitment
to CSHL. Lola retired from the Board this year and was elected an honorary trustee. Lola served on
the Board of Trustees since 1995, playing an active part as a member of many committees and pro-
viding leadership as an officer since 1998. 
We also extend our affection and gratitude for devoted service to retiring trustees Kristina Perkin
Davison (2002 to 2010) and Laurence F. Abbott (2004 to 2010). 
Two dear friends and former trustees passed away this year. We fondly remember George W. Cut-
ting, Jr. and Charles E. Harris III, who both contributed in unique and generous ways to the growth
of CSHL’s research and education programs. “Butch” Cutting was instrumental in the formation of
the Long Island Biological Association, which was later named the CSHL Association. Butch served
on the CSHL Board of Trustees from 1986 to 1993. Charlie served on the Board from 1998 to 2004
and was a founder of the President’s Council, created to support the CSHL Fellows program. 
CSHL Association
Thank you to the Cold Spring Harbor Laboratory Association (CSHLA) active leadership team of
President Tim Broadbent and 25 elected directors, who organized events and letter-writing cam-
paigns to raise $5.6 million of unrestricted funds in support of early-career scientists at CSHL. 
This year, more than 140 women gathered at Peacock Point, an exclusive enclave of Long Island’s
Gold Coast, for the Women’s Partnership for Science lecture and luncheon: “Autism: Breaking the
Code.” The speaker, Alea Mills, Ph.D., has received numerous awards for her work in the field of
cancer research and has recently turned her expertise in molecular biology toward understanding
the genetic basis of autism. Alea spoke about her recent success in generating a novel mouse model
with a chromosomal abnormality that is frequently found in children with autism. These mice,
which demonstrate the unique behavioral features of humans with autism, are the subjects of intense
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research in her lab as well as with a team of neurobiologists at CSHL. In its 9th year, the event
started by Kristina Perkin Davison has raised more than $500,000 to benefit the research of CSHL’s
female investigators. 
Other friend-raising and fund-raising events initiated by the CSHLA directors included hosting
a Regional Junior Chess Tournament and a Major Donor Reception in Old Westbury at the home
of Cornelia Guest. 
Research Faculty 
Awards 
Professor and Neuroscience Program Chair Tony Zador was awarded a prestigious $2.17 million
Transformative Research grant by the National Institutes of Health. He will use the 5-year research
grant to analyze the connectome—the brain’s wiring—and determine how its disruption
leads to diseases such as autism.
Tony also received one of seven Distinguished Investigator grants from the Paul G. Allen
Family Foundation. These—the first of their kind—are part of a program launched by the
Foundation to advance important neuroscience and cellular engineering research. Tony,
whose grant totals $1.6 million, proposes to develop a highly efficient method for deter-
mining the neural wiring diagram for any genetically accessible organism, a crucial require-
ment for understanding how the brain functions.
Assistant Professor Adam Kepecs was named a John Merck Scholar and received a
$300,000 research grant to develop new technologies that would help to reveal the role of
the cholinergic nervous system in cognitive tasks involved in learning and attention.
Adam also won recognition in the fall as a finalist for the Eppendorf and Science Prize
in Neurobiology. The award recognizes outstanding international neurobiological research
by a young, early-career scientist, as described in a 1000-word essay based on research per-
formed within the last 3 years. Dr. Kepecs’s essay, entitled “Are you certain? The neural
basis for decision confidence,” is available online at www.sciencemag.org.
Assistant Professor Raffaella Sordella received the 2010 Damon Runyon–Rachleff In-
novation Award to carry out bold, high-risk research to determine the molecular basis of
cancer drug resistance and strategies to overcome it, a result that could provide life-chang-
ing benefits for a large number of cancer patients.
In November, Genome Technology asked researchers in the field of systems biology to
identify its rising stars. Three of the 24 rising stars on the list were from CSHL. Two are
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recent WSBS graduates: Yaniv Erlich, for work in “Fast-Paced Bioinformatics,” and
Nicholas Navin, for work in “The Evolution of Cancer Tumors.” Assistant Professor
Michael Schatz was recognized for his work on “Genome Assembly and the Cloud.”
I was honored to receive the 2010 Louisa Gross Horwitz Prize from Columbia Univer-
sity with Thomas J. Kelly, M.D., Ph.D., of Memorial Sloan-Kettering Cancer Center, for
our work in elucidating mechanisms involved in the process by which DNA—the genetic
material contained within the nucleus of nearly all our cells—replicates itself. Tom and I
are proud to have contributed to understanding the way cells work in humans and to have
shed light not only on the duplication of normal cells, but also on how the process goes
awry in cancer.
New Staff
Fritz Henn, Professor, joined CSHL from neighboring research institution Brookhaven
National Laboratory (BNL), where he oversaw the biology and medical departments
and performed research, often using sophisticated imaging techniques, that has con-
tributed to our knowledge of how the brain functions, particularly in the field of de-
pression. Fritz earned a Ph.D. in physiological chemistry from The Johns Hopkins
University in 1967 and an M.D. from the University of Virginia in 1971. He performed
his residency in the Department of Psychiatry at Washington University School of Med-
icine from 1971 to 1974. He began his career at the University of Iowa College of Med-
icine, and, in 1982, he joined Stony Brook University (SBU), where he became Professor
and Chair of the department of psychiatry and behavioral medicine. Following an ex-
tensive period in Heidelberg, Germany, Fritz returned to the United States as Deputy
Director of BNL before accepting a professorship at CSHL. He has collaborated with
Assistant Professor Bo Li.
Anne Churchland, Assistant Professor, joined CSHL after completing her doctorate at
University of California, San Francisco, and postdoctoral research in a primate lab at the
University of Washington, Seattle. Shifting from primate research to rodent research, she
will be studying the circuitry underlying multimodal decision-making, in which animals—
rodents—gather evidence from multiple sources, for instance, aural and visual, before
making a decision. 
Molly Hammell, Assistant Research Professor, comes to CSHL after 5 years as a research
associate in genetics and genomics under Victor Ambros at the University of Massachu-
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setts. At CSHL, she is applying prediction algorithms to problems in cancer research. She is also
Manager of the CSHL Cancer Center’s Bioinformatics Shared Resource.
Chris Hammell, Assistant Professor, did his doctoral work at Dartmouth College and his post-
doctoral work in the lab of Victor Ambros at the University of Massachusetts. There, he became in-
terested in the machinery that prepares microRNAs to target specific genes, which they in turn
regulate. Using Caenorhabditis elegans and forward genetics, he continues to focus on how mutations
in this machinery could perturb a given microRNA’s gene-regulatory activity so as to give rise to a
developmental timing defect and set in motion a chain of events culminating in human illness. 
Justin Kinney was named our second Quantitative Biology Fellow. He earned his doctorate in
physics from Princeton University and spent the last 2 years in postdoctoral fellowships at Princeton
and at CSHL, applying his quantitative skills to biological problems. As a Fellow, he will focus on
the question of how sequences of very specific regions in the genome interact with proteins to execute
gene expression. He seeks to characterize the sequence–function relationship quantitatively.
Michael Schatz, Assistant Professor, developed methods for large-scale computational analysis of
DNA sequencing data at the University of Maryland. He is known for his pioneering use of cloud
computing for genomics and for the last several years has helped to run a large National
Science Foundation cloud computing project. His research at CSHL will focus on meta-
genomics—trying to understand individual genomes within a larger genomic context—
and on genome assembly and validation projects.
Hongwu Zheng, Assistant Professor, earned his Ph.D. in biochemistry at Boston Uni-
versity and completed postdoctoral studies at Harvard Medical School. He focuses on
glioblastoma, a brain cancer with a poor prognosis. He uses mice to recapitulate genetic
and epigenetic aspects of the cancer and approaches the problem from a developmental
perspective. Hongwu is exploring ways to resolve differentiation in cells as a method of
halting tumor progression.
Promotions
Congratulations to Dinu Albeanu, who was appointed Assistant Professor. Nicholas Navin was pro-
moted to the position of Research Investigator in the laboratory of Michael Wigler. Dan Levy was
promoted to the position of Senior Computer Scientist.
Departures
CSHL is proud of our long history as an incubator for early-career researchers who go on to suc-
cessful careers all over the world. In 2010, Matthew Vaughn became a Research Associate at Texas
Advanced Computing Center in Austin. Sheldon McKay took on the job of Scientific Lead, En-
gagement Team, iPlant Collaborative at the University of Arizona, Tucson. Professor Michael Zhang
moved to Dallas to become Director of the Center for Systems Biology, department of molecular
and cell biology, University of Texas, Dallas. 
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Education Programs
Watson School of Biological Sciences
In the National Research Council (NRC)’s latest assessment of 5000 doctoral programs
across 62 fields at 212 universities nationwide, the Watson School of Biological Sciences
(WSBS) was ranked between third and 17th across 20 cumulative categories. In the category
of citations per publication, CSHL ranked first. The NRC assessment is performed over
the period of 10 years, and so this is the first opportunity that the WSBS program has had
to be included in this national evaluation. 
Ten WSBS students, all of whom matriculated between 2004 and 2006, received their
Ph.D.s at the 2010 WSBS Commencement Convocation in April. 2010 graduate Yaniv Er-
lich won the Fred Hutchinson Cancer Research Center’s Harold M. Weintraub Graduate
Student Award for outstanding achievement during graduate studies. 
Honorary degrees were conferred upon Carla Jo Shatz, Ph.D. and Thomas R. Cech,
Ph.D. Dr. Cech is a Nobel laureate and pioneer in the study of RNA enzymes and telomerase and
was recently President of the Howard Hughes Medical Institute. Dr. Shatz, whose research has
helped to establish some of the basic principles of early brain development, is Professor of biology
and neurobiology and Director of the Bio-X program at Stanford University School of Medicine.
She was also an instructor in our neuroscience advanced courses program.
The 2010 Gavin Borden Visiting Fellow Lecture was presented on March 15 by Dr. Gerald F.
Joyce, Dean of the Faculty, Professor, Departments of Chemistry and Molecular Biology, and In-
vestigator, The Skaggs Institute for Chemical Biology, The Scripps Research Institute. The title of
the 16th annual CSHL Gavin Borden lecture was “The Origin of Life in the Laboratory.”
Meetings and Courses
On April 6, CSHL celebrated the opening of Cold Spring Harbor Asia Conferences in Suzhou,
China, a meetings program that aims to be the premier hub for scientists throughout Asia who are
exploring the frontiers of molecular biology, biomedicine, and biotechnology. The program kicked
off with the first James Watson Cancer Symposium, organized by leading scientists representing im-
portant current areas of research: Dr. Xiaodong Wang, a Howard Hughes Medical Institute Inves-
tigator affiliated with the University of Texas Southwestern Medical Center and the National
Institute of Biological Sciences, Beijing; Dr. Scott W. Lowe of HHMI and CSHL; Dr. Yusuke Naka-
mura of the University of Tokyo; Dr. Tak Mak of the University of Toronto; and Dr. Karen Vousden
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of the Beatson Institute for Cancer Research in the United Kingdom. This 6-day meet-
ing was followed by the first Francis Crick Neuroscience Symposium, which was sim-
ilarly organized by leaders in the field: Dr. Z. Josh Huang of CSHL; Dr. Mu-ming
Poo of the CAS Institute of Neuroscience, Shanghai and the University of California,
Berkeley; Dr. Linda Richards of the University of Queensland, Australia; Dr. Joshua
Sanes of Harvard University; and Dr. Keiji Tanaka of the Laboratory for Cognitive
Brain Mapping, Riken, Japan. In all, the new CSHL Asia program, which operates
from a 600,000-square-foot facility—the Suzhou Dushu Lake Conference Center—
hosted 10 meetings and more than 2000 scientists from around the world, but pri-
marily from Pacific Rim countries. 
Suzhou is only 60 miles west of a “megacity” even larger than New York—the economic power-
house of Shanghai, population 20 million. Importantly, the new conference center is less than an
hour by high-speed rail from Shanghai and, served by two regional airports, is only a 2- to 3-hour
plane ride from Japan, South Korea, Taiwan, and Hong Kong. Singapore and Sydney, Australia,
are, respectively, 5 and 10 hours distant by air.
This year marked the 75th anniversary of the Cold Spring Harbor Laboratory Symposia on
Quantitative Biology. The 2010 Symposium, with close to 70 talks and attendance of more than
400 scientists, was organized by Terri Grodzicker, David Spector, David Stewart, and me. It focused
on the topic of Nuclear Organization and Function. To celebrate the history of the symposia, Jan
Witkowski, Jim Watson, and I organized a special 1-day event chaired by Robert Tjian, CSHL
alumnus and President, Howard Hughes Medical Institute, called “Biology, Society, and the Future.”
More than 225 guests attended the lectures presented by world experts including Charles Sawyers,
Memorial Sloan-Kettering Cancer Center; Spencer Wells, National Geographic Society; Henry
Louis Gates, Harvard University; Mark Bear, Massachusetts Institute of Technology; Story Landis,
National Institute of Neurological Disorders & Stroke; Peter Neufeld, The Innocence Project; Craig
Venter, J. Craig Venter Institute; and Richard Roberts, New England BioLabs, Inc.
The Symposium on Quantitative Biology has become the cornerstone for our annual program
of Meetings and Courses, which in 2010 posted record attendance. A total of 7500 researchers from
around the globe attended meetings, and more than 1300 attended training courses on our Long
Island campuses. A new experimental laboratory teaching suite funded by the Howard Hughes Med-
ical Institute was opened in our Hillside Laboratories complex. 
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Dolan DNA Learning Center
In its second year of operation, the Harlem DNA Lab made significant strides in reaching under-
served students and teachers in New York City schools. The statistics speak for themselves: 75% of
the 6400 precollege students that attended field trips to the Harlem DNA Lab were African Amer-
ican or Latino; 75% of students attending the Harlem DNA Lab came from Title 1 schools, where
40% or more of students are considered low income. 
CSHL’s DNA Learning Center led by David Micklos also won acclaim for the success of its
iPhone app, “The 3D Brain.” With 50,000 downloads, it reached no. 7 among education apps for
the iPhone and no. 1 of educational iPad apps. 
Cold Spring Harbor Laboratory Press
Since 1933, the CSHL Press has continuously evolved and adapted its publications to best
serve the contemporary needs of the scientific community. This year, John Inglis’ team
launched a new initiative, CSH Perspectives in Biology, a monthly online publication comprising
reviews spanning the complete spectrum of the molecular life sciences. This new venture is in-
tended to provide the life sciences community with authoritative analyses of progress in emerg-
ing areas of molecular, cell, and developmental biology, genetics, evolutionary biology,
neuroscience, cancer biology, and molecular pathology. The contributions are written by lead-
ing researchers in each field and commissioned by a board of eminent academic editors. Subject
Collections gradually accumulate articles as new issues of the journal are published and, when
complete, each represents a comprehensive survey of the field that it covers. 
Development
More than 60 CSHL supporters participated in the Fall President’s Council retreat, the 16th year
of this event. Participants donated more than $25,000 to support early-career scientists in pursuit
of the most promising and innovative research projects. The 2-day retreat immerses these generous
philanthropists in the hottest topics in science. This year’s event, organized by Diane Fagiola, tackled
“The Science of Nanomedicine,” with a keynote on the applications of nanotechnology in medicine
by Bob Langer, David H. Koch Professor at the Massachusetts Institute of Technology. Other experts
included Harvard Professor George Whitesides, University of North Carolina chemistry department
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head Joseph DiSimone, and Dr. William Sherman of Brookhaven National Laboratory’s Center for
Functional Nanomaterials.
For the fifth year, 400 guests gathered in early November at the Mandarin Oriental Hotel in
Manhattan to honor recipients of the Double Helix Medal—extraordinary individuals who have
benefited human health through game-changing biomedical research or by raising awareness and
funds for such endeavors. Geneticist Mary-Claire King was honored for outstanding contributions
toward understanding the genetics of breast cancer and mental illness. Evelyn H. Lauder received
the Medal for her leadership as the Founder and Chairman of The Breast Cancer Research Foun-
dation, which has raised more than $300,000 million to support breast cancer research worldwide.
Nobel laureate in Economic Sciences John F. Nash was awarded the Medal for having brought
worldwide awareness to and appreciation for people suffering with schizophrenia. The gala event,
produced by Charlie Prizzi’s team in the development department, raised more than $3 million. A
special feature of this event was a musical performance by composer Carter Burwell, whose biography
includes a 2-year stint as Chief Computer Scientist at CSHL. 
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CSHL received Charity Navigator’s coveted four-star rating for sound fiscal prac-
tices, placing CSHL among the most fiscally responsible of more than 1.5 million phil-
anthropic organizations that currently exist in America. This is the ninth consecutive
year that CSHL has achieved this top ranking. 
Infrastructure Projects
In June, members of the CSHL community celebrated the completion of an expansion
and renovation of the Carnegie building, which dates to the institution’s infancy in
1905. In addition to a new state-of-the-art climate-controlled vault for storage of pre-
cious archival collections that trace the history of molecular biology and genetics, the updated build-
ing now also boasts an annex, named for CSHL alumnus and benefactor Waclaw Syzbalski, Ph.D.
Joining us at the opening ceremony was Nobelist Sydney Brenner, who generously donated his
archives to CSHL this year.
In November, Art Brings and the facilities department began a project to replace a structure that
was originally constructed in 1906 as a green house and potting complex. This structure, which was
ultimately named the Hershey Laboratory, after Nobel Prize–winning CSHL scientist Alfred Her-
shey, was renovated in 1979 to provide offices and to support research activities. The new building
currently under construction will be ~18,000 square feet and will house a teaching lab, a seminar
room, and a computer classroom for the Laboratory’s Meetings and Courses program. It will also
be home to the CSHL Cancer Center Shared Resources Flow Cytometry and Microscopy facilities,
which have been temporarily moved to the Hillside Laboratories. The Howard Hughes Medical In-
stitute provided $9 million for this project. 
CSHL’s Sammis Hall, designed by the noted postmodernist architect Charles Moore, was fea-
tured in the Heckscher Museum’s exhibit, “ARCADIA/SUBURBIA: Architecture on Long Island,
1930–2010.” This dormitory residence on the grounds of the Banbury Conference Center was a
stop on the house tour associated with the exhibit. 
Community Outreach
In celebration of National Lab Day, Professor Gregory Hannon opened the doors of his three-story
laboratory building named for Nobelist Barbara McClintock to more than 150 fifth and ninth
graders from Long Island and Manhattan schools. With help from his graduate students and post-
docs, the visiting children learned to use microscopes to identify lung cancer cells and fruit fly neu-
rons, among other lessons. Greg also spoke about his research endeavors at the February meeting of
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the Secret Science Club in Brooklyn, a monthly gathering of ~400 science enthusiasts primarily
from New York City. 
CSHL’s Partners for the Future program continues to recruit the brightest of Long Island’s bud-
ding scientists. This year, seven seniors from high schools across Long Island were accepted into the
program, giving them daily access to a CSHL mentor and a laboratory in which to conduct a research
project of their own. The students devote a large part of their year to working in a laboratory and
learning what it is like to be a researcher. At the end of the school year, the students present their
findings in a scientific seminar in Grace Auditorium. This year, three students working on cancer-
related research projects took an additional step, taking the time to translate their scientific presen-
tations for the public and the media. We offer thanks to the American Cancer Society for partnering
with us to publicize this as part of its local Relay For Life events.
Spearheaded by Amanda McBrien, Assistant Director of Instruction at
the DNALC, CSHL cohosted a National DNA Day scavenger hunt with
local museums and merchants in Cold Spring Harbor village. More than
200 area residents participated in the weekend event celebrating the sto-
ried history of the village. April 25 is congressionally designated as Na-
tional DNA Day, commemorating the completion of the Human
Genome Project in April 2003 and the discovery of the double helix struc-
ture of DNA in 1953. Each year, the National Human Genome Research
Institute encourages national participation in the creation of opportunities
for students, teachers, and families to explore the latest developments in ge-
nomic research. 
The Harlem DNA Lab Instructor Ileana Rios and a banana DNA extrac-
tion experiment have become a regular attraction at the World Science Fes-
tival Street Fair in Manhattan. CSHL is pleased to have been able to
participate once again in this event, which engages many thousands of New
York City residents in the celebration of science for a week each June.
Thanks to our students and postdocs who make our CSHL tour program
such a success. This year, our tour guides hosted 500-plus visitors. The 2-
hour walking tours showcase the history of our science, research, and edu-
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cation programs. Participants also experience the beauty of the cam-
pus’ architecture and landscapes.
The CSHL DNA Learning Center’s public programs continue to
be a hit in the community. During the school year, the DNALC
opened its doors on Saturdays for “Saturday DNA,” geared to middle
and high school students and their parents. During the summer
months, more than 900 students in grades 5 through 12 attended
week-long camp sessions, on topics ranging from “Fun with DNA” and “World of Enzymes” to
“Forensic Detectives” and “Silencing Genomes.”
We are thankful for the partnerships that we have with local organizations with whom we interact
in many different ways throughout the year. This year, Assistant Professor Hiro Furukawa lectured at
a meeting of the Alzheimer’s Association of the Long Island Board. We hosted a lecture and tour for
the Leukemia & Lymphoma Society board of directors, at which Chris Vakoc spoke. Diane Esposito,
Research Investigator in Mike Wigler’s laboratory, was an invited speaker on breast cancer research for
three different occasions, which were sponsored by the Suffolk County Women’s Bar Association, the
Women’s Center of St. Francis Hospital, and the Adelphi N.Y. Statewide Breast Cancer Program.
CSHL representatives cheered on participants in the LI2Day Walk and judged the organization’s an-
nual scholarship program. We were also well represented at a local Swim Across America event. We
thank these and many other partners who support CSHL through grants and donations. 
For details on grants and philanthropic donations received this year, please refer to separate sec-
tions of this report. In addition, please visit our newly designed public website, www.cshl.edu for
all of the latest news and information about the institution, including electronic access to annual
reports, the Harbor Transcript magazine, links to stories about us in the media, and postings about
research results and education program achievements. 
Public Lectures at Cold Spring Harbor Laboratory
March 21—Roger Reeves, Ph.D.: “Theory to Therapeutics in Mice and Men with Down Syn-
drome,” cosponsored by CSHL, the Association for Children with Down Syndrome, the Down
Syndrome Connection of Long Island, and the National Down Syndrome Society.
April 26—Thomas R. Cech, Ph.D., Distinguished Professor, University of Colorado-Boulder; In-
vestigator, Howard Hughes Medical Institute; winner, Nobel Prize in Chemistry, 1989: “Learning
to Teach, Teaching to Learn.”
June 8—Alea A. Mills, Ph.D., CSHL Associate Professor, with Nikita
Anand, Cold Spring Harbor High School, Norah Liang, Patchogue-Med-
ford High School, Joshua Weiss, Smithtown High School East: “Next-Gen-
eration Cancer Research: Long Island Teens on the Front Line of Discovery.”
June 29—Sydney C. Gary, Ph.D., CSHL Director, research operations;
Adam Kepecs, Ph.D., CSHL Assistant Professor; Stephen Dewey, Ph.D.,
The Feinstein Institute of Medical Research; Edward Nunes, M.D., Profes-
sor of clinical psychiatry, Columbia University: “Addiction: How the Brain
Measures Reward and Response,” cosponsored by CSHL, the North Shore–
Long Island Jewish Health System, and St. Johnland Nursing Center.
September 26—Steven Allen, M.D., Associate Chief of Hematology,
North Shore-LIJ; Johannes Zuber, M.D., CSHL Clinical Research Fellow; Christopher Vakoc,
M.D., Ph.D., CSHL Fellow: “Hitting Leukemia Where It Hurts: Researchers and Physicians Unite
to Knock Out Cancer,” cosponsored by CSHL, The Don Monti Memorial Research Foundation,
and the North Shore–Long Island Jewish Health System.
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Looking Forward
As we began 2010, our efforts in strategic planning prepared us for a challenging year. We accomplished
so much in the face of many external challenges, and this was possible because of the dedication of our
more than 1000 employees to excellence in research, education programs, and operations. No doubt,
we will continue to face direct challenges related to the recovering economy and leadership changes in
federal and state governments, but I am convinced that our continued commitment to excellence will
help us to navigate and ultimately prevail. Thanks to all of you who work for and with CSHL.
    Bruce Stillman, Ph.D., F.R.S.
    President
November 14—Nancy Berlinger, Deputy Director and Research Scholar
at The Hastings Center: “Ethics of Hope in End-of-Life Care,” The Lor-
raine Grace Lectureship on Societal Issues of Biomedical Research (can-
celled due to a sudden unavoidable conflict).
As the Internet continues to evolve, it offers more opportunities for
our researchers to speak to the public online. A web magazine,
BigThink.com, this year featured interviews of four of CSHL’s finest. In-
terviews are accessible on demand if you visit www.bigthink.com and
search for our “experts”: James D. Watson, Michael Wigler, Tony Zador,
and Adam Kepecs.
Public Concerts at Cold Spring Harbor Laboratory
22 Highlights of the Year
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February 16: Peter Orth, pianist
March 19: Ran Dank, pianist
April 24: Carducci String Quartet
May 7: Soo Bae, cellist
May 21: Einav Yarden and Sergey 
Ostrovsky, pianist and violinist
September 3: Di Wu, pianist
September 24: Hahn-Bin, violinist
October 8: Diane Walsh, pianist
October 29: Aaron Goldberg Trio
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This was a year of steady progress for the Laboratory. Although there are substantial
challenges on the horizon, we take some comfort from the continued recovery in the
financial markets since the 2008 debacle, and the resumption of growth, albeit
painfully slow, of the U.S. economy. 
What keeps Cold Spring Harbor Laboratory’s culture so dynamic and invigorating
is a sense of constant renewal. As we have absorbed and populated the new Hillside
Campus buildings, 11 dynamic new faculty members with diverse research concen-
trations have joined our community during the last 18 months. Add to this a new
class of Ph.D. students at the Watson School, our usual complement of 8000 Meeting
and Course attendees, and new scientific publications from the Laboratory Press,
and we end up with a unique brew of intellectual capital. Our campus landscape
continued to evolve as well, with the groundbreaking construction of the new Her-
shey Building, made possible by a generous grant from the Howard Hughes Medical
Institute.
It is gratifying to see the asset value of the Laboratory’s endowment fund approaching its pre-2008
high watermark. This growth is made possible by a relatively conservative annual spending policy, new
donations, and capital appreciation. The investment return for the 2010 calendar year was a positive
10.25% bringing the total value of the fund up to $283 million at year end—this following 20%
annual appreciation in 2009. During the last two years, the Investment Committee of the Board of
Trustees has sought to reduce the level of risk and volatility in the portfolio by increasing exposure to
conservative and proven hedged equity, absolute return, and international equity managers. Although
this might cause performance to be slightly below equity indices in bull markets, it should serve the
portfolio well over time by providing a prudent balance of capital preservation and growth.
For the fiscal year ending 12/31/10, the Laboratory operating budget reached approximately $147
million—an increase of 14% over the prior year. The substantial revenue growth was largely reflective
of compelling research resulting in high success rates with both private and public grant applications.
Although this is excellent news, there are caveats of which we must be mindful. Of the federal grant
awards received by our investigators, 9% came from funding made available through the American Re-
covery and Reinvestment Act. These “stimulus” funds, although welcome, are temporary in nature and
will not continue beyond 2 years. Of greatest concern is the uncertainty about the future of federal
funding for research as the U.S. government struggles with massive deficits and partisan political grid-
lock. We did achieve our goal of achieving cash-neutral operating results in 2010 after netting depreci-
ation expense against expenditures for capital improvements. However, this was partially achieved by
drawing down on the fund for “research start-up” that was prudently raised as part of the $200 million
Hillside Campus campaign completed in 2008. This fund is scheduled to be fully spent by 2016. As
always, we maintain a lean administration and devote great attention to diligently managing expenses. 
The challenges ahead are daunting. Doing cutting-edge research is expensive. Recruiting and retaining
the best and brightest investigators while investing in state-of-the-art laboratory equipment and computing
infrastructure demands tremendous resources. It is highly likely that the Laboratory will be forced to
maintain its level of excellence with less funding from the federal government. We are fortunate to have
such a substantial level of private support, but we will need to increasingly rely upon it in the future. 
Most importantly, we are inspired by the Laboratory’s mission and the work going on around
us. And we are ever grateful to our supporters and our loyal staff.
Dill Ayers
Chief Operating Officer
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Long-Term Service
Front row (left to right) Alyson Kass-Eisler, Linda Rodgers, Maureen Davies, Barbara Matusik, Madeline Wisnewski, Lisa Manche, Barbara 
Purcell, Leemor-Joshua Tor; top row (left to right) Edward Campodonico, Bruce Stillman, William Bishop, Barry Burbach, James Watson, 
Susan Schaefer, Ronald Romani, Giuditta Carino, Andrea Stephenson, Benjamin Veneable, Mona Spector, Bruce Fahlbusch, Nora Ruth, 
David Spector, Joshua Dubnau
The following employees celebrated milestone anniversaries in 2010:
40 Years Madeline Wisnewski
30 Years Bruce Fahlbusch, Linda Rodgers, Andrea Stephenson
25 Years Frank Carberry, Lisa Manche, David Spector
20 Years Edward Campodonico, Clare Clark, Beicong Ma, George Newell, 
Natalia Peunova, Barbara Purcell, Ronald Romani, Yew Teo, Nicholas Tonks
15 Years William Bishop, Barry Burbach, Giuditta Carino, Kenneth Chang, 
Jodi Coblentz, Maureen Davies, Joshua Dubnau, Leemor Joshua-Tor, 
Alyson Kass-Eisler, Scott Lowe, Barbara Matusik, Mary Muno, Nora Ruth, 
Susan Schaefer, Mona Spector, Benjamin Veneable, Claudia Zago
25
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See previous page for photos of the following scientific staff:
Row 1: W. Li (Mills lab); R. Solomon (McCombie lab); A. Tolpygo (Mitra lab); 
S. Weissmueller (Lowe lab)
Row 2: S. Schuck (Stenlund lab); P. Thekkat, A. Rosebrock, F. Karginov, J. Preall (Hannon 
lab); K. Creasy (Martienssen lab); C. Johns (Gingeras lab)
Row 3: M. Vigliotti (Lucito lab); A. Mofunanya (Powers lab); Z. Glass (Enikolopov lab); 
N. Simorowski (Furukawa lab)
Row 4: S. Das (Krainer lab); B. Boivin, X. Zhang (Tonks lab); K. Jiang (Lippman lab); 
J. Milazzo (Lazebnik lab)
Row 5: E. Plavskin (Timmermans lab); M. Rossman (Stillman lab); T. Schalch (Joshua-Tor 
lab); M. Mahdavi (Dubnau lab)
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Gene regulation and cell proliferation focuses on the regulation of gene expression, cell-division cycle
control, and chromosome structure in normal and cancer cells.
Through forward genetic approaches in C. elegans, Christopher Hammell and colleagues have
identified a variety of gene products that modulate the efficacy of and/or regulate the activity of
core microRNA (miRNA) machinery. miRNAs are RNAs ~22 nucleotides in length that negatively
and specifically regulate mRNA expression by binding to complementary sequences on their targets.
Hammell’s efforts have resulted in identification of a novel, highly conserved family of proteins
called TRIM-NHLs that physically associate with the molecular complex (called miRISC) through
which miRNAs induce gene silencing. These proteins, together with particular miRNAs, function
to regulate animal development. In addition to TRIM-NHL proteins, the team has used classical
genetic approaches to identify other regulatory components that tailor miRNA function (via re-
sponding to other developmental cues or physiological signals) to specific genetic pathways and/or
cell types. Because most of the components identified in these screens are highly conserved, the lab
uses model systems including Drosophila, mouse, and human to understand how these proteins work
at the molecular level.
Leemor Joshua-Tor’s lab studies the molecular basis of nucleic acid regulatory processes by using
the tools of structural biology and biochemistry to examine proteins and protein complexes associ-
ated with these processes. They use X-ray crystallography to obtain three-dimensional structures of
individual proteins. Biochemistry and molecular biology enable them to study properties that can
be correlated with protein structure and function. It was Joshua-Tor and her team that first obtained
the structure of a full-length Argonaute protein, work that instantly solved a long-standing puzzle
in the RNAi field. By observing the structure, they realized that Argonaute was the long-sought
Slicer, which performs the critical slicing event in RNAi, cleavage of the mRNA. Joshua-Tor is also
well known for her work on the helicase enzyme, which acts to unwind DNA strands during the
DNA self-replication process.
Adrian Krainer’s lab studies the mechanisms of RNA splicing, the ways in which they go awry
in disease, and the means by which faulty splicing can be corrected. Their approach has borne fruit
in the study of spinal muscular atrophy (SMA), a neuromuscular disease that is the leading genetic
cause of death in infants. Their ability to correct an mRNA splicing defect in SMA that makes a
gene called SMN2 only partially functional forms the basis of a potentially powerful therapeutic
approach. Last year, the team identified a compound that stimulates SMN protein production by
altering RNA splicing. This year, they demonstrated its efficacy. By introducing chemically modified
pieces of RNA called antisense oligonucleotides (ASOs) into the spinal cords of mice, they succeeded
in reversing symptoms of Type III SMA. The lab’s expertise in splicing has also helped to shed light
on the abnormal glucose metabolism of cancer cells, sometimes referred to as the Warburg Effect.
Krainer and colleagues this year described for the first time how three molecular splicing factors
contribute to high levels of PK-M2, an isoform of pyruvate kinase and a key mediator of glucose
metabolism in cancer cells. 
David L. Spector’s lab studies the spatial organization and regulation of gene expression. Their
in vivo approach is exemplified in a live cell gene expression system that has made possible the ex-
amination in real time of the recruitment of members of gene expression and silencing machineries.
A current research focus is the distribution and dynamics of nuclear Polycomb complex proteins,
known to keep genes in a silent state. The team seeks to target them to segments of DNA as a means
of selectively silencing specific genes. Another focus is the study of long noncoding RNAs (ncRNAs)
retained in the nucleus, whose functions are still mostly unknown. This year, Spector and colleagues,
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using three-dimensional live cell imaging, discovered that the formation of a type of nuclear sub-
compartment called the paraspeckle is triggered by a pair of RNA molecules, which also maintain
its structural integrity. The team uncovered this unique structure-building role for the RNAs by
keeping a close watch on them from the moment they came into existence within a cell’s nucleus.
This revealed that when the genes for these RNAs are switched on, and the RNAs are made, they
recruit other RNA and protein components and serve as a scaffolding platform upon which the
components assemble to form paraspeckles. Paraspeckles have a role in regulating the release of cer-
tain protein-coding mRNAs from the cell nucleus.
Arne Stenlund and colleagues have obtained a detailed understanding of processes required for
initiation of DNA replication from the papillomaviruses, using this system to gain a general bio-
chemical understanding applicable in other systems. Papillomaviruses are a large viral family that
induces cell proliferation at the site of infection, usually giving rise to benign tumors. But certain
types of human papillomaviruses (HPVs) generate tumors that progress toward malignancy. Among
these are HPVs that cause most cervical cancers. Members of the Stenlund lab also pursue studies
aimed at developing an effective small-molecule inhibitor of HPVs that might someday be used by
women who do not receive the preventive anti-HPV vaccine now available, or those already infected
with HPV who would not be helped by the vaccine.
Bruce Stillman’s lab studies the process by which DNA is copied within cells before they divide
in two. Working with yeast and human cells, Stillman and colleagues have identified many of the
cellular proteins that function at the DNA replication fork during the S phase, the portion of the
cell division cycle when DNA synthesis occurs. Among these proteins are those that facilitate the
assembly of chromatin, the protein–DNA complexes that form the chromosomes. The prime focus
of current research, however, is the mechanism that initiates the entire process of DNA replication
in eukaryotic cells. At the heart of this mechanism is a protein that binds to “start” sites on the chro-
mosomes, called the origin recognition complex (ORC). Stillman’s research has demonstrated that
the ORC is also involved in the process of segregating duplicated chromosomes in mitosis. The
team has found the ORC at centrosomes and centromeres, structures that orchestrate chromosome
separation in mitosis. This year, the team discovered how a protein known to be an essential activator
of DNA replication actually triggers this process. They found that DDK phosphorylates a protein
called Mcm4, specifically within a domain that acts as a brake to prevent the double helix from
being unwound. The phosphorylation releases this brake, thus initiating the replication of unwound
DNA strands.
30 Research
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DEVELOPMENTAL REGULATION OF MICRORNA ACTIVITY
C.M. Hammell D.M. King
Animal development is remarkably robust and requires
the integration of both spatial and temporal genetic
programs. Our understanding of the genetic circuitry
regulating spatial patterning has illuminated strategies
shared by most organisms, but the underpinnings of
how temporal gene expression is coordinated in animals
remain obscure. The genetic tractability, invariant cell
lineage, and ability to observe cell division patterns in
a living animal have made Caenorhabditis elegans the
premier organism to address these questions. Mutations
that alter stage-specific developmental programs have
revealed conserved classes of heterochronic genes that
control the cell fates of the essentially invariant postem-
bryonic cell lineages. 
One paradigm that emerged from these studies is
that the expression of master regulatory genes required
for early temporal developmental programs (usually en-
coding transcription factors, RNA-binding proteins
and other regulatory components) is posttranscription-
ally repressed by the activity of specific microRNAs
(miRNAs). Although much is known about the tran-
scriptional activation and biochemical maturation of
miRNAs, our understanding of how these processes are
coordinated to create sharp transitions in gene expres-
sion at the molecular and cellular levels is limited. 
Genetic Screens in C. elegans Identify
Components That Regulate miRNA
Expression and Ensure Normal
Developmental Timing
Under favorable environmental conditions, C. elegans
larva progress through four larval stages (L1–L4) that
are punctuated by molts to a reproductively competent
adult within ~40–50 h after hatching. At each of these
stages, a variety of cells (including hypodermal, neu-
ronal, muscular, and intestinal cells) execute stage-spe-
cific cell division and cell-fate specification programs.
The heterochronic genes control these stage-specific
events. Mutations of components in this regulatory
pathway result in two general types of developmental
timing defects. Precocious heterochronic mutants cause
stage-specific developmental programs to occur earlier
than normal (usually at the consequence of normal pro-
grams). In contrast, retarded mutants reiterate stage-
specific cell divisions and, as a consequence, retain
juvenile characteristics and lack adult-specific organs
and features. Importantly, each of these phenotypes is
robust, specific, and quantifiable and can be monitored
by directly observing cell division patterns in live ani-
mals or through surveying the expression of individual
genes via green fluorescent protein (GFP)-tagged re-
porter constructs.
To identify common molecular components that
modulate the temporal activity of miRNAs, we screened
for extragenic suppressors of mutations effecting essential
miRNA processing components or contained mutations
in specific miRNAs that are required for normal devel-
opmental timing. We initially chose three classes of mu-
tations that separately effect discrete phases of C. elegans
larval development. The first genetic background that
we screened focused on the lin-4 miRNA that is genet-
ically required after the first larval stage to repress the ex-
pression of the LIN-14 transcription factor that
functions to specify L1 cell fates. lin-4 null alleles (lin-
4(e912)) or point mutants that affect only the mature
~21-nucleotide miRNA (lin-4(ma161)) fail to down-
regulate LIN-14 expression and, as a consequence of
continued expression of LIN-14, reiterate L1-specific cell
division programs at all successive larval stages. The sec-
ond genetic context took advantage of specific point mu-
tations that disrupt the mid-domain of the C. elegans
miRNA-specific Argonaute, alg-1(ma192), that result in
severely retarded heterochronic phenotypes that manifest
in the L2 to L3 transition. alg-1(ma192) animals fail to
down-regulate the HBL-1 transcription factor that is
normally mediated by the let-7 family of miRNAs (miR-
48, miR-241, and miR-84) and sequence elements in
the hbl-1 3′UTR (untranslated region). As the down-
regulation of hbl-1 expression is essential to limit the
highly prolific cell divisions of the lateral seam cells, alg-
1(ma192) animals hyperproliferate their epidermal cell
components. The final genetic background for this sup-
pression analysis revolved around the highly conserved
regulatory circuit involving the let-7 miRNA required to
posttranscriptionally repress the expression of a critical
TRIM-NHL domain protein LIN-41 by binding to se-
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quences in the lin-41 3′UTR. Null mutations of let-7,
let-7(mn112), or hypomorphic alleles that mutate the
conserved sequence of the let-7 mRNA, let-7(n2585),
do not down-regulate LIN-41. As a consequence of in-
appropriate LIN-41 expression, the lateral seam cells fail
to terminally differentiate and reiterate larval cell division
programs, and animals burst from their vulval structures
at the normal L4 to adult transition.
Although each of these mutations cause very specific
developmental and cellular phenotypes that manifest at
distinct critical stages of larval development, we designed
a simple screening strategy that could be adapted for all
three screens. All three classes of mutants mentioned
above share one common phenotype: They lack normal
adult-specific gene regulation, which can be monitored
by incorporating a GFP reporter into the screened ani-
mals. Specifically, we chose the col-19 promoter (nor-
mally driving the adult-specific collagen gene present on
the adult cuticle) to drive a GFP-tagged reporter. The
col-19 promoter is positively regulated by the LIN-29
transcription factor, which is the penultimate gene prod-
uct of the heterochronic pathway. Each of these types of
retarded heterochronic mutants fail to turn on col-
19::GFP, which is easily observable in a fluorescent dis-
secting microscope. Suppressors for each mutant would
be found by identifying individual animals that could
restore col-19::GFP expression in the F2 generation. An-
imals positive for this assay would be further character-
ized for the correction of the stage-specific cell lineage
defects and production of other adult structures that
were absent in the initial mutant background.
Characterization of lin-42 and Its
Function in miRNA Metabolism
One would expect that the suppression of each of the
above mutants (which effect specific phases of develop-
mental timing) would result in the identification of at
least three classes of suppressors. Surprisingly, we were
able to identify a single complementation group, rep-
resented by multiple alleles in each screen that sup-
pressed all retarded heterochronic phenotypes. Several
of these alleles were positionally mapped to the left end
of chromosome II. Complementation, rescue with cos-
mids containing the wild-type gene, and sequencing of
the mutations indicated that all suppressors in this spe-
cial class were alleles of the lin-42 gene.
lin-42 encodes a C. elegans protein that has striking
homology with the period (Per) genes found in Drosophila
melanogaster, humans, and mice. Period homologs in
these animals coordinate gene expression patterns in a cir-
cadian (once a day) rhythm that function as essential neg-
ative regulatory components of the cellular clock. As clock
proteins, Drosophila, mouse, and human Per cycle in
abundance throughout the day, peaking in the subjective
daytime and reaching lowest levels in the evening. Al-
though C. elegans is not thought to have a clear, entrain-
able circadian rhythm, the LIN-42 protein also cycles in
abundance; it is most abundant during the intermolt pe-
riods and is almost absent during each of the molting cy-
cles. Our molecular analysis of lin-42 mutants suggests
that LIN-42 functions to antagonize the accumulation of
mature heterochronic and nonheterochronic miRNAs by
dampening their expression at a metabolic step at or up-
stream of pre-miRNA processing. Notably, LIN-42 and
the accumulation of primary miRNA (pri-miRNA) levels
are antiphasic to each other, with pri-miRNA abundance
peaking during the larval molts (low LIN-42) and unde-
tectable during the intermolt periods (when LIN-42 ex-
pression is highest). This complementarity in expression
raises the important question of whether LIN-42 controls
the accumulation of primary and, therefore, mature
miRNA levels. Importantly, the precocious heterochronic
phenotypes associated with lin-42 mutations arise as a
consequence of an inappropriate overaccumulation of
heterochronic miRNAs during the intermolt periods of
larval development. These results suggest that miRNA
maturation or activity can be directly coupled to the reg-
ulatory machinery that controls developmental timing.
Future Directions
We are currently in the process of using biochemical
approaches to identify additional cellular components
that function with LIN-42 to modulate miRNA expres-
sion and ensure normal developmental timing. These
efforts will be combined with experiments in
Drosophila and mouse cell lines to determine if Period
expression and activity also control miRNA expression
in these contexts.
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We study the molecular basis of nucleic acid regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystallog-
raphy enables us to obtain the three-dimensional
structures of these molecular machines. Biochemistry
and molecular biology allow us to study properties that
can be correlated to protein structure and function. 
Mechanisms of RNAi
T. Schalch, C. Faehnle, C. Kuhn, C. Kuscu, S. Lin, D. Bahel, C.
Ashar [in collaboration with G.J. Hannon, R.A. 
Martienssen, Cold Spring Harbor Laboratory; J. Partridge,
St. Jude Children’s Research Hospital]
RNA interference (RNAi) has made an enormous im-
pact on biology in a very short period of time. Not only
are we still discovering new cellular pathways for the
regulation of gene expression, but RNAi has become
an extraordinarily useful and simple tool for gene si-
lencing. Almost from its beginnings, people have used
genetics, biochemistry, molecular biology, and bioin-
formatics to study the mechanism of RNAi and related
pathways. We argued, however, that in order to get a
true mechanistic understanding of these pathways, we
must understand how the components of the RNAi
machinery worked at a molecular level. Therefore, we
embarked on structural and biochemical studies of key
proteins in the RNAi pathway.
During RNAi, long double-stranded RNA (dsRNA)
is processed to yield short (~19–31 nucleotides) dsRNAs
that trigger the RNAi response. These short RNAs be-
come incorporated into effector complexes called the
RNA-induced silencing complex (RISC), where in the
mature complexes, a single-stranded RNA (ssRNA), the
antisense strand of the original dsRNA, is retained in
the complex. This short RNA (small interfering RNAs
[siRNAs] or microRNAs [miRNAs]) then acts to guide
the RISC complex to its target through base comple-
mentarity. The best-characterized pathway, and the one
that is predominantly used for gene knockdown tech-
nology, is a posttranscriptional silencing (PTGS) path-
way called “slicing.” Here the RISC complex is targeted
to the mRNA and produces an endonucleolytic cut in
the mRNA target, thus preventing gene expression from
proceeding. Other RNAi silencing pathways such as
translational inhibition and transcriptional gene silenc-
ing (TGS) are also mediated through RISC complexes.
In all cases, these complexes contain a small ssRNA and
an Argonaute protein, which serve to define the RISC
complex. In the past few years, we have been studying
Argonaute family proteins, their complexes, and their
roles in various RNAi silencing pathways. 
In the fission yeast Schizosaccharomyces pombe, as-
sembly of centrometic heterochromatin requires the
RITS complex, which consists of Ago1, Tas3, Chp1,
and siRNAs derived from centromeric repeats. Our
crystal structure of Chp1’s chromodomain in complex
with a trimethylated lysine-9 H3 peptide (H3K9me)
revealed extensive sites of contact that contribute to
Chp1’s high-affinity binding. We found that this high-
affinity binding is critical for the efficient establishment
of centromeric heterochromatin, but preassembled het-
erochromatin can be maintained when Chp1’s affinity
for H3K9me is greatly reduced. We continue to study
this complex that forms a bridge between the RNAi
machinery and chromatin.
The Different Faces of E1: A Replicative
Hexameric Helicase
E.J. Enemark, S.-J. Lee
During DNA replication, two complementary DNA
strands are separated and each becomes a template for
the synthesis of a new complementary strand. Strand
separation is mediated by a helicase enzyme, a molecu-
lar machine that uses the energy derived from ATP hy-
drolysis to separate DNA strands while moving along
the DNA. Our crystal structure of the replicative heli-
case E1 from papillomavirus bound to ssDNA and nu-
cleotide molecules at the ATP-binding sites provided a
STRUCTURAL BIOLOGY OF NUCLEIC ACID REGULATORY PROCESSES
L. Joshua-Tor C. Ashar C. Faehnle C. Kuscu D. Sau
D. Bahel S. Goldsmith T. Lavy T. Schalch
J. Calarco C. Kuhn S.-J. Lee A. Tocilj
E. Elkayam P.R. Kumar S. Lin D. Wah
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unique look into the mechanism of translocation of this
molecular machine along DNA. 
Papillomaviruses are tumor viruses that cause benign
and cancerous lesions in their host. Replication of pa-
pillomaviral DNA within a host cell requires the viral
E1 protein, a multifunctional protein. E1 initially par-
ticipates in recognizing a specific replication origin
DNA sequence as a dimer with E2, another viral pro-
tein. Subsequently, further E1 molecules are assembled
at the replication origin until two hexamers are estab-
lished. These hexamers are the active helicases that op-
erate bidirectionally in the replication of the viral DNA.
To unwind DNA, helicases must separate the two
strands while moving along, or translocating, on the
DNA. On the basis of the structures of the DNA-bind-
ing domain of E1 bound to DNA that we determined
a few years ago in collaboration with Arne Stenlund’s
lab, we suggested a mechanism for DNA strand sepa-
ration. However, the mechanism that couples the ATP
cycle to DNA translocation has been unclear.
The E1 hexameric helicase adopts a ring shape with
a prominent central channel. ATP-binding (and hy-
drolysis) sites are located at the subunit interfaces, and
multiple configurations are observed within the hexa-
mer. These have been assigned as ATP-type, ADP-type,
and apo-type. The configuration of the site for a given
subunit correlates with the relative height of its DNA-
binding hairpin in the staircase arrangement. The sub-
units that adopt an ATP-type configuration place their
hairpins at the top of the staircase, whereas the hairpins
of apo-type subunits occupy the bottom positions of
the staircase. The hairpins of the ADP-type subunits
are placed at intermediate positions.
A straightforward “coordinated escort” DNA
translocation mechanism is inferred from the staircased
DNA binding and its correlation with the configura-
tion at the ATP-binding sites. Each DNA-binding
hairpin maintains continuous contact with one unique
nucleotide of ssDNA and migrates downward via ATP
hydrolysis and subsequent ADP release at the subunit
interfaces. ATP hydrolysis occurs between subunits lo-
cated toward the top of the staircase, whereas ADP re-
lease occurs between subunits located toward the
bottom of the staircase. The hairpin at the bottom of
the staircase releases its associated ssDNA phosphate to
conclude its voyage through the hexameric channel.
Upon binding a new ATP molecule, this subunit moves
to the top of the staircase to pick up the next available
ssDNA phosphate, initiating its escorted journey
through the channel and repeating the process. For one
full cycle of the hexamer, each subunit hydrolyzes one
ATP molecule, releases one ADP molecule, and trans-
locates one nucleotide of DNA through the interior
channel. A full cycle therefore translocates six nu-
cleotides with associated hydrolysis of six ATPs and re-
lease of six ADPs. A detailed comparison with other
multimeric ATPase motors that highlighted the roles
of individual site residues in the ATPase activity was
also performed. 
We continue to study this helicase and the role that
other domains of the protein might have in helicase as-
sembly and activity.
NADP Regulates the Yeast GAL 
Induction System 
P.R. Kumar, T. Lavy, D. Wah [in collaboration with R.
Sternglanz, Stony Brook University; S.A. Johnston, 
Arizona State University; J. Rabinowitz, Princeton 
University; A. Caudy, University of Toronto]
Transcriptional regulation of the galactose metabolizing
genes in Saccharomyces cerevisiae depends on three core
proteins: Gal4p, the transcriptional activator that binds
to upstream activating DNA sequences (UASGAL);
Gal80p, a repressor that binds to the carboxyl terminus
of Gal4p and inhibits transcription; and Gal3p, a cy-
toplasmic transducer which upon binding galactose and
ATP relieves Gal80p repression. The current model of
induction relies on Gal3p sequestering Gal80p in the
cytoplasm.However, the rapid induction of this system
implies that there is a missing factor. To understand the
molecular mechanism of the GAL regulatory system,
we have determined the structure of S. cerevisiaeGal80p
with the activation domain of Gal4p. 
To our surprise, we discovered that nicotinamide
adenine dinucleotide (NAD) is nestled between Gal80p
and Gal4p, making several key interactions with
Gal80p. Although NAD appears to be promoting this
interaction, we have shown by in vitro pull-down assays
that NADP disrupts this interaction. Alterations in the
NAD(P)-binding site affects the initial rate of GAL in-
duction in vivo, but not overall final expression levels. 
Although we do not understand precisely how this
trigger for GAL regulation functions, nor the involve-
ment of NADP versus NAD, we speculate that switch-
ing the cell to a fermentable galactose medium causes a
change in NADP/NADPH or NADP/NAD ratios in
the cell, and Gal80p effectively senses the metabolic
state of the cell. NADP might be acting as a “second
messenger” in triggering the system. Alternatively,
Gal80p may function as an oxidoreductase enzyme, ac-
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tively converting NADPH to NADP in the presence of
a substrate, causing it to disassociate from Gal4p. 
We are now examining possible enzymatic activities
as well as other complexes involved in this classic tran-
scriptional switch. 
PUBLICATIONS
Faehnle CR, Joshua-Tor L. 2010. Argonaute MID domain takes centre
stage, EMBO Reports doi:10.1038/embor.2010.110. 
Joshua-Tor L,  Hannon GJ. 2010. Ancestral roles of small RNAs: An
ago-centric perspective. Cold Spring Harb Perspect Biol 1: a003772. 
Seung-Jae Lee
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Mechanisms of Constitutive
and Alternative Pre-mRNA Splicing
RNA splicing is required for correct expression of most
eukaryotic protein-coding genes. The spliceosome se-
lects authentic splice sites with very high fidelity, rely-
ing on limited sequence information present through-
out introns and exons. In humans, >75% of genes are
expressed via alternative splicing, giving rise to multi-
ple protein isoforms. The choice of alternative splice
sites is commonly regulated to alter gene expression,
either tissue-specifically or in response to a develop-
mental program or to signaling pathways. The fact
that multiple protein isoforms can be expressed from
individual genes demonstrates that the classical “one
gene–one enzyme” paradigm is no longer valid and
provides an explanation for the unexpectedly small
number of genes uncovered by genome-sequencing
projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well
as RNA components that are part of small nuclear ri-
bonucleoprotein (snRNP) particles. The work in our
lab focuses on the identification and molecular charac-
terization of protein factors and sequence elements that
are necessary for the catalysis and fidelity of splicing
and/or for the regulation of alternative splice site selec-
tion. We are interested in how the spliceosome correctly
identifies the exons on pre-mRNA, and how certain
point mutations in either exon or intron sequences
cause aberrant splicing, leading to various human ge-
netic diseases. Related areas of interest include the re-
modeling of mRNP architecture as a consequence of
splicing, which influences downstream events, such as
nonsense-mediated mRNA decay (NMD); the role of
alternative splicing misregulation in cancer; and the de-
velopment of effective methods to correct defective
splicing or modulate alternative splicing, especially in
a disease context. A summary of some of our recently
published studies is provided below.
Autoregulation and Arginine
Methylation of SRSF1
SRSF1 (formerly SF2/ASF) is a prototypical serine- and
arginine-rich (SR) protein, with important roles in
splicing and other aspects of mRNA metabolism.
SRSF1, the gene encoding this protein, is a potent
proto-oncogene with abnormal expression in many tu-
mors. We found that SRSF1 negatively autoregulates
its expression to maintain homeostatic levels. We char-
acterized six alternatively spliced SRSF1 mRNA iso-
forms: The major isoform encodes full-length protein,
whereas the others are either retained in the nucleus or
degraded by NMD. Unproductive splicing accounts for
only part of the autoregulation, which occurs primarily
at the translational level. The effect is specific to SRSF1
and requires RNA recognition motif 2 (RRM2). The
ultraconserved 3′-untranslated region (UTR) is neces-
sary and sufficient for down-regulation. SRSF1 overex-
pression shifts the distribution of target mRNA toward
monoribosomes, and translational repression is partly
independent of Dicer and a 5′ cap. In collaboration
with Jun Zhu (Duke University), miR-7 was also
shown to contribute to SRSF1 autoregulation. Thus,
multiple posttranscriptional and translational mecha-
nisms are involved in fine-tuning the expression of
SRSF1.
Alternative splicing and posttranslational modifica-
tions (PTMs) are major sources of protein diversity in
eukaryotic proteomes.Functional studies of SR protein
PTMshave exclusively focused on reversible phosphor-
ylation of serine residues in their carboxy-terminal RS
domain. We confirmed that human SRSF1 is methyl-
ated at residues R93, R97, and R109, whichwere first
identified in a global proteomic analysis of arginine
methylation. We further investigated whether these
methylated residues regulate the properties of SRSF1,
which normally shuttles between the nucleus and the
cytoplasm. We found that the three arginines addi-
tively control the subcellular localization of SRSF1,
RNA SPLICING
A.R. Krainer M. Akerman S. Das M. Jensen M. Motley R. Sinha
O. Anczuków M. Faleiro Y. Liu J. Novatt S. Sun
I. Aznárez M. Fan Y.-H. Liu X. Roca R.-Y. Tzeng
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and both the positive charge and the methylation state
are important. Mutations that block methylation and
remove the positive charge result in cytoplasmic accu-
mulation of SRSF1. The consequent decrease in nu-
clear SRSF1 levels prevents it from modulating
alternative splicing of target genes, results in higher
splicing-enhancer-dependent translation stimulation,
and abrogates the enhancement of nonsense-mediated
mRNA decay.
Alternative Splicing and Cancer
Cell Metabolism
Alternative splicing has an important role in cancer,
partly by modulating the expression of many oncogenes
and tumor suppressors and also because inactivating
mutations that affect alternative splicing of various
tumor suppressor genes account for some of the inher-
ited and sporadic susceptibility to cancer. In addition,
alternative splicing controls a metabolic switch charac-
teristic of all cancer cells, which is known as the War-
burg effect. Cancer cells preferentially metabolize
glucose by aerobic glycolysis, characterized by increased
lactate production. This distinctive metabolism involves
expression of the embryonic M2 isozyme of pyruvate
kinase, in contrast to the M1 isozyme normally ex-
pressed in differentiated cells, and it confers a prolifer-
ative advantage to tumor cells. The M1 and M2
pyruvate kinase isozymes are expressed from a single
gene through alternative splicing of a pair of mutually
exclusive exons. In collaboration with Lewis Cantley
(Harvard Medical School), we measured the expression
of M1 and M2 mRNA and protein isoforms in mouse
tissues, tumor cell lines, and during terminal differen-
tiation of muscle cells and showed that alternative splic-
ing regulation is sufficient to account for the levels of
expressed protein isoforms. We further showed that the
M1-specific exon is actively repressed in cancer cell
lines—although some M1 mRNA is expressed in cell
lines derived from brain tumors—and demonstrated
that the related splicing repressors heterogeneous nu-
clear ribonucleoprotein (hnRNP) A1 and A2, as well
as the polypyrimidine-tract-binding protein PTB, con-
tribute to this control. Down-regulation of these splic-
ing repressors in cancer cell lines using short hairpin
RNAs (shRNAs) rescued M1 isoform expression and
decreased the extent of lactate production. These find-
ings extended the links between alternative splicing and
cancer and identified some of the factors responsible
for the switch to aerobic glycolysis.
Targeted Antisense Modulation of
Alternative Splicing for
Therapeutic Purposes
Spinal muscular atrophy (SMA) is a common, autoso-
mal-recessive motor neuron disorder caused by homozy-
gous deletion or mutation of the survival-of-motor-
neuron gene, SMN1. A closely related SMN1 paralog,
SMN2, is present in all patients and differs from SMN1
by a C to T transition in exon 7 that causes substantial
skipping of this exon, such that SMN2 expresses only
low levels of functional protein. SMN2 decreases the
severity of SMA in a copy-number-dependent manner.
We continue to explore strategies to increase the extent
of exon 7 inclusion during splicing of SMN2 transcripts,
for eventual therapeutic use in SMA. This translational
research is being done in collaboration with Frank Ben-
nett and colleagues (Isis Pharmaceuticals), and Marco
Passini and colleagues (Genzyme Corporation).
We previously identified a potent 2′-O-(2-methox-
yethyl) (MOE) phosphorothioate-modified antisense
oligonucleotide (ASO-10-27) that blocks an SMN2
splicing silencer element in intron 7 and efficiently pro-
motes exon 7 inclusion in transgenic mouse peripheral
tissues after systemic administration. We have now ad-
dressed its efficacy in the spinal cord—a prerequisite
for disease treatment—and its ability to rescue a mild
SMA mouse model that develops tail and ear necrosis,
resembling the distal tissue necrosis reported in some
SMA infants. Using a micro-osmotic pump, we directly
infused the ASO into a lateral cerebral ventricle in adult
mice expressing a human SMN2 transgene; the ASO
gave a robust and long-lasting increase in SMN2 exon
7 inclusion measured at both the mRNA and protein
levels in spinal cord motor neurons. A single embryonic
or neonatal intracerebroventricular ASO injection strik-
ingly rescued the tail and ear necrosis in this mild model
of SMA. 
Injection of ASO-10-27 into the cerebral lateral ven-
tricles of neonate mice with a severe form of SMA again
resulted in a splicing-mediated increase in SMN protein
in the central nervous system (CNS). In addition, this
resulted in an increase in the number of motor neurons
in the spinal cord, which led to improvements in mus-
cle physiology, motor function, and survival. Intrathecal
infusion of ASO-10-27 into cynomolgus monkeys de-
livered putative therapeutic levels of the oligonucleotide
to all regions of the spinal cord. These data demonstrate
that CNS-directed ASO therapy is efficacious and that
intrathecal infusion may represent a practical route for
delivering this therapeutic oligonucleotide in the clinic.
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More generally, these experiments demonstrate that
ASOs can be used to efficiently redirect alternative
splicing of target genes throughout the CNS.
Splice Site Recognition and
Human Genetics
We continued to analyze the relationship between splice
site mutations and genetic diseases. In 1997, we discov-
ered a very rare class of introns with noncanonical splice
sites that are nevertheless recognized by the major
spliceosome, and we characterized one such intron in a
voltage-gated sodium channel gene, SCN4A. Masanori
Takahashi (Osaka University) recently identified an in-
sertion/deletion mutation in this intron in a myotonia
patient, and we collaborated with his group to charac-
terize the nature of the splicing defect responsible for
the phenotype. The mutation prevents correct recogni-
tion of the 5′ splice site, resulting in activation of cryp-
tic splice sites. This gives rise to a 35-amino-acid
insertion in the sodium channel, which functions ab-
normally and causes muscle disease. 
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Most cellular processes can trace their beginnings to the
nucleus where a gene is activated, resulting in the pro-
duction of an RNA molecule that must get processed
and transported to the cytoplasm. Although much bio-
chemical information is available regarding many of the
factors involved in gene expression, the spatial and tem-
poral aspects of gene expression and the dynamics of
the nuclear domains that the gene expression machin-
ery occupies are less well understood. During the past
year, we have made significant progress in two main
areas: (1) examining the dynamics of gene expression/
repression and DNA repair in living cells and (2) char-
acterizing the dynamics of a long nuclear retained non-
coding RNA. 
The Dynamics of Gene
Expression/Repression
R. Zhao, Z. Lazar 
Our research during the past year has focused on the spa-
tial and temporal aspects of gene expression. Transcrip-
tion is silenced during cell division; however, it must be
reactivated upon exit from mitosis to maintain cell line-
age and cell cycle progression. The transmission of the
gene expression program from mother to daughter cells
has been suggested to be mediated by gene bookmarking,
which may involve transcription factors, histone modi-
fications/variants, and/or DNA methylation. However,
the mechanism by which gene bookmarking mediates
rapid postmitotic transcriptional reactivation remains
unclear. We used a real-time gene expression system to
quantitatively demonstrate that transcriptional activation
of the same genetic locus occurs with a significantly more
rapid kinetics in postmitotic cells versus interphase cells
(Fig. 1). RNA polymerase II large subunit (pol II) and
bromodomain protein 4 (BRD4) were recruited to the
locus in a different sequential order upon interphase ini-
tiation versus postmitotic reactivation resulting from the
recognition by BRD4 of increased levels of histone H4
lysine-5 acetylation (H4K5Ac) on the previously acti-
vated locus. BRD4 accelerated the dynamics of mRNA
synthesis in postmitotic cells by decondensing chromatin
and hence facilitating transcriptional reactivation.
Taken together, our results suggest the following
model to facilitate rapid postmitotic transcriptional ac-
tivation. Upon transcriptional induction in interphase,
various factors involved in gene expression are recruited
to the locus. Transcriptional activation results in an in-
creased level of H4K5Ac at the promoter region of the
locus. Upon entry into mitosis, transcription is shut
CELL BIOLOGY OF THE NUCLEUS
D.L. Spector J. Bergmann M. Hübner Y. Mao
M.S. Bodnar R.I. Kumaran C. Zepeda-Mendoza
M. Eckersley-Maslin Z. Lazar B. Zhang
S. Hearn J. Li R. Zhao
Figure 1. Transcriptional activation of the same locus exhibits
faster kinetics during postmitotic activation than in the previous
interphase. (a,b) Outline of experimental design. After transcrip-
tional induction in interphase (a) or postmitosis (b), the mCherry-
RNA pol II or MS2-YFP (nascent transcripts) fluorescent signals
were quantified over time and plotted (c,d). For RNA pol II: n =
17 for interphase induction, n = 19 for postmitotic reactivation.
For MS2: n = 13 for interphase induction, n = 25 for postmitotic
reactivation.
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down due to the condensation of chromatin and loss
of the transcription machinery. However, the enhanced
level of H4K5Ac is maintained during mitosis and
transmitted to daughter cells, serving as a gene book-
mark for postmitotic transcriptional reactivation. Upon
exit from mitosis, BRD4 is rapidly recruited back to
the daughter loci, presumably through recognition of
H4K5Ac at the promoter region, and this recruitment
leads to rapid chromatin decondensation at the locus,
which further facilitates the recruitment of other mem-
bers of the transcription complex, i.e., pol II and
CDK9. BRD4 and other members of the transcription
machinery then work cooperatively to achieve the rapid
postmitotic transcriptional reactivation of the daughter
loci in early G1 phase cells.
In summary, we established a system to investigate
gene bookmarking during postmitotic transcriptional
reactivation and its underlying mechanism with inte-
grative approaches. Using a real-time imaging ap-
proach, we quantitatively revealed the significantly
more rapid kinetics of postmitotic transcriptional reac-
tivation than interphase transcriptional activation at the
same genetic locus in individual living cells, demon-
strating that postmitotic transcriptional reactivation is
mediated by a distinct mechanism mediated by gene
bookmarking. Furthermore, tethering experiments re-
vealed a previously unrecognized function of BRD4 in
chromatin decondensation, which may be key to the
mechanism mediating the rapid kinetics of transcrip-
tional reactivation in postmitotic cells. Together, our
findings significantly advance the understanding of
gene bookmarking and the mechanism of epigenetic
memory in mediating transcriptional reactivation.
Examination of DNA Repair Pathway
Choice Upon Zinc Finger Nuclease-
Induced Double-Strand Breaks
R.I. Kumaran, J. Li, Z. Lazar
In addition to examining the dynamics of transcription,
we have also been interested in examining the assembly
of the DNA-repair nanomachinery at sites of DNA dam-
age. We have developed and utilized live-cell imaging ap-
proaches in order to gain insight into the issues and
choices that must be considered by a cell to repair DNA
double-strand breaks (DSBs). We have demonstrated the
recruitment of the DNA DSB nonhomologous end join-
ing (NHEJ) or homologous recombination (HR) repair
nanomachineries to green fluorescent protein (GFP)-
ZFN-induced DSBs, at a multicopy DSB reporter locus
in human U2OS 2-6-3 cells. Interestingly, upon expres-
sion of both the NHEJ (mCherry-Ku80) and HR (EYFP-
Rad51) marker proteins in U2OS 2-6-3 cells, a popu-
lation of cells exhibited recruitment of members of both
machineries, whereas others recruited only HR proteins
at the DSBs. This observation prompted us to carry out
a quantitative analysis of the frequency of recruitment of
NHEJ or HR repair pathway proteins to ZFN-induced
DSBs. Such analyses showed that the HR nanomachinery
was recruited to the DSBs in 90% of the asynchronously
dividing U2OS 2-6-3 cells, whereas the NHEJ proteins
were recruited in 66% of the cells. However, the recruit-
ment of both the NHEJ and HR machineries may be the
consequence of the 200-copy reporter locus.
To achieve our goal of visualizing the repair process
of a single DSB in living cells by the NHEJ/HR ma-
chinery, we have established a stable U2OS-pSOEP-
62L cell line carrying one to two copies of a DSB
reporter locus. In this cell line, we have demonstrated
the recruitment of mCherry-53BP1 to GFP-ZFN-in-
duced DSB at a single site in the human genome. Im-
aging (at 0.1% laser intensity and 5-ms exposure) of
the LacI-enhanced yellow fluorescent protein (EYFP)-
labeled locus in U2OS-pSOEP-62L followed by
postacquisition processing by a denoising algorithm al-
lows for live-cell data to be acquired at 100 times lower
light exposure. This is especially critical, during fast
image acquisition of dynamic events, at very high tem-
poral resolution in a defined window of time in living
cells. In addition, we have also optimized imaging
(without considerable photobleaching) the LacI-EYFP-
labeled one-to-two copy locus (containing ~5 x 102 to
1 x 103 FPs) in U2OS-pSOEP-62L cells using the
OMX microscope in structured illumination mode at
100-nm super-resolution. We are in the process of mak-
ing additional stable cell lines that will express multiple
DSB-repair components in a stable, inducible and
tightly regulatable way. We have also initiated optimiza-
tion of live-cell imaging in the one-to-two DSB re-
porter cell line. We followed the dynamic disassembly
of the DSB-repair nanomachinary (mCherry-53BP1)
at the one-to-two GFP-ZFN-induced DSBs, every 10
min for a period of 5 h. Ongoing studies are examining
the precise timing of the DSB-repair machinery disas-
sembly. Ultimately, by following living cells stably ex-
pressing various fluorescent protein markers through a
complete cell cycle, we will be able to distinguish (based
on cell size and morphology) the G1, G2, and M stages
of the cell cycle and correlate this to the recruitment of
NHEJ/HR proteins.
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Characterization of a Nuclear-Retained
Noncoding RNA Involved in the 
Assembly of a Nuclear Body
Y. Mao, B. Zhang
The cell nucleus is a highly compartmentalized organelle
harboring a variety of dynamic membraneless nuclear
bodies. How these subnuclear domains are established
and maintained is not well understood. During the past
year, we have continued our analysis of the role of long
nuclear retained noncoding RNAs (ncRNAs) in nuclear
organization. We have focused our efforts on the MEN
ε/β locus, which is up-regulated 3.3-fold upon myoblast
differentiation to myotubes. Two ncRNA isoforms are
produced from a single pol II promoter, differing in the
location of their 3′ ends. MEN ε is a 3.2-kb polyadenyl-
ated RNA, whereas MEN β is a ~20-kb transcript con-
taining a genomically encoded poly(A)-rich tract at its
3′ end. These RNA transcripts are broadly expressed in
adult mouse tissues and conserved among mammals.
The MEN ε/β transcripts are localized to nuclear
paraspeckles and directly interact with p54/nrb. Knock-
down of MEN ε/β expression results in the disruption
of nuclear paraspeckles. During the past year, we inves-
tigated the molecular mechanism of how paraspeckles
are assembled and organized. Paraspeckles are discrete
ribonucleoprotein bodies found in mammalian cells and
implicated in nuclear retention of hyperedited mRNAs.
We developed a live-cell imaging system that allows for
the inducible transcription of MEN ε/β ncRNAs and
the direct visualization of the recruitment of paraspeckle
proteins. The reporter, modified from our previous stud-
ies and integrated at a single site in the C2C12 genome,
is visualized by expression and binding of enhanced cyan
fluorescent protein (ECFP)-LacI at the LacO array.
Upon doxycycline (DOX) induction, a minimal cy-
tomegalovirus (CMV) promoter drives expression of
MEN ε/β ncRNAs tagged with 24 MS2 RNA stem-
loop repeats. Nascent MEN ε/β transcripts are visual-
ized by accumulation of EYFP-tagged MS2 viral coat
protein, which binds the MS2 repeats within the tran-
scripts. This system allows for the MEN ε/β ncRNAs
transcription site, nascent MEN ε/β ncRNAs tran-
scripts, and protein recruitment to be simultaneously vi-
sualized in single living cells. Using this system, we were
able to demonstrate that MEN ε/β ncRNAs are essential
to initiate the de novo assembly of paraspeckles. These
newly formed structures effectively harbor nuclear re-
tained mRNAs, confirming that they are bona fide func-
tional paraspeckles. By three independent approaches,
we showed that it is the act of MEN ε/β transcription,
but not the ncRNAs alone, that regulates paraspeckle
maintenance. Finally, fluorescence recovery after photo-
bleaching analyses supported a critical structural role of
MEN ε/β ncRNAs in paraspeckle organization. To-
gether, our findings established a model in which MEN
ε/β ncRNAs serve as a platform to recruit proteins to
assemble paraspeckles. These data established a seeding
model for nuclear body formation in which MEN ε/β
ncRNAs were identified as pivotal nucleating molecules,
driven by transcription, to recruit proteins to assemble
paraspeckles. Ongoing studies are examining the func-
tion of MEN ε/β RNAs in differentiation.
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The papillomaviruses are a group of viruses that infect
and transform the basal epithelium, inducing prolifera-
tion of the cells at the site of infection. The resulting tu-
mors (warts) are in most cases benign and will usually
regress after some time, but certain types of human pap-
illomaviruses (HPVs) give rise to tumors that are prone
to progress toward malignancy, especially frequently cer-
vical carcinoma. Indeed, HPV infection appears to be a
necessary cause of invasive cervical carcinoma and thus
represents one of the few firmly established links be-
tween viral infections and the development of cancer. 
An impediment to the study of papillomaviruses has
been the inability to define simple in vitro cell culture
systems for analysis of the viral life cycle. These viruses
normally require specialized differentiating cells that
only with difficulty can be generated in cell culture.
However, for a bovine papillomavirus (BPV-1), a con-
venient cell culture system exists where viral gene ex-
pression, oncogenic transformation, and viral DNA
replication can be studied. Thus, BPV has become a
useful model for these aspects of the viral life cycle. The
DNA replication properties of the papillomaviruses
show some unique and interesting characteristics. As
part of their normal life cycle, these viruses can exist in
a state of latency, which is characterized by maintenance
of the viral DNA as a multicopy plasmid in infected
cells. The copy number of the viral DNA is tightly con-
trolled, and the viral DNA is stably inherited under
these conditions. Papillomaviruses therefore provide a
unique opportunity to study plasmid replication in
mammalian cells. In addition, the viral DNA replica-
tion machinery represents one of the most promising
targets for antiviral therapy. 
In previous years, we have reported the characteriza-
tion of the papillomavirus replicon and the identification
of the viral components that are required for viral DNA
replication. In recent years, we have directed our atten-
tion toward the biochemical events associated with ini-
tiation of DNA replication. We are studying the
biochemical properties of the viral E1 and E2 proteins
and how these two proteins interact with the viral origin
of DNA replication and with the cellular replication ma-
chinery to generate initiation complexes. Our studies
demonstrate that the E1 protein has all of the character-
istics of an initiator protein, including ori recognition,
DNA-dependent ATPase activity, and DNA helicase ac-
tivity. The transcription factor E2, whose precise func-
tion has remained more elusive, appears to serve largely
as a loading factor for E1. Through direct physical inter-
actions with both E1 and the ori, E2 provides sequence
specificity for the formation of the initiation complex. 
We are currently attempting to elucidate how the E1
and E2 proteins orchestrate the precise biochemical
events that precede initiation of DNA replication at the
viral ori. These events include binding of the initiator
to the ori and the initial opening of the DNA duplex
(melting), as well as the assembly and loading of the E1
replicative helicase at the replication fork. Our studies
so far indicate that these activities are generated in an
ordered process that involves the sequential assembly of
E1 molecules on the ori. This sequential assembly gen-
erates different complexes with different properties that
in turn recognize ori, destabilize the double helix, and
function as the replicative DNA helicase. 
A Sequestration Module in the Amino
Terminus of E1 Controls Access
to the Region Containing the Nuclear
Localization Signal
The papillomavirus E1 protein is a multifunctional pro-
tein, which carries out essential functions in viral DNA
replication. Although E1 is well-studied, functions have
not been assigned to all parts of the protein. The func-
tion of the amino-terminal ~150 residues has especially
remained mysterious. Although a part of this sequence
is involved in nuclear import and export, these se-
quences account for only a fraction on the amino-ter-
minal domain. Given the parsimony that usually charac-
terizes viral proteins, it is likely that additional functions
are present in the amino-terminal domain. It has previ-
ously been demonstrated that a peptide derived from
the E1 nuclear localization signal (NLS) had DNA-
binding activity. We wanted to determine whether we
could detect this DNA-binding activity in the context
of the larger E1 protein. Because full-length E1 encodes
one DNA-binding activity in the E1 DNA-binding do-
MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
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main (DBD) and another DNA-binding activity in the
helicase domain, detection of this additional DNA-
binding activity in the context of the full-length E1
would be difficult. We therefore focused on just the
amino-terminal domain. We could isolate a minimal
fragment containing residues 92–120 that had strong
DNA-binding activity. Surprisingly, however, larger
fragments had reduced DNA-binding activity or lacked
DNA-binding activity altogether. Indeed, we could ob-
serve a distinct pattern. The intact amino-terminal frag-
ment (E11-159) lacked DNA-binding activity altogether.
Deletion of 25, 35, or 45 residues from the amino ter-
minus gradually increased the DNA-binding activity of
the fragment. Similarly, deletion of 30 residues from the
E11-159 fragment resulted in robust DNA-binding activ-
ity. These results indicate that in the presence of 30–40
residues from the amino terminus and 30–40 residues
from the carboxyl terminus of the E11-159 fragment, the
DNA-binding activity is hidden or sequestered. Re-
moval of either the amino-terminal or carboxy-terminal
residues results in strong DNA binding. To determine
the function of this sequestered DNA-binding activity,
we generated mutations in the minimal fragment with
DNA-binding activity and tested for DNA binding. We
identified one point mutation, R106A, that failed to
bind DNA. Interestingly, when introduced into the viral
genome, this mutation resulted in a severe transforma-
tion defect, indicating either that the mutation affects
nuclear localization or that the DNA-binding activity
has a role in the viral life cycle. To establish whether the
amino-terminal domain in E1 has a role in the biochem-
ical activity of the E1 protein, we expressed and purified
full-length E1 containing several of the amino-terminal
deletions described above. Interestingly, although a large
deletion mutant, which removes most of the amino-ter-
minal domain, was fully functional for cell-free DNA
replication, several smaller deletions lacked DNA repli-
cation activity in the cell-free system. On the basis of
our biochemical assays, these mutants are defective for
the formation of a specific E1 double trimer complex,
which serves to generate local melting at the viral origin
of DNA replication. These results indicate that the
amino-terminal domain most likely has a regulatory role
in viral DNA replication and is not essential for the ini-
tiation process. The role of the sequestration module still
remains to be determined. 
A Mechanism for Local Melting
Preparation of DNA templates for replication requires
the initial opening of the duplex to expose single-
stranded DNA (ssDNA). This locally melted region is
required for replicative DNA helicases to initiate un-
winding. How local melting is generated in any replicon
is unknown, but initiator proteins from some viruses, in-
cluding the BPV E1 protein, can perform this process.
E1 is therefore an excellent tool and can provide under-
standing of the local melting process. Incubation of E1
with an ori fragment in the presence of ATP gives rise to
an E1 double trimer (DT) complex, which slowly is con-
verted into an E1 double hexamer (DH) complex. In the
process, the ori DNA is unwound as demonstrated by
the appearance of ssDNA in the form of an ssDNA/SSB
(single-stranded DNA-binding protein) complex. 
To study the local melting process, we generated a
complete set of surface mutations in the E1 helicase do-
main based on the available structural information and
performed a screen for mutations that were capable of
forming the E1 DT but that failed to form the E1 DH.
Of ~70 surface mutants, we identified 10 that were de-
fective for the transition between the DT and the DH.
These ten mutants were tested for local melting in per-
manganate reactivity assays. Nine of the mutants ar-
rested the melting process at the same time, within the
first 2 min of melting, and one mutant arrested the
melting at ~10 min. Interestingly, when we determined
where these residues were located in the E1 hexameric
ring structure, we found that the nine mutants in the
group that arrested early all fell neatly in the interface
between adjacent helicase domains in the hexamer. The
tenth mutant was located on the inner surface of the
hexameric ring. Because the interface mutants all have
wild-type DNA helicase activity, which requires hexa-
mer formation, these mutants were not defective for
hexamer formation per se. Instead, the defect of the in-
terface mutants is in local melting, which is a prerequi-
site for DH formation. 
These results indicated to us that the E1–E1 interface
in the E1 hexamer was important for local melting but
not for hexamer formation. Because the hexamer is held
together by interactions between the oligomerization
domains, it is likely that the helicase domain interface
is involved in generating the force required for local
melting. On the basis of these results, we wanted to test
a model where the DT generates local melting by un-
twisting the ori DNA. Because such a mechanism would
depend on force being transmitted through the double-
stranded DNA (dsDNA), we could test this idea by gen-
erating ori templates containing nicks. Interestingly,
when nicks were present between the attachment sites
for the E1 DT, melting could not be observed, indicat-
ing that intact dsDNA is required for local melting, con-
027-047_01_CancerGeneExpSect_Annual Report_2009 template  7/8/11  11:55 AM  Page 43
44 Research
sistent with an untwisting mechanism. In contrast,
when nicks were introduced outside the E1 DT attach-
ment sites, no effect on local melting could be observed.
These results make it possible for the first time to pro-
pose a mechanistic model for local melting. Further-
more, although the structure of the interface between
the E1 monomers in the DT is not known, the muta-
tional screen maps the interface. The sensitivity of the
DT-to-DH transition to single-amino-acid substitutions
demonstrates that this interface is very sensitive to dis-
ruption, and because it is also well-conserved, it makes
this interface a potential target for small molecules that
could interfere with viral replication. 
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Our genome contains the genetic information that is
transmitted from one cell to its two daughter cells during
cell proliferation and development of tissues and organs.
The genetic information in DNA is also copied, and half
of the duplicated information is passed on from parent
to child. The process of duplicating the DNA double
helix—the process that is central to genome inheri-
tance—is therefore of fundamental importance and has
been the focus of research in this laboratory for 30 years
at Cold Spring Harbor. DNA is wrapped up with pro-
teins that form chromatin, and chromatin structures,
which happen to be different in the various cell types in
our body, are also transmitted from one cell generation
to the next during the process that yields ~100 trillion
cells in our adult body. Thus, the information transfer
must be accurate and efficient. This year, progress has
been made on understanding how the process of genome
duplication is controlled, and we have gained additional
insight into the mechanism of chromatin inheritance and
higher-order chromosome structure. 
Inheritance of Chromatin and
Gene Silencing
The genome of cells contains the DNA double helix that
is wrapped with histone proteins to form nucleosomes,
the fundamental building blocks for chromatin organi-
zation. Each nucleosome consists of two copies of a
dimer of histones H3 and H4 and two copies of a dimer
of H2A and H2B, the eight proteins forming a core pro-
tein structure around which ~140 bp of DNA is wound.
Strings of nucleosomes make up our entire genome, and
gaining access to the DNA in the nucleosomes has a
major role in controlling access to DNA regulatory re-
gions by proteins that control gene transcription. The
differentiated patterns of gene expression that are inher-
ited from one generation to the next in a particular de-
velopmental cell lineage are often referred to as epigenetic
inheritance. Every cell gets the same DNA sequences, but
modifications of DNA, via DNA methylation, and mod-
ifications on the histones by both methylation and acety-
lation, as well as other modifications, set up heritable dif-
ferences in gene expression patterns.
In the mid 1980s, we developed a biochemical sys-
tem that could assemble nucleosomes on DNA during
DNA replication and this process has been studied ever
since. A key player in this process is the chromatin as-
sembly factor-1 (CAF-1) that binds histone H3-H4
dimers and loads two dimers onto replicating DNA, fol-
lowed by loading two dimers of H2A-H2B to form the
nucleosomes with DNA wrapped around the outside of
the eight-histone protein core. CAF-1 was shown to
bind to a key DNA replication protein, PCNA (prolif-
erating cell nuclear antigen), that also functions as a
DNA polymerase clamp, which tethers the DNA poly-
merase to the replicating DNA and recruits many pro-
teins to the replicating DNA. We have shown that
certain mutations in PCNA and CAF-1 cause a defect
in inheritance of chromatin during DNA replication in
both yeast and human cells. Indeed, CAF-1 is essential
for human cell proliferation, but in yeast, it causes subtle
effects on chromatin structure and function.
Telomeres, the very ends of chromosomes, have long
been known to influence the expression of genes that lie
in their vicinity, and, in particular, they cause expression
of a gene in some cells and shut off expression in other
genetically identical cells. This epigenetic state is often
referred to as telomere position-effect variegation
(TPEV). Such an epigenetic state of gene expression near
telomeres was first observed in Drosophila, but it is
known to be widespread and even occurring in human
cells. A common assay for inheritance of the epigenetic
state of gene expression in chromatin involves the analysis
of a URA3 marker gene that is placed near one telomere
on chromosome VII in the yeast Saccharomyces cerevisiae.
The genetically tractable yeast thus offers a potentially
powerful system of understanding how telomeric gene
silencing occurs. Research by other investigators in the
1990s established that the URA3 gene placed at telomere
VII-L (URA3-TELVII-L) is expressed in some cells in
the population and thus the cells can grow on medium
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lacking uracil; however, in other cells in the same popu-
lation, the URA3 gene is shut off, causing cells to be re-
sistant to the toxic drug 5-fluoroorotic acid (5-FOA) that
the Ura3 enzyme metabolizes. This situation creates an
epigenetic state of expression of the URA3 gene near this
telomere, or TPEV. 
We demonstrated a number of years ago that muta-
tions in the DNA replication protein PCNA, encoded
by the POL30 gene and its partner CAF-1, are required
for inheritance of the silenced state of URA3-TELVII-
L and thus the yeast could not maintain a 5-FOA-re-
sistant phenotype. PCNA and CAF-1 cooperate to load
histones H3-H4 onto DNA for assembly of nucleo-
somes during DNA replication. We used a genetic
screen to identify additional proteins that might func-
tion in this pathway and obtained some surprising re-
sults that resulted in a reassessment of a large amount
of literature on telomeric silencing in yeast.
For three proteins implicated in TPEV, CAF-1,
PCNA, and the histone methyltransferase DOT1, our
results demonstrated that the TPEV phenotype is due
either to alterations in nucleotide metabolism or to spe-
cific promoter effects at that particular locus on chro-
mosome VLL and not due to heterochromatin
formation, which was widely assumed. Specifically, the
locus into which the URA3 gene was introduced just
happened to be a particularly sensitive locus for TPEV
because the URA3 gene was expressed at low levels;
however, it was induced when the drug 5-FOA was
added to cells. The increased Ura3 enzyme increased
the flux of the toxic 5-FOA into nucleotide precursors
of DNA replication via the enzymes ribonucleotide re-
ductase and thymidylate synthase. Thus, the very drug
used to measure the epigenetic state induced changes
in URA3 gene expression, and thus, the phenotype of
the cells was altered because of metabolic changes and
not changes in gene silencing. These 5-FOA-induced
changes in metabolism occurred more readily in pol30-
8, cac∆, and dot1∆ mutants, thereby inappropriately as-
signing them as modulators of TPEV. Although we
agreed that SIR proteins do silence gene expression at
this telomere, we suggested that the results of many
other mutant studies implicating a wide variety of genes
in TPEV could be explained not by defects in epige-
netic inheritance but by other effects of altered nu-
cleotide metabolism.
Our research, however, did discover what is most
likely the real defect in DNA replication-coupled as-
sembly by the CAF-1–PCNA pathway in yeast, namely,
a defect in global histone H3-H4 density, and hence
nucleosome density on chromosomes, that affects the
expression of genes normally not expressed or poorly
expressed in the haploid cells we studied. This observa-
tion is interesting because CAF-1 is essential in human
cells and binds histone H3.1 but not histone H3.3, yet
CAF-1 is not essential in yeast and yeast have only his-
tone H3.3. Thus, the H3.1-CAF-1 axis is essential for
propagation of the genomes of cells with large genomes.
Moreover, CAF-1 defects in plants cause profound var-
iegation among individuals (stem fasciation), and we
suggest that this is caused by a similar, global defect in
histone deposition that has major secondary conse-
quences for gene expression.
Break-Induced and DNA
Replication Factors
In last year’s report, we described results of an analysis
of the essential nature of the Cdc7-Cbf4 (DDK) pro-
tein kinase in DNA replication. We demonstrated that
the essential target for DDK is a domain in the Mcm4
protein that acts as an intrinsic inhibitor of the initia-
tion of DNA replication. We collaborated with the lab
of Jim Haber at Brandeis University to study the role
of DDK in double-stranded DNA break-induced repli-
cation (BIR). This replication-associated repair pathway
is an efficient homologous recombination pathway used
to repair a DNA double-strand break when homology
is restricted to one end of a chromosome. The Haber
lab has shown that all three major replicative DNA
polymerases are required for BIR, including the other-
wise nonessential Pol32 subunit of DNA polymerase δ.
BIR also requires the replicative DNA helicase (Cdc45,
the GINS, and Mcm2-7 proteins) as well as Cdt1. In
contrast, both subunits of the origin recognition com-
plex (ORC) and Cdc6, which are required to create a
prereplication complex (pre-RC), are dispensable. In
this collaboration, we showed that the Cdc7 kinase, re-
quired for both initiation of DNA replication and
postreplication repair, is also required for BIR. These
results suggest that origin-independent BIR involves
cross-talk between normal DNA replication factors and
post-replication repair and that DNA replication dur-
ing BIR involves many of the key replication proteins
that are required to replicate the DNA during S phase.
Origin Recognition Complex
and Heterochromatin
A number of years ago, Mike Botchan and his col-
leagues showed that Drosophila ORC localized with
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heterochromatin protein 1 (HP1) and that the Orc1
subunit interacted with this protein. Prior work from
this laboratory demonstrated a similar interaction in
human cells; however, in the human cell system, there
was a paradox because Orc1 is degraded at the G1-to-
S-phase transition and yet HP1 proteins still colocalize
with Orc2 and Orc3 subunits during S and G2 phase
when there is no Orc1 in the cell. This prompted us to
investigate the interactions between HP1 and ORC in
more detail.
HP1, which exists in human cells in a number of iso-
forms (α, β, and γ), contains both chromo- and
chromo-shadow domains and localizes to all heterochro-
matic loci in animal cells, including centromeres. It par-
ticularly localizes to heterochromatin marked with the
histone K9–trimethylation modification. Surprisingly,
it was shown by a number of groups a few years ago that
the HP1 proteins were dynamically associated with the
heterochromatin, with an apparent half-life on the chro-
matin of ~4 seconds. We have now demonstrated that
in human cells, multiple ORC subunits associate with
HP1α- and HP1β-containing heterochromatic foci.
Fluorescent bleaching studies indicated that multiple
subcomplexes of ORC existed at heterochromatin, with
Orc1 stably associated with heterochromatin in G1
phase, whereas other ORC subunits have transient in-
teractions throughout the entire cell division cycle. In
addition to Orc1, we demonstrated that Orc3 directly
bound to HP1α and two domains of Orc3, a coiled-coil
domain and a separate MIR domain, that is also present
in CAF-1 independently bound to HP1α. However,
both domains were essential for in vivo localization of
Orc3 to heterochromatic foci. Direct binding of both
Orc1 and Orc3 to HP1 suggests that following the
degradation of Orc1 at the G1/S boundary, Orc3 facili-
tates assembly of ORC/HP1 proteins to chromatin. Al-
though depletion of Orc2 and Orc3 subunits by small
interfering RNA (siRNA) caused loss of HP1α associa-
tion to heterochromatin, loss of Orc1 and Orc5 caused
aberrant HP1α distribution only to pericentric hetero-
chromatin surrounding nucleoli. Depletion of HP1α
from human cells also showed loss of Orc2 binding to
heterochromatin, suggesting that ORC and HP1 pro-
teins are mutually required for each other to bind to het-
erochromatin. Similar to HP1α-depleted cells, Orc2
and Orc3 siRNA-treated cells also showed loss of con-
densation at α-satellite repeats, suggesting that ORC to-
gether with HP1 proteins may be involved in organizing
higher-order chromatin structure and centromere func-
tion. More recent studies, to be published later, have
demonstrated that Orc2 and Orc3 have a direct role in
centromere activity in human cells.
PUBLICATIONS
Kawakami H, Katayama T. 2010. DnaA, ORC, and Cdc6: Similarity
beyond the domains of life and diversity. Biochem Cell Biol 88: 49–
62.
Lydeard JR, Lipkin-Moore ZM, Sheu Y-J, Stillman B, Burgers PM,
Haber JE. 2010. Break-induced replication requires all essential
DNA replication factors except for those specific for pre-RC assem-
bly. Genes Dev 24: 1133–1144.
Mok J, Kim PM, Lam HY, Piccirillo S, Zhou X, Jeschke GR, Sheridan
DL, Parker SA, Desai V, Jwa M, et al. 2010. Deciphering protein ki-
nase specificity through large-scale analysis of yeast phosphorylation
site motifs. Sci Signaling 3: ra12.
Prasanth SG, Shen Z, Prasanth KV, Stillman B. 2010. Human origin
recognition complex is essential for HP1 binding to chromatin and
for heterochromatin organization. Proc Natl Acad Sci 107: 15093–
15098.
Sheu Y-J, Stillman B. 2010. The Dbf4-Cdc7 kinase promotes S phase
by alleviating an inhibitory activity in Mcm4. Nature 463: 113–117.
In Press
Hoek M, Myers MP, Stillman B. 2011. An analysis of CAF-1-interacting
proteins reveals dynamic and direct interactions with the KU com-
plex and 14-3-3 proteins. J Biol Chem 286: 10876–10887.
McJunkin K, Mazurek A, Premsrirut PK, Zuber J, Dow LE, Simon J,
Stillman B, Lowe SW. 2011. Reversible suppression of an essential
gene in adult mice using transgenic RNA interference. Proc Natl
Acad Sci (in press).
Rossmann MP, Luo W, Tsaponina O, Chabes A, Stillman B. 2011. A
common telomeric gene silencing assay is affected by nucleotide me-
tabolism. Mol Cell 42: 127–136.
Cancer: Gene Regulation and Cell Proliferation     47
027-047_01_CancerGeneExpSect_Annual Report_2009 template  7/8/11  11:55 AM  Page 47
CANCER: GENETICS
Cancer genetics focuses on understanding the genetic basis of cancer, cancer progression, and devel-
opment of resistance to chemotherapy.
Gregory Hannon is a pioneer in the study of RNA interference (RNAi), a process in which dou-
ble-stranded RNA molecules induce gene silencing. Hannon and colleagues have elucidated key el-
ements of the RNAi machinery and have led the way in using RNAi to study cancer biology and
genetics, generating a library of short hairpin RNAs (shRNAs) that have been widely applied in
gene silencing studies. This year, by analyzing an miRNA molecule produced in developing red
blood cells, Hannon’s team discovered an alternative pathway of miRNA generation. Existence of
this alternative pathway helps to explain evolutionary pressure to maintain a catalytically active Arg-
onaute protein in animal cells. In other work, the Hannon lab discovered that mRNAs can be tar-
geted for destruction by several modes and molecules, highlighting a previously unanticipated
complexity in the control and regulation of the cell’s genetic messages. Also in 2010, innovative se-
quencing technologies developed in recent years by Hannon and colleagues were brought to bear
in the Neanderthal genome project. The array-capture resequencing method enabled the team to
show the remarkable similarity in proteins encoded by corresponding sets of 14,000 Neanderthal
and human genes. Exome resequencing also enabled the team to quickly and economically identify
a point mutation that causes Joubert syndrome, a rare and devastating neurological illness that dis-
proportionately afflicts Ashkenazi Jews.
Scott Lowe’s laboratory studies cancer gene networks and determines how genetic lesions affecting
these networks contribute to tumor development and resistance to therapy. This year, Lowe and col-
leagues showed how mutations in K-ras and p53 act to reinforce one another to change the character
of blood precursor cells, transforming them into cells that can renew themselves—and thus prolif-
erate—indefinitely, somewhat as cancer stem cells are theorized to do. Lowe’s team has adapted
RNA interference (RNAi) technology to produce animal models in which genes can be switched
on and off in a spatial, temporal, and reversible manner and has used this to study the impact of
tumor suppressor genes on tumor development and tumor maintenance. He also has spearheaded
a collaborative effort involving four other CSHL labs to identify novel tumor suppressor genes. He
combined his earlier integrated oncogenomics approach on human liver cancers with RNAi-based
screening in a mouse model. The lab also studies cellular senescence, a potentially powerful mech-
anism for suppressing tumor formation. This year, they discovered that the gene-suppressing activity
of the retinoblastoma (Rb) gene can be traced to its ability to trigger senescence. The team had pre-
viously demonstrated that senescence also helps to limit wound-healing responses in liver disease, a
finding that suggests that growth arrest has functional relevance, in addition to cancer, in the main-
tenance of tissue homeostasis following damage.
Robert Lucito has had an important role along with Michael Wigler in developing innovative
technologies, including RDA, ROMA, MOMA, and CGH, that have proven to be valuable to cancer
researchers worldwide. As an experimentalist, Lucito conducts studies using these techniques to detect
copy-number changes in large sets of human ovarian and pancreatic cancer tissue samples. His lab
also has turned its attention to epigenetics, specifically to the study of methylation throughout the
genome. When methyl groups in sufficient numbers attach to cytosine bases in DNA, the packing
of DNA into the chromosomes can be altered, reducing the levels at which methylated genes are ex-
pressed. Under circumstances that Lucito is exploring, this may be a means by which normally pro-
tective tumor suppressor genes are turned off, rendering cells tumorigenic.
Alea Mills is studying genetic pathways important in cancer and aging, identifying the genetic
players and determining how aberrations in their functions culminate in human disease. Through
innovative use of a technique called chromosome engineering, the Mills group identified a tumor
suppressor gene that had eluded investigators for three decades. The gene, called Chd5, was shown
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by Mills to regulate an extensive cancer-preventing network. The epigenetic role of Chd5 in devel-
opment, cancer, and stem cell maintenance is currently being investigated. The Mills lab is also
studying p63 proteins, which regulate development, tumorigenesis, cellular senescence, and aging,
in vivo. They succeeded in halting the growth of malignant tumors by turning on production of
one of the proteins encoded by the p63 gene, called TAp63. During the last year, they discovered
that a different version of p63, called ∆Np63, reprograms stem cells of the skin to cause carcinoma
development—the most prevalent form of human cancer. Modulation of these proteins may offer
new ways to treat human malignancies in the future.
Scott Powers’ work focuses on gene mutations that cause cancer and factors that influence re-
sponses to specific anticancer drugs. His lab uses technologies that probe the entire genome to iden-
tify candidate cancer genes and evaluate their functional role in cell transformation and tumor
biology. They also use whole-genome technologies to guide development of novel cancer diagnostics
and therapeutics. Using DNA copy-number analysis, the Powers group pinpoints novel amplified
oncogenes and then applies functional studies to address the validity of candidate genes and the
mechanisms by which they are implicated in oncogenesis. They have successfully applied this ap-
proach in liver, colon, and lung cancer. Powers has also had an important role in the development
of a distinctive CSHL approach to functional study of cancer genes. Called integrative oncoge-
nomics, the approach uses a rapid, large-scale screen for genes that are deleted or amplified in human
cancers and suspected of being tumor suppressors in the case of deletions, or oncogenes in the case
of amplifications. As a follow-on study to last year’s discovery of 13 previously unknown tumor
suppressors whose deletion resulted in aggressive cancers, this year Powers, together with the Lowe
lab, discovered 10 new amplified oncogenes. This is now the basis for a new targeted therapeutic
strategy for treating liver cancer.
Michael Wigler’s group uses methods for comparative genome analysis to study cancer (together
with Jim Hicks of CSHL) and human genetic disorders. These methods evolved from earlier tech-
niques—from representational difference analysis (RDA), used to find tumor suppressors, oncogenes,
and pathogenic viruses, to microarray and now to DNA sequence-counting methods, to reveal changes
in the numbers of copies of sections of the genome (regions of deletion and duplication), mutations
that may underlie the evolution of cancers and human genetic disorders. Wigler’s group focuses on
breast cancer and leukemias and is engaged in collaborative clinical studies with major national and
international research oncologists to discover mutation patterns predicting treatment response and out-
come. The group has developed methods for the analysis of the genomes of single cells that have led
to new insights into the clonal evolution and heterogeneity of cancers. This work may lead to a better
understanding of metastasis and progression, shed light on the stem cell hypothesis of cancer, and have
clinical application in the early detection of cancer and its recurrence. Wigler and colleagues made
great headway in the discovery of the causative mutations in autism. Their results show that spontaneous
mutation has a far greater role in autism than previously suspected. They have developed a new theory
of autism’s genetic basis that explains otherwise bewildering patterns of inheritance, and they are testing
the new genetic model in other disabling genetic disorders, such as congenital heart disease (with
Dorothy Warburton at Columbia University) and pediatric cancer (with Ken Offit at Memorial Sloan-
Kettering Cancer Center). Wigler also has spearheaded the development of a Center for Quantitative
Biology at CSHL, with initial funding from the Simons and Starr Foundations.
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treme small RNAs, and two summer undergraduates,
Connie Martin and Ashley Maceli having worked with
Felix Muerdter and Emily Hodges, respectively.
Genome-Wide Analysis of DNA
Methylation During Stem Cell
Differentiation and Development
E. Hodges, A. Molaro [in collaboration with A. Smith,
University of California, Los Angeles]
DNA methylation is a stable, mitotically inherited epi-
genetic mark that contributes to the transcriptional pro-
gramming underlying cellular identity and specifi-
cation. During the last year, we produced and exten-
sively analyzed genome-wide maps of DNA methyl-
ation at single-base resolution for the methylomes of
three specific cell types purified from the hematopoietic
lineage: an early stem cell and two derived, terminally
differentiated cell types of the myeloid and lymphoid
branches. Through this project, we have generated the
first sequenced methylomes derived from purified
human cell populations, as well as the first to be se-
quenced exclusively from female individuals. Examina-
tion of the relationships between the three cell types
chosen for this project revealed several interesting find-
ings, including dynamic patterns of expansion and con-
traction of domains of hypomethylation that correlated
significantly with changes in gene transcription. Aber-
rant DNA methylation leads to deficiencies in stem cell
self-renewal and can ultimately disrupt the normal de-
velopment of mature tissues. In addition, abnormal lev-
els of DNA methylation near the loci of tumor sup-
pressors and oncogenes have been shown to contribute
to tumor progression. Therefore, establishing the refer-
ence sequence for the methylomes of normal cell types
is critical for understanding the changes that contribute
to disease. Furthermore, these data will provide insight
into differential methylation patterns that influence lin-
eage decisions.
Our lab continues to focus on three distinct areas. First,
we study RNA biology, with a focus on noncoding
RNAs. Second, we study the roles of small RNAs in
cancer, mainly breast cancer, and use these small RNAs
as tools to uncover tumor-specific vulnerabilities as po-
tential therapeutic targets. Third, we develop technolo-
gies, mainly in the areas of mammalian genetics and
genomics, with a particular focus on next-generation
sequencing. A selected set of laboratory projects are de-
scribed in detail below. 
This year, three students obtained their Ph.D. de-
grees and departed the laboratory. Ikuko Hotta joined
Jim Manley at Columbia and Colin Malone departed
to Ruth Lehman’s lab at New York University, both as
postdoctoral fellows. Yaniv Erlich became a Whitehead
fellow at the Massachusetts Institute of Technology.
After a brief postdoctoral stint, Adam Rosebrock ac-
cepted a position as a fellow at the University of
Toronto. Ania Jankowska, who originally joined the lab
as an undergraduate volunteer from Stony Brook Uni-
versity, left her technician position at CSHL to enter a
Ph.D. program at Columbia University. Finally,
Pramod Thekkat moved from CSHL to Novartis.
The lab was joined by four outstanding students.
Xin Zhou came from Stony Brook University, whereas
Wee Siong Goh (aka Sho), Silvia Fenoglio, and Kaja
Wasik came from the Watson School. We were also
joined by three new postdoctoral fellows. Sung Wook
Chi came from the Darnell lab at The Rockefeller Uni-
versity, and Yang Yu joined us from Case Western Re-
serve. Stephanie Shaw, who completed her Ph.D. with
Adrian Krainer, came back to CSHL after working for
a time with Rui Ming Xu. 
With the expansion of several large-scale projects,
we were joined by a number of new research associates,
including Michael Baer, Emily Harrison, Christine Pe-
terson, and Kui Tian, who left recently to take a posi-
tion in industry. 
We continued our tradition of hosting visiting inves-
tigators, with Tasman Daish coming to work on mono-
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characterized an unprecedented set of repeat copies (in-
cluding retrotransposons) as evading de novo methyla-
tion in a germ-cell-specific fashion. We also investigated
the methylation status of CpG islands in mature sperm
and showed that hypomethylation of these regions was
not prerequisite for their maintenance during evolution
because many CGIs remain methylated in mature germ
cells. In general, sequence conservation correlated well
with conservation in methylation status; however, re-
gions of divergence exist. We consequently quantified
the impact of CpG variation on methylation in regions
of otherwise high sequence conservation and showed
that a certain level of decoupling exists between genome
and epigenome evolution.
Using Oct4-GFP transgenic mice, we sorted and an-
alyzed the methylation of 13.5-dpc embryonic gonad
and showed that only 4% of all CpGs retained methyl-
ation at this stage. We also analyzed the methylation
profiles of mouse 2-day spermatocytes and saw similar
patterns than observed those with human and chimp
samples. 
We also performed a detailed characterization of
methylation as well as transcriptional patterns at several
stages of germ cell maturation in wild-type and Piwi-
interacting RNA (piRNA)-deficient animals. We found
that despite the significant number of retrotransposons
potentially targeted by piRNAs, only a small subset de-
pend on the pathway for proper remethylation as the
overall methylation levels only drop by 10%. We
showed that these elements display a strong transcrip-
tional reactivation prior to their silencing, indicating
that they might help their selective targeting by over-
loading Piwi proteins by displaying nascent transcripts.
We propose that whereas most remethylation is estab-
lished by default as germ cells mature, some retrotrans-
posons mimic regions normally protected (e.g.
promoters) and require a transcription-dependent
piRNA-mediated pathway to be properly targeted by
the de novo methylation machinery. 
Probing the Initiation and Effector
Phases of the Somatic piRNA
Pathway in Drosophila
A. Haase, S. Fenoglio, F. Meurdter, P. Guzzardo, B. Czech, A.
Gordon, D. Pappin [in collaboration with C. Chen, Applied
Biosystems] 
Combining RNA interference (RNAi) in cultured cells
and analysis of mutant animals, we probed the roles of
known piRNA pathway components in the initiation
and effector phases of transposon silencing. Squash as-
Structural Variation in Human
Cancer
A. Canela
Structural variations including copy-number polymor-
phisms (CNV), as well as insertions, inversions, and
translocations, have an important role in tumor devel-
opment. Although the mutagenic effects of transloca-
tions have long been seen as critical to the development
of hematological malignancies, only recently have tech-
nological advances allowed genome-scale analysis of re-
arrangements in common solid tumors. We study
structural variation in breast cancer cells at single-base
resolution by next-generation sequencing. As a first ap-
proach, we focused on regions previously characterized
by comparative genomic hybridization (CGH) as con-
taining CNVs as landmarks for identifying complex
chromosomal rearrangements. We purified these re-
gions in breast cancer cell lines by array-based genomic
capture and deciphered them by sequencing the precise
structure of genomic rearrangements, which leads to
detection as copy-number loss and gain in the CGH
(in collaboration with the Wigler lab at CSHL). Be-
cause not all the areas of CNV may contain complex
chromosomal rearrangements, we used as an unbiased
approach large-fragment genomic libraries as “jumping
libraries” to scan by sequencing the whole genome for
structural variation events. The use of these approaches
in a panel of breast cancer cell lines allows us not only
to characterize structural variation and study their
repercussion in breast tumorigenesis, but also to iden-
tify areas of the genome that act as hot spots of struc-
tural variation and their potential as landmarks for
chromosomal rearrangements in cancer.
Investigating DNA Methylation Profiles
during Mammalian Gametogenesis
A. Molaro, E. Hodges, K. Marran [in collaboration with
A. Smith, University of California, Los Angeles]
We profiled genome-wide CpG methylation in male
germ cells at various stages of gametogenesis. Using
high-throughput bisulfite sequencing, we generated the
complete map of methylation marks in primary sperm
cells from humans and chimpanzees and compared
these with somatic cultured cells (Lister et al., Nature
462: 315 [ 2009]). We showed that despite ~70% of all
CpGs being methylated, mature germ cells transmit a
large number of hypomethylated regions (HMRs) over-
lapping all genomic annotations. Among these, we
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Pathways Driving Mammary
Epithelial Development
C. Dos Santos [in collaboration with A. Smith, 
University of California, Los Angeles]
Mammary gland stem cells (MaSCs) are a highly dynamic
population of cells responsible for the generation of the
gland during puberty and its expansion during pregnancy.
Understanding how MaSCs are regulated has become a
particularly important area of research, given that they
may be particularly susceptible targets for transformation
in breast cancer. However, a major challenge in the field
is the prospective identification of MaSC, with currently
used cell surface markers (CD24+ and CD29high) only
being capable of enriching for MaSCs. The improved
identification of MaSCs would enable enormous insight
into the mechanisms of self-renewal pertinent to normal
mammary physiology and breast cancer. 
To improve specific isolation of MaSCs, we are using
a label-retention strategy to distinguish quiescent stem
cells from their more proliferative progenitor cell pop-
ulations. Our approach uses a transgenic mouse strain
where histone H2b is linked to green fluorescent pro-
tein (GFP) under the conditional regulation of doxy-
cycline (from Elaine Fuchs at Rockefeller).
Our findings indicate that mammary cells that retain
H2b-GFP following transient induction are enriched for
self-renewal characteristics in vitro and in vivo, beyond
all currently used markers for MaSC. Moreover, global
expression analysis using RNA-Seq of sorted label-retain-
ing cells has enabled identification of novel candidate sur-
face markers specifically expressed in H2b-GFP-positive
cells compared to all other mammary gland cell types.
Ultimately, the discovery of new markers that better
define the MaSC compartment may provide comple-
mentary insights into mammary gland development
and mammary tumorigenesis.
Variations in Gene Expression
among Single Cells
S.W. Chi [in collaboration with J. Kulik, R. Taft, Jackson lab,
Cold Spring Harbor Laboratory]
A tumor is composed of a heterogeneous population of
cells. One type of diversity can arise as a subpopulation
of cells with multilineage potential, “cancer stem cells.”
According to this model, mechanisms underlying tumor
heterogeneity parallel fundamental principles of differ-
entiation processes during mammalian development.
These decisions are both preceded and reflected by vari-
sociated physically with Piwi, and reductions in its ex-
pression led to modest transposon derepression without
effects on piRNAs, consistent with an effector role. Al-
terations in Zucchini or Armitage reduced both Piwi
protein and piRNAs, indicating functions in the for-
mation of a stable Piwi RISC (RNA-induced silencing
complex). Notably, loss of Zucchini or mutations
within its catalytic domain led to accumulation of un-
processed precursor transcripts from flamenco, consis-
tent with a role for this putative nuclease in piRNA
biogenesis.
Functional Dissection of Primary piRNA
Biogenesis in Drosophila
F. Muerdter, P. Guzzardo, A. Haase, B. Czech
piRNAs together with Piwi-clade Argonaute proteins
constitute an evolutionary conserved germline-specifc
small RNA silencing system that is implicated in gene
silencing, particularly of repetitive elements, germline
differentiation, and maintenance of germline stem cells;
mutations in Piwi almost universally lead to sterility
and germ cell loss.
In Drosophila melanogaster, primary piRNA biogen-
esis involves the processing of a primary transcript into
mature small RNAs by so far unknown factors. To se-
lectively search for enzymes involved in such biogenesis
or downstream effector pathways, we make use of an
insect cell line derived from the ovary of Drosophila.
This cell line, the ovarian somatic sheet (OSS) cell line,
only expresses Piwi but not Aubergine or Argonaute3.
Consequently, these cells do not show signatures of sec-
ondary piRNA biogenesis or the ping-pong cycle. 
We are preparing a genome-wide high-throughput
RNAi screen in OSS cells. So far, this included estab-
lishing the cell line, testing our capability to transfect
and knock down endogenous genes, and ultimately de-
veloping an assay to screen for transposon derepression
upon disruption of primary piRNA pathways. By test-
ing each one of the ~16,500 double-stranded RNAs in
our Drosophila RNAi library in individual transfec-
tions, we are now able to assess the impact of each par-
ticular knockdown on primary piRNA biogenesis or
function. The disruption of known and novel factors
involved in these pathways leads to elevated transposon
levels, which can be detected by quantitative poly-
merase chain reaction (PCR). With this unbiased ap-
proach, we are going to explore new and maybe
unexpected directions in this exciting field of RNAi re-
search.
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makes the aim of producing a complete high-resolution
(microscopic) network map extremely expensive and time-
consuming. In contrast, our technique will use a molecular
carrier to transport a genetic “bar code” among neurons.
The circuit-specific recombination of bar codes, each one
specific for a single neuron, will be read with great effi-
ciency by next-generation sequencing, and bioinformatics
will be used to reconstruct the network map. This method
will allow us to map at single-cell resolution hundreds of
thousands of cells in a reasonable time. In the past year,
we have explored several options to find the ideal molec-
ular “carrier” to transport the bar code. We are about to
start a screen to identify novel proteins capable of moving
a genetic sequence across synapses. It is our hope that this
work will contribute to the broader “connectome” project
as part of our collaboration with the Zador lab.
Mechanisms of Transformation 
in Sarcomas
E. Tonin, A. Gordon [in collaboration with R. Maestro, 
CRO, Aviano, Italy]
Sarcomas represent a rare form of tumor (~1% of all
neoplasms) arising from still-undefined mesodermal
cells. Despite their rarity, their very aggressive behavior,
their often early onset, and their poor response to con-
ventional therapies (5-year disease-free survival is less
than 10%) make sarcomas one of the most challenging
types of tumors. Histologically, they have been subdi-
vided into more than 50 different categories, depending
on cell shape and immunophenotipic features. Unfor-
tunately, current classification fails to predict tumor be-
havior or provide useful information about treatment.
Thus, a novel and more efficient classification criteria—
the identification of the molecular pathways involved
in the transformation of mesenchymal cells and their
potential therapeutic targeting—represent important
goals in the field of cancer research. With these consid-
erations, we focus on two main projects. 
First, we performed microRNA (miRNA) expression
profiling of different subtypes of soft tissue sarcomas
using deep-sequencing approaches to identify and
quantify small RNAs involved in their development
and progression. In fact, data available to date clearly
support the involvement of miRNA in cancer etiology
and strongly suggest their possible use as valid markers
of diagnosis and prognosis and, eventually, as new tar-
gets or tools for a specific therapy. An aberrant miRNA
expression is correlated with specific biopathologic fea-
tures, disease outcome, and response to specific thera-
pies in different tumor types, but very little is known
ations in the expression patterns of individual cells, pat-
terns that would never be revealed in aggregate expres-
sion profiles within a tissue. A second source of diversity
is the potential for different cells to harbor private mu-
tations, contributing to tumor progression and therapy
resistance. This is the driving force behind “clonal evo-
lution.” Yet, virtually all studies of developing tissues
and tumors are aggregate analyses of potentially different
cell types. Both types of diversities can be investigated
by analysis of single cells. For this purpose, we are de-
veloping a platform to map transcriptome profiles of
single cells, initially studying population diversity in de-
veloping embryos as a means to validate the approach
and then using the method to analyze transcriptome and
mutation diversity among single cancer cells. These
studies will provide new insights into mechanisms un-
derlying tumor heterogeneity and may impact the way
we use genomic information to guide cancer therapy.
We have optimized RNA-Seq methods for profiling
mRNAs in a single cell (single-cell RNA-Seq) and suc-
cessfully generated cDNA from a single oocyte (~470 pg
of total RNA) with great reproducibility (R 2 = 0.8; be-
tween two individual oocytes) and coverage (~10,000
transcripts detected; reaching the number of transcripts
detected by microarray in RNA derived from an aggregate
collection of thousands of oocytes). We have also success-
fully scaled down our procedure to smaller RNA quanti-
ties (~12.5–125 pg of total RNA) within the estimated
range of RNA from developing embryos up to the 32-cell
stage (~15 pg). Twelve eight-cell embryos have been col-
lected with the aid of Rob Taft and John Kulik at the Jack-
son Labs. Among them, two eight-cell embryos were
preliminary analyzed by single-cell RNA-Seq, showing
some transcript variation in individual eight-cells. We con-
tinue to optimize the protocol and complete the rest of
the eight-cell embryos to further investigate the differential
expression of transcripts during embryo development.
HITMAN: Methods to Trace
Neuronal Connectivity
D. Bressan [in collaboration the Zador Lab, Cold Spring
Harbor Laboratory]
Our research seeks to develop a novel technique to resolve
the connectivity map of a complex neural network—
namely, the animal brain—with an unprecedented effi-
ciency and throughput. Until now, all the efforts directed
toward the resolution of this problem, a fundamental one
in neuroscience, have used an approach based on mi-
croscopy, by imaging multiple neurons in the brain and
reconstructing the pattern of their processes. This strategy
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sites. This makes it possible to explain the transcriptome-
wide systemic effects of miRNA. We investigate the iden-
tity of mouse embryonic stem (ES) cells from the per-
spective of transcripts inhibited by miRNAs. The data
obtained also give insight into the cellular control of gene
expression on the posttranscriptional level in ES cells.
The Long and Short of Noncoding RNAs
J. Preall
Noncoding RNAs (ncRNAs) are rapidly emerging as cen-
tral players in the regulation of the epigenome, and they
can act by guiding X-chromosome inactivation, DNA
demethylation, imprinting, or other chromatin modifica-
tions. Chromatin organization and epigenetic regulation
by ncRNAs is likely to be a complex, global phenomenon.
Many potential mechanisms of ncRNA action would re-
quire their stable association with chromatin as they re-
cruit protein machinery or guide epigenetic changes. 
We have been working to identify novel ncRNA
species that are stably bound to chromatin with the 
intention to eventually examine their correlation with
epigenetic marks that accompany malignant transforma-
tion. We have developed a pulse-chase method for label-
ing and sequencing RNAs specifically associated with
chromatin that enriches for stably associated nuclear
RNAs versus nascent transcripts. This method involves
metabolic labeling with modified ribonuclosides fol-
lowed by in vitro biotinylation and subsequent purifica-
tion. We have also been working to identify RNAs
bound in the vicinity of known chromatin marks and
chromatin-bound protein complexes using a modified
ChIP protocol. There is also much speculation regarding
the physical nature of chromatin-bound RNA, and
among the possibilities is that regions of RNA:DNA hy-
brid duplex are formed that tether the RNA to their site
of action. We are currently building sequencing libraries
from material precipitated by a monoclonal antibody
(S9.6) that specifically interacts with the RNA:DNA hy-
brid duplex structure. These approaches combined will
provide a unified view of the origins, localization, and
structure of chromatin-bound RNAs that are hypothe-
sized to have important roles in epigenetic control and
cell fate decisions. 
The Conservation of Argonaute Catalysis
S. Cheloufi
The Argonaute proteins are highly conserved through-
out evolution. They associate with diverse classes of
about sarcomas. We collected formalin-fixed/paraffin-
embedded samples (Dr Dei Tos, Treviso City Hospital,
Italy) of ~150 untreated primary sarcomas of eight dif-
ferent subtypes and their normal counterpart. Briefly,
we extracted the total RNA, isolated the small RNA,
and then prepared the cDNA libraries. We submitted
them for high-throughput sequencing by Illumina.
Data were analyzed using Galaxy bioinformatic tools.
So far, we have collected preliminary data that must be
statistically improved, increasing the number of se-
quenced samples for each subtype. The most represen-
tative group we have is composed of leiomyosarcomas,
in which, for instance, we saw a consistent overexpres-
sion of miR-144 and miR-451 and a down-regulation
of miR-1 and miR-143 (differentiation of smooth mus-
cle cells), compared to their normal counterparts. 
Second, we focused on the study of one of the most
common soft tissue sarcomas in adults, the myxoid li-
posarcoma (MLS). Approximately 90% of cases show a
characteristic t(12;16)(q13;p11) translocation, which
produces the FUS-CHOP (FC) oncogene. Not much is
known about this transcription factor and about how it
participates in the development and progression of this
neoplasia. A big step forward would be to identify all its
potential binding sites. For that, we decided to use the
chromatin immunoprecipitation high-throughput se-
quencing (ChIP-Seq) technique to find DNA fragments
enriched for FC-binding sites. Briefly, we used the ChIP
technique for FC in MLS cell lines and in FC-trans-
fected cells (we used a dedifferentiated liposarcoma cell
line as negative control). We then made a DNA library
of the immunoprecipitated DNA and sequenced it by
using the Solexa platform. The reads we obtained were
mapped to the genome using a personalized implemen-
tation of Bowtie (an ultrafast, memory-efficient short-
read aligner). We then used the peak caller MACS to
identify the enriched regions. From a list of FC target
genes (HSPA9, HSPA5, BEST1, AKT3, USP30), we
predicted three possible binding-site motifs. All these
data are now being confirmed by RNA-Seq analysis.
miRNA Regulation of Mouse Embryonic
Stem Cells
M. Kudla
miRNAs are small RNA molecules, which have recently
emerged as major regulators of various cellular processes.
They act by inhibiting translation or causing degradation
of the protein encoding transcript. Thanks to the cross-
linking immunoprecipitation (CLIP) method, it is now
possible to have a direct read-out of the miRNA target
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small RNAs to mediate gene silencing in developmental
programs and participate in defense responses to
viruses, transposons, and cellular stress. Vertebrate
genomes encode four argonaute clade proteins. In mice,
AGO2 is essential for embryogenesis, hematopoiesis,
and oogenesis. The developmental functions of the re-
maining Argonaute family members, AGO1, AGO3,
and AGO4, remain elusive. We demonstrate that indi-
vidual deletions of Ago1, Ago3, and Ago4, or deficiency
of all three Argonautes have no apparent impact on
normal mouse development or fertility. In contrast to
its family members, we found that AGO2 is uniquely
expressed in the extraembryonic lineage and is required
for proper placental development. The nucleolytic ac-
tivity of Argonautes is deeply conserved, despite its hav-
ing no obvious role in miRNA-directed gene silencing.
AGO2 is the only family member retaining this enzy-
matic activity. To investigate the evolutionary pressure
to conserve Argonaute enzymatic activity, we engi-
neered a mouse with catalytically inactive Ago2 alleles.
Homozygous mutants died shortly after birth with an
obvious anemia. Examination of miRNAs and their po-
tential targets revealed a loss of miR-451, a small RNA
important for erythropoiesis. Althhough this miRNA
is processed by Drosha, its maturation does not require
Dicer. Instead, the pre-miRNA becomes loaded into
AGO2 and is cleaved by the AGO2 catalytic center to
generate an intermediate 3′ end, which is then further
trimmed. We demonstrate that this novel AGO2-me-
diated miRNA biogenesis pathway can be exploited to
engineer artificial silencing molecules at both the pri-
mary miRNA and the drosha product pre-miRNA, en-
abeling us to hijack the pathway at different levels.
These findings link the conservation of Argonaute
catalysis to a conserved mechanism of miRNA biogen-
esis that is important for vertebrate development. Fu-
ture studies using the Argonaute genetic models will
help us define the biological mechanisms that dictated
Argonaute gene family conservation and illuminate the
wonders of the diverse RNAi pathways. 
PUBLICATIONS
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Cancer arises through an evolutionary process whereby
normal cells acquire mutations that erode growth con-
trols, leading to the expansion of aberrantly proliferating
cells. Such mutations activate oncogenes or inactivate
tumor suppressors, each bestowing new capabilities to
developing cancer cells. Still, cancer is not an inevitable
consequence of oncogenic mutations; instead, cells ac-
quiring such mutations can be eliminated or kept in
check by the intrinsic tumor suppressor programs acti-
vated in damaged cells. We previously showed that genes
controlling apoptosis and cellular senescence are integral
components of such intrinsic programs and, surpris-
ingly, contribute to the tumor suppressive effects of
many anticancer agents. Hence, mutations that disable
tumor suppressor networks can promote tumor progres-
sion and impair treatment response. 
Our research is based on the premise that the path
of cancer evolution dictates a tumor’s subsequent re-
sponse to therapy and creates unique vulnerabilities that
represent therapeutic opportunities. Hence, we apply
mouse models, RNA interference (RNAi), and cancer
genomics in a coordinated effort to identify compo-
nents of tumor suppressor gene networks and under-
stand molecular determinants of treatment response
(Fig. 1). We use conditional RNAi technology to iden-
tify tumor maintenance genes and explore the cell in-
trinsic and extrinsic mechanisms involved in tumor
regression (Fig. 1). Our goal is to gain a more compre-
hensive understanding of tumor suppressor networks
and identify therapeutic targets relevant to specific can-
cer genotypes.
Accelerating the Pace of Discovery:
Mosaic Mouse Models and RNAi
E. Antinis, C. Bialucha, J. Cappellani, L. Dow, S. Ebbesen,
D. Grace, L. Lintault, K. McJunkin, C. Miething, Y. Park, 
P. Premsrirut, A. Rappaport, M. Saborowski, C. Scuoppo, 
J. Simon, V. Sridhar, M. Taylor, S. Weissmueller, J. White, 
Z. Zhao, J. Zuber [in collaboration with G. Hannon, 
S.Y. Kim, M. Camiolo, C. Malone, R. Sordella, A. Mazurek, 
B. Stillman, Cold Spring Harbor Laboratory] 
Cancer is extraordinarily heterogeneous, with each
tumor harboring a distinct set of mutations that creates
the variability in disease trajectory seen in patients. Ge-
netically engineered mice provide powerful tools to
study cancer, yet their generation and analysis is time-
consuming and expensive. Loss-of-function studies—
essential for characterizing tumor suppressor genes or
candidate drug targets—are laborious and typically re-
quire tissue-specific conditional knockouts harboring
multiple alleles. Moreover, to validate drug targets,
genes must be inactivated in each cell of an established
tumor, a technical challenge that has only been achieved
in a few instances. Even where feasible, conditional
gene deletions are not reversible and hence do not
mimic transient pharmacologic target inhibition. Con-
sequently, traditional mouse-modeling approaches are
not sufficiently fast or flexible to comprehensively
model cancer heterogeneity or evaluate the range of
emerging drug targets.
INTEGRATED APPROACHES TO CANCER GENETICS AND BIOLOGY
S. Lowe E. Antinis S. Ebbesen L. Lintault C. Miething A. Shroff V. Thapar
J. Bolden C. Fellmann Y. Liu Y. Park J. Simon S. Weissmueller
J. Cappellani D. Grace A. Lujambio P. Premsrirut M. Spector J. White
C. Chen X. Guo B. Ma A. Rappaport V. Sridhar A. Yu
A. Chicas C. He K. McJunkin M. Saborowski N. Tasdemir Z. Zhao
Y. Chien T. Kitzing O. Mert C. Scuoppo M. Taylor J. Zuber 
L. Dow
Figure 1. Our laboratory studies intrinsic tumor suppressive pro-
grams involving cell death and senescence. More recently, we
have studied tumor maintenance programs whose inhibition leads
to the death, senescence, or differentiation of cancer cells. Often,
we use RNAi to mimic tumor suppressor gene loss or model drug
target inhibition.
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To address these issues, we developed strategies to
accelerate genetic studies in the mouse. We take a “mo-
saic” approach, where cancer-predisposing alleles or re-
porters are transduced into stem and progenitor cells
derived from different tissues or mouse strains; these
modified cells are then transplanted orthotopically into
syngeneic recipients. Because the genetic configuration
of the target cells, transduced genes, and recipients is
easily varied, genotypic diversity can be readily pro-
duced. To date, we have developed mosaic models of
lymphoma and leukemia, as well as carcinomas of the
liver, breast, bile duct, and pancreas. Armed with these
models, a single investigator can study the impact of
many cancer genotypes on tumor behavior and rapidly
test new hypotheses based on the results. This versatility
is impossible with germline approaches.
To facilitate loss-of-gene-function studies, we
worked with Gregory Hannon to develop inducible
short hairpin RNA (shRNA) technology as a rapid and
reversible alternative to conditional gene deletions. Re-
cently, we showed that shRNAs embedded in a natural
microRNA (miRNA) structure are effectively expressed
from polymerase II promoters, thereby enabling robust
gene knockdown using constitutive and inducible vec-
tors. We then developed effective strategies for suppress-
ing proliferation and survival genes where strong
selection against shRNA expression creates technical
challenges (Zuber et al. 2011). We also developed a
high-throughput miRNA “Sensor” approach to func-
tionally identify potent shRNAs (Fellmann et al. 2011).
Together with Dr. Hannon, we are developing prevali-
dated shRNA libraries. 
In vivo RNAi is a powerful tool for studying gene
function in lower organisms such as Caenorhabditis el-
egans and Drosophila. To achieve similar capabilities in
the mouse, we initially produced transgenic mice har-
boring a tetracycline-inducible p53 shRNA and used
them to establish a role for p53 loss in tumor mainte-
nance. We next developed an efficient and scalable plat-
form for mouse production that involves (1) producing
potent shRNAs, (2) using a recombination-mediated
cassette exchange strategy developed by Jaenisch (Mass-
achusetts Institute of Technology) to efficiently target
embryonic stem (ES) cells, (3) incorporating an expres-
sion cassette that links the tet-responsive shRNA to a
fluorescent reporter, (4) scaling up ES cell production,
and (5) producing germline transgenic mice rapidly by
tetraploid embryo complementation (Premsrirut et al.
2011). 
Using this platform, we are producing hundreds of
targeted ES cell lines and are developing transgenic
strains capable of reversibly suppressing tumor suppres-
sors, drug targets, and essential genes (P.K. Premsrirut
et al.; K. McJunkin et al.; both in press]. Together with
Gregory Hannon, we are also using this platform to
produce a series of ES cells capable of inducibly express-
ing all known miRNAs, as well as miRNA sensors.
These ES cells will be made available as a public re-
source to facilitate the study of miRNA biology in vivo.
Finally, we are also generating improved tet trans-acti-
vator strains that enable potent gene knockdown in
most tissues. Our goal is to develop a general platform
that will enable the spatial, temporal, and reversible
suppression of any mammalian gene. 
Cell Survival and Cell Death
C. Bialucha, Y. Chien, Y. Liu, C. Miething, C. Scuoppo,
J. Simon [in collaboration with G. Hannon, Cold Spring
Harbor Laboratory; J. Pelletier, McGill University] 
Since its inception, our laboratory has studied genes
that modulate cell death and survival. In 1993, we
demonstrated that activated oncogenes could induce
p53 to promote apoptosis and suppress transformation.
Then, upon joining CSHL, our laboratory character-
ized the mechanisms of “oncogene-induced apoptosis.”
Some highlights include the identification of ARF as a
component of oncogene signaling to p53, and several
cell death effectors that mediate p53’s effects. We also
showed how phosphoinositol-3 kinase (PI3K) signaling
can attenuate apoptosis and promote tumorigenesis, in
part, via deregulated translation. 
Current work in this area exploits the Eµ-myc B-cell
lymphoma model, where disruption of the ARF-p53
pathway, or overexpression of the prosurvival genes Bcl-
2 or Akt, cooperates to accelerate lymphomagenesis. Fol-
lowing up “hits” from in vivo RNAi screens (see below),
we are characterizing new tumor suppressors that mod-
ulate apoptosis. For example, we showed that Rad17 acts
as a haploinsufficient tumor suppressor that mediates a
DNA-damage apoptotic response to replicative stress. In
unpublished work, we identified two tumor suppressors
involved in polyamine biology, each of whose suppres-
sion attenuates apoptosis and promotes tumorigenesis as
part of a previously obscure tumor suppressor network.
Understanding this network and other hits from this
screen is an important component of future research. We
will also identify cell survival components that are essen-
tial for tumor maintenance. Studies using inducible
shRNA transgenic mice targeting eIF4E and PTEN are
already under way. 
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Senescence and Self-Renewal
J. Bolden, A. Chicas, Y. Chien, A. Lujambio, B. Ma, O. Mert,
J. Simon, Z. Zhao, J. Zuber [in collaboration with X. Wang,
C. Zhang, M. Zhang, Cold Spring Harbor Laboratory; 
K. Shannon, S. Kogan, University of California, San 
Francisco]
Cellular senescence represents an intrinsic tumor sup-
pressive program that limits proliferation. In 1997, we
discovered that—in normal cells—oncogenic ras trig-
gers a senescence program involving the retinoblastoma
(Rb) and p53 tumor suppressor pathways. We went on
to identify factors that regulate and execute senescence
and demonstrated an Rb-directed repressive chromatin
state that silences growth promoting genes. Using
mouse models, we also demonstrated that senescence
contributes to the antiproliferative effects of cancer
therapy, providing the first evidence that this process
limits tumor progression in vivo. We continue to study
the action of Rb, p53, and chromatin-modifying activ-
ities during senescence. By performing a genome-wide
analysis of gene expression, histone modifications, and
Rb chromatin association, we showed that Rb acts pref-
erentially to suppress genes involved in DNA replica-
tion, particularly as cells exit the cell cycle into
senescence (Chicas et al. 2010). We believe that this
function is crucial for its tumor suppressor role. 
We expanded efforts to explore the biology of senes-
cence in vivo, recently showing that induction of senes-
cence in tumor cells can trigger their clearance by innate
immune cells. These studies reveal a non-cell-au-
tonomous program that contributes to p53 action in
tumor suppression and identifies a novel form of im-
mune surveillance involving the innate immune system.
We then discovered a role for senescence in limiting liver
fibrosis, a tissue-damage response that is a predisposing
factor for cirrhosis and hepatocellular carcinoma. Our
results revealed the first noncancer pathology for which
senescence has a protective role, and they imply that it
acts to limit certain wound-healing responses. More re-
cent studies suggest that the perforin/granzyme B path-
way triggered by NK cells contributes to this clearance
and that the NF-κB pathway is a master regulator of the
secretory phenotype. Future studies to further dissect
these and other tumor–host interactions will be greatly
enabled by the use of mosaic models as well as tissue-spe-
cific inducible RNAi. 
Cells that evade oncogene-induced senescence be-
come “immortalized” in a continuous state of self-re-
newal. Surprisingly, recent work implies p53 limits
normal stem cell self-renewal and the reprogramming
of induced pluripotent stem cells. Merging these con-
cepts, we showed that p53 loss enables the aberrant self-
renewal of Ras-expressing myeloid progenitor cells, thus
increasing their leukemia-initiating potential (Zhao et
al. 2010). Together, these observations suggest links be-
tween p53 loss, epigenetic reprogramming, and onco-
genic transformation. Future work will test whether
p53 inactivation creates a distinct epigenetic state that
may be targeted therapeutically.
Mechanisms of Drug Resistance
and Tumor Maintenance
C. Chong, C. Miething, A. Rappaport, J. Simon, M. Spector,
M. Taylor, Z. Zhao, J. Zuber [in collaboration with C. Vakoc,
Cold Spring Harbor Laboratory; S. Kogan, University of Cali-
fornia, San Francisco; M. Le Beau, University of Chicago] 
Most approved cancer drugs work in only a subset of
cancers, yet even these initially responsive tumors typ-
ically develop resistance. Years ago, we showed that p53
inactivation could, by disabling apoptosis, produce re-
sistance to certain cytotoxic anticancer agents. As the
first decisive example of how tumor cell genotype could
influence treatment outcome, this observation stimu-
lated our interest in understanding the interrelationship
between cancer development and therapy response. 
We continue to identify genes that modulate treat-
ment sensitivity, particularly in aggressive cancers. For
example, we used a lymphoma model to show that
translational regulators are important determinants of
rapamycin sensitivity and that NF-κB loss causes
chemotherapy resistance when senescence is the domi-
nant outcome of therapy. We used AML (acute myeloid
leukemia) models to study factors that influence high-
dose chemotherapy in leukemia and confirmed that p53
has a major role in this response. Although some of these
effects may arise from apoptotic defects, other data sug-
gest that p53 loss facilitates the production of so-called
“cancer stem cells” considered more refractory to ther-
apy (Zhao et al. 2010). We are currently using these
models in preclinical studies to test new drugs and drug
combinations.
Beyond resistance mechanisms, our work is also point-
ing toward new therapeutic targets. Using inducible
shRNA systems, we are exploring the requirement for
tumor suppressor gene inactivation in established tumors.
For example, we showed that INK4a/ARF reactivation
in aggressive lung carcinomas leads to tumor regression
associated with enhanced apoptosis (Premsrirut et al.
2011). We also showed that Apc loss is required to main-
tain the proliferation of T cells in acute lymphoid leu-
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kemia, thus validating the Wnt pathway as a therapeutic
target (Premsrirut et al. 2011). Current efforts are study-
ing the impact of PTEN restoration in aggressive T-cell
lymphomas. Future studies will compare these effects to
pharmacological inhibition of the PI3K pathway. 
We are also using RNAi to identify genotype-specific
drug targets. For example, by characterizing how MLL
(mixed lineage leukemia) fusion proteins promote self-
renewal, we identified the Myb transcription factor as
specifically required for the maintenance of AMLs that
are refractory to conventional chemotherapy. These ob-
servations provide direct evidence that targeting aberrant
self-renewal programs can eradicate cancer. With Christo-
pher Vakoc (CSHL), we screened an shRNA library tar-
geting “epigenetic” regulators and have identified several
histone-modifying activities whose suppression causes the
selective arrest or death of leukemic cells. One of these is
a target of an available small-molecule inhibitor, and pre-
liminary studies indicate that this drug is active against
our AML models and certain human AML lines.
We will continue to apply our mouse modeling and
RNAi technologies to identify context-dependent tumor
maintenance genes, particularly in those cancers that are
refractory to current therapies. In this regard, we are al-
ready producing optimized shRNA libraries targeting
relevant drug targets and developing screening strategies
in vivo. Beyond mosaic models, our shRNA transgenic
platform provides a rapid way to examine the normal
function of any gene in whole animals as well as the po-
tential toxic effects of transient target inhibition. 
Integrated Approaches to Cancer
Gene Discovery
C. Bialucha, C. Chen, S. Ebbesen, C. He, T. Kitzing, Y. Liu, 
B. Ma, C. Miething, A. Rappaport, M. Saborowski, C.
Scuoppo, J. Simon, M. Spector, M. Taylor, S. Weissmueller,
Z. Zhao, J. Zuber [in collaboration with X. Wang, National
Institutes of Health; A. Kraznitz, M. Wigler, J. Hicks, 
G. Hannon, S. Powers, Cold Spring Harbor Laboratory]
Cancer genomes are complex and can harbor cancer-pro-
moting “driver” mutations together with “passenger” mu-
tations that have no biological effect. To accelerate cancer
gene discovery, we use mosaic mouse models to filter
through candidates obtained through genomics to iden-
tify genes that actively contribute to tumorigenesis. We
presume that (1) recurrent amplifications and deletions
in human tumors are enriched for oncogenes and tumor
suppressors, respectively, and (2) lesions that give rise to
cancer in humans often do so in mice. Since 2006, can-
didate testing has identified the cell death inhibitor
cIAP1, the hippo pathway gene Yap, the eIF4E kinase
MNK, and the chromobox protein CBX7 as potent
oncogenes, as well as the Rho-GAP DLC1 as a tumor
suppressor, without producing a single germline trans-
genic or knockout strain. 
We developed strategies to multiplex this approach
by transducing tissue stem and progenitor cells with
pools of cDNAs or shRNAs corresponding to genes
that are amplified or deleted in human tumors and se-
lected for those constructs that promote tumorigenesis
following transplantation into recipient mice. Initial ef-
forts surveyed nearly 400 recurrently deleted genes in
human hepatocellular carcinoma (HCC) and identified
12 new tumor suppressor genes. In a conceptually sim-
ilar screen performed by Scott Powers using full-length
cDNAs (CSHL), we identified 10 new oncogenes in
human HCC, including FGF19 as a therapeutic target
for existing neutralizing antibodies (Sawey et al. 2011). 
In parallel to these screening efforts, we are perform-
ing our own genomics analysis of human and murine
cancers to facilitate functional studies in mice. Such
studies have already pinpointed candidate tumor sup-
pressors in aggressive forms of AML. Validation efforts
are currently under way.
Through our screening approaches, we have noted
that recurrent gene amplifications and gene deletions in
tumors frequently harbor multiple drivers genes. For ex-
ample, in a screen for additional tumor suppressors cor-
responding on human chromosome 8p—a frequent site
of large heterozygous deletions in human cancers—we
identified several new tumor suppressors that cooperate
with DLC1 suppression to promote tumorigenesis.
Moreover, in a second-generation shRNA screen using
the Eµ-myc model described above, we used shRNA
pools targeting genes deleted in human B-cell lymphoma
to identify ~10 tumor suppressors. Surprisingly, four
tumor suppressors corresponded to genes on human
chromosome 6p, two on chromosome 8p, and two
linked to p53 on 17p. These observations suggest that
the impact of cancer-associated deletions provide a
greater selective advantage than single gene mutations
and should be viewed and studied as distinct events. 
Beyond identifying new activities of cancer relevance,
our approach is revealing unexpected principles about
the nature and organization of cancer genes. As exam-
ples, we were surprised that so many tumor suppressors
are haploinsufficient, encode secreted proteins, or have
pro-oncogenic activities in other contexts. We also did
not expect recurrent amplifications and deletions to con-
tain more than one relevant activity, yet our results
imply this is the rule rather than the exception. We hope
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that further efforts will facilitate the functional annota-
tion of the genomic alterations occurring in human can-
cers and identify vulnerabilities these lesions create.
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In addition to genetic mutation, such as amplification
and deletion, epigenetic aberrations are frequent events
that can have far-reaching affects in the phenotype of a
cancer cell. A common epigenetic modification is the
methylation of cytosine residues that are next to gua-
nine residues. It has been shown that methylation pres-
ent in the DNA of the transcriptional control region
has been involved in the silencing of gene expression of
tumor supressors in cancer. We have previously adapted
ROMA (representational oligonucleotide microarray
analysis) to methylation detection oligonucleotide mi-
croarray analysis (MOMA). This methodology was use-
ful and allowed us to identify genes that were
methylated in the tumor cells, but it only gave us a gen-
eral idea of where in the CpG island the methylation
had occurred. In addition, after performing the analysis,
sequencing validation was required to determine which
of the array measurements accurately identified methyl-
ated fragments. With the development of next-genera-
tion sequencing technologies, it is now possible to
identify the methylation status for the vast majority of
CpG islands. Our approach is to sequence MspI repre-
sentations of the genome. We have developed several
different approaches to generate the libraries for se-
quencing and have decided to prepare Illumina libraries
from bisulfite-treated MspI representations. 
We have presently sequenced three tumors and two cell
lines. We have determined the coverage and the number
of sequences required to obtain appropriate coverage of
many of the CpG islands and have developed methods to
carry out the analysis on the sequencing data. Mapping
the reads to the genome is not trivial because the bisulfite
treatment essentially changes the genome sequence to only
three bases due to the conversion of most cytosines to
thymine. We have used a program developed by Andrew
Smith (formerly of CSHL) to map the reads to an in silico
bisulfite-treated human genome. After mapping the reads,
the sequences that map to CpG islands are separated from
other sequences, which represents ~20% of the reads.
These reads are contigged using the program Velvet to
form larger regions for analysis. The data can now be an-
alyzed to determine gene-specific methylation states. 
We have thus far used these data to identify which
genes are methylated in the tumor samples. More im-
portantly, we have expression data for these samples and
will use these data to determine which region of the
CpG island is methylated for genes that have suppres-
sion of transcription. In addition, it will be interesting
to determine the effect of methylation of island se-
quences within the coding region of the gene. We plan
on increasing the number of samples for two reasons.
We will be analyzing a new set of ovarian tumor sam-
ples from our collaborator Dr. Douglas Levine from
Memorial Sloan-Kettering Cancer Center. The data
from these samples will serve as an independent valida-
tion of the genes we have found to be methylated from
our MOMA results (see below). These data will also
give us a much more accurate view of the regions
methylated and the purpose of this methylation with
respect to gene expression. 
Genomic Analysis of Ovarian Cancer
E. Lum, M. Vigliotti, K. Wrzeszczynski, N. Cutter,
N. Dimitrova
In the United States, there will be ~22,000 new cases
of ovarian cancer in 2011. Of these cases, ~14,000 will
succumb to the disease. To better treat these women,
and improve survival, our goal is to determine the mo-
lecular changes that have occurred in the patients’ tu-
mors and be able to interpret the significance these
changes have on the growth and development of the
tumor. This aberrant growth is a result of chromosomal
abnormalities and epigenetic variations. In addition,
generally low rates of somatic nucleotide mutation in
ovarian cancer as compared to other solid tumors sug-
gest an increased significance of copy number and epi-
genetic aberrations. This type of regulation has been
shown to effect the many tumor suppressors and onco-
genes discovered in ovarian cancer. The identification
of genetic and epigenetic alterations from primary
tumor cells has become a common method to identify
genes critical to the development and progression of
REPRESENTATION METHYLATION SEQUENCING ANALYSIS
R. Lucito N. Cutter S. Powers
N. Dimitrova M. Vigliotti
E. Lum K. Wrzeszczynski
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cancer. We provide a bioinformatic analysis of copy-
number variation and DNA methylation covering the
genetic landscape of ovarian cancer tumor cells. We in-
dividually examined the copy-number variation and
DNA methylation for 42 primary serous ovarian cancer
samples using our MOMA-ROMA technology and
379 tumor samples analyzed by The Cancer Genome
Atlas. We have identified 346 genes with significant
deletions or amplifications among the tumor samples.
Utilizing associated gene expression data, we predict
156 genes with significantly altered copy number and
correlated changes in expression. Among these genes,
CCNE1, POP4, UQCRB, PHF20L1, and C19orf2 were
identified within both data sets. We were specifically
interested in copy-number variation as our base ge-
nomic property in the prediction of tumor suppressors
and oncogenes in the altered ovarian tumor. We there-
fore identified changes in DNA methylation and ex-
pression for all amplified and deleted genes. We
predicted 615 potential oncogenes and tumor suppres-
sors candidates by integrating these multiple genomic
and epigenetic data types. Genes with a strong correla-
tion for methylation-dependent expression exhibited at
varying copy-number aberrations include CDCA8,
ATAD2, CDKN2A, RAB25, AURKA, BOP1, and
EIF2C3. Moreover, well-characterized tumor suppres-
sors and oncogenes exhibit varying copy-number vari-
ations, methylation, and expression features within
cancers. We therefore compared significant copy-num-
ber variation and methylation effects on expression for
many known tumor suppressors, oncogenes, and can-
cer-related genes in order to identify altered gene func-
tion properties specific to primary ovarian tumors. We
analyzed multiple genomic modalities from two pri-
mary ovarian tumor data sets for the identification of
candidate genes. We predict genes with tumor suppres-
sor and oncogenic properties, identifying new serous
ovarian cancer candidate genes. 
Resistance Mechanisms
in Ovarian Cancer
N. Cutter, M. Vigliotti, K. Wrzeszczynski
Epithelial ovarian cancer is the leading cause of death
from gynecological malignancies. Currently, platinum-
based chemotherapy (such as cisplatin or carboplatin),
coupled with a taxane-based drug such as paclitaxel, is
the primary treatment for ovarian cancer. Approximately
25% of patients either present with or rapidly develop
resistance to chemotherapy, and all recurrent tumors are
resistant. Epigenetic modifications have been associated
with tumor formation and progression and may con-
tribute to therapy response. We have screened a number
of genes and family members for methylation in resistant
patients and not in sensitive patients. We show for one
such gene, CHD3, a member of the Mi-2 NuRD com-
plex, that loss of expression is linked to chemoresistance.
CHD3 is silenced through an epigenetic mechanism in
both ovarian cancer cell lines and primary ovarian tu-
mors. When ovarian cancer cell lines that are transcrip-
tionally silenced for CHD3 are challenged with
carboplatin, they display a striking decrease in growth.
Additionally, these cells are more invasive, have migra-
tory ability, and display a transformed epithelial-to-mes-
enchymal (EMT) phenotype. Moreover, our results
indicate that cells silenced for CHD3 have an increased
resistance to the chemotherapy drugs carboplatin and
cisplatin. Taken together, this provides the first evidence
for a role for CHD3 as an important mediator of chemo-
resistance in ovarian cancer, and we hypothesize that
EMT is one of the underlying mechanisms. Further-
more, CHD3 might represent a response predictor and
potential therapeutic target for predicting chemoresis-
tance in this disease.
Genomic Alterations of Phosphatases
E. Lum, F. Chaudhary, G. Fan [in collaboration with
N. Tonks, Cold Spring Harbor Laboratory]
The goal of this collaborative study is to integrate gene
discovery technology with experimental strategies devel-
oped in Dr. Tonks’ lab for the characterization of the pro-
tein tyrosine phosphatase (PTP) family of enzymes, to
investigate how tyrosine phosphorylation-dependent sig-
naling pathways are disrupted in cancer. We have taken
advantage of several different forms of genomic data to
determine which PTPs are affected in cancer cells. 
We have used genomic copy-number data, expres-
sion data, and now epigenetic DNA methylation data
to determine which PTPs are altered in ovarian cancer.
We have also expanded our extension of analysis of
PTPs in cancer into the proteins with which PTPs in-
teract. An interesting gene in this class encodes the
MTSS1 protein that interacts with a PTP, the receptor-
like PTP RPTPδ, and regulates cytoskeletal organiza-
tion. It is known to be preferentially methylated in
several cancers, including breast cancer, and its expres-
sion is markedly decreased in ovarian cancer.
We first generated short hairpin RNAs (shRNAs) to
suppress expression of the MTSS1 gene in cell culture as-
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says, which would mimic the transcriptional repression
caused by promoter methylation. Because this gene was
selected based only on the comparison of tumor to nor-
mal, we did not have a selection for assay development.
We surmised that because MTSS1 possessed an actin-
binding domain, the protein might have a role in cy-
toskeletal rearrangement, cell movement, and invasion.
Therefore, we performed an invasion assay with MCF10A
mammary epithelial cells, which are used typically as a
normal line. We observed that very few cells migrate with-
out the addition of the attractant epidermal growth factor
(EGF). Furthermore, RNA interference (RNAi)-mediated
suppression of MTSS1 enhanced migration in the pres-
ence of EGF. There is evidence in the literature that in
ERBB2-positive breast cancer, there is loss of MTSS1 tran-
scription. To determine whether ERBB2 overexpression
synergizes with loss of MTSS1, we performed an invasion
assay in MCF10AN cells. These cells express a chimeric
ERBB2 gene in which the activity of the cytoplasmic PTK
domain of ERBB2 is acutely regulated by a small-molecule
dimerizing agent. We noted that the level of invasion is
highest in the cells in which MTSS1 was suppressed and
ERBB2 activated, demonstrating cooperation between
these two gene products. Our current data indicate that
these effects are mediated via changes in tyrosine phos-
phorylation regulated by RPTδ.
Michele Vigliotti
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The Mills laboratory generates novel mouse models and
uses them to identify the genes responsible for human
diseases of interest and to elucidate the mechanism
whereby the encoded proteins regulate the disease
process, with the ultimate goal of applying these find-
ings to the human disease under study. These ap-
proaches have provided significant insight into
developmental syndromes, aging, and cancer. Research
areas include (1) the role of CHD5 in chromatin dy-
namics and cancer and (2) function of the p53 ho-
molog p63 in development, cancer, and aging.
CHD5 in Chromatin Dynamics
and Cancer
CHD5: A new tumor suppressor mapping to human
1p36. CHD5 maps to 1p36, a region of the genome
that has a three-decade history as being deleted in a
wide variety of human cancers. Despite the rich body
of evidence indicating that one or more tumor suppres-
sors reside in this region, the causative gene had re-
mained elusive. By generating mice with gain and loss
of the genomic region corresponding to 1p36 using
chromosome engineering technology—a strategy that
allows us to generate precise rearrangements in the
mouse—we pinpointed a region of the genome with
potent tumor suppressive activity (Bagchi et al., Cell
128: 459–475 [2007]; Bagchi and Mills, Cancer Res 68:
2551–2556 [2008]). Using a series of genetic and mo-
lecular approaches, we identified Chd5 as the tumor
suppressor gene in the region and found that its prod-
uct was a master switch for a tumor suppressive net-
work. In addition, we discovered that CHD5 was
frequently deleted in human glioma. Identification of
CHD5 as a tumor suppressor had a major impact in
the cancer field, as it is now known that CHD5 is mu-
tated in human cancers of the breast, ovary, and
prostate, as well as in melanoma and neuroblastoma,
and that CHD5 status correlates directly with patient
survival following anticancer therapy.
Chd5 modulates chromatin dynamics and cancer.
Given the critical importance of CHD5 in human can-
cer, we focused on elucidating its mechanism of tumor
suppression. From our earlier work, we know that
Chd5 transcriptionally activates the Ink4/Arf locus,
thereby facilitating expression of p16 and p19, two
tumor suppressors encoded by this locus (Bagchi et al.,
Cell 128: 459–475 [2007]). Compromised Chd5 ac-
tivity, either by engineered heterozygous deletion of the
interval encompassing Chd5 or by specific depletion of
Chd5 using RNA interference (RNAi), cripples the
tumor suppressive network, compromising p16/Rb-
and p19/p53-mediated pathways, predisposing to can-
cer (Mills 2010). Chd5 is a predicted chromatin re-
modeling protein, consistent with the idea that it
regulates Ink4/Arf by maintaining this locus in a tran-
scriptionally competent chromatin state. 
Within the past year, we discovered that Chd5’s
tumor suppressive capability was dependent on its abil-
ity to bind amino-terminal tails of histone 3 (H3) that
are unmodified, an activity mediated by the dual plant
homeodomains (PHDs) of Chd5. Modeling provided
a testable explanation for this Chd5-H3 interaction,
and indeed, point mutations within the PHDs effec-
tively abolished H3 binding, abrogated the ability of
Chd5 to inhibit proliferation, and led to tumorigenesis
in vivo. In line with the findings from in vitro assays,
global chromatin immunoprecipitation sequencing
(ChIP-Seq) analyses indicate that Chd5-bound loci
tended to have less H3K4Me3 in vivo. These findings
provide mechanistic insight into Chd5’s ability to mod-
ulate chromatin dynamics and cancer.
Chd5-deficient mice are cancer prone. Although
the chromosome engineered mouse models were in-
valuable for functionally pinpointing the tumor sup-
pressive interval, the region affected was 4.3 Mb and
contained 52 annotated genes. To unequivocally
demonstrate the role of Chd5 in the context of sponta-
neous tumorigenesis, we generated mice deficient for
Chd5 and monitored for tumor development. Chd5–/–
MAMMALIAN FUNCTIONAL GENOMICS
A. Mills Y. Chang S. Paul
G. Horev Y.-E. Son
D.-W. Hwang E. Vernersson-Lindahl
W. Li A. Vestin
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mice were viable, yet like we had found for mice het-
erozygous for the 52-gene interval encompassing Chd5,
Chd5+/– mice were prone to spontaneous tumors such
as carcinoma, sarcoma, and lymphoma. We are cur-
rently analyzing these models to provide a better un-
derstanding of the biological role of CHD5 in vivo and
to assess how its perturbation affects chromatin dynam-
ics that precludes to tumorigenesis. This work should
provide the groundwork for developing more effective
anticancer therapies in the future.
Function of the p53 Homolog p63
in Development, Aging, and Cancer
p63 is essential for development. A long-standing focus
of the laboratory has been to elucidate the in vivo role
of p63—a p53-related protein that we discovered to be
a new member of the p53 family. With the advent of
the p53 family of proteins, the leading question in the
cancer field was whether p63 (and its sibling p73) had
tumor suppressive capabilities similar to p53. Using ge-
nomic technologies that we were just in the process of
developing, we generated p63-deficient mouse models
and discovered that p63 was essential for development
of the limbs and stratified epithelia (Mills et al., Nature
398: 708–713 [1995]). This demonstrated that even
though p63 had significant homology with p53, it had
distinct biological roles in vivo. These mouse models
provided a clue that revealed that p63 mutations were
responsible for seven different human developmental
disease syndromes. Because some of these syndrome-re-
lated p63 mutations correlated precisely with p53 hot-
spot mutations found in human cancer, we used a
gene-targeted knockin to generate mouse models carry-
ing these missense mutations, allowing us to recapitulate
the human disease as well as to establish a link between
this syndrome and cellular senescence.
p63 modulates aging and cancer.During our studies
aimed at determining whether p63 had the same tumor
suppressive capabilities as p53, we uncovered an unex-
pected link between p63, cellular senescence, and aging
(Keyes et al., Genes Dev 19: 1986–1999 [2005]). The
conditional mouse models we established were the first
to implicate p63 as a modulator of cellular senescence,
as well as the first to uncover a link between cellular
senescence and organismal aging in vivo. Whereas p53
was known as an inducer of senescence, we found that
p63 deficiency triggered this process. Our realization that
p63 compromised mice were not prone to spontaneous
or chemically induced tumors suggested that the ability
of p63 loss to trigger senescence provided a robust tumor
protective mechanism that could be exploited therapeu-
tically. Indeed, we recently reported that TAp63 isoforms
are potent tumor suppressors that induce senescence and
shut down growth of p53-deficient/Ras-driven tumors
in vivo (Guo et al., Nat Cell Biol 11: 1451–1457
[2009]). Using chromosome engineering, we established
conditional mouse models in which we could specifically
ablate TAp63 isoforms while keeping ∆Np63 isoforms
intact, allowing us to demonstrate that TAp63 isoforms
prevent sarcoma development in vivo. In contrast to this
tumor suppressive role of TAp63 in mesenchymal cells,
we discovered that in the context of epithelial cells,
∆Np63α bypasses senescence, thereby promoting stem-
like proliferation and carcinoma development in vivo
(Keyes et al. 2011). We found that ∆Np63α maintains
the keratin-15-positive stem cell population, promoting
senescence bypass and carcinogenesis by inducing ex-
pression of the SNF2-like chromatin remodeler Lsh.
These findings provide an explanation for ∆Np63α
overexpression being such a frequent and highly pene-
trant event in human carcinoma. In addition, this work
suggests that transformation of the keratin-15-expressing
stem population lies at the heart of carcinoma—the
most prevalent type of human cancer. Thus, our work
identifies p63 as a key modulator of cellular senescence,
with TAp63 isoforms being tumor suppressors that pre-
vent sarcoma, and ∆Np63α being an oncogene that
drives carcinoma development. This not only highlights
the distinct tissue-specific roles of p63 isoforms; our
work provides an explanation for the “tumor suppressive
versus oncogenic” debate that has surrounded this p53
family member since its discovery. The double-edged
tumor suppressive/oncogenic picture that has emerged
for p63 is now being extended to p53 itself, as the tis-
sue-specific roles of the multiple p53 isoforms in cancer
are just beginning to be appreciated. 
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Our laboratory studies cancer in order to find out more
about its basic causes but also to contribute directly to
its treatment. Our primary focus has been the identifi-
cation and functional validation of genetically altered
driver genes (oncogenes) that together with genetically
altered tumor suppressor genes are the cause of the can-
cer. Our approach is always to study the process from
as wide a perspective as possible, which means that we
consider every gene in the genome. 
Identification of Driver Genes 
and Therapeutic Targets in
Hepatocellular Carcinoma 
E. Sawey, M. Chanrion, J. Li, A. Mofunanya [in 
collaboration with S. Lowe, Cold Spring Harbor
Laboratory; R. Finn, University of California, 
Los Angeles; D. Chiang, University of North 
Carolina; D. French, Genentech] 
Hepatocellular carcinoma (HCC) afflicts more than
560,000 people worldwide each year and has one of the
worst 1-year survival rates of any cancer type. Currently,
there are no molecular therapies that target specific mu-
tations or other genetic alterations in HCC. By per-
forming a forward-genetic screen guided by genomic
analysis of human HCC, we identified 18 tumor-pro-
moting genes, including CCND1 and its neighbor on
11q13.3, FGF19. Although it is widely assumed that
CCND1 is the main driving oncogene of this common
amplicon (15% frequency in HCC), both forward-
transformation assays and RNA interference (RNAi)-
mediated inhibition in human HCC cells established
that FGF19 is an equally important driver gene in
HCC. Furthermore, clonal growth and tumorigenicity
of HCC cells harboring the 11q13.3 amplicon were se-
lectively inhibited by RNAi-mediated knockdown of
CCND1 or FGF19, as well as by an anti-FGF19 anti-
body. These results show that 11q13.3 amplification
could be an effective biomarker for patients most likely
to respond to anti-FGF19 therapy. Our study under-
scores the potential for clinical translation of results ob-
tained from genetic screens guided by cancer genome
analysis. 
This year, we completed a pilot program to find mu-
tations in the exome of primary HHCs, with the pri-
mary goal of finding recurrent oncogenes. On the basis
of our analysis in collaboration with Derek Chiang at
the University of North Carolina, CTNNB1 is the most
commonly mutated oncogene in HCC, and the rest ap-
pear to be low-frequency events, similar to what has
been found in other epithelial cancers.
Of course, the best targets for treating HCC do not
necessarily have to be the driver oncogenes. In principle,
other alterations that occur during HCC progression
could cause certain tumor dependencies that would not
be found in normal liver cells. To find these, A. Mofu-
nanya has been screening human HCC cells for tumor
dependencies using genome-wide RNAi screens under
conditions of hypoxia to more closely mimic the phys-
iological state of tumor cells growing in vivo. 
Identification of Driver Genes
and Therapeutic Targets in
Ovarian Carcinoma
E. Sawey, M. Gallo, R. Gerdes, J. Marchica, J. Li [in 
collaboration with A. Krasnitz, S. Lowe, Cold Spring 
Harbor Laboratory; K. Cho, University of Michigan; 
S. Orsulic, Cedars-Sinai; NCI Cancer Target Discovery 
and Development Network (CTD2)]
A group of scientists here at CSHL received funding
from the National Cancer Institute (NCI) for a pilot
project in translating genomic information emanating
from cancer genome projects such as TCGA into ther-
apeutic targets. The strategy of the CSHL CTD2 group
for discovering and developing targets incorporates com-
putational analysis of cancer genomes with oncoge-
nomic screening and mouse modeling. This year, we
have analyzed more than 500 ovarian cancer (high-grade
serous) genomes and found an amazing degree of DNA
copy-number instability. Through an innovative ap-
proach to make sense of this chaos, Alex Krasnitz found
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the most consistently recurring alterations, and based
on this analysis, we screened more than 100 of the af-
fected genes in a transplantable mouse model for ovarian
cancer and discovered that 24 of these can promote tu-
morigenicity. Although this is just the beginning, Shirley
Guo in Scott Lowe’s group has begun application of the
“speedy” mouse model to determine the suitability of a
subset of these oncogenes as therapeutic targets.
Studies of the DNA Methylome of HCC
K. Revill [in collaboration with R. Finn, University 
of California, Los Angeles; T. Wang, Massachusetts 
Institute of Technology] 
Recent advances in whole-genome methylation profiling,
specifically the Illumina Infinium platform, have allowed
us to investigate the methylation status of a cohort of
more than 50 HCC and normal liver samples for which
we also investigated the expression and gene copy num-
ber (CGH) status. We have been able to identify two very
distinct groups of HCCs based on their methylation sta-
tus. In each class of tumors, there are both hypo- and hy-
permethylated genes relative to normal liver. Several of
these tumor-specific alterations have been validated by
pyrosequencing. In one class of tumors, many genes that
are normally repressed by polycomb group proteins in
stem cells are hypermethylated, consistent with the
tumor cell of origin being a progenitor stem cell. The
other class of tumors does not show this association and
likely originate from a different type of normal cell. In-
triguingly, these two classes also correspond to distinct
groups based on both DNA copy-number analysis and
expression analysis. Combining these three independent
methods of global analysis—transcriptome profiling,
epigenome analysis, and aCGH data—has provided a
robust new classification scheme for HCC.
Identification of Sensitizers
to PI3K Inhibitors
C. Eifert [in collaboration with R. Wooster, 
GlaxoSmithKline] 
We previously reported on using Greg Hannon’s RNAi
library to screen for sensitizers to a polo-like kinase in-
hibitor and through that discovered that retinoic acid
sensitizes lung cancer cells to this mode of inhibition.
This year, we have looked at genes that if inhibited, to-
gether with partial inhibition of phosphoinositol-3-ki-
nase (PI3K), could enhance killing of cancer cells. Thus
far, we have validated another enzyme upstream of the
PI3-biosynthetic pathway, as well as a relatively under-
studied glucose transporter. 
Identification of Oncogenic Determinants
in the Tumor Cell of Origin
M. Chanrion, E. Sawey
The notion that the phenotype of individual human tu-
mors results from its own specific set of accumulated
mutated oncogenes and tumor suppressor genes forms
the major framework behind many studies into the un-
derlying causes of specific cancer phenotypes. In con-
trast, it is rarely addressed whether the differentiated
state of the normal cell of origin has a role in the phe-
notypic behavior of tumor cells following their acquisi-
tion of mutated cancer genes, despite examples where it
clearly has profound effects. In fact, certain molecular
subclasses of HCCs are likely to reflect different cells of
origin, but the genes that underlie their different malig-
nant properties are poorly understood. We developed an
approach to find oncogenic determinants within tumor
cells of origin that draws on pathway and functional
analysis of different cells of origin in a mouse model in-
tegrated with parallel analysis of human HCC. Using
this approach, we identified higher levels of RXRα in
differentiated mouse hepatocytes and its associated sub-
class of human HCC as a potential oncogenic determi-
nant. This was confirmed by demonstrating that
RNAi-mediated silencing of RXRα in hepatocytes con-
fers immature hepatoblast-like properties to their sus-
ceptibility to malignant transformation, consistent with
its role in coordinating nuclear receptors involved in
growth and differentiation. We also found that more dif-
ferentiated HCC cells expressing higher levels of RXRα
are the only type that can be inhibited by retinoids,
which were previously tried on HCC patients indiscrim-
inately. These results demonstrate the potential of this
unbiased genomic approach to discover the genes un-
derlying differential malignant properties of distinct
tumor cells of origin and furthermore that such genes
can be critical determinants of treatment response. 
Identification and Functional Analysis
of Genes Involved in Breast Cancer–
Stromal Fibroblast Interactions
M. Rajaram [in collaboration with M. Egeblad, Cold Spring
Harbor Laboratory]
Although some molecules that mediate the protumori-
genic interaction of stromal fibroblasts and cancer cells
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have been identified, there is still uncertainty about the
nature and scope of all relevant interactions. To address
this issue, we developed a model for breast cancer—stro-
mal fibroblast interaction using coculture and coxeno-
grafting of human breast cancer cell lines with fibroblasts
that stimulate tumorigenic growth (productive fibrob-
lasts) or other fibroblasts that do not (nonproductive fi-
broblasts). By transcriptome profiling and pathway
analysis, we found that the signaling pathways activated
specifically in productive fibroblasts when cocultured
with tumor cells overlapped significantly with pathways
activated in the stroma of human breast cancer samples
relative to stroma from normal breast tissue. Pathways
that were up-regulated in both our model system and in
human breast cancer stroma included extracellular ma-
trix interactions, cytokine–cytokine receptor interac-
tions, and integrin signaling. Of note was that not only
were a large number of ligands and receptors up-regu-
lated in productive fibroblasts, but their reciprocal lig-
ands/receptors were also up-regulated in the cocultured
breast cancer cells. Because this analysis pinpointed a
large number of potentially important up-regulated
genes, we used short hairpin RNA (shRNA) knockdown
to test for their functional relevance in promoting
tumor–stromal cooperativity in vivo. For example, the
ability of productive fibroblasts containing stable
shRNAs toward CCL2 to cooperate with breast cancer
cell lines in a coxenograft model was significantly dimin-
ished. Furthermore, a similar effect could be achieved
by silencing one of its receptors—CCR1 on the breast
cancer cells. Our results indicate that a productive in-
teraction may be mediated by several different genes be-
longing to diverse pathways acting together to promote
tumorigenesis. 
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Our group uses methods for comparative genome analy-
sis to study cancer and human genetic disorders. New
mutations, somatic and germline, underlie the cancers
and human genetic disorders. Our main focus to date
has been studying mutations that change the numbers
of copies of sections of the genome, causing regions of
deletion and duplication, in cancer and pediatric disor-
ders. Our research in cancer is a collaborative effort to
discover mutational patterns that predict clinical out-
come. Additionally, we have recently developed methods
for the analysis of the genomes of single cells, which has
led to new insights into tumor evolution and metastasis.
This work has application to the early detection of can-
cer and its recurrence. Our work on human genetic dis-
orders is predicated on the hypothesis that common
disorders under strong negative pressure result from new
and rare variants of high penetrance. Our methodology
is therefore directed to their discovery. We have made
headway in the discovery of the causative mutations in
autism. The same underlying theory and methodology
are being applied to other disabling genetic disorders,
such as congenital heart disease and pediatric cancer. All
of our programs are collaborative.
Cancer 
Our work in cancer is divided into three parts. First,
we do outcome research (Hicks et al., Genome Res 16:
1465 [2006]). We use copy-number profiling to find
markers that predict which breast cancers respond to
which therapies. In particular, we ask which patients
will respond to drugs targeting the Her-2 receptor. We
are also studying ductal carcinoma in situ (DCIS) to
determine if there are reliable markers that reliably pre-
dict progression to invasive disease. This work has re-
quired finding solutions to the technological problems
of extracting DNA from formalin-fixed and paraffin-
embedded tissue and forming collaborations with clin-
ical oncologists (e.g., Larry Norton at Memorial Sloan-
Kettering Cancer Center and Lindsay Harris at Yale).
Second, we pursue studies to elucidate the ontogeny
of cancer based on the analysis of population substruc-
ture. We used subpopulation partitioning to demon-
strate the clonal heterogeneity of some breast cancers
(Navin et al. 2010), and then developed single-cell se-
quencing techniques to study this in greater depth
(Navin et al. 2011). The single-cell analysis revealed the
population substructure of two cancers. One breast can-
cer was what we call monogenomic, with one major ad-
vanced subpopulation, and another cancer was what we
called polygenomic, with multiple advanced subpopu-
lations. No intermediate cells were found, suggesting
that successful clones emerge suddenly during tumor
formation, probably marking a phase change in the
tumor growth pattern, and lead to metastasis. (There
is an alternate hypothesis to explain the absence of in-
termediate cells, namely, that the cancers evolve off site,
diverge greatly from their progenitors, and then rein-
vade the primary site.) One fundamentally surprising
finding was the presence of a major subpopulation of
pseudodiploid cells, each with many genomic markers,
but none that resembled each other or the advanced
tumor subpopulations. We suspect, but have not yet
proven, that these cells are indicators of the presence of
an early diploid progenitor of the tumor that benefits
from, and may benefit, the advanced subpopulations. 
The applications of single-cell genomic sequencing
are potentially profound. Critical to all applications is
developing the method so that it is inexpensive, en-
abling the sequencing of hundreds or even thousands
of single cells in parallel for the cost of sequencing one
genome in depth. Fortunately, to be useful, single-cell
sequencing does not need deep coverage, so this goal is
theoretically feasible. When we achieve this goal, appli-
cations include detecting cancer cells in blood and other
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body fluids for the purpose of monitoring early occur-
rence or recurrence, extracting more information from
biopsies, even directing the placement of surgical
boundaries. This is the third part. 
Genetic Disorders
After our discovery that copy-number variation is com-
mon in the human gene pool (Sebat et al., Science 305:
525 [2004]), we studied the role of copy-number vari-
ants (CNVs) in human disease and, in particular, in the
role of spontaneous (or de novo) germline CNVs. Our
findings established that germline mutation is a more
significant risk factor for autism spectrum disorders
(ASD) than previously recognized (Sebat et al., Science
316: 445 [2007]), and established a new approach for
the further study of the genetic basis of this and other
genetic disorders. We also study the role of spontaneous
mutation in congenital heart disease (a collaboration
with Dorothy Warburton at Columbia University),
rheumatoid arthritis (with Peter Gregersen at North
Shore University Hospital), and pediatric cancers (with
Ken Offit at Memorial Sloan-Kettering Cancer Center,
New York).
One of the de novo events we identified in autism in
our 2007 paper was a deletion on 16p. This event has
now been shown by two other groups to explain perhaps
as much as 1% of autism. We assisted Alea Mills of
CSHL to engineer mice with the orthologous deletion
on mouse chromosome 7, and she has continued to
search for phenotypic consequences. We are hopeful that
these mice will provide animal models suitable for un-
derstanding the underlying neuropathology of the con-
dition and the search for palliative treatments.
Analysis of autism incidence in families, a collabora-
tion with Kenny Ye at Albert Einstein School of Medi-
cine, provided evidence for a unified theory of the
genetic basis for the disorder (Zhao et al., Proc Natl Acad
Sci 104: 12831 [2007]). Autism families are divided into
simplex (only one affected child) and multiplex (multi-
ply affected children). By inspecting the records from
the AGRE consortium, we found that the risk to a male
newborn in an established multiplex family is nearly
50%, the frequency expected of a dominant disorder.
Autism incidence and sibling concurrence rates are con-
sistent with a model in which new or recent mutations
with strong penetrance explain the majority of autism
in males and are consistent with a one-hit event. 
We are now in the midst of a larger study of sponta-
neous mutation in autism, based on a population of
simplex families (families with only one child on the
spectrum, and at least one unaffected child) collected
by the Simons Foundation. Early initial results confirm
our previous findings, and we observe de novo (copy-
number) mutation more frequently in children with
autism than in their unaffected siblings. The statistical
evidence is strong for deletion events, but much weaker
for amplifications, an assessment that was not possible
before because of lack of statistical power. Because our
new studies are performed with higher-resolution mi-
croarrays, we also see many more examples of narrow
new mutations (altering only a few genes), thus expand-
ing our list of good candidate genes involved in the dis-
order. 
Our analysis of autism families has revealed two ad-
ditional major findings. The first is statistical evidence
that inheritance of rare copy-number variation also has
a role in contributing to autism risk. The second is the
relative absence of inherited rare deletions affecting
genes compared to inherited rare duplications affecting
genes. The clear implication is that most deletions are
under strong negative pressure and is consonant with
the observation that de novo deletions are more
strongly implicated in autism than are duplications.
Our study based on copy number does not pinpoint
the genes that cause autism, because even the narrow
events typically contain multiple genes. Pathway analy-
sis, performed in collaboration with Ivan Iossifov of
CSHL and Dennis Vitkup of Columbia University,
does suggest a plausible set of interrelated genes. We
are now pursuing our leads by sequence analysis of
trios (mother, father, and child) from the Simons col-
lection (a collaboration with the McCombie lab at
CSHL). We are conducting a search for recurrent de
novo point mutations that disrupt function in candi-
date genes. From our unified hypothesis, knowledge
of the rate of de novo mutation in the germline, and
the rate of autism in males, we estimate that there are
on the order of 300–500 autism genes. In the 1000+
trios we expect to sequence, we predict to see a signal
in the form of recurrent mutations only in the actual
autism genes. 
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Signal transduction focuses on signaling pathways and cell architecture in normal and cancer cells.
Mikala Egeblad and colleagues study tumors, and in particular, the microenvironment in which
tumors arise and live. Solid tumors are abnormally organized tissues that contain cancer cells, stromal
cells, and the extracellular matrix. Communications among the different components of the tumor
influence its progression, for example, by regulating metastasis, the immune response to tumors, or
the response to therapy. The lab seeks to separate functions and behaviors of the different stromal
components of tumors, using mouse models of breast cancer and real-time imaging of cells in tumors
in live mice. This enables them to follow the behaviors of and the interactions between cancer and
stromal cells in tumors during progression or treatment. Among the tumor-associated stromal cells,
their main focus is on myeloid-derived immune cells, a diverse group of cells that can enhance an-
giogenesis and metastasis and suppress the immune response against tumors. Egeblad is interested
in how different types of myeloid cells are recruited to tumors and how their behavior in the tumor
microenvironment, for example, their physical interactions with cancer cells and other immune
cells, influences cancer progression. Stromal cells and the extracellular matrix can also influence
drug responses, for instance, by impairing drug delivery to the cancer cells. The lab is addressing
how therapy affects cancer and stromal cells in different tumor microenvironments, in part by using
imaging to follow the response to chemotherapy in mice in real time.
Yuri Lazebnik and colleagues study cell fusion in the context of the hypothesis that viruses and
other common human pathogens might cause cancer under certain conditions. They have estab-
lished that massive chromosomal instability can be engendered by a transient event causing genomic
destabilization without permanently affecting mechanisms such as mitosis or proliferation. The
agent, in this instance, is an otherwise harmless virus that causes chromosomal disruption by fusing
cells whose cell cycle is deregulated by oncogenes. The resulting cells have unique sets of chromo-
somes and some can produce aggressive epithelial cancers in mice. Having developed a method of
producing hybrid cells more efficiently—a means of isolating viral fusogenic proteins—Lazebnik
and colleagues are attempting to induce fusion under controlled conditions in order to explore the
consequences for cell viability and survival.
Changes in tissue architecture are often the first signs of cancer, but very little is known about
the genes, proteins, and pathways that regulate cellular shape and polarity. Senthil Muthuswamy
has developed a new paradigm for thinking about this aspect of cancer biology. Using sophisticated
model systems such three-dimensional cell culture platforms and transgenic mice, his team found
that a protein called Scribble normally regulates proper differentiation of breast epithelial cells and
coerces them into the correct organization and shape and enforces resistance to cancer. They also
found that deregulation of the Scribble pathway results in the development of undifferentiated tu-
mors in mice. Muthuswamy’s team finds that Scribble is frequently mislocalized from cell mem-
branes or not expressed in human breast cancer lesions, which suggests that understanding the
pathways regulated by Scribble can identify therapies aimed at preventing precancerous lesions from
becoming invasive.
Darryl Pappin’s lab develops chemical and computational methods for analysis of proteins and
peptides. These are fundamental tools for proteomics and are vital in many fields of biological in-
vestigation. Proteins and peptides are typically analyzed via mass spectrometry, a method that in-
volves fragmenting samples by colliding them with gas atoms in a vacuum. Masses of the resulting
fragments are measured, and computer algorithms match results with known or predicted molecules
whose amino acid sequences are either known or inferred. Pappin has developed search engines for
mass spectrometry data that enable investigators to sift hundreds of thousands of experimental spec-
tra at a time for database matches. He also seeks to reduce sample complexity via an approach he
calls chemical sorting. This includes the use of chelation to enrich phosphopeptides from the total
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peptide pool and the use of specific affinity-tagged small-molecule inhibitors to segregate classes of
kinases or phosphatases for more specific mass spectroscopic analysis.
Despite their large variety of genetic abnormalities, cancer cells have been found to be extremely
sensitive to the reversal of certain mutations. Raffaella Sordella and colleagues study why cells in
certain cancers are responsive to the inhibition of one particular gene or gene product. Why, for in-
stance, do non-small-cell lung cancer (NSCLC) cells that have a particular mutation in the EGF
(epidermal growth factor) receptor respond dramatically to its inhibition by the drug Tarceva? This
occurs in 15%–20% of patients, the great majority of whom, within 1–3 years, develop resistance.
Various mutations have been implicated in about half of resistant patients. This year, Sordella and
colleagues discovered a new resistance mechanism in a subpopulation of NSCLC cells that are in-
trinsically resistant to Tarceva. These tumor cells were observed to secrete elevated amounts of a
growth factor called transforming growth factor-β (TGF-β), which in turn increases secretion of
interleukin-6 (IL-6), an immune signaling molecule. Significantly, these effects were independent
of the EGF receptor pathway. The team therefore hypothesizes that inflammation is one factor that
can render a tumor cell resistant to treatment with Tarceva.
Nicholas Tonks and colleagues study a family of enzymes called protein tyrosine phosphatases
(PTPs), which remove phosphate groups from other proteins. By changing the phosphorylation
state of proteins, PTPs can profoundly affect the health of entire organisms. Tonks’ group seeks to
characterize fully the PTP family, understand how its activity modifies signaling pathways, and how
those pathways are abrogated in serious illnesses, from cancer to Parkinson’s disease. The overall
goal is to identify new targets and strategies for therapeutic intervention in human disease. They
have, for instance, sought to define the role of JNK stimulatory phosphatase 1 in regulating a sig-
naling pathway critical in Parkinson’s and have investigated new roles for PTPs in regulating sig-
naling events in breast cancer, identifying three PTPs as potential novel tumor suppressors. This
year, Tonks and colleagues published results of experiments suggesting one way in which cascades
of intracellular signals are regulated at what they call a decision point, where cells commit to repair
broken DNA strands or commit suicide following DNA damage. A protein, EYA, was found by
the lab to regulate the formation of specialized microenvironments on DNA called γ-H2A.X foci,
which allow the cell to summon repair enzymes to the site of broken DNA strands.
Several years ago, Lloyd Trotman discovered that the loss of a single copy of a master tumor sup-
pressing gene called PTEN is sufficient to permit tumors to develop in animal models of prostate
cancer. His team later found that complete loss of PTEN paradoxically triggers senescence, an ar-
rested state that delays or blocks cancer development in affected cells. These findings explained why
many patients only display partial loss of this tumor suppressor and established a novel mechanism
of cancer initiation. His lab has recently been expanding these findings in collaboration with clini-
cians at Memorial Sloan-Kettering Cancer Center, with the aim of identifying patients who have
developed tumors with metastasis-favoring mutations. The interdisciplinary team aims to generate
mouse models that accurately reflect the core genetic changes driving human metastatic prostate
cancer, with the aim of developing novel molecular assays that separate the few men who are at risk
of developing lethal disease from the rest. Moreover, their mouse models can be used to test new
therapies using small molecules or RNA interference technology developed at CSHL. Trotman’s
lab also is studying regulation of PTEN stability and nuclear transport, because many patients have
tumors that aberrantly target PTEN for cytoplasmic degradation.
Linda Van Aelst’s lab studies how aberrations in intracellular signaling involving enzymes called
small GTPases can result in disease. They are particularly interested in Ras and Rho GTPases, which
help control cellular growth, differentiation, and morphogenesis. Alterations affecting Ras and Rho
functions are involved in cancer and various neurodevelopmental disorders. This year, Van Aelst’s
team extended their study of mutations in a Rho-linked gene called oligophrenin-1 (OPHN1), part
of an effort to connect the genetic abnormalities associated with mental retardation to biological
processes that establish and modify the function of neuronal circuits. In addition to a role for
OPHN1 in activity-driven glutamatergic synapse development, they obtained evidence that OPHN1
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also has a critical role in mediating mGluR-LTD, a form of long-term synaptic plasticity, in CA1
hippocampal neurons. Their findings provide novel insight not only into the mechanism and func-
tion of mGluR-dependent LTD, but also into the cellular basis by which mutations in OPHN1
could contribute to the cognitive deficits in patients. In addition, the Van Aelst team discovered a
critical role for a novel activator of Rho proteins in the genesis of cortical neurons. Defects in cortical
neurogenesis have been associated with cerebral malformations and disorders of cortical organization.
They found that interfering with the function of the Rho activator in neuronal progenitors in em-
bryonic cerebral cortices results in an increase in the number of proliferating neuronal progenitors
and defects in the genesis of neurons. This provides novel insight into mechanisms that coordinate
the maintenance of the neural progenitor pool and neurogenesis.
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Solid tumors are composed of the cancer cells and the
stroma, a supportive framework. The stroma include
the extracellular matrix (ECM), which is composed of
proteoglycans, hyaluronic acid and fibrous proteins
(e.g., collagen), and stromal cells. The stromal cells in-
clude mesenchymal supporting cells (e.g., fibroblasts
and adipocytes), cells of the vascular system, and cells
of the immune system. Interactions between epithelium
and stroma are essential for normal organ development.
As tumors develop and progress, they undergo dramatic
morphological changes, which involve both the cancer
cells and the stroma. Stromal components that have
been proposed to have a more pronounced tumor-pro-
moting function in advanced stages than in earlier
stages include the immune cell infiltrate.
We have developed an imaging method that permits
real-time spinning-disk microscopy of tumor–stroma
interactions in mouse models of human breast cancer.
This allows us to follow, for example, vascular leakage,
immune cell infiltration, and cancer cell proliferation
and death in real time. We use this technology to un-
derstand how breast cancer is affected by the stroma. 
Effects of the Tumor Microenvironment on
Response to Cancer Therapy
When tumors do not respond to treatment, patients
die. However, it is often impossible to predict the clin-
ical response. Understanding the mechanism of therapy
resistance is therefore of vital concern. Surprisingly little
is known about how cancer cells in intact tumors re-
spond to classical chemotherapy, although these drugs
have been used for decades. Most knowledge on the re-
sponses has been obtained from cell culture or xenograft
animal experiments, but such experiments are often not
predictive of drug responses in patients. 
Development of resistance can be caused by cancer
cell intrinsic factors (genetic or epigenetic changes) or
by extrinsic factors such as survival factors secreted from
stromal cells or impairment of drug penetration
through the altered tumor ECM. Certain organs, such
as the bone marrow and the thymus, have been shown
to offer protection from chemotherapy mediated by se-
creted factors from stromal cells (e.g., interleukin 6).
However, it is not known how the evolving microenvi-
ronment of solid tumors shapes drug sensitivity.
We are using in vivo spinning-disk confocal imaging
to study drug sensitivity in the context of evolving
tumor microenvironments. We have treated mouse
models of mammary carcinoma with doxorubicin and
observed very varied drug response between individual
tumors. Using imaging, we revealed that the microen-
vironment of different tumor stages participated in reg-
ulating the drug response. Early-stage lesions responded
poorly compared to intermediate-sized, early carcinoma
stage tumors. However, in vitro, sensitivity to doxoru-
bicin was similar for cancer cells from different stages.
Live imaging further showed that cell death started ~24
h after doxorubicin treatment and that stromal cells as
well as cancer cells in the tumor mass were killed. Treat-
ment also led to a new microenvironment, as dead cells
recruited new myeloid-derived cells, changing the mi-
croenvironment of the responding tumors. Myeloid cell
infiltration was associated with increased vascular per-
meability, and tissue penetration of dextran and doxoru-
bicin was most prominent in the early carcinoma stages.
When vascular permeability was increased by deleting
matrix metalloproteinase (MMP) 9, an improved re-
sponse to doxorubicin was observed in ErbB2-driven tu-
mors. In conclusion, imaging intact tumors acutely after
treatment with chemotherapy revealed a complex and
evolving relationship among microenvironment, drug
penetration, and the drug sensitivity of cancer cells.
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During the last year, we continued to test a hypothesis,
which we proposed previously, that some viruses can
contribute to carcinogenesis and tumor progression by
fusing cells. Two consequences of such fusion are of par-
ticular interest. One is an abnormal combination of
properties in a cell that is derived from fusion of cells
of different types, such as a transformed cell and a bone
marrow stem cell. The hypothesis that such an outcome
could be consequential to carcinogenesis was supported
by recent findings that bone marrow stem cells fuse to
differentiated cells in the body and reprogram the re-
sulting hybrids into progenitors. Remarkably, it was
also found that the rate of stem cell fusion increases
manyfold in animals that were irradiated or suffered
from chronic inflammation. Another consequence of
cell fusion is chromosomal instability (CIN), which is
a well-known feature of cell hybrids, although the
mechanistic link between cell fusion and CIN is poorly
understood. The facts that CIN is also a common fea-
ture of solid cancers and that cells of many of these tu-
mors have increased ploidy suggested that cell fusion
could be one of the processes that trigger CIN in pre-
malignant cells. A recent report that carcinogenesis in-
volves a yet to be identified “single catastrophic event”
that causes massive rearrangement in one or more chro-
mosomes suggested again that this event could be cell
fusion. 
During the last year, we focused our limited resources
on understanding the fate of tetraploid cells, which are
formed by cell fusion or cytokinesis failure. According
to a long-standing model, many solid cancers are caused
by chromosomal aberrations consequent to tetraploidy.
Two mechanisms for these aberrations have been con-
sidered: (1) spontaneous chromosome missegregation
with gradual accumulation of aberrations and (2) mul-
tipolar mitosis, which can cause multiple aberrations
and produce cells with ploidy characteristic of solid can-
cers merely by distributing four chromosome comple-
ments among three daughter cells (Fig. 1). However, the
prevailing view is that such distribution is too chaotic
to result in viable progeny, a minimal requirement for
carcinogenesis. We questioned this assumption by ana-
lyzing multipolar mitoses caused in normal human cells
by the ability of oncoprotein E1A to inhibit centrosome
clustering. We showed that during these mitoses, chro-
mosomes distribute not as random individual entities,
as commonly presumed, but in partial or complete chro-
mosome complements, as was proposed for bipolar mi-
tosis. We found that the resulting progeny is viable and
that multipolar mitosis can frequently produce near-
diploid daughters (Fig. 1), which suggests that even
some near-diploid cancers might have a tetraploid pre-
cursor. Considering the track record of E1A for uncov-
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Figure 1. Multipolar mitoses caused by E1A produce diverse and
viable progeny. (A) To visualize centrosomes and chromatin,
DERP cells (DEIR transduced with p53R175H) were transduced with
α-tubulin–EGFP and H2A–Cherry. The resulting cell line (DERP-
HT) was processed with blebbistatin to obtain binuclear cells that
were recorded by confocal time-lapse microscopy as they were
entering mitosis. The recordings were analyzed to determine how
the cells divided (B). The thickness of the arrows in B is propor-
tional to the number of cells that took a particular route, which
were designated R1.1 to R3.2. Note that expressing α-tubulin–
EGFP increased the incidence of multipolar mitoses, perhaps by
interfering with the endogenous α-tubulin.
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ering oncogenic pathways, and our finding that this
oncogene inhibits centrosome clustering, we proposed
that E1A mimics oncogenic events that cause multipolar
mitosis and the consequent chromosomal aberrations in
human neoplasia.
To facilitate studies on the consequences of cell fu-
sion, in particular those to genome stability, we reported
a simple, versatile, scalable, and nontoxic approach to
cause cell fusion in vitro. We called this approach V-fu-
sion, as it is based on the ability of the vesicular stom-
atitis virus G protein (VSV-G), a viral fusogen of broad
tropism, to become rapidly and reversibly activated. We
suggest that this approach will benefit a broad array of
studies that investigate consequences of cell fusion or
use cell fusion as an experimental tool.
During the last year, we were pleased to note that
our suggestion, which we reported in 2007, that me-
tabolism of glutamine should be revisited as a promis-
ing target for cancer therapy has been successfully
implemented by a number of laboratories and pharma-
ceutical companies.
Finally, we published a commentary that questions
the prevailing and widely accepted view of cancer as a
combination of six hallmarks. We hope that this com-
mentary will help to maintain a healthy discussion
about the origin and nature of the disease that remains
as incurable as it has been for decades in a majority of
instances.
Overall, we hope that our research will help to de-
velop an experimental and conceptual framework to
test the role of cell fusion, ploidy increase, and chro-
mosomal instability in cancer. 
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Pathologists use a number of criteria to diagnose and
predict prognosis of premalignant breast lesions. Salient
among them are changes in cell number and in cell and
tissue architecture. Although we are beginning to un-
derstand a lot about the mechanisms that regulate cell
proliferation, very little, if anything, is known about
the mechanisms that regulate disruption of cell and tis-
sue architecture. We believe that gaining better insights
into the mechanisms that regulate changes in cell archi-
tecture during the development and progression of pre-
malignant lesions will identify molecular targets that
pathologists can use to better prognose premalignant
lesions. In this process, we may also identify novel
strategies to treat premalignant disease. 
The epithelial cells lining the luminal space have an
asymmetric distribution of membrane proteins where
the membrane that is in contact with lumen, referred
to as the apical surface, is rich in glycoproteins and mi-
crovilli, and the membrane that is in contact with the
neighboring cell or the surrounding tissue is rich in
cell–cell and cell–matrix junctions and is referred to as
the basolateral surface. This characteristic organization
is lost early in premalignant disease, and the tissue con-
tinues to lose its structure and organization during pro-
gression to malignancy. Surprisingly, we know little
about what role these changes have during the cancer
process and, more importantly, if the changes observed
in premalignant lesions are harbingers of what is yet to
come.
We recently demonstrated that the oncogene ErbB2
interacts with Par6/aPKC, a protein complex involved
in the regulation of asymmetric cell division, cell junc-
tion biogenesis, and epithelial morphogenesis. This in-
teraction was required for the ability of ErbB2 to
disrupt epithelial cell polarity and transform three-di-
mensionally organized epithelial structures. In addition
to interacting with Par6/aPKC, activation of ErbB2 also
induces disruption of Par3 from the polarity complex.
We now report that expression of Par3 is down-regu-
lated both in human breast cancers and in lung metas-
tasis of ErbB2 transgenic mice. Down-regulation of
Par3 cooperated with the ErbB2 oncogene to induce
migration, invasion, and metastasis of transformed and
tumor-derived mammary epithelial cells in culture and
in vivo. Interestingly, acquisition of invasive and
metastatic ability was not associated with an overt mes-
enchymal phenotype. However, epithelial cells lacking
Par3 activated a Tiam1/Rac/GTP/IRSp53/WAVE2/
Arp2/3 pathway that induced disruption of cortical
actin organization, blocked E-cadherin junction matu-
ration, and decreased cell–cell cohesion. Changes in
cortical actin organization and mislocalization of
Arp2/3 complex were observed in epithelial cells lack-
ing Par3 both in culture and in primary tumors in mice
and in humans. Thus, we demonstrated that loss of
Par3 deregulates cortical actin dynamics and E-cadherin
junction maturation to promote metastatic behavior in
epithelial cells without inducing a mesenchymal phe-
notype.
Previous results from our lab (Zhan et al., Cell 135:
865 [2008]) provided evidence that overexpression of
a Scribble mislocalization mutant (ScrP305L) disrupted
three-dimensional morphogenesis of mammary epithe-
lial cells, whereas overexpression of wild-type (ScrWT)
Scribble did not. Therefore, we sought to investigate
the signaling pathways activated in response to Scribble
mislocalization in these cells. In the current study, we
find that ScrP305L, but not ScrWT, specifically in-
duces activation of Akt and phosphorylation of down-
stream Akt targets. To extend these observations to an
in vivo setting, we generated transgenic mice expressing
ScrP305L in the mammary epithelium, under the con-
trol of the mouse mammary tumor virus (MMTV) pro-
moter. ScrP305L mice display defects in branching
morphogenesis, including loss of tertiary ducts and
small alveolar structures. This is followed by develop-
ment of hyperplasia by 6 months of age and tumor for-
mation after 1 year. Analysis of P305L tumors reveals a
striking heterogeneity in pathology as well as marker
expression, suggesting that Scribble cooperates with sec-
ondary genetic events for tumor progression. Impor-
tantly, despite their heterogeneity, ScrP305L tumors
show high levels of activated Akt. Overall, our results
suggest that the impaired polarization of epithelial cells
noted in advanced cancers may be a cause, and not
merely a consequence, of human tumorigenesis. To-
EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy D. Akshinthala K. Krishnamurthy
M. Feigin B. Xue
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gether, these studies are likely to identify new ways for
treating breast cancer.
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Identifying Guardians of Germline
Genomes
This work was done in collaboration with A. Haase and
G. Hannon. 
The Piwi clade of Argonaute proteins and their asso-
ciated small RNAs, Piwi-interacting RNA (piRNA), act
in an evolutionarily conserved genome defense pathway
that silences transposons in germline cells. Piwi proteins
are required for germline differentiation and mainte-
nance of germline stem cells, with mutations almost uni-
versally leading to sterility and germcell loss. Insights
into piRNA biogenesis and function emanate from
cloning and sequencing of piRNAs associated with dif-
ferent Piwi proteins, although the mechanisms of pri-
mary piRNA biogenesis and function remain largely
elusive. We used affinity immunoprecipitation to iden-
tify proteins associated with Drosophila Piwi and three
other known components of the piRNA silencing path-
way: Zucchini (a potential nuclease), Armitage (an RNA
helicase), and Squash (a protein of unknown function).
The analysis revealed that Piwi, Armitage, and Squash
associate with one another. Identification of proteins
copurifying with either component revealed a common
set of interactors constituting the core of this RNA-si-
lencing machinery. The laboratory is further investigat-
ing the molecular function of candidate genes emerging
from this analysis, in vitro and in vivo.
Quantitative Proteomic Analysis
of the Effect of Anti-let-7 on
Protein Expression
This work was done in collaboration with C. Dos San-
tos, I. Ibarra, S. Obad, S. Kauppinen, and G. Hannon.
The challenge of deciphering the role of hundreds
of animal RNAs, in conjunction with the large num-
ber of predicted target mRNAs, demands the develop-
ment of robust technologies that can dissect the bio-
logical functions of individual microRNAs (miRNAs)
and miRNA families in vivo. An alternative approach
to miRNA gene knockouts is to use chemically modi-
fied antisense oligonucleotides, termed anti-miRs,
which bind to the mature miRNA in competition with
cellular target mRNAs, leading to functional inhibi-
tion of the miRNA and derepression of the targets.
The Hannon Laboratory has used seven to eight nu-
cleotide fully locked nucleic acid (LNA)-modified
phosphorothioate oligonucleotides (termed tiny
LNAs) to target the seed region of the let-7 family with
high stability. Western blot analysis showed a concen-
tration-dependent increase of the major HMGA2 tar-
get in anti-let-7-treated HeLa cells, whereas the
controls showed no effect. Quantitative proteomics
screens using whole-cell lysates and iTRAQ (isobaric
tags for relative and absolute quantitation) labeling
confirmed the increase of HMGA2 while revealing
much more subtle off-target effects on other proteins.
The conclusion is that tiny seed-targeting LNAs can
be used to effectively inhibit the function of individual
miRNAs and entire miRNA families in cultured cells.
The study also validated the use of tiny LNA-based
knockdown in exploring miRNA function, with im-
portant implications for the development of therapeu-
tics targeting disease-associated miRNAs.
Mapping Posttranslational Modifications
of the Splicing Factor SF2/ASF
This work was done in collaboration with Y. Liu, R.-Y.
Tzeng, O. Fregoso, R. Sinha, and A. Krainer.
We used a combination of bottom-up and middle-
down approaches to map a significant number of post-
translational modifications of human SF2/ASF following
magnetic bead immunoprecipitation of the protein from
HeLa and 293E cells. For the bottom-up approach, a
triple-digest protocol was used (trypsin, elastase, and sub-
tilisin) followed by two-dimensional MudPIT (multidi-
mensional protein identification technology) LC-MS
(liquid chromatography/mass spectrometry) analysis of
PROTEOMICS LABORATORY AND PROTEOMICS
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the overlapping, nonspecific digest products to increase
coverage. For the middle-down approach, we used Lys-
C to generate larger fragments, which were analyzed by
both CID (collision-induced dissociated) and ETD (elec-
tron transfer dissociation) fragmentation. In total, we
identified six sites of SY phosphorylation, six sites of KR
monomethylation, and one site of R dimethylation. Eight
of these sites (including four sites of phosphorylation) had
not been previously reported. Subsequent work by mu-
tagenesis and cellular assays has shown that three of the
R methylations are important for controlling the parti-
tioning of the protein between nucleus and cytoplasm.
This has functional consequences for its effects on pre-
mRNA splicing and nonsense-mediated decay (NMD)
in the nucleus and on translation in the cytoplasm.
Novel Regulatory Modification
of PTP1B
This work was done in collaboration with N. Krishnan,
N. Tonks, and C. Fu.
Hydrogen sulfide (H2S) has recently been implicated
in the regulation of several biological processes, but cel-
lular targets and possible modes of action are not well
understood. Protein tyrosine phosphatases (PTPs) have
been established as regulators of a wide variety of signal
transduction pathways, and they use an essential reactive
Cys residue, which is characterized by a low pKa and is
very susceptible to oxidation. We tested whether H2S
may also target the catalytic Cys residue to regulate PTP
function. Using high-resolution mass spectrometry (MS)
we identified a novel covalent modification (persulfa-
tion) of the active-site Cys-215 in PTP1B that occurs in
response to the generation of hydrogen sulfide in vivo.
This sulfhydration reaction also inactivates PTP1B, but
it is subject to different mechanisms of reduction and re-
activation compared to the reversibly oxidized enzyme.
To understand the relevance of this modification to the
control of cell signaling, we used RNA interference
(RNAi) to suppress the critical enzyme in H2S produc-
tion, cystathionine-γ-lyase (CSE), in 293T cells, where
we observed sulfhydration of Cys-215 following ER (en-
doplasmic reticulum) stress only in control cells. Using
a novel phosphopeptide-trapping mutant, we searched
for potential substrates of PTP1B in the ER stress re-
sponse and identified a tryptic phosphopeptide derived
from PERK (protein-kinase-like ER kinase). The phos-
phorylation of Y619 in PERK has a critical role in the
activation of PERK, which phosphorylates the eukaryo-
tic translational initiation factor 2α (eIF2α), leading to
translational attenuation. We have since demonstrated
that PTP1B dephosphorylates Y619 PERK and that this
event is regulated by H2S production in ER stress. These
data suggest the possibility that different modes of re-
duction and reactivation of PTPs in response to distinct
gasotransmitters may introduce new levels of control
over signal transduction.
Interacting Partners of MECP2
This work was done in collaboration with A. Paul and
J. Huang.
MECP2 was identified as a methyl-CpG DNA-binding
protein and is known to be a trancriptional modulator and
regulator of chromatin structures and alternative splicing.
MudPIT LC-MS analysis of MECP2 complexes obtained
by magnetic bead immunoprecipitation discovered a host
of new MECP2 interacting proteins. In particular, eukary-
otic elongation factor 1A (EF1A1), DEAD- box protein 6
(DDX6/ P54), and synaptotagmin-binding cytoplasmic
RNA-interacting protein (SYNCRIP) were identified with
high significance. All three proteins have known roles in
translational regulation and mRNA transport.
Because EF1A1 is integral to the translation machin-
ery and is present in kinesin-associated mRNP granules,
its interaction with MECP2 could influence the trans-
lation state of MECP2-associated mRNAs. DDX6/P54
is a well-known member of the cytoplasmic P-bodies
and has been shown to repress translation and shuttle
between P-body and actively translating fractions. SYN-
CRIP was found in kinesin-associated mRNPs as well
as in dendritic mRNA transport granules. The associa-
tion of MECP2 with multiple proteins that regulate
translation and mRNA transport for local protein syn-
thesis suggests a potential mechanism of how MECP2
deficiency results in altered protein levels for its target
transcripts without changes in mRNA levels. Together,
these results established that MECP2 not only is associ-
ated with translating mRNAs in the cytoplasm, but also
imposes a regulatory function by interacting with other
factors involved in mRNA metabolism and translation.
The results establish a novel regulatory function of
MECP2 and suggest translation regulation as a patho-
genic mechanism of Rett syndrome.
Functional Analysis of the Protein
Phosphatase Activity of PTEN 
This work was done in collaboration with X. Zhang
and N. Tonks.
The tumor suppressor phosphatase PTEN displays
intrinsic activity toward both protein and phosphatidyl-
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inositol phospholipid substrates in vitro. Whereas the
lipid phosphatase activity of PTEN is important for its
tumor suppressor function, the significance of its protein
phosphatase activity is unknown and represents a gap in
our understanding of the function of this important reg-
ulator of cell signaling. The Tonks laboratory has devel-
oped an in vivo assay of PTEN function, which has
revealed an effect of its protein phosphatase activity on
the density of neuronal spines in cultured hippocampal
organotypic brain slices. In summary, the data suggest
that the protein phosphatase activity of PTEN and the
phosphorylation of Ser and Thr residues in its carboxy-
terminal segment are of regulatory significance to the
control of spine density. We are thus focused on defining
these critical phosphorylation sites within PTEN and
the identity of the regulatory binding proteins with
which it associates.
Identification of Origin Recognition
Complex Interactors
The Stillman Laboratory has identified a new mecha-
nism by which the pre-recognition complex (pre-RC)
is activated by protein kinases at the G1-to-S phase tran-
sition that involves targeting the Cdc7-Dbf4 (DDK)
protein kinase to a regulatory region of the Mcm4 pro-
tein subunit of the MCM2-7 helicase complex. The
studies led to the identification of an inhibitory amino
acid sequence in Mcm4 that, when deleted, bypassed
the requirement for the DDK kinase. Using MCM2-7
immunoprecipitation and mass spectrometry, Cdc45
was identified as a major cell-cycle-regulated MCM-in-
teracting protein that depended on DDK activation of
the pre-RC before it could bind MCM2-7.
When Orc2 and Orc3 were depleted from human
cells using RNAi, ~30% of the cells arrested with a ter-
minal phenotype in which the mitotic chromosomes are
abnormally condensed and are not attached to the mi-
totic spindle, and the cells have multiple centrosomes
with only one centriole per centrosome. It was shown
that the Orc2- or Orc3-depleted cells attempt to form a
metaphase plate and then begin the metaphase-to-
anaphase transition, but then the chromosomes pull off
the spindles and form abnormally condensed structures.
Thus, the spindle assembly checkpoint (SAC) was sat-
isfied, but in the absence of Orc2 or Orc3, chromo-
somes lost spindle attachment to the kinetochores when
tension was placed on the spindle to pull the cen-
tromeres apart. Subsequent biochemistry demonstrated
that Orc2 and Orc3 associated with the BubR1 kineto-
chore protein that is involved in sensing tension when
the kinetochores are correctly attached to bioriented
spindles. Also associated with Orc2 and Orc3 were
CenpE and Plk1, a protein kinase that phosphorylates
BubR1, as well as the heterochromatin protein 1. The
interactions between Orc2 and Orc3 at centromeres and
the kinetochore proteins only occurred during mitosis
and were observed during interphase; in addition, the
interactions were phosphorylation dependent. We are
currently performing mass spectrometry of ORC sub-
unit immunoprecipitations to determine other proteins
associated with ORC in mitosis and at centrosomes.
The Molecular Basis of Oncogene
Addiction 
This work was done in collaboration with M. Pineda
and R. Sordella.
The Sordella laboratory is interested in the possibility
that the platelet-derived growth factor receptor (PDGFR)
could modify the activity of SOCS3, because it could
provide a molecular mechanism explaining the decreased
sensitivity to the epidermal growth factor receptor
(EGFR) inhibitor in NSCLC cells expressing PDGFR.
Mass spectrometry of SOCS3 was performed after in
vitro phosphorylation with both PDGFR and EGFR
using cold ATP. Several approaches used both the linear
trap quadrupole (LTQ) and quadrupole time-of-flight
(Q-TOF) mass spectrometers and in-solution and in-gel
digestion of samples. Initially, several phosphotyrosines
were identified within the protein, but it was suspected
that they might be due to nonspecific phosphorylation.
The protocol was modified by decreasing the temperature
of the kinase assay and varying the concentration of the
kinase, and accurate mass Q-TOF LC-MS with phos-
pho-chip titanium dioxide enrichment was carried out.
Using these approaches, the PDGFR phosphorylation
site in SOCS3 was identified at amino acid 165 (YYIY),
located within the gp130-binding pocket. This suggested
that PDGFR may be involved in the molecular mecha-
nism of cytokine regulation. 
Quantitation of Alternative Splice
Variants at the Protein Level
This work was done in collaboration with O. Fregoso,
M. Jensen, A. Krainer, M. Akerman, and M. Zhang.
The Shared Resource is currently collaborating with
the Krainer Laboratory to develop the use of iTRAQ
quantitative proteomics to identify and quantify chang-
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es in exon-junction peptides as a measure of changes in
alternative splicing isoforms of abundant proteins. In
multiple duplex iTRAQ experiments, protein lysates
were prepared from cytoplasmic and nuclear fractions
of control HeLa cells and cells overexpressing the
SF2/ASF splicing factor. The lysates were digested
(trypsin) and labeled with two members of the 4-plex
iTRAQ reagent set before mixing. The pooled, labeled
peptides were analyzed by 15-16 salt step MudPIT LC-
MS or capillary LC-MS following first-dimension pep-
tide separation by OffGel isoelectric fosusing (24
fraction; pH3-10). CID spectra are currently being
matched to a splice peptide isoform database specifically
created for the project.
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MOLECULAR TARGETED THERAPY OF LUNG CANCER
EGFR MUTATIONS AND RESPONSE OF EGFR INHIBITORS
R. Sordella M. Camiolo M. Pineda
S. Fenoglio A. Saborowski
T. Lindsted Z. Yao 
In recent years, rapid advances in our understanding of
the molecular events required for tumor onset and pro-
gression have led to the development of novel cancer
agents referred to as “molecular targeted therapies.” Be-
cause they specifically target the product of selective can-
cer mutations that are required for cancer cell survival,
they are thought to become invaluable therapeutic tools.
Specifically in the case of lung cancer, much excitement
has been generated by the finding that patients harboring
oncogenic epidermal growth factor receptor (EGFR) mu-
tations highly benefit from treatment with selective in-
hibitors (erlotinib and gefitinib). Erlotinib and gefitinib
are members of a class of quinazolium-derived agents that
inhibit the EGFR pathway by binding in a reversible fash-
ion to the EGFR ATP pocket domain. Remarkably, ret-
rospective studies showed a striking correlation between
occurrence of certain EGFR oncogenic mutations and er-
lotinib/gefitinib responses. The presence of deletions in
exon 19of EGFR or EGFR L858R missense substitutions
are in fact found in more than 80% of non-small-cell lung
cancer (NSCLC) patients that respond to erlotinib or
gefitinib treatment. Yet, as in the case of other targeted
therapies, the emergence of resistance presents a major
hurdle for the successful utilization of these agents. Clin-
ical data in fact have shown that in the majority of the
cases, responses to drug treatment are transient, and
within a short period of time, patients who initially re-
sponded progress or relapse with resistant disease. The ac-
quisition of an additional mutation in exon 20 of EGFR
resulting in a threonine-to-methionine substitution at po-
sition 790 (T790M mutation) and/or amplification of c-
MET can account for ~50% of cases of erlotinib-acquired
resistance. However, the mechanisms that lead to resist-
ance in the remaining cases are unknown.
Intrinsic and Extrinsic Mechanisms of
Resistance to Targeted Therapies
To uncover new molecular mechanisms of gefitinib and
erlotinib resistance in NSCLC, we have developed a
cell-based model system using the broncho-alveolar
cancer cell line H1650. This cell line harbors an onco-
genic deletion within the EGFR (delE746-A750) and
has a half-maximal inhibitory concentration (IC50) to
gefitinib or erlotinib treatment of ~5 µM. By culturing
this cell line in the presence of a constant high concen-
tration of erlotinib, we have been able to isolate cell
lines capable of growing in the presence of up to 20 µM
of the drug. Interestingly, ~13% of the erlotinib-resis-
tant cells displayed the morphological appearance of
mesenchymal cells (16 of a total of 123 colonies exam-
ined), enhanced motility, and Matrigel invasion com-
pared to parental cells. These striking morphological
features were associated at the molecular level with an
increased expression of the mesenchymal protein Vi-
mentin and with decreased expression of the epithelial
marker E-cadherin, as well as with an EGFR-indepen-
dent augmented secretion of transforming growth fac-
tor-β1 (TGF-β1) and TGF-β2. 
We determined that the increased autocrine secretion
of TGF-β was sufficient to activate a complex program
that led to the acquisition of mesenchymal-like mor-
phology, increased motility, invasion ability, and er-
lotinib resistance. In the latter case, we provided
evidence that an up-regulation of interleukin-6 (IL-6)
secretion by TGF-β was sufficient to unleash cells har-
boring mutant EGFR from their EGFR dependency, as
manifested by their decreased sensitivity to erlotinib
treatment. 
By using a surface marker signature derived from the
erlotinib-resistant cells, we also showed that cells which
are mesenchymal and erlotinib-resistant were already
present in NSCLC-derived cell lines as well as in early-
stage treatment-naive tumors. 
These data thus indicate that cell-autonomous
mechanisms could generate subpopulations of cells in-
trinsically resistant to erlotinib treatment. Yet because
both IL-6 and TGF-β are secreted factors prominently
produced during the inflammatory response, the acti-
vation of the tumor microenvironment could also con-
tribute to erlotinib resistance. By using a mouse model
system in which inflammation was induced either by
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tetradecanoyl-phorbol-13-acetate (TPA) or with lipo-
polysaccharide (LPS), we were indeed able to show that
the induction of inflammation was successful in stim-
ulating IL-6 secretion and decreasing the tumor re-
sponse to erlotinib treatment. Hence, our data provide
compelling evidence indicating that acquired resistance
to molecular targeted therapies could arise not only as
a consequence of genetic and/or epigenetic heterogene-
ity within cancer cells, but also through the activation
of the tumor microenvironment. 
Because we identified cells that are intrinsically re-
sistant to erlotinib in NSCLC prior to treatment, it was
also tempting to speculate that this same mechanism of
erlotinib-acquired resistance could explain the hetero-
geneity of primary erlotinib responses observed in pa-
tients. In fact, although the majority of patients
harboring similar EGFR oncogenic mutations do re-
spond to erlotinib treatment, overall responses can vary
from 5% to 90% and remission could span from 3
months to more than 5 years. Notably, several studies
have already reported increased levels of IL-6 in ~30%
of NSCLC. 
Why IL-6 is required for the survival of the cancer
cells is yet not clear. Our data seems to indicate a role
of IL-6 in protecting cells from apoptosis. This seems
to be consistent with current literature. Catlett-Falcone
et al. (Immunity 10: 105–115 [1999]) in fact demon-
strated that IL-6-induced STAT3 protects myeloma
cells from FAS-induced apoptosis by up-regulating the
expression of BCL-X
L. Similarly, Haga et al. (J Clin In-
vest 102: 989 [2003]) demonstrated that constitutively
active STAT3 provided protection against FAS-medi-
ated liver injury likely through an augmented expres-
sion of the antiapoptotic proteins FLIP, BCL-2, and
BCL-XL. Consistent with a role of IL-6/STAT3-medi-
ated survival, we observed an up-regulation of Surivin,
BCL-X1, and BCL-2 in the erlotinib-resistant cells. 
Interestingly, the erlotinib-resistant cells character-
ized in this study also have an increased metastatic po-
tential. They display mesenchymal-like features, are
highly motile and invasive, and can be found with an
increased representation in the bone marrow of patients
compared to primary tumors. Notably, many of the
genes that we see increasingly expressed in the resistant
cells compared to the parental line have already been
associated with a metastatic signature and/or with poor
prognosis. These genes include HOXB2, S100A4,
S100A2, Tenascin C, SUSD, MCAM, and TCF-4. 
Notably, although the epithelial–mesenchymal tran-
sition (EMT) has been previously reported to be asso-
ciated with erlotinib resistance, our data indicate that
the programs that lead to mesenchymalization and drug
resistance are distinct. Although we found that TGF-β
is required and sufficient for EMT, invasion, and motil-
ity, as well as inducing an increased expression of IL-6,
reducing the expression of the EMT master regulator
SNAI only impaired EMT/motility/invasion but did
not change the cells’ sensitivity to erlotinib. Further-
more, treatment of cells with IL-6 increased their re-
sistance to erlotinib but did not induce EMT. Our data
are consistent with the observation that certain cell lines
harboring mutant EGFR (e.g., PC9), despite being ex-
tremely sensitive to erlotinib, display mesenchymal-like
features.
In conclusion, our data provide compelling evidence
indicating that resistance to molecular-targeted thera-
pies could arise not only as a consequence of genetic
and/or epigenetic changes within cancer cells, but also
through the activation of the tumor microenvironment.
Hence, the contribution of selective and adaptive mech-
anisms adds a new layer to the complexity of cancer
drug resistance and poses new challenges for the clinical
use of molecular targeted therapies. In particular, it
clearly indicates that, in the case of lung tumors driven
by mutant EGFR, treatment based only on the inhibi-
tion of EGFR will not be effective and suggests the in-
triguing possibility that adjunctive therapies designed
to either control inflammation and/or decrease the
bioavailability of IL-6 may provide effective means to
improve response to EGFR TKI treatment. Interest-
ingly, clinical trials combining Cox2 inhibitors (e.g.,
rofecoxib and celecoxib) and gefitinib/erlotinib have al-
ready shown encouraging results. 
A Novel Splice Isoform of p53 Involved
in Tissue Damage Response Assists in the
Bypass of Senescence and the Acquisition
of the Metastatic Phenotype
Gene expression profile analysis of CD44high/CD24low-
derived cells (H1650-M3) revealed a substantial de-
crease in expression of p53 compared to parental cells.
Interestingly, when we validated these data by reverse
transcriptase–polymerase chain reaction (RT-PCR)
analysis for p53 mRNA, we found a less-intense and
slower-migrating band in the CD44high/CD24low-de-
rived cells compared to parental cells. We reasoned that
this band might represent an alternatively spliced tran-
script from the p53 gene. Indeed, sequence analysis in-
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dicated the existence in CD44high/CD24low-derived cells
of a novel p53 alternative slice isoform that we refer to
as p53Ψ. Interestingly, comparison of the p53 gene se-
quence across species pointed out that the intronic se-
quence surrounding the alternative acceptor site in
intron 6 is highly conserved. 
The alternative splicing event observed in
CD44high/CD24low-derived cells results in a frameshift
placing a stop codon 19 amino acids downstream from
the splice junction and the generation of a protein that
is devoid of the oligomerization domain, the nuclear lo-
calization sequence (NLS) and part of the DNA-binding
domain. As a consequence, p53Ψ is mainly localized in
the cell cytoplasm and lacks transcriptional activity. 
Yet, similarly to certain p53 mutants (i.e., R273H
and R280K), p53Ψ expression leads to an increased in-
vasion ability and decreased expression of E-cadherin.
Interestingly, subcutaneous transplantation of p53-null
cells (H1299) ectopically expressing either p53 wild
type or p53Ψ also indicated that p53Ψ also increases
the seeding capabilities of tumor cells. 
Surprisingly, we noticed that the ectopic expression
of wild-type p53 in the CD44high/CD24low cells resulted
in cellular senescence. Interestingly this happens rather
rapidly when compared to oncogene-induced senescence
(5 days vs. 12 days in case of oncogene-induced senes-
cence) and was exclusive to the CD44high/CD24low cells. 
Because CD44high/CD24low cells express several genes
that have been shown to be sufficient to drive senes-
cence in a p53-dependent manner (e.g., IL6, IGFBP7,
SMARACA2, SMARACA4, SOCS1, and SPIN1), we
hypothesize that one function of this alternative splicing
event is to reduce p53 activity and by doing so to pre-
vent senescence.
One hallmark of senescent cells is the increased ex-
pression of certain secreted proteins—a phenomenon
known as senescence-associated secretory phenotype,
or SASP. While the overall physiological role of SASP
secretion by senescent cells is still not completely un-
derstood, it has been proposed that in some cases, these
proteins can induce epithelial cell proliferation and re-
sistance to apoptosis. Because the CD44high/CD24low
cells also expressed many reported SASP components
such as MMP1, MMP3, MMP10, MICA, ULBP2,
PVR, and IL-6 that were found recently to be up-reg-
ulated in CD44high/CD24low-derived cells in activated
hepatic stellate cells upon injury, we reasoned that this
novel p53 alternative splicing could have a physiological
significance during tissue damage/repair. We found that
p53Ψ is indeed expressed in activated stellate cells dur-
ing the early phase of injury/response, thus allowing
these cells to linger in a presenescent state and con-
tribute to tissue repair through the secretion of certain
SASP components. Eventually, as the damage response
progresses, the activated stellate cells will reexpress wild-
type p53, become senescent, and be cleared in the in-
jury/resolution phase as previously proposed. 
Our experimental evidence thus indicates that
p53Ψhas an important role in tissue-damage response
likely by preventing premature senescence of cells in-
volved in tissue remodeling and injury resolution.
In light of the functional and structural similarities be-
tween p53 mutants and p53Ψ, it is tempting to speculate
that p53 gain-of-function mutants by functionally taking
off the p53Ψ splice isoform have highjacked a highly reg-
ulated and reversible physiological response occurring
during the tissue-damage response. This phenotypic
mimicry may then contribute to tumorigenesis by pre-
venting senescence, increasing cell-invasive capabilities,
and enhancing the expression of CD44. Fascinatingly,
tumors have been referred to as “wounds that never heal.”
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The phosphorylation of tyrosyl residues in proteins is a key
component of the regulation of signaling pathways that
control many fundamental physiological processes, includ-
ing cell proliferation, differentiation, and survival. Protein
phosphorylation is a reversible, dynamic process in which
the net level of phosphate observed in a target substrate re-
flects the coordinated activity of the kinases that phosphor-
ylate it and the protein phosphatases that catalyze the
dephosphorylation reaction. We study the family of pro-
tein tyrosine phosphatases (PTPs), which, like the kinases,
comprise both transmembrane, receptor-linked forms and
nontransmembrane, cytoplasmic species and represent a
major family of signaling enzymes. Overall, the objective
of the lab is to develop tools for analysis of PTP regulation
and function and integrate them with state-of-the-art cell
and animal models, to define critical tyrosine phosphory-
lation-dependent signaling events in human disease and
thereby identify novel therapeutic targets. Currently, there
are four broad areas of research in the lab covering func-
tional analysis of members of the PTP family, regulation
of PTP function, in particular by reversible oxidation, de-
velopment of novel approaches to therapeutic intervention
in PTP function, and characterization of a knockout
mouse model to define the function of JSP1, a member of
the PTP family that is a novel regulator of mitogen-acti-
vated protein kinase (MAPK) signaling.
During the last year, two of our graduate students,
Guang Lin and Aftab Haque, successfully defended
their Ph.D.s. They are currently staying in the lab while
their papers are under review, but they will be moving
on to pursue postdoctoral opportunities in 2011. 
Identification of PTPN23 as a Novel
Regulator of Cell Invasion in Mammary
Epithelial Cells from a Loss-of-Function
Screen of the “PTPome” 
We had constructed a short hairpin RNA (shRNA) library,
which contains five shRNAs specifically designed to target
each of the PTPs and would allow us to interrogate the
function of these signaling enzymes by RNA interference
(RNAi). We conducted an RNAi-mediated loss-of-func-
tion screen to study systematically the role of the PTP su-
perfamily of enzymes in mammary epithelial cell motility,
in the absence or presence of the oncoprotein tyrosine ki-
nase ErbB2. Although shRNAs directed against most of
the PTP family members were without effect, consistent
with functional specificity within this family of signaling
enzymes, we identified PTPs that either promoted or in-
hibited motility. In particular, we have focused on three
PTPs that appear to be novel tumor suppressors in breast
cancer, and we are currently characterizing their mecha-
nism of action. Suppression of PRPN23, PTPRG, and
PTPRR enhanced cell motility. Furthermore, we found
that suppression of PTPN23, but not PTPRG or PTPRR,
induced cell invasion. Suppression of PTPN23 increased
E-cadherin internalization, impaired trafficking of E-cad-
herin from early endosomes, induced the expression of
mesenchymal proteins, and caused cell scattering. The ac-
tivity of β-catenin, a regulator of cell adhesion, and SRC,
a protein tyrosine kinase, were elevated when PTPN23 was
suppressed. Moreover, we identified E-cadherin, β-catenin,
and SRC as direct substrates of PTPN23. Inhibition of
SRC with the small-molecule inhibitor SU6656 blocked
the effects of PTPN23 depletion. These findings suggest
that loss of PTPN23 may increase the activity of SRC and
the phosphorylation status of the E-cadherin/β-catenin cell
adhesion/signaling complex to promote tumor growth and
metastasis in breast cancer. Our studies suggest that inhi-
bition of SRC may offer a novel therapeutic approach to
treatment of tumors in which PTPN23 is lost and, fur-
thermore, illustrate how loss-of-function screens reveal new
roles for PTPs in mammary epithelial cell biology. 
Identification and Characterization of a
Novel Inhibitor of PTP1B
To date, drug discovery efforts in signal transduction
have emphasized the protein kinases, in particular pro-
PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL
OF SIGNAL TRANSDUCTION
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tein tyrosine kinases. Recently, with the validation of
PTP1B as a major regulator of signaling by the insulin
and leptin receptors, this protein tyrosine phosphatase
became a highly prized target in the pharmaceutical in-
dustry for therapeutic intervention in diabetes and obe-
sity. In addition, the establishment of PTP1B as a critical
positive regulator of signaling downstream from the
HER2 oncoprotein tyrosine kinase has identified it as a
candidate therapeutic target in breast cancer. Conse-
quently, there have been major programs in industry fo-
cused on developing small-molecule inhibitors of
PTP1B to address these important unmet medical
needs. Nevertheless, these efforts have been frustrated
by technical challenges arising from the chemical prop-
erties of the PTP-active site. The tendency of potent in-
hibitors to be highly charged presents problems with
respect to bioavailability. Consequently, new approaches
to inhibition of PTP1B, other than active-site-directed
small-molecule inhibitors, are required to reinvigorate
drug development efforts. We have characterized the
mechanism of action of a natural product, isolated from
shark liver, which we have shown to be an allosteric in-
hibitor of PTP1B and which is known to induce weight
loss, and increase insulin sensitivity, in diet-induced and
genetically obese animal models. In addition, we have
observed that this natural product inhibits cell migration
induced by HER2 in the MCF10A cell model of breast
cancer, in a similar manner to PTP1B-directed shRNA.
Through this analysis, we have identified a novel al-
losteric site in PTP1B outside the catalytic domain in
the regulatory carboxy-terminal segment of the protein.
This is important because it suggests a novel mechanism
of inhibition and supports the presence of an additional
binding site(s) for inhibitory small molecules within this
noncatalytic portion of PTP1B. These sites would have
been missed in the high-throughput screens that have
been conducted to date in industry, which have used a
truncated form of the enzyme comprising only the cat-
alytic domain. Currently, we are testing this inhibitor in
cell and animal models of breast cancer. 
Isolation of Conformation-Sensor
Recombinant Antibodies to Study
Redox Regulation of PTP1B; Implications
for Development of Novel Therapeutics
PTP1B is regulated by reactive oxygen species (ROS)
produced in response to a wide variety of stimuli, includ-
ing insulin. The reversibly oxidized form of this enzyme
is inhibited and undergoes profound conformational
changes at the active site. We hypothesized that a con-
formation-sensor antibody that recognizes the reversibly
oxidized form of PTP1B (PTP1B-OX) may stabilize the
inactive state and inhibit phosphatase activity. We iden-
tified a double point mutant (C215A/S216A or CASA)
in the active-site PTP motif, which adopts a stable con-
formation that is identical to the reversibly oxidized form
(Fig. 1). We have generated a phage display antibody li-
brary consisting of single-chain variable fragments (scFvs)
against this mutant PTP1B. To isolate PTP1B-OX-spe-
cific antibodies from the scFv library, we used a subtrac-
tive panning strategy. PTP1B-CASA was biotinylated at
the amino terminus in Escherichia coli overexpressing bi-
otin ligase and purified to homogeneity. This biotiny-
lated CASA mutant was mixed with the library under
reducing conditions in the presence of a 50-fold molar
excess of wild-type PTP1B, to eliminate the scFvs that
recognize the reduced conformation of the enzyme. The
PTP1B-CASA-scFv-phage complex was isolated and am-
plified through four rounds of panning to enrich the li-
Figure 1. Expression of conformation-sensor scFv antibodies that
sequester the oxidized form of PTP1B leads to enhanced insulin
signaling. Insulin binding triggers autophosphorylation and activa-
tion of its receptor, which is a protein tyrosine kinase, and the phos-
phorylation of IRS1, its immediate substrate, which initiates the
signaling response. The effects of the kinase are counterbalanced
by PTPs, such as PTP1B. Activation of the insulin receptor induces
the production of hydrogen peroxide (ROS) by NADPH oxidases
(NOX), which leads to transient oxidation and inactivation of
PTP1B. This removes the inhibitory effect of PTP1B and potentiates
the signaling response. We have generated scFv antibodies that se-
quester PTP1B in its oxidized, inactive conformation and inhibit
reduction and restoration of phosphatase activity. By trapping
PTP1B in its inactive state, these antibodies enhance and sustain
the signaling response to insulin.
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brary with pools of antibodies selective for the mutant
form of the enzyme. From the panned pools of scFvs, we
have short-listed candidate antibodies in an activity-
based “in-solution” screen, in which we tested the ability
of individual scFvs to stabilize the oxidized, inactive form
of PTP1B in enzymatic assays in vitro. These candidate
scFvs displayed significant inhibition of the reactivation
of PTP1B-OX by reducing agent, but they did not exert
any direct inhibitory effect on activity of the reduced,
wild-type enzyme. Selected scFvs were characterized fur-
ther and shown to bind to the reversibly oxidized con-
formation of PTP1B, but not to PTP1B in its reduced
active state, both in vitro and when expressed in 293T
cells as intracellular antibodies or “intrabodies.” Expres-
sion of the intrabody had no impact on the basal level of
tyrosyl phosphorylation of either the β-subunit of the in-
sulin receptor or its substrate IRS-1, but it enhanced and
extended the time course of insulin-induced phosphory-
lation. Intrabody expression also caused significant en-
hancement of signaling downstream from the insulin
receptor, as revealed by increased phosphorylation of
PKB/AKT in insulin-stimulated cells. These effects on
signaling were diminished when we ectopically coex-
pressed catalase to quench cellular H2O2. Our data sug-
gest that conformation-sensor scFvs can be used as
potential inhibitors of PTP1B by stabilizing the tran-
siently inactivated form that is generated following lig-
and-induced production of ROS. Reversible oxidation
of PTP1B results in a conformation in which the prob-
lematic chemical properties of the active site of the re-
duced enzyme are circumvented and new binding
surfaces are presented. Therefore, if it is possible to sta-
bilize the oxidized, inactive form of PTP1B with an ap-
propriate therapeutic molecule that mimics the effects of
these antibodies, then this strategy may provide a new
approach for PTP-directed drug development that cir-
cumvents the difficulties that are encountered when tar-
geting the highly charged PTP-active site.
Hydrogen Sulfide Signals through
Sulfhydration of PTP1B
Hydrogen sulfide (H2S), a colorless gas with the odor of
rotten eggs, has been considered a toxic molecule; how-
ever, with the burgeoning interest in gasotransmitter
function, it has recently been implicated in the regula-
tion of several biological processes. H2S is generated in
a number of different mammalian tissues as a by-prod-
uct of the transulfuration pathway in which dietary me-
thionine is converted to cysteine. In order to understand
the physiological function of H2S, and its potential role
in signaling, it is essential to identify its cellular targets.
PTPs have been established as regulators of a wide vari-
ety of signal transduction pathways that underlie fun-
damentally important aspects of cell physiology. The
mechanism of PTP catalysis utilizes an essential, reactive
Cys residue, which is characterized by a low pKa and is
susceptible to oxidation. We tested whether H2S may
also target the catalytic Cys residue to regulate PTP
function. We focused on PTP1B, the founding member
of this enzyme family. We observed that PTP1B was in-
activated by H2S in vitro; the reaction was reversible, as
phosphatase activity was fully recovered with reducing
agent. Of particular interest was the observation that
H2S-inactivated PTP1B was reactivated 60-fold faster
using thioredoxin (Trx) than with dithiothreitol (DTT)
and glutathione (GSH). This contrasted with oxidized
PTP1B, which was reactivated to a similar (slower) rate
by Trx and DTT. One potential explanation for this
strong preference was provided by analysis of H2S-inac-
tivated PTP1B by mass spectrometry, which revealed a
persulfide modification of the active-site Cys. 
To understand the relevance of this modification to
the control of cell signaling, we used RNAi to suppress
the critical enzyme in H2S production, cystathionine-
γ-lyase (CSE), in 293T cells. As it has been demon-
strated that H2S accumulation can lead to endoplasmic
reticulum (ER) stress, we tested whether PTP1B was
modified during ER stress that was induced by treat-
ment with tunicamycin. PTP1B was immunoprecipi-
tated following ER stress from both control and CSE
knockdown cells, and the modification status of the ac-
tive-site Cys residue was monitored by mass spectrom-
etry. We observed sulfhydration of the active-site Cys
in control cells, which was attenuated in CSE-deficient
cells. To examine further the significance of this modi-
fication, we searched for potential substrates of PTP1B
in the ER stress response. The phosphorylation of Y615
in PERK (protein-kinase-like endoplasmic reticulum ki-
nase) has a critical role in its activation; it then phos-
phorylates the eukaryotic translational initiation factor
2 (eIF2α), leading to translational attenuation. Our
data suggest that PTP1B dephosphorylated Y615 in
PERK and that this event was regulated by H2S pro-
duction in ER stress. We propose that H2S inhibits
PTP1B in the context of ER stress, thereby increasing
PERK activity and in turn decreasing the rate of protein
translation so as to reduce the accumulation of un-
folded proteins. The susceptibility of PTPs to sulfhy-
dration may also represent a mechanism to prevent
permanent inactivation of the enzymes by oxidative
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stress. These data suggest the possibility that different
modes of reduction and reactivation of PTPs in re-
sponse to distinct gasotransmitters may introduce new
levels of control over signal transduction.
Myristoylation of the Dual-Specificity
Phosphatase JSP1 Is Necessary
for its Activation of JNK Signaling
and Apoptosis
Activation of the c-JUN amino-terminal kinase (JNK)
pathway is implicated in a number of important phys-
iological processes, from embryonic morphogenesis to
cell survival and apoptosis. JNK stimulatory phos-
phatase 1 (JSP1) is a member of the dual-specificity
phosphatase subfamily of PTPs. In contrast to other
dual-specificity phosphatases, which catalyze inactiva-
tion of mitogen-activated protein kinases, expression of
JSP1 activates JNK-mediated signaling. JSP1 (and its
relative DUSP15) are unique among members of the
PTP family in that they contain a potential myristoy-
lation site at the amino terminus (MGNGMXK). We
investigated whether JSP1 was myristoylated and ex-
amined the functional consequences of myristoylation.
Using mass spectrometry, we showed that wild-type
JSP1, but not a JSP1 mutant in which glycine 2 was
mutated to alanine (JSP1-G2A), was myristoylated in
cells. Abrogation of myristoylation did not impair the
intrinsic phosphatase activity of JSP1, but it changed
the subcellular localization of the enzyme. Compared
to wild type, the ability of nonmyristoylated JSP1 to
induce JNK activation and phosphorylation of the tran-
scription factor c-JUN was attenuated. Upon expres-
sion of wild-type JSP1, a subpopulation of cells with
highest levels of the phosphatase was induced to float
off the dish and undergo apoptosis; in contrast, cells ex-
pressing similar levels of JSP1-G2A remained attached.
These observations highlight the importance myristoy-
lation for JSP1 function.
Pseudophosphatases as Regulators
of Cell Signaling
Throughout the PTP family are examples of pseudo-
phosphatases, which adopt a PTP-like three-dimensional
fold, but for which enzymatic activity is dispensable for
their signaling function. The prototypic member, STYX,
interacts with the testicular RNA-binding protein
CRHSP-24 and plays an undefined role in spermato-
genesis. For many transmembrane receptor-like PTPs,
the intracellular segment comprises two PTP-like do-
mains that cluster in separate clades upon sequence
analysis, suggesting conserved, but distinct, functions.
The membrane-proximal, D1 domains are catalytically
active, whereas the membrane-distal, D2 domains are
pseudophosphatases. Various roles have been postulated
for these D2 domains, from redox sensors to chaperones.
Pseudophosphatases are most prevalent among the my-
otubularins (MTMs), which regulate the phosphoryla-
tion status of phosphatidylinositol phospholipids. Of the
14 MTM genes in humans, six encode pseudophos-
phatases that form complexes with the active enzymes
to regulate both catalytic function and subcellular loca-
tion. Roles for pseudophosphatases as phospho-amino-
acid-binding proteins have now also been demonstrated.
MK-STYX is a pseudophosphatase member of the
dual-specificity phosphatase subfamily of the PTPs. It is
catalytically inactive due to the absence of two amino
acids from the signature motif that are essential for phos-
phatase activity. The nucleophilic Cys residue and the
adjacent His, which are conserved in all active dual-
specificity phosphatases, are replaced by Ser and Phe, re-
spectively, in MK-STYX. When we generated mutations
to introduce His and Cys residues into the active site of
MK-STYX, we produced an active phosphatase. Ras-
GTPase-activating protein SH3 domain-binding pro-
tein 1 (G3BP1), a regulator of RAS signaling, has been
identified as a binding partner of MK-STYX. We ob-
served that G3BP1 bound to native MK-STYX; how-
ever, binding to the mutant, catalytically active form of
MK-STYX was dramatically reduced. G3BP1 is also an
RNA-binding protein with endoribonuclease activity
that is recruited to “stress granules” (SGs) after stress
stimuli and can induce formation of SGs itself following
overexpression. Stress granules are large subcellular struc-
tures that serve as sites of mRNA sorting in which un-
translated mRNAs accumulate. We observed that
expression of MK-STYX inhibited G3BP-induced stress
granule formation; however, the catalytically active mu-
tant MK-STYX was impaired in its ability to inhibit
G3BP-induced stress granule assembly. These data reveal
a novel facet of the function of a member of the PTP
family, illustrating a role for MK-STYX in regulating
the ability of G3BP1 to integrate changes in growth fac-
tor stimulation and environmental stress with the regu-
lation of protein synthesis.
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PTEN is a tumor suppressor that is among the most fre-
quently lost or mutated genes of human cancer. It is
unique in directly opposing the enzymatic activity of
phosphoinositol 3-kinase (PI3-K) and the downstream
proto-oncogene Akt kinase, which promotes cell survival
and proliferation. This signaling pathway is deregulated
in a majority of, for example, breast, prostate, and brain
tumors. By modeling Pten loss in mice, we have discov-
ered how cells in the prostate can sense the complete loss
of Pten and respond to this insult by withdrawing into
cellular senescence, which is now recognized as a cell-in-
trinsic human antitumoral defense mechanism. This
finding defines a clear role for the p53 gene. It is essential
for preventing lethal prostate cancer by mounting the
senescence response after Pten loss, but does not initiate
tumor growth when lost on its own. Moreover, the dis-
covery of the senescence response suggests that tumors
should favor retention of some PTEN. Indeed, many
human cancers present with either partial loss of the
PTEN gene or with partial functional impairment. Col-
lectively, these findings have defined PTEN as a haploin-
sufficient tumor suppressor in several tissues and thus
emphasize the need for understanding its regulation.
The emergence of patient genome data is now en-
abling us to probe for genome-wide changes that are
consistent with the progression features identified in
mouse. Conversely, we also probe the mouse tumor
genome for spontaneous changes that drive tumorigen-
esis downstream from their engineered genetic changes.
This two-pronged approach is allowing us to move
from identification and validation of new cancer genes
to connecting the dots by uncovering the principles that
underlie PTEN-mutant cancer progression.
Nuclear versus Cytoplasmic Akt
Activity in Cancer
M. Chen, D. Nowak, C. Pratt, M. Zeeman [in collaboration
with A. Newton, University of San Diego, California; 
B. Carver, C. Sawyers, Memorial Sloan-Kettering 
Cancer Center, New York]
Through our previous studies, we have learned that not
only quantitative, but also qualitative regulation of Akt
kinase controls Pten mutant tumorigenesis and its pro-
gression via a senescence defeat or senescence bypass
pathway. The qualitative change in active Akt kinase lo-
calization from plasma membrane to the nucleus is a
direct consequence of loss of promelocytic leukemia
(PML) nuclear bodies (NBs). We could show that in
mice, PML achieves pAkt inactivation through its abil-
ity to recruit both Akt and its phosphatase PP2a into
these bodies, resulting in specifically nuclear Akt inac-
tivation. These findings demonstrated the importance
of coordinated Akt inactivation and revealed that this
process is efficiently achieved through the phosphatase
Pp2a. Furthermore, it highlighted how deregulating
cellular partitioning of Akt activity via control of phos-
phatases could bypass the senescence response. 
Recently, a second direct phosphatase of Akt, named
PHLPP, has been identified. PHLPP joins PTEN and
PP2a phosphatases with the potential of regulating tu-
morigenesis. In contrast to the qualitative changes men-
tioned above, PHLPP controls the amplitude of Akt
activation, similar to PTEN. By studying mice that are
mutant for Phlpp or Phlpp and Pten, we have been able
to define Phlpp as a tumor suppressor in prostate. It an-
tagonizes Akt activation at the plasma membrane, and
this function is crucial in preventing prostate cancer after
partial loss of Pten. Intriguingly, combined loss of Pten
and Phlpp triggers the above-mentioned p53 response,
and we find that tumors need to abolish p53 to form.
Thus, we find that the cooperating phosphatases direct
Akt activity and localization with entirely differential
outcomes with respect to p53 activation. We validate
these observations in human prostate cancer progression.
Nuclear PTEN and Cancer
A. Naguib, H. Cho, M. Zeeman, C. Pratt [in collaboration
with B. Carver, W. Gerald, C. Sawyers, Memorial
Sloan-Kettering Cancer Center, New York]
Despite its plasma membrane function, PTEN has been
consistently observed in cell nuclei, but the mechanism
and relevance of this localization have remained unclear.
We have recently resolved this paradox by demonstrat-
ing that contrary to polyubiquitination, nuclear PTEN
EMERGING PRINCIPLES OF TUMOR SUPPRESSION
L. Trotman M. Chen D. Nowak
H. Cho C. Pratt
A. Naguib M. Zeeman
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import depends on its monoubiquitination and that
mutation of the main PTEN ubiquitination site abol-
ishes import in vitro and in patients, giving rise to in-
heritable Cowden’s Disease because of low cytoplasmic
PTEN stability. But most notably, this mutant retains
catalytic activity, demonstrating that PTEN nuclear im-
port is essential for tumor suppression. These findings
exemplify an elemental insight into cancer biology by
demonstrating how the collaboration of a genetic lesion
(the inherited mutation) with a posttranslational cellular
response (enhanced degradation) cooperates in tumori-
genesis. Through this analysis, we have furthermore un-
raveled a link between two critical means of PTEN
regulation, namely, stability and nucleocytoplasmic
shuttling. We are currently investigating the mediators
of both processes in vitro by using RNA interference
(RNAi) approaches and in vivo through gene targeting
in mouse.
Regulation of PTEN Activity in Prostate
Cancer Initiation and Treatment
H. Cho, M. Zeeman [in collaboration with C. Miething and
P. Premsrirut, S. Lowe Lab, Cold Spring Harbor Laboratory]
On the basis of our previously published work, the ac-
tual Pten protein levels inside prostatic epithelia decide
over benign or malignant tumor formation (Trotman
et al., PLoS Biol 3: 385 [2003]), whereas complete Pten
loss was shown to prevent tumorigenesis through the
p53-dependent senescence response until p53 mutation
paves the way for full-blown cancer. Accordingly,
prostates of mice harboring partial Pten loss sponta-
neously degrade Pten to allow formation of prostate
cancer. Yet, importantly, these lesions do not go on to
completely lose Pten at the gene or protein level, a com-
pelling illustration of their ability to maximize prolif-
eration while avoiding the senescence response caused
by complete Pten loss. Our analysis of human prostate
cancer specimens also confirms frequent retention of
clearly reduced PTEN levels. Therefore, by using mouse
models with partial Pten loss, we found that sponta-
neous and subtle further reduction of Pten levels trig-
gers activation of the downstream oncogenic kinase
Akt, illustrating that a threshold must be crossed for
initiation of cancer. 
It is important to note that such spontaneous down-
regulation of Pten is never observed in prostates of wild-
type animals, sometimes observed in Pten+/– prostates
(30% of mice), and is always occurring in Ptenhy/– ani-
mals (mice with one-fourth of normal Pten levels).
These observations strongly suggest that lower Pten lev-
els increase the probability of its spontaneous reduction
below the Akt-activating and tumor promoting thresh-
old. Thus, they demonstrate the importance of stable
Pten levels in a tissue even after Pten has received a ge-
netic hit. Because this finding should form the basis of
a therapeutic approach, we set out to test the therapeu-
tic effect of Pten up-regulation in prostate. An impor-
tant open question behind this approach is that
restoration of PTEN might not just antagonize tumor
growth, but also revert tumor growth, analogous to the
concept of oncogene addiction, even after cells have suf-
fered spontaneous cooperating lesions. 
In collaboration with the lab of Dr. Lowe, we have
established several mouse models that allow for RNAi-
mediated reversible knockdown of Pten in prostate.
These models now enable us to systematically test if and
how established tumors respond to restoration of Pten.
Thus, they serve as a genetic model for PI3-K-inhibitor
therapy. We will also test how Pten restoration treatment
depends on context through genetic alterations, includ-
ing loss of Phlpp, Pml, and other cooperating tumor
suppressors that we have identified. Through this ap-
proach, we have knocked down Pten levels in mouse
prostate until tumors have formed with features that are
highly similar to those of the traditional knockout mod-
els. We are now following up the effects of Pten restora-
tion using magnetic resonance imaging (MRI) methods.
Of the 250,000 American men diagnosed with prostate
cancer each year, roughly half will present with partial
PTEN loss in their lesions, and thus, we expect our re-
sults to be of great importance in establishing the ge-
netic framework for successful treatment of prostate
cancer through PTEN stabilization or PI3-K pathway
inhibition.
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Research in my laboratory focuses on signal transduc-
tion pathways involving Ras and Rho GTPases. Ras
and Rho family members have key roles in cellular ac-
tivities controlling cell growth control, differentiation,
and morphogenesis. Alterations in Ras and Rho func-
tions have been shown to result in several disease
processes, including cancer and neurodevelopmental
disorders. Our ultimate goal is to understand how aber-
rations in Ras and Rho signaling components con-
tribute to the development of these disease processes.
Toward this end, my lab has continued to define the
functions of selected GTPases, their regulators, and ef-
fectors in models of cancer and neurodevelopmental
disorders. Below are highlighted the main projects that
have been carried out during the past year. 
Role for Rho-Linked Mental Retardation
Protein Oligophrenin-1 at the
Hippocampal CA3-CA1 Synapse 
Mutations in genes encoding regulators and effectors
of Rho GTPases have been found to underlie various
forms of mental retardation (MR). Oligophrenin-1
(OPHN1), which encodes a Rho-GTPase activating
protein, was the first identified Rho-linked mental re-
tardation gene. It was initially identified by the analysis
of a balanced translocation t(X;12) observed in a female
patient with mild mental retardation. Subsequent stud-
ies have revealed the presence of OPHN1 mutations in
families with mental retardation associated with cere-
bellar hypoplasia and lateral ventricle enlargement. All
OPHN1 mutations identified to date have been shown,
or predicted, to result in OPHN1 loss of function; how-
ever, the pathophysiological role of OPHN1 has re-
mained poorly understood. 
We found that the OPHN1 protein is highly ex-
pressed in the brain throughout development, where it
is found in neurons of all major regions, including hip-
pocampus and cortex, and is present pre- and postsy-
naptically. We have begun to unveil the function of
OPHN1 both at the pre- and postsynaptic site of the
hippocampal CA3-CA1 synapse. By temporally and
spatially manipulating OPHN1 gene expression, we ob-
tained evidence that postsynaptic OPHN1 through its
Rho-GAP activity has a key role in the activity-depen-
dent maturation and plasticity of excitatory synapses by
controlling their structural and functional stability. In
particular, OPHN1 is recruited or stabilized in den-
dritic spines by spontaneous activity through the acti-
vation of N-methyl-D-aspartate receptors (NMDARs).
In turn, OPHN1 signaling regulates activity-dependent
AMPAR synaptic incorporation and stabilization, as
well as maintenance of spine structure, thereby permit-
ting synaptic maturation and plasticity. Consequently,
decreased or defective OPHN1 signaling prevents glu-
tamatergic synapse maturation and causes loss of synap-
tic structure, function, and plasticity. These data
indicate that normal activity-driven glutamatergic
synapse development is impaired by perturbation of
postsynaptic OPHN1 function. More recently, we have
obtained evidence that postsynaptic OPHN1 also has
a critical role in mediating mGluR-dependent long-
term depression (LTD), a form of plasticity relying on
rapid local protein synthesis, in CA1 hippocampal neu-
rons. This function of OPHN1 can be dissociated from
its effects on activity-dependent maturation and
strengthening of synapses. Together, these findings
point to a multifunctional role for postsynaptic
OPHN1 at CA1 synapses. Independent of its role in
activity-driven glutamatergic synapse development,
OPHN1 could operate to weaken synapses in response
to behaviorally relevant stimuli, providing an intriguing
potential explanation for some of the behavioral deficits
exhibited by OPHN1 patients. 
With regard to OPHN1 presynaptic function, we
found that OPHN1 is important for efficient retrieval
of synaptic vesicles (SVs). The rate of endocytosis was
significantly reduced in hippocampal neurons in which
OPHN1 was silenced by RNA interference. In addi-
RAS AND RHO GTPASES AND THE CONTROL
OF SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner Y. Tai
X.L. Gu C.-L. Wang
J. Janas Y.-T. Yang
A. Kobayashi J.-R. Yu
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tion, presynaptic OPHN1 knockdown impaired the ef-
ficacy of synaptic transmission under high-frequency
stimulation, indicating that presynaptic OPHN1 is im-
portant for maintaining synaptic efficacy during repet-
itive firing at hippocampal synapses. Insight into the
mechanism by which OPHN1 controls SV retrieval
came from our findings that OPHN1 forms a complex
with endophilin A1, a protein implicated in membrane
curvature generation during SV endocytosis. Impor-
tantly, OPHN1 mutants defective in endophilin A1
binding, or with impaired Rho-GAP activity, failed to
substitute for wild-type OPHN1, indicating that
OPHN1’s interactions with endophilin A1 and Rho
are important for its function in SV endocytosis. These
findings also suggest that defects in efficient SV retrieval
may contribute to the pathogenesis of OPHN1-linked
cognitive impairment.
The Rac Activator DOCK7 Has
an Important Role in Early Steps
of Neuronal Development
DOCK7 is a member of the evolutionarily conserved
DOCK180-related protein superfamily, which we iden-
tified as a novel activator of Rac GTPases. We found
that DOCK7 is highly expressed in major regions of
the brain during early stages of development and, im-
portantly, that the protein is asymmetrically distributed
in unpolarized hippocampal neurons and becomes se-
lectively expressed in the axon. We then obtained evi-
dence that DOCK7 has a critical role in the early steps
of axon formation in cultured hippocampal neurons.
Knockdown of DOCK7 expression prevents axon for-
mation, whereas overexpression induces the formation
of multiple axons. We further demonstrated that
DOCK7 and Rac activation leads to phosphorylation
and inactivation of the microtubule destabilizing-pro-
tein stathmin/Op18 in the nascent axon and that this
event is important for axon development. Thus, our
findings unveiled a novel pathway linking the Rac ac-
tivator DOCK7 to a microtubule regulatory protein
and highlight the contribution of microtubule dynam-
ics to axon development. 
More recently, we began to assess the role of
DOCK7 in the development of cortical neurons in
vivo. To this end, we implemented the in utero electro-
poration method that enables highly efficient introduc-
tion of vectors coexpressing proteins or short hairpin
RNAs (shRNAs) of interest with a fluorescent protein
marker into ventricular zone (VZ) cells in embryonic
cerebral cortices. We found that either reducing or in-
creasing DOCK7 expression levels in progenitor cells
in the embryonic cerebral cortex impairs normal mi-
gration of cortical cells, indicating that appropriate lev-
els of DOCK7 are critical for this event. Interestingly,
we also obtained evidence for a key role of DOCK7 in
the genesis of neurons. In particular, we observed that
DOCK7 knockdown in the VZ progenitors increases
the number of proliferating S-phase cells and maintains
the cells as cycling progenitors, thereby attenuating dif-
ferentiation of daughter cells into neurons. On the
other hand, ectopic expression of DOCK7 decreases
the number of progenitors, promotes cell cycle exit, and
increases the number of neurons. Thus, these findings
reveal that DOCK7 function is required for cortical
neurogenesis. We are currently unraveling the cellular
and molecular mechanisms by which DOCK7 exerts
its effects on the genesis and migration of cortical neu-
rons, processes that have been associated with numer-
ous neurodevelopmental disorders.
Role of Rap1 Signaling in
Morphogenetic Processes
The Rap1 protein, a member of the Ras family, was ini-
tially identified as an antagonist of oncogenic Ras pro-
teins; however, more recent studies indicate that the
function of Rap1 is largely Ras-independent. Rap1 has
been assigned critical functions in the morphogenesis
of epithelial tissues, and recent studies suggest that dys-
regulated Rap1 signaling may be intrinsic to malignant
processes. However, how Rap1 controls epithelial mor-
phogenesis in vivo has remained largely elusive. We
have identified a signaling module that contains PDZ-
GEF, a Rap1-specific exchange factor, Rap1 itself, and
the adaptor protein AF-6. By investigating develop-
mental events in Drosophila as a genetically tractable
model system, we demonstrated that PDZ-GEF, Rap1,
and Canoe, the Drosophila AF-6 ortholog, function in
a linear pathway that governs epithelial migration and
gastrulation events in the embryo as well as cell shape
in expanding imaginal discs, the precursors to diverse
adult structures. We found that the activity of this path-
way in part impinges on myosin II as a motor protein
that modulates cell shape in epithelial morphogenetic
processes.
More recently, we have uncovered an additional role
for Canoe/AF-6 as a Rap1 effector in mitotically active
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epithelia, such as imaginal discs. Our experiments show
that AF-6/Canoe is key to a mechanism that reconsti-
tutes E-cadherin-based adherens junctions at the apical
membrane between sister cells late in cytokinesis. A fail-
ure in this process causes cells to lose cohesion and mis-
sort during tissue morphogenesis. By conducting
further genetic analysis, we found that AF-6/Canoe in
this context acts on its interacting protein Echinoid, a
Drosophila homolog of the Nectin family of IgG adhe-
sion proteins. Echinoid expands the apical adherens
junctional belt to its normal circumferential size down-
stream from AF-6/Canoe. Surprisingly, our functional
dissection also suggests that an independent function
of Echinoid acts in parallel to AF-6/Canoe in the gen-
eral maintenance of adherens junctions. Together, these
results suggest a more complex relationship between the
Nectin and AF-6/Afadin proteins in the regulation of
the mammalian adherens junctions than anticipated so
far. Our observations thus provide insights into a novel
molecular framework that perpetuates adherens junc-
tional continuity in mitotically active epithelia. 
Oncogenic Tyrosine Kinases Target
Dok-1 for Ubiquitin-Mediated
Proteasomal Degradation to
Promote Cell Transformation
Dok-1 (also called p62dok) was initially identified as a ty-
rosine phosporylated 62-kD protein associated with
Ras-GAP in Ph+ chronic myeloid leukemia blasts and in
v-Abl-transformed B cells. This protein was termed Dok
(downstream of kinases) because it was also found to be
a common substrate of many receptor and cytoplasmic
tyrosine kinases. Subsequently, six additional Dok family
members have been identified, Dok-1 to Dok-7. Among
them, Dok-1 and Dok-2 share the ability to bind to a
negative regulator of Ras, Ras-GAP. We described pre-
viously that Dok-1 attenuates growth-factor-induced
cell proliferation and that Dok-1 inactivation in mice
causes a significant shortening of the latency of the fatal
myeloproliferative disease induced by p210bcr-abl, suggest-
ing that it possesses tumor suppressive activity in the
context of myeloid leukemia. In support of this, we
found in collaboration with Dr. Pandolfi’s group that
mice lacking both Dok-1 and Dok-2 spontaneously de-
velop a chronic myelogenous leukemia (CML)-like
myeloproliferative disease. Furthermore, more recent
studies have shown that mice with combined Dok-1,
Dok-2, and Dok-3 knockouts also develop lung adeno-
carcinoma with penetrance and latency dependent on
the number of lost Dok family members.
These studies thus indicate that the Dok-1 to
Dok-3 proteins possess tumor suppressive activities
and that their inactivation can contribute to
disease/tumor progression associated with deregu-
lated protein kinase signaling, as, for example, in the
case of p210bcr-abl-driven CML-like disease in mice.
To date, however, very little is known about the reg-
ulation of Dok proteins by oncogenic tyrosine kinases
(OTKs). We have focused on Dok-1 and mechanisms
of its regulation by p210bcr-abl and other OTKs. We
found that OTKs, including p210bcr-abl and oncogenic
forms of Src, down-regulate Dok-1 by targeting it for
degradation through the ubiquitin-proteasome path-
way. This process is dependent on the tyrosine kinase
activity of the oncoproteins and is mediated primarily
by lysine-dependent polyubiquitination of Dok-1. Im-
portantly, restoration of Dok-1 levels strongly sup-
presses transformation of cells expressing OTKs, and
this suppression is more pronounced in the context
of a Dok-1 mutant that is largely refractory to OTK-
induced degradation. Together, our findings indicate
that proteasome-mediated down-regulation of Dok-1
is a key mechanism by which OTKs overcome the in-
hibitory effect of Dok-1 on cellular transformation and
tumor progression.
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CSHL neuroscientists focus on understanding how neural activity and neural circuitry underlie be-
havior and how disruptions in these circuits lead to neurological and neuropsychiatric disorders
such as Alzheimer's disease, autism, schizophrenia, and depression. These questions are addressed
in two model systems—rodents and Drosophila—using molecular, cellular, genetic, developmental,
theoretical, physiological, and behavioral approaches. Neuroscience research at CSHL is highly col-
laborative and can be divided into three broad themes: sensory processing, cognition, and cognitive
disorders. In addition, there is an effort to develop new anatomical methods to improve our under-
standing of brain circuits, connectivity, and function.
The study of decision-making provides a window on the family of brain functions that comprise
cognition. It intervenes between perception and action and can link one to the other. Although
much is known about sensory processing and motor control, much less is known about the circuitry
connecting them. Anne Churchland’s lab investigates the neural machinery underlying decision-
making. They use carefully designed paradigms that encourage experimental subjects, both rodents
and humans, to deliberate over incoming sensory evidence before making a decision. To connect
this behavior to its underlying neural circuitry, they measure electrophysiological responses of cortical
neurons in rodents as they perform designated tasks. The lab’s current focus is on parietal cortex,
which appears to be at the midpoint between sensory processing and motor planning. Churchland
and colleagues also use theoretical models of varying complexity to further constrain how observed
neural responses might drive behavior. This approach generates insights into sensory processing,
motor planning, and complex cognitive function.
Because biological mechanisms of memory are highly conserved through evolution, many features
of human memory are observed in simpler organisms such as fruit flies. Joshua Dubnau and col-
leagues identify genes that are important for memory and conserved across phyla, many of which
are likely to be relevant to human memory. They recently discovered genes involved in controlling
when and where specific proteins are synthesized within a neuron. These genes likely regulate neu-
ronal communication during learning. Efforts in the Dubnau lab are focused on a genome-wide
understanding of this neuronal control of protein synthesis. The lab also seeks to discover how the
neural circuitry of the fly brain works. They have recently shown that short- and long-term memories
form in different sets of neurons: One circuit provides a memory that decays quickly and the other
a memory that forms slowly but persists. Both types of traces, the team discovered, depend on the
activity of a gene called rutabaga. Dubnau’s team also explores how groups of genes interact to form
memories, an approach designed to shed light on complex gene networks whose dysfunction likely
underlies human cognitive disorders.
Grigori Enikolopov and colleagues study stem cells in the adult brain. They have generated several
models to account for how stem cells give rise to progenitors and, ultimately, to neurons and are
using these models to determine the targets of antidepressant therapies, identify signaling pathways
that control generation of new neurons, and search for neuronal and neuroendocrine circuits in-
volved in mood regulation. Recent experiments have suggested to the team a new model of how
stem cells are regulated in the adult brain, with a focus on stem cells’ decision on whether to di-
vide—and embark on a path of differentiation—or remain quiescent. This model explains why the
number of new neurons decreases with advancing age and may lead to impairments in memory and
depressed mood. This year, Enikolopov and colleagues, as a part of a team of researchers, located
the precise source of hematopoietic stem cell (HSC) maintenance and regulation within the bone
marrow: signals emanating from another stem cell population, mesenchymal stem cells (MSCs),
that create a supportive niche for the HSCs. This year, the team also identified the elusive target of
deep brain stimulation (DBS), a type of precursor cell that matures into adult hippocampal neurons.
Enikolopov’s group is also part of a team that identified and validated the first biomarker that per-
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mits neuronal progenitor cells to be tracked, noninvasively, in the brains of humans and animals.
The lab is now using these discoveries to reveal how neurogenesis is related to the course of diseases
such as depression, bipolar disorder, and Parkinson’s.
Hiro Furukawa’s lab is studying neurotransmission at the molecular level. They focus on the struc-
ture and function of NMDA (N-methyl-D-aspartate) receptors, ion channels that are expressed in
excitatory neurons. Dysfunctional NMDA receptors cause neurological disorders and diseases in-
cluding Alzheimer’s disease, Parkinson’s disease, schizophrenia, depression, and stroke-related is-
chemic injuries. NMDA receptors are very large molecules whose three-dimensional atomic structure
Furukawa’s group has undertaken to solve by dividing it into several domains. They seek to under-
stand the pharmacological specificity of neurotransmitter ligands and allosteric modulators in different
subtypes of NMDA receptors at the molecular level. Toward this end, they use cutting-edge tech-
niques in X-ray crystallography to obtain crystal structures of NMDA receptor domains and validate
structure-based functional hypotheses by a combination of biophysical techniques including electro-
physiology, fluorescent analysis, isothermal titration calorimetry, and analytical centrifugation. The
crystal structure of NMDA receptors will serve as a blueprint for creating and improving the design
of therapeutic compounds with minimal side effects for treating neurological disorders and diseases.
To better understand neuronal circuits, Josh Huang and colleagues have developed novel means
of visualizing the structure and connectivity of different cell types at high resolution in living animals
and of manipulating the function of specific cell types with remarkable precision. Huang is partic-
ularly interested in circuits that use GABA (γ-amino-n-butyric acid), the brain’s primary inhibitory
neurotransmitter. The lab’s work has direct implications in neurological and psychiatric illness such
as autism and schizophrenia, which involves altered development and function of GABAergic cir-
cuits. This year, their work shed new light on synapse validation, which is at the heart of the process
by which neural circuits self-assemble and is directly implicated in neurodevelopmental pathologies.
Huang’s team looked closely at neurexins, proteins that interact with neuroligins to form the “zipper”
that holds synapses together. They discovered that α and β neurexins respond in different ways to
neural activity—the α molecules search out compatible connection partners and the β molecules
secure preliminary connections that prove to be strong. This adds to past studies in the lab on the
underlying framework of molecular guides called glial cells that nudge nerve fibers to grow in the
right direction and make the right contacts. Huang’s lab has also made good progress in studying
perturbations in the developing GABAergic system in a mouse model of Rhett’s syndrome, one of
the autism spectrum disorders.
Adam Kepecs and colleagues are interested in identifying the neurobiological principles under-
lying cognition and decision-making. They use a reductionist approach, distilling behavioral ques-
tions to quantitative behavioral tasks for rats and mice that enable the monitoring and manipulation
of neural circuits supporting behavior. Using state-of-the-art electrophysiological techniques, they
first seek to establish the neural correlates of behavior and then use molecular and optogenetic ma-
nipulations to systematically dissect the underlying neural circuits. Given the complexity of animal
behavior and the dynamics of neural networks that produce it, their studies require quantitative
analysis and make regular use of computational models. The team also has begun to incorporate
human psychophysics to validate their behavioral observations in rodents by linking them with anal-
ogous behaviors in human subjects. Currently, the team’s research encompasses the study of (1) the
role of uncertainty in decision-making, (2) the division of labor among cell types in prefrontal
cortex, (3) how the cholinergic system supports learning and attention, and (4) social decisions that
rely on stereotyped circuits. A unifying theme is the use of precisely timed cell-type- and pathway-
specific perturbations to effect gain and loss of function for specific behavioral abilities. Through
such manipulations of genetically and anatomically defined neuronal elements, the team hopes to
identify fundamental principles of neural circuit function that will be useful for developing therapies
for diseases such as schizophrenia, Alzheimer’s, and autism spectrum disorder.
Alexei Koulakov and colleagues are trying to figure out the mathematical rules by which the
brain assembles itself, with particular focus on the formation of sensory circuits such as those in-
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volved in visual perception and olfaction. The visual system of the mouse was chosen for study in
part because its components, in neuroanatomical terms, are well understood. What is not known
is how projections are generated that lead from the eye through the thalamus and into the visual
cortex, how an individual’s experience influences the configuration of the network, and what pa-
rameters for the process are set by genetic factors. Even less is known about the assembly of the
neural net within the mouse olfactory system, which, in the end, enables the individual to distinguish
one smell from another with astonishing specificity and to remember such distinctions over time.
These are among the challenges that engage Koulakov and his team.
Dysfunction of excitatory, glutamatergic synapses in the brain is believed to have an important
role in the pathogenesis of major psychiatric disorders, including schizophrenia and depression. But
what are the causes? Where in the brain does this dysfunction occur? How does it result in the be-
havioral symptoms of illness? To address these issues, Bo Li and colleagues are studying normal
synaptic plasticity and disease-related synaptic changes in brain circuits involved in schizophrenia
and depression. Their long-term goal is to develop methods allowing manipulation of activity in
specific brain circuits in order to change disease-related behaviors. They use a variety of method-
ologies, including patch-clamp recording and calcium imaging of labeled neurons, two-photon im-
aging of spine morphology and tagged receptors, in vivo virus injection, RNA interference
(RNAi)-based gene silencing, activation of specific axon terminals using light-gated cation channels,
activation or silencing of specific brain regions using transgenes, and assessment of the behavioral
consequences of certain manipulations. A new project focusing initially on a gene called ErbB4
seeks to determine the genetic causes of NMDA receptor hypofunction, a pathology believed to
contribute to the etiology of schizophrenia. 
Partha Mitra seeks to develop an integrative picture of brain function, incorporating theory, in-
formatics, and experimental work. His lab is developing computational tools for integrative analysis
of neurobiological data, spanning electrophysiological, neuroanatomical, and genomic data from
multiple species pertaining to the brain. In the Mouse Brain Architecture Project, Mitra and col-
leagues are well on their way to generating the first-ever brainwide mesoscopic-scale circuit map of
the entire mammalian brain. This is a first step toward mapping vertebrate brain architecture across
species and in mouse models of human disease, starting with schizophrenia and autism. These maps
will be cross-referenced to the Allen Brain Atlas of gene expression, a complementary landmark
data set on which the Mitra lab has innovated multiple analyses. These analyses include assessing
coexpression patterns and networks of addiction-related genes and determining evolutionary ages
of genes with respect to their brain region of expression.
Pavel Osten’s lab works on identification and analysis of brain regions, neural circuits, and con-
nectivity pathways that are disrupted in genetic mouse models of autism and schizophrenia. Osten
hypothesizes that (1) systematic comparison of many genetic mouse models will allow determination
of overlaps in pathology—neural circuit endophenotypes—responsible for the manifestation of
neuropsychiatric disorders and (2) neural-circuit-based classification of autism and schizophrenia
will provide key circuit targets for detailed mechanistic studies and therapeutic development. Osten
and colleagues are developing the first systematic approach to the study of neural circuits in mouse
models of psychiatric diseases, based on a pipeline of anatomical and functional methods for analysis
of mouse brain circuits. An important part of this pipeline is high-throughput two-photon mi-
croscopy for whole-mouse-brain imaging. Other methods include viral-vector-based anatomical
tracing, transgenic and knockin “indicator” mouse lines for monitoring expression of activity-reg-
ulated genes, and both in vitro and in vivo two-photon imaging and electrophysiology. 
Jonathan Sebat’s lab studies the role of genetic variation, and particularly, gene copy-number
variation, in schizophrenia, autism, and other neuropsychiatric illnesses. Sebat and collaborators
have discovered a rare mutation associated with dramatically increased schizophrenia risk, a gene
copy-number variation in a chromosomal region, 16p11.2, already linked to autism. Previously,
they had demonstrated a significantly increased rate of rare structural mutations in the genomes of
people with schizophrenia as compared with healthy controls. They found, moreover, that the mu-
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tations were powerful and that the genes disrupted by the mutations nearly half the time were in-
volved in pathways known to be important in brain development. One implication is that the uni-
verse of genetic risk factors for schizophrenia consists of many different rare mutations, each one
present in comparatively few individuals, or even a single one. In prior work, Sebat, in collaboration
with Michael Wigler, discovered that spontaneous mutations—genetic errors in children that do
not occur in either parent—are far more common in autism than previously thought.
Stephen Shea’s lab studies the neural circuitry underlying social communication and decisions.
He uses natural social communication behavior in mice as a model to understand circuits and
processes that are evolutionarily conserved and therefore shared broadly across species, likely con-
tributing to disorders such as autism. Previously at Duke University, Shea and colleagues examined
how emotion and arousal enable mice, via their olfactory systems, to store memories of other indi-
viduals and of related social signals. The team exploited the intimate relationship between memory
and emotion to effectively create memories in anesthetized mice, providing unprecedented access
to neurobiological processes that typically only occur during behavior. To advance understanding
of the circuit mechanisms of these memories, this year Shea’s lab developed techniques to make
technically challenging targeted recordings from a specific type of inhibitory neuron whose function
remains mysterious. The data suggest that these cells not only participate in storing olfactory mem-
ories but do so in surprising and complex ways. Also this year, Shea’s team began a series of studies
of a different form of social recognition: auditory recognition of pup vocalizations by their mothers.
Preliminary data show that the brains of mother mice encode the sound of a pup’s voice differently,
and this may relate to differences in the quality of their maternal care. Ultimately, the Shea lab aims
to include recordings from awake and behaving mice and other techniques to understand the social
decision process all the way from the level of a live social encounter to the movement of neurotrans-
mitter receptors at the synapse. 
What is a memory? When we learn an association, information from two different sensory streams
somehow becomes linked together. What is this link in terms of neural activity? For example, after a
few bad experiences, we learn that the “green” smell of an unripe banana predicts its starchy taste.
How has the neural response to that green smell changed so that it becomes linked to that taste?
What are the underlying mechanisms—what synapses change strength or what ion channel properties
change? These are the questions that drive research in Glenn Turner’s laboratory. His team addresses
these questions by monitoring neural activity using a combination of electrophysiological methods
to examine individual neurons with very high resolution and functional imaging to track the activity
of hundreds of neurons simultaneously. They have developed optical techniques to monitor the ac-
tivity of the entire set of cells in the learning and memory center of the fly brain. This comprehensive
view of neural activity patterns enables them to actually predict the accuracy of memory formation
in separate behavioral experiments. By examining the effects of learning-related genes on this process,
they can connect their network-level view of memory formation to the underlying molecular mech-
anisms governing the basic cellular and synaptic changes that drive learning. 
Anthony Zador and colleagues study how brain circuitry gives rise to complex behavior. Work
in the lab is focused on two main areas. First, they ask how the cortex processes sound, how that
processing is modulated by attention, and how it is disrupted in neuropsychiatric disorders such as
autism. Second, they are developing new methods for determining the complete connectivity of the
mouse brain at single-neuron resolution. In contrast to previous methods that make use of mi-
croscopy, these methods exploit high-throughput DNA sequencing. Because the costs of DNA se-
quencing are plummeting so rapidly, these methods have the potential to yield the complete wiring
diagram of an entire brain for mere thousands of dollars.
Yi Zhong’s lab studies the neural basis of learning and memory. The team works with fruit fly
models to study genes involved in human cognitive disorders, including neurofibromatosis, Noonan
syndrome (NS), and Alzheimer’s disease. Mutations leading to a lack of function of the neurofibro-
matosis 1 (NF1) gene cause noncancerous tumors of the peripheral nervous system as well as learning
defects. The lab’s analyses of Drosophila NF1 mutants have revealed how expression of the mutant
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gene affects a pathway crucial for learning and memory formation. The NF1 gene and a gene called
corkscrew, implicated in NS, share a biochemical pathway. Recently, the lab succeeded in linking
changes in this pathway due to specific genetic defects in NS with long-term memory deficiencies.
In fly models, they discovered the molecular underpinnings of the "spacing effect”—the fact that
memory is improved when learning sessions are spaced out between rest intervals.  Zhong’s team
also has succeeded in reversing memory deficits in mutant flies, work suggesting that  longer resting
intervals for Noonan’s patients might reverse their memory deficits. This year, they identified a
means of reversing memory loss in fruit flies while suppressing brain plaques similar to those im-
plicated in Alzheimer’s disease. Separately, having discovered that memory decay is an active process,
regulated by the Rac protein, the team has proposed that Rac’s role in erasing memory is related to
its influence on downstream cytoskeleton remodeling agents.
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Making use of sensory information requires more than
simply relaying incoming signals from the sensory or-
gans. It requires interpreting information, classifying it,
drawing inferences, and ultimately using the context of
behavioral goals to make a decision about its meaning.
A decision is a commitment to a particular choice or
proposition at the expense of competing alternatives.
In some situations, decisions involve integration of ev-
idence, i.e., they make use of multiple pieces of infor-
mation from the environment or from memory. These
decisions can provide a framework in which to investi-
gate complex cognitive processes and open a window
onto higher brain function in general. 
Although previous experiments have begun to reveal
how neural systems combine evidence to make deci-
sions, they have left a critical gap in our understanding.
Specifically, very little is currently known about the neu-
ral mechanisms that make it possible to combine infor-
mation from multiple sensory modalities for decisions.
The gap is apparent, although it is clear from behavioral
observations that neural systems can combine multisen-
sory information: When parsing speech in a crowded
room, for example, the listener makes use of both audi-
tory information (the speaker’s vocal sounds) and visual
information (the speaker’s lip movements). Understand-
ing the neural mechanisms of multisensory integration
is critical for two reasons. First, it is essential for a com-
plete understanding of decision-making because real-
world stimuli rarely affect a single sense in isolation.
Therefore, understanding how the brain interprets in-
coming information requires understanding how the
brain merges information from different senses. Second,
of clinical importance is the fact that several develop-
mental abnormalities appear to be related to difficulties
in integrating sensory information. For example, abnor-
malities in multisensory processing are a hallmark of in-
dividuals with autism spectrum disorder. Impairments
in multisensory processing are also observed in those
with a collection of sensory abnormalities known to-
gether as sensory processing disorder and may also be
evident in patients with Rett syndrome. Understanding
the neural mechanisms of multisensory integration
could inform treatment of those conditions. 
Our long-term goal is to understand how the brain
can make decisions that integrate inputs from our mul-
tiple senses, stored memories, and innate impulses. Our
current projects, described below, are a first step toward
this complete understanding of perceptual decision-
making.
Measuring Behavior on a Multisensory
Decision-Making Task
We present both rat and human subjects with ambigu-
ous stimuli about which they make decisions. The stim-
uli consist of visual flashes, auditory tones, or both.
Subjects judge the repetition rate of the stimulus. To
determine whether subjects benefit from multisensory
integration, we compare the speed and accuracy of the
single sensory and the multisensory conditions. 
Uncovering the Neural Mechanisms
of Multisensory Decision-Making
We collect electrophysiological responses from single
neurons in the parietal cortex. The parietal cortex is
known to receive inputs from both auditory and visual
sensory areas and is known to have a key role in deci-
sion-making. By comparing the electrophysiological re-
sponses of parietal neurons when the animals are
engaged in single sensory versus multisensory decisions,
we can explore the nature of the cortical circuitry that
makes it possible to support the behavioral improve-
ment in multisensory integration.
Connecting Behavior and Physiology
Using Theoretical Models
Behavior and physiology from decision tasks about vi-
sual motion have been consistent with a class of models
known as bounded accumulation. In these models, ran-
dom samples of evidence are accumulated over time up
NEURAL CIRCUITRY FOR PERCEPTUAL DECISIONS
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to a threshold level or bound. Although this class of
model has been successful for visual motion decisions,
it is not yet known whether it will generalize to multi-
sensory decisions. Our working hypothesis is that the
models will be easily extendable to multisensory deci-
sions: Instead of accumulating random samples of evi-
dence only across time, the models can be designed to
accumulate random samples of evidence across modal-
ities. We are in the process of testing whether this class
of models can accurately predict the speed and accuracy
of decisions, and whether its predictions are compatible
with electrophysiological observations. Other kinds of
models that are currently under consideration are mod-
els of Bayesian inference, or attractor models. 
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Understanding complex behaviors such as memory will
require a multidisciplinary approach that will include
discovery and manipulation of the relevant genetic/cell
signaling pathways and the relevant neural circuits.
Work in genetic model systems such as Drosophila can
contribute to our understanding in several ways. First,
by enabling discovery of genes and genetic pathways
underlying behavior, such model systems provide entry
points for dissection of cellular mechanisms that are
often conserved. Second, systematic manipulation of
gene function in relevant anatomical loci of the brain
allows a conceptual integration of findings from cellu-
lar, neuroanatomical, and behavioral levels. Our gene
discovery efforts already have identified a role in mem-
ory for highly conserved pathway(s) involved with sub-
cellular control of translational regulation. Many of
these molecules have counterparts in vertebrates that
also appear to have important roles in brain function
and, in some cases, may be linked to human cognitive
dysfunction. Our genetic investigations also provide in-
sight to investigate the neural circuitry relevant to
memory because gene expression patterns often suggest
hypotheses that can be tested spatially restricted genetic
manipulations. 
Neuronal Translational Regulatory
Network
W. Li, L. Prazak, J. Dubnau
A fundamental property of the brain is that perceptual
experiences drive modifications in number and strength
of synaptic connections among neurons. These synapse
modifications, which are thought to be neural correlates
of memory and cognition, require synthesis of specific
proteins at individual synaptic sites in response to neu-
ral activity. The mechanisms governing this local syn-
thesis of synaptic proteins are poorly understood. We
are using the Drosophila model to investigate neuronal
translation in two different ways. First, we are develop-
ing a novel approach to screen broadly for neuronal
translational regulation in terms of both targets and
trans-activators. Second, we are focusing on specific reg-
ulatory interactions that we discover to investigate a few
translational regulatory pathways in some detail. These
efforts are focused on pumilio, a translational repressor
that we have shown has a role in memory as well as on
RNA-induced silencing complex-mediated regulation.
A global screen for regulatory interactions. We are
developing a platform to identify the suite of regulatory
mechanisms and translational targets in the brain. The
approach involves several steps. First is a high through-
put method to create in vivo reporters of translation for
each gene. Second is a strategy to identify the set of
genes whose translation is governed by a particular reg-
ulator. As a proof of principle, we will define the targets
of five key translational regulators, including Fragile-X
protein. Fragile-X is the most common inherited form
of mental retardation. Our method, which is concep-
tually similar to enhancer trapping for transcriptional
control, takes advantage of the exceptional genetic ma-
nipulability of the Drosophila model system. The high
degree of conservation of gene regulatory mechanisms
and function ensures that much of what we learn will
be transferable to humans.
Synaptic targets of pumilio. We identified a role in
memory for a number of mRNA-binding proteins
(Dubnau et al., Curr Biol 13: 286 [2003]). These in-
clude several with known roles in mRNA localization
and translational control, including staufen and oskar,
which are known components of a cellular mRNA lo-
calization machinery in oocytes, and pumilio, which is
a translational repressor protein whose vertebrate or-
thologs are highly conserved but largely unstudied. Al-
though pumilio function has been most carefully
studied in the context of embryonic patterning, several
recent findings demonstrate that pumilio also has an
important role in the nervous system, including long-
term memory formation (see, e.g., Berger et al., Alcohol
Clin Exp Res 32: 895 [2008]; Chen et al., PLoS Comput
Biol 4: 340 [2008]; Dubnau et al., Curr Biol 13: 286
[2003]). In neurons, pumilio appears to have a role in
homeostatic control of excitability via down-regulation
of para, a voltage-gated sodium channel, and may more
GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau M. Cressy L. Prazak
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097-149_04_Neurosci_Annual Report_2009 template  7/8/11  11:57 AM  Page 104
Neuroscience     105
generally modulate local protein synthesis in neurons
via translational repression of eIF-4E. Aside from these,
the biologically relevant targets of pumilio in the nerv-
ous system were largely unknown in any species. 
We hypothesized that pumilio might have a role in
regulating the local translation underlying synapse-spe-
cific modifications during memory formation. To iden-
tify relevant translational targets, we used an infor-
matics approach (in collaboration with M. Zhang’s lab
at CSHL) to predict pumilio targets among mRNAs
whose products have synaptic localization (Chen et al.,
PLoS Comput Biol 4: 340 [2008]). We then used both
in vitro binding and two in vivo assays to functionally
confirm the fidelity of this informatics screening
method. We found that pumilio strongly and specifi-
cally binds to RNA sequences in the 3′UTR (untrans-
lated region) of four of the predicted target genes,
demonstrating the validity of our method. We then
demonstrated that one of these predicted target se-
quences, in the 3′UTR of discs large (dlg1), the
Drosophila PSD95 ortholog, can functionally substitute
for a canonical Nanos response element (NRE) in vivo
in a heterologous functional assay in the embryo. We
also demonstrated that endogenous levels of dlg1 (Chen
et al., PLoS Comput Biol 4: 340 [2008]) and another
neuronal target, 14-3-3, can be regulated by pumilio in
a neuronal context, the adult mushroom bodies (MB),
an anatomical site of memory storage. Our current ef-
forts focus on several additional neuronal targets of
pumilio as well as on putative cofactors that act in con-
cert with pumilio in the early embryo.
Small-RNA-mediated gene regulation in the brain.
microRNAs (miRNAs) are ~21–23-nucleotide noncod-
ing RNA transcripts that regulate gene expression at the
posttranscriptional level by binding to complementary
sequences in the 3′UTRs of target mRNAs. miRNAs
function as part of an RNA-induced silencing complex
(RISC) that includes one of the argonaute protein fam-
ily members. In Drosophila, miRNAs are most often as-
sociated with argonaute-1. Via a forward mutagenesis
screen for defective memory, we identified mutations
that mapped to an miRNA gene (Dubnau et al., Curr
Biol 13: 286 [2003]). Using classical Drosophila molec-
ular genetics, we have confirmed a causal relationship
between the disrupted expression of the miRNA and
the behavioral defect. We also have identified a role in
memory for argonaute-2, rather than argonaute-1, and
have also shown that argonaute-1 and pumilio interact
genetically. These and other findings suggest a core
translational regulatory mechanism in the brain in
which common mRNA targets are regulated coordi-
nately by pumilio and by a RISC complex involving
small RNAs loaded onto argonaute-2.
Neural and Genetic Circuitry
of Memory
M. Cressy, H. Qin, J. Dubnau 
A common feature of memory and its underlying
synaptic plasticity is that each can be dissected into
short-lived forms involving modification or trafficking
of existing proteins and long-term forms that require
new gene expression. An underlying assumption of this
cellular view of memory consolidation is that these dif-
ferent mechanisms occur within a single neuron. At the
neuroanatomical level, however, different temporal
stages of memory can engage distinct neural circuits, a
notion that has not been conceptually integrated with
the cellular view. A recent study in our lab has highlighted
the significance of this integrated view. Blum et al. (Curr
Biol 19: 1341 [2009]) has shown that rutabaga adenylyl
cyclase function is required in a specific neuronal cell type
in a learning center called the mushroom bodies. These
so-called γ-lobe neurons require rutabaga function to sup-
port short-term memory (STM), but in contrast, rutabaga
expression is needed in α/β-lobe neurons to support long-
term memory (LTM). On the basis of this observation,
Blum et al. (Curr Biol 19: 1341 [2009]) and Blum and
Dubnau (2010) proposed a hypothesis that two parallel
STM traces are formed in the MBs, in different cell types.
To test this model, we have established a genetic means
to generate animals that are capable of forming only the
rutabaga-dependent or only the rutabaga-independent
STM forms. This allows us to investigate the cellular
substrates and consolidation kinetics of each of these
genetically distinct memory traces.
Enhancer/Suppressor Screening by Selective
Breeding: Modeling Rubenstein–Taybi
Syndrome in Drosophila
M. Cressy, J. Dubnau [in collaboration with P. Mitra, 
D. Valente, K. Honneger, Cold Spring Harbor Laboratory]
One of the great challenges in understanding the genetic
impact on human disease is that some complex disor-
ders, such as schizophrenia, likely emerge from coinher-
itance of multiple common gene variants, each of which
would have little clinical impact on their own. Despite
their widespread relevance, mechanisms by which multi-
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gene interactions modulate phenotype are ill-understood
because almost all mechanistic studies of gene interaction
are limited to pair-wise studies. To investigate this ques-
tion, we have developed and implemented a novel ap-
proach in Drosophila, using the biologically important
and clinically relevant cAMP pathway as a model. We
used selective breeding to evolve combinations of alleles
capable of suppressing the learning defect associated with
mutations in the rutabaga adenylyl cyclase gene. Unlike
a classical suppressor screen, our use of experimental evo-
lution allows us to explore the potential impact of
higher-order gene interactions. And unlike a classical se-
lective breeding experiment, we constrained the genetic
variability to a set of 23 known loci, providing access to
the underlying causal alleles. Using independent genetic
experiments, we exhaustively tested the effects of each of
the identified loci as well as of all diallele combinations.
Our results indicate that numerous genotypic solutions
are present and that typical solutions involve combina-
tions of between three and six loci. 
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Our research is focused on stem cells, on their contri-
bution to tissue maintenance and regeneration, and on
signals that control their division and fate. We generate
animal models to study stem cells and their environment
and to investigate the mechanisms that determine the
division and differentiation choices of these cells. Our
main interest is in stem cells of the adult brain. Contin-
uous production of new neurons in neurogenic regions
of the adult brain is important for learning and memory,
neural tissue repair, and response to therapies. We work
to understand how different factors, ranging from drugs
and surgery to aging and disease, affect adult neural stem
cells and their progeny. We also investigate interactions
between different types of stem cells that help coordinate
tissue growth and repair. Furthermore, we study the
multifunctional signaling molecule nitric oxide (NO)
for which we have demonstrated an important role in
organism development and tissue differentiation. Fi-
nally, we work to translate the results we obtain with an-
imals to human physiology and therapy.
Neural Stem Cells and Brain Disorders
Continuous production of new neurons is supported
throughout life in several areas of the brain, among them
the hippocampus, a brain region that is crucial for cog-
nitive function. New neurons are produced from neural
stem cells and their birth is the result of a complex cascade
of events that include symmetric and asymmetric divi-
sions of stem and progenitor cells, exit from the cell cycle,
programmed elimination of a vast number of newborn
cells, and continuous changes of their morphology; this
cascade culminates with the young neuron establishing
connections with other cells and becoming integrated
into the preexisting neuronal circuitry. Production of new
neurons from stem cells can be modified by a wide range
of intrinsic and extrinsic factors, acting to increase (e.g.,
antidepressants and physical exercise) or decrease (e.g.,
stress, aging, and disease) hippocampal neurogenesis.
These factors may affect any step of the differentiation
cascade or may converge on a few defined targets. We are
working to unravel the basic rules and mechanisms con-
trolling the quiescence, division, self-renewal, and differ-
entiation of neural stem cells and their progeny.
To define the steps of the division/differentiation
cascade and to determine the targets of important pro-
or anti-neurogenic stimuli, we use transgenic reporter
animal lines, often in combination with other geneti-
cally modified lines. We use the resulting compound
lines to dissect the neurogenesis cascade into distinct
stages and then to identify the steps that are specifically
affected by a particular stimulus; this analysis has been
complemented by computational modeling of the stem
and progenitor cell dynamics, performed in continuous
collaboration with Dr. Alex Koulakov at CSHL. This
has allowed us to produce a comprehensive scheme of
the neurogenic and astrogenic arms of the cascade. This
detailed description of the hippocampal stem cell life
cycle provides a conceptual framework with which to
map the targets of various neurogenic stimuli and com-
pare different strategies by which stem cells are har-
nessed for tissue regeneration. 
We have already used this scheme to identify the tar-
gets of various antidepressant drugs and treatments, ex-
ercise, radiation, chemotherapeutic agents, trauma,
ablation of dopaminergic neurons, and aging. In par-
ticular, we found that such diverse antidepressant ther-
apies as fluoxetine, running, and deep brain stimulation
of distant brain regions converge on the same step of
the cascade and increase the number of divisions of the
transit-amplifying progenitor population. Importantly,
these treatments do not affect the pool of stem cells; in
contrast, we found that electroconvulsive shock, a
highly efficient antidepressant therapy, activates divi-
sion of stem cells in the adult hippocampus.
We have also found that trauma and disease can ac-
tivate stem cells of the hippocampus, even when distant
regions of the brain are damaged. In particular, we
found that moderate trauma of the cortex induces di-
vision of stem cells in the adult hippocampus. Further-
more, we found that in the mouse model of Parkinson’s
STEM CELLS, SIGNAL TRANSDUCTION, AND BRAIN FUNCTION
G. Enikolopov N. Bondar T. Michurina G. Rudensky
A. Burlet-Parendel J.-H. Park K. Sayed
Z. Glass N. Peunova M. Tackenberg 
N. Kudryavtseva
097-149_04_Neurosci_Annual Report_2009 template  7/8/11  11:57 AM  Page 107
108 Research
disease, ablation of dopaminergic neurons of the sub-
stantia nigra can transiently activate division of stem
cells in the hippocampus (which receives dopaminergic
inputs from the substantia nigra). We also found that
L-DOPA, used in the clinical treatment of Parkinson’s
disease, does not alter the effect of neuronal ablation
on cell division in the hippocampus. Together, our re-
sults suggest that even distant events which do not di-
rectly impact the hippocampal area, such as cortical
trauma or ablation of midbrain neurons, can activate
neural stem cells of the hippocampus. Such activation
may reflect the induction of innate repair and plasticity
mechanisms by the injured brain; however, it may also
potentially lead to a premature exhaustion of the neural
stem cell pool, particularly in the aging organism. 
Our results also shed light on the age-related decrease
in the production of new neurons. This age-related de-
cline in the number of new neurons is profound and has
been observed across mammalian species. Given the sig-
nificance of new neurons for cognitive function, it is
conceivable that reduced neurogenesis contributes to
age-related cognitive impairment. We found that age-
related decrease in hippocampal neurogenesis under
normal conditions is driven by the disappearance of
neural stem cells via their conversion into mature hip-
pocampal astrocytes. Importantly, this astrocytic differ-
entiation is coupled to a rapid succession of asymmetric
divisions of the activated stem cells. Thus, in contrast to
the conventional model of multiple cycles of activation
and quiescence of stem cells, hippocampal neural stem
cells, once activated, leave the stem cell pool. We de-
scribed the life cycle of an adult neural stem cell and
proposed a “disposable stem cell” model which posits
that an adult hippocampal stem cell is quiescent
throughout the entire postnatal life, but, when activated,
it undergoes several rapid asymmetric divisions (even-
tually producing a neuron) and then exits the pool of
stem cells by converting into an astrocyte. This model
reconciles observations on the age-related decrease in
production of new neurons, the age-related increase in
astrocyte number, the disappearance of hippocampal
neural stem cells, and the remodeling of the neurogenic
niche. Together, these continuous changes underlie age-
dependent decrease in production of new neurons and
may contribute to age-related cognitive impairment.
With the increasing evidence that adult neurogenesis
is important for cognitive function and mood regulation,
the ability to detect variations in the level of neurogenesis
in the live brain becomes important for diagnostic pur-
poses. In a broad collaboration with Dr. Helene Ben-
veniste (Stony Brook University and Brookhaven National
Laboratory), we are working to characterize changes in
magnetic resonance spectra in the live human and animal
brain that would be indicative of the changes in neuroge-
nesis. By modifying and adjusting widely used methods
of analyzing in vivo spectra, we are able to reliably detect
indicative signals in the live animal brain under normal
conditions and after electroconvulsive shock. Moreover,
this approach is now being investigated in preclinical and
clinical trials and may become useful for following neu-
rological and psychiatric disorders and cancer.
Stem Cells in Nonneural Tissues
Adult tissues undergo continuous cell turnover in re-
sponse to stress, damage, or physiological demand. New
differentiated cells are generated from dedicated or fac-
ultative stem cells or from self-renewing differentiated
cells. Adult stem cells are located in specialized niches
that restrict their division and support their undifferen-
tiated status. Some time ago, we found that the same re-
porter lines that we developed and used to identify stem
cells of the brain can also help to highlight stem and pro-
genitor cells in a range of other tissues. This list is not
limited to cells of neural origin; it now includes stem
cells of such dissimilar structures as brain and spinal
cord, hair follicles, liver, pancreas, skeletal muscle, testis,
ciliary margin of the eye, anterior pituitary, skin, and
bone marrow. This observation provides a means of iso-
lating adult stem and progenitor cells, tracing their lin-
eage, and studying mechanisms controlling their
quiescence, division, self-renewal, and differentiation.
In an important application of this reporter-based
approach, in collaboration with Dr. Paul Frenette, we
identified mesenchymal stem cells in bone marrow and
demonstrated that they form a niche for hematopoietic
stem cells. These two types of stem cells are found in
close association; furthermore, mesenchymal stem cells
express high levels of genes that are important for
hematopoietic stem cell maintenance and, when de-
pleted, result in a reduced ability of hematopoietic stem
cells to home in the brain marrow. This is the first ex-
ample of a partnership between two distinct somatic
stem cell types, suggesting that such heterotypic stem
cell pairs may exist in other tissues.
NO, Development, and Differentiation
Much of our interest is related to a signaling molecule,
nitric oxide (NO). NO has been extensively character-
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by function-dependent stabilization of cilia growth and
determined the signaling pathway that links the
XNOS1 activity to ciliogenesis and cilia polarity. More-
over, we have now extended these observations to the
tracheal and bronchial epithelium of mammals; these
results indicate a conserved evolutionary role for NO
in the regulation of cilia structure and function and
highlight the role of NO in human health and disease.
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ized as an indispensable regulator of vasodilation, neu-
rotransmission, immune response, and cell death.
Throughout the last two decades, we have demonstrated
that in several developmental and differentiation con-
texts, ranging from differentiating neurons to developing
fruit flies and frogs, NO helps to control the balance be-
tween proliferation and differentiation by suppressing
cell division. For instance, it acts as a negative regulator
of cell division in the developing and adult nervous sys-
tem, such that by manipulating NO levels, we can
change the number of neural stem and progenitor cells.
Furthermore, we found that the neuronal NO synthase
isoform (nNOS), usually associated with brain function,
regulates hematopoiesis in vitro and in vivo: nNOS is ex-
pressed in stromal cells and produces NO which acts as
a paracrine regulator of hematopoietic stem cells. Thus,
NO acts as a regulator of stem and progenitor cell activity
and cell differentiation in a range of tissues. 
Continuing to explore the diversity of NO’s biolog-
ical functions, we found that NO also acts as a regulator
of morphogenesis during early development by coordi-
nating two major morphogenetic processes, cell division
and cell movement, through two overlapping but sep-
arate signaling pathways. Inhibition of NO synthase
during early development of Xenopus increases prolif-
eration in the neuroectoderm and inhibits convergent
extension in the axial mesoderm and neuroectoderm,
indicating that during development, NO suppresses di-
vision and facilitates movement of cells. Such concur-
rent control by NO helps ensure that the crucial
processes of cell proliferation and morphogenetic move-
ments are coordinated during early development. 
We have now discovered yet another role of NO and
nNOS during early development—its function as a reg-
ulator of planar polarity of cilia growth and function in
the mucosecretory epithelium, as exemplified by the
skin in Xenopus larvae and the airway epithelium in
mammals. In these tissues, the spatial organization of
cilia is important for the polarized beating of cilia and
the directional distribution of mucus. We demonstrated
planar polarity of the distribution of cilia in the Xenopus
larvae and found that NO and XNOS1 (an ortholog
of nNOS) are important mediators of this polarity. We
also found a new mode of establishing planar polarity
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The research in my group is aimed at understanding the
molecular basis for the function of cell surface proteins
that trigger cellular signal transductions involved in neu-
rotransmission in the mammalian brain. It is hoped that
this work will help in the design of compounds with
therapeutic potentials in neurological diseases and dis-
orders including schizophrenia, depression, stroke, and
Alzheimer’s disease. Toward this end, we are conducting
structural and functional studies on neurotransmitter
receptor ion channels and intramembrane enzymes,
which facilitate and regulate the strength of neurotrans-
mission. To achieve our goals, we use X-ray crystallog-
raphy to determine three-dimensional structures of
target proteins and test structure-based mechanistic hy-
potheses by site-directed mutagenesis in combination
with biochemical and biophysical techniques including
electrophysiology. Our group is currently focused on un-
derstanding the structure and function of three classes
of cell surface proteins, N-methyl-D-aspartate receptor
(NMDAR) and γ-secretase, dysfunctions of which are
highly implicated in the pathogenesis of neurodegener-
ative diseases including Alzheimer’s disease.
Structure and Function
of NMDARs 
NMDARs belong to the family of iGluRs, which me-
diate the majority of excitatory synaptic transmission
in the mammalian brain. Dysfunctional NMDARs are
implicated in neurological disorders and diseases in-
cluding seizure, stroke, schizophrenia, Parkinson’s dis-
ease, and Alzheimer’s disease. NMDARs are
multimeric ligand-gated ion channels composed of the
GluN1 and GluN2 subunits, which bind glycine and
L-glutamate, respectively. Unlike non-NMDARs that
can form functional ion channels as homotetramers,
the NMDARs can only function as heteromultimers
composed of GluN1 and GluN2, and opening of the
ion channels requires concurrent binding of both
glycine and glutamate to GluN1 and GluN2, respec-
tively. The four distinct GluN2 subunits define phar-
macological subtypes of NMDARs that differ in ion
channel properties, ligand specificity, and spatial and
temporal expression patterns. Subtype-specific regula-
tions of NMDARs have shown some neuroprotective
effects and therefore are considered an effective strategy
to treat neurological disorders and diseases. There has
been an enormous enthusiasm to understand the mo-
lecular basis for subtype specificity in NMDARs and
to create subtype-specific compounds that can target
specific neuronal circuits. 
The NMDAR subunits are modular proteins com-
posed of the amino-terminal domain (ATD), ligand-
binding domain (LBD), transmembrane domain
(TM), and carboxy-terminal domain (CTD) (Fig. 1).
The focus of our study in 2010 was LBD of the
GluN2D subunit, which binds to agonists including L-
glutamate and NMDA. GluN2D is a predominant
subtype of NMDARs that are expressed during the
early developmental stage of the brain. The GluN2D
NMDARs are also distinct from other subtypes of 
NMDARs in that they elicit significantly slow deacti-
vation and have low open channel probability. To un-
derstand the molecular basis for the pharmacological
properties unique to the GluN2D receptors, we have
solved the crystal structures of GluN2D LBD in com-
plex with L- and D-glutamate, L-aspartate, and NMDA
and finished refinement of the structural models for all
of the forms (Fig. 2). The GluN2D LBD has an overall
clamshell-like architecture composed of domain 1 (D1)
and domain 2 (D2), similar to the GluN2A LBD pre-
viously solved. 
All of the agonists bind to the interdomain cleft be-
tween the D1 and D2 domains and appear to stabilize
closed clamshell conformation. Importantly, this is the
first study that successfully visualizes the mode of bind-
ing of an NMDA molecule; therefore, we can assess the
mechanism of NMDA subfamily specificity. Binding of
NMDA involves displacement of a water molecule (W
MOLECULAR ANALYSIS OF NEURONAL RECEPTORS
AND ION CHANNELS
H. Furukawa E. Karakas
N. Simorowski
P. Singh
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One intriguing aspect of the GluN2D LBD struc-
tures was that a region of the structure, which we call
the hinge loop, located at the back side of the ligand-
binding site, is different between the L-glutamate-
bound form and all the other forms. That led us to two
hypotheses: (1) L-glutamate uniquely activates and de-
activates the GluN1/GluN2D NMDARs, and (2)
structural variability around the hinge loop may be re-
sponsible for regulating speed of deactivation. We have
tested these hypotheses by using an electrophysiological
approach in collaboration with Stephen Traynelis at
Emory University. We have made a series of chimera
receptors between GluN2A and GluN2D within the
LBD and measured deactivation speeds by the patch-
clamp method coupled to fast perfusion. GluN2A was
used as a chimera partner because it mediates fast de-
activation (~50 msec) compared to GluN2D (~3000
msec). The chimeric receptors tested, so far, are as fol-
lows: (1) GluN2A (GluN2D LBD), (2) GluN2A
(GluN2D D1), and (3) GluN2A (GluN2D D2). As
shown in Figure 4, all of the chimeras have substantially
slow deactivation compared to the wild-type GluN2A.
This tentatively indicates that both D1 and D2 are im-
portant in regulating deactivation speeds and that the
GluN2D LBD domains facilitate slower deactivation
speed compared to GluN2A LBD. 
Figure 2. Refined crystal structure of GluN2D LBD. The structure
is clamshell-like composed of domain 1 (D1) and domain 2 (D2).
Agonists including NMDA (stick) bind at the interdomain cleft
(between D1 and D2). Glycine-threonine linker used to tether S1
and S2 peptides is shown as gray sphere.
in Fig. 3A) by the N-methyl group whose placement is
favored by the surrounding hydrophobic residues, Tyr-
755 and Val-759. The equivalent residues for Tyr-755
in the AMPAR (α-amino-3-hydroxy-5-methyl-4-isox-
azole proprionic acid receptors) and kainate receptor are
leucine and methionine, respectively, pointing away
from the binding pocket (Fig. 3C). The corresponding
residues for Val-759 are methionine in AMPARs and
threonine in kainate receptors, which are more hy-
drophilic (Fig. 3C). Furthermore, Asp-756 “folds” away
from the binding pocket so that its β-carboxyl group
does not interfere with the placement of the N-methyl
group of NMDA. The aspartate residue at the 756 po-
sition is conserved among the subunits of NMDARs.
In non-NMDARs, the equivalent residue of Asp-756 is
glutamate, whose longer side chain would collide with
the N-methyl group and disallow the placement of an
NMDA molecule in the binding pocket.
Figure 1. Domain organization of NMDAR subunit. The amino-
terminal domain (ATD) at the extracellular region is followed by
S1, transmembrane region (TM) 1 and 2, P-loop, the S2 segment,
TM3, and carboxy-terminal domain (CTD). The S1 and S2 pep-
tides form a ligand-binding domain (LBD) that binds agonists and
antagonists. ATD in NMDARs bind allosteric modulators (zinc
and phenylethanol-amines). TM forms the ion channel in the
context of the heteromultimeric assembly of GluN1 and GluN2
subunits, which is blocked by magnesium at resting membrane
potential. CTD interacts with intracellular proteins such as
PSD95 and CAMKII to mediate cellular signal transduction im-
portant for synaptic plasticity.
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Structure and Function
of γ-Secretase
γ-Secretase is a multimeric protein complex of four
transmembrane proteins including presenilin, nicastrin,
APH-1, and PEN-2. Together, the complex mediates a
molecular event called regulated intramembrane prote-
olysis, which is a type of proteolysis that occurs within
the membrane. Intramembrane proteases are involved
in numerous cellular processes including cholesterol
homeostasis, development, immunosurveillance, and
Alzheimer’s disease. 
γ-Secretase is an aspartyl-protease that cleaves various
single-transmembrane substrates. One of the most well-
studied substrates is amyloid protein whose cleaved frag-
ment diffuses out of the membrane, forms β-amyloid
oligomers and fibril, and initiates signaling cascades re-
sulting in neuronal cell death. Deposition of β-amyloid
fibril is one of the hallmarks of the brain affected by
Alzheimer’s disease. However, mechanistic understand-
ing of activities in γ-secretase and intramembrane pro-
teases in general is restricted due to limited numbers of
available molecular structures. The structural informa-
tion of γ-secretase is currently limited to low-resolution
images obtained from a single-particle analysis using cry-
oelectron microscopy. Our group is interested in reveal-
ing atomic structures of γ-secretase to gain insights into
intramembrane proteolysis, substrate specificity, inhibi-
tion, and functional modulation at the molecular level.
Currently, we are working toward understanding the
mechanism of substrate recognition mediated by one of
the γ-secretase components, nicastrin.
Figure 3. Ligand-binding site of GluN2D LBD in stereoview. (A,B) The GluN2D LBD structures in complex with L-
glutamate and NMDA. Shown on the right-hand side in mesh are electron density maps contoured at 4σ. (C) Orien-
tation of nonconserved residues in GluA2 LBD.  
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Figure 4. Roles of hinge loop. (A) Structures of GluN2D LBD in complex with various ligands. Note that the confor-
mation of the L-glutamate-bound structure (cyan) is different from all the others. (B) Design of chimeric receptors be-
tween GluN2A and GluN2D and deactivation speeds measured by whole-cell patch clamp. The horizontal scale bar
represents 2 sec for all traces, and the vertical scale bar represents ~200 pA for all traces. 
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We combine genetic, imaging, and physiology ap-
proaches to study the organization, function, and de-
velopment of neural circuits in cerebral cortex, focusing
on GABAergic inhibitory interneurons.
Genetic Dissection of the GABAergic
System in the Neocortex
In the mammalian neocortex, the delicate balance and
dynamic assembly of the functional architecture of neu-
ral circuits are achieved through a rich repertoire of in-
hibitory control mechanisms. A key obstacle to under-
standing cortical circuits is the diversity of GABAergic
interneurons, which poses general questions in neural
circuit analysis: How are diverse cell types generated and
assembled into stereotyped local circuits, and how do
they differentially contribute to circuit operations that
underlie cortical functions ranging from perception to
cognition? Using genetic engineering and the Cre/LoxP
strategy in mice, we have generated and characterized
~20 Cre and inducible CreER knockin driver lines that
reliably targeted major classes and lineages of GABAer-
gic neurons. More distinct populations are captured by
intersection of Cre and Flp drivers and by engaging lin-
eage and birth-timing mechanisms. Genetic targeting
allows reliable identification, monitoring, and manipu-
lation of GABAergic neurons, thereby enabling system-
atic and comprehensive analysis from cell-fate specifi-
cation, migration, and connectivity to their function in
networks and behavior. 
Genetic Analysis of Chandelier Cells
during Cortical Circuit Assembly
We have genetically captured chandelier cells (CHCs),
the most distinctive class of cortical interneurons. CHCs
exclusively innervate pyramidal cells at axon initial seg-
ments, the site of action potential generation. CHCs
may thus exert decisive control over pyramidal cell firing
and thereby dynamically configure neural ensembles.
Because of their exceptional stereotypy and specificity,
genetic capture of CHCs establishes a powerful experi-
mental paradigm for studying their entire developmen-
tal history, from origin to function in cortical circuits.
We have found that CHCs undergo massive pruning in
both cell numbers and axons before the emergence of
characteristic chandelier arbors in the third postnatal
week. Conserved from mouse to humans, CHCs have
been implicated in several brain disorders including
schizophrenia and epilepsy. Alteration of CHCs, either
as a direct consequence of mutations or indirectly
through developmental compensation and maladapta-
tion, is likely a hallmark and a sensitive probe for de-
tecting aberrant cortical circuits in mouse models.
Genetic analysis of CHCs not only will provide a key
entry point to understanding the assembly and function
of cortical circuitry but will also shed light on the path-
ogenic mechanisms of neuropsychiatric disorders. 
Role of GABA Transmission 
Activity-Dependent Development
of Inhibitory Synapses 
The synaptic connectivity of GABAergic interneurons in
the neocortex is often characterized by both specificity
and robustness. For example, basket interneurons selec-
tively target the soma and proximal dendrite (i.e., peri-
somatic region) of pyramidal neurons, and a single basket
cell innervates hundreds of pyramidal neurons with tens
of synapses on each target cell. Such specific and exuber-
ant patterns of synaptic innervation likely contribute to
the effective control of the output and synchrony of py-
ramidal neurons, but the underlying developmental
mechanisms are largely unknown. In the past year, we
have made significant progress in understanding how
GABA signaling, presynaptic GABAB receptors, and
neurexin (NRX)–neuroligin synaptic adhesion molecules
contribute to GABA-mediated regulation of inhibitory
CONSTRUCTION AND FUNCTION OF GABA INHIBITORY
CIRCUITS IN NEOCORTEX 
Z.J. Huang Y. Fu Y. Lin H. Taniguchi
M. He J. Lu P.J. Tucciarone
S.K. Krishnan A. Paul P. Wu
M. Lazarus R. Pike X. Wu
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synapse development. We found that developing basket
cell axons and presynaptic boutons are highly dynamic.
Interfering with GABAB receptor function by either an-
tagonists or single-cell knockout destabilizes nascent
GABAergic terminals. These results suggest that local ac-
tivation of presynaptic GABAB receptors stabilizes nas-
cent synaptic contacts and contributes to activity-de-
pendent regulation of inhibitory synapse development.
NRXs and neuroligins are key synaptic adhesion mole-
cules that also recruit synaptic signaling machineries.
NRXs consist of α and β isoforms, but how they couple
synaptic transmission and adhesion to regulate activity-
dependent synapse development remains unclear, in part
due to poor understanding of their cell biology and reg-
ulation in the relevant neurons. Here, we examined the
subaxonal localization, dynamics, and regulation of
NRX1α and NRX1β in cortical perisomatic inhibitory
synapses. Both isoforms are delivered to presynaptic ter-
minals but show a significant and different turnover rate
at the membrane. Although NRX1α is highly diffuse
along developing axons and filopodia, NRX1β is strictly
anchored at terminals through binding to postsynaptic
ligands. The turnover rate of NRX1β is attenuated by
neural activity and presynaptic GABAB receptors. NRXs
are thus intrinsically dynamic, but they are stabilized by
local transmitter release. Such an activity-adjusted adhe-
sion system seems to be ideally suited to rapidly explore
and validate synaptic partners guided by synaptic trans-
mission. 
Impact of GABAergic Deficiency
in Synaptic Transmission and Behavior 
A highly reproducible observation in schizophrenia (SZ)
is the reduction of mRNA for GAD67—the principle
enzyme for GABA synthesis in cortex—in certain types
of cortical interneurons, particularly those expressing
parvalbumin (PV). GAD67 expression is regulated by
cellular activity, and its reduction in schizophrenia is
most likely a downstream impact of reduced engage-
ment of the PV cell network. Because PV cells have an
important role in the generation and maintenance of γ
wave activity, dysfunction in these cells is thought to
contribute to cognitive deficits in SZ, such as working
memory impairment. However, there are no effective
treatments to target GABA-system dysfunction in schiz-
ophrenia or to limit cognitive deficits in the disease. To
model the cell-type-specific changes observed in SZ, we
used a cre/lox system in mice to conditionally knock
down GAD67 in PV cells. Virus-vector-mediated green
fluorescent protein (GFP) expression was used for paired
recordings from PV to pyramidal cells and for behavioral
tests, including Y-maze spontaneous alternation to assess
working memory function. 
In young mice, reduction of GAD67 in PV cells led
to weakened synaptic inhibition. Removal of one allele
of Gad1 (heterozygote) led to a 33% reduction of
GAD67 in PV cells and further caused a supralinear
deficit in synaptic transmission. Young mutant mice
also demonstrated a behavioral phenotype, with re-
duced spontaneous alternation in the Y-maze. Addi-
tionally, pyramidal cells demonstrated hyperactive
spiking properties in response to current injection. In
adult mice, however, both the synaptic and behavioral
deficits had resolved, leading the mutant mice to be in-
distinguishable from controls in all measured parame-
ters. We therefore have demonstrated that GABA
deficiency does in fact lead to weakened synaptic trans-
mission, with a concurrent behavioral phenotype.
However, weakened inhibition in juvenile mice appears
to not produce any irreversible changes, as homeostatic
mechanisms were able to fully eliminate the impact of
this artificially induced GAD67 deficit. Our results
from this rodent study support that PV cell function,
or possibly GAD67 expression level itself, presents a
possible treatment target for cognitive dysfunction.
Cell-Type-Based Epigenomic Analysis
of GABAergic Neurons
A systematic understanding of gene expression profiles and
the epigenomes of different classes of interneurons during
development and in response to stimulus will yield fun-
damental insight into the genetic logic underlying the con-
struction and function of GABAergic circuits. A major
challenge in epigenomic analysis of mammalian brains is
cellular heterogeneity—distinct epigenomes are inaccessi-
ble to sequencing technology. Using genetic engineering
in mice, we are building a comprehensive tagging system
that allows purification of chromatin DNA, ncRNA (non-
coding RNA), and mRNA from genetically defined cell
populations from tissues. Genetic tagging of nucleic acids
is achieved by cell-type-specific expression of epitope-
tagged DNA- or RNA-binding proteins. DNA or RNA
species from a defined cell type are isolated directly from
tissue homogenates by affinity purification using antibod-
ies against the epitope tags or by fluorescence-assisted cell
sorting (FACS) of cells from dissociated tissues. We are
analyzing major GABAergic neuron types from several
cortical areas and across key stages of cortical development. 
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microRNAs (miRNAs) regulate gene expression in a
sequence-specific manner and are implicated in devel-
opment and function of mammalian brain, but the cel-
lular heterogeneity impedes in-depth studies of miRNA.
We have established a cell-type-based “miRNA-tagging”
affinity purification method using a Cre-loxP binary sys-
tem in genetically engineered mice. We have demon-
strated the success of this method by profiling miRNAs
in major types of neurons in the mouse neocortex and
cerebellum using deep sequencing. We have discovered
highly distinct profiles of miRNA expression in different
cell types, novel miRNAs, and novel features of miRNAs
biogenesis. These tools will facilitate the functional stud-
ies of miRNAs in the brain. 
A Novel Function of MeCP2
in mRNA Translation
MECP2 was identified as a nuclear methyl-CpG DNA-
binding protein and is best known as a regulator of tran-
scription and chromatin. Mutations in MECP2 are
linked to autism spectrum disorders, especially Rett syn-
drome (RTT), but the pathogenic mechanisms remain
elusive. Here, we report a translation regulatory function
of MECP2. MECP2 is detected in discrete puncta of the
neuronal cytoplasm, in brain polyribosomes, and inter-
acts with numerous messenger ribonucleoproteins with
translation regulatory functions. MECP2 further asso-
ciates with hundreds of mRNAs which, in its absence,
show altered protein levels. Importantly, actively trans-
lating mRNAs, but not the steady-state transcript levels,
show pronounced changes in the MeCP2-null brain.
MECP2-regulated mRNAs are involved in synaptic
transmission, cell signaling, and ion homeostasis and
likely contribute to a range of neural and physiological
processes deficient in RTT. Our results establish a novel
biological function of MeCP2 and implicate translation
regulation in RTT pathogenesis.
GABAergic Interneurons and
Neurodevelopmental Disorders
We are studying alterations of GABAergic inhibitory
circuits in mouse models of RTT, one of the autism
spectrum disorders, caused by mutations in the X-
linked gene MeCP2. Our general hypothesis is that
MeCP2 mutations perturb the postnatal maturation of
the connectivity, function, and plasticity in subsets of
inhibitory interneurons in distributed brain areas, lead-
ing to altered development and maladaptive plasticity
of neural circuits, and characteristic behavioral deficits. 
Neuronal circuits in the brain are shaped by experi-
ence during “critical periods” in early postnatal life. In
the cortex, this activity-dependent development is co-
incident with the functional maturation of parvalbu-
min (PV+) GABAergic interneurons, although the
underlying mechanisms are unclear. We found that loss
of methyl-CpG-binding protein (MECP2) results in
accelerated maturation of PV+ fast-spiking cortical in-
terneurons, likely resulting in a shift in critical period
onset using molecular markers and physiological pa-
rameters. Furthermore, loss of MeCP2 in PV+ interneu-
rons resulted in increased expression of the rate-limiting
enzyme GAD67, which synthesizes GABA, the major
inhibitory neurotransmitter in the brain. Previous stud-
ies from our lab have provided evidence for the role of
GABA signaling not only in mediating inhibitory trans-
mission, but also in regulating activity-dependent mat-
uration of inhibitory synapses and innervation patterns.
Our current results indicate a requirement for MeCP2
in regulating the development of activity-dependent
maturation of PV+ GABAergic interneurons via
GAD67, which in turn innervate the perisomatic re-
gion of pyramidal neurons and control their output. As
MeCP2-null mice serve as a model for RTT, a devastat-
ing neurodevelopmental disorder, our findings provide
insight into the inappropriate synaptic plasticity under-
lying the pathogenesis of this disease. 
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We are interested in identifying the neurobiological
principles underlying cognition and decision making.
We use a reductionist approach, distilling behavioral
questions to quantitative behavioral tasks for rats and
mice that enable us to monitor and manipulate the neu-
ral circuits supporting behavior. Using state-of-the-art
electrophysiological techniques, we first seek to estab-
lish the neural correlates of behavior and then use mo-
lecular and optogenetic manipulations to systematically
dissect their underlying neural circuits.
Given the complexity of animal behavior and the dy-
namics of neural networks producing it, our studies re-
quire quantitative analysis and computational models to
guide and sharpen the neurobiological questions. In ad-
dition, we started incorporating human psychophysics
into our research to validate our behavioral observations
in rodents by linking them with analogous behaviors in
human subjects.
In terms of topics, our approach is multifaceted. We
study (1) the roles of uncertainty in decision making,
(2) the division of labor between cell types in prefrontal
cortex, (3) how the cholinergic system supports learn-
ing and attention, and (4) social decisions that rely on
shallow, stereotyped circuits. A unifying theme is the
use of cell-type-specific and pathway-specific perturba-
tions to effect gain and loss of function for specific be-
havioral abilities. Through such manipulations of
genetically and anatomically defined neuronal ele-
ments, we hope to identify fundamental principles of
neural circuit function that will be ultimately useful for
developing therapies for diseases such as schizophrenia,
Alzheimer’s disease, and autism spectrum disorder. 
Role of Orbitofrontal Cortex
in Confidence Judgments
J. Sanders, J. Hirokawa, A. Lak, G. Costa [in collaboration
with Z.F. Mainen, Champalimaud Neuroscience Program,
Portugal]
If you are asked to evaluate your confidence in your de-
cision—how sure are you that you made the correct
choice—you can readily answer. What is the neural basis
for such judgments? Is knowledge about beliefs an ex-
ample of the human brain’s capacity for self-awareness?
Or is there a simpler explanation that might suggest a
more basic yet fundamental role for uncertainty in neu-
ral computation? Previously, we discovered neurons in
orbitofrontal cortex (OFC) that signal decision confi-
dence. We are pursuing these initial observations by try-
ing to establish that confidence-related neural activity in
the OFC is causally required for confidence judgments. 
First, we established a new olfactory decision task for
rats, in which an estimate of decision uncertainty or con-
fidence about the original decision is turned into a be-
havioral action. We designed a task in which we could
measure confidence behaviorally on a trial-by-trial basis
in order to examine the neural mechanisms of confi-
dence judgments. To manipulate confidence, we used an
olfactory mixture categorization task in which we can
systematically vary decision uncertainty by changing the
ratio of the two components in the odor mixture. To
measure confidence, we delayed reward delivery after
correct choices and measured the time an animal was
willing to wait at the reward ports. This task allows us
to examine how the timing of the decision to leave the
reward port (“abort decision”) depends on the uncer-
tainty about the original decision. 
Although we observed neural correlates of confidence
in OFC, it may be one of several nodes in a network sub-
serving confidence-guided decisions. Interestingly, how-
ever, several studies have shown that humans with OFC
lesions are insensitive to the degree of uncertainty, indi-
cating that the OFC may be causally involved in some
uncertainty-guided behaviors. Therefore, we hypothesized
that inactivating OFC leaves the odor-guided decision in-
tact while impairing the use of confidence-guided abort
decisions. To test this, we bilaterally implanted double
cannulae to temporary blockade neural activity in OFC.
We found that inactivation of OFC disrupted the de-
pendence of waiting time on decision confidence without
changing the accuracy of the sensory decision. These re-
sults establish, for the first time, that there is an anatom-
ical locus for confidence and that confidence reports and
the computation of decisions are distinct processes local-
ized to different brain regions.
NEUROBIOLOGY OF COGNITION AND DECISION MAKING 
A. Kepecs E. Demir D. Kvitsiani S. Rengarajan 
B. Hangya H.J. Pi J. Sanders 
J. Hirokawa S. Ranade 
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If OFC activity directly controls abort decisions,
then activation of the relevant neurons should trigger
aborting in rats. How might OFC activity directly in-
fluence behavior? We are currently testing the hypoth-
esis that a distinct output pathway from OFC is
responsible for initiating abort decisions. We use a viral
strategy to retrogradely deliver ChR2 to OFC neurons
from several known target areas with motor functions,
such as the striatum and the periaqueductal gray. Our
ultimate aim is to define a precise neural circuit for
computing and using decision confidence.
Confidence Judgments in Humans
J. Sanders
Methods for measuring decision confidence in humans
have traditionally been limited to various forms of ver-
bal reports and postdecision wagers. Our goal was to
develop a new confidence-reporting task that provides
both implicit and explicit measures of decision confi-
dence and is suitable for both rodents and humans in
order to make direct comparisons.
Toward this goal, we developed an auditory stereo
click train discrimination task in which subjects are
asked to report the side with the higher click rate. Our
implicit measure of confidence is based on the notion
that when confident, it makes sense to wait longer for
an uncertain reward. Preliminary results demonstrate
that both humans and rats optimize their decision-
making strategies in this task by adjusting this waiting
time measure to match the quality of sensory evidence.
In humans, we can also prompt subjects for explicit self-
reports of confidence (1–5 scale), and these correlate
with the implicit waiting time measure.
On the basis of these results, we are now in a posi-
tion to use these quantitative measures of decision con-
fidence for human studies, through collaborations,
using neuroimaging and genetic analysis. Aside from its
usefulness in human studies, by showing that a single
confidence measure is applicable to humans and ro-
dents, our results strengthen the case for using the rat
as a model system for studying decision confidence.
Auditory Sequences and Novelty
Processing in Hippocampus
J. Sanders
The hippocampus is thought to have a key role in
episodic memories, those linked to a specific time and
place, as well as in encoding the temporal order and fa-
miliarity of events. Electrophysiological studies in the ro-
dent hippocampus have traditionally focused on the
spatial correlates of neurons, characterizing them as “place
cells,” which represent unique spatial locations in space.
Although these neurons are known to exhibit a number
of nonspatial correlates as well, their responses to abstract
nonspatial attributes remain poorly understood.
We are studying the nonspatial correlates of hip-
pocampal neurons in head-fixed mice trained to listen
for a target sound following a sequence of eight unique,
natural sounds. We record single units from the CA1
subfield of hippocampus while head-fixed mice listen
to the familiar sequence, novel sequences, and a hybrid
sequence (familiar order, but interrupted by novel ele-
ments). We noted that many CA1 cells have short-la-
tency responses to sound onsets and signal abstract
attributes not explicitly present in the sounds them-
selves: temporal context, reward cues, and reward out-
come. 
These results show that in a head-fixed setting, the
awake rodent hippocampus rapidly encodes abstract
properties of auditory events. Because most recordings
from rodent hippocampus describe neurons as “place
cells,” we are currently comparing the response of
sound-selective neurons to spatial cues. We expect that
these results will open a new avenue for exploring non-
spatial computations in the hippocampus. 
Neural Circuit Dynamics of Genetically
Identified Interneuron Types
in Behaving Mice 
D. Kvitsiani, S. Ranade [in collaboration with Z.J. Huang,
Cold Spring Harbor Laboratory]
The medial prefrontal cortex (mPFC) in humans and
rodents has been implicated in a variety of goal-directed
behaviors, including working memory, inhibitory re-
sponse control, and attentional set switching. Electro-
physiological recordings from the mPFC show great
diversity of neuronal responses to specific behavioral
variables. On the other hand, we know that the mam-
malian cortex is composed of variety of cell types
among which GABAergic interneurons exhibit the
largest diversity in connectivity, morphology, and in-
trinsic physiology. Does the anatomical and molecular
variety of interneuronal types map onto the diversity of
neuronal responses in behaving animals? To answer this
question, we developed a method to electrophysiologi-
cally record freely behaving animals from a genetically
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defined neural population. Our method relies on com-
bining optogenetic tools with behavioral electrophysi-
ology. We focused on somatostatin (SOM)- and par-
valbumin (PV)-expressing interneurons that target, re-
spectively, the distal dendritic and perisomatic regions
of pyramidal cells and are thought to have complemen-
tary functions in regulating principal cell firing. We
used a simple auditory-cued reward anticipation task
where mice are trained to run back and forth on a linear
track and collect water rewards at the end of the track
by nose poking in the water port. 
We found that the majority of PV and SOM neu-
rons showed distinct and homogeneous response pro-
files to behavioral periods when animals were initiating
the runs on a linear track shortly after reward consump-
tion. PV neurons abruptly ramped up their activity
while SOM neurons slowly decreased firing. We also
observed that artificially activating groups of PV and
SOM neurons provide respectively short and long in-
hibition to putative pyramidal cells, suggesting that
these two groups of interneurons are temporal special-
ists for inhibition.
The homogeneity of responses within PV and SOM
interneurons and their “inhibitory footprint” has strong
implications for mPFC circuit dynamics. We hypothesize
that SOM neurons are in a position to gate intracortical
inputs to layer-5 pyramidal cells. On the other hand, fast
and homogeneous modulation of PV interneuron firing
might provide a “reset signal” for ensembles of pyramidal
cells by synchronizing their activity.
Function of VIP Interneurons
in Cortical Microcircuits
H.J. Pi [in collaboration with Z.J. Huang, Cold Spring Harbor
Laboratory]
We are interested in understanding how the diversity
of cortical inhibitory interneurons underlies distinct
neural circuit dynamics that direct perception and be-
havior. As part of this project, we have begun to study
vasoactive intestinal peptide-expressing (VIP) interneu-
rons. Although VIP neurons constitute less than 2% of
the total cortical neuronal population, previous studies
indicate that VIPs might have a distinct function in the
local cortical column. VIP neurons are mostly bipolar,
and their processes are vertically oriented. Interestingly,
these neurons specifically target other inhibitory neu-
rons and avoid pyramidal cells. On the basis of these
ideas, we are currently testing the hypothesis that VIP
inhibitory interneurons provide local excitation to a
patch of cortex via disinhibition of other interneurons.
Neural Representation of Social
Decisions and Rewards 
E. Demir [in collaboration with R. Axel, Columbia 
University]
Mice, like humans, are social animals. To interact, co-
operate, and compete with others, mice have to collect
information about each others’ identity, fertility, and
likely intent. We want to understand how social infor-
mation is represented, computed, and used by mice. In
rodents, a main source of information for social deci-
sion making and reward valuation is the chemosensory
system. These circuits tend to be shallow, from sensory
input to motor actions, and highly stereotyped, en-
abling the systematic dissection of this system.
We have begun our studies by recording from the me-
dial amygdala, the first brain region that combines in-
formation from the two olfactory systems, the main
olfactory system transducing volatile odors and the
vomeronasal system detecting behaviorally significant
chemical cues, such as pheromones. To deliver social
stimuli and determine their “value” for a mouse, we de-
veloped a new behavioral setup—the “mouse carousel.”
This system will improve stimulus delivery precision and
repertoire. In the future, we hope to find molecular
markers that will enable us to identify and record from
a specific population of neurons in the medial amygdala.
Addicted to Light: Optogenetic Control
of Dopamine during Behavior 
S. Rengarajan
Dopaminergic neurons in the ventral tegmental area
(VTA) have been implicated in driving learning and re-
ward-seeking behaviors. Electrophysiological recordings
show that these neurons signal the discrepancy between
reward prediction and outcome, the “prediction error
signal,” a theoretically important variable for learning.
However, it is not known whether prediction error sig-
nals have a causal role in changing behavior.
To test this idea, we are using an optogenetic ap-
proach in behaving mice. We are using a two-choice
discrimination paradigm to test whether prediction
error signals influence updating in subsequent trials. To
control VTA firing, we implant fiberoptic probes in
TH-cre mice expressing either ChR2 or Arch to respec-
tively activate and suppress dopamine neuron firing.
Our hope is to artificially induce behavioral updating
by optical activation and suppress normal updating by
optical inhibition of dopaminergic neurons.
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Paying Attention to Light: Optogenetic
Dissection of the Cholinergic System
during Behavior
S. Ranade, H. Retallack, S. Rengarajan, J. Woldenberg,
B. Hangya
The cholinergic basal forebrain (CBF) is a vitally impor-
tant yet poorly understood neuromodulatory system that
is thought to have significant roles in cognitive functions
including attention. Projections of CBF innervate the
entire cortical mantle and release acetylcholine, which
enhances cortical processing. Although lesion studies and
pharmacology have delineated a role for acetylcholine in
attention, these techniques are lacking in spatial, tem-
poral, and neurochemical specificities. The goal of this
project is to understand the function of the CBF in at-
tention, using a powerful combination of molecular ge-
netic, electrophysiological, optogenetic, and psycho-
physical techniques.
We use a knockin mouse line (Chat-cre) to specifi-
cally target cholinergic neurons in the basal forebrain.
We can express optical activators/inactivators delivered
via viral vectors specifically in these neurons to manip-
ulate their activity with high spatiotemporal precision.
We have successfully developed visual and auditory ver-
sions of sustained attention tasks in mice. In this task,
mice report the occurrence or nonoccurrence of a rare
and unpredictable sound/light flash at two different lo-
cations to receive water. Performance of the task is an
indicator of attention. We are currently testing the
causal role of acetylcholine in this task by transiently
inactivating cholinergic neurons with light during be-
havior. We also plan to record the activity of “optoge-
netically tagged” cholinergic neurons in mice engaged
in this task to understand the response dynamics of
these neurons. In general, these tools enable an un-
precedented degree of mechanistic investigation of the
behavioral functions of the CBF system and provide an
entry point for future studies of cholinergic degenera-
tive diseases, such as Alzheimer’s disease.
Mechanisms of Cholinergic Modulation
in the Auditory Cortex
S. Ranade, T. Hromadka, B. Hangya [in collaboration
with T. Zador, Cold Spring Harbor Laboratory]
Acetylcholine (Ach) has profound physiological effects
on cortical neurons. For instance, electrical stimulation
of the nucleus basalis leads to desynchronization of the
cortical EEG. Cholinergic agonists increase firing rate,
decrease firing correlations between neighboring neu-
rons, and change the receptive field properties of corti-
cal pyramidal neurons. 
What is the physiological mechanism by which Ach
modulates coritical neuronal firing? The goal of this
project is to investigate the cellular and circuit mecha-
nisms of cholinergic modulation of spontaneous and
stimulus-evoked activity of cortical neurons in A1. We
targeted the light activator, ChR2, to cholinergic neu-
rons (see previous section) projecting to A1 to evoke
light-triggered release of Ach. Using this technique, we
observed the effects of Ach on auditory cortical re-
sponses. A high percentage of neurons increased their
firing rate in response to light activation and some also
showed changes in their auditory tuning curves. Using
cell-attached recordings, we now plan to investigate the
underlying cellular mechanism of cholinergic modula-
tion. Furthermore, by recording from identified cholin-
ergic neurons in awake mice, we would like to correlate
their firing with network states of neurons.
Rapid Light-Induced Transcription
in Mammalian Cells
A. Kepecs [in collaboration with F. Albeanu, Cold Spring
Harbor Laboratory]
Genetically encoded optical modulators have revolu-
tionized neuroscience. A serious impediment to their
use in probing neural circuitry during behavior is that
at present we cannot target them to functionally de-
fined neural populations—only to neurons defined by
genetic markers or anatomical projections. One way to
achieve functional targeting is to first use imaging tech-
niques to characterize a functional population of neu-
rons and then use light-activated transcription to
induce genetically encoded activity indicators and op-
tical modulators specifically in this functionally defined
neuron class. 
Toward this goal, we are developing a genetically en-
coded light-induced transcription system that can be
used in the brain in vivo. We are presently testing a two-
component system that upon light activation would rap-
idly and persistently release a tTa driver to induce the
transcription of any construct under the tTA-responsive
promoter, tetO. In principle, this system is generic, and
therefore, depending on its efficiency and leak, we foresee
applications beyond neuroscience for precise spatiotem-
poral targeting of gene expression.
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Our laboratory develops mathematical models of neural
processing. We work in parallel on three important top-
ics. First, we are formulating a mathematical model for
combining genetic information and experience (nature
and nurture) during the development of neural connec-
tivity. Our model describes how genes can help build
neural networks and how neural activity adds a layer of
plasticity to the network topology that reflects learning
and experience. This model has been tested on simple
circuits that are formed in the visual system and can be
rewired using genetic, surgical, and pharmacological
manipulations. 
Second, we have been developing the neural network
theory for olfactory processing. Our theory attempts to
describe the olfactory space, which has been an elusive
concept that excites the imagination of chemists, neu-
roscientists, and experimental psychologists alike. In our
theory, we attempted to link several levels of olfactory
perception: chemical, genetic, neural, and perceptual.
Our main result so far has been the mapping between
chemical and perceptual spaces that was established on
the basis of a database of human olfactory responses. We
have developed a robust description of the human per-
ceptual olfactory space. This description is analogous to
understanding the main directions in the human color
space, i.e., red, green, and blue. These main perceptual
dimensions can be understood in terms of properties of
the underlying chemical compounds, at least, on the
level of correlation. We also proposed a network theory
for information processing in the olfactory bulb. We
suggest that the granule cells, the inhibitory neurons of
the olfactory bulb, form representations of smells using
the network implementation of sparse overcomplete
representations. Granule cells are remarkable because,
unlike most of the neurons in the adult mammalian
nervous system, they are continuously replaced by the
new neurons produced from the neural stem cells. 
Third, we have been working on the mathematical
description of adult neural stem cell differentiation and
proliferation in hippocampus. 
These models can describe the evolution in time of
various markers that experimental researchers use to
study the division/differentiation cascade. By compar-
ing the computational/theoretical models to experi-
mental data, one can understand changes occurring in
neurogenesis due to aging and antidepressant therapies. 
Competition Is a Driving Force
in Topographic Mapping
A. Koulakov [in collaboration with C. Pfeiffenberger,
J.W. Triplett, J. Yamada, B.K. Stafford, D. Feldheim,
University of California, Santa Cruz]
Connectivity in the brain is established on the basis of
chemical labels and structured activity. For the two-di-
mensional, topographically organized projection from
the retina to the superior colliculus (SC), the Eph family
of receptor tyrosine kinases and their ephrin ligands
exert the role of chemical labels. Despite specific effects
of receptor activation on retinal axons, axons respond to
relative levels, rather than absolute levels, of chemical la-
bels, which endows the mapping mechanism with sub-
stantial robustness. However, it is not known how axons
compare global levels of chemical labels. Here, we pres-
ent experimental and computational evidence that inter-
axon competition has a nonredundant role as a mapping
mechanism for the retinocollicular projection. We in-
vestigated topographic maps in the SC of Math5 mutant
mice in which the overall number of retinal axons is se-
verely reduced. We showed that topographic maps are
substantially distorted under conditions of reduced
competition (Fig. 1). RGC axons project almost entirely
to the anterior-medial portion of the SC where repulsion
from ephrin-A ligands is minimized and where their at-
traction to ephrin-Bs is maximized. We conclude that
chemical labels alone do not instruct the formation of
the map. We provide a mathematical model for topo-
graphic mapping that incorporates molecular labels,
neural activity, and axon competition. 
The Structure of Human Olfactory
Space of Mixtures
A. Koulakov [in collaboration with A. Enikolopov,
D. Rinberg, HHMI Janelia Farm]
We investigated the responses of human observers con-
tained in the atlas of human character profiles (AOCP)
THEORETICAL AND COMPUTATIONAL NEUROSCIENCE 
A. Koulakov
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by Andrew Dravnieks. We have shown previously that
146D profiles of odorants that represent the responses
of human observers to a variety of monomolecular odor-
ants can be accurately described by a two-dimensional
curved manifold. Here, we investigate the responses of
human subjects to the set of 15 mixtures contained in
the same database. The particular question that we ad-
dress is whether the percepts of mixtures (the mixture
space) reside close to the olfactory space determined
from the monomolecular odorants. We show that in-
deed the mixture space can be predicted by the percepts
of monomolecular odorants. The important difference,
however, is that the mixture space contains one extra di-
mension compared to monomolecular odorants. Thus,
approximating 146-dimensional profiles of monomol-
ecular odorants with the two-dimensional curved man-
ifold allows us to include 51% of variance contained in
the data. In the case of mixtures, the same amount of
variance can be explained by a three-dimensional curved
space. One extra dimension, however, is predicted by
the small residual fluctuations of monomolecular per-
cepts around the two-dimensional curved monomolec-
ular space. We conclude that the responses of human
observers to mixtures can be found to be low dimen-
sional and predictable from the percepts of monomole-
cular odorants.
Sparse Incomplete Representations:
A Novel Role for Olfactory Granule Cells
A. Koulakov [in collaboration with D. Rinberg, HHMI Janelia
Farm]
Mitral cells of the olfactory bulb form sparse represen-
tations of odorants and transmit this information to the
cortex. The olfactory code carried by the mitral cells is
sparser than the inputs that they receive. In this study,
we analyzed the mechanisms and functional significance
of sparse olfactory codes. We consider a model of the ol-
factory bulb containing populations of excitatory mitral
and inhibitory granule cells. We argue that sparse codes
may emerge as a result of self-organization in the net-
work, leading to the precise balance between mitral cells’
excitatory inputs and inhibition provided by the granule
cells. We propose a novel role for the olfactory granule
cells. We show that these cells can build representations
of odorant stimuli that are not fully accurate. Due to
the incompleteness in granule cell representation, the
exact excitation-inhibition balance is only established by
some mitral cells leading to sparse responses. Our model
suggests a functional significance of the dendrodendritic
synapses that mediate interactions between mitral and
granule cells. The model accounts for the sparse olfac-
Figure 1.As the number of retinal cells is progressively decreased
in the model, the projection from retina to the superior colliculus
(SC) of the midbrain deforms until only a part of the target is filled
with axons (top right). The case of ~5% of retinal cells present
corresponds to the phenotype observed in Math5–/– knockout
mice, in which retinal progenitors produce only 5% of the nor-
mal number of neurons. The structure of retinocollicular connec-
tivity observed in these animals is consistent with the results of
the model shown here (top right). This argues strongly in favor of
the mechanism involving competition among axons for space
and trophic factors in the target. Chemical labels alone (Eph re-
ceptors and ephrins) cannot enforce the correct connectivity. 
Figure 2. Structure of human olfactory space. Odors (crosses)
cluster around a two-dimensional curved surface in the percep-
tual space. The two-dimensional surface exists in a 146-dimen-
sional space of various perceptual descriptors. The parameters
defining the positions on the surface (X and Y) are related to the
molecule’s chemical composition and hidrophobicity. 
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tory code in the steady state and predicts that transient
dynamics may be less sparse.
Disposable Tissue Hypothesis: A New
Model for Hippocampal Neurogenesis
A. Koulakov [in collaboration with G. Enikolopov, Cold
Spring Harbor Laboratory]
New neurons are continuously generated throughout
the life of an animal in at least two areas of the mam-
malian brain: olfactory bulb and hippocampal dentate
gyrus. Hippocampal neurogenesis dynamically re-
sponds to a multitude of extrinsic stimuli and may be
important for behavior, pathophysiology, brain repair,
and the response to drugs that modulate mood. New
neurons are produced from a limited population of
stem cells whose number declines with age. What fac-
tors determine the rate of decline in the hippocampal
stem cell population? How can the rate of production
of new neurons be varied? In this study, we have shown
that soon after a stem cell is used for production of new
neurons, it becomes an astrocyte, i.e., leaves the pool
of neuroprogenitors. Therefore, one can think of the
stem cells as disposable: Once they are used, they can-
not be reused again. The decline in the number of stem
cells therefore occurs in a use-dependent manner. Does
this mean that the more neurons produced, the faster
the stem cells are lost? Not necessarily. The sequence of
transformations that a cell must undergo before it be-
comes a new neuron is very complex. One of the steps
involves an intermediate form of neuroprogenitors that
are called amplifying cells. These cells divide rapidly,
about once per day, to make more neurons. It turns out
that antidepressant drugs, such as Prozac, affect the di-
visions of the intermediate amplifying cells without
much impact on primary (disposable) stem cells. To-
gether with experimental group of Grisha Enikolopov
at CSHL, we have developed a computational model
for the division/differentiation cascade that leads to the
production of new neurons. Comparing the computa-
tional model to experimental results leads to detailed
information about the changes occurring in the neuro-
genesis cascade due to antidepressant drugs, aging, and
other therapies. Our approach will provide unique in-
sights to the computational properties of the neural
stem cells and their importance for mental health. 
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Research in my laboratory is directed toward under-
standing the synaptic mechanisms of aberrant behavior
in animal models of psychiatric disorders. Synaptic plas-
ticity is believed to serve as the cellular mechanism for
learning and memory, and impairments in this process
have been linked to psychiatric disorders, including
schizophrenia and depression. We use rodent models of
these disorders, and employ a number of complemen-
tary methodologies, including behavioral assays, elec-
trophysiology, two-photon imaging, in vivo circuit tracing,
electrical deep-brain stimulation, molecular genetics, and
optogenetic techniques, to address questions in three
major areas: (1) the synaptic mechanisms of depression;
(2) the synaptic mechanisms underlying normal adap-
tive behaviors, such as resilience to depression or be-
havioral flexibility; (3) the synaptic mechanisms of
schizophrenia. 
The Synaptic Circuitry of the Lateral
Habenula and Behavioral Depression
The cellular basis of depressive disorders is poorly under-
stood. Recent studies in monkeys indicate that neurons
in the lateral habenula (LHb), a nucleus that mediates
communication between forebrain and midbrain struc-
tures, can increase their activity when an animal fails to
receive an expected positive reward or receives a stimulus
that predicts aversive conditions (i.e., disappointment or
anticipation of a negative outcome). LHb neurons project
to and modulate dopamine-rich regions such as the ven-
tral–tegmental area (VTA) that control reward-seeking
behavior and participate in depressive disorders. Our
study shows in two learned helplessness models of depres-
sion that excitatory synapses onto LHb neurons project-
THE FUNCTION AND PLASTICITY OF CENTRAL SYNAPSES
IN ANIMAL MODELS OF PSYCHIATRIC DISORDERS
B. Li S. Ahrens S. Liu
H. Chae R. Paik
K. Delevich Z. Perova
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Figure 1. Increased excitatory synaptic transmission onto VTA-
projecting LHb neurons in the learned helplessness models of
depression. (a) Examples of mEPSCs recorded from VTA-project-
ing LHb neurons (VTA-p) from wild-type (WT), cLH, cLHms, and
aLH animals. (b) Means (bars) and individual recordings (circles)
of mEPSC frequency from VTA-projecting LHb neurons in differ-
ent groups of animals. (Left) (WT) 2.4 ± 0.3, n = 65 (6 animals);
(cLH) 4.0 ± 0.7, n = 85 (8 animals), p < 0.05, bootstrap; (cLHms)
4.7 ± 0.7, n = 70 (8 animals), p < 0.001, bootstrap. (Right) (WT)
1.8 ± 0.2, n = 19 (4 animals); (aLH) 3.9 ± 1, n = 24 (4 animals),
p < 0.05, bootstrap. (c) Frequency distribution of mEPSC frequen-
cies of all cells recorded exhibited bimodal distribution. (d) The
cumulative probability of mEPSC frequency of VTA-projecting
LHb neurons in different groups of animals (p < 0.05, K-S test
comparing WT with any other groups). (e) The amplitude of
mEPSC was not different among different animal groups (p > 0.3,
bootstrap).
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ing to the VTA are potentiated (Fig. 1). Synaptic poten-
tiation correlates with an animal’s helplessness behavior
and is due to an enhanced presynaptic release probability.
Depleting transmitter release by repeated electrical stim-
ulation of LHb afferents, using a protocol that can be ef-
fective in depressed patients, dramatically suppresses
synaptic drive onto VTA-projecting LHb neurons in
brain slices and can significantly reduce learned helpless-
ness behavior in rats (Fig. 2). Our results indicate that in-
creased presynaptic action onto LHb neurons contributes
to the rodent learned helplessness model of depression.
Depression and Resilience: The Role
of the Medial Prefrontal Cortex 
We are testing the hypothesis that normal synaptic plas-
ticity in neurons of the medial prefrontal cortex
(mPFC) has an important role in behavioral flexibility
and resilience to depression, whereas its impairments
lead to behavioral depression. The mPFC has been im-
plicated in executive function and behavioral flexibility.
Recent studies suggest that mPFC is critical in the de-
termination of whether an organism has control over a
stressor. Rats with inactivated mPFC are prone to be-
havioral depression induced by stressors (Amat et al.,
Nat Neurosci 8: 365–371 [2005]). Aberrant activity of
the mPFC also accompanies clinical depression, and
deep-brain stimulation in mPFC leads to remission of
treatment-resistant depression (Mayberg et al., Neuron
45: 651–660 [2005]). However, the cellular processes
in mPFC accompanying behavioral depression are not
clear. The cellular mechanisms in mPFC that underlie
controllability—therefore affording resilience to behav-
ioral depression—are also unknown. 
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Figure 2. DBS in LHb suppresses excitatory synaptic transmission
and reverses learned helplessness. (a, Left) Example EPSPs
(paired-pulses) recorded from a VTA-projecting LHb neuron be-
fore (1), during (2), and after (3) stimulation mimicking DBS. Ar-
rows indicate when paired-pulses were given. (Right) Average
EPSP slope at indicated time points: (1) before (first pulse 1.1 ±
0.1; second pulse 0.9 ± 0.1; n = 6 [4 animals]); (2) during (first
pulse 0.2 ± 0.07; second pulse 0.03 ± 0.03), p < 0.001 for both
pulses compared with those in 1; (3) after (first pulse 1.2 ± 0.3;
second pulse 0.9 ± 0.2) DBS. (b) A schematic diagram showing
the experimental procedures. (c) Lever presses (left) and test com-
pletion time (right) for animals that received DBS or sham stimu-
lation in the LHb, or DBS in the LPLR (lateral postthalamic nuclei,
laterorostral), before (baseline), or after DBS of different intensi-
ties. DBS in LHb (n = 9): Lever press baseline 1.2 ± 0.4; 150 µA
session 3.9 ± 1; 300 µA session (n = 8) 5.8 ± 2. Test completion
time baseline 19.9 ± 0.4; 150 µA session 17.1 ± 1; 300 µA ses-
sion (n = 8) 15.4 ± 2. Sham (n = 14): Lever press baseline 1.8 ±
0.5; 150 µA session 2.4 ± 0.9; 300 µA session 2.4 ± 1. Test com-
pletion time baseline 19.2 ± 0.5; 150 µA session 18.7 ± 0.9; 300
µA session 18.5 ± 1.1. DBS in LPLR (n = 7): Lever press baseline
0.4 ± 0.2; 150 µA session 2 ± 1; 300 µA session 1.1 ± 0.3. Test
completion time baseline 20.6 ± 0.2; 150 µA session 19 ± 1.2;
300 µA session 19.9 ± 0.3. For DBS in LHb group, *p < 0.05
compared with baseline. Sham and DBS in LPLR group: p > 0.05
for both measurements at both sessions compared with baseline
(bootstrap). (d) Immobility during FST. DBS Day 1: 0.06 ± 0.01,
Day 2: 0.06 ± 0.01, n = 9; Sham Day 1: 0.05 ± 0.01, Day 2: 0.17
± 0.05, n = 10; DBS vs. Sham in Day 2: ***p < 0.001, bootstrap.
(e) Representative cresyl violet staining of coronal brain sections;
arrows indicate electrode track in the LHb (upper) or LPLR
(lower). All error bars represent S.E.M.
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To determine cellular activity in the mPFC in differ-
ent groups of animals, we measured c-Fos expression in
the infralimbic (IL) and prelimbic (PL) regions of the
mPFC. We found that in the learned helplessness (LH)
model of depression, neurons in the mPFC were acti-
vated. After the LH procedure, animal behavior diverged
to become either depressed or resilient to depression. In-
terestingly, the resilient animals had significantly en-
hanced neuronal activation compared with depressed
animals, indicating an active coping process. Further ex-
periments are needed to examine whether deferential
plastic changes in the synapses onto mPFC neurons in
response to stress are critical in determining an animal’s
susceptibility or resilience to behavioral depression. 
The mPFC and lateral habenula are synaptically
connected and belong to a synaptic circuitry strongly
implicated in depression. The first and second projects
are integral components of a synergistic effort aimed at
a more complete understanding of the synaptic and cir-
cuitry mechanisms underlying depression. 
Genetic Deficiency, Glutamatergic
Hypofunction, and Schizophrenia
In this project, we are studying the genetic causes of
glutamatergic hypofunction, a pathological process be-
lieved to contribute to the etiology of schizophrenia.
We first focus on ErbB4, a gene that has been linked to
both schizophrenia and bipolar disorder. We choose to
study brain circuits that have the highest levels of
ErbB4 expression.
The thalamic reticular nucleus (RT) is critical in
processing and filtering sensory stimuli. It is thought
to have an important role in attention, and impairment
in RT function has been implicated in psychiatric dis-
orders such as schizophrenia. RT neurons, which are
exclusively GABAergic, receive glutamatergic inputs
from the cortex and thalamus and send projections to
the thalamus where they modulate the activity of thal-
amic relay neurons. Interestingly, RT neurons are highly
enriched in ErbB4. Previous studies indicate that ErbB4
controls glutamatergic synapse maturation and plastic-
ity. On the basis of these findings, we hypothesize that
ErbB4 controls the development and function of glu-
tamatergic synapses in RT neurons, thereby controlling
the normal function of the RT–thalamic circuitry in at-
tention. To manipulate ErbB4 function specifically in
the RT, we took advantage of the observation that so-
matostatin (SOM) expression perfectly matches that of
ErbB4 in the RT, but not in other brain areas including
cortex and hippocampus. By crossing the SOM-Cre
line with the ErbB4lox/lox animals, we have generated
SOM_ErbB4–/– mice in which the ErbB4 gene is selec-
tively ablated in SOM-positive neurons. We are cur-
rently examining the potential synaptic changes in RT
neurons in these animals and testing the role of the RT-
thalamic circuitry in a behavioral task designed to
specifically test attentional modulation of behavior.
PUBLICATIONS
Li B, Piriz J, Mirrione M, Chung C, Proulx C, Schulz D, Henn F, Ma-
linow R. 2010. Synaptic potentiation onto lateral habenula neurons
in the learned helplessness model of depression. Nature 470:
535–539.
Perova Z, Li B. 2010. Medial prefrontal cortical plasticity and behavioral
depression. Program No. 667.11; Neuroscience Meeting Planner. San
Diego, CA: Society for Neuroscience. Online.
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Our basic research philosophy is to combine theoreti-
cal, computational, and experimental approaches for
the study of complex biological systems, with a partic-
ular focus on neurobiological questions. Efforts in our
group fall into three main areas: informatics, theory,
and experimental work. 
Our neuroinformatics research involves the applica-
tion of analytical tools to large volumes of neurobiolog-
ical data, as well as the development of informatics
infrastructures for data and knowledge integration. Our
study in the area of theoretical engineering applies the-
ories developed in human-engineered systems to study
the theoretical principles underlying biological systems.
The final area of our research is experimental and has
previously consisted of collaborative studies in multiple
species including Drosophila, zebra finch, macaque mon-
key, and human infants. We are now undertaking a
major in-house experimental project to generate the first
brainwide mesoscale connectivity map in the mouse.
Continuing in our laboratory in 2010 are Pascal
Grange (postdoctoral fellow), Jamie Jones (laboratory
technician), Jayant Kulkarni (postdoctoral fellow), San-
dra Michelsen (administrator), Vadim Pinskiy (graduate
student), and Caizhi Wu (research associate). Swagatam
Mukhopadhyay (postdoctoral fellow), David Prevzner
(laboratory technician), Alex Tolpygo (laboratory tech-
nician), Gregor Havkin (informatics manager), Osama
El Demerdash (analyst), Wen Huang (graduate student),
Joshua Novy (laboratory technician), Andrew Weber
(laboratory technician), Zhen Gong (graduate student),
Linzie Wood (project assistant), and Thomas Pologruto
(consultant) joined us this past year. 
We also have close collaborative ties with multiple re-
search groups at CSHL and other institutions, which cur-
rently include Dr. Nicholas D. Schiff at the Weill Medical
School of Cornell University, where Dr. Mitra is an adjunct
associate professor; a consortium of zebra finch researchers;
an integrative analysis of memory formation in Drosophila
with Josh Dubnau at CSHL; the Brain Architecture Proj-
ect, with collaborators at multiple institutions, notably
Harvey Karten (University of California, San Diego),
Kathy Rockland (Massachusetts Institute of Technology),
and Michael Hawrylycz (Allen Institute of Brain Research);
and a collaboration with Gregory Hannon at CSHL on
improving next-generation sequencing technologies. 
Mouse Brain Architecture Project
V. Pinskiy, A. Tolpygo, C. Wu, P. Grange, J. Jones, D. Prev-
zner, A. Weber, J. Novy, G. Havkin, O. El Demerdash
Brain function is determined by its circuitry, but very
little is known about how the mammalian brain is con-
nected. We have set out to address this problem in the
Mouse Brain Architecture Project, in which we are
comprehensively determining the patterns of neural
connectivity between brain regions.
We have obtained two National Institutes of Health
(NIH) grants (a Transformative-R01 and an RC1 Chal-
lenge Grant) that are running concurrently to produce
the connectivity map. The RC1 grant is to produce a
connectivity draft for wild-type C57BL/6J mice and to
align these results to the Allen Brain Atlas. The initial
draft of a connectivity atlas will be available by fall or
winter of 2011. The T-RO1 grant will be used to increase
the sample size and coverage and to compare connectivity
maps of schizophrenia and autism mouse models to a
reference connectivity map in the C57 mouse brain.
These data and the data analysis tools will be released on
the Mouse Brain Architecture project website.
This project is now in full production phase. The
pipeline to process tissue from tracer-injected mice
through to image analysis is fully functional and all
equipment has been integrated into a Laboratory Infor-
mation Management System (LIMS). This was devel-
oped in-house and serves as an electronic lab notebook,
facilitates quality control procedures, and is also the meta-
data repository that will be finally published on the web.
Our plan involves grouping injections into major brain
systems (i.e., cortical areas, basal ganglia, thalamus, hy-
pothalamus, etc.). Each injection site yields information
about the other regions of the brain projecting to and
INTEGRATIVE SYSTEMS NEUROBIOLOGY
P. Mitra H. Cox J. Jones V. Pinskiy A. Weber 
O. El Demerdash J. Kulkarni T. Pologruto C. Wu
P. Grange S. Mukhopadhyay D. Prevzner
G. Havkin J. Novy A. Tolpygo
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from the injected region. We are incorporating specific
advice from anatomists who specialize in these individual
areas, in terms of injection strategies and interpretation
of results. The initial 200 injection sites consist of a set
covering the cortex in a defined grid. CTB (cholera toxin
B), BDA (biotin dextran amine), fluorescent-modified ra-
bies viruses, and AAV (adeno-associated virus) will be the
initial tracers. We have already injected more than 400
production animals at 100 different sites. 
For these experiments, a computer-guided apparatus
for stereotactic injections into the mouse brain has been
developed. A laser scanner of the mouse skull, assembled
by Vadim Pinskiy and Thomas Pologruto, gives rise to
a profile of the surface of the skull of the live animal. A
reference atlas of the mouse skull was provided by Mark
Henkelman (Mouse Imaging Center, University of
Toronto). A registration algorithm developed by Pascal
Grange allows us to align the skull and to work out its
variation in size relative to the reference. The injection
is guided accordingly. The method was presented at the
Society for Neuroscience meeting in November 2010.
Other improvements to the pipeline include devel-
opment of an embedding system that consistently ori-
ents the brains for sectioning and allows two brains to
be sectioned simultaneously. We have also developed a
Giemsa counterstain for the BDA and CTB tracers. This
increases the signal/noise ratio for the diaminobenzidine
(DAB) staining and subsequent registration. A set of
Nissl-stained sections for each brain will be used to cap-
ture the cytoarchitecture. All of these improvements to
the pipeline increase both the throughput rate and the
proper segmentation of individual brains and registra-
tion to a common atlas space. The 20-µM brain sections
are imaged using an automated microscope and new and
updated software has been written to aid with data crop-
ping, transfer, and storage. This will be incorporated
into the LIMS and used for quality control of the tissue
samples and data analysis. Other software components,
currently under development, will take the stacks of dig-
itized microscopy images and perform segmentation and
three-dimensional reconstruction to reconstitute the
three-dimensional brain. This brain volume is then reg-
istered with the Allen Reference Atlas (ARA) (Fig. 1).
Although the total amount of data generated by the
project is expected to be large (terabytes to petabytes),
we expect that the principal challenges will be in terms
of software to enable suitable compression schemes to
permit effective transmission through the Internet
(which remains a low-bandwidth medium), as well as
suitable visualization and search tools. The Allen Insti-
tute has extensive experience in this domain, and Dr.
Mitra has established a collaborative relationship with
Dr. Mike Hawrylycz at the Allen Institute.
The preliminary data will be made available to the
research community via an informatics platform (along
with basic informatics tools to query, organize, visual-
ize, and manage the data). We have implemented soft-
ware to transform proprietary image data into readable
and web-compatible formats and are beginning to as-
semble the hardware and software infrastructure for
sharing image data with collaborators and the outside
world. We anticipate that the data set produced will be
important for analysis of many kinds, and we expect to
be actively engaged in new analyses even beyond the 5-
year grant period. The availability of public data sets
and open-source duplicable pipeline technologies will
potentially impact the entire neuroscience community.
We are additionally developing a novel technique for
assaying long-range connectivity in the human brain
and are pursuing the aims of mining and integrating
information about brain connectivity from the research
literature using computational linguistics techniques.
Finally, this project has also benefited from a summer
course that Dr. Mitra cofounded at CSHL in the be-
ginning of June 2010. Through this project, Cold
Spring Harbor Laboratory has become a leading center
for filling the critical knowledge gap urged by Dr.
Crick, and championed by Jim Watson.
For more information, see the Brain Architecture
Project website: http://brainarchitecture.org
Analysis of Gene Expression 
in the Mouse Brain
P. Grange
We are determining networks of spatial coexpression in
the brain, of addiction-related genes. An initial list of
more than 400 genes related to addiction was compiled
from on-line databases. For each pair of genes in the
list, the spatial overlap between gene expression patterns
across the brain was computed. The resulting coexpres-
sion networks of genes can be rendered graphically—
genes with similar expression energies appear as
clustered nodes. These graphs have been made available
online to the research community. This project was sup-
ported the NIDA grant 1R21DA027644-01, Co-ex-
pression networks of addiction-related genes. 
We also developed numerical methods to rank genes
and sets of genes as markers of brain regions. Localiza-
tion scores for individual genes are available online
(www.addiction.brainarchitecture.org, which also shows
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results of the coexpression study described above). Op-
timal sets of genes with coefficients determined by lin-
ear-algebraic methods can have much higher scores than
individual genes. These results were presented for 12
major brain regions at the Society for Neuroscience
meeting in November 2010. Results for finer brain par-
cellations are being prepared for publication. In collab-
oration with Claudio Mello (Oregon Health and
Science University), we are determining whether mouse-
brain-region markers show a similar pattern of gene ex-
pression in the zebra finch brain. Such comparisons will
provide quantitative tests of hypotheses regarding con-
servation of brain regions during evolution.
We are also determining the evolutionary ages of genes
cataloged in the Allen Institute mouse brain atlas, with
the goal of discovering whether there are correlations be-
tween the spatial pattern of gene expression in the brain
and their evolutionary ages. We intend to provide evolu-
tionary age as an added layer of information to brain-spe-
cific genes, with the hope of understanding whether
major anatomical regions of the brain have characteristic
signatures in the profile of evolutionary ages of their rep-
resentational genes. For this purpose, two separate data
sets of orthologs from published work are being used—
the OMA data set and the Ensembl data set. The former
is a comprehensive list of all orthologs found among
~1000 species, including ~100 eukaryotes. By grouping
genes into sets of first appearance of homologs in major
phylogenetic taxa, we are able to order genes in the set
being analyzed by evolutionary age. Integrating this in-
formation with the gene expression data is in progress.
Next-Generation Sequencing: Data Analysis
S. Mukhopadhyay
We are working on analytic methods for improving ge-
nomic analyses, using a next-generation sequencing plat-
Figure 1. Examples of processed materials from the pipeline. Cholera toxin, subunit B (A,C,E) and retrograde mutant
rabies virus (B,D,F) were injected into the caudoputamen of 56-d-old C57BL/6 mice (two separate animals; tracer in-
jection placed in right caudate close to the labeled sections). (A,B) Full coronal sections containing tracer label, (C,D)
presence of retrograde labeled neurons in both ipsilateral and contralateral cortex, consistent with known bilateral
projections from cortical pyramidal cells to caudoputamen, (E,F) individual labeled neurons.
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form (single-molecule real-time sequencing, Pacific Bio-
systems). In collaboration with the McCombie lab at
CSHL, the objectives of this project are to investigate
error profiles in sequencing results and to improve base-
calling algorithms by modeling the physical processes in-
volved in polymerase kinetics and signal from the
fluorescent-tagged (phospholinked) nucleotide incorpo-
ration. The short-term goal includes developing algo-
rithms for direct detection of DNA modifications by
utilizing their signatures on polymerase kinetics. We are
in the process of developing new tools for the various se-
quencing methods used in the platform, such as Strobe
sequencing and Circular Consensus sequencing. Our
long-term goal is to use the single-molecule signature of
polymerase kinetics to refine our understanding of poly-
merase motor itself. 
Multimedia Signal Processing
for Quantative Phenotyping
in Autism Spectrum Disorders
Z. Havkin
We have been studying phenotypes of autism spectrum
disorders (ASDs) with support from the Simons Foun-
dation Autism Research Initiative (SFARI). The work has
focused on the application of multimedia signal process-
ing (MMSP) techniques to audiovisual recordings of
ASD patients made during the administration of a stan-
dardized diagnostic instrument (the Autism Diagnostic
Observation Schedule). The ultimate goal of this research
is to objectively determine early-age ASD phenotypes, as
it has been previously shown that early diagnosis and in-
tervention leads to substantially improved outcomes.
Our key clinical collaborators are Woodfords Family
Services in Maine and the Autism & Communication
Disorders Center at the University of Michigan. We
will be applying our MMSP techniques to their longi-
tudinal studies which include ASD patients, non-ASD
patients, and typically developing peers.
PUBLICATIONS
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What causes autism and schizophrenia? It is well estab-
lished that both disorders are highly heritable, and today,
geneticists are uncovering the relevant susceptibility genes
and loci. The wealth of genetic data, however, does not
guarantee rapid progress in understanding the disease
mechanisms. In fact, the susceptibility genes comprise a
heterogeneous group that includes genes regulating tran-
scription, protein degradation, synaptic signaling, and
cell adhesion. What do these genes have in common?
How can we best progress from identifying genes to test-
ing therapeutic strategies?
We have developed a high-throughput pipeline of
methods that can be used to systematically search for
changes in brain functions in mouse models carrying
genetic mutations linked to autism and schizophrenia.
Our current work aims at identifying disrupted brain
circuits that lie downstream from autism genes. Once
such circuit deficits are known, we and others can focus
on determining the underlying cellular and molecular
mechanisms. Importantly, the same methods that we
use to discover disrupted circuits in the mouse brain
can be also used to screen drugs that eliminate the ab-
normality and restore normal functions. Our approach
thus uniquely links basic and translational research,
promising rapid progress from mechanistic studies to
testing therapeutic strategies.
Sectioning-Based Serial Two-Photon
Microscopy
A novel imaging technique, which we termed section-
ing-based serial two-photon (SSTP) microscopy, is a key
part of our experimental approach (Fig. 1). The SSTP
microscope, developed in a collaboration with Tissue-
Vision, Inc. (Cambridge), works as follows: (1) A top
view of a fixed mouse brain is imaged as a mosaic of
20x objective fields of view (“tiles”), (2) a built-in vi-
bratome cuts off the imaged top region, and (3) the cy-
IDENTIFICATION OF DISRUPTED BRAIN CIRCUITS IN MOUSE
MODELS OF AUTISM AND SCHIZOPHRENIA
P. Osten Y. Bao R. Palaniswamy K.U. Venkataraju
L. Kadiri N. Takada D. Xu
Y. Kim J. Taranda L. Zhang
Figure 1. SSTP microscopy. (A) Microscope scheme. The x-y-z stage moves the brain under the objective, so that
the top view is imaged as a mosaic. The stage also moves the brain to the vibratome for sectioning. (B) An example
of a GFP (green fluorescent protein) mouse brain imaged in 280 coronal sections.
A B
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we are testing a hypothesis that the functions of brain
circuits involved in mediating social interactions are dis-
rupted downstream from autism candidate genes. The
aims of both experiments are (1) to find differences in
brain functions between mutant and wild-type litter-
mates and (2) to compare these differences between dif-
ferent mutants in order to identify common disruptions
downstream from multiple autism genes.
Anatomical Tracing and
Electrophysiology
Our current work focuses on identification of brain areas
and circuits disrupted in five genetic mouse models of
autism. Once such regions are found, our next step is to
use electrophysiology and anatomical mapping to study
in detail the cellular mechanisms underlying the circuit
deficits. Electrophysiological experiments are done in
vitro in acute brain sections and in vivo by whole-cell
recording in anesthetized mice. Anatomical mapping is
done using traditional tracers, such as virus-vector-based
GFP expression for anterograde tracing and cholera
toxin B for retrograde tracing (Fig. 3). 
Summary
We hope that our work will provide better understand-
ing of neural circuit disruptions underlying autism and
schizophrenia and lead to therapeutic developments in
the future. 
Figure 2. Brain activation in mice in-
jected with (A) saline or (B) haloperi-
dol (1 mg/kg). (C) Preliminary quantita-
tion of c-fos-GFP-positive neurons be-
tween the two conditions in individual
coronal sections. The asterisk marks
the approximate position of prominent
c-fos-GFP induction in the striatum
(B,C). 
cles of mosaic imaging and sectioning are repeated.
Once all data are collected, image-processing and brain-
morphing algorithms are used to assemble the three-di-
mensional brain volume for data analysis (Fig. 1). 
Transgenic “Indicator” Mice
To study mouse brain functions by SSTP microscopy,
we use transgenic indicator mice expressing GFP as a
reporter of neural activation, such as c-fos-GFP mice
expressing GFP from the promoter of the activity-reg-
ulated immediate early gene (IEG) c-fos. These mice
enable visualization of brain activation at cellular reso-
lution in response to behavioral tasks or applications
of drugs, such as the antipsychotic drug haloperidol
(Fig. 2). 
The use of SSTP microscopy to screen brain circuits
in genetic mouse models of autism involves (1) breed-
ing of the selected mouse models with the indicator c-
fos-GFP mice and (2) analysis of c-fos-GFP activation
in the mouse offspring. We have initiated work on five
mouse models of autism: 16p11.2 deletion and dupli-
cation mice generated by our collaborator Alea Mills at
CSHL and previously published Neuroligin R451C,
Neuroligin 4 knockout, and CNTNAP2/Caspr2
knockout mice. We currently focus on two questions.
We are testing a hypothesis that autism susceptibility
genes cause an imbalance in brain excitation and inhi-
bition, which leads to higher propensity for seizures and
contributes to disruptions of brain circuits relevant to
autism manifestation. In a parallel set of experiments,
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Figure 3. Retrograde tracing with Alexa-conjugated CTB. (A) Overview of the injection area. (B) Injection area of
the barrel cortex (1) and retrogradely connected cortical areas (2–4). (C) Enlarged views of the marked areas.
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Figure 1. Detection of 16p11.2 microduplications by MeZOD.
The major focus of our laboratory is to identify genetic
causes of mental illness using a successful approach that
we pioneered: high-resolution analysis of rare copy-
number variants (CNVs) in the human genome. We
have developed an experimental design that allows us
to identify rare mutations that confer high risk for dis-
ease. Our approach is to screen the genomes of patients
with schizophrenia and bipolar disorder to identify
deletions and duplications of the DNA that disrupt
genes. These mutations are subsequently tested for as-
sociation with disease in families and in large samples
of patients and healthy individuals. This approach is
based in part on the findings of our previous genetic
studies of autism spectrum disorders (ASDs), which es-
tablished an important role for rare spontaneously oc-
curring CNVs in the etiology of ASDs. With support
from the Stanley Foundation, we have now successfully
applied this approach to studies of schizophrenia and
bipolar disorder, and our work has already had a signif-
icant impact on the field. Our findings, coupled with
studies by other groups, have shown that rare CNVs
have an important role in the genetics of psychiatric
disorders. Furthermore, we have shown that a substan-
tial number of the risk variants detected in the DNA
of patients are not inherited from a mother or father
but instead occur by spontaneous mutation. Most in-
dividual CNVs that have been definitively identified to
date increase risk of mental illness by ≥10-fold, strongly
suggesting that these mutations have a causal role. 
Analysis of Copy-Number Variation
in Schizophrenia
V. Vacic, S. McCarthy
Studies by our group and others have demonstrated that
individually rare structural variants contribute to risk of
schizophrenia (SZ) and other neurocognitive disorders.
Multiple studies have now shown that the mutational
burden of rare structural variants is significantly greater
in patients with SZ than in healthy controls. In addition,
specific loci have been identified where structural muta-
RARE STRUCTURAL VARIATION IN THE GENOME
AND ITS ROLE IN HUMAN DISEASE 
J. Sebat M. Kusenda V. Vacic
D. Malhotra K. Ye
S. McCarthy S. Yoon
tions are significantly associated with SZ. For example,
large deletions at 1q21.1, 15q13.3,  and 22q11.2 have
been shown to confer substantial risk of SZ. A recent
study by our group has found that microduplications of
16p11.2 are significantly associated with SZ (Fig. 1, Table
1; see McCarthy et al., Nat Genet 41: 123 [2009]). The
SZ-associated regions described here confer significant
risk. For instance, the observed odds ratios for the mi-
croduplication of 16p11.2 range from 8.3 to 25.8. 
These findings suggest that rare structural variants
have a role in the etiology of SZ. Furthermore, evidence
suggests that little of the overall contribution of rare
CNVs to SZ can be explained by the handful of loci
described above (Sebat et al., Trends Genet 25: 528
[2009]). We hypothesize that genetic risk of SZ consists
in part of rare variants, and these risk alleles involve
many different genes. Analysis of structural variation in
larger samples is required to definitively identify novel
CNV risk factors. 
In an effort to identify novel CNV risk factors in
SZ, we have recently carried out a two-stage study of
copy number variation, using a primary sample of 742
cases and 856 controls scanned in the Nimblegen HD2
platform, and using as a replication data set CNV calls
made from the GAIN and MGS studies of SZ and the
International Schizophrenia Consortium (ISC). The
replication sample consisted of 7488 cases and 6689
controls, bringing the combined sample size to 8230
cases and 7545 controls.
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Investigating the Role of Rare CNVs
in Bipolar Disorder
D. Malhotra
Our research in bipolar disorder (BD) aims to make a
significant contribution to the field in two ways: by im-
proving the scientific understanding of BD through ge-
netic studies and by creating a novel genomic resource
for geneticists. To these ends, we have initiated a genetic
study, the genetics of early-onset mania (GEM).  The
goals of our genetic study of bipolar disorder are (1) to
perform genome-wide analysis of copy-number varia-
tion in bipolar families, (2) to assess the overall contri-
bution of de novo and inherited mutations in sporadic
and familial BD, and (3) to identify novel candidate
genes for further study.
Central to this study is the recruitment of new bipo-
lar families who will form the GEM family collection.
GEM is unique from other family collections in that a
significant fraction of patients are “sporadic” cases and
a significant fraction of patients are young at onset
(AAO < 18). This new collection will be made available
to the scientific community where we anticipate it will
become a valuable resource for researchers who are in-
terested in investigating genetic and epigenetic causes
of bipolar disorder.
We have completed a preliminary analysis of data from
our genetic study of BD (described in this report), and
these data showed that rare structural variants, including
de novo mutations and inherited CNVs, contribute to
BD. We have performed an analysis of de novo CNVs in
families and observed a higher rate of de novo mutation
In the first stage, we screened the primary sample for
CNVs that are present in multiple cases and not present
in a sample of matched controls. After eliminating
CNVs that were less than 100 kb in size and CNVs that
did not impact genes, we identified a total of 66 unique
target loci. To measure statistical association in the
replication sample, we tested the difference in locus-
based mutational burden between cases and controls
using a Fisher’s exact conditional test. In this study, all
of the previously identified loci described above showed
a statistically significant association (data not shown).
In addition, duplications at a single 7q36.3 region was
significantly associated with SZ after correction for the
66 loci tested (α = 0.0008). 
The 7q36.3 region represents a novel locus that
confers significant risk of SZ (see Table 2). This finding
serves to highlight novel genes within the region. One
of particular interest is the vasointestinal peptide re-
ceptor 2 (VIPR2). VIPR2 is a class II G-protein-cou-
pled receptor that is activated by both vasoactive
intestinal peptide (VIP) and pituitary-adenylyl-cyclase-
activating polypeptide (PACAP). VIP and PACAP
have been shown to have wide pharamacological effects
and biological functions. Notably, PACAP is involved
in pain-related behavior, psychomotor functioning,
and memory performance. PACAP-deficient mice dis-
play increased locomotor, exploratory and explosive
jumping activity, and a deficit in prepulse inhibition
of the acoustic startle response, all of which are atten-
uated by risperidone. In addition, within the suprachi-
asmatic nucleus, VIPR2 is required for maintenance of
normal circadian rhythms.
Table 2. Significant Association of 7q36.3 Microduplications with Schizophrenia
Primary sample Replication sample
Locus CNV type cases controls cases controls OR (96% CI) replication P value
7q36.6 duplication 2 0 12 0 INF (3.3, INF) 0.0002
2p16.3/NRXN1 deletion 2 0 14 2 6.4 (p1.7, INF) 0.0022
3q29 duplication 2 0 8 0 INF (2.0, Infinity) 0.0049
Table 1. Duplications and Deletions at 16p11.2 among Persons with Schizophrenia and Controls
Subjects Deletions Duplications
Series Diagnosis (n) n % n % OR (95% CI) P value
Primary schizophrenia 1906 1 0.05 12 0.63 24.8 (3.3, 199) 1.2 x 10–5
controls 3971 3 0.08 1 0.03
Replications schizophrenia 2645 0 0.00 9 0.34 8.4 (1.3, 50.5) 0.022
controls 2420 1 0.04 1 0.04
Combined schizophrenia 4551 1 0.02 21 0.46 14.5 (3.3, 62.0) 4.3 x 10–5
controls 6381 4 0.06 2 0.03
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in BD compared to healthy controls. Furthermore, we
observed a higher rate of de novo mutation in sporadic
cases as compared to patients with a family history of
mental illness. These results provide strong preliminary
evidence that de novo CNVs contribute in part to the ge-
netics of BD. A majority of these mutations involve genes,
thus highlighting strong candidate regions for further
study. In addition, we have performed an analysis of rare
inherited CNVs in families. These results provide prelim-
inary evidence for the increased mutational burden of rare
inherited CNVs in BD.
Analysis of Structural Variation
in the 1000 Genomes Project
S. Yoon, K. Ye
The primary goal of this project is to define genome-
wide patterns of structural variation by high-resolution
analysis of CNV using two advanced technologies: mi-
croarray comparative genomic hybridization (CGH)
and next-generation sequencing (NGS). We have a
complete collection of all primary data for the project,
including a total of more than 500 HapMap samples.
We have begun the process of validating CNVs and
genotype calls and have designed a custom Agilent array
containing dense coverage of ~800 common CNVs and
an additional set of rare inherited and de novo CNVs.
Microarray CGH analysis will be performed on
HapMap samples using this custom array to validate
our CNV calls and to better define the breakpoints of
variants identified in this study.
Through our participation in the 1000 genomes
project, we have performed an analysis of structural
variation in whole-genome sequence data on multiple
individuals. For these studies, we developed a novel
method for detection of CNVs based on coverage
depth: event-wise testing (EWT). This call set is cur-
rently being integrated with CNV call sets from multi-
ple groups using complementary approaches. These
results will constitute the first official data release of the
1000 genomes pilot project, which will tentatively be
published in late fall.
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The overarching research goal in our laboratory is to
understand how processing in specific brain circuits
works to support natural communication behaviors.
We aim to reveal neural mechanisms that allow organ-
isms to detect and recognize familiar individuals, to
gather information about their identity and social sta-
tus, and to select appropriate behaviors. Mice are capa-
ble of acquiring detailed profiles of one another from
the smells and sounds experienced during their social
encounters. These dossiers may include information on
a mouse’s sex, genetic identity, reproductive state, levels
of distress or sexual interest, or even recently consumed
foods, details that are indispensable for survival and
mating success. Initially, we are working to understand
the neuronal activities and mechanisms in primary sen-
sory brain areas that support these forms of communi-
cation. In the future, we anticipate moving deeper into
the brain to ascertain where the sensory data from those
regions are collected and integrated into hormonal and
electrical signals that promote appropriate behavioral
choices.
The scientific benefit of this approach is twofold.
First, we want to identify fundamental principles of
how the brain controls complex behavior. To this end,
it is our belief that the nervous system’s function is best
interpreted in the context of the behaviors it was evo-
lutionarily designed to perform. Thus, it is advanta-
geous to use natural behaviors such as intraspecific
communication. Second, impairment of social percep-
tion and cognition is a core feature of autism spectrum
disorder (ASD); for example, patients may have diffi-
culty perceiving and interpreting communication ges-
tures such as speech, facial expressions, and “body
language.” This broad feature is recapitulated in many
mouse models of ASD that carry genetic variants iden-
tified in human ASD populations. Therefore, if we can
ascertain the neural circuit substrates of social behavior
in normal mice, we can make and test predictions for
how the circuitry is affected in the mouse models. The
results are likely to tell us more about the synaptic mod-
ifications that occur in human autism.
There are three broad areas of research in the lab.
One concerns olfactory communication and memories
for familiar individuals. Another direction is an exam-
ination of vocal (auditory) communication between
mother mice and their pups. Our final avenue of study
involves recording from neurons in awake, behaving an-
imals to reveal the neural encoding of social cues during
a live encounter with another mouse.
Noradrenaline and Memories
for Familiar Individuals
H. Demmer, D. Eckmeier, J. Dos Santos
How do we remember individuals who we have previ-
ously encountered? Substantial evidence indicates that
many animals remember each other based on olfactory
cues. Memories are especially strong for individuals en-
countered during key life events such as mating with a
new partner or the birth of a litter of young. These im-
portant events typically evoke massive release of the neu-
rochemical noradrenaline (NA), initiating a heightened
state of emotion and arousal. This surge appears to cause
long-lasting modifications to the responses to odorants
in the olfactory bulb, which is the first processing station
for scent in the mammalian brain. Indeed, it was hypoth-
esized that the coincidence of an odor stimulus with a
surge of NA is minimally sufficient to store a memory.
We exploited the intimate relationship among NA, ol-
factory bulb activity, and behavior to create and study
olfactory memories in the anesthetized mouse. We dis-
covered that, indeed, when NA release is evoked by stim-
ulating locus coeruleus, the source of most NA, while the
sleeping mouse sniffed an odorant, neural responses to
that odor underwent specific long-term alterations. Re-
markably, once awake, the mouse’s subsequent behavior
toward the odorant was also changed. In other words,
the mouse seemed to remember the odor and treat it as
though it were familiar.
The ability to induce ethologically relevant memories
under anesthesia opens up exciting possibilities for ob-
serving the synaptic mechanisms underpinning such
memories using advanced techniques that are currently
impossible in behaving animals. For example, we are be-
ginning to use a variety of imaging approaches in genet-
NEURAL CIRCUITRY FOR SOCIAL COMMUNICATION
S. Shea H. Demmer D. Eckmeier
J. Dos Santos R. Hu
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ically modified mice during memory formation. These
experiments will allow us to separately visualize olfactory
bulb input and output as well as wide-scale neuronal
populations to ascertain how and where NA-dependent
plasticity is coordinated and interacts among neuronal
populations. We are also beginning to use high-resolu-
tion electrophysiological techniques, targeted to specific
cell types in order to build a circuit picture of how dif-
ferent olfactory bulb cell types adapt their firing to result
in long-term changes to circuit output. 
How are olfactory memories for individuals stored
mechanistically among the specific synaptic connec-
tions of the various neuronal types in the olfactory
bulb? To answer this question, this year in our lab, Dr.
Heike Demmer developed techniques for making tech-
nically challenging targeted recordings from a specific
type of inhibitory neuron (granule cells) whose func-
tion remains mysterious. She then made these record-
ings during the induction of NA-dependent plasticity
to examine how they contribute to memories. The data
suggest that these cells not only participate in storing
olfactory memories, but do so in surprising and com-
plex ways. Although we anticipated that the granule
cells might increase their activity to suppress responses
to remembered odors, we found the opposite was true
(Fig. 1). One interpretation is that NA input uncouples
granule cells’ synaptic output from their action poten-
tial firing. This unique property could be an important
factor in maintaining memory specificity.
How are changes in the firing rate of olfactory bulb
neurons read out by deeper stations in the brain? It has
been hypothesized that NA may modulate behavior by
suppressing input to downstream targets that mediate
innate behavioral responses. To begin testing this hy-
pothesis, Julien Dos Santos made recordings from some
of these deep-brain structures including the bed nucleus
of the stria terminalis and the medial amygdala. He was
able to demonstrate that these regions respond robustly
to biologically important stimuli such as urine from the
opposite sex and predator odors. This work sets the
stage for examining how NA shapes these responses and
relating these effects to different behaviors.
Vocal Communication between
Mothers and Pups
R. Hu
Far outside the range of our hearing, in the ultrasound
range, mice are constantly holding conversations with
one another in a language that is poorly understood at
best. Many types of vocalizations are emitted by males
and females, juveniles and adults, in a variety of behav-
ioral contexts. We would like to better understand the
perceptual significance of these calls to the mice and
how they are used to guide behavioral choices.
One form of vocalization that is actually reasonably
well understood is the ultrasonic distress vocalization
(USV). Young mice prior to vision and full mobility
will occasionally become separated from the nest. This
is stressful for them and they will therefore call out to
their mother with a very-high-frequency peep. New
Figure 1. Granule cell interneurons of the main olfactory bulb show long-term suppression of odor responses after
locus coeruleus (LC) stimulation. This figure depicts the effects on a granule cell’s odor responses of electrical LC
stimulation (which releases NA) paired to that odor. (Left panel) Two PSTHs showing the pre- and poststimulation
response of the granule cell to the odor. (Right panel) A plot of response strength (spikes/s above baseline) for each
of 120 consecutive trials of odor presentation with the shaded region denoting the period of LC stimulation pairing.
097-149_04_Neurosci_Annual Report_2009 template  7/8/11  11:57 AM  Page 139
140 Research
mothers develop sensitivity to these cries and respond
by moving toward their source (phonotaxis) to retrieve
the pup. Mothers will also approach a speaker emitting
playback of synthetic calls, providing a simple assay for
their perception of manipulated calls. Such experiments
suggest that there are sharp limits to the types of sounds
that will elicit phonotaxis, possibly implying a neural
selectivity mechanism that creates a perceptual bound-
ary between pup distress cries and other sounds and vo-
calizations. Moreover, nulliparous females who have
never given birth do not show approach responses to
pups or their calls, suggesting that the underlying neu-
ral responses may also differ.
To begin to search for such neural correlates of ma-
ternal behavior, Ruilong Hu, a summer URP student,
made recordings from the auditory cortex of mothers
and naïve nulliparous females and assessed the response
to a series of synthetic pup calls. He found that neurons
in the auditory cortex of mothers were much more
sharply tuned to pup-call frequencies as compared to
the neurons of naïve females (Fig. 2). These data imply
that somehow maternal experience rewires the brain to
more optimally discriminate biologically important
stimuli. How is this neural selectivity constructed at the
synaptic level? We have hypothesized that the answer
critically involves intracortical inhibitory processing.
Therefore, we are using optogenetic techniques to in-
activate inhibitory inputs to ultrasound-sensitive neu-
rons to assess their necessity for proper auditory pro-
cessing.
Neural Activity during Social Encounters
D. Eckmeier
We are building a setup for recording individual neu-
rons during social encounters and other behavioral as-
says involving the perception of social and nonsocial
information. There are two broad related goals to this
approach. The first goal is to examine the encoding of
social information such as body odors and vocalizations
in primary sensory structures of awake animals. We hy-
pothesize that activity in response to these signals may
be labile to associative learning, attention, and arousal
which we may be able to manipulate in the context of
social encounters. The second goal is to record from
neurons in deep-brain neuromodulatory centers during
these encounters as well. Neurons that release noradren-
aline and dopamine are likely responsive to social sig-
nals and may modulate encoding of sensory data and
associative plasticity. Understanding the context-depen-
dent activity patterns of these neurotransmitters is
therefore critical to developing models for how they af-
fect behavior.
Figure 2. Auditory cortical neurons in mothers show greater spectral selectivity for USV frequencies
than neurons in naïve females. (Left panel) A schematic representation of the bandpass noise stimuli
that were randomly presented to anesthetized mothers and naïve females during recordings of au-
ditory cortical neurons. (Right panel) Neurophysiological results. As more low-frequency content
was added to the stimulus, responses in mothers dropped off precipitously, demonstrating that these
neurons are more selective for USV content. All responses were normalized to the response to the
narrowest band stimulus.
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The brain has a tremendous capacity to form many
highly accurate memories; it is precisely this facility that
is lost in diseases such as Alzheimer’s and other demen-
tias. Our overall goal is to understand how brain areas
involved in learning and memory represent different
stimuli with distinct patterns of neural activity and how
these activity patterns are modified by learning. 
We use the olfactory system of Drosophila as a model
for investigating these questions. Our research focuses
mostly on a brain area involved in learning and memory
known as the mushroom body (MB), which is analogous
to the olfactory cortex in the mammalian brain. To un-
derstand how olfactory information is represented in the
MB, we monitor neural activity using both electrophysi-
ological and functional imaging techniques. We have
found that MB neurons are extremely odor selective in
their responses. This high selectivity is a general feature of
brain areas involved in learning and memory, including
the hippocampus and cerebellum. Using the simplicity
and genetic manipulability of Drosophila, our goal is to es-
tablish how this specificity arises and how it is maintained
in the face of learning-related changes. The extremely pow-
erful genetic tools in Drosophila enable us to manipulate
neural activity in precisely defined ways that help us to un-
derstand how this circuit functions. For example, by con-
trolling activity of the neurons immediately presynaptic to
the MB, we can determine how MB neurons integrate dif-
ferent inputs and establish the number, strength, and dy-
namics of the synaptic connections across these layers.
Using this type of approach, we are currently evaluating
how MB response properties arise and how they are mod-
ified by the action of important neuromodulatory systems.
Additionally, extensive genetic studies of olfactory learning
and memory have identified many of the genes involved
in learning and memory; one of our goals is to understand
how these molecules affect network-level activity. 
Functional Imaging of Population Coding
in Olfaction: Neural Activity to Perception 
R. Campbell, K. Honegger
A central goal in systems neuroscience is to understand
the relationship between neural activity and sensory
perception. How different do two response patterns
have to be in order to be perceived as distinct? This dif-
ference can be considered a unit of the neural code: the
smallest difference in activity that the animal can per-
ceive. We have addressed this question in the olfactory
system of Drosophila, focusing on a brain area known
as the MB, which is essential for learned olfactory dis-
crimination. Using imaging techniques to track more
than half the population of MB neurons, we address
this question with a completeness not currently feasible
in mammalian systems. 
We compared behavioral measures of olfactory dis-
crimination with neural activity patterns monitored
using calcium imaging. Flies were trained to form a
Pavlovian association with one odor and then to choose
between the trained odor and a different odor in a T
maze. To track neural activity, we targeted expression
of the calcium sensor, GCaMP 3.0, specifically to MB
neurons using genetic tools available in Drosophila. We
used two-photon imaging to record activity patterns,
incorporating a piezoelectric z-motor to image the en-
tire MB in a three-dimensional volume during a single
odor presentation. This approach enabled us to rou-
tinely monitor neural activity of most MB neurons. By
measuring odor responses on a trial-by-trial basis, we
could accurately quantify response variability. This en-
abled us to construct an algorithm to classify odors
based on the patterns of active neurons, taking into ac-
count the noise inherent in neuronal responses. 
MB odor responses were sparse, consistent with elec-
trophysiological recordings. Different monomolecular
odors could be readily distinguished from one another
based on activity patterns, even when odors evoked ex-
ceptionally similar patterns of activity in the population
of olfactory receptor neurons. Behavioral tests showed a
similar level of discriminability. We then tested a series
of progressively similar binary blends of odor, which en-
abled us to construct a psychometric curve characterizing
discriminability as a function of stimulus similarity. We
established a corresponding neurometric curve describ-
ing our ability to classify odors based on those activity
patterns. There was a close correspondence between the
neurometric and psychometric curves, indicating that
NEURAL CODING AND MEMORY FORMATION IN THE DROSOPHILA
OLFACTORY SYSTEM
G. Turner R. Campbell T. Hige
E. Gruntman K. Honegger
097-149_04_Neurosci_Annual Report_2009 template  7/8/11  11:57 AM  Page 142
Neuroscience     143
we can interpret the patterns of MB activity in naive flies
in a way that accurately predicts how finely they can
learn to discriminate odors. Overall, our results show
that small differences in input are nevertheless easily dis-
tinguished in the MB population, a transformation that
likely underlies accurate information storage.
Robustness of Sparse Coding in the
DrosophilaMushroom Body
K. Honegger, R. Campbell
Theoretical work suggests that sparse representations
are useful for learning and memory because they enable
synaptic changes to modify representation of one stim-
ulus without interfering with another. However, an im-
portant underlying assumption is that these sparse
representations are robust to natural variations in the
stimulus. There are two broad challenges to maintain-
ing a sparse representation: variations in stimulus in-
tensity and variations in stimulus complexity. We have
examined how the sparse, specific MB responses are
maintained in the face of these challenges. 
We examined robustness to stimulus intensity by lin-
early varying odor concentration across two orders of
magnitude. We found that in general, responses are ex-
tremely similar across different concentrations, a useful
feature that would enable odor recognition indepen-
dent of intensity. Interestingly, there is a form of plas-
ticity that sets this invariance: When the same odor is
presented in a series of pulses of steadily increasing con-
centration, the MB response appears to be completely
concentration invariant. When pulses are steadily de-
creasing, however, response strength is proportional to
odor concentration. This suggests that when traveling
up a concentration gradient, the MB only conveys in-
formation about odor identity, perhaps to confirm that
the odor is still present, whereas decreasing odor inten-
sity should be readily detectable by neurons down-
stream from the MB. 
To evaluate the effects of stimulus complexity, we
tested responses to multicomponent odors, including
naturally occurring smells. Several considerations sug-
gest that natural odors may evoke responses in the MB
fundamentally different from those produced by
monomolecular odorants. In other systems such as vi-
sion, it is the stimuli that have meaning to the animal
that evoke strong responses in neurons at the deeper lay-
ers. Studying deeper olfactory areas with monomolecu-
lar odorants the animal has never before encountered
may have led to an impoverished view of MB response
properties. Additionally, our observations that individual
Kenyon cells (KCs) integrate input from several different
projection neurons (PNs) (see below) raise the possibil-
ity that many KCs respond selectively to odor blends,
such as natural odors. In contrast to these expectations,
we find that natural odors evoke responses that are com-
parably sparse and selective to responses to monomole-
cular odorants. 
Additionally, imaging allows us to determine whether
odor responses are in some way spatially clustered, with
pockets of dense activity. In earlier layers of the olfactory
system, there is a clear spatial organization of responses;
however, in the MB, no obvious structure exists and re-
sponses appear to be distributed randomly. We also
ruled out the possibility that MB neurons are spatially
arranged according to their odor-tuning properties. Al-
together, these results are consistent with the notion that
the MB is a purely associative area: Natural stimuli that
have intrinsic meaning do not elicit qualitatively distinct
responses from monomolecular stimuli nor is there any
obvious spatial segregation based on odor response pref-
erences that would suggest olfactory information is
channeled into distinct anatomical pathways. 
Integration Properties of MB Neurons
E. Gruntman
The nervous system has to represent a large number of
different stimuli using a relatively small number of neu-
rons. At the sensory layer, combinatorial coding by large
ensembles of neurons enables a small number of cells to
represent a much larger number of different stimuli. In
deeper layers, sparse representations by highly stimulus-
selective neurons can ensure that similar stimuli evoke
markedly distinct patterns of activity, a feature thought
to be important for accurate memory formation. The
olfactory system in Drosophila melanogaster displays
these fundamental characteristics: The olfactory receptor
neurons represent odors combinatorially, and they are
maintained as functional units by projecting to form
synapses in distinct glomeruli within the second layer of
the system, the antennal lobe. At the third layer, a learn-
ing and memory area termed the MB, neurons known
as KCs are highly stimulus specific and odor responses
are relatively sparse in this population. 
One hypothesis for how KCs achieve their high odor
specificity is that they integrate across several different
input channels and require the combined activity of
those inputs in order to spike. Projection neurons from
the second layer of the system relay information from
distinct glomeruli to the KCs; however, it is yet un-
known whether each individual KC receives informa-
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tion from the same glomerulus, thus acting as an am-
plifier, or from different glomeruli, acting as an inte-
grator. 
We expressed the calcium sensor GCaMP3.0 in sin-
gle KCs and used two-photon imaging to monitor the
olfactory responses of individual dendritic sites in a liv-
ing fly. This enabled us to construct an odor-tuning
curve for each dendritic input site. By comparing tun-
ing curves for different sites, we directly tested whether
KCs integrate combinations of different inputs and
whether the integration is a prerequisite for a spiking
response. Our results suggest that some KC types inte-
grate information whereas others mainly amplify. We
also found that KC spiking requires simultaneous acti-
vation of most of the input units. By integrating across
different input channels, KCs in effect read the combi-
natorial code of the earlier layers.
Decoding Sparse Representations
T. Hige
Sparse representations are useful for learning and mem-
ory, but how do downstream neurons integrate this in-
formation? Ultimately, the information in layers with
sparse representations has to be converted into a behav-
ioral response. How does this process occur and how
do neurons downstream from a sparsely responding
brain area integrate that information? 
In Drosophila, this process appears to occur imme-
diately after the MB, as the 2500-Mb neurons converge
onto an estimated 50 output neurons. Individual mem-
bers of this output population can be green fluorescent
protein (GFP) labeled using the genetic tools available
in Drosophila, making this an excellent system to deter-
mine the basic principles of information processing
downstream from sparse representations. Using GFP-
targeted intracellular recordings, we have characterized
the odor responses of one of these MB output neurons.
In contrast to the highly odor-specific tuning of MB
neurons, this output cell responds to a broad array of
different odors. These functional properties are reflected
in the cell’s anatomy: It has very extensive dendritic
processes within the output lobes of the MB, suggesting
it receives highly convergent input from many MB neu-
rons. Although the neuron responds to almost all tested
odors, it nevertheless responds distinctly to different
odors, suggesting that this neuron is capable of carrying
odor-specific information. However, the odor-tuning
properties of this neuron vary among individual flies—
the same neuron has very different tuning curve shapes
in different animals. One explanation for this variability
is that it reflects synaptic plasticity that operates on a
developmental timescale. Our working hypothesis is
that the tuning curves of the MB output neurons are a
product of the prior olfactory experience of the indi-
vidual fly. We are currently testing this by examining
the role of olfactory experience in shaping the response
properties of these neurons. 
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My laboratory is interested in how neural circuits un-
derlie normal processing and attention in the auditory
cortex, and how this processing is disrupted in cognitive
disorders such as autism. To address these questions, we
use a combination of computational, electrophysiolog-
ical and imaging techniques at the molecular, synaptic,
cellular, circuit, and behavioral levels.
Sequencing the Connectome
S. Chattopadhyay, G. Cao, H. Oyibo, S. Peikon, H. Zhan 
[in collaboration with J. Dubnau, L. Enquist, Princeton 
University]
The brain is a complex network, consisting of billions of
neurons connected by trillions of synapses. The details of
these connections—which neurons form synaptic connec-
tions with which other neurons—are crucial in determin-
ing brain function. Malformation of these connections
during prenatal and early postnatal development can lead
to mental retardation, autism, or schizophrenia; loss of
specific connections later in life is associated with neu-
rodegenerative diseases such as Alzheimer’s. An efficient
method for determining the brain’s wiring diagram would
transform neuroscience research.
Inspired in part by the success of the Allen Brain
Atlas, the Human Genome Project, and other major ef-
forts, there is growing excitement in neuroscience to
determine the complete connectivity diagram—the
“connectome”—of the brain. So far, the complete con-
nectome has been established for only one organism,
the tiny worm Caenorhabditis elegans, with 302 neurons
connected by ~7000 synapses. However, determining
the connectome of even this simple nervous system was
a heroic task, requiring more than 50 person-years of
labor to collect and analyze the electron micrographs.
All current approaches to determining the connectome
are based on microscopy. Unfortunately, microscopy is
poorly suited to the study of neural connectivity because
brains are macroscopic structures, whereas the synaptic
connections between neurons require electron microscopy.
Reconstructing the complete wiring diagram of such a
brain is akin to piecing together the complete roadmap of
the United States from a collection of postage-stamp-sized
photographs. 
To circumvent the considerable challenges associated
with determining the connectome based on microscopy,
we are developing an entirely novel approach based on
high-throughput DNA sequencing technology. Sequenc-
ing technology has not previously been applied in the con-
text of neural connectivity. The appeal of using sequencing
is that it is already fast—sequencing hundreds of millions
of individual pieces of DNA in a single day is now rou-
tine—and, like microprocessor technology, getting faster
exponentially. Moreover, the cost of sequencing is plum-
meting: Predictions are that it will be possible to sequence
an entire human genome (~3B nucleotides) for $1000
within a few years. Thus, by converting brain connectivity
from a problem of microscopy to a problem of sequenc-
ing, we render it tractable using current techniques. 
A cheap and rapid method for deciphering the
wiring diagram of a neural circuit of an entire brain
would have a profound impact on neuroscience re-
search. Knowing the neuronal wiring diagram would
provide a foundation for understanding neuronal func-
tion and development, in the same way that knowing
the complete genomic sequence provides the starting
point for much of modern biological research in the
postgenomic era. Moreover, many neuropsychiatric dis-
eases such as autism and schizophrenia are thought to
result from disrupted neuronal connectivity, but iden-
tifying the disruptions even in mouse models is a major
challenge given current technology. Our approach may
help to usher in an era when understanding the con-
nectivity of a new mouse model of neuropsychiatric dis-
ease is the routine first step to analyzing its deficits. 
Disruption of Auditory Cortical Circuits
by Autism Candidate Genes
T. Hromadka, Q. Xiong
Autism is a highly heritable disorder thought to arise
through disruption of neural circuits. Many candidate
NEURAL CIRCUITRY OF UNDERLYING NORMAL AND ABNORMAL
PROCESSING IN THE CORTEX 
A. Zador K. Borges T. Hromadka H. Oviedo A. Reid H. Zhan
G. Cao S. Jaramillo H. Oyibo Q. Xiong P. Znamenskiy
S. Chattopadhyay S. Koh S. Peikon Y. Yang
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genes have been implicated, but how these genes lead to
the autistic phenotype remains unclear. We hypothesize
that the circuit defect underlying autism involves an im-
balance between excitatory and inhibitory neural activity.
To test this hypothesis, we are using in vitro and in vivo
methods to assess circuit dysfunction in the auditory cor-
tex. Previous work from my laboratory has shown that
excitation and inhibition are exquisitely balanced in the
auditory cortex, and so this assay should be a very sensi-
tive measure of disruption in animal models in which
autism candidate genes have been disrupted.
Role of Interneurons in Auditory
Cortex Function
K. Borges, A. Reid
Fast synaptic inputs to neurons in the auditory cortex are
either inhibitory or excitatory. Cortical interneurons are
tremendously diverse. One interneuron subclass, defined
molecularly by the expression of parvalbumin (“PV+”),
seems to be ideally positioned to mediate the fast com-
ponent of the characteristic barrage of inhibition elicited
by a sound. We are testing the hypothesis that PV+ in-
hibitory interneurons mediate fast sound-evoked in-
hibitory synaptic currents in the auditory cortex. 
Our proposal seeks to establish a causal link between
a physiological property—the fast sound-evoked inhi-
bition that contributes to receptive field dynamics—
and a component of the underlying cortical circuitry.
We approach the problem at three different levels, from
brain slices through in vivo physiology to behavior. Al-
though we are currently focusing on the role of one par-
ticular interneuron subclass (PV+), our approach
combining electrophysiological and molecular tools can
readily be generalized to other subclasses and can be ex-
tended to probe the circuitry underlying other sensory
and behaviorally elicited neuronal responses.
Processing of Spatial Information
in the Auditory Cortex
S. Koh
In vision and somatosensation, spatial information is
already present at the receptor level. In audition, spatial
information is not available at the cochlear level and
must be computed using information from both hemi-
spheres. A subpopulation of neurons in the primary au-
ditory cortex conveys sound location and sound motion
information, but little is known at the neural circuit
level because of technical difficulties in identifying neu-
rons during in vivo recordings.
We have previously developed a technique called
PINP (photostimulation-assisted identification of neu-
ronal populations) which allows us to “tag” subpopu-
lations of neurons based on their axonal projections.
The tag is a light-gated ion channel channelrhodopsin-
2 (ChR2), which can be triggered by a brief flash of
blue laser with millisecond precision. We inject herpes
simplex virus (HSV), which can be taken up by axons
and travels in a retrograde fashion, in order to deliver
ChR2 specifically to the neurons projecting to the in-
fected area. ChR2-tagged neurons can be identified
during in vivo recording by responsiveness to a flash of
blue light.
We are using PINP to test the hypothesis that layer-
3 ACx neurons projecting to the contralateral ACx are
more sensitive to auditory spatial information than
other subpopulations in ACx. Layer-3 neurons seem to
be ideal candidates, deduced from facts (1) that many
layer-3 ACx cells project to the contralateral ACx, un-
like the visual and somatosensory cortex where layer-3
cells predominantly project to ipsilateral cortical areas
and (2) that processing of spatial information requires
inputs from both hemispheres.
Temporal Expectation Modulates 
Neuronal Responses in the
Auditory Cortex
S. Jaramillo 
When a stimulus occurs at a predictable instant in time,
anticipation of the stimulus improves the speed and ac-
curacy with which it is detected. We have developed a
two-alternative choice task paradigm in freely moving
rats to study the neural mechanisms underlying this
phenomenon in the auditory system. Behavioral meas-
urements confirm that valid expectations improved
both reaction times and detection thresholds. We are
also using tetrodes to record responses from single neu-
rons in the auditory cortex of rats performing the task.
Responsive neurons often showed an increased evoked
response to tones immediately preceding the expected
moment of appearance of the target when compared
against responses to the same tones occurring long be-
fore the expected target. In addition, grouping behav-
ioral trials according to the subject’s reaction time
reveals correlations between the strength of the neu-
ronal responses and performance (Jaramillo and Zador
2011). 
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Mapping of Auditory Cortex Circuitry Using
Laser-Scanning Photo Stimulation
H. Oviedo [in collaboration with I. Bureau, K. Svoboda,
Cold Spring Harbor Laboratory]
It is widely assumed that the organization of the sensory
cortex can be described by a “canonical” circuit. Ac-
cording to this view, sensory input from the thalamus
arrives at cortical layer 4, propagates to layer 2/3, and
then descends to layer 5 before exiting a brain region.
However, until recently, it has been technically difficult
to test this hypothesis directly. We are applying a new
approach—laser-scanning photostimulation—to map
the circuitry within the rodent auditory cortex. Using
this approach, we can directly compare the circuitry
within the auditory cortex with that of other sensory
cortices, such as the better-studied barrel cortex. Our
results indicate that although the auditory cortex is or-
ganized according to many of the same general princi-
ples, the detailed structure appears to be quite different
(Oviedo et al. 2010). 
Using Cortical Timing Information
to Guide Behavior
Y. Yang, G. Otazu, M. DeWeese
It is well established that animals can exploit the fine
temporal structure of some stimuli; for example, inter-
aural time differences of less than 1 msec are used for
spatial localization of sound. It is also clear that cortical
neurons can lock with millisecond precision to the fine
temporal structure of some stimuli. However, it has
been difficult to establish whether the fine temporal
structure of cortical responses can be used in a behav-
ioral context to guide decisions. Indeed, in the case of
spatial localization of sound, the relevant interaural
time difference cues are processed below the level of the
cortex by means of specialized circuitry.
We have therefore adopted a direct approach to
probe the precision with which cortical timing infor-
mation can be used to guide behavior in the rat (Yang
et al., Nat Neurosci 11: 1262 [2008]). To bypass sub-
cortical auditory pathways, we stimulate the primary
auditory cortex directly, using transient biphasic cur-
rent trains delivered via chronically implanted intra-
cortical microelectrodes. The behavioral paradigm we
use is a two-alternative choice task in which stimulus
1 consists of the simultaneous stimulation of two in-
tracortical sites (A and B), and stimulus 2 consists of
sequential stimulation of the two sites separated by a
brief interval dt(A–dT–B). After the subjects are
trained to perform to criterion (1–2 weeks) with the
initial long interstimulus interval (dT > 50 msec) for
stimulus 2, we probe the subjects’ psychophysical
threshold by reducing dT, until the subjects can no
longer distinguish between the two stimuli. Our exper-
iments indicate that the cortex can make use of infor-
mation on a timescale as short as 3 msec (Yang et al.,
Nat Neurosci 11: 1262 [2008]). 
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We combine genetic and functional analyses to study
the cellular and molecular bases of learning and mem-
ory in Drosophila. One of our major approaches is to
research genes identified in human disorders with a
component of cognitive dysfunction. We are currently
working with genes indicated in neurofibromatosis 1,
Noonan syndrome, Alzheimer’s disease, schizophrenia,
and autism. Studies of these genes will allow us to gain
new insights into brain functions that have been dif-
ficult to work with otherwise, such as forgetting, spac-
ing effect, and memory retrieval. Another major effort
has been devoted to imaging brain activities of living
flies with the hope that we will be able to gain insights
into sensory coding and memory traces of such cod-
ing. Such effort led us to identify “perceptive coding”
neurons, through which we believe that sensory cod-
ing is transformed into perceptive coding that directly
predicts behaviors. Some of our research is detailed
below.
Trace Conditioning in Drosophila
Y.-C. Shuai
Trace conditioning is valued as a simple experimental
model to assess how brains associate events that are dis-
crete in time. Organisms as simple as the fruit fly are
able to acquire trace conditioning by learning to avoid
an odorant that precedes an electric shock punishment
by many seconds. We observed that this type of learn-
ing is supported by mechanisms remarkably divergent
from the well-characterized simultaneous condition-
ing, in which presentation of the odorant and punish-
ment overlap. First, the rutabaga-encoded adenyl
cyclase, which is central to simultaneous conditioning
and is thought to act as a coincidence detector, turns
out to be dispensable in trace conditioning. Second,
inhibition of the Rac-forgetting mechanism does not
affect acquisition of simultaneous conditioning. Re-
markably, this same manipulation enhances trace con-
ditioning. 
Food-Seeking Neuron in Drosophila
J. Beshel
For all motile organisms, survival depends on accurately
identifying and localizing appropriate food sources.
Odors are one of the most important sensory cues ani-
mals use to track, evaluate, and select among available
foods. Fruit flies are no exception, using olfactory cues
to navigate their environment and make determinations
regarding the relative merits of following such a cue to
its source. We identified the neuropeptide Y homolog
Drosophila neuropeptide F (dNPF) as critical in medi-
ating innate and satiety state-appropriate approach be-
haviors to olfactory cues from likely food sources. We
monitored single dNPF-positive neurons and showed
that these neurons respond to olfactory stimuli with in-
creases in intracellular calcium. In vivo odor-evoked ac-
tivity profiles are larger in response to the category of
natural food odors than to other complex odorants, syn-
thetic monomolecular odorants, or monomolecular
components of natural food odors. Moreover, these in-
creases are satiety-state-dependent, with hungry flies ex-
hibiting larger levels of activity as compared to satiated
flies. Remarkably, the level of dNPF neuronal activation
exactly parallels the degree of odor-associated food seek-
ing in hungry and satiated flies and furthermore suggests
coding of preference as opposed to simple binary attrac-
tion-aversion. Additionally, silencing dNPF neurons
eradicates food seeking in hungry flies, whereas activat-
ing these neurons makes satiated flies behave as though
hungry. Together, these results suggest that single neu-
rons can encode the significance of an encountered stim-
ulus, adjusting its comparative worth based on internal
need. Such neurons, as we demonstrate, ultimately may
predict behavior with astonishing specificity.
NF1 and Long-Term Memory in Drosophila
C. Xu
Neurofibromatosis type 1 (NF1) is a single gene disor-
der that affects about one in every 3500 people in the
NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
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097-149_04_Neurosci_Annual Report_2009 template  7/8/11  11:57 AM  Page 148
Neuroscience     149
population. The gene involved, named neurofibromin,
encodes a large 25-kD protein and is highly conserved
throughout the animal kingdom. In addition to tumor
predisposition in various somatic tissues, NF1 patients
also show learning difficulties and cognitive defects.
Drosophila melanogaster is an established learning and
memory model, and its NF1-coding sequence shares
~75% similarity with that of human NF1. For these
two reasons, Drosophila is an attractive model for study-
ing how NF1 affects cognitive function. Our lab has
previously reported that flies lacking NF1 show im-
paired immediate memory. After repetitive training,
NF1 mutants can eventually perform as well as wild
type, but they are unable to sustain the same level of
long-term memory (LTM) as wild-type animals. This
indicates that NF1 is involved in LTM. The stages and
biochemical pathways involved in turning the imme-
diate memory into LTM, however, are complicated and
less well understood. We are currently conducting be-
havioral experiments on NF1 mutant animals to un-
cover which stages are NF1 dependent.
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Uncovering the molecular processes governing how plants grow and develop is of fundamental bi-
ological interest and importance, with vital implications both for agriculture and human health.
Plant genetics has had a major role in the advance of all areas of research at CSHL almost since the
Laboratory’s inception, epitomized by the work of Nobel laureate Barbara McClintock, who dis-
covered transposable genetic elements in her work on maize in the 1940s. Plant geneticists at CSHL
have been among the leaders of efforts to sequence the first plant genomes and continue to be at
the center of sequencing and genome-annotation projects involving a host of cereal crops that feed
the planet’s growing population. CSHL plant geneticists also have been pioneers in the study of
RNA interference, stem cell research, and, most recently, efforts to spur the development of next-
generation biofuels and related alternative energy sources. 
David Jackson and colleagues study genes and signals that regulate plant growth and architecture.
They are investigating a unique way in which plant cells communicate, by transporting regulatory
proteins via small channels called plasmodesmata. These channels, which direct the flow of nutrients
and signals through growing tissues, are regulated during development. The team discovered a gene,
CCT8, that controls the transport of a transcription factor, KNOTTED1, between cells in the plant
stem cell niche, or meristem. KNOTTED1 is critical for stem cell maintenance, and studies of the
CCT8 gene indicate that movement of KNOTTED1 between cells is required for this function.
The lab also continues to identify other genes that control plant architecture through effects on
stem cell maintenance and identity. A recent example is the discovery of a subunit of a heterotrimeric
G protein that is conserved throughout animals and plants; their studies indicate that this gene con-
trols stem cell proliferation. A second example is the identification of a gene, GRASSY TILLERS1,
that appears to have been instrumental in the domestication of the corn plant, a process that led to
the development of agriculture ~10,000 years ago. The lab has also started to characterize system-
wide networks of gene expression in inflorescence development, using “next-generation” profiling
methods. Jackson has also undertaken to develop a collection of maize lines that can drive expression
of any reporter or experimental gene in any tissue type. These tools, of great interest to maize re-
searchers, are being made available to the broader scientific community, enabling experiments never
before possible in crop plants. 
Zachary Lippman’s research focuses on identifying genes that cause tomato plants to produce
their flowers in an elegant repetitive zigzag arrangement on a branching structure called an inflo-
rescence. Proceeding from a base of knowledge that they have built regarding a universal growth
habit represented by the tomato, called sympodial growth, Lippman’s lab is addressing the funda-
mental question of how plants are able to stop making leaves and start making flowers. Of particular
interest is how these “reproductive phase transitions” have contributed to the evolution of diverse
inflorescence branching patterns in the tomato’s larger Solananaceae family, which includes plants
that make just one flower in each inflorescence as well as plants whose inflorescences produce dozens
of branches and hundreds of flowers. Using classical and modern genetic techniques, Lippman is
dissecting the gene networks that are responsible for the variation in inflorescence branching found
in nature. He hopes to leverage these discoveries to improve crop yields in several Solanaceous plants
such as pepper, eggplant, and potato. Already, a collaboration between Lippman’s group and scien-
tists at Hebrew University has identified a gene called florigen that is responsible for making flowers
in plants and can be altered using simple genetic tricks that push hybrid tomato plants to increase
their yield by as much as 60%. Lippman plans to extend this finding to corn through a collaboration
with David Jackson’s group.
Epigenetic mechanisms of gene regulation—chemical and conformational changes to DNA and
the chromatin that bundles it—have important impact on genome organization and inheritance
and on cell fate. These mechanisms are conserved in eukaryotes and provide an additional layer of
PLANT GENETICS
150-174_05_PlantGenet_Annual Report_2009 template  7/8/11  11:58 AM  Page 150
151
information superimposed on the genetic code. Robert Martienssen, a pioneer in the study of epi-
genetics, investigates mechanisms involved in gene regulation and stem cell fate in yeast and model
plants including Arabidopsis and maize. He and colleagues have shed light on a phenomenon called
position-effect variegation, caused by inactivation of a gene positioned near densely packed chro-
mosomal material called heterochromatin. They have found that heterochromatin is programmed
by small RNA molecules arising from repeating genetic sequences. Recently, Martienssen and col-
leagues described a remarkable process by which “companion cells” to sperm in plant pollen grains
provide them with instructions that protect sperm DNA from transposon damage. With collabora-
tors in Mexico, Martienssen this year coaxed Arabidopsis, a flowering plant, to reproduce asexually
in a process related to apomixis. The key was shutting down the Argonaute 9 protein, which tricked
an ovule into manufacturing multiple gametes, rather than one. These gametes carried the full com-
plement of genetic material for the next generation. This is an important step in a long-time goal of
plant breeding: generating clonal offspring to perpetuate hybrid vigor. Martienssen’s group also con-
tinues to work on problems related to the creation of plant-based biofuels.
The growing tips of plants, called meristems, contain a population of stem cells that serve as a
persistent source of daughter cells from which new organs arise. They also produce signals important
for the determination and patterning of lateral organs. Marja Timmermans and colleagues are using
a genomic approach to study genes active in the meristem. They have also used mutational analyses
to unravel the mechanism that suppresses stem cell fate during organ development. They have shown
that this process requires a highly conserved epigenetic mechanism. In particular, they have found
that the chromatin-remodeling factor HIRA, through interaction with specific DNA-binding pro-
teins, mediates the recruitment of Polycomb repressive complexes to stem cell factors, an action that
stably represses their expression in differentiating organs. The Timmermans lab has also identified
regulatory mechanisms that allow for the precise spatial accumulation of developmentally important
small RNAs in plants. This work has revealed that polarity in leaves is established via opposing gra-
dients of mobile small RNAs that act as morphogen-like signals. Their most recent findings identified
a third small RNA gradient involved in maintenance of organ polarity. These findings illustrate the
complexity with which small RNAs generate developmental patterns. Mathematical modeling sug-
gests that such opposing small RNA gradients might serve to generate robustness during develop-
ment.
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Our research aims to identify genes, signals, and path-
ways that regulate plant growth and development. All
organisms develop by carefully controlling the flow of
information (“signals”) that passes between cells and
tissues. We are particularly interested in discovering
these signals and finding out how they are transmitted
and how they function. As an example, we have iden-
tified genes that control how plant cells communicate
with each other through small channels, called plas-
modesmata. These channels were described in plants
more than 100 years ago, but their central importance
and how they are regulated is just beginning to emerge.
Plasmodesmata are critical for plant growth, because
they allow the passage of nutrients and signals through
growing tissues. In the past year, we elucidated an im-
portant mechanism by which transport through these
channels is controlled, via a chaperonin gene that reg-
ulates the specific transport of a transcription factor,
KNOTTED1. This factor is a homeodomain protein
that is expressed in the plant stem cells and is necessary
to keep these cells in a pluripotent state. We found that
KN1 function depends on chaperonin activity, high-
lighting the importance of cell-to-cell trafficking in
plant stem cell function.
We also continue to identify maize genes with novel
roles in shoot development and plant architecture. We
have recently identified genes that control branching,
stem cell proliferation, and leaf growth. One of these,
compact plant2, encodes a subunit of a heterotrimeric
G protein that has previously not been linked with stem
cell proliferation in plants. Studies of CT2 have, for the
first time, linked the action of a plant hormone,
giberellin, with the control of stem cell proliferation.
Finally, we continue to develop a collection of “fluores-
cent-protein”-tagged maize lines that are an essential
resource for all maize researchers. This is the first col-
lection of its kind and promises to enhance maize ge-
netics research through characterization of developmen-
tal gene pathways and identification of maize promoters
that can be used in crop improvement.
Characterization of a Dominant
Phyllotaxy Mutant, Abphyl2,
in Maize
F. Yang, V. Llaca, H. Sakai, DuPont Crop Genetics, 
Delaware; Robyn Johnston, Cornell University,
New York
Plant morphology and diversity are largely dependent
on phyllotaxy, which is the geometric arrangement of
new leaf primordia formed by the shoot apical meri-
stem (SAM). Auxin and its polar transport through
PINFORMED1 (PIN1) proteins are crucial for control-
ling phyllotactic patterns. Recently, our studies on
ABPH1 in maize have shown that cytokinin hormone
signaling, as well as its cross-talk with auxin, have an im-
portant role in this process. abphyl1 (abph1) mutations
change maize phyllotaxy from alternate to decussate.
Here, a similar phyllotaxy mutant, Abph2, is described.
Abph2 is dominant and originated from a Chinese in-
bred line; it has a decussate leaf pattern that becomes
visible at leaf ~4–5 stage. Map-based cloning done in
three genetic backgrounds has mapped Abph2 in a re-
gion of ~20 kb on chromosome 7, containing five pre-
dicted genes in the reference B73 genome. However,
direct sequencing of the open reading frames (ORFs) of
these five genes, as well as their transcript level analysis
by reverse transcriptase–polymerase chain reaction (RT-
PCR), did not give any obvious clues as to the identity
of the Abph2 gene. Next, a bacterial artificial chromo-
some (BAC) library generated from the Abph2 mutant
was screened using probes located within the 20-kb
mapping interval and identified six positive clones. One
of them fully covers the 20-kb mapping interval. We are
currently analyzing the sequence of this BAC to obtain
clues into the molecular basis of the Abph2 mutation.
Meanwhile, putative knockout lines of the dominant
Abph2 mutation were screened by ethylmethanesul-
fonate (EMS) mutagenesis. These putative knockouts
will be used to confirm the gene, once a candidate has
been identified. In addition, introgression lines are being
DEVELOPMENTAL BIOLOGY: STEM CELLS, SIGNALING,
AND CONTROL OF PLANT ARCHITECTURE
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generated to investigate the influence of different genetic
backgrounds on Abph2 phenotypes. Among three intro-
gression lines in A619, B73, and W23 backgrounds, re-
spectively, Abph2 phenotypes show a dramatic enhance-
ment in A619, characterized by splitting of the SAM
into two to three distinct shoots. In contrast, B73 and
W23 appear to weaken the Abph2 phenotypes, since the
decussate leaf pattern becomes visible much later. Analy-
sis of additional introgression lines are in progress. Fi-
nally, informed by the fact that auxin patterning and
PIN1 maxima in the leaf initiation site are diminished
in abph1, we are currently analyzing auxin distribution
in Abph2meristems, using PIN1-YFP and DR5-RFP as
markers. Preliminary analysis revealed that the expres-
sion of PIN1 in the Abph2 SAM appears to be de-
creased, suggesting a common mechanism by which
these mutants control phyllotaxy. More detailed analysis
to confirm these observations is under way.
Regulation of the Cell-to-Cell Trafficking
of the Transcription Factor KNOTTED1:
Identification of Chaperonins and
Additional Factors through
Genetic Screens
X.M. Xu, J. Wang, L. Panda, N. Hariharan
Cell-to-cell communication has critical roles in speci-
fying cell fate and coordinating development in all mul-
ticellular organisms. A special paradigm for such
communication in plants is the selective trafficking of
informational macromolecules, e.g., transcription fac-
tors and small RNAs through plasmodesmata (PDs),
channels that traverse the cell wall and connect all plant
cells. In addition to cell-fate specification, PDs are also
involved in viral movement, transport of metabolites,
and cell-to-cell spread of RNA interference (RNAi),
which points to their fundamental importance in co-
ordinating plant defense, metabolism, and develop-
ment. Despite the discovery of PD more than 100 years
ago, and our increasing recognition of their functional
significance, the underlying components and mecha-
nisms of PD trafficking remain poorly understood.
Hence, we are taking an unbiased genetic strategy to
dissect these molecular components and mechanisms,
using a transgenic reporter system. 
The maize KNOTTED1 (KN1) homeodomain
protein was the first plant protein found to selectively
traffic through PDs, and its trafficking has been sug-
gested to be important for its function in shoot stem
cell maintenance. A gain-of-function trafficking assay
in Arabidopsis was developed to demonstrate that the
carboxy-terminal region of KN1 (KN1C), which con-
tains the homeodomain, is necessary and sufficient for
KN1 trafficking in vivo. The trafficking assay relies on
complementation of leaf hair (trichome) development
in hairless glabra1 (gl1) mutants. GL1, a MYB tran-
scription factor, is required in the epidermis for tri-
chome initiation and acts cell autonomously. However,
expression of a fusion between GL1 and KN1C in cells
underlying the epidermis can rescue trichomes in a gl1
mutant background, because the fusion protein can
traffic through PDs into the epidermal cells. Thus, this
system provides a simple and tractable model to under-
stand how proteins traffic cell to cell. Factors critical for
KN1 trafficking can be uncovered through isolating
mutants defective in trichome rescue. Through screen-
ing ~2500 M2 plants, several mutants have been ob-
tained which all show an attenuated KN1 trafficking.
Through combining traditional mapping and illu-
mina-based high-throughput sequencing, one such mu-
tant was identified as a chaperonin gene. Using artificial
microRNA knockdowns, we found that additional
chaperonin subunits also function during KN1 traffick-
ing, suggesting that the whole chaperonin complex is re-
quired for trafficking. Physical association between the
chaperonins and KN1 also strengthens the idea that the
chaperonins are directly involved in KN1 trafficking.
Genetic interaction data provide evidence that the en-
dogenous function of KN1-related genes in Arabidopsis
also requires chaperonin, and chaperonins are coex-
pressed with KN1-related genes in the SAM (Fig. 1),
clearly supporting the functional relevance of chaper-
onin-mediated trafficking through PDs. Furthermore,
tissue-specific complementation assays point to a role
for chaperonins during the posttranslocational refolding
process. In addition, chaperonins also appear to be es-
sential for the PD trafficking of non-cell-autonomous
proteins other than KN1, suggesting chaperonin de-
pendency is a general mechanism for protein trafficking.
Together, our data highlight the importance of confor-
mational changes for PD trafficking and identify a chap-
erone that promotes protein trafficking through PDs. 
Meanwhile, we also took a transgenic approach to
address the in vivo significance of KN1 cell-to-cell traf-
ficking. For the ease of transformation, we worked with
Arabidopsis and used the Arabidopsis homolog of KN1,
SHOOTMERISTEMLESS (STM), as our model pro-
tein. Like KN1, STM has also been shown to move be-
tween cells, and mutations in STM cause a defect in
150-174_05_PlantGenet_Annual Report_2009 template  7/8/11  11:58 AM  Page 153
154 Research
meristem maintenance. Through attaching a nuclear
localization signal (NLS) to STM, we have developed
a modified version of STM with reduced mobility. In
the stm mutant background, we expressed this less mo-
bile form of STM in its native expression domain. By
asking if the less-mobile STM can complement stmmu-
tants, we can tell whether mobility is essential for its
function. Preliminary data showed that the less-mobile
STM complements the mutant less well, when com-
pared to the nonmodified STM, suggesting that mo-
bility is important for proper STM function. Efforts
are under way to address at which developmental stage,
and where in the meristem, STM movement is re-
quired. In summary, our analysis has furthered our un-
derstanding of the developmental regulation and
mechanisms of selective cell-to-cell trafficking.
Illuminating Maize Biology: Using
Fluorescent Proteins to Study the
Mechanisms Controlling Maize
Inflorescence Development
S. DeBlasio, A. Goldshmidt, T. Zadrozny, J. Wang [in
collaboration with A. Chan, J. Craig Venter Institute;
A. Sylvester, University of Wyoming]
Like animals, the formation and patterning of repro-
ductive structures (inflorescences) in maize depend on
hormonally induced changes in gene expression that
occur within meristematic stem cells in response to
cues from the environment. These stem cells and their
daughter cells undergo several important identity tran-
sitions to produce the male tassel and the female ear
inflorescences. First, a highly organized group of stem
cells called SAM develops within the embryo and starts
generating the vegetative organs of the plant, including
the leaves. Later in development, the SAM transitions
into the inflorescence meristem, which in turn pro-
duces several files of intermediate meristems along its
flank, which will produce the floral structures. How
these floral organs develop under normal and stress
conditions has a major effect on agronomic processes
including crop yield and nutrient content. Therefore,
studying the underlying mechanisms controlling meri-
stem maintenance and differentiation will ultimately
uncover guiding information for crop improvement.
One of the ways in which our lab is studying these
processes is through the use of fluorescent protein (FP)
technology. 
When fused to a protein, FPs make the attached, nor-
mally invisible protein visible and easy to track. Because
of their relatively small size, FP fusions rarely interfere
with native protein targeting, function, and trafficking.
Thus, FP technology is a powerful tool that can be used
to noninvasively mark protein expression and localiza-
tion to study various subcellular processes, live and in
vivo. To date, we have generated more than 90 stable,
natively expressed, maize FP fusion lines that highlight
most subcellular compartments and allow us to study
hormone signaling, cytoskeletal behavior, vesicle traf-
ficking, and other important developmental and physi-
ological processes. For example, a modified FP synthetic
reporter for the plant hormone auxin has provided an
easy way to visualize the changes in auxin signaling that
occur during inflorescence development. This reporter
introgressed into the classical ramosa mutants (in which
spikelet pair meristems lose determinacy and form
branches) has revealed distinct differences in how auxin
is distributed within the mutant meristems, even before
they deviate morphologically from normal development
(Fig. 2). We are also using these lines to immunoprecip-
itate tagged proteins and isolate additional components
of these pathways. In the case of FP-tagged transcrip-
tional regulators, chromatin immunoprecipitation
(ChIP) is also being used to identify putative DNA-
binding sites and/or to confirm gene targets that have
Figure 1. Expression of the chaperonin
gene (CCT8-GFP, B) overlaps with that
of STM-YFP in the shoot apical meristem
(A); expression is shown as white areas
and is arrowed.
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been detected by transcriptional profiling of the respec-
tive mutant. 
Currently, we are working on optimizing the LhG4
two-component trans-activation expression system for
use in maize. This system relies on the transcription fac-
tor LhG4 being expressed by a cell or tissue-specific pro-
moter, to drive the expression of a reporter in trans, via
the pOp-binding sites. The reporter can be any gene,
such as GUS, FPs, an FP fusion protein, a gene of interest
for tissue-specific expression, a silencing construct for tis-
sue-specific knockdowns, or a gene encoding a toxin for
ablation experiments. Our goal is to produce an array of
cell- and tissue-specific driver lines, which we will use to
analyze the changes that occur within meristems during
differentiation and development. From our previous
work creating natively expressed, FP-tagged protein fu-
sion lines, we have already identified several meristem-
specific promoters, such as pZMM16, pABPHYL1, and
pWUSCHEL (Fig. 2), which we will initially use to test
the reliability of the system. Driver lines will include new
maize optimized FP color variants, as well as a tagged ri-
bosomal protein (RPL18) for tissue-specific profiling by
immunoprecipitation of translating mRNAs. Data on
the characterization of all of the FP transgenic lines we
have created, including confocal micrographs and
movies, are publicly available on http://maize.jcvi.org/
cellgenomics/index.shtml. The website also contains a
community submission form to request your favorite
maize gene or regulatory element to be tagged.
Role of the fasciated ear2 Gene in Maize
Seed Production and Crop Improvement
P. Bommert, Y.K. Lee [in collaboration with M. Komatsu,
H. Sakai, Dupont Crop Genetics]
The cob structure of maize is unique among the grasses,
and it is derived from the distichous (two-rowed) inflo-
rescence of its wild-type ancestor teosinte, through more
than 9000 years of domestication. Teosinte seeds are en-
cased in hard shells and the teosinte inflorescence is char-
acterized by only two alternating rows of seed, whereas
maize ears display hundreds of exposed kernels arranged
in up to 24 rows. This morphological change is consid-
ered an important factor for the massive increase in yield
associated with the domestication of maize.
Seed row number is dependent on the number of
spikelet pair meristems, and we were able to show that
this number in turn is directly dependent on the size of
the inflorescence meristem. Following genetic approach-
es, we were able to identify several genes controlling the
size of the inflorescence meristems in maize (see also sec-
tion on fasciated mutants). One of them is the fasciated
ear2 (fea2) gene, which, when mutated leads to plants
with strongly enlarged inflorescence meristems and more
than 40 rows of seeds. 
To address whether allelic variation in fea2 has an im-
pact on seed row number, we performed a quantitative
trait locus (QTL) analysis using 250 lines of the inter-
mated B73-Mo17 (IBM) recombinant inbred popula-
Figure 2.Maize fluorescent protein reporters. Expression of the synthetic auxin reporter DR5::RFP.ER in (A) wild-type
(WT) and (B) ramosa1 (ra1) maize ear primorida. In wild-type spikelet pair meristems (SPM), an auxin maximum
forms discretely along the edge of the meristem, whereas in ramosa1, an additional auxin maximum can be detected
in the central region of the SPM, prior to the manifestation of the mutant phenotype (white arrows). (C) Expression of
pWUSCHEL::4XNLS-RFP reports the stem cell niches in ear meristems (arrows). 
150-174_05_PlantGenet_Annual Report_2009 template  7/8/11  11:58 AM  Page 155
156 Research
tion, in three replicates. The mean row number of B73
was ~18, whereas Mo17 develops ~11 rows. The mean
row number in the IBM families was ~14, with a range
from ~10 to 20. We found the most significant seed row
number QTL to be located on chromosome 4, overlap-
ping with the fea2 locus, suggesting that allelic variation
in fea2 could regulate row number. 
To substantiate these findings, we searched for hy-
pomorphic EMS-induced alleles, via TILLING. We
were able to isolate four new alleles of fea2, all predicted
to be weak. Analysis of seed row number in three of
them showed a statistically significant increase. Subse-
quent genotyping confirmed a significant correlation
between row number increase and presence of the new-
ly identified, weak fea2 allele, providing further evi-
dence that allelic variation at the fea2 locus can lead to
changes in seed row number. Field trials to assess the
impact of increased seed rows on maize yield are cur-
rently in progress.
The Regulation of Meristem Size in Maize
P. Bommert, M. Pautler , Y.K. Lee, B.I. Je, H. Szilagyi,
A. Eveland, J. Kendall [in collaboration with M. Komatsu, 
H. Sakai, Dupont Crop Genetics]
All plant organs derive from populations of stem cells
called meristems. These stem cells have two purposes:
to divide in order to replace themselves and to give rise
to daughter cells, which will differentiate into lateral
organs or stems. Consequently, plant meristems must
precisely control the size of the stem cell niche via a net-
work of positive and negative feedback signals. A loss
of function in a negative regulator of stem cell fate can
result in an enlarged or fasciated meristem phenotype
and a dramatic alteration in the morphology of the
maize ear and tassel.
Maize is an excellent genetic model system, because
of a large collection of developmental mutants and a
sequenced reference genome. Our lab has undertaken
a forward genetic approach to identify key regulators
of stem cell homeostasis and meristem size. Two previ-
ously cloned mutants, fasciated ear2 and thick-tassel
dwarf1, encode orthologs of the Arabidopsis thaliana
genes CLAVATA1 and CLAVATA2, indicating the well-
known CLAVATA-WUSCHEL regulatory feedback
loop is conserved from dicots to monocots. However,
little else is known about the control of this important
developmental process in maize. Here, we describe our
progress in identifying additional genes contributing to
stem cell niche homeostasis. 
ct2 is a classical mutant of maize that exhibits a fas-
ciated inflorescence phenotype as well as semi-
dwarfism. ct2 was identified by positional cloning and
was found to encode the α-subunit of a heterotrimeric
GTPase. The protein was localized by a fluorescent pro-
tein translational fusion and was expressed strongly in
meristems. Several experiments demonstrated that ct2
is deficient in giberrellic acid (GA) signaling, a plant
hormone with no previous connection to meristem size
control. We are currently using both genetic and pro-
teomic approaches to determine how CT2 interacts
with established pathways for regulating meristem size. 
Another fasciated ear mutant that we recently
cloned is fea3. fea3 is predicted to be similar to previ-
ously described stem cell receptor genes, and sequence
analysis indicates that it might encode a membrane-
bound receptor. The fea3 mutant possesses several fa-
vorable characteristics relevant to crop improvement.
First, plant height does not seem to be affected as in
most fasciated ear mutants. Second, although mutant
tassels have a higher spikelet density than wild type, the
overall size of the tassel is not reduced. This could lead
to increased pollen shed, a desirable trait for hybrid
crop production. Future work will include character-
izing the spatial expression of fea3 and profiling the
transcriptome to understand which pathways with
which it interacts.
fea1905 is another semidwarfed mutant, with mas-
sively fasciated ears and tassels. We mapped the mutant
to an ~2.7-Mb region on chromosome 6, which con-
tains ~30 genes. We are using targeted resequencing by
genomic hybrid capture of the interval to find the
causative mutation. Probes were designed for Agilent
244K arrays that tiled gene models in the mapping in-
terval, and hybridization was carried out according to
protocols from Emily Hodges (Hannon lab, CSHL).
Preliminary results suggest that the amount of DNA
captured is limited and not enriched for the target re-
gion. We are also beginning to use mRNA-Seq to search
for mutations in transcripts arising from within the in-
terval. A complementary approach is to create double
mutants to assemble genetic pathways. We have ana-
lyzed double mutants between fea1905 and ramosa1
and ramosa2, two mutants that display increased inflo-
rescence branching. The ramosa mutants appear to be
epistatic to fea1905, indicating that they likely act
downstream. This represents a previously unknown
connection between meristem size control and meris-
tem determinancy. Future work will include molecular
cloning of the gene, expression analysis, and transcrip-
tome profiling. 
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In addition, we are in the process of mapping ~50
fasciated ear mutants from nontargeted EMS mutage-
nesis screens. Our current approach involves creating
F2 mapping populations and rough mapping by bulked
segregant analysis. We take advantage of the precise
quantitative genotyping capability of the Sequenom
MassArray system to look for areas of the genome that
are linked to the phenotype. We have determined rough
positions for several of these mutants and are proceed-
ing with fine mapping and molecular cloning.
Resolving Networks Controlling Axillary
Meristem Determinacy 
A. Eveland, A. Goldshmidt [in collaboration with
D. Ware, Cold Spring Harbor Laboratory; M. Beatty, 
H. Sakai, DuPont Crop Genetics; R. Schmidt,
University of California, San Diego; E. Vollbrecht,
Iowa State University]
A rising challenge in developmental biology is elucidat-
ing the mechanisms by which genes are regulated in
space and time, and how their actions form networks
that modulate differentiation and development. We use
the maize inflorescence as our model to study how
branching patterns are determined at the molecular
level and the genetic interactions responsible for inflo-
rescence architecture. Branching in grass inflorescences
is determined by the developmental fate of highly or-
ganized stem cell populations called axillary meristems.
These meristems can either maintain continual growth
of indeterminate branches or terminate in determinate
structures such as flowers. Actions of genes that regulate
meristem determinacy, as well as the genetic interac-
tions between them, are responsible for the wide varia-
tion in architectures among inflorescences throughout
the plant kingdom. The genetic control of branching
in maize, especially in ears where kernels are borne, has
clear relevance to grain yield and harvesting ability. In
addition, its unique inflorescence architecture, charac-
terized by flowers borne on spikelet pairs, is shared ex-
clusively among the Andropogoneae tribe, which
includes important energy crops such as sorghum,
switchgrass, and sugarcane. Loss-of-function mutations
in the RAMOSA (RA) genes cause a branched pheno-
type, due to derepression of branching in spikelet pair
meristems (SPMs). We make use of these branching
mutants as well as Illumina’s high-throughput sequenc-
ing technology to identify transcriptional signatures re-
lated to a gene network controlling inflorescence archi-
tecture. 
Primary objectives of this work are to establish a
framework for studying developmental networks that
control branching and to use both experimental and
computational approaches to generate and address
testable hypotheses. Initially, this framework consists of
large-scale expression data sets and known genetic in-
teractions. Candidate genes identified as putative reg-
ulators of meristem determinacy will be tested as to
whether they interact with RA genes and for their po-
sition in a network controlling SPM determinacy. This
year, we published results from an analysis of sequence-
based expression profiles in maize inflorescences, which
identified genes that were differentially expressed be-
tween wild-type and ramosa3 mutants. We identified
strand-specific expression signatures and classes of dif-
ferentially expressed genes having putative functions in
SPM determinacy. Work is currently under way to an-
alyze loss-of-function mutations in these candidate loci,
as well as crosses to the ramosa mutants to study poten-
tial genetic interactions. 
We have also generated mRNA-Seq libraries at var-
ious stages of development from ears and tassels as well
as from loss-of-function ra mutants. A pipeline for
analysis of these data sets was developed and includes
methods for data processing, mapping short reads to
the maize reference genome, and statistical analyses to
identify differentially expressed genes and/or those shar-
ing similar expression patterns. We leveraged a set of
high-confidence maize gene models and comparative
functional information from other model plant species
to classify transcription factor (TF) family members,
based on their specific expression signatures in time and
space. We used a clustering approach to group coex-
pressed genes during ear and tassel development. As
predicted by their colocalized expression in ear primor-
dia, RA1 and RA3 also show coexpressed profiles during
both ear and tassel development. In addition, genes that
were differentially expressed in ra1 and ra3 mutants
tended to be coexpressed with RA1 and RA3. As a con-
trol for the mRNA-Seq data, we analyze dynamic
changes in expression profiles of the Auxin response
DR5::RFP.ER marker and additional developmental
markers, such as pWUS1::NLS::RFP. Overlaying these
marker profiles on the mRNA-Seq-based expression
map will provide insight for linking dynamic changes
in gene expression to hormonal signaling pathways in
stem cells during meristem differentiation.
We are integrating the RNA-Seq data sets with other
types of genomics data and further experimentation.
We are currently analyzing DNA-occupancy maps of
RA1, using chromatin immunoprecipitation followed
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by high-throughput sequencing (ChIP-Seq). This will
provide a genome-wide view of gene targets potentially
regulated by RA1. Using these data, we can infer puta-
tive mechanisms of regulation acting through RA1 to
control branching in maize. We have also sequenced
transcriptomes of comparable inflorescence stages in
sorghum and will use these data in comparative analyses
with the maize RNA-Seq data. These analyses will help
in selecting candidate genes that act as key developmen-
tal regulators. The function of such candidate genes will
be tested in follow-up genetic and molecular experi-
ments.
Identification of Genes Participating
in the RAMOSA3 Network
A. Goldshmidt, M. Pautler, D. Jackson
The characterization of molecular mechanisms control-
ling the branching of cereal inflorescences and the iden-
tification of novel genes that participate in this process
are crucial for the improvement of yield traits of com-
mercial crops. In our current research, we have been
using maize mutants ramosa1 (ra1), ramosa2 (ra2), and
ramosa3 (ra3), which have increased branching in the
inflorescences, in order to characterize molecular net-
works regulated by these genes. Ramosa3 is of particular
interest, because it encodes a predicted metabolic en-
zyme, a trehalose phosphate phosphatase, rather than a
transcription factor or signaling molecule that are more
typical of developmental regulators. We have used a
classic genetic approach—analysis of multiple mutant
phenotypes—for identification of the relationships be-
tween RAMOSA genes and other genes involved in de-
velopmental networks. We first characterized double
mutants of the ramosa genes with mutants involved in
auxin transport (barren inflorescence2 [bif2]) and in
auxin synthesis (sparse inflorescence1 [spi1]). Here, we
found additive interactions, suggesting that networks
regulated by the RAMOSA genes act in parallel to the
auxin-related networks. Second, we characterized dou-
ble mutants with mutants of genes involved in net-
works regulating meristem maintenance, such as
knotted1 (kn1), fasciated ear2 (fea2), and thick-tassel
dwarf1 (td1). Here, our analysis revealed that pheno-
types of the ra1 and ra2 mutants were enhanced by kn1
loss-of-function mutations, whereas ra3 mutant phe-
notypes were suppressed. ra2 and ra3 mutants showed
additive interactions with fea2, whereas fea2 phenotypes
were suppressed by ra1, and all three ramosa mutants
showed additive interactions with td1. These results in-
dicate that RAMOSA gene activities are involved in net-
works regulating meristem maintenance. However, our
results indicate that different RAMOSA genes may reg-
ulate determinacy by different mechanisms, some of
which are overlapping and some distinct. 
We also wish to gain a more detailed understanding
of the RAMOSA3 network using chemical mutagenesis
followed by suppressor enhancer screens. So far, 850 seg-
regating families were screened, and 46 suppressors and
17 enhancers were identified. Due to variability of the
ra3mutant phenotype, it is important to verify enhance-
ment/suppression in different environments. Therefore,
all modifiers were regrown in at least two different fields
for verification and crossed to ra3 mutants in a different
genetic background to generate mapping populations.
Nine suppressor and three enhancer families have been
verified and are being prepared for mapping. Interest-
ingly, only one out of the nine suppressors and one out
of the three enhancers showed single-mutant phenotypes,
resulting in dwarfism and validating the use of the mod-
ifier approach. In the next year, we will focus on mapping
and identification of these modifiers and characterize
novel genes participating in the RAMOSA3 network. 
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Beauty and agricultural productivity in the Plant King-
dom is directly linked to the number and arrangement
of branches and flowers on specialized shoots known as
inflorescences. Inflorescence branching is determined
by specialized groups of pluripotent stem cells at grow-
ing tips called shoot apical meristems (SAMs), which
undergo reproductive “phase transitions” in response
to environmental cues coinciding with innate molecular
events. Inflorescences can be simple, producing only a
single flower, or they can be highly complex, producing
dozens of branches and hundreds of flowers. Our re-
search is focused on the hypothesis that the rates at
which SAMs undergo reproductive transitions dictate
inflorescence diversity, which provides a basis for tax-
onomy as well as a primary point of selection in domes-
tication and crop improvement. Little is known about
the molecular dynamics regulating reproductive phase
transitions, especially for species with different growth
habits. In particular, one of the most fundamental, yet
poorly understood, decisions is whether an inflores-
cence grows indefinitely (indeterminate growth) or if
signals are received to end growth (determinate
growth). Determinate plants produce the most elabo-
rate inflorescence architectures, particularly among
species having the widely deployed “sympodial” growth
habit, represented by tomato. We are uniting genetics
with quantitative genomics to discover the genes and
networks that control sympodial reproductive phase
transitions, which are a hallmark of perennial species,
such as trees, and represent the growth habit of half of
the world’s flowering plants. We are taking advantage
of several tools in tomato (Solanum lycopersicum) to un-
derstand how sympodial reiteratation is modulated to
give rise to its multiflowered inflorescence, and what
molecular mechanisms are responsible for variation in
inflorescence branching in the larger nightshade
(Solanaceae) family. Importantly, the Solanaceae com-
prises several crop and ornamental species, including
potato, pepper, eggplant, petunia, and tobacco, as well
as many edible wild species. Therefore, our research ad-
dresses questions that are relevant to evolution as well
as agriculture.
In a related project, we are exploring the phenome-
non of hybrid vigor, or heterosis, which occurs when
different inbred plants are crossed to produce superior
hybrids yielding more flowers, fruits, and seeds. Het-
erosis, first described by Darwin, is widespread in na-
ture and is responsible for the dramatic and necessary
increase in crop yields achieved over the last century.
We are testing the hypothesis that heterosis can be
caused by subtle changes in gene dosage originating
from heterozygous single-gene mutations affecting
growth and development. In a screen involving dozens
of tomato heterozygous mutants, we have identified
three heterosis genes, including a reproductive transi-
tion gene and an inflorescence branching gene. A con-
clusion from our findings during the last year is that
there are several unknown genes that regulate reproduc-
tive transitions and inflorescence architecture, which
are major factors influencing reproductive capacity and
yield. Therefore, our continued efforts to expose new
genes and networks affecting flowering in tomato will
provide new targets for functional studies that can be
applied to crop improvement.
Sympodial Growth in Tomato
Tomato is a powerful model to study mechanisms of
sympodial reproductive transitions because it is com-
posed of three distinct shoot systems, each of which un-
dergoes a termination event (Fig. 1). The first termin-
ation originates from the embryonic meristem, which
produces about eight leaves before ending growth with
a multiflowered inflorescence. The next termination is
in the sympodial shoot (SYM), which grows out from
the last axillary meristem produced from the primary
shoot. All SYMs develop three leaves before producing
a final inflorescence, and each tomato shoot after the
primary transition is derived from the indefinite reiter-
ation of SYMs. The third termination occurs in the in-
florescence, which produces about seven flowers in a
zigzag arrangement. The inflorescence is also com-
pound, consisting of reiterating sympodial inflorescence
PLANT DEVELOPMENTAL BIOLOGY, STEM CELLS, AND
FLORAL BRANCHING SYSTEMS
Z. Lippman K. Jiang C. MacAlister
K. Liberatore S.-J. Park
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meristems (SIMs). Finally, each axillary meristem pro-
duces primary, sympodial and axillary shoots and in-
florescences. Thus, tomato growth is modular, and
numerous reproductive transitions throughout life give
rise to a plant with hundreds of branches, inflores-
cences, and flowers.
Two Major Genes Controlling
Inflorescence Meristem Determinacy
and Branching in Tomato
In previous work, we identified two inflorescence
branching genes called COMPOUND INFLORES-
CENCE (S) and ANANTHA (AN). S produces normal
fertile flowers as well as branching patterns that resemble
wild species, suggesting that branching complexity in
the Solanaceae family might be based on S, or the path-
way in which it resides. S encodes a homeodomain tran-
scription factor related to Arabidopsis WUSCHEL
HOMEOBOX 9 (WOX9) that, interestingly, has no ef-
fect on branching in inflorescences that grow continu-
ously (indeterminate “monopodial” shoots). In contrast,
our genetic and molecular analyses have revealed that
the transient sequential expression of S followed by AN
promotes branch termination and flower formation in
sympodial plants. Thus, these two genes are major reg-
ulators of the transition and reiteration of SIMs, such
that when either gene is mutated, there is a delay in flo-
ral termination that allows for additional branches to
develop. S is the key gene responsible for branching vari-
ation in domesticated tomatoes, as we have found that
all highly branched varieties carry mutations in S, with
most based on a classical mutant allele first described
150 years ago. Furthermore, our recent quantitative trait
locus (QTL) genetic analyses on weak branching vari-
eties of tomato show that at least one responsible gene
resides on chromosome 2 in close proximity to S. We
are now expanding genetic and molecular studies to ex-
plore whether S is responsible, at least in part, for the
single inflorescence branching events (bifurcations) that
are characteristic of several wild tomato species, such as
Styrax peruvianum.
A Comparative Morphological Study of
Solanaceae Inflorescence Development
K. Liberatore, S.-J. Park
How inflorescences develop and branch is only begin-
ning to be studied in diverse species, and there is little
known about how meristems elaborate in sympodial
plants. To establish a morphological foundation for how
sympodial inflorescence complexity arises, we are carry-
ing out a comprehensive, comparative morphological
study involving carefully selected Solanaceae representing
a developmental continuum of inflorescence complexity.
By combining scanning electron microscopy (SEM), in
situ hybridization, and transgenic candidate gene knock-
down experiments, we are deciphering the “rules” of SIM
branching. In particular, we have compared s with wild
tomato species and other Solanaceae to establish a devel-
opmental baseline on which to draw conclusions about
how SIMs are initiated, reiterated, and branch. By
screening more than 120 Solanaceae, we have selected a
subset of species that represent a range of architecture
types, including Nicotiana benthamiana, Capsicum an-
nuum (pepper), and Petunia nyctaginiflora (petunia) (sin-
gle-flower inflorescences), Styrax cleistogamum and
Sicotiana prinophyllum (two flowers per inflorescence),
S. conglobatum and S. americanum (tomato-like inflores-
cence), and S. peruvianum and Nicotiana tobaccum
(branched, many flowers per inflorescence). We have al-
ready studied in detail the ontogeny of N. benthamiana
Figure 1. Determinate sympodial growth and floral reiteration in
tomato. (A) A typical tomato plant and SEM image of meristems
corresponding to the inflorescence and the vegetative shoot. (B)
Schematic of modular sympodial shoot (SYM) growth and reiter-
ation. (C–E) Sequential SEM images (C–D) and mature inflores-
cence (E) highlighting sympodial inflorescence meristem (SIM)
reiteration.
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and S. peruvianum, which has revealed that primary tran-
sitions are faster and slower, respectively, compared to
tomato. We have also developed an interest in assessing
if there is any relationship between the level of branching
and species-specific phyllotactic patterning. To address
these questions, we are developing a series of marker
genes fused to fluorescence proteins to generate reporter
lines for studying sympodial transitions in four dimen-
sions (time and space) using confocal and two-photon
microscopy.
A Comparative Molecular Study
of Inflorescence Development
K. Liberatore [in collaboration with X. Wu, University of
Southern California] 
As mentioned above, it is unclear to what extent repro-
ductive transitions are similar or different in plants such
as the monopodial Arabidopsis and the sympodial
tomato. We are determining if branching genes such as
S in tomato are functionally conserved across diverse
species by using a series of transgenic knockdown tools
(e.g., artificial microRNAs) to determine if WOX9 has
an unforeseen role in inflorescence development in Ara-
bidopsis. Curiously, mutations in Arabidopsis WOX9
have been characterized, but phenotypic defects seem
to be restricted to the early stages of embryonic pattern-
ing. This early embryonic defect and resulting seedling
lethality has prevented a more detailed analysis of later
stages of development. By selectively targeting the elim-
ination of WOX9 transcripts, we hope to determine if
and when WOX9 functions to regulate inflorescence
meristem elaboration. Our first set of experiments sug-
gest targeting WOX9 using RNA interference (RNAi)
constructs driven by a floral-specific promoter causes
the Arabidopsis floral meristem to branch in a way that
is reminiscent of s mutations in tomato.
The Molecular Dynamics Underlying
Sympodial Meristem Transitions in
Tomato and Related Solanaceae
S.-J. Park, K. Jiang [in collaboration with M. Schatz, 
Cold Spring Harbor Laboratory]
We are taking advantage of the three types of meristems
of tomato (primary shoot, SIM, and SYM) to elucidate
the dynamic changes in gene expression that take place
during reproductive transitions in plants, with a focus on
determinate sympodial growth. Tomato meristems, like
other Solanaceae, are extremely large and easily dissected
and collected in sufficient amounts for RNA extraction.
Using a simple acetone fixation protocol we have devel-
oped this past year, we are growing uniform batches of
wild-type plants and precisely harvesting meristems hav-
ing no more than two leaf primordia every 3 days until
floral termination. After the transition, we collect SYM,
SIM, and FM (floral meristem) tissue. To date, we have
completed gene expression analyses on seven stages of
sympodial growth using quantitative deep mRNA se-
quencing (Illumina mRNA-Seq), and we have achieved
excellent temporal resolution to reveal that reproductive
transitions are highly quantitative and dynamic (Fig. 2).
Furthermore, each meristem stage has its own molecular
identity and age. We have been able to quantify meristem
state using several algorithms, which predict that the
SYM shares identity with the late vegetative meristem
(LVM) stage from the primary shoot. This suggests that
upon inception, SYMs are preprogrammed as if young
leaves have already been initiated. These data provide an
early clue to explain how sympodial shoots reiterate if
they somehow sense the termination rate of the primary
shoot, perhaps through changes in apical dominance,
which then causes LVM genes to turn on early and strong
in each initiating SYM. Interestingly, SIMs have dual
identities, overlapping with the transition meristem
(TM) and FM. The SYM and SIM also express their
Figure 2. Six representative clusters of tomato gene expression
dynamics showing gradual (A–C) and transient, stage-specific
peaks (D–F) as sympodial meristems undergo termination. Data
were grouped into 25 clusters (see text for details) and up to five
representative genes are plotted out of the total in each cluster
(indicated at top) (A). Early vegetative meristem (EVM) genes, (B)
late vegetative meristem (LVM) genes, (C) reproductive (TM, SIM,
FM) genes, (D) TM genes, (E) SIM genes, (F) SYM genes.
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own stage-enriched genes, indicating that each meristem
has unique identity. We are now performing quantitative
transcriptomics on several Solanaceae species from a
morphological allelic series to decipher the differential
dynamics that determine whether a SIM exists, to what
extent it reiterates, and whether it branches. To study dif-
ferences in sympodial programs, our project requires that
quantitative transcriptomics be performed on nonmodel
Solanaceae to compare sympodial reproductive transi-
tions. We have verified that other species’ meristems can
be harvested at similar temporal resolutions and, most
important, that reference transcriptomes can be estab-
lished to enable robust species-specific quantification by
using N. benthamiana, a single-flowered species repre-
senting the most distantly related Solanaceae within our
chosen species set. Our findings have thus far indicated
that de novo transcriptome assembly and quantification
in nonmodel Solanaceae are achievable and will prove
powerful for comparing expression dynamics among di-
verse sympodial programs. These data are also providing
a first list of candidate genes for functional studies using
reverse genetic tools.
Novel Inflorescence Branching Mutants
C. MacAlister 
To increase our knowledge of the genes and networks reg-
ulating sympodial inflorescence patterning, we are inves-
tigating new mutants with inflorescence architecture
defects. In particular, we are characterizing and cloning
the gene responsible for a new tomato mutant called fasci-
ated inflorescence (fin), which produces a highly branched
inflorescence with greatly enlarged flowers and fruits with
increased organs (Fig. 3). The phenotypes of fin mutants
suggest some genes have dual roles in regulating determi-
nacy, affecting both the inflorescence and floral meri-
stems. In contrast, s and an seem to be specific to the
inflorescence meristem. Indeed, our analysis of fin:s dou-
ble mutants indicates that these genes operate in separate
genetic pathways. We have cloned the FIN gene by unit-
ing map-based cloning with mRNA-Seq and found that
FIN encodes a protein of unknown function, lacking any
known protein motifs. Mutants of fin are reminiscent of
clavata mutants in Arabidopsis, except that fin produces
an enlarged meristem early in the vegetative phase of de-
velopment and continues to enlarge as the primary repro-
ductive transition ensues. This results in an oblong
enlarged meristem that produces leaves ectopically, alters
phyllotaxy, and initiates several additional sympodial
shoots (SYMs). In addition to standard molecular analy-
sis, we are now studying an allelic series of fin mutants in
more detail by (1) performing mRNA-Seq on fin meri-
stems before and after the reproductive transition, (2)
studying double-mutant combinations with other tomato
inflorescence and flowering mutants, and (3) exploring
phenotypic consequences of mutations in the orthologous
genes of Arabidopsis, which is facilitated by fin being a
member of a small gene family all the way down to moss.
We are also studying a classical mutation called ter-
minating flower (tmf ), which uniquely causes an early
termination of the primary inflorescence meristem to
generate a single terminal flower that fails to produce
SIMs and SYMs. Interestingly, all axillary meristems
develop normally, generating typical SIMs and SYMs.
By taking advantage of our recent efforts to sequence
the most closely related wild species of tomato, S.
pimpinellifolium, we have map-based cloned the defec-
tive gene in tmf and found that it encodes yet another
protein of unknown function. Our finding of several
new genes controlling tomato inflorescence architecture
highlights that novel mechanisms regulate determinate
sympodial growth.
Identification and Characterization
of Single-Gene Mutations Causing
Heterosis in Tomato
K. Jiang [in collaboration with D. Zamir, Hebrew
University, Israel]
The genetic and molecular bases for how hybrid prog-
eny outperform their parents (heterosis) have not been
resolved. On the basis of classical studies in noncrop
Figure 3.New tomato mutant (fasciated inflorescence) produces
greatly enlarged flowers and fruits.
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plants and recent findings in yeast, we have tested the
hypothesis that single-gene mutations cause phenotypic
overdominance in the heterozygous state through a re-
duction in gene dosage. By taking advantage of a large
“mutant library” in an isogenic cultivated tomato back-
ground (Solanum lycopersicum, cv. M82), we have iden-
tified multiple genes that show heterosis through
overdominance. We have discovered that SINGLE
FLOWER TRUSS (SFT ), which is the genetic originator
of the flowering hormone florigen that drives the repro-
ductive transition in all plants, increases yield up to 60%
when loss-of-function alleles are heterozygous. Yield
overdominance from sft heterozygosity translates to sev-
eral distinct genetic backgrounds and environments, and
we show that several traits integrate pleiotropically to
drive heterosis in a multiplicative manner. Our results
suggest that a simple reduction in the dosage of a single
gene can cause dramatic transgressive variation. These
findings provide the first example of a single overdomi-
nant gene for yield, and they suggest that screening for
mutations with heterozygous effects on growth can im-
prove productivity in other agricultural organisms. On
the basis of these findings, we have extended our studies
to screen for other mutants that show heterosis in the
heterozygous state. In collaboration with Dani Zamir in
Israel, we have found that heterozygosity for the com-
pound inflorescence mutant increases yield by causing
20%–40% of inflorescences to branch once (bifurcate),
without any pleiotropic effects on growth. Importantly,
we have found that heterosis from s/+ heterozygotes is
heritable through meiosis and acts additively with other
heterotic mutants, thereby opening the door for pyra-
miding heterosis genes to increase flower and fruit pro-
duction even further. A fundamental question on
single-gene heterosis is how subtle changes in gene
dosage affect the transcriptional networks that drive
phenotypic heterosis. Because of the greatly reduced ge-
nomic complexity of single-gene heterosis, we have
begun performing targeted and global quantitative gene
expression analyses to link heterotic effects with tran-
scriptional changes in developmental pathways and
larger transcriptional networks. To our surprise, we have
found that the florigen-encoding SFT, which is believed
to be expressed only in leaves [4, 5], is transcribed specif-
ically in the TM and SIM meristem stages and overlaps
with transcription of its antagonist SP. One intriguing
possibility we will explore is whether local transcription
and a changing balance of SFT and SP in transitioning
meristems from sft/+ heterozygotes is the basis for this
form of heterosis. 
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Plants and fission yeast provide excellent model organ-
isms to address the question of how epigenetic informa-
tion is propagated to daughter cells, including transposon
regulation, heterochromatic silencing, and gene imprint-
ing, important both for plant breeding and for human
health. We are investigating the inheritance of hetero-
chromatic silencing and the role of RNA interference
(RNAi) in the fission yeast Schizosaccharomyces pombe and
the plant Arabidopsis thaliana, as well as continuing our
work on Zea mays. In the past year, we have found that
RNAi is important in determining germ cell fate as well
as in transposon activation, whereas in fission yeast, trans-
posable elements (TE) control DNA replication via the
highly conserved centromere-binding protein B (CENP-
B), which contributes to their epigenetic regulation. 
This year, we welcomed postdocs Yannick Jacob and
Jie Ren, computational biologist Evan Ernst, graduate
student Stephane Castel, and research technician Chantal
LeBlanc. We said farewell to Rulan Shen, who retired
after more than 15 years in the plant group. Danielle
Irvine accepted a faculty position at the Murdoch Chil-
dren’s Research Institute in Melbourne, Australia. Matt
Vaughn left for a position at the Texas Advanced Com-
puting Center at the University of Texas in Austin, and
Klavs Hansen returned to Copenhagen. Filipe Borges was
a visiting student from the Gulbenkian institute (Lisbon,
Portugal), Sophie Thomain visited from École Normale
Supèrieure, and Benoit Arcangioli joined the laboratory
for 6 months on sabbatical from Institut Pasteur (Paris).
CENP-B Preserves Genome Integrity
at Replication Forks Paused by the
Retrotransposon LTR
M. Zaratiegui, M. Vaughn, D. Irvine [in collaboration 
with J. Bahler, University College London; 
B. Arcangioli, Institut Pasteur]
CENP-B is a widely conserved DNA-binding factor as-
sociated with heterochromatin and centromeric satellite
repeats. In fission yeast, CENP-B homologs have been
shown to silence long terminal repeat (LTR) retrotrans-
posons by recruiting histone deacetylases. However,
CENP-B factors also have unexplained roles in DNA
replication. We have shown that a molecular function
of CENP-B is to promote replication fork progression
through the LTR. Mutants have increased genomic in-
stability caused by replication fork blockage that de-
pends on the DNA-binding factor switch-activating
protein 1 (Sap1), which is directly recruited by the
LTR. The loss of Sap1-dependent barrier activity allows
the unhindered progression of the replication fork, but
this results in rearrangements deleterious to the retro-
transposon. We conclude that retrotransposons influ-
ence replication polarity through recruitment of Sap1
and transposition near replication fork blocks, whereas
CENP-B counteracts this activity and promotes fork
stability. Our results may account for the role of LTR
in fragile sites and for the association of CENP-B with
pericentromeric heterochromatin and tandem satellite
repeats in mammalian genomes including humans. 
RNAi Promotes Heterochromatic Histone
Modification through Replication-Coupled
Transcriptional Silencing
M. Zaratiegui, J. Ren, A.-Y. Chang, D. Irvine, S. Castel 
[in collaboration with F. Antequera, University of 
Salamanca, Spain; W.Z. Cande, University of California,
Berkeley; B. Arcangioli, Institut Pasteur]
Heterochromatin comprises tightly compacted repetitive
regions of eukaryotic chromosomes. It is inherited
through mitosis and has roles in transcriptional silencing
and genome integrity. In fission yeast, the epigenetic in-
heritance of heterochromatin requires RNAi to guide his-
tone modification, which occurs during the DNA repli-
cation phase of the cell cycle. The alternating arrangement
of origins of replication and small RNA clusters in fission
yeast centromeres provokes the collision of the transcrip-
EPIGENETIC INHERITANCE AND REPROGRAMMING IN PLANTS
AND FISSION YEAST
R. Martienssen B. Arcangioli K. Creasey D. Irvine J. Ren M. Tanurdžic’
F. Borges E. Ernst Y. Jacob A. Schorn S. Thomain
J. Calarco P. Finigan C. LeBlanc R. Shen F. van Ex
S. Castel J.-J. Han U. Ramu J. Simorowski M. Vaughn
A.-Y. Chang K. Hansen M. Regulski C. Tang M. Zaratiegui
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tion and replication machineries. We propose that RNAi
promotes release of RNA polymerase (pol II), allowing
completion of centromeric DNA replication by the lead-
ing-strand DNA polymerase, which recruits histone-
modifying enzymes and spreads heterochromatin. In the
absence of RNAi, stalled forks are repaired by homolo-
gous recombination without histone modification. Our
results may explain the participation of noncoding tran-
scription and DNA replication in many systems of het-
erochromatin inheritance.
Comparative and Functional Analysis
of Fission Yeast Genomes Reveals
Conserved Regulation of Transposons
by RNAi and CENP-B
K. Hansen, M. Zaratiegui [in collaboration with N. Rhind,
University of Massachusetts]
Genome and small RNA sequencing from relatives of the
fission yeast S. pombe has revealed a near extinction of
transposons and the innovation of transposon-free cen-
tromeres in S. pombe. Small RNA corresponding to
Gypsy class LTR retrotransposons were found in S. japon-
icus, but not in S. pombe, which correlates with the pres-
ence of LTR transposons in pericentromeric regions,
where they presumably fulfill the same function as peri-
centromeric repeats in S. pombe. The S. japonicus genome
lacks CENP-B proteins, suggesting that RNAi may have
supplanted some of its functions, including transposon
control and replication fork restart. Recent studies have
found Dicer to be associated with LTR in S. pombe, even
in the absence of abundant small interfering (siRNA), in-
dicating a conserved function for transposon RNAi.
Role of RNAi in Epigenetic Inheritance
and Plant Evolution
F. van Ex, K. Creasey, C. Tang [in collaboration with W.R. 
McCombie, Cold Spring Harbor Laboratory; R. deSalle,
American Museum of Natural History; G. Coruzzi, New
York University; D. Stevenson, New York Botanical Garden]
Using expressed sequence tag (EST) and genome se-
quence analysis, we identified proteins that have poten-
tial significance in the evolution of seed plants based
on the direction of partitioned branch and hidden sup-
port on a 16-species tree, constructed from 2557 con-
catenated orthologous genes. In addition to basic
metabolic functions, such as photosynthesis or hor-
mones, genes involved in posttranscriptional regulation
by small RNAs were significantly overrepresented in
key nodes of the phylogeny of seed plants. For example,
Argonaute1 and the RNA-dependent RNA polymerase 6
were found to be overrepresented in the angiosperm
clade. We are exploring the functional basis of differ-
ences in the mutant phenotypes in rice (a monocot) and
Arabidopsis (a dicot), as well as the potentially epigenetic
consequences for floral development and germ cell fate.
Figure 1. CENP-B and switch-activating protein 1 have opposite
effects on retrotransposon Tf2 stability. (A) Ectopic recombination
fluctuation assay. Strains with a reporter ura4+ gene inserted in
the Tf2-6 retrotransposon were plated onto 5-fluoro-orotic acid
media that selects for ura4 loss. Two potential mechanisms of
ura4 loss from the marked Tf2-6::ura4 are indicated: gene con-
version and eviction by LTR recombination. Columns represent
total ura4 loss frequency in wild-type, ∆abp1, ∆cbh1,
∆abp1sap1-c, and ∆cbh1sap1-c mutants, and shading indicates
distribution of mode of ectopic recombination events in the ura4
colonies obtained from wild-type (n = 93), ∆abp1 (n = 88), ∆cbh1
(n = 94), ∆abp1sap1-c (n = 91), and ∆cbh1sap1-c (n = 89) mu-
tants. (B) Model for the interactions among Abp1, Cbh1, Sap1,
and the replication fork at the LTR. In the triple mutant, replica-
tion of LTR retrotransposons in both directions results in gene
conversion and eviction.
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Arabidopsis thaliana Chromosome 4
Replicates in Two Phases That Correlate
with Chromatin State
M. Tanurdžic’, M. Vaughn [in collaboration with 
L. Hanley-Bowdoin, B. Thompson, North 
Carolina State University]
We used flow cytometry and tiling microarrays to pro-
file DNA replication of Arabidopsis chromosome 4
(chr4) during early, mid, and late S phase. Replication
profiles for early and mid S phase were similar and en-
compassed the majority of the euchromatin. Late S
phase exhibited a distinctly different profile that in-
cludes the remaining euchromatin and essentially all of
the heterochromatin. Termination zones were consis-
tent between experiments, allowing us to define 163
putative replicons on chromosome 4 that clustered into
larger domains of predominately early or late replica-
tion. Early-replicating sequences, especially the initia-
tion zones of early replicons, displayed a pattern of
epigenetic modifications specifying an open chromatin
conformation. Late replicons, and the termination
zones of early replicons, showed an opposite pattern.
Histone H3 acetylated on lysine 56 (H3K56ac) was en-
riched in early replicons, as well as the initiation zones
of both early and late replicons. Replicon organization
in Arabidopsis is strongly influenced by epigenetic mod-
ifications to histones and DNA. 
Control of Female Gamete Formation
by a Small RNA Pathway in Arabidopsis
F. van Ex, K. Creasey [in collaboration with J.-P. Vielle-
Calzada, Langebio, CINVESTAV, Mexico]
In the ovules of most sexual flowering plants, female ga-
metogenesis is initiated from a single surviving gametic
cell, the functional megaspore, formed after meiosis of
the somatically derived megaspore mother cell (MMC).
The Arabidopsis protein ARGONAUTE 9 (AGO9)
controls female gamete formation by restricting the
specification of gametophyte precursors in a dosage-de-
pendent, non-cell-autonomous manner. Mutations in
AGO9 lead to the differentiation of multiple gametic
cells that are able to initiate gametogenesis. Mutations
in RNA-DEPENDENT RNA POLYMERASE 6 exhibit
a defect identical to that of ago9mutants, indicating that
the movement of small RNA silencing out of somatic
companion cells is necessary for controlling the specifi-
cation of gametic cells. AGO9 preferentially interacts
with 24-nucleotide small RNAs derived from TEs, and
its activity is necessary to silence TEs in female gametes
and their accessory cells. Our results show that AGO9-
dependent small RNA silencing is crucial to specify cell
fate in the Arabidopsis ovule and that epigenetic repro-
gramming in companion cells is necessary for small-
RNA-dependent silencing in plant gametes. 
Small RNA and Epigenetic Reprogramming
in the ArabidopsisMale Germline
Y. Jacob, J. Calarco, C. Tang, C. LeBlanc, F. Borges [in 
collaboration with J. Becker, J. Feijó, Gulbenkian 
Institute, Lisbon, Portugal]
Most of the core proteins involved in the microRNA
(miRNA) pathway in plants have been identified, and
hundreds of miRNA sequences processed in the Ara-
bidopsis sporophyte have been discovered by exploiting
next-generation sequencing technologies. On the basis
of comparative analysis of miRNAs identified in sperm
cells by in-depth sequencing, 25 potentially novel 
miRNAs processed in sperm cells and pollen were iden-
tified, as well as enriched variations in the sequence
length of known miRNAs, which might indicate sub-
functionalization by association with a putative germline-
specific Argonaute complex. ARGONAUTE 5 (AGO5),
by close homology with AGO1 and localizing preferen-
tially to the sperm cell cytoplasm in mature pollen, may
be part of such a complex, as might 21-nucleotide “epi-
genetically activated” siRNAs that accumulate in sperm.
We are examining epigenetic modifications of the ge-
nome during pollen development and how these might
influence the profile of small RNA.
Transposon Instability in Interspecies
Hybrids Is Mediated by RNAi
M. Tanurdžic’, P. Finigan, E. Ernst, M. Vaughn [in 
collaboration with L. Comai, University of California, 
Davis; B.C. Meyers, University of Delaware; R.W. Doerge,
Purdue University]
Silencing of transposable elements ensures genome sta-
bility and lowers the mutagenic effects of transposition.
We have shown that COPIA retrotransposons from the
pollen parent are activated in Arabidopsis interspecific
hybrids, but only when matching 24-nucleotide siRNA
are absent from the seed  parent. Activated elements lose
DNA methylation, and hybrid leaves accumulate 21-nu-
cleotide “epigenetically activated siRNA” (easiRNA)
normally found in pollen, along with RNA and extra-
chromosomal cDNA transposition intermediates. Our
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results indicate that small RNA from the germline pro-
vides a general recognition mechanism for transposons
in interspecific hybrids, reminiscent of hybrid dysgenesis
and hybrid lethality in Drosophila, and may contribute
to postfertilization hybridization barriers in a similar way.
Sequencing the Maize Methylome
M. Regulski [in collaboration with J. Kendall, 
D. McCombie, J. Hicks, D. Ware, Cold Spring 
Harbor Laboratory; S. Tingey, A. Rafalski, 
DuPont/Pioneer Genetic Discovery]
We have sequenced the methylome of B73 and Mo17
inbreds at 28.7- and 19.7-fold coverage, respectively,
using bisulphite conversion and Illumina next-genera-
tion sequencing. In agreement with previous results, we
have found that the vast majority of cytosine methyla-
tion in all three contexts (CG, CXG, and CHH) are
found in intergenic regions and transposable elements,
with exons containing only 5%–10% CG methylation.
CHH methylation is rare and confined mostly to in-
tergenic regions. Exemplars of transposable elements
that differ in DNA methylation have been found, and
variation between Mo17 and B73 was detected in re-
gions of primary sequence similarity. Strategies for de-
termining the inheritance and biological significance of
epigenetic variation are being developed.
The Maize Mutant Tunicate1 Is Caused
by Ectopic Expression of a MADS-Box
Transcription Factor, Zmm19, in a
Dosage-Dependent Manner
J.-J. Han [in collaboration with M. Aukerman, 
DuPont Crop Genetics; D. Jackson, Cold 
Spring Harbor Laboratory]
Pod corn was once regarded as the ancestral form of
cultivated corn and was prized by pre-Columbian peo-
ples for its magical properties. The Tunicate1 (Tu1)
mutant of maize is a naturally occurring dominant mu-
tation, resulting in a striking pod corn phenotype. The
Zmm19 MADS box gene maps close to Tu1 and was
previously sequenced from Tu1 mutants and half-tu-
nicate derivatives (T. Meunster, G. Thiessen, unpubl.).
This analysis revealed that Tu1 has duplicated copies
of Zmm19 interrupted by a novel mutator-like DNA
transposon in the 5′UTR (untranslated region), caus-
ing misexpression, but fine mapping proved impossi-
ble. We have found that yellow fluorescent protein
(YFP)- and red fluorescent protein (RFP)-tagged
Zmm19 transgenic maize plants phenocopy Tu1.
Moreover, misexpression of miR172 is detected in Tu1,
suggesting that Zmm19 may target the miR172 gene,
a conclusion supported by the phenotype of miR172
transgenic lines. The 22-Mb region surrounding the
tu1 locus in inbred B73 was selected for finishing dur-
ing the maize genome sequencing project, and we have
found that insertion of the mutator-like element re-
sulted in a 1.8-Mb inversion immediately upstream of
Zmm19 in Tu1. This rearrangement prohibits recom-
bination, and so likely accompanied the origin of this
ancient mutation. 
Aquatic Plants as Biofuel Feedstocks
E. Ernst, M. Regulski [in collaboration with 
W.R. McCombie, Cold Spring Harbor Laboratory; 
J. Shanklin, Brookhaven National Laboratory; 
V. Citovsky, SUNY Stony Brook]
Aquatic flowering plants, such as common duckweed,
have considerable potential as biofuel feedstocks due to
their very rapid growth and high carbon accumulation
per unit mass. Work is currently under way to assemble
a draft of the 450-Mb Lemna gibba genome. 300 mil-
lion Illumina GAIIx paired-end reads from short insert
and mate pair libraries have contributed to an initial as-
sembly of 300 Mb in contigs over 1 kb, with the largest
reaching 250 kb. In addition, we obtained sequences
from both small RNA and gene transcript libraries,
which have already been used to identify 10 genes cen-
tral to the oil biosynthesis pathway. These two libraries
also enabled cloning native miRNA precursors to im-
plement artificial miRNA gene silencing in Lemna. We
successfully induced flowering in cultured common
duckweed and continue to explore methods for large-
scale seed production. Advances in transformation
made this year by Brookhaven National Laboratory in
conjunction with the progress in sequencing the
genome and transcriptome should lead to the develop-
ment of duckweed strains tailored to the production of
lipid biofuels.
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Specification of adaxial–abaxial (upper/lower) polarity in
the developing leaf drives the flattened outgrowth of the
leaf blade and directs the differentiation of distinct cell
types within the leaf’s adaxial/top and abaxial/bottom do-
mains. Both are important innovations in the evolution
of land plants that maximize photosynthesis while mini-
mizing water loss to the environment. In addition to being
a key developmental process, adaxial–abaxial patterning is
of particular interest from a mechanistic point of view and
has proven to be an excellent model to study small RNA-
mediated gene regulation. We previously showed that pat-
terning of this developmental axis involves a cascade of
opposing small RNAs, in which microRNA (miRNA)
miR390 triggers the biogenesis of the TAS3-derived 21-
nucleotide tasiR-ARF on the adaxial side of developing
leaves. These confine the accumulation of abaxial deter-
minants, including AUXIN RESPONSE FACTOR3
(ARF3) and miR166, to the lower side of leaves. miR166,
in turn, demarcates the abaxial side by repressing expres-
sion of class III homeodomain leucine zipper (HD-ZIPIII)
transcription factors that specify adaxial fate. 
Importantly, our analysis of the TAS3 trans-acting short
interfering RNA (tasiRNA) pathway in Arabidopsis dem-
onstrated that tasiR-ARF functions as a mobile positional
signal in adaxial–abaxial patterning. Movement of this
small RNA from its defined source of biogenesis in the two
uppermost cell layers of leaves creates a gradient of accu-
mulation that dissipates abaxially. The tasiR-ARF gradient
generates a sharply defined expression domain of the abax-
ial determinant ARF3 on the bottom side of leaf primordia,
suggesting that small RNAs can establish pattern through
a morphogen-like activity. This work provided the first di-
rect evidence that small RNAs are mobile and can function
as instructive signals in development, thereby revealing a
novel patterning activity of small RNAs.
Dissecting Small RNA Mobility in Plants
D. Skopelitis
Given the scope of miRNA-regulated gene networks, the
cell-to-cell movement of small RNAs has important im-
plications with respect to their potential to act as instruc-
tive signals in development and in response to physio-
logical and stress stimuli. We are using artificial miRNAs
targeting easy-to-score reporter genes to study parameters
of miRNA movement, such as tissue specificity, direc-
tionality, dose dependence, and the kinetics of move-
ment. Previously generated lines, expressing artificial
miRNAs from the epidermis, against PHYTOENEDE-
SATURASE (PDS) resulted in a range of photobleaching
phenotypes, due to silencing of PDS in the subepidermal
mesophyll layers, consistent with small RNA mobility
from the epidermis into underlying cells. To further in-
vestigate miRNA mobility in multiple distinct develop-
mental contexts, we are expressing miRNAs targeting
cell-autonomous GUS and GFP reporters from a num-
ber of promoters that drive expression in various spa-
tiotemporal patterns. A first analysis showed that
miRNAs expressed from the vascular-specific SUC2 and
ATHB8 promoters lead to miRNA-mediated gene silenc-
ing in the surrounding mesophyll and in the pavement
cells of the epidermis, consistent with the idea that 
miRNAs can traffic from the vasculature into adjacent
cells. Interestingly, no reporter silencing was observed in
the trichomes of the epidermis, which are symplastically
isolated. The tissue specificity of the promoters was ver-
ified using transgenic lines that express the respective
transcriptional fusions to the GUS reporter gene, and the
accumulation of the artificial miRNAs is being moni-
tored by in situ hybridization. Genetic resources to sim-
ilarly investigate properties of tasiRNA mobility are also
being generated. In addition, with the knowledge that
miRNAs and tasiRNAs can traffic from the epidermis
into underlying tissue layers, we are carrying out forward
genetic screens to identify factors influencing this process.
The START Domain Regulates HD-ZIPIII
Activity and Organ Polarity
A. Husbands
On the basis of our previous observations regarding the
expression and function of miR166 and tasiR-ARF, it is
evident that adaxial–abaxial patterning involves a cascade
of positional signals. The mobile signals that pattern the
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newly formed leaf are distinct from those that maintain
polarity during subsequent development. We have re-
cently started a new project to identify additional signals
in adaxial–abaxial patterning. Defining the identity of
mobile positional signals remains not only a pressing
question in the field of organ polarity, but also one of the
main challenges in contemporary plant development.
The adaxial-promoting HD-ZIPIII transcription fac-
tors contain a predicted START lipid-binding domain
(Fig. 1A). Modeling of the START domain of the HD-
ZIPIII member PHABULOSA (PHB) suggests structural
similarity to human PC-TP, a phosphatidylcholine-bind-
ing START domain (Fig. 1B,C). This model and se-
quence conservation with other START domains was
used to predict amino acids in PHB critical for START
domain ligand binding. To assess the role of the START
domain to PHB function, we generated transgenic Ara-
bidopsis lines that express START domain variants of a
PHB–YFP fusion protein. These PHB-YFP reporters also
carry silent mutations in the miR166-target site, which
normally leads to the formation of severely adaxialized
leaves (Fig. 1D–G). Expression of a PHB-YFP variant, in
which residues lining the ligand-binding pocket in the
START domain are mutated (Fig. 1C), yielded plants
with less-severe leaf phenotypes, whereas lines expressing
a PHB-YFP variant with a deletion of the START domain
resemble wild-type plants. These findings reveal positive
regulation of HD-ZIPIII activity by an unknown ligand.
Experiments to determine the mechanism via which
the START domain controls HD-ZIPIII function are
ongoing. Ligand binding does not appear to affect the
subcellular localization of these transcription factors, as
confocal imaging showed that the PHB-YFP derivatives
correctly localize to the nucleus. We are currently inves-
tigating whether ligand binding affects PHB’s ability to
bind DNA, activate transcription, or interact with re-
quired protein partners. We have also developed a yeast-
based assay that allows the high-throughput screening
of chemical libraries for compounds that are bound by
the HD-ZIPIII START domain and modulate protein
activity. Compounds identified in this screen may not
only provide critical insight into the nature of the HD-
ZIPIII ligand, but also identify agonists/antagonists of
the START domain that enable innovative experimen-
tation into the mechanism via which HD-ZIPIII pro-
teins regulate diverse aspects of plant development,
including stem cell activity and organ polarity. 
Characterization of Novel tasiRNA
Loci in Maize
M. Dotto [in collaboration with M. Aukerman, M. Beatty, 
R. Meeley, DuPont-Pioneer]
tasiRNAs are processed from noncoding TAS precursor
transcripts. Following cleavage by a miRNA-loaded
Figure 1. Activity of the HD-ZIPIII transcription factors is regulated by the START lipid-binding domain. (A)
Schematic representation of the domain structure of HD-ZIPIII proteins. (HD) Homeodomain, (LZ) leucine zipper,
(START) START lipid-binding domain, (MEHKLA) MEKHLA/PAS transcription regulatory domain. (B) Representation
of the structure of the human PC-TP START domain modeled in SwissExpasy. (C) Predicted fold of the PHB START
domain modeled in SwissExpasy. Amino acids mutated in the PHB-YFP derivative are highlighted in black (arrows).
(D) Distribution of phenotypes observed in plants transformed with various PHB derivatives that either remain
under control of miR166 (left) or carry mutations that render the transcripts resistant to miR166 (right). (PHB) Full-
length PHB protein; (PHB*) PHB derivative with critical amino acids in the START ligand-binding pocket mutated;
(PHB-∆) PHB derivative with the START domain deleted; (N) number of transformants analyzed. (E–G) Phenotypes
in the transformants were grouped into three categories: (E) severely adaxialized, indicated in black, (F) weakly
adaxilized, indicated in light gray, (G) largely normal, indicated in dark gray. Mutation or deletion of the START
domain suppresses the ability of miR166-resistant PHB to adaxialize developing leaves.
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ARGONAUTE (AGO) complex, one of the cleavage
products is converted into double-stranded RNA
through the activities of RNA-DEPENDENT RNA
POLYMERASE6 (RDR6) and LEAF BLADELESS1
(LBL1/SGS3) and subsequently processed by DICER-
LIKE4 (DCL4) into phased 21-nucleotide siRNAs.
Arabidopsis contains four characterized TAS gene fam-
ilies. AGO1 is required for the biogenesis of tasiRNAs
from the TAS1, TAS2, and TAS4 loci, whereas
miR390-loaded AGO7 triggers the biogenesis of TAS3
tasiRNAs. We previously identified four TAS3 loci in
the maize genome; however, the TAS1, TAS2, and
TAS4 loci are not conserved between Arabidopsis and
maize. To identify potential novel TAS loci in maize,
we used a deep-sequencing approach to compare the
small RNA content between wild-type and lbl1 mutant
apices. This identified four novel TAS candidates, all of
which are targeted by miR390 and generate tasiRNAs
closely related to the known tasiR-ARFs. We are cur-
rently using bioinformatics approaches to identify ad-
ditional phased small RNA clusters in an attempt to
determine whether these TAS3 loci are the only phased
siRNA generating loci in the maize genome.
In a separate approach, we are characterizing small
RNAs that associate with specific AGO proteins. The
maize genome encodes 20 AGO proteins, including one
AGO7 and four AGO1 homologs. We are generating
transgenic maize plants expressing FLAG-tagged versions
of ZmAGO7 and ZmAGO1b to isolate associated small
RNAs via immunoprecipitation. We expect to identify
novel tasiRNAs, miRNAs, and possibly the transcripts
that are targets of these small RNAs. For additional infor-
mation regarding the small RNA pathways in maize, we
are also characterizing small RNAs that associate with
ZmAGO10. This AGO protein has been implicated in
the miRNA- and tasiRNA-mediated regulation of meris-
tem maintenance and leaf development in Arabidopsis.
Phylogenetic analysis showed that the maize genome con-
tains two close homologs of AtAGO10. Transposon in-
sertion alleles for both genes have been identified, and we
are currently assessing possible contributions of the
ZmAGO10 homologs to meristem function and leaf de-
velopment in maize. We analyzed the small RNAs associ-
ated with ZmAGO10 by deep sequencing the small
RNAs present in immunoprecipitates with a ZmAGO10-
specific peptide antibody. We found that ZmAGO10 pro-
teins preferentially bind 21-nucleotide small RNAs
containing a 5′-U, which are features common to nearly
all plant miRNAs. However, the immunoprecipitation
fraction was enriched for just a subset of known miRNAs
and tasiRNAs, and these include miR166 and tasiR-ARF,
which we had previously shown to function in the speci-
fication of maize leaf polarity. A previously uncharacter-
ized miRNA was most enriched in the immuno-
precipitation fraction. In situ hybridization showed that
this miRNA also accumulates in a polar pattern, estab-
lishing a gradient on the adaxial side of developing leaves,
presenting the possibility that organ polarity is also regu-
lated by a fourth small RNA signal. Screens for mutations
affecting this miRNA and its targets are ongoing. 
Small RNA-Regulated Gene Networks
in Adaxial–Abaxial Patterning
K. Petsch
Mutants that disrupt tasiRNA biogenesis exhibit defects
in leaf polarity, which are characterized by sectors of abaxial
identity on the adaxial leaf surface and/or by radialization
of the leaves. In maize, the severity of these phenotypes is
largely dependent on the inbred background, with specific
inbreds, e.g., A619, Mo17, and W22, typically enhancing
the defects of tasiRNA biogenesis mutants, whereas other
backgrounds, e.g., B73, lead to a weaker phenotype. This
inherent diversity across different maize inbreds provides
a useful tool to discover novel enhancers/suppressors of
small RNA biogenesis or function, as well as inbred-spe-
cific targets of the tasiRNA pathway. We are using the se-
vere lbl1-rgd1mutant allele of lbl1 to identify such genetic
modifiers. The lbl1-rgd1 is embryo-lethal in W22, but it
develops into a viable seedling in B73. Genetic analysis in-
dicates the presence of at least one major modifier locus
on chromosome 8 that is dominant in the W22 back-
ground. Currently, we are using mapping populations to
fine map this inbred-specific enhancer/suppressor. In ad-
dition, we are performing a transcriptomics analysis of
lbl1-rgd1mutant embryos and nonmutant siblings in the
W22 and B73 backgrounds. Similar experiments are also
in progress to characterize genetic modifiers of dcl4 mu-
tants. By combining these approaches, we hope to achieve
a better resolution of the factors contributing to natural
variation in the tasiRNA pathway.
Adaxial–Abaxial Patterning
by the AS1-AS2 Complex
A. Husbands, A. Benkovics
Our findings indicate that establishment of organ polar-
ity requires the precise spatiotemporal accumulation and
relative efficacy of tasiR-ARF and miR166. We are using
genetic and biochemical approaches to identify genes
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that regulate the accumulation and activities of these po-
larizing small RNAs. We have previously shown that the
Arabidopsis DNA-binding proteins ASYMMETRIC
LEAVES1 (AS1) and AS2 form a complex that con-
tributes to organ polarity. Using chromatin immunopre-
cipitation (ChIP), we have identified several polarity
determinants that are direct targets of the AS1-AS2 com-
plex. These include selected MIR166 precursors as well
as components of the TAS3 tasiRNA pathway. Our ChIP
results have been verified using reporter constructs and
reverse-transcriptase–polymerase chain reaction (RT-
PCR) analysis, and we are currently using ChIP-Seq to
examine AS1-AS2 targets in a genome-wide context. 
The abaxial determinants ARF3 and ARF4 are targets
of the TAS3-derived tasiR-ARFs. We have shown that tran-
script levels for both ARF genes are up-regulated in as2.
Considering that tasiRNA pathway components are direct
targets of AS1-AS2, these transcription factors may control
ARF3 and ARF4 expression through regulation of tasiR-
ARF accumulation. To test the interaction between the
AS1/AS2 and tasiR-ARF pathways, we generated as2 plants
expressing a tasiR-ARF-insensitive allele of ARF3 (ARF3-
D). Interestingly, double mutants develop highly serrated
leaves with ectopic leaf-like outgrowths at the proximal
margins. Removal of ARF3 activity results in complete sup-
pression of leaflet formation, as does the chemical disrup-
tion of polar auxin transport. These and other data led us
to propose that leaflet formation occurs at auxin maxima
in response to ARF3 activity. Confirming this, as2 ARF3-
D plants expressing the PIN1:GFP polar auxin transport
reporter show colocalization of auxin maxima with sites of
incipient leaflet formation and prolonged activity of this
reporter. We are currently examining the putative connec-
tion among the tasiR-ARF pathway, auxin transport, and
the production of compound leaf architecture.
The Ancestral Role of the tasiRNA Pathway
E. Plavskin [in collaboration with R. Quatrano,
Washington University, St. Louis, Missouri; M. Hasebe,
National Institute for Basic Biology, Okazaki, Japan]
The diversity of multicellular organisms raises the question
of how so many varied morphologies evolved. A number
of studies have demonstrated that novel structures often
arise through the hijacking of existing developmental path-
ways for new functions. The pathways controlling leaf de-
velopment seem to be no exception, as many of these have
been shown to be conserved in the moss Physcomitrella
patens, whose ancestors diverged from the lineage of flow-
ering plants ~100 million years before leaves first evolved
in the latter. Thus, studying the role of leaf polarity path-
ways in moss provides a unique opportunity to explore
the evolution of complex novel structures.
We are focusing on the miR390-dependent tasiRNA
pathway, which regulates expression of the abaxial de-
terminants ARF3 and ARF4.The genes involved in bio-
genesis of tasiRNAs, including SGS3, RDR6, and
DCL4, and the tasiRNA targets are conserved among
maize, Arabidopsis, and P. patens. Elucidating the func-
tion of this pathway in Physcomitrella may lead to an
understanding of its ancestral role in plant develop-
ment. To dissect the developmental processes in P.
patens regulated by tasiR-ARFs, we are taking advantage
of the unique ability of this moss to be transformed by
homologous recombination and characterizing knock-
outs of genes involved in tasiRNA biogenesis, as well as
the targets of the moss tasiR-ARFs. Our preliminary re-
sults indicate a role for tasiRNA regulation in filamen-
tous stem cell division in moss. sgs3 loss-of-function
mutants display increased branching in the filamentous
stage of growth, and mutants of some tasiRNA targets
are lethal, potentially reflecting a defect in the ability
of filamentous stem cells to divide. These results are fur-
ther supported by a transcriptional reporter of miR390
in moss, which shows expression in dividing cells. Be-
cause the miR390-dependent tasiRNA pathway is also
involved in meristem maintenance, our preliminary re-
sults suggest a conserved role for the pathway in plant
stem cell function. We are continuing to explore the
function of miR390-dependent tasiRNA biogenesis in
moss through the generation of additional knockouts
and expression reporters. We have also begun exploring
the function of a miRNA regulatory site in tasiRNA
targets, which presents the unique opportunity to study
the coregulation of a gene by a tasiRNA and miRNA.
Establishment of Determinacy during
Organ Development
M. Lohda, C. Clendaniel
Plants have the distinctive ability to form new organs
throughout their lifetime, which can span hundreds or
even thousands of years. The growing tip of a plant con-
tains a population of stem cells that are located within
a specialized niche, termed the shoot apical meristem
(SAM). These stem cells divide to maintain the SAM
and to generate daughter cells from which lateral or-
gans, such as leaves and flowers, arise. Our project in
the lab aims to dissect the genetic networks that regu-
late stem cell homeostasis and that distinguish indeter-
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minate stem cells from their differentiating derivatives.
Stem cell activity in the SAM is maintained in part by
the class I KNOX homeobox genes. To give rise to differ-
entiating structures, such as leaves, KNOX gene expression
needs to be maintained in a stable “off” state throughout
lateral organ development. We have previously shown
that this process is mediated by the transcription factors
AS1 and AS2, which form heterodimers that bind specific
sites in the KNOX promoters and recruit the chromatin-
remodeling factor HIRA to these loci in developing
leaves. We have now identified a role for a Polycomb re-
pressive complex 2 (PRC2) in the stable silencing of
KNOX genes during leaf development. PRC2 complexes
have histone H3K27 trimethylation (H3K27me3) activ-
ity, and we have identified this repressive mark on nucle-
osomes at the BP and KNAT2 loci in leaves of Arabidopsis.
Mutations in the PRC2 component CURLY LEAF
(CLF) lead to reduced levels of this repressive H3K27me3
chromatin mark at the KNOX loci and to ectopic expres-
sion of KNOX genes in developing leaves. Likewise,
H3K27me3 levels at the KNOX loci are dramatically re-
duced in the as1 and as2mutants, identifying these DNA-
binding proteins as upstream components in the KNOX
silencing pathway and possible recruitment factors for the
PRC2 complex. We have used biomolecular fluorescence
complementation (BiFC) assays to study possible direct
interactions between AS1 or AS2 and the PRC2 subunits.
This assay revealed that AS1 but not AS2 interacts with
two of the PRC2 subunits. Similar assays also revealed a
direct interaction between HIRA and PRC2 components.
To complement these BiFC assays, we are performing im-
munoprecipitation assays using an epitope-tagged version
of the PRC2 component FIE, which will test an interac-
tion among PRC2, AS1, and the chromatin-remodeling
factor HIRA in vivo. In addition, tagged FIE is being used
in chromatin immunoprecipitation assays to show direct
binding of PRC2 at BP and KNAT2. In the future, these
same FIE-HA lines will be used to study genome-wide
targets of PRC2 by ChIP-Seq. 
We have also established a role for the polycomb re-
pressive complex 1 (PRC1) in the stable silencing of
KNOX genes during leaf development. PRC1 is a down-
stream component in the polycomb pathway that main-
tains long-term silencing. In plants, this complex contains
LIKE HETEROCHROMATIN PROTEIN1 (LHP1),
which recognizes the H3K27me3 signature deposited by
PRC2. We found that LHP1 directly binds silenced
KNOX loci, and as expected, this binding is partially lost
in an as2mutant. These data demonstrate that cellular dif-
ferentiation is achieved via an epigenetic mechanism in
which the AS1-AS2 complex serves to recruit Polycomb
group proteins to pluripotency factors to suppress their ex-
pression during organ differentiation.
Small RNA-Regulated Gene
Networks in SAM Function
M. Javelle
A number of key regulatory genes involved in meristem
indeterminacy and organ initiation are under the con-
trol of miRNAs. To gain insight into small RNA-con-
trolled gene networks required for SAM function and
organogenesis, we are characterizing the precise expres-
sion patterns of selected mature miRNAs by in situ hy-
bridization. Six miRNAs (miR394, miR528, miR160,
miR167, miR164, and miR319) have been analyzed
thus far. Each miRNA shows a distinct expression pat-
tern, suggesting diverse contributions of small RNAs
and the pathways they target to the regulation of SAM
function. The observed expression patterns suggest that
nearly all six miRNAs have functions associated with
leaf initiation and leaf development. Two of these small
RNAs show a polar pattern of expression in developing
leaves, presenting the possibility that maintenance of
organ polarity is regulated by additional mobile small
RNA signals. In addition, we used laser microdissection
to collect cells from distinct functional domains within
the SAM and developing leaf primordia of maize to an-
alyze the expression profiles of the small RNA precur-
sors and downstream targets. Cells from 12 distinct
regions of the shoot apex—including the epidermal and
subepidermal layers of the SAM, the stem-cell-contain-
ing tip of the SAM and determinate leaf primordia P0
to P3, the abaxial and adaxial sides of young leaf pri-
mordia, and tissues in the vasculature and stem—were
collected separately. The quality of RNA isolated from
these tissue samples has been verified using known
marker genes. A first expression analysis of miRNA pre-
cursor genes revealed that complex regulatory mecha-
nisms underlie the generation of the distinct miRNA
expression patterns. These RNA samples will also be
analyzed by deep sequencing to compare the global
gene expression profiles of these distinct cell popula-
tions in the SAM and developing leaf primordia.
Characterization of chups, an Embryonic
Patterning Mutant in Arabidopsis 
C. Fernandez-Marco
Embryogenesis in Arabidopsis proceeds through a series
of highly stereotyped divisions and gives rise to a struc-
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ture that contains two stem cell niches—the shoot api-
cal meristem and the root apical meristem—which are
the sources of all cells for postembryonic development.
An asymmetric division of the zygote gives rise to the
apical embryonic lineage and the basal extra-embryonic
suspensor. After several more rounds of cell division,
the upper tier of the embryo generates the shoot apical
meristem, whereas the upper cell of the suspensor un-
dergoes two successive asymmetric divisions to give rise
to the root apical meristem. We have identified a mu-
tant that delays embryonic development. At the time
that wild-type embryos have reached maturity, mutant
embryos show globular or heart stage morphologies.
We have called this mutant chupa chups (chups), which
means lollipop in Spanish, as a reminder of the globular
shape of mutant embryos. Despite the delay in embryo-
genesis, patterning of the shoot apical meristem is un-
affected in chups mutants. In contrast, cell division of
the hypophysis, the specialized cell of the suspensor that
ultimately gives rise to the quiescent center of the root
stem cell niche, is perturbed in chups. Auxin transport
and signaling are key to the specification of the hypoph-
ysis and patterning of the root stem cell niche. Prelim-
inary data show that expression of markers for auxin
transport and signaling are altered in chups and that an
auxin maxima is no longer established at the boundary
between the proembryo and suspensor, which affects
specification of the hypophysal cell. Although chups
mutant embryos are not normally viable, mutants can
be rescued by transferring fertilized ovules onto culture
medium. Consistent with the above-mentioned defects,
rescued mutant seedlings lack a root. chups maps to the
top arm of chromosome IV. We are currently determin-
ing the underlying mutation. The outcome of these ex-
periments will allow us to characterize and position
CHUPA CHUPS in the genetic network that patterns
the root stem cell niche during embryogenesis.
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The genomics program is composed of faculty working across disciplines and research areas. Their
main research interests are genomic organization, structural variation of the human genome as re-
lated to disease, computational genomics and transcriptional modeling, and sequencing technology.
The genomics faculty is located at both the main campus and the Woodbury Genome Center, which
is located a few miles from the main campus. Faculty in the genomics program conduct research in
the areas of human genetics, functional genomics, small RNA biology, and bioinformatics.
Thomas Gingeras and colleagues study where and how functional information is stored in
genomes. These efforts help us to explain the biological and clinical effects of disease-causing gene
mutations in humans and other organisms. Gingeras is a leader of the ENCODE (ENCyclopedia
of DNA Elements) and modENCODE (model genome ENCODE) projects of the National Insti-
tutes of Health. His research has revealed that almost the entire lengths of genomes in organisms
ranging from bacteria to humans can be transcribed into RNA and that most RNA products are
not destined to be translated into proteins. In fact, noncoding RNAs (ncRNAs) are proving to be
involved in a variety of other important biological functions. Some have been shown to be critical
components in the pre- and posttranscriptional and translational processes. Others serve as scaffolds
upon which large protein complexes are assembled. This year, Gingeras and colleagues published
18 papers detailing results of the modENCODE project to date. With these, the annotated portions
of the Drosophila and Caenorhabditis elegans genomes have now grown severalfold, bringing func-
tional regulatory networks into view in unprecedented detail.
The insights of W. Richard McCombie and colleagues have led to the introduction and optimiza-
tion of novel methods of high-throughput genome sequencing. His team has made it possible to cat-
alog variation among individual organisms in a way that would have been unthinkable a decade ago.
They have brought online a new generation of Solexa sequencers and optimized their function to a
level at which 10 billion DNA bases can be sequenced in a typical day, and on some days, as many
as 20 billion. McCombie’s team has been involved in international efforts culminating in genome
sequences for maize and rice, two of the world’s most important food crops. They have also had an
important role in projects to sequence the flowering plant Arabidopsis thaliana, the fission yeast
Schizosaccharomyces pombe, and Homo sapiens. In 2010, they contributed to the sequencing of Theo-
broma cacao, the tree variety whose seeds are used to make the world’s finest chocolate. McCombie’s
group is currently involved in other important projects to sequence genes of special interest to human
health, including DISC1, a strong candidate gene for schizophrenia, as well as genomic regions likely
implicated in bipolar illness. In collaboration with the Memorial Sloan-Kettering Cancer Center, the
group is using a method called hybrid resequencing, developed with Greg Hannon, to look at mu-
tations in samples collected from patients with prostate cancer.
Lincoln Stein’s lab is developing databases, data analysis tools, and user interfaces to organize,
manage, and visualize the vast body of information generated by biologists. They run the modEN-
CODE (model genome ENCODE) Data Coordination Center, which is responsible for collecting,
integrating, and publishing the information collected by the ENCODE (ENCyclopedia of DNA
Elements) consortium in a form that can be extended and combined with information from other
human and model organism genome databases, and they contributed to two major modENCODE-
papers published in Science in December 2010. The group also develops algorithms for identifying
key actors in cancer genomes as well as software for identifying aberrant splicing and expression of
genes in cancers. Stein’s group manages and curates the WormBase and Reactome databases and is
involved in the iPlant Collaborative, an effort to better enable plant biology researchers to collaborate
in cyberspace.
Using multidisciplinary approaches that combine computational analysis, modeling, and pre-
diction with experimental verification, Doreen Ware’s lab seeks a deeper understanding of the evo-
GENOMICS
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lution of genome sequences in plants and their implications for agricultural improvement. By look-
ing comparatively across the genomes of plants in the same lineage, they seek answers to the follow-
ing questions: How are genes conserved and lost over time? What are the fates of duplicated genes?
Ware’s team also studies gene regulation in plants, looking at cis-regulatory elements and character-
izing transcription factors and miRNA genes and their respective targets, with the objective of un-
derstanding how these parts of the plant genome work together in determining spatial and temporal
expression of genes. The lab had an important role in the 4-year project to produce a reference
genome of maize, providing annotations for the genome and helping to generate a draft haplotype
map, a gauge of maize’s genetic diversity. They have devoted special attention to examining diversity
within maize and grape, aiming to accelerate the development of strategies to introduce new
germplasm needed to meet demands of an increasing population and a changing environment. This
year, Ware was part of a team that uncovered a surprising degree of genetic diversity in the domes-
ticated grape plant. The lab also has brought fully sequenced genomes into an integrated data frame-
work to enhance the power of their comparative studies. This framework now includes 13 genomes
of model plants such as Arabidopsis and important agricultural species including maize, rice,
sorghum, grape, and poplar. 
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ENCODE Project
K. Bell, S. Chakrabortty, C. Davis, A. Dobin, J. Drenkow, 
M. Fastuca, S. Jha, W. Lin, K. Persaud, F. Schlesinger, 
L.-H. See, H. Wang, C. Xue, C. Zalenski
Overall goals. The goals of the ENCODE Transcrip-
tome Group are to generate a comprehensive collection
of maps detailing the sites of RNA transcription and to
characterize the diverse collection of RNAs produced
at these loci providing transcriptional start sites (TSS),
transcriptional termination sites (TTS), RNA splices
sites, chemical modifications of RNAs at 5′ends, and
the possible product–precursor relationships between
mapped long and short RNA transcripts. The Tran-
scriptome Group consists of members from Cold
Spring Harbor Laboratory (Hannon), the University of
Lausanne (Reymond), the University of Geneva (An-
tonarakis), RIKEN (Hayashizaki-Carninci), GIS
(Ruan-Wei), and Guigo (CRG).
Type of mapped elements. ere are nine diﬀerent
classes of RNA elements and two copy-number varia-
tion maps for the tier-one cell lines that have been
mapped as part of this project. ese elements and the
cell lines/subcellular compartments that were mapped
are presented in Table 1.
Summary of maps generated for 2010. A total of 226
data sets obtained from 113 samples have been submitted
to the ENCODE data coordination center (DCC) at the
University of California (Santa Cruz) this year. All sam-
ples were done in duplicate, and the RNAs described in
Table 1 were isolated from whole-cell, nucleus, or cytoso-
lic compartments. For two cell lines studied, the chro-
matin, nucleolus, and nucleoplasm subcompartments
were also analyzed. A detailed dashboard created by our
collaborators at CRG in Barcelona of this current year’s
summary and the summary for the last 3.5 years can be
found at http://genome.crg.es/~jlagarde/encode_ RNA_
dashboard/demo_9.html or at the main ENCODE web
site at http://encodewiki.ucsc.edu/EncodeDCC/index.
php/Transcriptome_project_%28Gingeras%29.
ModENCODE Project
C. Davis, A. Dobin, D. Fagegaltier, S. Jha, C. Xue
Two studies have been successfully completed this year.
The first involves the analysis of the transcriptional out-
put of long RNAs from 25 cell lines identified by the
modENCODE consortium as being the common set
of control cell lines for the project. Drosophila
melanogaster cell lines have become valuable resources
for developmental geneticists and cell biologists, and
their use continues to grow. The analyses are detailed
in Cherbas et al. (2010). The results of this analysis in-
dicated that unannotated transcription is substantial
(19% of total euchromatic signal in a typical line).
Conservatively, we have identified 1405 novel tran-
scribed regions (contigs); 684 of these appear to be
novel exons of neighboring, often distant, genes. Of the
14,807 annotated genes probed, 64% were expressed
at a detectable level in at least one cell line, but only
21% of genes were detected in all 25 lines. Each cell
line, on average, expressed 5885 genes including a core
set of 3109 genes expressed in all of the lines. Gene ex-
pression levels vary over several orders of magnitude.
Major known signaling pathways are well represented
TRANSCRIPTOMES: VIEW OF GENOME ORGANIZATION
AND REGULATION AND FUNCTIONAL ROLES
OF NONCODING RNAS
T.R. Gingeras P. Batut J. Drenkow I. Lassa L.-H. See
K. Bell D. Fagegaltier W. Lin H. Wang
S. Chakrabortty M. Fastuca K. Persaud C. Xue
C. Davis S. Jha F. Schlesinger C. Zalenski
A. Dobin
Table 1. Data Types Analyzed in All Samples  
RNA types Total A+ A–
Long (>200 nt) X  X  X 
Short (<200 nt) X
CAGE X  X  X
PET Ditag X  X
DNA PET
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in the lines and all lines appear to be sensitive to insulin,
hedgehog, and BMP (bone morphogenetic protein) sig-
nals. Despite variations among lines, most differentia-
tion pathways are “off” and survival and growth
pathways are “on.” About 50% of the genes expressed
by each line are not part of the core set and these show
remarkable individuality; 31% are expressed at a higher
level in at least one cell line than in any single develop-
mental stage, suggesting that each line is an enriched
version of cells that are a small part of the whole organ-
ism. This is most strikingly illustrated by the imaginal
disc-derived lines where most of the lines can be as-
signed on the basis of known spatial expression patterns
to small regions within the developing imaginal disc.
These mappings show remarkable and unexpected sta-
bility of even fine-grained spatial determination. As an-
other sign of individuality, no two cell lines are identical
in the pattern of transcription factor expression. We
conclude that each line, although derived from a mixed
cell population, has retained distinctive features of an
individual founder cell superimposed on a core “cell
line” gene expression pattern. All of the data and ex-
pression scores for genes and exons are available from
the DCC of modENCODE (http://modencode.org)
and also from the websites of the Drosophila Genomic
Resources Center (https://dgrc.cgb.indiana.edu/) and
FlyBase (http://flybase.org/).
The second study involves the transcriptional analy-
ses of 30 developmental time points during the matu-
ration of the D. melanogaster embryo to 4-week-old
adult (Gravely et al. 2010). These data were combined
with analyses of the regulatory elements found in the
fly genome and was included as one part of an overall
integration manuscript (The modENCODE Consor-
tium 2010). All data cited in this manuscript is avail-
able on http://www.modencode.org/.
Role of Antisense RNA as a Global
Regulation of Gene Expression
A. Dobin, D. Fagegaltier, I. Lassa
Antisense transcripts are RNA molecules that map in
an overlapping fashion to the complementary strand of
sense strand transcripts. Their function in regulating
gene expression is recognized but is considered to be re-
stricted to a limited number of genes in an organism.
In a genome-wide transcriptional analysis of Staphylo-
coccus aureus, the use of antisense transcription was ob-
served to enable the processing of sense transcripts by
means of creating double-stranded substrates for RNase
III endoribonuclease (I. Lassa et al., in prep.). Removal
of RNase III activity uncovers a large but discrete col-
lection of antisense transcripts hidden from detection,
as well as allowing for increased levels of the correspon-
ding sense transcripts. These results explain why detec-
tion of pervasive antisense transcription has escaped
previous detection and provide a mechanism to define
the minimum levels of sense RNA expression. Such a
mechanism appears to be a common feature of all
Gram-positive organisms tested thus far.
Novel Exon Detection by Hierarchical 
Clustering and Spike-In Controls for
RNA-Seq
F. Schlesinger, C. Davis
Within the ENCODE consortium, our lab has gener-
ated a collection of more than 120 strand-specific, deeply
sequenced RNA-Seq data sets from poly(A)+ and
poly(A)– RNAs from different compartments of several
cell lines, including technical and biological replicates
and spike-in standards (see ENCODE project described
above). These data were tested for incorrect strand as-
signments of sequencing reads, overamplification, strong
sequence biases, mapping problems, and other issues that
could affect downstream analysis with the help of exter-
nal RNA standards (see Spike-In section below). The ini-
tial detection of novel expressed elements using both
simple coverage analysis and read clustering, considering
split-read information about splice sites, was carried out
using the element detection algorithm developed for this
purpose. The reproducibility of these elements was tested
using the irreproducible discovery rate (IDR) analysis
(http://www.encodestatistics.org/publications/IDR101.
pdf), a novel statistical framework for rank-order corre-
lations of significance values between replicates. In this
way, the robustness of algorithm being developed is mea-
sured relative to the input noise. This analysis showed a
large number of significant, reproducible unannotated
expressed elements including many that are antisense and
intronic to known transcripts.
Clustering software. A software package for RNA fea-
ture detection by read clustering has been developed and
implemented. Functional genomic features are detected
as clusters of reads from sequencing experiments above
local background. They are found by recursively parti-
tioning the genome into blocks of different signals using
maximum-likelihood splits, Bayesian model comparison,
and a negative binomial error model. This error model
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accounts for overdispersion of reads relative to Poisson
sampling. This overdispersion can be shown and quanti-
fied relative to the known structure and abundance of the
external RNA spike-in standards present in our data sets.
Using this correct error model is important to prevent
detection of spurious significant signal enrichment within
features, such as exons and false differences between data
sets. In some functional genomics experiments, only the
number of reads in a given region is relevant.
In those cases, the complex read-mapping informa-
tion can be reduced to a cumulative sparse vector of
read counts (“signal”) along the genome for very fast
computation of the signal in any genomic region. How-
ever, for the shotgun RNA-Seq, the read alignments
themselves contain information, most notably on splic-
ing of transcripts and the exact end of exons. For this
purpose, the program was extended to consider reads
individually, only counting those falling fully within a
given region and considering split-mapping informa-
tion about splice sites when choosing endpoints of clus-
ters. The tool is multithreaded to exploit the easy
parallelism of the recursive clustering problem. All this
allows handling and analysis of very large data sets (e.g.,
>200 million reads of paired-end 76-bp RNA-Seq data)
in a relatively short time (depending on the parameters
used for analysis) with reasonable memory require-
ments. In addition to extensive manual inspection on
the genome browser, reproducibility analysis suggests
that the derived significance values for novel clusters are
a meaningful measure of confidence and that the cluster
locations and boundaries are consistent between repli-
cates in the presence of biological noise. Further evalu-
ation of the tool will be possible using the results from
ENCODE validation RACE (rapid amplification of
cDNA ends) experiments of novel intergenic and anti-
sense transcripts currently being performed.
Spike-in controls.Through collaboration with a group
at the National Institute of Standards and Technology
(NIST), we obtained a pool of 96 reference RNAs with
diverse sequence properties and spanning a six order of
magnitude range of concentration. Adding them as
“spike-in controls” to RNA-Seq libraries primarily allows
us to derive a standard curve and convert read counts into
absolute RNA concentrations in the studied sample. In
this way, robust comparisons between different samples
in the absence of internal controls are possible. Addition-
ally, the spike-ins were used to assess the random error
and biases of our RNA-Seq protocols to help with reliable
downstream analysis, especially the detection of novel fea-
tures. Fitting different regression models between read
counts of each spike-in in different replicate libraries
showed the presence of significant overdispersion of noise
compared to pure sampling noise. The same can be ob-
served when analyzing variance in the read distribution
along each reference RNA. This could be fit by a negative
binomial distribution which serves as a robust null model
when searching for new features within a sample or for
differential expression between samples. They also allowed
us to study the sequence-dependent biases in read counts,
both within a transcript (where we see strong effects of
random hexamer reverse transcription priming) and be-
tween transcripts (where overall GC content has the
strongest influence). These effects are quite strong and can
be included in models analyzing RNA-Seq data. External
RNAs make this analysis easier and more robust as they
do not suffer from biological variance, alternative iso-
forms, incomplete annotation, and similar issues. Espe-
cially their use in deriving standard curve and error
estimates for quantification depending on transcript
abundance and sequence features is of general interest (X.
Deng et al., in prep.).
Transposons and Evolution of
Transcriptional Regulation in
the Drosophila Clade 
P. Batut
Transposable elements (TEs) have long been proposed
to have a role in the evolution of gene regulation and
have in some particular instances been shown to indeed
do so. The overall aim of this project is to study the ex-
tent to which transposons have contributed to the evo-
lution of transcriptional regulation in the Drosophila
group and to characterize some of the mechanisms
through which they may have achieved this. Specifi-
cally, the role of TE in reshaping the temporal aspects
of gene expression throughout embryonic development
is an important area to explore. Two mechanisms are
being explored through which they may do so: namely,
either the contribution of new transcriptional start sites
(TSSs) and proximal promoters to existing genes or the
addition of new regulatory sequences that affect the ac-
tivity of existing promoters. A combination of tools
comprising experimental and computational genomics
is being used to undertake a comparative study of the
developmental regulation of transcription by trans-
posons in several species of drosophilids.
Evidence for transposon-derived transcriptional
promoters. The massive transcriptome data produced
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for D. melanogaster by the modENCODE Consortium
(The ModENCODE Project Consortium 2010) con-
stitute a rich and structured data set that can be very in-
formative within the scope of this project. These data
are being exploited to search for genes whose TSSs lie
within transposable elements. The CAGE (cap analysis
of gene expression) data set produced from mixed-stage
embryos has been searched for TSSs (as defined by
CAGE tag clusters) embedded within transposons. This
entailed the development of a peak-calling algorithm tai-
lored and optimized for this task. The modENCODE
RNA-Seq developmental time course data will now be
mined for evidence supporting the existence of tran-
scripts linking such TSSs to annotated genes. Compar-
ative genomics approaches are currently being harnessed
to investigate the evolutionary conservation of TSS gene
pairs.
Development and optimization of an algorithm
for the detection of CAGE tag clusters. Although peak
calling is a very common task in genomics, the very
unique features of the CAGE data and of the questions
we have set out to answer make current algorithms un-
suitable for our situation. Thus, an algorithmic ap-
proach has been developed that takes into account the
particular features of the data (short reads, background
signal overdispersion) and of the genomic regions of
interest (high repetitiveness) to improve both speci-
ficity and sensitivity in the detection of CAGE peaks.
This is achieved principally by accounting for missing
data at genomic sites where no read can be uniquely
mapped. This approach has led to the identification of
23,384 CAGE peaks across the genome, of which 942
fully overlap UCSC Repeat Masker transposon anno-
tations; 700 of these would not have been identifiable
without correcting for the mappability of individual
genomic positions. After further filtering using multi-
ply-mapping CAGE tags, 687 regions are retained as
high-confidence transposon-contained CAGE peaks.
Evidence for transcripts connecting. As a prelimi-
nary screen before undertaking this phase, the TE con-
tained TSSs whose genomic position indicates that they
may be alternative promoters for annotated transcripts.
We have identified 123 such TSSs that lie between the
middle point of a Flybase transcript annotation and 15
kb upstream of its 5′ end. The existence of transcripts
connecting these TSS gene pairs is now being tested.
Protocol for paired-end Illumina sequencing of 5′-
complete cDNAs. It is crucial for the generation of our
developmental transcriptome data to make use of an
RNA-Seq protocol that both allows for TSS identifica-
tion and optimizes throughput. An adaptation of
CAGE for paired-end sequencing would be ideal for
this purpose. Much progress has been made in devel-
oping and sequencing paired-end CAGE libraries, op-
timizing insert size and yield, and minimizing PCR
(polymerase chain reaction) amplification. We are now
in the process of investigating high-background issues
in order to match the high degree of specificity achieved
by the Carninci laboratory (RIKEN Institute, Japan),
which developed the original protocol. The portion of
the protocol that has to be corrected is fortunately iden-
tical to this original one, but this troubleshooting will
clearly require some more work.
Validation of transposon gene transcript topology
by gene-targeted RACE or RT-PCR. A list of candi-
date transposon-gene pairs has been made using the
analysis of the modENCODE data. Reverse transcrip-
tase (RT)-PCRs are being performed to investigate the
existence of transcripts linking those genes to their pu-
tative transposon-contained TSSs. We are also planning
on investigating the evolutionary conservation of func-
tional transposon gene pairs by performing similar RT-
PCR experiments for the same genes in other strains of
D. melanogaster, or for their orthologs in other Dro-
sophila species.
RNA-Mediated Intercellular Signaling
S. Chakrabortty
Proper functioning of a multicellular organism requires
an intricate and sophisticated system of intercellular
communication that ensures proper coordination
among different cell and tissue types and synchroniza-
tion between different cells of the same type. Traditional
and well-established modes of intercellular communi-
cation include cell–cell contact and cell–ECM (extra-
cellular matrix) contact by gap junctions, secreted
signaling molecules and physical interaction of mem-
brane proteins. 
Recently, the role of exosomes as communication
through intercellular transference of RNA has come into
focus. Exosomes as intercellular carriers of RNA and pro-
teins have been appreciated and investigated. Exosomes
are small 30–100-nm vesicles of endocytic origin that
are secreted to the extracellular milieu on fusion of mul-
tivesicular bodies (MVB) to the plasma membrane.
Under electron microscopy, exosomes have a character-
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istic cup-shaped morphology and have a sucrose density
of 1.13–1.19 g/ml. Because of their endocytic origin, ex-
osomes often contain proteins involved in membrane
transport and fusion, MVB biogenesis, integrins,
tetraspanins, and heat shock proteins. They are also en-
riched in raft lipids such as cholesterol, sphingolipids,
and glycerophospholipids. Upon secretion, exosomes
may bind to recipient cells through receptor–ligand in-
teractions, attach and fuse with the target cell mem-
brane, or be internalized through endocytosis. So far,
exosomes have been found to be present in almost all bi-
ological fluids and secreted in culture by almost all cells
investigated. Exosomes from dendritic cells and B cells
have been shown to have potent immunostimulatory
and antitumor effects in vivo and have been used in an-
titumor vaccines, whereas those from breast cancer and
platelets promote angiogenesis and tumor progression. 
Exosomes are an attractive vehicle of RNA transfer
because they provide a protected environment thereby
ensuring their stability from extracellular RNAs. Exo-
somes have been shown to carry intact and functional
mRNA to neighboring or distant cells that can be trans-
lated into proteins upon uptake. microRNA transferred
by exosomes can bind and repress its targets in the re-
cipients. Some of the RNA packaged in exosomes are
present severalfold higher than the secreting cell, sug-
gesting some kind of sorting mechanism to collect and
package specific RNA in the exosomes. Thus, exosome-
mediated transport of RNAs may represent an impor-
tant mode of communication that allows cells to have
coordinated intercellular regulation of gene expression. 
Isolated exosomal profile. Exosomes are cup or
round-shaped membrane-bound vesicles with a floata-
tion density of 1.13–1.19 g/ml. The isolation of these
vesicles from cell-free culture media entails three rounds
of differential centrifugation. Vesicles are treated with
RNase and DNase prior to lysis of the vesicles to eval-
uate the contents (Fig. 1).
Validation of enrichment of exosomes. Several pro-
teins have been previously identified as part of the
inner-membrane component of virtually all exosomes.
Tumor susceptibility gene 101 (TSG101) and fibrillarin
are two multivesicle body markers that were used to
evaluate the enrichment of these isolated exosomes via
northern analysis. The results of these analyses showed
a 100–1000-fold enrichment. Nucleic acids extracted
from the isolated exosomes are sensitive to RNase but
insensitive to DNase. RNase-treated exosomes (prior to
lysis and nucleic acid extraction) provide both long
(>200 nucleotides) and short (<200 nucleotides) RNAs
similar in amount and length to the RNAs isolated di-
rectly from exosomes. Both long and short RNAs are
being characterized by deep sequencing.
The next stages of this project will include the es-
tablishment of primary rat primary neuronal and gan-
glia cell lines in which each cell type is isolated from a
genetically distinguishable strain. The presence of exo-
somes and the RNA complement present in these exo-
somes will be analyzed.
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Figure 1. Electron micrographs of isolated exosomes from K562
cell culture medium.
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Investigating Genome Variation:
Infrastructure Development and
Quality Assurance 
The Genome Center continued to expand resources for
large-scale genomic studies in 2010, in terms of both
next-generation sequencing and analysis capabilities
and usage by the wider CSHL community. We contin-
ued to focus on training and development of standard
operating procedures to ensure that quality remained
high during this expansion (see Fig. 1).
Four new Illumina HiSeq 2000 instruments were in-
troduced to the Genome Center that increased capacity
by fourfold over the Illumina Genome Analyzer IIx
(GAIIx) instruments that we replaced. In addition, we
upgraded the Illumina software and incorporated an
improved enzyme in the reagent kits that allowed for
reduced run times. 
We also became a beta test site for the new PacBio
RS technology that allows for amplification-free single-
molecule sequencing. We are focusing on increasing
yield and accuracy on this platform, but we have al-
ready achieved long read lengths that should comple-
ment our shorter Illumina reads.
To address the increased demand for secondary
analysis, several postdocs joined the bioinformatics
staff, and new alignment and variant detection pipelines
were investigated. We will continue to update and aug-
ment the informatics workflow in order to provide
comprehensive and efficient analyses.
We began working with the Wigler lab on the devel-
opment of a new LIM system to provide more detailed
sample reports, automated status updates, and quality
metrics. These improvements will enhance users’ ability
to monitor and modify the large and diverse projects
that are possible with next-generation sequencing. 
We have begun the testing of cloud computing and
are working with resources such as Galaxy, which pro-
vide a simplified web interface to help ease the burden
on local servers, as well as to accommodate users who
require assistance with bioinformatic components of
their data analysis. Streamlining the analysis pipeline
and the tools available to the community will remain
an important goal in 2011. This will be done in collab-
oration with the Bioinformatics Shared Resource of the
CSHL Cancer Center (Molly Hammell, Director).
Investigation of Bipolar Disorder
Genetics Using Exome Capture
and Resequencing
is work was done in collaboration with J. Potash, R.
Karchin, and A. Chakravarty (Johns Hopkins School
of Medicine) and I. Iossifov (Cold Spring Harbor Lab-
oratory).
Bipolar disorder I (BP) is a major mental illness with
a significant genetic component, as demonstrated by
family, twin, and adoption studies (Smoller and Finn,
Am J Med Genet C Semin Med Genet 123C: 48 [2003]).
Molecular investigation into the genetics of BP has in-
cluded linkage analyses and, more recently, several large
genome-wide association studies (GWAS) (Wendland
DEVELOPMENT OF NEXT-GENERATION SEQUENCING
TECHNOLOGY
W.R. McCombie     M. Bell I. Grabill        D. Lewis           M. Ossipov
                                L. Cardone A. Ji               S. Mavruk         J. Parla
                                G. Cheang A. Karim        S. McCarthy     R. Solomon
                                E. Ghiban M. Kramer     P. Mocombe     J.C. Yao
                                M. Gierszewska S. Lata           S. Muller          
Figure 1. Comparison of total bases generated versus total high-
quality bases for monthly Illumina runs from December 2009
through December 2010. We use Q30 bases as a metric to en-
sure very high data quality.
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and McMahon 2010). Although GWAS has yielded a
small number of genome-wide significant results, the
“missing heritability” problem suggests that the major-
ity of variants contributing to BP are rare variants.
Other approaches are therefore necessary to uncover
these rare BP susceptibility variants. We are applying
exome capture and resequencing toward finding rare
genetic variants that contribute to BP. 
Our work in 2010 involved the exome capture and
resequencing of 186 samples, which included a pilot-
family-based study, and BP probands and unrelated con-
trols. Each sample was prepared for capture and se-
quencing using Illumina-compatible sequencing adapters
with or without bar codes, individually captured, and se-
quenced on one lane of an Illumina GAIIx instrument
programmed for PE 76 cycle sequencing. Sequence data
quality, genome alignment, and exome capture statistics
were computed to determine the efficiency of the capture
and sequencing using an analysis pipeline developed by
Ivan Iossifov. Samples that required more raw sequence
data to obtain improved exome coverage were included
in a second round of sequencing and pooled during se-
quencing when possible (with barcode multiplexing).
On average, 36.5 million pass-filter sequence read
pairs (5.5 billion bases) were produced per captured sam-
ple, with 99.7% of bases attributed to library DNA
(rather than sequencing adapter), 93.5% of read pairs
properly mapped with unique chromosome start and end
coordinates, 57.5% of properly mapped read pairs
mapped to exome probe sequences, and 31.3% of the
total input pass-filter sequence data mapped to the exome
target. The raw sequence data that we produced provided
81.6% of the exome covered at greater than 20x depth,
13,694 coding single-nucleotide polymorphisms (SNPs),
7545 synonymous SNPs, and 6149 nonsynonymous
SNPs per sample, on average (Table 1). On the basis of
our current exome data, we have identified 275 genes
with possibly damaging, nonsynonymous SNPs found in
cases but not in controls. There also appears to be an en-
richment of nonsynonymous SNPs in BP GWAS-iden-
tified genes in cases compared to controls.
Further work for this project will include implement-
ing a custom exome capture design that provides higher
coverage of genes that encode postsynaptic proteins; this
will allow us to additionally investigate the neurological
basis of BP, exome captures with at least ~650 additional
cases and ~350 additional controls, and more in-depth
analyses of SNPs identified in this project.
Family-Based Analysis of Bipolar
Disorder by Whole-Genome
Resequencing
is work was done in collaboration with D. Black-
wood, K. Evans, and D. Porteous (University of Edin-
burgh).
We are studying a large Scottish pedigree where
many family members have bipolar disorder or recur-
rent major depressive disorder. A genetic study of this
family by our collaborators at the University of Edin-
burgh suggested that a 20-Mb haplotype on chromo-
some 4 has significant linkage to bipolar disorder (Le
Hellard et al., Biol Psychiatry 61: 797 [2007]).
We decided to use next-generation sequencing (Illu-
mina GAIIx) to resequence the entire genome of indi-
viduals from this family, focusing analysis on the 20-Mb
critical region on chromosome 4. We hope to discover
rare variants associated with bipolar disorder susceptibil-
ity. Three affected (two with BD, one with MDD) and
two unaffected married-in individuals from this family
were selected for whole-genome sequencing using paired-
end 101- and 125-cycle runs. We achieved 58x–36x cov-
erage on each individual. Reads from all flow cells for
each individual sample were then aligned to UCSC hg8.
We processed the mapping and SNP calling by using the
Burrows–Wheeler alignment (BWA) and sequence align-
ment map (SAM) tools (Li et al., Bioinformatics 25: 2078
[2009]) pipeline. Potential polymerase chain reaction
(PCR) duplicates were removed, and error-prone variant
calls were then filtered out by using a minimum consen-
sus quality score of 20 and a minimum read depth of
Table 1. Overview of Human Exome Coverage and SNP Calling Results for the 186 Case and Control
Samples Captured and Resequenced in 2010 
                          % Exome target                Total no.            No. synonymous       No. nonsynonymous
                          covered at ≥20x            coding SNPs                  SNPs                              SNPs
Min                           65.43                        11,677 6,399                            5278
Max                          92.56                        18,493 10,100                            8393
Mean                        81.60                        13,694 8,545                            6149
Human exome captures were performed individually with SeqCap EZ Exome Library v1.2 (Nimble-
Gen) and sequenced with paired-end 76-base reads on GAIIx sequencing instruments (Illumina).
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10x. See Table 2 for the SNP distribution across all five
individuals. Each individual has ~3.6 million SNP vari-
ants compared to the reference human genome sequence. 
Quality control of the sequence data was carried out
by comparison of each individual’s sequence with pre-
viously determined genotype (Illumina IVb whole-
genome SNP panel) or exon-based capillary sequence
data (for chromosome 4). For affected individuals 1 and
2, the average concordance for each chromosome be-
tween genotype data and Illumina sequence data was
94% and 93%, respectively. For affected individuals 3
and 1 and unaffected individual 2, the concordance be-
tween the exon-based capillary sequence data and Illu-
mina sequence data for chromosome 4 was 100%,
97%, and 96%, respectively.
We focused our analysis on the 20-Mb disease-
linked haplotype (see Table 3 for summary statistics).
A total of 292 SNPs were shared by all three affected
individuals but were not present in the married-in fam-
ily members, dbSNP (build 130), or the 1000
Genomes Project (build release date: March 2010).
Table 3 summarizes the data for all SNPs detected on
chromosome 4 with at least 10-fold coverage in any one
individual. The number in parentheses refers to the num-
ber of SNPs that lie outside repeat regions, as defined by
using the RepeatMasker track (default settings) from the
UCSC Genome Browser (http://genome.ucsc.edu/).
We are currently extending this study to other fam-
ilies that show linkage to the chromosome-4 20-Mb
haplotype to genetically refine further the possible bipo-
lar-associated variants. The resulting studies will en-
hance our understanding of the molecular mechanisms
of the cause and development of bipolar disorder; fur-
thermore, these studies will lead to novel diagnoses and
treatment of this psychiatric disorder.
Targeted Sequencing of Circulating
Tumor Cells from Patients with
Castration-Resistant Prostate Cancer
is work was done in collaboration with D. Danilla,
C. Sawyer, and H. Scher (Memorial Sloan-Kettering
Cancer Center).
Circulating tumor cells (CTCs) are representative of
the genomic makeup of a tumor and can provide the
molecular snapshot of the disease when treatment is
being considered. Somatic mutations detected in CTCs
isolated from patients with castration-resistant prostate
cancer (CRPC) can serve as predictive markers of tumor
sensitivity to targeted therapies. The goal of this project
is to identify somatic mutations that are present in CTC,
but not in paired white blood cells (WBCs) using next-
generation sequencing.
We initialized optimizing sequencing of 75 cancer-
related genes for a low number of heterogeneous cancer
cells before proceeding to clinical samples. We tested
mixes of DNA from LNCaP with DNA from VCaP
Table 2. Number of SNPs Identified by Whole-Genome Sequencing Across the Five Individuals
Exonic Synonymous Nonsynonymous
Individual Diagnosis SNPs SNPs coding SNPs coding SNPs
Affected individual 1 BD 3,694,870 53,541 11,295 10,827
Affected individual 2 MDD 3,714,782 53,672 11,330 10,863
Affected individual 3 BD 3,619,932 51,836 10,876 10,553
Unaffected individual 1 – 3,573,886 51,635 10,952 10,438
Unaffected individual 2 – 3,594,225 51,155 10,699 10,265
Table lists all SNPs with at least 10x coverage in any one individual.
Table 3. SNP Discovery by Sequence Analysis of Five Family 22 Individuals
SNPs on chromosome 4                                                                                                      Number
Affected individual 1                                                                                              267,358 (127,159)
Affected individual 2                                                                                              271,759 (129,130)
Affected individual 3                                                                                              261,995 (124,580)
Unaffected individual 1                                                                                          270,646 (128,372)
Unaffected individual 2                                                                                          267,699 (127,232)
     Subset shared by all three affected individuals                                                     116,034 (56,626)
          Subset of above not present in unaffected individuals                                      30,110 (14,720)
                Subset of above not present in dbSNP                                                            3,261 (1,363)
                Subset of above not present in 1000 Genomes Project                                 1,676 (590)
                Subset of above that map to 20-Mb linkage region                                    292 (117)
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prostate cancer cells at 20%, 50%, 80%, and 100% to
establish the limit of detection from deep sequencing.
We next tested ratio mixes of 50 cells total for isolation
and wheat germ agglutinin (WGA). With each set of
samples, we performed PCR amplification using a Rain-
Dance microfluidic PCR device to stream an emulsion
of sample DNA into a microfluidic device that merges
that stream with a mix of emulsion droplets containing
large numbers of distinct PCR primer pairs. The result
is that each reaction occurs individually after the streams
merge, because each droplet contains a specific primer
pair and eliminates primer competition. The emulsion
is used as input for PCR and then broken to isolate the
total DNA from the amplification for the gene panel of
interest. Sequencing was performed on an Illumina
GAII using single-end 36- and 76-cycle runs. Our initial
analysis has confirmed the gene panel sequencing cov-
erage (see Fig. 2) and that at least in some cases we can
see amplified region amplification by counting the num-
ber of reads that match to the amplified region com-
pared to other, nonamplified regions of the genome. 
We then performed targeted sequencing on 29 flo-
rescence-activated cell sorted (FACS) CTC and WBC
whole-genome-amplified samples isolated from eight
patients with progressive CRPC. Before sequencing, we
also performed PCR amplification using a RainDance
microfluidic PCR device on each sample. We identified
~10–100 coding single-nucleotide variants (SNVs) in
each CTC sample that were not present in the paired
WBC samples. Figure 3 shows a missense amplified re-
gion mutation that is present in CTC50 but not in
paired WBC20 and WBC10 in a selected patient.
Currently, we are validating selected variants using
Sanger sequencing and also extending the study to ad-
ditional patients enrolled in amplified-region-targeted
clinical trials using exome sequencing. This study may
lead to identification of biomarkers to guide treatment
selection for patients with CRPC. 
Targeted Resequencing of the Human
Disrupted-in-Schizophrenia-1 Gene
Using Long-Range PCR and Illumina
Sequencing
is work was done in collaboration with D. Black-
wood, D. Porteous, P. ompson, and I. Deary (Uni-
versity of Edinburgh) and P. Visscher and A. McRae
(University of Queensland).
Disrupted-In-Schizophrenia-1 (DISC1) is a strong
candidate gene for bipolar disorder, schizophrenia, and
cognitive disorders. A translocation disrupting this novel
gene was first described by our collaborators in Edin-
burgh who showed that it segregated significantly with
psychiatric disorder in a Scottish pedigree. In conjunc-
tion with our collaborators, we initiated a pilot project
to resequence ~523 kb on chromosome 1 containing
DISC1 using long-range PCR. We designed primers to
tile across the 0.5-Mb region and showed that we were
able to cover up to 98% of our amplified target at >30x
coverage with a minimum of 20x needed for accurate
mutation discovery. The planned sequencing of ~523
kb of chromosome 1 in 2088 samples was completed
during 2009; the data were processed, and putative
SNPs were identified using MAQ (Li, Genome Res 18:
1851 [2008]). The sample set consisted of 266 bipolar
disorder, 277 schizophrenia, 271 major depression, and
1274 control individuals (the majority of controls are
Figure 2. Coverage of 75 targeted genes from 50-cell VCaP after WGA. Mean coverage of the amplified AR gene was ~5000x.
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samples from the Lothian Birth Cohort). Validation and
analysis of the resulting large number of novel variants
are now taking place. Due to the very deep coverage, the
analysis parameters for choosing SNPs were a consensus
quality of >90 and a read depth of >30x. Variants were
screened to exclude repeat regions (RepeatMasker),
primer regions, and triallelic regions.
Of the 2088 samples sequenced, 1706 were con-
firmed by comparison either to available GWAS data
or to an SNP typing panel of 12 genotype positions
across the region selected by Allan McRae for valida-
tion.
We identified almost 4100 variants, with 19% map-
ping to known polymorphisms (dbSNP130). Interest-
ingly, ~1% (39/4099) were nonsynonymous changes in
coding and noncoding exons of DISC1, DISC2, or
TSNAX, which are all genes located in this region. Of
these exonic variants, 18% lead to changes in amino
acid composition of the encoded protein and poten-
tially its function (Table 4). 
Since December 2009, we have been validating these
discovered variants using capillary sequencing (ABI
3730). Although our initial validations indicate a high
rate of false positives (~50% of selected exonic SNPs
were confirmed), our false-negative rate is very low
using preexisting genotype data from the majority of
Figure 3. A missense amplified region mutation that is present in CTC50 but not in paired WBC20 and WBC10.
subjects analyzed on alternative technologies. We then
tested the individual PCR amplicon pools and found
that >80% of the pools showed that the nonreference
Table 4. Overview of DISC1 Mutation Screen
DISC1 Summary                                                                          
Total confirmed samples                                                  1706
     No. with >80% coverage                                           1552
     No. of bipolar disorder                                                 221
     No. of schizophrenia                                                    241
     No. of unipolar disorder                                               192
     No. of controls + Lothian Birth Cohort                         898
Total no. of variants                                                         8267
     Total variants after screening                                      4099
          No. of known SNPs (db130)                                    778
No. in exons inc. untranslated regions                               209
     No. in DISC1                                                                125
     No. in DISC2                                                                  72
     No. in TSNAX                                                                12
     No. in coding regions                                                     56
     No. synonomous                                                            17
     No. nonsynonomous                                                      39
Descriptive summary of mutation discovery in DISC1 by rese-
quencing. 1552/1706 (90%) of subjects were sufficiently covered
for reliable sequence variant discovery across 80% or more of the
target region including DISC1, DISC2, and TSNAX. 81% of vari-
ants were previously unknown. Interestingly, 39/209 (~18%) of
all exonic polymorphisms were predicted to be nonsynonymous.
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allele was detected in the amplicons. Thus, it appears
that we introduced a small number of variants into the
process (in the long-range PCR) and then effectively
detected them. As a follow-up validation, 460 random
variants were chosen across the entire region, and ~79%
of those variants were confirmed by ABI capillary se-
quencing. Thus, the rate of validation outside exons ap-
pears to be higher, which seems to correlate with
findings in the community that evolutionary con-
straints on exons make variants in those coding regions
more likely to be errors due to the presence of fewer
real, rare variants. We are continuing with various val-
idation studies to identify the major sources of false
positives, including testing alternative alignment soft-
ware Novoalign (Novocraft), which allows for more
sensitive read alignment. 
To further investigate our variant calls, our collabora-
tors compared our data to 903 variants (from 60
HapMap samples) that were called in the European-only
set of the 1000 Genomes Project (www.1000genomes.
org). Minor allele frequency distribution looked quite
similar (see Fig. 4), although we called more rare variants,
probably due to our greater sequence depth.
We are working on revising our validation plan based
on our ongoing results. We plan to complete final analy-
sis of the data this year and publish our findings. It is
known that DISC1 causes cognitive disorders in the ini-
tial translocation family. This study will finally deter-
mine how frequently other rare mutations in DISC1
contribute to these disorders and give some perspective
on the types of variants that may contribute to disease.
PUBLICATIONS
Wendland JR, McMahon FS. 2010 Behavioral neurobiology of bipolar
disorder and its treatment (ed. HK Manji, CK Zarate Jr.), pp. 19–30.
Springer-Verlag, Dordrecht.
Figure 4. Comparison of minor allele frequency in 903 overlap-
ping variants in the 1000 Genomes (EUR) University of Michigan
MACH call set and the CSH DISC1 variant call set.
Rebecca Solomon
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I moved the bulk of my laboratory to the Ontario In-
stitute for Cancer Research in Toronto, Ontario, in
2009, but I still maintain a small group at CSHL work-
ing on the iPlant Collaborative project.
The iPlant Collaborative is a virtual organization of
faculty, students, postdoctoral fellows, staff, high-perfor-
mance computing experts, and professional software de-
velopers drawn from CSHL, the University of Arizona,
and the Texas Advanced Computer Center.  iPLant is de-
signed to solicit and meet biological grand challenge ques-
tions from the plant science community, and, in close
consultation with this community, create a cyberinfra-
structure that makes it possible to meet these challenges.
In 2009, two self-forming grand challenge teams were
chosen by a community-representative Board of Directors
to work with iPlant personnel to develop “Discovery En-
vironment (DE),” a cyberinfrastructure and user interface
to help with the biological grand challenges.
Our group works on the iPlant Tree of Life (iPToL)
and the Genotype to Phenotype (Gen2Phen) Grand
Challenge Project.  The fundamental aim of the first
project is to assemble a comprehensive phylogenetic tree
of half a million known species of green plants for better
knowledge of evolutionary relationships, which will yield
new insights across the plant sciences.  The second proj-
ect aims to create databases and tools to integrate and
analyze experiments that connect the genotype of plants
to their physical properties, such as agronomically im-
portant traits. Both projects are working toward releasing
web-based discovery environments during 2011.
The list of publications below represent work both at
CSHL and at the Ontario Institute for Cancer Research.
PUBLICATIONS
Cancer Target Discovery and Development Network, Schreiber SL,
Shamji AF, Clemons PA, Hon C, Koehler AN, Munoz B, Palmer M,
Stern AM, Wagner BK, et al. 2010. Towards patient-based cancer
therapeutics. Nat Biotechnol 28: 904–906.
Gerstein MB, Lu ZJ, Van Nostrand EL, Cheng C, Arshinoff BI, Liu T,
Yip KY, Robilotto R, Rechtsteiner A, Ikegami K, et al. 2010. Inte-
grative analysis of the Caenorhabditis elegans genome by the mod-
ENCODE project. Science 330: 1775–1787. 
Harris TW, Antoshechkin I, Bieri T, Blasiar D, Chan J, Chen WJ, De
La Cruz N, Davis P, Duesbury M, Fang R, et al. 2010. WormBase:
A comprehensive resource for nematode research. Nucleic Acids Res
38: (Database issue) D463–467. 
Hurwitz BL, Kudrna D, Yu Y, Sebastian A, Zuccolo A, Jackson SA, Ware
D, Wing RA, Stein L. 2010. Rice structural variation: a comparative
analysis of structural variation between rice and three of its closest
relatives in the genus Oryza. Plant J 63: 990–1003. 
International Cancer Genome Consortium, Hudson TJ, Anderson W,
Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola
I,  et al. 2010. International network of cancer genome projects. Na-
ture 464: 993–998.
Jassal B, Jupe S, Caudy M, Birney E, Stein L, Hermjakob H, D’Eusta-
chio P. 2010. The systematic annotation of the three main GPCR
families in Reactome. Database 10: baq018.
modENCODE Consortium. Roy S, Ernst J, Kharchenko PV, Kherad-
pour P, Negre N, Eaton ML, Landolin JM, Bristow CA, Ma L, Lin
MF, et al. 2010. Identification of functional elements and regula-
tory circuits by Drosophila modENCODE. Science 330: 1787–
1797. 
Nègre N, Brown CD, Shah PK, Kheradpour P, Morrison CA, Henikoff
JG, Feng X, Ahmad K, Russell S, White RA, et al. 2010. A compre-
hensive map of insulator elements for the Drosophila genome. PLoS
Genet 6: e1000814.
Reese MG, Moore B, Batchelor C, Salas F, Cunningham F, Marth GT,
Stein L, Flicek P, Yandell M, Eilbeck K. 2010. A standard variation
file format for human genome sequences. Genome Biol 11: R88.
Stein LD. 2010. The case for cloud computing in genome informatics.
Genome Biol 11: 207. 
Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP,
Zeggini E, Huth C, Aulchenko YS, Thorleifsson G, et al. 2010.
Twelve type 2 diabetes susceptibility loci identified through large-
scale association analysis. Nat Genet 42: 579–589.
Wang L, Stein LD. 2010. Localizing triplet periodicity in DNA and
cDNA sequences. BMC Bioinformatics 11: 550.
Wu G, Feng X, Stein L. 2010. A human functional protein interaction
network and its application to cancer data analysis. Genome Biol 11:
R53.
GENOME-SCALE DATABASES OF PATHWAYS, GENETIC VARIATIONS,
AND EVOLUTION
L. Stein S. Avraham B. Faga A. Kanapin G. Wu
S. Cain G. Gopinathrao W. Spooner Z. Zha
N. de la Cruz T. Harris P. Van Buren W. Zhao
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Our lab has dual goals of conducting plant genomics re-
search and of enabling access to genomics resources and
discovery tools to the broader research community. Re-
search includes a broad range of activities in physical, sta-
tistical, and functional genomics in both model systems
and crop plants, with applications in agriculture. During
the past year, we were joined by postdoc Christos Nout-
sos, Marcela Karey Monaco, undergraduate intern
Michael Levy, and high school intern Rigina Gallagher.
We said good-bye to Liya Ren and Shuly Avraham. On
sabbatical from University of Missouri, Columbia,
Michael McMullen has joined us as a visiting professor.
Gramene
A. Chuah, M. Karey Monaco, S. Pasternak, W. Spooner, 
J. Stein, J. Thomason, S. Wei, K. Youens-Clark [in 
collaboration with E. Buckler, USDA, Cornell 
University; S. McCouch, Cornell University; 
P. Jaiswal, Oregon State University]
Gramene was conceived from the notion that the juxta-
position of annotation across multiple genomes by com-
parative mapping provides a synthesis of knowledge
greater than the sum of its parts. Gramene is a collabo-
rative project that leverages sequence and functional in-
formation from plant reference genomes to promote
research and translational genomics in agriculture. The
Gramene website (http://www.gramene. org) serves as a
portal to multiple genome browsers and manually cu-
rated databases of genes, proteins, biochemical pathways,
quantitative trait loci (QTL), ontologies, germplasm, and
genetic diversity data. In the last year, our group has com-
pleted several milestones on the Gramene project, includ-
ing its 31st and 32nd releases since 2000. Of the many
improvements made, we increased the number of partial
and complete sequenced genomes in our Ensembl ge-
nome browser to 19 scientifically and economically im-
portant species including rice, corn, grape, sorghum,
poplar, and the basal land plant Selaginella. Gramene is
also home to reference sequences for three cultivated and
eight wild species of rice, making it the single most com-
prehensive genus-level (Oryza) resource in plants. This
year, we released pathway databases for maize (MaizeCyc)
and Brachypodium (BrachyCyc), complementing existing
pathway databases for rice, sorghum, and other plants.
Gramene is also positioning itself as a principal resource
for conducting population-based genetics research. We
added several new diversity/phenotype data sets covering
Arabidopsis, rice, and maize and have added new tools
for querying single-nucleotide polymorphisms (SNPs)
and visualizing genome-wide association studies. All of
this work has contributed to a 38% increase of traffic on
the site during the last 2 years from users all over the
world. Our databases are created in partnership with the
European Bioinformatics Institute (EBI) and are now
also available through the Ensembl Plant portal. During
the next year, we will continue to add new reference
genomes, data sets, and functionalities to this resource.
Maize Project
S. Pasternak, A. Olson, J. Stein [in collaboration 
with the Maize Genome Sequencing Consortium;
J. Glaubitz, Cornell University; E. Buckler, USDA, 
Cornell University; M. McMullen, USDA, 
University of Missouri, Columbia]
Our group leads data coordination, analysis, and visu-
alization for the Maize Genome Sequencing Consor-
tium, a 4-year, multi-institutional project funded by the
National Science Foundation (NSF). In the last year,
we released version 5b.60 of MaizeSequence.org, the
official public portal of the maize project. This release
is based on the most recent version of the reference as-
sembly (B73 RefGen_v2) for which we conducted a
new evidence-based gene build. The new gene set in-
cludes improved gene models for thousands of loci and
hundreds of new high-confidence loci that were not de-
tected in the previous version of the assembly. Despite
the many improvements to the reference sequence,
there are still gaps of missing genes and stretches of se-
quences that are not definitively positioned within
chromosomes. In a new initiative, we are working to
capture missing gene space using de novo assemblies of
whole-genome shotgun sequence reads. We have devel-
PLANT GENOME ORGANIZATION, EVOLUTION, AND FUNCTION
D. Ware J.-M. Chia M. Karey Monaco Z. Lu S. Pasternak J. Thomason K. Youens-Clark
A. Chuah S. Kumari C. Noutsos W. Spooner P. Van Buren L. Zhang
A. Eveland Z. Liu A. Olson J. Stein S. Wei
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oped a novel approach that builds gene-centered scaf-
folds by guided assembly onto cDNA sequences. To an-
chor these, we are taking advantage of a very high-
resolution genetic map containing nearly half a million
markers generated by a genotype by sequencing ap-
proach. Preliminary data indicate that we are able to
anchor thousands of de novo contigs corresponding to
hundreds of genes. These data will contribute to future
improved assemblies of the maize reference genome.
Maize HapMap Project
J.-M. Chia [in collaboration with E. Buckler, USDA, 
Cornell University; M. McMullen, USDA, 
University of Missouri, Columbia]
Maize has abundant diversity that is evident from the
large variation of observable traits in the species. This
diversity translates to the DNA level, where large dif-
ferences exist between individuals of the species. Much
of this genetic diversity in maize resolves to single DNA
base differences (SNPs), but perhaps more significantly,
structural variations as well as copy-number variations
have a strong impact in the genetic diversity in the
species. As a result, the concept of a maize genome is
fluid, with DNA content varying greatly between indi-
viduals of the species. It is estimated that 30% of the
genome of each maize inbred line is unique to itself and
this unique space contains genes, thus likely to impact
traits.
With this in mind, we set out to study the genetic
variation in the species. In this iteration of the Maize
HapMap Project, using high-throughput DNA se-
quencing technologies, we scale out the breadth and
depth of the study by resequencing more than 100 in-
bred lines of the Zea mays genus. The volume of se-
quence generated per inbred line is approximately five
times the size of the genome, and from these sequences,
we can identify variant loci. Given the complexity of
the genome, these variations were scored using carefully
designed population genetics-based filters that leverage
the carefully constructed maize breeding populations.
In total, more than 55 million SNPs were identified.
Furthermore, by comparing the distribution of read
depth across the genome we could determine copy-
number and structural variations. The results reveal the
plasticity of the genome with more than 80% of the
genome affected by copy-number or structural varia-
tion. We used the combined set of SNPs and structural
variations as markers and tested the potential of these
to affect maize traits. The results highlight the signifi-
cant impact of structural variation on traits. Finally, be-
cause wild ancestors of domesticated maize were in-
cluded in the sampling population, based on regions of
lower genetic diversity, we are able to address questions
about genes that were selected for during the domesti-
cation and improvement of maize as a crop. 
Maize breeders have long been exploiting the diver-
sity in maize for improving the yield of this crop through
selective breeding programs, contributing to its current
position at the apex of the production crop list. We are
in an era where traditional crop-breeding techniques are
being supplemented and, in some cases, supplanted by
molecular breeding approaches that speed up the breed-
ing process. Understanding the diversity in maize and
how it impacts agronomic traits is crucial in implement-
ing these new approaches and will be an important plat-
form for sustainable agriculture in the future. 
The iPlant Collaborative
J. Lu, C. Noutsos
This project employs more than 50 staff and is headquar-
tered at the University of Arizona (principal investigator
Stephen Goff ). Dozens of collaborators hail from over
20 institutions.
Driven by the large-scale generation of data, ranging
from genomics to imaging, research in biology is becom-
ing increasingly information-based. Lagging behind is
the ability of individuals to make efficient use of this in-
formation because of limitations in data access, compu-
tational infrastructure, and available tools. In addition,
to tackle big questions in biology, researchers need to col-
laborate in effective ways to reach across institutional and
disciplinary lines. The iPlant Collaborative (http://iplant
collaborative.org) is an NSF-funded cyberinfrastructure
project that provides access to high-performance com-
puting, data storage, and tools via customized “Discovery
Environments.” The project’s mission is to foster the de-
velopment of a diverse, multidisciplinary community of
scientists, teachers, and students who will apply transfor-
mative approaches and computational thinking to ad-
dress grand-challenge questions in plant biology. In its
first 3 years, iPlant has engaged the plant science com-
munity to develop two Grand Challenge projects: Geno-
type to Phenotype (iPG2P) and the Tree of Life (iPToL).
The goal of the iPToL Grand Challenge is to assem-
ble a comprehensive phylogenetic tree that describes the
diversification and evolutionary histories of the half-
million described species of green plants. The sheer
scale of this endeavor will require a 100-fold scale-up
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of existing phylogenetic reconstruction methods and
concomitant innovations in tree visualization and post-
analysis. One fundamental requirement is to start with
standardized taxonomic names for each species—a non-
trivial task. Erroneous and synonymous taxonomic
names are a major challenge for virtually every field of
plant biology. Large organismal databases (GBIF,
SpeciesLink, VegBank, SALVIAS, TraitNet, GenBank,
TreeBASE) are plagued by taxonomic error and uncer-
tainty. In some databases, up to 30% of names do not
match to any published name. Furthermore, 5%–20%
of published names may be synonymous. Currently,
correcting and harmonizing taxonomy are the time-
consuming and ad hoc responsibility of the individual
researcher. Thus, a subproject of iPToL is development
of iPlant’s Taxonomic Name Resolution Service
(TNRS). Creating this TNRS tool will remove a barrier
scientists must now overcome to conduct higher-quality
comparative biodiversity science. With its deployment
in iPlant’s Discovery Environment, TNRS will be avail-
able to others wishing to perform similar taxonomic
name resolutions on their data sets, enabling a wider
community to expand the public scientific knowledge
base. The TNRS is currently in beta-testing phase. 
The iPG2P project aims to elucidate the relationship
between plant genotypes and the resultant phenotypes in
complex environments, one of the foremost challenges in
biology. We contributed efforts to incorporate ultra-high-
throughput sequence (UHTS) data analysis work flows
into the Discovery Environment. The work flows enable
users to work with data from Illumina and AB SOLiD
sequencing machines to (1) preprocess UHTS sequence
data, (2) determine transcript abundance (RNA-Seq), and
(3) perform variant detection analysis. This will allow the
general research community to access UHTS technology.
The Maize Methylome Project
J. Lu [in collaboration with A. Rafalski, DuPont 
Crop Genetics; R. Martienssen, Cold Spring 
Harbor Laboratory]
Heritable differences between maize germplasms can be
caused by epigenetic loci that affect gene function by
modification of chromatin structure. One type of mod-
ification, DNA methylation, has an important role in
the regulation of gene expression and control of trans-
posable elements. To begin to understand how variations
in methylation affect phenotype, we have sequenced the
methylomes of two heterotic maize inbreds, B73 and
Mo17. The method used bisulfite to convert unmethyl-
ated cytosine to thymine, followed by Illumina sequenc-
ing to generate paired-end reads. For each background,
we have generated 20x–30x coverage over the mappable
portion of the maize genome. This has revealed hun-
dreds of millions of cytosine methylation sites mapped
with single-base resolution. Preliminary analysis shows
that patterns of methylation correlate closely with an-
notated genome features, such as genes, expressed re-
gions, and repeats. Future work will pinpoint the
differences between the two inbreds to provide a basis
for investigation of how these differences affect gene reg-
ulation and other biological functions.
A Systems Approach to Infer
Developmental Networks in Maize
A.L. Eveland, S. Kumari [in collaboration with 
D. Jackson, Cold Spring Harbor Laboratory; 
M. Beatty, H. Sakai, DuPont Crop Genetics]
The integration of various genome-scale data types can
reveal biologically significant information at the systems
level that may otherwise not be accessible from analysis
of a single data set. Recently, the availability of a maize
reference genome and next-generation genomics tools
has promoted maize as a central model for grain yield
and bioenergy. In this work, we evaluated methods for
analyzing sequence-based expression data with respect
to the maize genome, as well as in comparative analyses
with other plant genomes. We developed analysis
pipelines, which include various computational meth-
ods to interrogate large data sets and extract relevant
metadata in the context of heterogeneous genomic in-
formation. These analyses serve as a baseline for infer-
ring networks underlying maize developmental pro-
cesses and response to environment. Here, we initially
focused on a system for maize inflorescence develop-
ment and utilized RNA-Seq libraries and predicted cis-
regulatory modules in the promoter region of maize
inflorescence genes based on the position weight ma-
trices (PWM).
A primary objective in 2010 was to establish robust
methods for analysis of sequence-based expression data
and for deriving biological significance related to maize
developmental processes. Our RNA-Seq pipeline in-
cludes data processing, mapping sequence reads to a ref-
erence genome, quantifying expression of a given locus,
and using statistical methods to test for differential ex-
pression and to cluster genes with similar expression
signatures. An initial study was published based on our
maize inflorescence development model, which de-
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scribed methods for analysis of sequence-based tran-
scriptome profiling in maize and identified candidate
genes involved in regulating stem cell fate in maize ear
primordia (Eveland et al. 2010). In this study, we used
comparative genomics to leverage information from
other plant genomes in the analysis of uncharacterized
maize genes. We identified ~850 genes that showed al-
tered expression profiles upon perturbation (loss-of-
function mutation) of a key developmental regulator in
2-mm maize ear primordia. Among these, specific
classes of transcription factors (TFs), such as AP2-
EREBP family members, were coexpressed. Interest-
ingly, AP2-EREBP genes have been implicated not only
in developmental processes, but in stress-based net-
works as well. This work also highlighted the potential
impact of antisense transcription in our analysis of gene
expression data in maize. Approximately 49% of genes
showed clear evidence for both sense and antisense ex-
pression and ~200 genes showed a twofold change in
sense versus antisense transcription in the mutant back-
ground. 
We also used the available RNA-Seq data sets to val-
idate annotated transcript models and to uncover po-
tentially novel transcripts. The current data sets show
significant differences in levels of transcript variants as-
sociated with developmental stage and tissue specificity.
We used a clustering strategy to identify genes that
shared similar expression profiles during development
in wild-type inflorescences and characterized classes of
TFs with specific spatiotemporal expression signatures
and determined whether their expression patterns were
altered upon genetic perturbation. We also determined
whether clusters of coexpressed genes shared common
cis-regulatory elements in proximity to their annotated
transcription start sites (TSS). 
Characterization and Conservation
Studies of the Arabidopsis stele
Gene Regulatory Network
L. Zhang, S. Kumari [in collaboration with S. Brady,
University of California, Davis]
Tightly controlled gene expression is a hallmark of
multicellular development and is accomplished by TFs
and microRNAs (miRNAs). We are using high-
throughput yeast one-hybrid (Y1H) and yeast two-hy-
brid (Y2H) assays to map the root stele-enriched TF
and miRNA gene regulatory network (GRN). We also
integrated computationally identified miRNA–mRNA
interactions and the analysis resulted in a GRN com-
posed of 103 interactions between 58 TFs and eight
miRNAs (Fig. 1). The strength of many of these inter-
actions was experimentally quantified using systematic
perturbation and modeling. Although root or vascular
phenotypes were associated with only 16% of these
TFs, we identified molecular or gene expression phe-
notypes for 65%. This indicates that gene redundancy
does not solely occur at the level of gene regulation and
that gene expression changes may be canalized or
buffered. TF and miRNA promoters with the most in-
teractors corresponded to key developmental regula-
tors. Recent work has focused on improving and
extending the existing TF library and development of
an automated enhanced Y1H (eY1H) mating pipeline,
which has been validated. Using this system, we in-
creased the number of interactions with these promot-
ers from 33 to 82 and have now identified interactions
with all 13 promoters. 
Our next goal is to identify the critical TF–promoter
interactions with conserved function in different species.
Figure 1.The stele-enriched gene regulatory network depicting 103 interactions among transcription factors, promot-
ers, miRNAs, and miRNA targets. (From Brady et al. 2011.)
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We projected sorghum orthologs onto the Arabidopsis
stele GRN to identify the conserved macromolecular in-
teractions. The identification of putative conserved in-
teractions can be used to model the network in different
species to determine if these interactions are evolution-
arily conserved and to generate testable hypothesis. 
Dissection of the Regulatory Network
Underlying Waterlogging Stress in Maize
Z. Liu [in collaboration with Professor Y. Zheng, 
Huazhong Agricultural University, China]
Waterlogging is a critical factor constraining maize pro-
duction in tropical and subtropical regions. In south-
eastern China and other parts of the world, excessive
springtime rainfall inhibits seed germination and se-
verely damages growing seedlings, leading to yield losses
of up to 30%. The primary effect of water submergence
is the lack of available oxygen to roots. Survival depends
on the degree to which plants are able to mount a myr-
iad of adaptive responses ranging from metabolic
switching to complex developmental changes. We have
devised an experimental system to monitor stress re-
sponses in growth chamber reared seedlings that takes
advantage of natural variation among maize inbreds:
Hz32 (tolerant line), B73 (mid-tolerant line), and
Mo17 (sensitive line). On the basis of the sequencing
of small RNA libraries, we identified 21 miRNA genes
that have significant changes in expression in the Hz32
tolerant line after 4 hours of treatment. Using quanti-
tative assays in a time-course experiment, we found dra-
matic differences between the inbred lines with respect
to miRNA expression profiles (Fig. 2). In the sensitive
line, miRNAs were generally repressed or showed late,
weak, or transient induction. This contrasts with the
tolerant line in which miRNAs generally showed early,
strong, and persistent induction. The mid-tolerant line
exhibited a distinct pattern in which some miRNA
genes were induced early and persistently and others
were not induced or repressed. These differences suggest
that miRNA genes have a role in pathways connected
to the ability of plants to survive waterlogging stress.
Clustering of the miRNA expression profiles suggests
that groups of miRNA genes may be coregulated within
common gene regulatory networks. In future work, we
plan to analyze miRNA promoters to detect potential
cis-regulatory modules that may explain expression pat-
terns. We also plan to profile transcripts of TF genes
that are predicted to be targets of miRNAs.
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Figure 2. Expression profiles of 21 miRNA genes after waterlog-
ging treatment in a sensitive line (Mo17), mid-tolerant line (B73)
and a tolerant line (Hz32). Chamber-grown seedlings were sub-
merged in water up to the soil line at time 0 and root samples
were taken at 1, 2, and 4 hours. Transcripts were assayed by
quantitative PCR. Fold changes are shown, averaged from three
biological replicates, relative to untreated controls.
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CSHL recently opened the Simons Center for Quantitative Biology (SCQB). The areas of expertise
in the SCQB include applied mathematics, computer science, theoretical physics, and engineering.
Members of the SCQB interact closely with other CSHL researchers and apply their approaches to
research areas including genomic analysis, population genetics, neurobiology, evolutionary biology,
and signal and image processing.
Gurinder S. “Mickey” Atwal and colleagues are applying insights from the physical sciences to
the study of biological phenomena. Specifically, they develop and use mathematical and computa-
tional tools to address quantitative principles governing the behavior of correlated “many-body” bi-
ological systems. Such systems range from molecular interactions in a single cell to the evolution of
Homo sapiens. They are now seeking to understand evolutionary forces acting on the genome in the
context of human diseases. In collaborations with colleagues at the Institute for Advanced Study in
Princeton, Atwal has modeled the process by which genetic variants, or alleles, evolve. This has re-
cently led to surprising insights about the role in reproduction played by p53, a master tumor sup-
pressor gene. This work also bears on the question of demonstrating recent selective pressures acting
on our genomes.
Alexander Krasnitz and colleagues use mathematical and statistical tools to discover key genetic
elements involved in cancer and to understand how cancer cells evolve. Array-based comparative
genome hybridization, a technique developed in the Wigler lab, and more recently, sequencing ex-
periments have revealed subtle patterns of frequent and widespread aberration in cancer genomes.
Krasnitz hypothesizes that aberrant genomic loci observed to recur in a range of cancer types are
under selection and therefore are enriched in important cancer genes. He has developed a novel,
comprehensive methodology to study such “epicenters” and has used it to analyze multiple-genome
data sets in breast, lung, colon, and liver cancer. The results have been shared with cancer biology
labs across CSHL, and they have been a key enabling agent of functional studies using mouse models
and RNA interference (RNAi). Krasnitz has begun to apply advanced statistical methods to the
latest generation of experimental data, which have characterized tumor samples down to the level
of single cells. With such data, he and colleagues seek to learn how specific cancer types evolve and
how cancer cells migrate in metastasis. 
Michael Schatz is a computational biologist and an expert at large-scale computational exami-
nation of DNA sequencing data including the alignment, assembly, and analysis of short sequencing
reads. He is a pioneer in applying the power of many computers at once to solve data-intensive bi-
ological problems—often called “cloud computing.” Schatz has developed several breakthrough ap-
plications under the National Science Foundation (NSF) cloud computing initiative, and he brings
that expertise to harness the collective power of the thousands of computing cores on the CSHL
campus to genomics, particularly within the CSHL Cancer Center and the plant biology group. In
2009, Schatz published the first cloud-based sequence analysis tool, called Cloudburst, which dra-
matically accelerates mapping short sequencing reads to a reference genome with applications to
genotyping and expression profiling. Since then, he has published a series of high-throughput algo-
rithms using this technology for single-nucleotide polymorphism (SNP) profiling, sequencing error
correction, machine learning, and other important applications. He is currently developing a cloud-
computing-based genome assembler called Contrail and a suite of large-scale comparative genomics
tools that he plans to use in a collaborative project with the Wigler lab to identify de novo mutations
within ~3000 families in which only one child is affected with autism.
Michael Zhang’s laboratory develops mathematical and computational methods that can be com-
bined with advanced experimental technologies to transform data into biological knowledge about
transcription and gene expression, work that has manyfold implications for the study of cancer and
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other diseases. Their tools, used by investigators throughout CSHL and beyond, are designed to
identify functional genetic elements within molecular sequences as well as pathways that control
and regulate gene expression. Zhang’s group has developed a series of computational tools that
make use of statistical pattern-recognition techniques to identify exons, promoters, and posttrans-
lational modification signals in large genomic DNA sequences. They also study alternative splicing
of exons and collaborate with other labs to characterize splicing enhancers and silencers. 
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Suyash Shringapure, a summer research intern during
2009, has returned to Carnegie Mellon University to
resume his graduate studies at the computer science de-
partment, but he will continue to collaborate with Bud
Mishra and myself on the project we initiated at CSHL.
Joshua Weiss completed work as a volunteer as a mem-
ber of the Partners for the Future program.
Genome-Wide Interchromosomal
Interactions and Population Differentiation
Physically interacting proteins or subunits of proteins are
expected to evolve in a correlated manner in order to pre-
serve the functional interactions between them. The se-
quence changes accumulated during the evolution of one
of the interacting units can be compensated by changes
in the other. Recent studies have shown that strong pair-
wise correlations exist between amino acid residues of the
same protein necessitated by compensatory mutations.
Furthermore, we previously showed that functional sin-
gle-nucleotide polymorphisms (SNPs) in different genes
in the p53 network are correlated across different human
populations, arguably to maintain homeostatic balance
of p53 activity. We performed a genome-wide analysis of
all the interchromosomal pairwise interactions of exonic
SNPs in all 11 Hapmap populations. We find extensive
evidence of significant interactions, backed up by an
analysis of the similarity of protein functions. Protein net-
work analysis demonstrated that correlated proteins were
separated by significantly fewer nodes in the protein–pro-
tein interaction network. Finally, we showed that corre-
lated SNPs exhibit greater population differentiation,
indicating that local geographic adaptation in humans is
dependent on networks of correlated polymorphisms
rather than simply independent mutations.
Cancer Risk and Haplotype Structure
of the TSC1 and TSC2 Genes
TSC1 acts coordinately with TSC2 in a complex to in-
hibit mTOR, an emerging therapeutic target and known
promoter of cell growth and cell cycle progression. Per-
turbation of the mTOR (mammalian target of rapa-
mycin) pathway, through abnormal expression or
function of pathway genes, could lead to tumorigenesis.
TSC1 and TSC2 expression is reduced in invasive breast
cancer as compared with normal mammary epithelium.
In a collaborative effort with the Cancer Institute of New
Jersey, association studies were performed on TSC1 and
TSC2 SNPs for their associations with clinical features
of breast cancer. TSC1 and TSC2 haplotypes were con-
structed from genotyping of multiple loci in both genes
in healthy volunteers. SNPs were selected for further
study using a bioinformatics approach based on SNP as-
sociations with drug response in NCI-60 cell lines and
evidence of selection bias based on haplotype frequencies.
Genotypings for five TSC1 and one TSC2 loci were per-
formed on genomic DNA from 1137 women with breast
cancer. This study found that for TSC1 rs7874234, TT
variant carriers had a 9-year later age at diagnosis of es-
trogen-receptor positive (ER+), but not ER–, ductal car-
cinomas (P = 0.0049). No other SNP locus showed an
association with age at diagnosis, nor any other breast
cancer phenotype. TSC1 rs7874234 is hypothesized to
be functional in ER+ breast cancer because the T allele,
but not the C allele, may create an ER element site, re-
sulting in increased TSC1 transcription and subsequent
inhibition of mTOR.
Regulation of Human Fertility by SNPs
in the p53 Pathway
We continued our work in collaboration with Cornell
Medical School and the Cancer Institute of New Jersey,
investigating the association of human fertility and ge-
netic polymorphisms in the p53 pathway. The tumor
suppressor protein p53 has an important role in maternal
reproduction in mice through transcriptional regulation
of leukemia inhibitory factor (LIF), a cytokine crucial for
blastocyst implantation. To determine whether these ob-
servations could be extended to humans, a list of SNPs
in the p53 pathway that can modify the function of p53
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was assembled and used to study their impact on human
fertility. Selected alleles in SNPs in LIF, Mdm2, Mdm4,
and Hausp genes, each of which regulates p53 levels in
cells, was found to be enriched in IVF (in vitro fertiliza-
tion) patients. More recently, we have begun to investi-
gate the association of SNPs in p63 and p73 and the
initial results are encouraging, although we await an in-
crease in sample numbers for the results can be deemed
to be statistically significant. 
Fine-Scale Detection of Recent Selection
Signatures Using Haplotype Entropy
Creation of a coherent genomic map of recent selection
is one of the greatest challenges for a better understand-
ing of human evolution. Various methods have provided
the means for genome-wide linkage disequilibrium
analysis; however, there is still a gap for scanning with
short-intermediate resolution. Entropy, a measure of dis-
order in physics, has been proposed as a new concept to
measure genetic diversity and strength of linkage dis-
equilibrium of sequences. We produced a fine-scale ge-
nomic scan using haplotype entropy. The analysis with a
median resolution size of ~23 kb for HapMap SNP data
of African and Caucasian populations depicted new re-
cent selection signatures, as well as known signatures.
Gene enrichment analysis on the signatures showed as-
sociations with diverse diseases such as cardiovascular,
immunological, neurological, and skeletal and muscular
diseases. The novel entropy framework would be of value
for deciphering recent evolutionary histories of humans.
Localization of Tumor
Suppressor Genes
Preliminary results from the Lowe Lab’s ongoing ef-
forts to identify new tumor suppressor genes (TSGs)
by in vivo screens in mice have found instances of
tumor suppressor genes in close proximity to each
other. We carried out a systematic analysis of the spatial
distribution of known (TSGs) to test the hypothesis
that there exists an evolutionary selection pressure to
cluster TSGs throughout the genome. To this end, we
developed a computational and analytical model to de-
termine the extent to which we expect to find adjacent
TSGs under no selection. Preliminary results indicate
a strong tendency for tumor suppressor genes to cluster
and for this clustering to occur across many species.
Furthermore, by analyzing genome-wide microarray
data, we show that proximal TSGs exhibit significant
correlation in their expressions. Ongoing investigations
are focused on understanding the implications of this
spatial distribution of TSGs for the risk and develop-
ment of human cancer. 
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Research in our group is focused on in silico cancer ge-
nomics. In the last 5 years, there has been explosive
growth in the volume as well as quality and detail of can-
cer-related genomic data available for analysis. This de-
velopment came about through rapid accumulation of
public data sets generated by individual laboratories
worldwide, through large-scale cancer genome projects
such as The Cancer Genome Atlas (TCGA) and the In-
ternational Cancer Genome Consortium (ICGC), and
with the advent of new experimental methodologies, es-
pecially next-generation sequencing. We see our goal in
channeling this flood of data into a number of clinically
relevant applications, including pinpointing and priori-
tizing targets for functional analysis, discovery of genomic
markers for clinical outcome, and molecular classification
of cancer. All our work is done in close coordination with
experimental studies performed by the Wigler, Powers,
Lowe, and Stillman laboratories at CSHL.
Recurrence and Search for Drivers
in Cancer Genomes
Evidence suggests that recurrent somatic genomic aber-
rations in cancer are at least partially due to selective
pressure on regions harboring oncogenes and tumor
suppressor genes. Conversely, one can expect regions of
recurrent aberration to be enriched in such driver genes.
Recurrence is particularly pronounced in cancer-related
somatic copy-number variation. We set out to build
computational tools exploiting this property of cancer
genomes and make optimal use of both in-house and
public DNA copy-number data in order to derive, for
each cancer type considered, a set of regions of recurrent
and consistent copy-number variation and to compile
prioritized lists of candidate driver genes. Starting with
genomic profiles of individual tumors, we sift through
putative copy-number events and eliminate experimen-
tal errors. Next, we mask germline mutations and infer,
for any given genomic location, how many copy-num-
ber changes it has undergone. Finally, we round event
boundaries to the nearest gene affected by the event.
The resulting set of preprocessed genomic profiles
serves as input for our multigenome analysis. Several
versions of the latter exist. In the simplest of these, each
copy-number event is interpreted as evidence that genes
affected by the event are under selective pressure. We
further assume that this evidence is shared equally
among all of the genes affected by the event. For each
gene, its share of evidence is then summed over all
events of a given sign (gains or losses) to result in a score
prioritizing the gene as a candidate oncogene or tumor
suppressor. In early 2010, we applied this technique to
a set of ~240 DNA copy-number profiles of serous
ovarian tumor tissues, collected and analyzed by TCGA
using Agilent 244A array-CGH (comparative genome
hybridization) platform. Our findings formed the bulk
of an oncogene candidate list of 105 genes. Oncogenic
potential of these genes was subsequently examined by
Scott Powers’ lab in a murine ovarian cell line; 35% of
the candidates were found to induce oncogenic trans-
formation upon overexpression.
An alternative strategy consists of deriving a set of
genomic regions subject to recurrent and consistent
copy-number variation. For a region contained in an
event, we say that the region “explains” its portion of
the event. The algorithm first finds a region that gives
maximal explanation of the data and proceeds itera-
tively finding, at each step, the most explanatory region
for the data not explained so far. This procedure, com-
plete with statistical analysis of significance and repro-
ducibility of findings, is dubbed FOCAL (finder of
consistently aberrant loci). The benefit of this analysis
is twofold. First, regions delineated by FOCAL are ex-
pected to be enriched in cancer-related genetic ele-
ments. Second, a drastic reduction of complexity is
achieved: from between 105 and 106 CGH array probe
readings per tumor to a much smaller (dozens or hun-
dreds) set of observables, each indicating the degree to
which a FOCAL region is present in a tumor. 
FOCAL has found a number of applications in the
course of 2010. A set of ~230 DNA copy-number pro-
files of advanced breast tumors of patients in two
CALGB (cancer and leukemia group B) clinical trials
was generated by Dr. James Hicks at CSHL. The data
from the two trials were combined in order to examine
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clinical response to trastuzumab. Although trastuzumab
is routinely prescribed to patients with an amplification
of ERBB2 gene, we identified two FOCAL regions as
potential markers for benefit from trastuzumab in pa-
tients with no such amplification. This finding suggests
the possibility of significantly improving the overall sur-
vival in ~15% of advanced breast cancer cases. 
In collaboration with Dr. Kandasamy Ravi of the
Wigler lab, we applied FOCAL to genomic profiles of
mammary gland tumors in mice with a variety of ge-
netic backgrounds. Here again, we observed that reduc-
tion of the profiles to strings of values at FOCAL
regions retains enough biological information to ro-
bustly classify the tumors by their genetic backgrounds
(TP53 loss, TP53 and PTEN loss, TP53 and BRCA1
loss, BRCA1 loss, point mutation of BRCA1).
Finally, we used FOCAL to analyze a massive (516
profiles) high-resolution (Agilent 1.1 million probe
CGH platform) DNA copy-number data set accumu-
lated by TCGA for serous ovarian cancer and used the
output for molecular subtyping of the disease.
Statistically Supported Tree-Based
Clustering and Molecular Classification
of Cancer
Tree-based clustering has long been an exploratory tool
of choice for unsupervised interpretation of complex
biological data, and it has found a broad range of ap-
plications, from fossil-driven reconstruction of phylo-
genies to molecular subtyping of cancer. In our recent
study, we sought to substantially boost the utility of this
technique by assigning statistical significance to the
branches of the tree and thereby enabling the researcher
to identify statistically meaningful subsets of the data.
The validity of this novel approach does not depend on
the form of dissimilarity between data items or on the
agglomeration rule for growing the tree. We tested this
technique in a number of contexts. In application to a
published set of expression profiles of breast cancer, we
found that established molecular subtypes of the disease
correspond to statistically significant branches of a tree
grown from the set. Likewise, application of the
method to a set of sequence-based copy-number pro-
files of 100 individual cells harvested from a breast
tumor resulted in a four-way partition of the set corre-
sponding to the four major cell populations found in
the tumor and differing from each other by overall
amount of DNA in the nucleus. 
Next, we used statistically supported clustering to
partition the TCGA set of 516 genomic profiles into
four classes. Our preliminary analysis suggests that there
are significant genomic and clinical differences among
the classes in terms of tumor grade, disease-free survival,
and point mutation frequency. To our knowledge, this
may be a first example of molecular subtyping of cancer
based on genomic data, rather than transcriptional data.
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I joined CSHL in July from the Center for Bioinfor-
matics and Computational Biology at University of
Maryland College Park. Previously, I participated in the
genome assembly and comparative genomics group at
the Institute for Genomic Research (TIGR, now the J.
Craig Venter Institute) and in the Ravel Lab for Micro-
bial Genomics at the University of Maryland School of
Medicine. Since joining the lab, I have recruited
Matthew Titmus from the Molecular and Cell Biology
graduate program at Stony Brook University.
Cloud Computing and the 
DNA Data Race
In the race between DNA sequencing throughput and
computer speed, sequencing is winning by a mile. Se-
quencing throughput is currently ~200–300 billions of
bases per run on a single sequencing machine, and it is
improving at a rate of about fivefold per year. In com-
parison, computer performance generally follows
“Moore’s Law,” doubling only every 18 or 24 months.
As the gap in performance widens, the question of how
to design higher-throughput analysis pipelines becomes
crucial. One option is to enhance and refine the algo-
rithms to make better use of a fixed amount of com-
puting power. Unfortunately, algorithmic break-
throughs of this kind, like scientific breakthroughs, are
difficult to plan or foresee. The most practical option
is to develop methods that make better use of multiple
computers and processors in parallel.
Parallel computing systems have existed for decades
in different forms, but a new system called MapReduce
is especially promising for accelerating data intensive ge-
nomics research. MapReduce was developed at Google
for their large data analysis, especially for scanning across
billions of webpages to find the most relevant pages for
a search query. Google currently uses MapReduce to an-
alyze ~1 exabyte of data every month. The power of
MapReduce is that it can intelligently distribute com-
putation across a cluster with hundreds or thousands of
computers, each analyzing a portion of the data set
stored locally on the compute node. After an initial
round of independent parallel computations, the ma-
chines efficiently exchange intermediate results, from
which the final results are computed in parallel. The sys-
tem was originally developed for text and Web process-
ing and was only available at Google, but an open source
implementation called Hadoop is now available to in-
stall on any cluster for any application domain.
The first-ever application of this technology to ge-
nomics, which I in published 2009, was to accelerate
the short-read mapping algorithm CloudBurst. In
CloudBurst, many computers work together using
Hadoop to map reads to a reference genome allowing
for any number of differences to determine from where
each read originated and if any variations are present. In
experiments with 96 cores, the mapping algorithm was
~100 times faster than using a single core, thus reducing
the runtime from several weeks to a few hours. The
compute cluster used for these experiments was com-
pletely virtual and was leased from the Amazon Elastic
Compute Cloud (EC2), which offers computing time
in their cloud at a small fee per node per hour used.
In a follow-up system called Crossbow, I partnered
with colleagues at the University of Maryland to extend
the design of CloudBurst to further enable high-per-
formance genotyping. Crossbow identified 3.2 million
single-nucleotide polymorphisms (SNPs) from 2.7 bil-
lion short reads comprising 38x coverage of the human
genome. Using Hadoop to distribute the computation
across 320 computer cores rented from Amazon EC2,
Crossbow completed the analysis in less than 4 hours
whereas it would have taken >1000 hours on a single
computer. 
Since these pioneering efforts, numerous applica-
tions have been developed to leverage Hadoop and
cloud computing. For example, in the last year, I and
colleagues developed a system called Quake to detect
and correct errors in DNA-sequencing reads. Quake is
now a standard component of several genome assembly
and analysis pipelines, and it uses a maximum likeli-
hood approach incorporating quality values and nu-
cleotide-specific miscall rates to pinpoint and accurately
correct errors. By using Hadoop, Quake can scale to
virtually any sized genome, including correcting more
than 1 billion reads from a deep coverage human
genome resequencing study. In a second project, I de-
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veloped a Hadoop-based framework called Schimmy
for accelerating an entire class of analysis problems re-
lated to graphs. Graphs themselves are analyzed in
many important contexts, including module detection
of protein–protein interaction networks, and genome
assembly. Many graphs of interest are difficult to ana-
lyze because of their large size, often spanning millions
of vertices and billions of edges. Schimmy optimizes
Hadoop for large-scale graph analysis, and our experi-
ments demonstrate how Schimmy reduces the runtime
of an important machine-learning graph algorithm
called PageRank on a graph with 1.4 billion edges by
nearly 70%. Future work for my lab is to develop ad-
ditional high-throughput sequence analysis pipelines
using Hadoop and other enabling high-performance
technologies.
Genome Assembly
A second major research focus of my Lab is developing
enhanced methods for de novo genome assembly and ap-
plying those methods to reconstruct the genomes of pre-
viously unsequenced organisms. Second-generation
sequencing technology can now be used to sequence the
equivalent of an entire human genome in a matter of days
and at low cost. Sequence read lengths, initially very short,
have rapidly increased since the technology first appeared,
and we now are seeing a growing number of efforts to se-
quence large genomes de novo from these short reads. 
de Bruijn graphs are a theoretical framework under-
lying several modern genome assembly programs, espe-
cially those that deal with very short reads. In a study
published last year, I and colleagues described a novel
application of de Bruijn graphs to analyze the global re-
peat structure of prokaryotic genomes. This study was
the first survey of the repeat structure of a large number
of genomes, and it gives an upper-bound on the per-
formance of genome assemblers for de novo reconstruc-
tion of genomes across a wide range of read lengths.
This work demonstrated that the majority of genes in
prokaryotic genomes can be reconstructed uniquely
using very short reads even if the genomes themselves
cannot. In addition, the nonreconstructible genes are
overwhelmingly related to mobile elements (trans-
posons, IS elements, and prophages). 
In a major application of genome assembly, I con-
tributed to a substantial effort to sequence the domestic
turkey (Meleagris gallopavo) using a combination of two
next-generation sequencing platforms along with a de-
tailed comparative bacterial artificial chromosome
(BAC) physical contig map. Heterozygosity of the se-
quenced source genome allowed discovery of more than
600,000 high-quality single-nucleotide variants. De-
spite this heterozygosity, the current genome assembly
(~1.1 Gb) includes 917 Mb of sequence assigned to
specific turkey chromosomes. Annotation identified
nearly 16,000 genes, with 15,093 recognized as protein
coding and 611 as noncoding RNA genes. Compara-
tive analysis of the turkey, chicken, and zebra finch
genomes, and comparing avian to mammalian species,
supports the characteristic stability of avian genomes
and identifies genes unique to the avian lineage. Clear
differences are seen in the number and variety of genes
of the avian immune system where expansions and
novel genes are less frequent than examples of gene loss.
The turkey genome sequence provides resources to fur-
ther understand the evolution of vertebrate genomes
and genetic variation underlying economically impor-
tant quantitative traits in poultry. This integrated ap-
proach may be a model for providing both gene and
chromosome level assemblies of other species with agri-
cultural, ecological, and evolutionary interest.
Furthermore, in collaboration with researchers from
the USDA, I contributed to the de novo assembly and
analysis of the ectoparasitic mite Varroa destructor,
which is a primary pest of domestic honey bee (Apis
mellifera). This collaboration extended their previous
work to sequence another major pest of honey bees, the
microsporidian Nosema ceranae. These two organisms
are especially significant to agriculture because they are
two of the most likely agents of honeybee colony col-
lapse disorder, and assembling their genomes enables
unique opportunities for understanding the molecular
basis of this serious condition. In the current work,
they presented an initial survey of the V. destructor
genome carried out to advance our understanding of
Varroa biology and to identify new avenues for mite
control. The genome size was estimated by flow cytom-
etry to be 565 Mbp, larger than most sequenced insects
but modest relative to some other Acari. Genomic
DNA pooled from ~1000 mites was sequenced to 4.3×
coverage with 454 pyrosequencing. The 2.4 Gbp of se-
quencing reads were assembled into 184,094 contigs
with an N50 of 2262 bp, totaling 294 Mbp of se-
quence after filtering. Genic sequences that have ho-
mology with other eukaryotic genomes were identified
on 13,031 of these contigs, totaling 31.3 Mbp. Align-
ment of protein sequence blocks conserved among V.
destructor and four other arthropod genomes indicated
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a higher level of sequence divergence within this mite
lineage relative to the tick Ixodes scapularis. A number
of microbes potentially associated with V. destructor
were identified in the sequence survey, including ~300
kbp of sequence deriving from one or more bacterial
species of the Actinomycetales. The presence of this bac-
terium was confirmed in individual mites by poly-
merase chain reaction (PCR) assay but varied
significantly by age and sex of mites. Fragments of a
novel virus related to the Baculoviridae were also iden-
tified in the survey. The rate of SNPs in the pooled
mites was estimated to be 6.2 × 10–5 per base pair, a
low rate consistent with the historical demography and
life history of the species. 
This survey has provided general tools for the re-
search community and novel directions for investigat-
ing the biology and control of Varroa mites. Ongoing
development of Varroa genomic resources will be a
boon for comparative genomics of underrepresented
arthropods and will further enhance the honey bee and
its associated pathogens as a model system for studying
host–pathogen interactions.
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In the last year, the majority of my lab moved to the
University of Texas at Dallas and I became an adjunct
professor at CSHL. D. Lewis moved to the McCombie
lab, M. Tang moved to the Lucito lab, K. Wrzeszczynski
moved to the Hicks lab, and M. Kato moved to the
Krasnitz lab. J. Kinney has become a CSHL Computa-
tional Junior Fellow. Miss Diana LaScala-Gruenewald
was our URP student from Massachusetts Institute of
Technology, and we had visiting Ph.D. student Yu Liu
from Tsinghua University working in the Huang lab on
a joint project. M. Akerman and J. Wu remain at CSHL
working closely with the Krainer lab. W. Liu and Y. Ma
also remain at CSHL to work on the STARR project in
collaboration with Dr. Ming Li at Memorial Sloan-Ket-
tering Cancer Center.
Comparison of Sequencing-Based 
Methods to Profile DNA Methylation 
and Identification of Monoallelic 
Epigenetic Modifications
Analysis of DNA methylation patterns relies increas-
ingly on sequencing-based profiling methods. The four
most frequently used sequencing-based technologies are
the bisulfite-based methods MethylC-seq and reduced
representation bisulfite sequencing (RRBS), and the en-
richment-based techniques methylated DNA immuno-
precipitation sequencing (MeDIP-seq) and methylated
DNA-binding domain sequencing (MBD-seq). In col-
laboration with the NIH Roadmap Epigenome Com-
sortium, we applied all four methods to biological
replicates of human embryonic stem cells to assess their
genome-wide CpG coverage, resolution, cost, concor-
dance, and the influence of CpG density and genomic
context. The methylation levels assessed by the two
bisulfite methods were concordant (their difference did
not exceed a given threshold) for 82% for CpGs and
99% of the non-CpG cytosines. Using binary methyl-
ation calls, the two enrichment methods were 99%
concordant and regions assessed by all four methods
were 97% concordant. We combined MeDIP-seq with
methylation-sensitive restriction enzyme (MRE-seq) se-
quencing for comprehensive methylome coverage at
lower cost. This, along with RNA-seq and ChIP-seq of
the embryonic stem (ES) cells, enabled us to detect re-
gions with allele-specific epigenetic states, identifying
most known imprinted regions and new loci with
monoallelic epigenetic marks and monoallelic expres-
sion (Harris et al. 2010). In particular, we show that
our new version of software RMAP—which imple-
ments function for pair-end and bisulfite next-genera-
tion sequencing reads (Smith et al., Bioinformatics 25:
2841 [2009])—is more sensitive than Bowtie, a popular
reads mapping software.
Development of the Human Cancer 
microRNA Network
In collaboration with Drs. Bandyopadhyay and Mitra
at the Indian Statistical Institute, a cancer-miRNA (mi-
croRNA) network (Bandyopadhyay et al. 2010) was de-
veloped by mining the literature of experimentally
verified cancer-miRNA relationships. This network re-
veals several new and interesting biological insights that
were not evident in individual experiments, but become
evident when studied in the global perspective. From
the network, a number of cancer-miRNA modules have
been identified based on a computational approach to
mine associations between cancer types and miRNAs.
The modules that are generated based on the association
are found to have a number of common predicted target
onco/tumor suppressor genes. This suggests a combina-
torial effect of the module-associated miRNAs on target
gene regulation in selective cancer tissues or cell lines.
Moreover, neighboring miRNAs (a group of miRNAs
located within 50 kb of genomic location) of these mod-
ules show similar dysregulation patterns, suggesting a
common regulatory pathway. In addition, neighboring
miRNAs may also show similar dysregulation patterns
(differentially coexpressed) in the cancer tissues. In this
COMPUTATIONAL GENOMICS
M.Q. Zhang M. Akerman D. Lewis M. Tang
M. Kato W. Liao K. Wrzeszczynski 
J. Kinney Y. Ma J. Wu
D. LaScala-Gruenewald
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study, we found that 67% of the cancer types have at
least two neighboring miRNAs showing down-regula-
tion that is statistically significant (P < 10–7, randomiza-
tion test). A similar result is obtained for the neigh-
boring miRNAs showing up-regulation in a specific can-
cer type. These results elucidate the fact that neighboring
miRNAs might be differentially coexpressed in cancer
tissues as those in the normal tissue types. Additionally,
the cancer-miRNA network efficiently detects hub miR-
NAs dysregulated in many cancer types and identify
cancer-specific miRNAs. Depending on the expression
patterns, it is possible to identify those hubs that have
strong oncogenic or tumor suppressor characteristics.
This work was based on our new SFSSClass, an inte-
grated method for miRNA-based tumor classification
(Mitra et al. 2010).
Dissecting the Unique Role of the
Retinoblastoma Tumor Suppressor 
during Cellular Senescence
The retinoblastoma (RB) protein family (RB, p107,
and p130) has overlapping and compensatory functions
in cell cycle control. However, cancer-associated muta-
tions are almost exclusively found in RB, implying that
RB has a nonredundant role in tumor suppression. In
collaboration with the Lowe lab at CSHL, we demon-
strated that RB preferentially associates with E2F target
genes involved in DNA replication and is uniquely re-
quired to repress these genes during senescence but not
other growth states. Consequently, RB loss leads to in-
appropriate DNA synthesis following a senescence trig-
ger and, together with disruption of a p21-mediated
cell cycle checkpoint, enables extensive proliferation
and rampant genomic instability. Our results (Chicas
et al. 2010) identified a nonredundant RB effector
function that may contribute to tumor suppression and
reveal how loss of RB and p53 cooperate to bypass
senescence.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows Program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity
for these young scientists to work independently at the Laboratory for a period of 3 years on projects
of their own choosing. Fellows are provided with a salary, research support, and technical assistance so
that they can accomplish their goals free of distraction. The interactions among research groups at the
Laboratory and the program of courses and meetings on diverse topics in biology contribute to a re-
search environment that is ideal for innovative science by these Fellows. The CSHL Fellows Program
has been tremendously successful and has served as a paradigm for several analogous programs at other
institutions, most recently a Fellows Program sponsored by the National Institutes of Health.
The success of the program is apparent from the list of distinguished alumni. Most notably, Carol
Greider, recipient of the 2009 Nobel Prize in Physiology or Medicine for her work on telomerase
and telomere function, joined the Fellows Program in 1998. After completing her fellowship, Carol
was on the CSHL faculty for 9 years, and she is currently the Daniel Nathans Professor and Director
of Molecular Biology and Genetics at Johns Hopkins University School of Medicine.
Previous CSHL Fellows Adrian Krainer (1986), Scott Lowe (1995), and Marja Timmermans
(1998) are now professors at the Laboratory. Scott is the Deputy Director of the CSHL Cancer
Center and a Howard Hughes Medical Institute Investigator, and Marja is the Director of the Fel-
lows Program. Eric Richards (1989) currently is the Vice President of Research and Senior Scientist
at the Boyce Thompson Institute for Plant Research at Cornell University; David Barford (1991)
is a Fellow of the Royal Society and Professor of Molecular Biology at the Institute of Cancer Re-
search in London; Ueli Grossniklaus (1994) is Professor at the Institute of Plant Biology, University
of Zürich, Switzerland; and Térence Strick (2000) left at the end of his fellowship to become a
Group Leader at the Institute Jacques Monod in Paris. Both Lee Henry (2000) and Ira Hall (2004)
moved to Virginia upon completion of their fellowships. Lee joined a project headed by Thomas
Südhof at HHMI’s Janelia Farm in Ashburn, and Ira is Assistant Professor in the Department of
Biochemistry & Molecular Genetics at the University of Virginia in Charlottesville. Patrick Paddi-
son, who had joined the Fellows Program in 2004, currently is an Assistant Member at the Fred
Hutchinson Cancer Research Center in Seattle, Washington.
In 2010, the Laboratory hosted two Fellows: Florin Albeanu did his graduate studies at Harvard
University in the laboratories of Venki Murthy and Markus Meister, where he investigated the logic
of odor maps in the olfactory bulb of rodents. As a Fellow, Florin has taken advantage of optical
imaging, electrophysiology, and optogenetic tools to understand what computations occur at the
neural circuit level in the olfactory bulb of behaving mice. His research program has been very suc-
cessful and he has therefore recently been promoted to Assistant Professor. Chris Vakoc joined us
from Gerd Blobel’s laboratory at the University of Pennsylvania, where he studied chromatin looping
mechanisms in long-range enhancer function. As a Fellow, Chris is studying the role of histone
lysine methylation in normal and malignant hematopoiesis. 
Understanding Neuronal Circuits in the
Mammalian Olfactory Bulb
F. Albeanu, H.G. Chae, P.G. da Silva, M. Davis, A. Dhawale, F.
Marbach, H. Patel, S. Rengarajan
In many regions of the brain, neurons form an ordered
representation of the outside world. For example, the
“homunculus” of the somatosensory cortex is a point-to-
point topographic map of the body surface onto the brain
surface. The spatially organized convergence of sensory
inputs often leads to similar response properties in target
neurons that are in close vicinity. Whether their individ-
ual information content is redundant or independent de-
pends on the circuit architecture (the interplay between
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common input, lateral signals, and feedback from other
brain areas) and the computational goals of the network. 
We use optogenetic tools (such as two-photon im-
aging of genetically encoded neuronal activity reporters
or light-gated neuronal activity switches) coupled with
electrophysiological measurements (extracellular and
intracellular recordings) to study how sensory systems
encode information from the environment. We want
to understand how these inputs get processed at differ-
ent junctions or synapses of the underlying neuronal
circuits and how these representations change with the
state of the system and its circuits (awake vs. anes-
thetized, naïve vs. conditioned). The broad scope of this
effort is observing how perceptions arise.
The olfactory system, particularly the olfactory bulb
(OB), in rodents provides us with an ideal substrate to
answer these questions, given its well-defined circuitry
and multilayered organization. Rodents, being nocturnal
animals, depend heavily on olfaction for survival—find-
ing food and mates or avoiding predators. Airborne
chemicals or odors are translated into neuronal signals by
specific receptors in the nose and sent first to the bulb and
then to higher centers in the brain (olfactory cortex). The
bulb thus being the relay center provides the opportunity
to study both the nature of the inputs it receives and the
nature of output it sends to the brain and the computa-
tions that allow for this input–output transformation.
In the bulb, sensory neurons expressing the same type
of olfactory receptor converge in tight focus, forming
~2000 clusters of synapses called glomeruli. The layout
of glomeruli on the bulb is highly reproducible across
individuals with a precision of one part in 1000. How-
ever, nearby glomeruli are as diverse in their responses
to odors as distant ones, lacking an apparent chemotopic
arrangement (Soucy et al., Nat Neurosci 12: 2 [2009]).
From each glomerulus, a few dozen mitral cells (princi-
pal output neurons of the OB) carry the output further
to the olfactory cortex and several other brain areas. The
mitral cells typically have only one primary dendrite that
projects to a single glomerulus, but they can sample in-
puts on their primary and secondary dendrites from
functionally diverse glomeruli via several types of in-
terneurons (Fig. 1). Thus, a few dozen mitral cells share
input from the same parent glomerulus (sister cells), but
they may have different inhibitory surrounds. 
Are Outputs from the Same
Glomerulus Redundant?
We generated transgenic mice expressing channelrhodop-
sin-2 in all olfactory sensory neurons under the control of
the olfactory marker protein (OMP) promoter. By selec-
tively stimulating individual glomeruli via DLP-patterned
illumination and recording extracellularly from the mitral
cell layer using tetrodes, we identified mitral cells that re-
ceive common input (Fig. 2). We found that sister mitral
cells had highly correlated responses to odors as measured
by average spike rates, but their spike timing with respect
to respiration was differentially altered. In contrast, non-
sister mitral cells correlated poorly on both these measures.
Sister mitral cell pairs fired synchronously (at the same
phase) within a respiration cycle at rest, and upon odor
presentation, they became desynchronized in a stimulus-
specific manner. We therefore propose that sister cells carry
two different channels of information to the cortex: (1) av-
erage activity representing shared glomerular input and (2)
phase-specific information that refines odor representations
and is substantially independent for sister mitral cells
(Dhawala et al., Nat Neurosci 13: 1404–1412 [2009]).
What Roles Does the Inhibitory Network
Have in Shaping the Bulb Outputs?
Activity in the bulb is a rich mix of excitation and inhi-
bition, via both direct inputs and feedforward and feed-
back connections by a wide variety of cell types.
Juxta-glomerular cells are local interneurons that sur-
round the glomeruli and send neurites within and across
glomeruli. In the external plexiform layer, another class
of interneurons, the granule cells, mediates cross-talk be-
tween mitral cells via reciprocal synapses with lateral mi-
tral cell dendrites (Fig. 2). Both interneuron types are
generic denominations for heterogeneous neuronal pop-
ulations with respect to wiring, gene expression, and
physiological properties. Despite decades of study in the
slice preparation, little is known about how these in-
terneurons operate in the intact circuit in vivo.
Figure 1. Main olfactory bulb wiring schematics. (Courtesy of F.
Markopoulos.)
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First, we aimed at understanding whether bulb in-
terneurons modulate the spiking time of mitral cells, i.e.,
the changes in phase tuning described above. We have
started by expressing light-gated molecular switches of
neuronal activity (such as channelrhodopsin 2 and
halorhodopsin) in genetically defined subsets of bulb in-
terneurons. We are using a Cre/Lox strategy and taking
advantage of several interneuron-specific Cre lines gen-
erated by Josh Huang’s group at CSHL. In particular,
we are targeting local dopaminergic interneurons in the
glomerular layer (tyrosine-hydroxylase-positive) that
mediate interglomerular cross-talk, as well as deeper in-
terneurons situated in the external plexiform layer (par-
valbumin and or VIP-positive) that synapse with the
lateral dendrites of mitral cells.
Optical Dissection of Olfactory 
Microcircuits: What Computations
Are Performed on the Inputs
by the Bulb Circuitry?
We set out to sample activity of large and diverse neu-
ronal populations from the two layers of the bulb in re-
sponse to numerous odorants. Recent developments in
multiphoton microscopy and new generations of genet-
ically encoded neuronal activity reporters allow monitor-
ing both glomeruli (inputs) and mitral cell (outputs)
responses simultaneously within the same animal and in
response to the same set of odorants. Toward this end,
we built two custom multiphoton microscopes that allow
for fast x-y-z scanning and two large-scale odor delivery
machines (165 odorants). Preliminary experiments indi-
cate that activity patterns at the level of mitral cell bodies
are not simply scaled down versions of glomerular rep-
resentations (Fig. 3). Therefore, we have started to sys-
tematically investigate the contributions of lateral signals
and feedback from other areas to bulb input-output
transform via optogenetic strategies. 
Dissecting the Spatial and Temporal
Features of the Glomerular Code
in Awake Behaving Animals via
Optogenetics Strategies
We are using light activation of glomeruli in awake head-
restrained OMP-chr2 mice to ask how different spa-
tiotemporal input patterns get processed at the level of the
mitral cells and influence behavior. Using light activation
Figure 2. DLP patterned illumination in ORC mice maps the parent glomeruli of mitral cells in vivo. (A, Left) A
DLP projector coupled to a system of three lenses delivered light patterns to activate individual glomeruli on the
dorsal surface of the bulb. A CCD (charge-coupled device) camera was used to visualize the bulb surface and
record the position of the light stimulus. (Top panel, right) Dorsal surface of the bulb with a tetrode positioned in
the mitral cell layer. One square light spot is being projected onto the surface of the bulb. (Inset) Cartoon schematic
of glomeruli on the bulb, a subglomerular-size light spot and dual tetrodes positioned in the mitral cell layer. (a)
DLP projector, with color wheel removed from optical path, (b) focusing lens, (c) blue excitation filter, (d) dichroic
mirror, (e) emission filter, (f) CCD camera, (g) dual-tetrode, (h) olfactory bulb. (B, Top) Raw voltage traces corre-
sponding to the four channels of a tetrode showing light-induced changes in firing patterns of the units recorded.
(Center) Raster plot shows changes in spiking activity of a single isolated unit across 25 light-stimulation trials,
each 200 msec long; dots mark spike occurrence times. (Bottom) Peristimulus time histogram (PSTH) with 25-
msec time bins, summing spikes over the trials shown in the center panel.
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of the glomeruli bypasses the inherent uncertainty of ol-
factory stimuli delivery, as odor plumes diffuse slowly and
in complex patterns. Our goal is to generate olfactory per-
cepts by strictly controlled patterned light stimulation and
dissect the neurocorrelates of those patterns that dictate
olfactory behavior at the level of olfactory bulb circuitry.
Using the strategy described above, we are stimulating se-
lect sets of glomeruli with a combination of blue and or-
ange light via the DMD-based patterned illumination/
multiphoton imaging rig. The mice are trained to identify
this particular pattern, called “A” in a two alternative
forced-choice (2AFC) tasks as being unique from any
other stimulus pattern “NOT A.” For instance, when
studying interglomerular timing as a feature, “NOT A”
may contain variations of “A” with altered intensities,
added or dropped glomeruli, “A” in presence of foster
odors, etc. Posttraining, probe trials are conducted in
which only the feature of interest (timing in the above de-
scribed case) is varied. The behavior is monitored for errors
in classification and differences in response latencies. As a
second-level perturbation, different subsets of interneurons
are inhibited/activated over distinct time windows while
stimulating with pattern “A,” and any changes in behavior
are determined. The behavioral effects imposed by these
two kinds of perturbations will then be compared to elu-
cidate which subsets of interneurons mediate the process-
ing of that particular feature of the odor code.
Other Collaborative Projects
with CSHL Groups 
We are colloborating with fellow scientists on the fol-
lowing projects: optical monitoring of cholinergic mod-
ulation of cortical circuits (with A. Kepecs); bridging the
gap between the functional responses of glomeruli to
odors and odor receptor sequences (with A. Koulakov);
monitoring synaptic plasticity of bulb circuits and
AMPA receptor trafficking in real time, during learning
(with B. Li); optical monitoring of neuronal activity in
genetically and anatomically defined cortical circuits in
animal models of cognition (with A. Zador); using op-
tical tools to study molecular mechanisms controlling
branching of maize inflorescence (with D. Jackson). 
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Analysis of Complex Phenotypes
via Molecular Networks and
New-Generation Sequencing
I. Iossifov
I am studying the genetics of common diseases in humans
using two main tools: new-generation sequencing and
molecular networks representing functional relationships
among genetic loci. In combination, these tools enable
large-scale studies necessary for furthering our under-
standing of the complex etiology of disorders such as
autism, bipolar disorder, and cancer. I focus both on the
development of new methods and tools—for sequence
analysis, for building, and for using molecular networks—
and on their application for specific biomedical problems.
ONGOING PROJECTS
Whole-Exome Sequencing of the SSC 
The Simons simplex collection (SSC) is expected to
grow to 4000 families, with one child diagnosed with
Figure 3.Odor responses of glomerular and mitral cell body layers via multi-photon imaging of GCAMP2 signals.
(Left) Glomeruli, (center) mitral cell bodies, (right) best functional matches between glomerular and mitral cell
bodies odor responses to a panel of 125 stimuli. (G) Glomerulus; (M) mitral cells from Kv3.1 GCAMP2 mice
(Fletcher et al., J Neurophysiol 102, 817 [2009]).
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autism spectrum disorder and with at least one unaf-
fected child. Such a collection is ideally suited for iden-
tification of de novo mutations with a strong effect on
the disorder. Recent improvements of the techniques
for enrichment of coding genomic sequences and of the
new-generation sequencing technology made feasible
whole-exome sequencing for a large number of samples.
The generated data are of high quality and can be used
to identify de novo single-nucleotide, short-indel, and
copy-number mutations. This project was carried out
in collaboration with Michael Wigler and Richard 
McCombie at CSHL.
Analysis of the Pathways Affected
by De Novo Copy-Number
Mutations Identified in 2000 Families
from the SSC Collection
Recent evidence suggests that rare variants, including
copy-number variants (CNVs), have a significant role in
the etiology of autism. Although many such variants have
been identified, the specific molecular networks associ-
ated with this complex disorder remain largely unknown.
In this study, we develop a method for network-based
analysis of genetic associations (NETBAG). We use
NETBAG to identify a large biological network of genes
affected by rare de novo CNVs in autism. The genes
forming the network are primarily related to synapse de-
velopment, axon targeting, and neuron motility. This
project is being carried out in collaboration with Michael
Wigler (CSHL) and Dennis Vitkup (Columbia Univer-
sity). 
Analysis of the Overall Sharing
of Parental Genome by Concordant
and Discordant Autistic Siblings
The goal is to test the hypothesis that a substantial pro-
portion of inherited autism is caused by a dominant mu-
tation inherited from the mother, with different mothers
having different affected loci. So far, we see a suggestive
increase of sharing of the mothers’ genomes in a cohort
of ~300 multiplex families from the AGRE collection
with microsatellite markers. The next step is to see if the
signal is preserved and statistically significant in a larger
set of 700 families genotyped with a 10K single-nu-
cleotide polymorphism (SNP) array. We are carrying out
this project in collaboration with Michael Wigler and
Kenny Ye at CSHL.
Sequencing of Treatment-Related
tAML 5q and 7q Chromosomes
A large proportion of treatment-related acute myeloid
leukemia (tAML) cases present with hemizygous 7q or
5q chromosomes. In collaboration with Mona Spector
and Scott Lowe at CSHL, we are sequencing 50 samples
with the hope of identifying a gene within the 5q and 7q
regions with recurrent variants affecting protein sequence.
Epigenetics and Cancer
C.R. Vakoc
Chromatin is the fundamental packaging material of eu-
karyotic genomes, composed of DNA in its native com-
plex with protein. The basic organizational unit of
chromatin is the nucleosome, composed of an octamer
of core histones wrapped by 147 bp of DNA. Chromatin
is charged with the critically important task of both pro-
tecting the genetic code and animating its many func-
tions. Replication, recombination, and transcription of
DNA in the cell all occur in a chromatin context, and
hence, elaborate control mechanisms have evolved to
govern chromatin structure in these diverse scenarios.
The central interest of our laboratory is to understand
the enzymatic mechanisms that control chromatin and
how such pathways establish heritable chromatin states
and participate in the pathophysiology of cancer. 
A major focus of our work is a class of molecules re-
ferred to as human Trithorax proteins, also known as the
mixed-lineage leukemia (MLL) family. MLL proteins are
large, modular chromatin regulators that use catalytic
(methyltransferase activity for histone H3 lysine 4) and
noncatalytic (chromatin-binding and scaffold functions)
mechanisms to maintain the “ON” state of gene expres-
sion. One fascinating feature of MLL and its orthologs
in other species is their capacity to maintain heritable
states of gene activity, as exemplified by MLL in
Drosophila maintaining heritable programs of Hox gene
expression, a phenomenon known as cellular memory.
Although most of the classic epigenetic inheritance phe-
nomena have been linked with the “OFF” state of ex-
pression, the epigenetic maintenance of the “ON” state
by MLL stands alone as one of the only known mecha-
nisms in nature that stably preserves active chromatin in
a manner heritable through somatic cell divisions. One
key interest in our laboratory is to define the molecular
mechanism of epigenetic inheritance by MLL proteins.
In addition to having essential functions in maintain-
ing active chromatin during normal ontogeny and dif-
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ferentiation, the MLL protein is also a proto-oncogene
in acute leukemia. MLL is frequently mutated via chro-
mosomal translocation to generate oncogenic fusion pro-
teins. MLL fusion proteins induce a hyperactive chro-
matin state as compared to wild-type MLL, which leads
to up-regulation of MLL’s normal target genes to block
hematopoietic cell differentiation and induce leukemia.
Thus, MLL leukemias represent a clear situation where
chromatin dysfunction directly causes a human cancer.
A major thrust of our research is to use MLL leukemia as
a model system to study how epigenetic pathways par-
ticipate in cancer pathogenesis. Our primary approach is
to evaluate whether therapeutic targeting of epigenetic
pathways can eradicate leukemia cells in vivo. Because
MLL leukemia represents a poor-prognosis subtype of
this disease, we hope to identify novel therapeutic targets
in this cancer by mining epigenetic pathways.
RNAi Screening to Expose Epigenetic
Vulnerabilities in AML
E. Wang, J. Shi
The central hypothesis our work on acute myeloid
leukemia (AML) is that suppression of epigenetic path-
ways can be an effective means to achieve selective eradi-
cation of leukemia cells in vivo. However, the challenge
is in how one identifies candidate epigenetic targets as
novel cancer therapies. To this end, we have begun RNA
interference (RNAi) screening as a means of revealing and
distinguishing the epigenetic requirements between nor-
mal and malignant cells. First, we generated a custom
short hairpin RNA (shRNA) library targeting all known
chromatin regulators, which includes ~1100 shRNAs tar-
geting 250 genes. Next, we introduced this library in a 1-
Figure 1. RNAi screen for unique epigenetic requirements needed for MLL-leukemia growth. (A) Experimental
strategy. A mosaic mouse model of MLL–AF9/NrasG12D was transduced with the Epigenetics-246 shRNA library.
(B) Primary screen identified 129 shRNAs that inhibit proliferation (in gray) (C) Comparison of shRNA effects in
leukemia and 32D myeloid contexts. The triangle demarcates shRNAs that tested positive in the screen by prefer-
entially inhibiting leukemia proliferation. Positive control shRNAs are labeled.
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by-1 or pooled fashion into a mouse model of MLL–
AF9/ NrasG12D leukemia. We then scored the impact of
each shRNA on AML growth in vitro and compared the
effects on a number of nontransformed hematopoietic
cell lines, representing normal cells. Through this ap-
proach, we were able to identify several candidate shRNA
pathways, which we want to validate in vivo. Using a sim-
ilar “negative-selection” strategy, we introduced shRNAs
targeting various epigenetic pathways into normal or
leukemic cells and transplanted into lethally or sublethally
irradiated recipients. The impact of each shRNA was
scored using a two-color fluorescence-activated cell sorting
(FACS)-based assay. This analysis reliably distinguished
the in vivo growth requirement for normal and malignant
cells and identified several candidate epigenetic pathways.
Among the top hits in the RNAi screen were the Eed
and Suz12 genes, which both encode subunits of the
PRC2 (Polycomb repression complex). PRC2 is a histone
methyltransferase that selectively modifies histone H3 at
lysine 27. This chromatin modification has a clear role in
gene repression, which it serves as a docking site for other
repressive complexes. Identifying two subunits in the
screen provides strong evidence that this complex was in-
volved in AML progression. Following knockdown of
PRC2 in MLL-AF9/NrasG12D leukemia cells, we observed
robust differentiation of leukemic blasts into cells with an
obvious macrophage morphology, indicating that PRC2
is required to prevent differentiation of leukemic cells. This
phenotype bears striking resemblance to suppressing
MLL-AF9, the driver oncogene in this disease. To identify
the core downstream targets of PRC2 in AML, we per-
formed expression microarrays comparing evaluating
global changes in gene expression signatures, followed by
large-scale chromatin immunoprecipitation experiments
to distinguish direct from indirect targets. Using a combi-
nation of overexpression and loss-of-function approaches,
we were able to pinpoint the Ink4a/Arf tumor suppressor
locus as the key downstream target of PRC2 in AML. In
addition, we were also able to demonstrate that the onco-
genic drivers of AML in this model, MLL-AF9 and
NrasG12D, both provide a signal that stimulates Ink4a/Arf
expression, which threatens to inhibit growth of AML cells
in vitro. In our model, we speculate that PRC2 provides a
buffering system in AML for diminishing oncogenic stress.
By suppressing PRC2 with RNAi, we eliminate this buffer
and unravel the transformed cellular state through induc-
tion of Ink4a/ Arf expression. We speculate that PRC2 will
represent a promising new therapeutic target in AML.
Another hit identified in the RNAi screen is the BET-
bromo domain protein Brd4. Notably, among the 250
candidate genes in the screen, Brd4 inhibition displayed
the most profound elimination of leukemia cells in vitro,
making it the top hit. Like PRC2, suppression of Brd4
leads to similar induction of myeloid differentiation with
associated loss of leukemia stem cell populations. Quite
fortunately, our studies have converged with those of the
James Bradner laboratory at Harvard, which has recently
developed small-molecule inhibitors of the Brd4 bromo-
domains. In collaboration with Bradner and Scott Lowe’s
laboratory at CSHL, we have begun investigating the an-
tileukemic activity of Brd4 inhibitors in vitro and in vivo.
This example represents the overall effort in the lab of
identifying epigenetic sensitivities in cancer that might
be exploited using small-molecule inhibitors, which
could be developed in the future as drugs in AML.
PUBLICATIONS
Speck NA, Vakoc CR. 2010. PAF is in the cabal of MLL1-interacting
proteins that promote leukemia. Cancer Cell 17: 531–532.
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WATSON SCHOOL OF BIOLOGICAL
SCIENCES DEAN’S REPORT
Yet another year has flown by here at the Watson School of Biological
Sciences (WSBS). In 2010, we were extremely fortunate to recruit
Dr. Keisha John back to the School as our new Associate. Keisha was
in the School’s Entering Class of 2004 and did her doctoral research
with Dr. Linda Van Aelst. She graduated in April 2009 and was a
postdoctoral fellow with Dr. Mary Beth Hatten at The Rockefeller
University. Keisha’s professional interests moved in the direction of
education administration and we are thrilled to have her as the newest
member of “Team Watson.” 
Faculty Changes
Five new faculty members joined the Laboratory in 2010: Florin Albeanu, Anne Churchland,
Christopher Hammell, Michael Schatz, and Hongwu Zheng.
Dinu Florin Albeanu, an Assistant Professor, first came to CSHL in 2008 as a Cold Spring Har-
bor Fellow. He is a neuroscientist who uses electrophysiology and imaging to study how sensory
input, such as olfaction, encodes information from the environment and ultimately leads to per-
ceptions.
Assistant Professor Anne Churchland was a postdoctoral fellow at the University of Washington
before coming to CSHL. Her research focuses on the circuitry connecting sensory processing and
motor control. She uses both humans and rodents to study how sensory input leads to decision-
making. 
Assistant Professor Christopher Hammell was a postdoctoral fellow at the University of Massa-
chusetts Medical School before coming to the CSHL. His research focuses on the regulation of the
microRNA machinery, which has an important role in the regulation of gene expression. In partic-
ular, he is using the model organism, Caenorhabditis elegans, to understand the role of microRNAs
in development. 
Following a career as a software engineer, Michael Schatz, received his Ph.D. from the Center
for Bioinformatics and Computational Biology at the University of Maryland before joining CSHL
as an Assistant Professor. His research combines computational biology with advances from high-
performance computing to address problems in the field of genomics. 
Before coming to CSHL as an Assistant Professor, cancer biologist Hongwu Zheng was an Instructor
of Medicine at the Dana-Farber Cancer Institute. He uses multiple approaches in his research to study
the causal relationship between aberrant differentiation and gliomagenesis. He applies this knowledge
to target differentiation control pathways as a novel approach for treating malignant gliomas. 
We are very excited to have each of these exciting newcomers work with our students. They have
already become members of student thesis committees, and instructors and guest lecturers in our
fall courses. We look forward to their participation in additional WSBS activities in the future.
Just one faculty member departed the Laboratory in 2010: Michael Zhang. Michael served as
an instructor in the first entering class’ Fundamentals of Bioinformatics Specialized Disciplines
course. He also served on student thesis committees, as a rotation advisor, and on the admissions
committee. We are grateful for his contributions and wish him well in his new endeavor.
Team Watson: (Left to right) Alyson Kass-Eisler, Dawn Meehan,
Pologruto, Keisha John, Leemor Joshua-Tor, and Kim Geer
215-246_wsbs_Annual Report_2009 template  7/8/11  12:21 PM  Page 217
218 Watson School of Biological Sciences
The Seventh WSBS Graduation
On April 25, we celebrated the Watson School’s seventh and largest graduation ceremony to date.
The 10 (!) graduating students of 2010 are Galen Collins, Oliver Fregoso, Shraddha Pai, and David
Simpson from the entering class of 2004; Amy Leung, Hiroshi Makino, Katie McJunkin, and Oliver
Tam from the entering class of 2005; and Yaniv Erlich and Colin Malone from the entering class
of 2006. All were awarded the Ph.D. degree. Honorary degrees were bestowed upon Dr. Carla Shatz
from Stanford University and Nobel laureate Dr. Tom Cech from the University of Colorado, Boul-
der, who also gave the commencement address. 
As with each graduation, we extended a special welcome to the family members and friends of
our students who attend the ceremony. Among these special guests were family members who trav-
eled from Australia, Israel, and Japan to take part in this special event.
Teaching Award
At this year’s graduation, Josh Dubnau was presented with the fifth annual Winship Herr Faculty
Teaching Award named in honor of the School’s founding dean. Josh was the lead in-
structor of our fall Specialized Disciplines course in Genetics and Genomics. He was cho-
sen by the students for this award, based on his enthusiasm, excellence, and creativity in
teaching. This is the second time Josh has won this award—he was also recognized in
2006. The winner of this award is nominated and voted on by the students. Here are
some of the comments the students had to say about Josh:
He mixed historical context, current techniques, and a clear explanation of concepts together
with a touch of humor that enabled me and the other students to grasp the information on
first pass.
He clearly worked hard on putting together the lectures and homeworks and was very helpful
and accessible when additional clarification was needed.
Oliver Fregoso, Colin Malone, Yaniv Erlich, Oliver Tam, Amy Leung, Katherine McJunkin, Galen Collins, 
Hiroshi Makino, David Simpson, Shraddha Pai (not pictured)
Josh Dubnau
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                                    Thesis                      Academic           
Student                       advisor                    mentor                Current position
Galen Collins                William Tansey          Marja                    Postdoctoral fellow with Dr. Fred Goldberg at Harvard 
                                                                        Timmermans      Medical School
Yaniv Erlich                   Gregory Hannon       John R. Inglis        Whitehead Fellow, Whitehead Institute, Massachusetts
                                                                                                     (Independent Position)
Oliver Fregoso               Adrian R. Krainer      Nicholas Tonks      Postdoctoral fellow in Dr. Michael Emerman’s laboratory 
                                                                                                     at Fred Hutchinson Cancer Research Center, Washington
                                                                                                     (to start early 2011)
Amy Leung                    William Tansey          David L. Spector    Postdoctoral fellow with Dr. Rama Natarajan, City of 
                                                                                                     Hope, California
Hiroshi Makino             Roberto Malinow       Hollis Cline           Postdoctoral fellow with Dr. Yang Dan at the University 
                                                                                                     of California, Berkeley
Colin Malone                Gregory Hannon       David J. Stewart    Postdoctoral fellow with Dr. Ruth Lehmann at The 
                                                                                                     Skirball Institute of Biomolecular Medicine, New York 
                                                                                                     University School of Medicine
Katherine McJunkin      Scott Lowe                 Terri Grodzicker    Postdoctoral fellow with Dr. Victor Ambross at University 
                                                                                                     of Massachusetts Medical Center
Shraddha Pai                 Carlos D. Brody         Anthony Zador      Postdoctoral fellow with Dr. Arturas Petronis at the 
                                                                                                     Centre for Addiction and Mental Health, University of 
                                                                                                     Toronto, Canada
David Simpson              William Tansey          Scott Lowe             Postdoctoral fellow with Dr. Alejandro Sweet-Cordero
                                                                                                     at Stanford University (to begin early 2011)
Oliver Tam                    Gregory Hannon       David Jackson        Postdoctoral fellow with Dr. Janet Rossant at The 
                                                                                                     Hospital for Sick Children, University of Toronto, Canada
2010 THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 2004
Galen Collins, March 15, 2010
Activator turnover and proteolysis in transcriptional activation. 
Thesis Examining Committee
Chair:                              David L. Spector
Research mentor:            William Tansey
Academic mentor:           Marja Timmermans
Committee member:       Adrian R. Krainer
Committee member:       Michael Hampsey, Robert Wood 
                                       Johnson Medical School
External examiner:          Bruce Futcher, Stony Brook  
                                       University 
Oliver Fregoso, February 25, 2010
Elucidating the functions of splicing regulatory proteins
through the use of high-throughput proteomics.
Thesis Examining Committee
Chair:                              Scott Powers
Research mentor:            Adrian R. Krainer
Academic mentor:           Nicholas Tonks
Committee member:       Michael P. Myers
Committee member:       Gregory Hannon
Committee member:       Brian Chait, The Rockefeller 
                                      University
External examiner:          Alan M. Zahler, University of 
                                       California, Santa Cruz
Shraddha Pai, January 14, 2010
Neuroanatomical localization of timing-specific brain loci in
the rat.
Thesis Examining Committee
Chair:                              Josh Dubnau
Research mentor:            Carlos D. Brody
Academic mentor:           Anthony Zador
Committee member:       Partha Mitra
Committee member:       Lizbeth Romanski, The Rockefeller 
                                      University
External examiner:          Mark Laubach, Yale University
David Simpson,March 16, 2010
Regulation of myc-induced apoptosis in the mammary 
epithelia.
Thesis Examining Committee
Chair:                              Gregory Hannon
Research mentor:            William Tansey
Academic mentor:           Scott Lowe
Committee member:       Senthil K. Muthuswamy
Committee member:       George Prendergast, Lankenau 
                                       Institute for Medical Research
External examiner:          Steven McMahon, Kimmel Cancer 
                                       Center
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2010 THESIS DISSERTATION DEFENSES (continued)
ENTERING CLASS OF 2005
Amy Leung, March 5, 2010
Regulation of chromatin by histone H2B ubiquitylation. 
Thesis Examining Committee
Chair:                              David Jackson
Research mentor:            William Tansey
Academic mentor:           David L. Spector
Committee member:       Robert Martienssen
Committee member:       Rolf Sternglanz, Stony Brook 
                                       University
External examiner:          Mary Ann Osley, University of 
                                       New Mexico 
Hiroshi Makino, March 8, 2010
AMPA receptor dynamics and synaptic plasticity at excitatory
synapses.
Thesis Examining Committee
Chair:                              Anthony Zador
Research mentor:            Roberto Malinow
Academic mentor:           Bo Li 
Committee member:       Pavel Osten
Committee member:       Linda Van Aelst
External examiner:          Edward Ziff, New York University
Katherine McJunkin, February 25, 2010
Inducible RNAi targeting essential genes.
Thesis Examining Committee
Chair:                              Gregory Hannon
Research mentor:            Scott Lowe
Academic mentor:           Terri Grodzicker
Committee member:       Raffaella Sordella
External examiner:          Vivek Mittal, Memorial Sloan-
                                      Kettering Cancer Center
External examiner:          Andrea Ventura, Cornell University 
                                       Medical College
Oliver Tam, February 11, 2010
Characterization of small RNA populations and DNA 
methylation in mammalian development.
Thesis Examining Committee
Chair:                              Marja Timmermans
Research mentor:            Gregory Hannon
Academic mentor:           David Jackson
Committee member:       Zachary Lippman
Committee member:       Richard Schultz, Stony Brook 
                                       University
External examiner:          Robert A. Taft, The Jackson 
                                       Laboratory
ENTERING CLASS OF 2006
Yaniv Erlich, March 19, 2010
Compressed sequencing. 
Thesis Examining Committee
Chair:                              Adrian R. Krainer
Research mentor:            Gregory Hannon
Academic mentor:           John R. Inglis
Committee member:       Partha P. Mitra
Committee member:       Michael Q. Zhang
External examiner:          David Donoho, Stanford 
                                       University 
Colin Malone, February 8, 2010
Evolution, inheritance, and specialization of transposon con-
trol pathways in Drosophila.
Thesis Examining Committee
Chair:                              David L. Spector
Research mentor:            Gregory Hannon
Academic mentor:           David J. Stewart 
Committee member:       Robert Martienssen
Committee member:       Ruth Lehmann, New York 
                                      University
External examiner:          Craig Mellow, University of 
                                       Massachusetts
ENTERING CLASS OF 2010
Arkarup Bandyopadhyay, Tata Institute of Fundamental 
Research, University of Delhi, India
Academic mentor: Zachary Lippman
Colleen Carlston, Harvard University  
Academic mentor: Alexander Gann
Matthew Koh, University of California, Berkeley 
Academic mentor: Bo Li
Lisa Krug, Skidmore College 
Academic mentor: Stephen Shea
Mark Orcholski, Buck Institute, Dominican 
University 
Academic mentor: Nicholas Tonks 
John Sheppard, Northwestern University 
Academic mentor: Josh Dubnau
Jack Walleshauser, University of North Carolina,
Greensboro 
Academic mentor: Christopher Hammell
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2010 Entering class: (Left to right) Lisa Krug, Arkarup Bandyopadhyay, Colleen Carlston, John Sheppard,
Jack Walleshauser, Mark Orcholski, and Matthew Koh.
The 2010 class enjoys a sail on Oyster Bay.
Admissions 2010
The School received 170 applications for the 2010/2011 academic year and is deeply indebted to its
Admissions Committee, which reviewed, interviewed, and selected candidates for our doctoral pro-
gram. The Admissions Committee for the 2010 entering class comprised Gregory Hannon (chair),
Mickey Atwal, Leemor Joshua-Tor, Adam Kepecs, Adrian R. Krainer, Zachary Lippman, W. Richard
McCombie, Nicholas Tonks, Lloyd Trotman, and Linda Van Aelst—a truly remarkable team!
Entering Class of 2010
On August 30, 2010, the Watson School opened its doors for the 12th time to welcome yet another new
class. This year, seven students joined the School: Arkarup Bandyopadhyay, Colleen Carlston, Matthew
Koh, Lisa Krug, Mark Orcholski, John Sheppard, and Jack Walleshauser. Colleen was a participant in
the summer Undergraduate Research Program in 2008 under the mentorship of Josh Dubnau.
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DOCTORAL THESIS RESEARCH
Academic Research 
Student mentor mentor Thesis research 
ENTERING CLASS OF 2005
Patrick M. Finigan Senthil K. Muthuswamy Robert Martienssen Epigenetic mechanisms involved in centromere
Beckman Graduate Student function.
Frederick D. Rollins Jan A. Witkowski Gregory Hannon An RNAi screen for modifiers of cellular 
Cashin Fellow response to the targeted therapeutic Erlotinib.
ENTERING CLASS OF 2006
Eyal Gruntman Josh Dubnau Glenn Turner Olfactory perception in Drosophila.
Elisabeth Sloan Livingston Fellow
Amy Rappaport William Tansey Scott Lowe Identification and characterization of tumor
Barbara McClintock Fellow suppressor genes in acute myeloid leukemia.
Thesis defense: March 2011
Claudio Scuoppo Scott Lowe Gregory Hannon Identification of novel oncosuppressors through
Engelhorn Scholar an in vivo RNAi screen in the Eµ-myc model.
Thesis defense: March 2011
ENTERING CLASS OF 2007
Megan Bodnar Nicholas Tonks David L. Spector The nuclear choreography of chromatin 
Starr Centennial Scholar dynamics, gene expression, and gene repression 
in embryonic stem cells.
Ralph Burgess Bruce Stillman Gregory Hannon Recombination hot spots: Characterizing fine-
Starr Centennial Scholar scale variation in the frequency of meiotic  
recombination across the mammalian genome.
Joseph Calarco David Jackson Leemor Joshua-Tor Transposable element regulation in the
David H. Koch Fellow flowering plant.
Saya Ebbesen David J. Stewart Scott Lowe In vivo identification and characterization 
NIH Predoctoral Trainee of novel tumor suppressors relevant to 
human breast cancer.
Paloma Guzzardo Adrian R. Krainer Gregory Hannon Dissecting the piRNA pathway in the
Leslie C. Quick, Jr. Fellow Drosophila ovarian somatic sheet.
NIH Predoctoral Trainee
Kyle Honegger John R. Inglis Glenn Turner Neuronal and circuit mechanisms creating 
Crick-Clay Fellow sparse odor representations in the mush-
NIH Predoctoral Trainee room body of Drosophila.
Marek Kudla David Jackson Gregory Hannon CLIP method as a way of direct readout of
George A. and Marjorie H. Anderson Fellow microRNA target sites.
Hassana Oyibo Hiro Furukawa Anthony Zador Reconstruction of connectivity of neurons by 
Farish-Gerry Fellow reading of oligonucleotide labels (ROC-N-ROL).
Michael Pautler Robert Lucito David Jackson The RAMOSA pathway and inflorescence 
William R. Miller Fellow branching in maize.
Maria Pineda Adrian R. Krainer Raffaella Sordella Mechanism of “addiction” to receptor 
CSHL Women’s Partnership for Science tyrosine kinases in non-small-cell lung 
Student carcinoma.
Yevgeniy Plavskin Jan A. Witkowski Marja Timmermans The evolution of the miR390-dependent  
Alfred Hershey Fellow tasiRNA pathway and its function in the 
NIH Predoctoral Trainee bryophyte development.
Joshua Sanders Bruce Stillman Adam Kepecs Trans-regional coordination of activity in 
Edward and Martha Gerry Fellow the mouse brain.
Zhenxun Wang Terri Grodzicker Adrian R. Krainer Alternative splicing of pyruvate kinase M 
A*STAR Fellow in tumorigenesis.
222 Watson School of Biological Sciences
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DOCTORAL THESIS RESEARCH (continued)
Academic Research 
Student mentor mentor Thesis research 
Petr Znamenskiy Terri Grodzicker Anthony Zador Pathways for attention and action in the 
David and Fanny Luke Fellow auditory system.
ENTERING CLASS OF 2008
Philippe Batut Alexander Gann Thomas Gingeras Transposable and evolution of transcriptional 
Florence Gould Fellow regulation in the Drosophila clade.
Mitchell Bekritsky W. Richard McCombie Michael Wigler High-throughput microsatellite genotyping. 
Beckman Graduate Student
Dario Bressan Z. Josh Huang Gregory Hannon A genomic approach toward the elucidation of
Lindsay Fellow connectivity patterns at cellular resolution in 
complex neural networks.
Carrie Clendaniel David Jackson Marja Timmermans Role of HIRA in the regulation of develop-
Beckman Graduate Student mentally important target loci.
Melanie Eckersley-Maslin Gregory Hannon David L. Spector Making the choice: Mechanistic insights 
Genentech Foundation Fellow into random autosomal monoallelic expres-
sion in mammalian cells.
Sang Geol Koh Glenn Turner Anthony Zador Attention-dependent information routing 
George A. and Marjorie H. Anderson Fellow in the mouse auditory cortex.
Katie Liberatore Adrian R. Krainer Zachary Lippman Inflorescence development and heterosis.
NSF Graduate Research Fellow
Ozlem Mert John R. Inglis Scott Lowe Characterization of the role of E2F7 in 
George A. and Marjorie H. Anderson Fellow oncogene-induced senescence and tumori-
genesis.
Elizabeth Nakasone Alea A. Mills Mikala Egeblad Understanding the effects of cytotoxic chemo-
DoD BCRP Predoctoral Fellow therapeutics on the innate immune response.
Zinaida Perova Linda Van Aelst Bo Li Role of medial prefrontal cortex in behav-
Charles A. Dana Fellow ioral depression.
Felix Schlesinger Gregory Hannon Thomas Gingeras Classification of novel transcription start sites. 
Crick-Clay Fellow
Nilgun Tasdemir Josh Dubnau Scott Lowe Investigating the molecular overlaps be-
Lindsay Fellow tween epigenetic reprogramming and trans-
formation.
Elvin Wagenblast Jan A. Witkowski Gregory Hannon Role of stem/progenitor cells in mammary 
Boehringer Ingelheim Fonds Scholar gland and breast tumors.
Susann Weissmueller Raffaella Sordella Scott Lowe In vivo identification and characterization
Annette Kade Fellow of tumor suppressor genes in hepatocellular 
carcinoma.
ENTERING CLASS OF 2009
Stephane Castel Lloyd Trotman Robert Martienssen RNAi-mediated heterochromatin in S. pombe.
Cashin Fellow 
Proposal defense: February 2011
Kristen Delevich Stephen Shea Bo Li Elucidating the role of Disrupted-in-Schizo-
NIH Predoctoral Trainee phrenia-1 in development of prefrontal cortical 
Proposal defense: January 2011 circuits.
Silvia Fenoglio Linda Van Aelst Gregory Hannon RNAi screening to identify putative therapeutic 
Elisabeth Sloan Livingston Fellow targets for the treatment of pancreatic cancer.
Proposal defense: December 2010
Wee Siong Goh Hiro Furukawa Gregory Hannon Determining piRNA primary biogenesis, and 
A*STAR Fellow MIWI and late piRNA function in mice using 
Proposal defense: January 2011 C. elegans as a model system for genetic screening.
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Academic Mentoring
The Watson School takes great pride in the level of mentoring that it offers its students. One of the
very special aspects in this regard is our two-tiered mentoring approach whereby each student receives
an academic mentor as well as a research mentor. Entering students select by mutual agreement a
member of the research or nonresearch faculty to serve as an academic mentor—a watchful guardian
to look over and encourage students through the sometimes-trying process of their doctoral educa-
tion. This program continues to receive much support from the faculty who volunteer to be academic
mentors, and it has rightfully become a vital ingredient in our success. The following are this year's
new academic mentors for the entering class of 2010:
The Fall Term Curriculum
Our faculty continues to do an outstanding job of developing and delivering the curriculum. We are
extremely grateful for their considerable time and effort in maintaining the high-quality course work
that we strive to provide. The Curriculum Development and Integration Committee (CDIC)—Adrian
Krainer (Chair), David Jackson, Leemor Joshua-Tor, Nicholas Tonks, and Glenn Turner—continues
to carefully monitor and develop the curriculum. In addition to the outstanding course instructors and
guest lecturers from within the Laboratory, our courses also continue to attract an impressive array of
guest lecturers from other institutions.
New Courses in Quantitative Biology
This year, we developed two new courses in the rapidly emerging field of quantitative biology. Today’s
science often relies on the use of theoretical modeling and the analysis of vast quantities of data. We
therefore need to train scientists who not only are experts in biology, but also have skills in mathematics,
physics, chemistry, and computation. The new courses were designed to expand the curriculum to the
areas of statistics, programming, bioinformatics, and theoretical modeling and analysis and take different
approaches to quantitative thinking. The first course, Physical Biology of the Cell, which was developed
by Leemor Joshua-Tor and Rob Phillips from the California Institute of Technology, teaches the students
DOCTORAL THESIS RESEARCH (continued)
Academic Research 
Student mentor mentor Thesis research 
Ian Peikon Mickey Atwal Anthony Zador Reverse engineering the brain.
George A. and Marjorie H. Anderson Fellow
Proposal defense: February 2011
Kaja Wasik Jan A. Witkowski Gregory Hannon A screen for novel components of the piRNA 
George A. and Marjorie H. Anderson Fellow pathway in Drosophila melanogaster.
Proposal defense: February 2011
Cinthya Zepeda Mendoza Thomas Gingeras David L. Spector Analysis of higher-order chromatin organization
Gonzalo Rio Arronte Fellow at the mouse syntenic region of human 1p36
Proposal defense: January 2011 upon genomic copy-number changes.
STUDENT MENTOR
Arkarup Bandyopadhyay Zachary Lippman
Colleen Carlston Alex Gann
Matthew Koh Bo Li
Lisa Krug Stephen Shea
STUDENT MENTOR
Mark Orcholski Nicholas Tonks
John Sheppard Josh Dubnau
Jack Walleshauser Christopher Hammell
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how to apply concepts from the physics world and how to use computational approaches in looking at
biological concepts in a new way. The second course, Quantitative Biology, was developed by faculty
member Mickey Atwal to provide students with the tools to interpret large complex data sets and to
use statistical methodology in their research. Full descriptions of these courses can be found in the Cur-
riculum section.
Recruiting Efforts
Recruitment for the graduate program’s 2010 class and our Undergraduate Research Program (URP)
of 2010 was once again managed by Ms. Dawn Pologruto, the School’s Director for Admissions and
Student Affairs. As in years past, Dawn, our faculty, and our students traveled the length and breadth
of the country representing CSHL and WSBS. This year, they were joined by Keisha John who made
special recruitment visits aimed at enhancing diversity. The table below details recruitment fairs and
conferences in which we have participated, together with the names of faculty, students, and admin-
istrators who represented WSBS on these occasions. To further raise awareness of our programs, we
also mailed more than 15,000 letters to colleges and universities in the United States and abroad.
A New Website
The WSBS website (http://www.cshl.edu/gradschool) underwent a complete redesign in 2010. This
newly enhanced and modernized website describes our unique approach to graduate education and
showcases our students, faculty, and alumni through personalized profiles and perspectives. The en-
hanced site is more user friendly and more visually appealing. Potential students can now link di-
rectly to the online Ph.D. program and URP applications and complete their applications online,
making it easier to apply and reducing the amount of paper being used. Although still being
“tweaked,” the new site is already having an impact on our recruitment efforts. The School witnessed
an increase of more than 50% in the number of applications received for the entering class of 2011,
our second largest pool of applicants since we were founded.
Interinstitutional Academic Interactions
It is important to bear in mind that many of the graduate students who pursue their thesis research
at CSHL are not in the WSBS graduate program. Indeed, a large percentage of students are from
Stony Brook University (SBU), via a program established between CSHL and SBU more than 30
years ago. In addition, we often have visiting students from institutions around the world who come
and do their studies in our laboratories. WSBS provides an on-site “home” for these students, helps
to ensure that they feel part of the CSHL community, and assists them with the complexities of
performing doctoral research away from their parent institutions. The following students, listed in
the box below, joined us this year.  
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
Student                                         CSHL research mentor                  Affiliation and program
Fatma Bezirci                                      Adrian R. Krainer                                 Stony Brook, Molecular and Cellular Biology
Wen Huang                                        Partha Mitra                                         Stony Brook, Biomedical Engineering
Huan Qi                                             Scott Powers                                         Stony Brook, Applied Math and Statistics
Junwei Shi                                          Bruce Stillman                                      Stony Brook, Molecular and Cellular Biology
Guoli Sun                                           Alexander Krasnitz                                Stony Brook, Applied Math and Statistics
Matthew Titmus                                Michael Schatz                                      Stony Brook, Molecular and Cellular Biology
Jason Tucciarone                                 Z. Josh Huang                                      Stony Brook, Neuroscience
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2010 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE
Event                                                            Location                                      Date                        WSBS attendees/titles
Hunter College: MARC/RISE Program Visit Cold Spring Harbor Laboratory January 14 Dawn Pologruto, Director of 
Admissions and Student Affairs
Rice University: The Institute of Biosciences Rice University January 27 Dawn Pologruto
and Bioengineering Information Fair
University of Notre Dame: Career and University of Notre Dame February 3 Information sent for distribution
Internship Fair
Wellesley College: Women in Science Fair Wellesley College February 24 Information sent for distribution
Molloy College: Information Session Cold Spring Harbor Laboratory April 9 Alyson Kass-Eisler, Director of 
and Visit Curriculum; Katie Liberatore, 
Graduate Student; Hassana Oyibo, 
Graduate Student; Dawn Pologruto:
Amy Rappaport, Graduate Student
Stanford University: Spring Career Fair Stanford University April 14–15 Dawn Pologruto
California Forum for Diversity: Graduate University of California, April 17 Dawn Pologruto
School Fair Channel Islands
Practical Summer Workshop in Functional The Ohio State University June 24 Doreen Ware, Associate Professor
Genomics: Information Session
New York City College of Technology: NSF Cold Spring Harbor Laboratory July 15 Dawn Pologruto; Amy Rappaport
STEP Program Visit
University of Medicine and Dentistry, New Cold Spring Harbor Laboratory July 23 Dawn Pologruto; Fred Rollins, Graduate 
Jersey: Summer Internship Program Visit Student
The Protein Society: 24th Annual  San Diego, California August 4 Hassana Oyibo
Symposium and Graduate School Fair 
Brookhaven National Laboratory: Graduate Brookhaven National Laboratory August 11–12 Keisha John, WSBS Associate
School Fair and Annual Symposium
Hispanic Association of Colleges and San Diego, California September 18–20 Hassana Oyibo; Petr Znamenskyiy, 
Universities: 24th Annual Conference Graduate Student
University of Maryland, Baltimore County: University of Maryland, September 20 Keisha John
Meyerhoff Scholarship Program Visit Baltimore County
The Johns Hopkins University: Information The Johns Hopkins University September 21 Keisha John
Session
Morgan State University: MBRS-RISE Morgan State University September 22 Keisha John
Program Graduate Career Workshop and
Information Session
Massachusetts Institute of Technology: Massachusetts Institute of September 23 Amy Rappaport; Jeremy Wilusz, WSBS 
Career Fair Technology Alumni
University of Maryland, Eastern Shore: University of Maryland, Eastern September 23 Keisha John
Information Session Shore
Duke University: Information Session Duke University September 23 Ian Peikon, Graduate Student
Massachusetts Institute of Technology: Massachusetts Institute of September 24 Amy Rappaport; Jeremy Wilusz, WSBS 
Information Session Technology Alumni
Big 10+ Graduate School Fair Purdue University September 27 Josh Sanders, Graduate Student
Cornell University: Information Session Cornell University September 28 Eugene Plavskin, Graduate Student;
Petr Znamenskiy
The Johns Hopkins University: Career Fair The Johns Hopkins University September 29 Marek Kudla, Graduate Student
Cornell University: Graduate and Cornell University September 29 Eugene Plavskin; Petr Znamenskiy
Professional School Day
Notre Dame University: Information Session Notre Dame University September 30 Kristen Delevich, Graduate Student
Society for Advancement of Chicanos and Anaheim, California September 30– Melanie Eckersley-Maslin, Graduate 
Native Americans in Science (SACNAS) October 2 Student; Keisha John
Hampton University: Information Session Hampton University October 4 Keisha John
Hunter College: Minority Access for Hunter College October 6 Hassana Oyibo; Chris Vakoc, CSHL
Research Careers (MARC) Program Fellow
Information Session 
Howard University: Research Talk and Howard University October 6 Keisha John; Alea Mills, Associate
Information Session Professor
University of Puerto Rico, Rio Piedras: University of Puerto Rico, October 6 Paloma Guzzardo, Graduate Student
Minority Access for Research Careers Rio Piedras
(MARC) Program Information Session
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2010 WATSON SCHOOL OF BIOLOGICAL SCIENCES RECRUITMENT SCHEDULE (continued)
Event                                                            Location                                      Date                        WSBS attendees/titles
University of California, Berkeley: Graduate University of California, Berkeley October 6–7 Megan Bodnar, Graduate Student
School Fair
Oberlin College: Information Session Oberlin College October 7 Saya Ebbesen, Graduate Student
Northwestern University: Information Session Northwestern University October 7–8 Mitch Bekritsky, Graduate Student
Barry University: Minority Access for Barry University October 8 Maria Pineda
Research: Careers (MARC) Program 
Information Session
Washington University, St. Louis: Washington University, St. Louis October 12 Keisha John
Information Session
University of Wisconsin, Madison: Graduate University of Wisconsin, Madison October 13 Dario Bressan, Graduate Student
School Fair
Princeton University: Information Session Princeton University October 14 Michael Pautler, Graduate Student
University of North Carolina, Chapel Hill: University of North Carolina, October 15 Zina Perova, Graduate Student
Graduate School Fair Chapel Hill
Princeton University: Graduate and Princeton University October 15 Michael Pautler
Professional School Fair
Rowan University: Information Session Rowan University October 15 Dawn Pologruto
Duke University: Graduate School Fair Duke University October 18 Stephen Shea, Assistant Professor
Howard University: Information Session Howard University October 19 Keisha John
Queens College, City University of New Queens College, City University October 20 Keisha John
York: MARC-USTAR Program of New York
Information Session
Emory University: Graduate School Fair Emory University October 21 Keisha John
Spelman College: MARC-USTAR Program Spelman College October 21 Keisha John
Information Session
State University of New York, Farmingdale: Cold Spring Harbor Laboratory October 22 Keisha John; Hassana Oyibo; Michael 
Information Session and Visit Pautler; Dawn Pologruto
Temple University: MARC Program: Temple University October 22 Keisha John
Information Session
California Institute of Technology: Career Fair California Institute of Technology October 26 Elizabeth Nakasone, Graduate Student
University of California, Los Angeles: University of California, Los October 27 Elizabeth Nakasone
Graduate School Fair Angeles
Yale University: Information Session Yale University October 28 Kyle Honegger, Graduate Student
University of Southern California: University of Southern California October 28 Elizabeth Nakasone
Information Session
University of Pittsburgh: Information Session University of Pittsburgh October 28 Kristen Delevich
Morehouse College: Graduate School Fair Morehouse College October 28–29 Keisha John
and Research Training Symposium
Harvard University: Information Session Harvard University October 29 Kyle Honegger
Atlanta University Center Consortium: Clark Atlanta University October 29–30 Keisha John
(Morehouse College, Spelman College, 
and Clark Atlanta University)
Vassar College: Genetics and Bioinformatics Cold Spring Harbor Laboratory November 1 Keisha John; Justin Kinney, CSHL 
Course Visit and Information Session Fellow; Sheldon McKay; Dawn 
Pologruto; Amy Rappaport
Annual Biomedical Conference for Charlotte, North Carolina November 10–13 Saya Ebbesen; Paloma Guzzardo; 
Minority Students (ABRCMS) Keisha John; Dawn Pologruto
University of New Mexico: Information University of New Mexico November 10 Katie Liberatore, Graduate Student
Session
Sigma Xi Annual Conference and Research Raleigh, North Carolina November 11–13 Maria Pineda
Symposium
American Indian Science and Engineering Albuquerque, New Mexico November 11–12 Katie Liberatore
Society: 2010 National Conference
Queensborough Community College, Queensborough Community November 16 Information sent for distribution
CUNY: Cooperative Education Forum College, CUNY
Brooklyn College of CUNY: MARC and Brooklyn College of CUNY November 16 Keisha John
RISE Program: Information Session
The American Society for Cell Biology Philadelphia, Pennsylvania December 11 Megan Bodnar
Annual Meeting: Graduate School Fair
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Graduate Student Symposium
Continuing the tradition that began in the summer of 2008, three Graduate Student Symposia
were held in 2010 at the Laboratory’s Genome Research Center in Woodbury: one each in January,
May, and October. Each Symposium consisted of a full day of activities including 20-minute and
10-minute talks by senior students and poster presentations by more junior students. Lunch and
a wine and cheese reception rounded out the program and provided opportunities for more infor-
mal interactions. As with the inaugural event held in August 2008, the students and faculty in at-
tendance found the Symposia to be very worthwhile events. The Graduate Student Symposium is
open to the entire Laboratory community, but it is run largely by the students themselves. We are
grateful to the two student chairs of the Symposium—Megha Rajaram (SBU) and Maria Pineda
(WSBS)—for their dedication and hard work and to Keisha John for overseeing the administrative
elements.
Graduate Student and Postdoctoral Fellow Departures
With each year come not only new arrivals, but also departures. The following graduate students
and postdoctoral fellows departed from the Laboratory during 2010:
Postdoctoral Fellows
Uli C. Bialucha Dheeraj Malhotra Rajesh K. Prakash Michael Wittinger
Chunlin Cai Louis Manganas Vladimir Vacic Zhiguang Yuchi
Iver K. Hansen Nael Nadif Kasri Daniel Valente Lixing Zhan
Danielle Irvine Michaela Oswald-Pisarski Haibin Wang Zhihua Zhang
Valery Krizhanovsky Mario Pagani
Graduate Students
Anne Burlet-Parendel Jiahao Huang Shraddha Pai Rahul Sinha
Sungwook Choi Mary Kusenda Benjamin Roland Shuying Sun
Galen Collins Lucile Lefevre Patrick Russell Oliver Tam
Ashesh Dhawale Amy Leung Laurianne Scourzic Sophie Thomain
Julien Dos Santos Hiroshi Makino Grzegorz Sienski Yang Yang
Ewa Grabowska Colin Malone David Simpson Jianping Zhang
Ikuko Hotta
Executive Committee 
A large measure of the Watson School's success can be traced to the sage advice, guidance, and gov-
ernance of the School's Executive Committee. I wish to thank faculty members Mickey Atwal, Terri
Grodzicker, Adrian Krainer, Alea Mills, David Spector, and Linda Van Aelst who served on the Ex-
ecutive Committee through 2010. Terri Grodzicker completed her second term in December 2010.
We are grateful for the insights and advice that Terri brought to the Committee as a member for 6
years. As happens each year, there was also turnover among the student representatives. SBU repre-
sentative Matthew Lazarus completed his term in October, and he was replaced by Matthew Cami-
olo. WSBS representative Megan Bodnar also completed her term in December. We are thankful to
Matthew and Megan for their honest and thoughtful advice.  
Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher
of Molecular Biology of the Cell, who died of cancer in 1991) brings to CSHL an eminent researcher
and educator to give the Gavin Borden Lecture, which is dedicated to the graduate students at the
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laboratory. Dr. Gerald Joyce, from The Scripps Research Institute, was this year’s Gavin Borden
Fellow. Dr. Joyce is interested in understanding how Darwinian evolution at the molecular level
helps to shape the living world. His current research involves the development of directed molecular
evolution techniques and their application to the analysis and design of RNA enzymes. His lecture
The Origin of Life in the Laboratory was thoroughly enjoyed and provoked many questions from the
audience. In addition, the students joined Dr. Joyce during a roundtable lunch and discussion on
“What Is Life … and Would You Know It If You Saw It?”
The Watson School Continues to Benefit from Generous Benefactors
We are extremely grateful for the generous donors, whose one-time gifts or continued support made
our 2010 programs possible, including The Banbury Fund, The Arnold and Mabel Beckman Foun-
dation, Bristol-Myers Squibb Corporation, Mr. and Mrs. Richard M. Cashin, Mr. and Mrs. Landon
Clay, Lester Crown, The Dana Foundation, The William Stamps Farish Fund, The Genentech
Foundation, Mr. and Mrs. Alan Goldberg, Florence Gould Foundation, William Randolph Hearst
Foundation, Dr. Mark Hoffman, Annette Kade Charitable Trust, Mr. David H. Koch, Mr. and
Mrs. Robert D. Lindsay and Family, Mr. and Mrs. David Luke III, Mr. and Mrs. William R. Miller,
The Millipore Foundation, OSI Pharmaceuticals Foundation, Mr. and Mrs. John C. Phelan, The
Quick Family, The Rathmann Family Foundation, and The Roy J. Zuckerberg Family Foundation.
We are also very fortunate to hold a National Research Service Award Predoctoral Training Grant
from the National Institutes of Health, National Institute of General Medical Sciences. The School
will be submitting a competitive renewal of this award in early 2011.
Student Achievements
The WSBS students continue to impress us all with their accomplishments. They publish their re-
search findings in prestigious international journals and obtain fellowships to pursue their research
interests. Our students have published more than 170 papers to date, a remarkable accomplishment
for a School in its 12th year. In addition, our current students and alumni have been successful in
receiving prestigious awards and fellowships. In 2010, Katie Liberatore was awarded a National Sci-
ence Foundation Graduate Research Fellowship. She was also selected to attend the PepsiCo Com-
pany Day at the New York Academy of Sciences. Elizabeth Nakasone was awarded a U.S. Army
Medical Research and Materiel Command Breast Cancer Research Program Predoctoral Fellowship.
Amy Rappaport was selected to present at the 5th annual “Cracking the Code with the Bear” Re-
search Symposium. Elvin Wagenblast was awarded a predoctoral fellowship from the Boehringer
Ingelheim Fonds. Recent graduate Yaniv Erlich was awarded the prestigious Harold M. Weintraub
International Award for Graduate Studies. He was also named a 2010 Genome Technology Young
Investigator. Graduate Christopher Harvey was named the 2010 Larry Katz Memorial Lecturer for
the CSHL meeting on Neuronal Circuits. Graduate Colin Malone received a Helen Hay Whitney
Postdoctoral Fellowship, and graduate Jeremy Wilusz received a Leukemia and Lymphoma Society
Postdoctoral Fellowship.
Alumni in Faculty and Senior Positions
To date, 45 students have received their Ph.D. degrees from the WSBS. Of these graduates, eight
currently hold tenure-track faculty positions and two hold independent research positions. Twenty-
seven of our former students are pursuing postdoctoral research and five of our alumni completed
their postdoctoral studies and have moved onto positions in administration, management consulting,
and journal editing. We are so proud of them all!
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2010 WSBS STUDENT (CURRENT OR PREVIOUS) PUBLICATIONS
Blum A, Dubnau JT. 2010. Parallel processing of olfactory memories in Drosophila. Fly (Austin) 4: 163–166.
Bolduc FV, Bell K., Rosenfelt C, Cox H, Tully T. 2010. Fragile X mental retardation 1 and filamin a interact genetically in
Drosophila long-term memory. Front Neural Circuits 3: 22.
Chicas A, Wang X, Zhang C, McCurrach M, Zhao Z, Mert O, Dickins RA, Narita M, Zhang M, Lowe SW. 2010. Dissecting
the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17: 311–414. 
Chiu SL, Cline HT. 2010. Insulin receptor signaling in the development of neuronal structure and function. Neural Dev 5: 7.
Collins GA, Gomez TA, Deshaies RJ, Tansey WP. 2010. Combined chemical and genetic approach to inhibit proteolysis by
the proteasome. Yeast 27: 965–974.
Edvardson S, Shaag A, Zenvirt S, Erlich Y, Hannon GJ, Shanske AL, Gomori JM, Ekstein J, Elpeleg O. 2010. Joubert syndrome
2 (JBTS2) in Ashkenazi Jews is associated with a TMEM216 mutation. Am J Hum Genet 86: 93–97.
Egeblad M, Nakasone ES, Werb Z. 2010. Tumors as organs: Complex tissues that interface with the entire organism. Dev
Cell 18: 884–901.
Erlich Y, Gordon A, Brand M, Hannon GJ, Mitra PP. 2010. Compressed genotyping. IEEE Trans Inf Theory 56: 706–723.
Haase AD, Fenoglio S, Muerdter F, Guzzardo PM, Czech B, Pappin DJ, Chen C, Gordon A, Hannon GJ. 2010. Probing the
initiation and effector phases of the somatic piRNA pathway in Drosophila. Genes Dev 24: 2499–2504.
Li J, Wang Y, Chiu SL, Cline HT. 2010. Membrane targeted horseradish peroxidase as a marker for correlative fluorescence
and electron microscopy studies. Front Neural Circuits 26: 6. 
Malone CD, Hannon GJ. 2010. Molecular evolution of piRNA and transposon control pathways in Drosophila. Cold Spring
Harbor Symp Quant Biol 74: 225–234.
Mangone M, Myers MP, Herr W. 2010. Role of the HCF-1 basic region in sustaining cell proliferation. PLoS One 5: e9020.  
Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS,
Parker JS, Paddison PJ, Tam W, Ferrando A, Wendel HG. 2010. Genome-wide RNA-mediated interference screen identifies
miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12: 372–379.
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A. 2010.
miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci 107: 264–269.
Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R. 2010. Amyloid β from axons and dendrites reduces
local spine number and plasticity. Nat Neurosci 13: 190–196.
Wilusz JE, Spector DL. 2010. An unexpected ending: Noncanonical 3′ end processing mechanisms. RNA 16: 259–266. 
Yao Z, Fenoglio S, Gao DC, Camiolo M, Stiles B, Lindsted T, Schlederer M, Johns C, Altorki N, Mittal V, Kenner L, Sordella
R. 2010. TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung
cancer. Proc Natl Acad Sci 107: 15535–15540.
WSBS GRADUATES IN FACULTY AND SENIOR POSITIONS
Name                        Current position
François Bolduc           Assistant Professor, University of Alberta, Canada 
Darren Burgess            Assistant Editor, Nature Reviews Cancer and Nature Reviews Genetics, UK
Amy Caudy                 Assistant Professor, University of Toronto, Canada 
Catherine Cormier       Scientific Liaison, Arizona State University
Yaniv Erlich                 Whitehead Fellow, Whitehead Institute
Rebecca Ewald             Project Manager, Roche Diagnostics, Inc.
Elena Ezhkova              Assistant Professor, Developmental and Regenerative Biology, Mount Sinai School of Medicine
Ira Hall                        Assistant Professor, Biochemistry and Molecular Genetics, University of Virginia School of Medicine 
Keisha John                 WSBS Associate
Zachary Lippman        Assistant Professor, Cold Spring Harbor Laboratory 
Patrick Paddison          Assistant Member, Human Biology Division, Fred Hutchinson Cancer Research Center 
Emiliano Rial-Verde     Engagement Manager, McKinsey & Co., Inc., Geneva, Switzerland
Ji-Joon Song                 Assistant Professor, Biological Science, Korea Advanced Institute of Science and Technology (KAIST), 
                              South Korea 
Niraj Tolia Assistant Professor, Molecular Microbiology, School of Medicine at Washington University, St. Louis 
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WSBS Family Events
Finally, I am pleased to announce that this was a great year for the WSBS students as we celebrated
some wonderful personal occasions. On April 24, Sang Geol Koh, from the entering class of 2008,
and his wife Bomi welcomed a son, Aiden, who weighed in at 8 lbs 11 oz. On May 30, Katie Lib-
eratore, also from the class of 2008, married her fiancée Brian Kramer in New Mexico. On June
21, Kyle Honegger from the entering class of 2007 married Laura Bozue in their home state of Illi-
nois. Silvia Fenoglio from the entering class of 2009 married postdoctoral fellow Agustin Chicas
on July 18. Silvia and Agustin welcomed their daughter Lucia on December 22. Our congratulations
and best wishes to all of them.
Leemor Joshua-Tor
Professor and Dean
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SPRING CURRICULUM
Topics in Biology
ARRANGED BY Leemor Joshua-Tor, Alyson Kass-Eisler, and Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting Lectureship;
The Fairchild Martindale Visiting Lectureship; The Lucy and Mark Ptashne Visiting 
Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer 7-day courses at the Banbury Conference Center
to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory faculty.
These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents read assigned papers. These intensive courses are modeled on the Cold Spring Harbor Labo-
ratory Lecture Courses held each summer at the Banbury Conference Center. In Spring 2010, there
were two such courses: a new course on Physical Biology of the Cell and Fundamental Concepts in
Statistics.
Physical Biology of the Cell
Attended by the entering classes of 2006 and 2009
INSTRUCTORS Rob Phillips, California Institute of Technology
Hernan Garcia, California Institute of Technology
Ron Milo, Weizmann Institute, Israel
Julie Theriot, Stanford University
Kerwyn Huang, Stanford University
Daniel Fisher, Stanford University
Jane Kondev, Brandeis University 
VISITING LECTURERS Daniel Fisher, Stanford University
Kerwyn Huang, Stanford University
Jané Kondev, Brandeis University
Ron Milo, Weizmann Institute, Israel
Julie Theriot, Stanford University
TEACHING FELLOW Hernan Garcia, California Institute of Technology
The aim of this course was to provide a hands-on experience in the use of quantitative models as a
way to view biological problems. We began with “order of magnitude biology,” showing how simple
estimates can be exploited in biology. We showed how to construct simple models of a variety of dif-
ferent biological problems, primarily using the tools of statistical mechanics. One of the key themes
of the course was to show how physical biology unites and organizes topics in a fundamentally different
way, often revealing that topics which are nearby in physical biology seem to be unrelated when viewed
from the vantage point of molecular or cell biology. The instructors guided the students from start to
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finish on several modeling case studies. The course ran from Saturday, March 21, to Sunday, March
28, and was one of the most interesting (and fun) but challenging courses the students have taken.
Fundamental Concepts in Statistics
Attended by the entering classes of 2007 and 2008
INSTRUCTOR Martina Bremmer, San Jose State University
VISITING LECTURERS Robert Martienssen, Cold Spring Harbor Laboratory
Madhu Mazumdar, Weill Cornell Medical College
TEACHING FELLOWS Tilman Achberger, Purdue University
Gayla Olbricht, Purdue University
Statistics and mathematics have become an integral part of research in many areas of biology. New
technology leads to large amounts of data produced in the fields of genomics, ecology, and epidemi-
ology. The statistical methods required to analyze the data evolve and adapt constantly with the chang-
ing demands. However, the underlying principles of statistical analysis remain the same. 
This course focused on the fundamental statistical concepts used in the analysis of biological data.
Emphasis was placed on statistical reasoning, rather than specific formulas and computations. How-
ever, examples of statistical applications were discussed and students were asked to apply the methods
they learned to real data sets using software. The major statistical concepts introduced in this course
included descriptive statistics, statistical inference, sampling and sampling distributions, correlation,
hypothesis testing, experimental design, regression, and ANOVA. The course integrated lectures by
the instructor with directed reading and interpretation of statistical analyses in publications by the
Physical Biology of the Cell course participants: (Top row) Wee Siong Goh, Jané Kondev, Ian Peikon, Hassana Oyibo, Daniel Fisher,
Felix Schlesinger, Kristen Delevich, Rob Phillips, Hernan Garcia, Julie Theriot, Leemor Joshua-Tor; (middle row) Saya Ebbesen, Megan
Bodnar, Melanie Eckersley-Maslin, Cinthya Zepeda Mendoza, Amy Rappaport, Stephane Castel; (bottom row) Claudio Scuoppo, Silvia
Fenoglio, Yaniv Erlich, Ron Milo.
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students. It was accompanied by lab sections in which the students were instructed on conducting
simple statistical analyses using software. In addition, invited speakers covered special topics in the
application of statistical methodology to the biological sciences. The course ran from Sunday to Sat-
urday, March 28–April 3, and was organized and largely taught by Martina Bremmer. Overall, the
students thought it was a great course and one of the most useful for their own research.
Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Micklos
INSTRUCTORS Amanda McBrien (Lead) Jermel Watkins
Jennifer Galasso Elna Gottlieb
Jason Williams Erin McKechnie
ADMINISTRATOR Carolyn Reid
As science plays an increasing role in society, there is also an increasing need for biologists to educate
nonscientists of all ages about biology. The Watson School of Biological Sciences doctoral program
offers its students unique teaching experiences through the Laboratory’s Dolan DNA Learning Cen-
ter, where students teach laboratory courses to high school and middle school students. From these
teaching experiences, they learn how to communicate with nonbiologists and to inspire and educate
creative young minds. The teaching module entailed pairs of students teaching one morning or af-
ternoon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors
Fundamental Concepts in Statistics course participants: (Front row) Paloma Guzzardo, Eugene Plavskin, Katie Liberatore,
Beth Nakasone, Carrie Clendaniel, Susann Weissmueller, Ozlem Mert, Martina Bremer, Megan Bodnar, Melanie 
Eckerley-Maslin, Nilgun Tasdemir; (back row) Josh Sanders, Saya Ebbesen, Peter Znamenskiy, Doug Baumann, Hassana
Oyibo, Sang-Geol Koh, Philippe Batut, Elvin Wagenblast, Molly Moscoe, Marek Kudla, Joe Calarco, Zhenxun Wang,
Kyle Honegger, Maria Pineda, Jiahao Huang, Zina Perova.
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taught the Watson School students the didactic process; it was not until the fifth week that the grad-
uate students taught on their own. At the end of the 12 weeks, the students were very excited about
their teaching experience. 
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research
that leads to a unique contribution to human knowledge. After the fall course term, students par-
ticipate in laboratory rotations. These rotations provide students and faculty the opportunity to get
to know each other and to explore possibilities for doctoral thesis research. At the end of each rota-
tion, students make short presentations of their studies to the other students and their rotation ad-
visors. These talks give students an opportunity to share their laboratory experiences and to learn
how to give a scientific presentation. With this latter goal in mind, in addition to the research men-
tors, the instructors of the Scientific Exposition and Ethics core course and members of the School’s
Executive Committee attend the talks and give individual feedback to students on their presentations.
This year, 13 WSBS faculty members and one CSHL fellow served as rotation mentors, some men-
toring more than one student.
ROTATION MENTORS Josh Dubnau Bo Li Bruce Stillman
Gregory Hannon Robert Martienssen Marja Timmermans
Z. Josh Huang Raffaella Sordella Christopher Vakoc
David Jackson David L. Spector Linda Van Aelst
Adam Kepecs
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FALL CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific 
Reasoning and Logic
INSTRUCTORS Gregory Hannon (Lead) Leemor Joshua-Tor
Alexander Gann Zachary Lippman
Z. Josh Huang Nicholas Tonks
GUEST LECTURERS Josh Dubnau Robert Martienssen
Mikala Egeblad Thomas Schalch (postdoctoral fellow)
David Jackson
VISITING LECTURER Tracy Bale, University of Pennsylvania
The SRL core course was revamped this year with respect to content and instructor participation.
Each module of the course has now been designed to cover a different general theme and proceeds
with the goal of considering an open, still unanswered, scientific question. In addition, the first two
modules of the course were combined into one longer module so that an integrated theme could be
tackled using two different approaches: molecular biology and structural biology. 
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core
course, which forms the heart of the curriculum, students (1) acquire a broad base of knowledge
about the biological sciences, (2) learn the scientific method, and (3) learn how to think critically.
The beginning of the course was divided into four to five modules, each of which had a different
general theme, and proceeded with the goal of considering an open, still unanswered, scientific ques-
tion. For each module, students read an assigned set of research articles (generally four articles) and
at the end of the module, they provided written answers to a problem set that guides them through
several of the articles. 
Twice weekly, students attended lectures related to the module’s topic that included concepts
and fundamental information as well as experimental methods. During each week, the students met
among themselves to discuss the assigned papers not covered by the problem set. Each week, students
spent an evening discussing the assigned articles with faculty. In the final part of the course, students
participated in a mock study section in which real National Institutes of Health, R01 grants were
reviewed and critiqued. This allows the students to evaluate the questions before the answers are
known, evaluate routes toward discovery before knowing where they will end, and make critical
judgments about how to proceed in the face of an uncertain outcome. 
The module topics for this course were as follows:
Topic Instructor(s)
Mechanism and Structure of Gene Regulation Alex Gann
Leemor Joshua-Tor
Developmental Genetics and Morphological Diversity Zachary Lippman
Signal Transduction and the Search for Novel Therapeutics Nicholas Tonks
The Brain: Does Chromatin Matter? Z. Josh Huang
Study Section Gregory Hannon
236
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The Darrell Core Course on Scientific Exposition and Ethics 
INSTRUCTORS David J. Stewart (Lead)
Alea A. Mills 
Arne Stenlund
TEACHING ASSISTANT Jonathan Ipsaro
GUEST LECTURERS Walter Goldschmidts
Jason Wen
Jan A. Witkowski
VISITING LECTURERS Olga Akselrod, The Innocence Project
Keith Baggerly, University of Texas, M.D. Anderson Cancer Center
Robert Charrow, Greenberg Traurig, LLC
Avner Hershlag, North Shore University Hospital 
Amy Harmon, The New York Times
Boyana Konforti, Editor, Nature Structural & Molecular Biology
Paul Offit, Children’s Hospital of Philadelphia
Joy Simha, Young Survivors Coalition, National Breast Cancer Coalition
Liz Wohl, National Breast Cancer Coalition
The Scientific Exposition and Ethics (SEE) core course in 2010 was taught by the same instructor
team as last year, with David Stewart taking the lead role, joined by Alea Mills and Arne Stenlund.
This year, CSHL postdoctoral fellow Jonathan Ipsaro participated in the course as a teaching assis-
tant. As usual, the course hosted expert guest lecturers who covered topics that included scientific
presentations, the editorial review process, ethical and legal responsibilities of scientists, DNA pro-
filing, and postconviction appeals, patient advocacy, and reproductive genetics.
This core course offered instruction in the fundamental elements of scientific exposition—writing
skills and public speaking—and ethics. The ability to communicate effectively and to appreciate
the intricacies of ethical issues are essential skills for biologists; both subjects were taught in a series
of example-based lectures and discussion groups. Writing skills included the fundamentals of modern
scientific English and the organization and preparation of papers, research abstracts, and grant ap-
plications. Oral presentation skills were taught by instructors with different modes of presentation.
Together with instructors, students critiqued formal seminar presentations at the Laboratory. In-
struction and discussions about ethics included the ethical implications of biological discovery on
society as well as the nature and boundaries of ethical behavior of scientists and their rights and re-
sponsibilities. A primary objective of the course was that students consider exposition and ethics
integral aspects of scientific research.
Research Topics
ORGANIZERS Kimberley Geer 
Alyson Kass-Eisler
This core course provided students with an in-depth introduction to the fields of research that the
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar,
at which faculty members and CSHL fellows presented their current research topics and methods
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of investigation each Wednesday evening over dinner. The students learned how to approach im-
portant problems in biology. These seminars, together with the annual fall Laboratory In-House
Symposium, provided students with a basis for selecting laboratories in which to do rotations. The
weekly speakers are listed below:
Florin Albeanu David Jackson Alea A. Mills Nicholas Tonks
Gurinder (Mickey) Atwal Leemor Joshua-Tor Partha Mitra Lloyd Trotman
Anne Churchland Adam Kepecs Pavel Osten Glenn Turner
Josh Dubnau Alexei Koulakov Darryl Pappin Christopher Vakoc
Mikala Egeblad Adrian R. Krainer Michael Schatz Linda Van Aelst
Grigori Enikolopov Alexander Krasnitz Stephen Shea Doreen Ware
Hiro Furukawa Bo Li Raffaella Sordella Michael Wigler
Thomas Gingeras Zachary Lippman David L. Spector Anthony Zador
Christopher Hammell Scott Lowe Arne Stenlund Hongwu Zheng
Gregory Hannon Robert Martienssen Bruce Stillman Yi Zhong
Z. Josh Huang W. Richard McCombie Marja Timmermans
Specialized Disciplines Courses
A new Specialized Disciplines course in Quantitative Biology was developed by Mickey Atwal to
provide the students with the tools to interpret large, complex data sets and to use statistical method-
ology in their research. It is one of two new courses in the areas of statistics, programming, bioin-
formatics, and theoretical modeling and analysis that the School developed in 2010 to complement
our existing curriculum. With the addition of this course, the students in the entering class of 2010
took a total of four Specialized Disciplines courses this fall.
The other three Specialized Disciplines courses are Cellular Structure and Function, Genetics and Ge-
nomics, and Systems Neuroscience. Cellular Structure and Function was again taught by lead instructor
Linda van Aelst and Raffaella Sordella, but ran as a week-long intensive course when the students first
arrived. Josh Dubnau led Genetics and Genomics and was joined again by Thomas Gingeras. Anthony
Zador led the Systems Neuroscience course, assisted by Adam Kepecs and Glenn Turner. 
Cellular Structure and Function
INSTRUCTORS Linda Van Aelst  (Lead)
Raffaella Sordella
GUEST LECTURERS Darryl Pappin
David L. Spector
Bruce Stillman
VISITING LECTURERS Gregg Gundersen, Columbia University
Aron Jaffe, Novartis
Alexey Khodjakov, Wadsworth Laboratory
Sandy Simon, The Rockefeller University
Marc Symons, The Feinstein Institute for Medical Research
With the complete genome sequence available for many organisms, there is now an increasing emphasis
on understanding the function of the gene products. This understanding requires an increasing ap-
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preciation of the structure and function of the cell as well as dynamic associations within the cell. This
course provided a basic overview of the structural and functional organization of cells with particular
emphasis on cellular compartmentalization and communication. Topics of focus included the cy-
toskeleton, cell adhesion and signaling, membrane transport, gene expression, and nuclear organization.
In addition, the course provided insight into the basic toolbox of the cell biologist of the 21st century.
Genetics and Genomics
INSTRUCTORS Josh Dubnau (Lead)
Thomas Gingeras
GUEST LECTURER Christopher Hammell
VISITING LECTURERS Hopi Hoekstra. Harvard University
Tim Tully, Dart Neuroscience
This course placed modern human genetics and genomics into the context of classical organismal
genetics. History, perspective, and technique were described around four levels of analysis: naturally
occurring variation, genome evolution, genetic screens, and gene epistasis. How do gene mutations
help to define biological processes? How are more complex traits genetically dissected into simpler
(underlying) components? What concepts and techniques are used to organize genes into pathways
and networks? How are genes mapped, cloned, and engineered to identify functional domains of
proteins? What gene variation exists in natural populations? What are the functional consequences
of gene variation? How is it detected? How are genomes organized and coordinately regulated? How
can genomic information be cataloged, organized, and mined? These questions and concepts were
fleshed out using examples from the literature.
Quantitative Biology 
INSTRUCTORS Mickey Atwal  (Lead)
Michael Schatz
GUEST INSTRUCTORS Justin Kinney (CSHL Fellow)
Alexander Krasnitz
With the advent of high-throughput technologies in biology, it has become necessary for biological
researchers to be able to analyze and interpret high-dimensional data and frame hypotheses mathe-
matically. To this end, the aim of this course was to equip the students with a basic training in modern
statistical methods. By the end of the course, the students were able not only to answer many of the
simple statistical questions that arise in data analyses, but also to became familiar with the more complex
techniques used by fellow computational biologists. Topics included error fluctuations, calculating the
significance of an experimental result, Bayesian inference, information theory, power calculations, di-
mensional reduction, and DNA sequence analyses. In addition, this course introduced mathematical
modeling, motivated by the classic examples in quantitative biology such as the Delbrück-Luria ex-
periment, Hopfield's kinetic proofreading, and Kimura's neutral theory of population genetics.
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Systems Neuroscience
INSTRUCTORS Anthony Zador (Lead)
Adam Kepecs
Glenn Turner
GUEST INSTRUCTORS Florin Albeanu
Alexei Koulakov
Stephen Shea
This course provided an overview of key aspects neuroscience. The emphasis was on spanning levels:
How can we go from molecules through cells and circuits to behavior? 
There were three main components to the class: lectures, problem sets, and a final project. The
last week of class was spent on the final project in which the students found and presented a neu-
roscience paper which spanned levels, for example, from the molecular to the synaptic or the circuit
level to the behavioral. 
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POSTDOCTORAL PROGRAM
PROGRAM DIRECTOR Nicholas Tonks
PROGRAM ADMINISTRATOR Alyson Kass-Eisler
Cold Spring Harbor Laboratory (CSHL) is proud of its rich tradition in postdoctoral education
and has a deep commitment to the postdoctoral experience. CSHL has long been recognized as a
place for nurturing young scientists, with postdoctoral researchers being an integral part of the dis-
covery process. The Laboratory currently employs ~160 postdoctoral fellows working in the labs of
47 principal investigators. Current fields of research expertise include genetics; molecular, cellular,
and structural biology; neuroscience; cancer; plant biology; genomics; and quantitative biology. The
postdoctoral community at CSHL is diverse and international, arriving at the Laboratory with many
different backgrounds and with needs that change during the course of the postdoctoral years. The
Postdoctoral Program Office works closely with the fellows and the Laboratory’s administration to
coordinate and organize educational and career development activities. Dr. Alyson Kass-Eisler, the
Postdoctoral Program Officer, and Dr. Nicholas Tonks, the Scientific Director of the Postdoctoral
Program, provide the day-to-day support for the postdoctoral program, which is overseen by the
Dean of the Watson School, Dr. Leemor Joshua-Tor.
In 2010, we held a number of courses and workshops aimed at postdoctoral fellows. On Decem-
ber 9, the Office of Sponsored Programs, the Development Department, and the Postdoc Program
Office held a very popular course on Grant Writing. The sessions included Introduction to Grants
and External Funding, Human Subjects/Tissue use in Research, The Grant Abstract—Do’s, Don’ts,
Peer Review Panel Discussion, Effective Writing Skills, Fellowships, Career Development Awards,
and Resources for Postdocs, and One-on-One Consultations.
CSHL has been a member of a special ambassador recruitment program from Merck Research
Laboratories (MRL) since 2005. This program provides the postdoctoral fellows and students at
CSHL an inside connection to a scientist working at MRL. As a result of this program, Dr. Maarten
Hoek, a postdoctoral fellow from Dr. Bruce Stillman’s laboratory, was hired as a Research Scientist
in 2007 and Dr. Zuo Zhang, a postdoctoral fellow from Dr. Adrian Krainer’s laboratory, joined
MRL as a Research Scientist in January 2009. Drs. Li and Hoek visited the laboratory again on Jan-
uary 15 for one-on-one recruitment session. In addition, Dr. Li gave a talk on Identification of Glu-
cose-Dependant Insulin Secretion Targets in Pancreatic β Cells by Combining Defined-Mechanism
Compound Library Screening and siRNA Gene Silencing, to give the fellows a feel for the type of
research being done in industry.
Leadership Training was held April 7 for postdocs interested in planning for their next career
step. Sessions included Mentoring Competencies for Success, Excellence Starts with Recruiting
High-Level Performers, Selecting A-Players—Right People Doing Right Things, Staffing on Three
Interfaces—Science, You, and the Chemistry with Your Staff, Behavior-Based Interviewing Guide-
lines, Defining Your Team—Providing Direction, and Setting and Managing Expectations.
In the afternoon session on Individual Development Plans (IDP) for Postdoctoral Fellows, Dr.
Ginsburg talked about creating an IDP and how the IDP can be a valuable tool for career develop-
ment. Stemming from this session, a group of postdoctoral fellows started their own “IDP” group
to meet monthly to discuss their career goals and plans to achieve them. The second annual National
Postdoc Appreciation Day (which this year was changed to National Postdoc Appreciation Week)
was held during the week of September 20. To celebrate, CSHL hosted an outdoor pizza party and
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a job-searching roundtable discussion. It was a nice opportunity for the Lab to say thank you for all
that the postdocs do.
Five years ago, the School initiated a prize for the best posters by a postdoctoral fellow and the
best poster by a graduate student at the Laboratory’s annual In-House Symposium. Each "prize" is
given in the form of an educational grant of $500. In addition to providing a forum for the post-
doctoral fellows to show off their research, and potentially win a prize, it gives the entire scientific
community a chance to come together and share ideas beyond the wall of their individual labora-
tories. It has been a great success for both the presenters and the laboratory community as a whole.
Seventeen posters were presented for the postdoctoral prize, which was shared this year by Fedor
Karginov, a postdoctoral fellow in Greg Hannon’s laboratory, and Navasona Krishnan in Nick Tonk’s
laboratory.
During the past couple of years, we have increasingly widened the role of postdoctoral fellows in
the curricular activities of the School. Our fellows have been involved in preparing our students for
the challenging Fall Term curriculum by working as one-on-one tutors during the summer. Through-
out the Fall Term, postdoctoral fellows are used as tutors for all aspects of the curriculum, providing
one-on-one tutoring, group tutoring, and participating in discussion sessions. In 2007, the Scientific
Exposition and Ethics course took further advantage of the expertise of our postdoctoral community
by hiring two fellows as teaching assistants (TAs). These two fellows were an integral part of the
course by providing their expertise in discussions, editing of the students writing work, and critiquing
oral presentations. This format was highly successful and was used again in Fall 2010. Jon Ipsaro, a
postdoctoral fellow from Leemor Joshua-Tor’s laboratory, was this year’s TA.
Since 2003, all postdoctoral fellows and graduate students at the Laboratory have been enrolled
in a special initiative of the New York Academy of Science (NYAS), called the Science Alliance. The
Science Alliance for graduate students and postdoctoral fellows is a consortium of universities, teach-
ing hospitals, and independent research facilities in the New York City metropolitan area that have
formed a partnership with NYAS. The aim of the Alliance is to provide career and professional de-
velopment monitoring for postdoctoral fellows and graduate students in science and engineering,
through a series of live events and a dedicated web portal. In addition, the Science Alliance gives
graduate students and postdoctoral fellows the opportunity to network with their peers across in-
stitutions and with key leaders in academia and industry. This year, the Science Alliance meetings
and workshops included The Art of Networking for Science Professionals, Evaluating and Negoti-
ating Job Offers: Demystifying the Process, Going on the Academic Market: Strategies for Scientists,
and Writing for Biomedical Publication. In addition, in June of this year, Alyson Kass-Eisler and
Dr. Keisha John attended a roundtable discussion with other local leaders in postdoctoral training.
They took part in a Workshop on Improvisation for Creativity, Collaboration, and Communication
in the Workplace and participated in breakout sessions on Career Development Programming: Ad-
dressing Issues and Sharing Ideas for Future Initiatives.
This year, the Laboratory applied to the National Institutes of Health for a postdoctoral training
program in cancer biology. The primary goal of the Cancer Gene Discovery and Cancer Biology
Postdoctoral Training Program is to prepare the next generation of cancer biologists to pursue in-
dependent research that integrates cancer gene discovery with functional biology in order to facilitate
the development of novel cancer therapeutic, diagnostic, and/or preventive strategies. We are very
pleased to report that the application has been recommended for funding by the review panels. 
Finally, a most important measure of our postdoctoral program’s success is the ability of post-
doctoral fellows to secure positions at the end of their training. In 2010, the Laboratory’s departing
postdoctoral fellows went on to positions at Albert Einstein College of Medicine; Cold Spring Har-
bor Laboratory; Donders Centre for Neurosciences, The Netherlands; North Shore University Hos-
pital; Mt. Sinai School of Medicine, N.Y.; Murdoch Children's Research Institute, Melbourne,
Australia; University of Buenos Aires, Argentina; University of Texas, Austin; U.S. Army Corps of
Engineers; Engineer Research and Development Center; and Weizmann Institute of Science, Israel.
242 Watson School of Biological Sciences
215-246_wsbs_Annual Report_2009 template  7/8/11  12:22 PM  Page 242
UNDERGRADUATE RESEARCH PROGRAM
PROGRAM DIRECTOR Zachary Lippman
PROGRAM ADMINISTRATOR Dawn Pologruto
The fundamental objective of this program is to give students an opportunity to conduct first-rate
research. Participants learn about scientific reasoning, laboratory methods, theoretical principles,
and scientific communication. The specific objectives of the program are to (1) give college under-
graduates a taste of conducting original research at the cutting edge of science, (2) encourage aware-
ness of the physical and intellectual tools necessary for modern biological research, (3) foster an
awareness of the major questions currently under investigation in the biomedical and life sciences,
and (4) promote interactions with laboratory scientists through an immersion in the research envi-
ronment.
During the 10-week program, URPs work with CSHL senior staff members on independent re-
search projects, specifically in the areas of cancer biology, neuroscience, plant biology, cellular and
molecular biology, genetics, macromolecular structure, and bioinformatics. 
URPs work, live, eat, and play among CSHL scientists. They have a very busy academic and
social calendar for the summer. They attend lectures in the Goldberg Faculty Lecture Series from
CSHL faculty members and outside faculty members including, in 2010, talks by Dr. Stanley Maloy,
San Diego State University, and Dr. Alfred Goldberg, Harvard University. URPs also attend a Bioin-
formatics Workshop Series, where they learn how to identify patterns in DNA and protein sequences
and how to interpret them. Lectures by CSHL faculty are specifically designed for URPs. URPs
were also invited to join Dr. and Mrs. Watson for a pizza party and Dr. and Mrs. Stillman for dinner.
BBQ and pool parties, volleyball games, sailing lessons, designing the URP T-shirt, competing in
the annual CSHL Petri Dish Race and Scavenger Hunt, and the ever-famous URP versus PI volley-
ball match rounded out the engaging program. 2010 was the second year the URPs beat the faculty
team in volleyball—quite an accomplishment!
At the beginning of the summer, URPs write an abstract and present a talk on their proposed re-
search. Concluding the program in August, URPs prepare a final report and present their results in
a 15-minute talk at the URP Symposium. The following students, selected from 720 applicants,
took part in the 2010 program:
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Robert Aboukhalil, McGill University
Advisor: Dr. Mickey Atwal
Sponsor: Robert H.P Olney Fund Fellowship
Colocalization of tumor suppressor genes.
Emily Bottle, University of Cambridge
Advisor: Dr. Anthony Zador
Sponsor: Former URP Fund Fellowship
Screening the brain areas involved in sensorimotor association.
Alexandra Bryson, Texas A&M University
Advisor: Dr. Bruce Stillman
Sponsor: Former URP Fund Fellowship
Exogenous expression of DDX5 RNA helicase.
Diana Cai, Columbia College
Advisor: Dr. Yi Zhong
Sponsor: Former URP Fund Fellowship
Combining two gene-targeting systems to investigate cross-talk
between the mushroom body and central complex in
Drosophila.
Joseph Cammarata, Hunter College
Advisor: Dr. Zach Lippman
Sponsor: Hunter College Scholar and National Science
Foundation Scholar
Searching for a marker of meristem reiteration in Solanum
lycopersicum.
215-246_wsbs_Annual Report_2009 template  7/8/11  12:22 PM  Page 243
244 Watson School of Biological Sciences
The URPs show off their class T-shirts.
Jonathan Coravos, Bowdoin College
Advisor: Dr. Josh Dubnau
Sponsor: National Science Foundation Scholar
Are dopamine receptors expressed in Drosophila glia?
Helen Cha, Williams College
Advisor: Dr. Marja Timmermans
Sponsor: National Science Foundation Scholar
The effect of a small RNA gradient on sharpening the adaxial-
abaxial boundary in Arabidopsis thaliana.
Tiffany Coupet, Johns Hopkins University
Advisor: Dr. Scott Powers
Sponsor: William Townsend Porter Foundation Fellowship
Exploring synergistic interactions with RNAi in combination with
a PI3K inhibitor.
Martin Fan, Washington University, St. Louis
Advisor: Dr. Adrian R. Krainer
Sponsor: Former URP Fund Fellowship
Characterizing the tumorigenic potential of several splicing
factors.
Nisha Hariharan, University of California, Berkeley
Advisor: Dr. David Jackson
Sponsor: Former URP Fund Fellowship
Cell-to-cell trafficking via plasmodesmata in Arabidopsis thaliana.
Ruilong Hu, Washington University, St. Louis
Advisor: Dr. Stephen Shea
Sponsor: URP Fund Fellowship
The mechanism of neural selectivity for pup isolation calls in the
mouse.
Edward Larkin, University of Notre Dame
Advisor: Dr. Z. Josh Huang
Sponsor: University of Notre Dame URP Scholar 
The birth and development of cortical chandelier cells.
Diana LaScala-Gruenewald, Massachusetts Institute of
Technology
Advisor: Dr. Michael Q. Zhang
Sponsor: 30th Anniversary URP Scholar
An interactive genomic map between budding yeast species for the
study of DNA replication,
Ashley Maceli, Suffolk University
Advisor: Dr. Gregory Hannon
Sponsor: James D. Watson Fellowship
Mammalian genomic simplification methods for studying DNA
methylation.
Connie Martin, University of California, Riverside
Advisor: Dr. Gregory Hannon
Sponsor: Howard Hughes Medical Institute Scholar
Transposon insertion profiling.
Meg McCue, Dartmouth College
Advisor: Dr. Partha Mitra
Sponsor: Former URP Fund Fellowship
The brain architecture project: Quantitative image analysis.
Matthias Minderer, University of Cambridge
Advisor: Dr. Lloyd Trotman
Sponsor: Former URP Fund Fellowship
The nuclear import mechanism of PTEN.
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Luis Montano, Universidad Nacional Autonoma de Mexico
Advisor: Dr. W. Richard McCombie
Sponsor: Former URP Fund Scholar
Solution-based exome capture: Is it useful to detect human
variation?
Claudio Morales-Perez, University of Puerto Rico
Advisor: Dr. Hiro Furukawa
Sponsor: National Science Foundation Fellowship
Understanding the molecular mechanism of antagonism in the
NMDA receptor.
Angelina Regua, Molloy College
Advisor: Dr. Leemor Joshua-Tor
Sponsor: National Science Foundation Fellowship
Organization of ClrC (Clr4-Rik1-Cul4) complex.
Hanna Retallack, Harvard University
Advisor: Dr. Adam Kepecs
Sponsor: Former URP Fund Fellowship
Acetylcholine and the basal forebrain in a sustained attention task.
Sarah Shareef, Harvard University
Advisor: Dr. Christopher Vakoc
Sponsor: Dorcus Cummings Scholar
Condensin localization along mitotic chromatin.
Ayse Trolander, Carleton College
Advisor: Dr. Alea A. Mills
Sponsor: Former URP Fund Fellowship
p63 point mutation causing EEC syndrome alters gene expression
in vitro.
Anil Wadhwani, Northwestern University
Advisor: Dr. Florin Albeanu
Sponsor: Former URP Fund Fellowship
Neuromodulation of olfactory sensory input: A photon counting
approach.
Unikora Yang, Brown University
Advisor: Dr. Bo Li
Fellowship: Steamboat Foundation Scholar
Establishing a novel attentional behavior test for mouse models of
schizophrenia.
Undergraduate Research Program      245
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PARTNERS FOR THE FUTURE
PROGRAM DIRECTOR David Jackson
PROGRAM ADMINISTRATOR Kathy LaForgia
The Partners for the Future Program, established by Dr. James Watson in 1990, provides an oppor-
tunity for talented Long Island high school students to have hands-on experience in biomedical re-
search at Cold Spring Harbor Laboratory. This highly competitive program is open to Long Island
high school students in their junior year. Each high school science chairperson may nominate up to
three students. The top candidates are interviewed by CSHL scientists and up to 11 top students
are chosen to participate in the program. Students selected to the program are paired with a scientist
mentor and spend a minimum of 10 hours per week, September through March of their senior
year, conducting original research. At the conclusion, the students present their projects to an en-
thusiastic audience of the students’ scientific mentors and colleagues, CSHL administrators, parents,
and teachers. Although the students learn a great deal about modern biology and state-of-the-art
research techniques, the main advantage of the program is that they are exposed to day-to-day life
in a lab. Interacting with scientists and support staff, the students learn to define and pursue a re-
search goal while solving problems that may occur along the way.
The 2010–2011 Partners for the Future—chosen from among 24 semifinalist nominations—
are listed below.
Partner High School CSHL Mentor Laboratory
Laura Bergsten Cold Spring Harbor High School Adam Naguib Lloyd Trotman
Gloria DiMino Garden City High School Mikala Egeblad Mikala Egeblad
Rigina Gallagher Sacred Heart Academy Doreen Ware Doreen Ware
Melissa Gluck Sanford H. Calhoun High School Hilary Cox Partha Mitra
Daniel Kim Syosset High School Michael Wittinger Alea Mills
Neha Kinariwalla Sayville High School Fred Van Ex Robert Martienssen
Victoria Lellis Harborfields High School Guy Horev Alea Mills
Kevin Liaw The Wheatly School Florin Albeanu Florin Albeanu
Heather Szilagyi Cold Spring Harbor High School Peter Bommert David Jackson
Jordan Woldenberg Friends Academy Sachin Ranade Adam Kepecs
Deanna Zhu Syosset High School Zachary Lippman Zachary Lippman
2010/2011 Partners for the Future participants
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ACADEMIC AFFAIRS
The meetings and courses program attracts scientists from all over the world to Cold Spring Har-
bor Laboratory to communicate, learn, and critique the latest ideas and approaches in the biological
sciences. The program consists of advanced laboratory and lecture courses, as well as large meetings
and biotechnology conferences that are held almost year-round. More than 8500 scientists ranging
from graduate students and postdoctoral fellows to senior faculty came from around the world to
attend these events at Cold Spring Harbor. A growing international program complements the main
program of meetings and courses.
In 2010, the 30 laboratory and lecture courses that were held at the Laboratory attracted more
than 1320 participants (including teaching faculty, students, and technicians). These courses covered
a diverse array of topics in molecular biology, neurobiology, structural studies, and bioinformatics.
The primary aim of the courses remains to teach students the latest advances that can be immediately
applied to their own research. Courses are always being evaluated and updated to include the latest
concepts and approaches. Increasingly, many courses feature a strong computational component as
biology grows ever more interdisciplinary, incorporating methodologies from computer science,
physics, and mathematics. 
Instructors, course assistants, and course lecturers come from universities, medical schools, re-
search institutes, and companies around the world to teach at Cold Spring Harbor. Their excellence
and dedication make the course program work so well. We especially thank Drs. Ravi Allada, Vicki
Alan, Beverly Errede, Ke Hu, Raymond Keller, John Kirby, Kristen Kroll, Amy Lee, John Murray,
Larysa Pevny, Susan Lovett, Anca Segall, Beth Stevens, William Tyler, and Mei Zhen, who all retired
this year after many years of service. 
Grants from a variety of sources support the courses. The core support provided through the re-
cently renewed grant from the Howard Hughes Medical Institute remains critical to our course pro-
gram. The courses are further supported by multiple awards from the National Institutes of Health
248
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(NIH) and the National Science Foundation (NSF), and additional support for individual courses
is provided from various foundations and other sources. The courses also depend on equipment and
reagents that are loaned or donated by a large number of companies. These are invaluable for making
it possible to keep up with the latest technologies.
The Laboratory held 25 academic meetings this year, which brought together almost 7500 sci-
entists from around the world to discuss their latest research. A major milestone for the meetings
program was the 75th anniversary of the annual Symposium. To do justice to this anniversary, a
special one-day celebration on “75 Years in Science—Biology, Society, and the Future” was organized
by Jan Witkowski and held immediately prior to the Symposium. The celebration was also marked
with a commemorative booklet with essays by leading scientists who have participated in these Sym-
posia. The Symposium proper this year focused on the nucleus, reflecting the growing convergence
between cell biological and mechanistic studies that are providing a major new synthesis in our un-
derstanding of how this command-and-control center of the cell operates. The Symposium attracted
over 400 participants including notable nuclear biologists such as Günter Blobel, Joseph Gall, Robert
Goldman, John Gurdon, Steven Henikoff, Robert Kingston, Barbara Meyer, Kim Nasmyth, Daniela
Rhodes, and Pam Silver. 
Cold Spring Harbor Laboratory meetings are unique in assembling a program with very few in-
vited speakers. Instead, meeting organizers are encouraged to select talks from abstracts that are sub-
mitted on the basis of scientific merit, ensuring that the latest findings will be presented and that
young scientists will have the chance to describe their work. The annual meetings on Gene Expres-
sion and Signaling in the Immune System, The Biology of Genomes, Retroviruses, and Translational
Control were all oversubscribed, and many others attracted strong or record attendances. The Ice-
landic volcano disrupted attendance at spring meetings, but thankfully, travel restrictions were soon
lifted. A new biotechnology conference on RNA and Oligonucleotide Therapeutics was held in
April this year. Many of these meetings have become essential for those in the field and are held on
a biannual basis. Partial support for individual meetings is provided by grants from NIH, NSF,
foundations, and companies. Core support for the meetings program is provided by the Laboratory's
Corporate Sponsor Program.
The joint Cold Spring Harbor/Wellcome Trust Conference series held at the genome campus
south of Cambridge, England, included four meetings on Computational Cell Biology, Systems Bi-
ology: Networks, Infectious Disease Genomics, and Global Health, and Genome Informatics. Initi-
ated in 2001, more than 3500 scientists have attended meetings on topics as diverse as genome
informatics, host–pathogen interactions, and prion biology. The Wellcome Trust Conference team
have now developed the tools and skills to manage the academic conference program independently.
Finally, 2010 saw the continued development of the Cold Spring Harbor Asia program, as a
wholly owned affiliate of Cold Spring Harbor Laboratory with a mission to develop an educational
hub based in Suzhou, China. Two inaugural Symposia—the Watson Symposium on Cancer and
the Crick Symposium on Neuroscience—nine other scientific meetings, and one Summer School
were held throughout the year. 
The meetings and courses program staff is composed of a lean team of talented professionals,
many who wear multiple “hats,” who handle the complexities of database design, programming,
web and multimedia design, and educational grants management.
Terri Grodzicker
Dean
Academic Affairs
David Stewart
Executive Director
Meetings and Courses Program
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75TH COLD SPRING HARBOR LABORATORY 
SYMPOSIUM ON QUANTITATIVE BIOLOGY
Dynamic Organization of Nuclear Function
June 2–7 408 Participants
ARRANGED BY Terri Grodzicker, David Spector, David Stewart, and Bruce Stillman,
Cold Spring Harbor Laboratory
The decision to focus the historic 75th Symposium on the Dynamic Organization of
Nuclear Function reflects the growing convergence between descriptive cell biological
approaches to the nucleus and mechanism-driven approaches to nuclear processes that
are now illuminating the structural and functional operations of the primary control
center of the cell. Many previous Symposia have been devoted to nuclear organization
and function, notably Genes and Chromosomes: Structure and Organization (1941);
Genetic Mechanisms: Structure and Function (1956); Chromosome Structure and
Function (1973); Chromatin (1977); Structures of DNA (1982); DNA and Chro-
mosomes (1993); and Epigenetics (2004). Every decade has seen important advances
in the field, so it is not surprising that past Symposia have shed light from many angles
on the function of the central organelle of biology.
A major theme of this year’s Symposium addressed the emerging relationships be-
tween chromosome structure, genome function, and gene expression. Techniques have
now emerged that allow the monitoring of chromatin states in cell lines and in vivo using molecular
tags and sophisticated microscopy during differentiation. New methods to pinpoint the molecular
mechanisms and intranuclear organization underlying transcriptionally active versus inactive chro-
matin are revealing extraordinary organizational complexity within the nucleus. 
Epigenetic mechanisms such as DNA methylation and histone posttranslational modifications
such as acetylation and methylation, imprinting, RNA interference, and gene silencing are also sub-
ject to dynamic organization in the nucleus. Epigenetic changes are important contributors to the
pathogenesis of disease in humans, animals, and plants, and they may lie at the heart
of many important gene–environment interactions. Research is illuminating how epi-
genetic mechanisms play important roles in regulating the structure and function of
the genome, and the 2010 Symposium particularly highlighted the relationship be-
tween the genome, the epigenome, and the nuclear architecture and environment.
The role of signaling in regulating transcription, mRNA export, and chromatin
structure was also examined. For example, signaling from or at the nuclear envelope
reveals novel mechanisms for influencing nuclear envelope morphology, breakdown,
and cell differentiation. Chromatin dynamics was another major theme, both of the
chromatin fiber and of chromatin-binding proteins involved in replication and repair,
with new results discussed in areas such as the programming of DNA replication ori-
gins and their specificity. The latest developments in our understanding of mitotic
and meiotic chromosome dynamics, as well as the roles for nuclear transport factors
in cell cycle progression, were also covered. 
Tremendous progress is also being made in analyzing the mechanisms of assembly for nuclear
bodies and their functional roles. Regulated transport into and out of the nucleus through the nu-
250
B. Stillman
T. Grodzicker
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clear pore complex and the operation of selective transport mechanisms also featured prominently,
leading to vigorous discussion of the competing models for facilitated transport, as well as reports
of new factors required for mRNA export, tRNA shuttling, and pore complex assembly. There is
growing evidence that pore permeability and nuclear leakiness change in a regulated way with cell
differentiation and age. 
The meeting addressed how nuclear organization and function are linked to the underpinnings
of several pathophysiological states including the laminopathies such as A-type lamin dysfunction
in the premature aging disease Progeria and the molecular determinants of cancer-prone symptoms
of xeroderma pigmentosum and Cockayne syndrome, of the fatal bone marrow failure syndrome
dyskeratosis congentia, and of the Roberts and Cornelia de Lange developmental syndromes. The
relationship between nuclear architecture, aging, and disease was the subject of a masterful Dorcas
Cummings Lecture on “The Unexpected Link between Premature Aging and Nuclear Organization”
by Robert Goldman to a combined audience of scientists and lay friends and neighbors.
In arranging this Symposium, the organizers were dependent on the guidance of a broad cadre
of advisors including Drs. Robert Goldman, Robert Kingston, Kim Nasmyth, Daniela Rhodes, and
Pam Silver. Opening night speakers included John Gurdon, Rob Martienssen, Barbara Meyer, and
Günter Blobel. Joseph Gall presented the Reginald Harris Lecture on “Transcription, RNA Pro-
cessing, and Nuclear Bodies.” Steven Henikoff closed the meeting with a masterful and thought-
provoking summary. 
This Symposium was attended by more than 400 scientists from over 25 countries, and the
program included 68 invited presentations and 219 poster presentations. To disseminate the latest
results and discussion of the Symposium to a wider audience, attendees were able to share many
of the Symposium talks with their colleagues who were unable to attend using the Leading Strand
videoarchive, and a series of interviews with leading experts in the field was arranged during the
Symposium and distributed as free video from the Cold Spring Harbor Symposium Chats web-
site.
Funds to support this meeting were obtained from the National Institute of General Medical
Sciences, a branch of the National Institutes of Health. Financial support from the corporate spon-
sors of our meetings program is essential for these Symposia to remain a success and we are most
grateful for their continued support.
M. Dundr, I. Raska, W. Bickmore, D. Spector
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PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
Chromatin Modifications and Gene Expression
Chairperson: W. Bickmore, MRC Human Genetics Unit,
Edinburgh, United Kingdom
DNA Replication and Genome Integrity
K. Nasmyth, University of Oxford, United Kingdom
Reprogramming and Differentiation
Chairperson: T. de Lange, The Rockefeller University, New York
Reginald B. Harris Lecture: Transcription, RNA Processing,
and Nuclear Bodies
J.G. Gall, Carnegie Institution for Science, Baltimore, Maryland
RNA Biology
Chairperson: D. Spector, Cold Spring Harbor Laboratory
Chromosome Structure and Mitosis
Chairperson: A. Amon, Massachusetts Institute of Technology,
Cambridge
Heterochromatin Formation and Gene Silencing
Chairperson: G. Almouzni, CNRS UMR218, Institut Curie,
Paris, France
S. Henikoff
Dorcas Cummings Lecture: The Unexpected Link between
Premature Aging and Nuclear Organization
R. Goldman, Northwestern University Medical School, 
Illinois
Transcription Meets RNA Processing
Chairperson: J. Steitz, HHMI/Yale University, New Haven,
Connecticut
Nuclear Periphery
Chairperson: W. Earnshaw, University of Edinburgh, United
Kingdom
Chromatin Structure and Organization
Chairperson: S. Gasser, Friedrich Miescher Institute for
Biomedical Research, Basel, Switzerland
Genome Regulation
Chairperson: E. Heard, CNRS UMR128, Institut Curie, Paris,
France
Summary
Chairperson: Steven Henikoff, Fred Hutchinson Cancer Research
Center, Washington
T. Khoduchenko, J. GallR. Tjian, C. Venter
252 Meetings
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MEETINGS
Neuronal Circuits
March 10–13 189 Participants
ARRANGED BY Cori Bargmann, The Rockefeller University
Ed Callaway, Salk Institute for Biological Sciences
Dmitri Chklovskii, Janelia Farm Research Campus
In the quest to understand the brain, neuronal circuits represent a central level of description. Es-
tablishing connectivity in neuronal circuits seems as essential for solving the brain as having a geo-
graphic map for planning one’s travel. Although such realization motivated Cajal to describe a
variety of neuronal circuits using Golgi stains, his contributions were technologically limited. With
the recent appearance of novel molecular genetic, imaging, and computational techniques, a com-
prehensive description of the wiring diagram—an old dream of neuroscientists—is about to become
a reality. 
Because technological advances have been made in different organisms and systems, we wanted
to create a forum that brings together researchers working on different topics, yet focus on neuronal
circuits. This meeting included six broad slide sessions covering the olfactory system, the visual sys-
tem, methods, behavior learning and memory, motor systems, and the cortex, as well as a very in-
teractive poster session.
For the third meeting of this kind, the response of the field was
very enthusiastic. The meeting brought together participants from
all over the world, most of whom made either oral or poster pre-
sentations. Invited talks were given by Larry Abbott (Columbia
University), Richard Axel (Columbia University), Axel Borst (Max-
Planck Institute of Neurobiology), Sreekanth Chalasani (Salk In-
stitute), Karl Deisseroth (Stanford University), Marla Feller
(University of California, Berkeley), Joseph Fetcho (Cornell Uni-
versity), Charles Gilbert (The Rockefeller University), Shaul Hes-
trin (Stanford University School of Medicine), Shawn Lockery
(University of Oregon), Liqun Luo (Stanford University), Jeffrey
Magee (LSUHSC), Ian Meinertzhagen (Janiela Farm Research
Campus of HHMI), Markus Meister (Harvard University), May-
Britt Moster (CBM), Michael Nusbaum (University of Pennsylvania), I. Sebastian Seung (MIT),
and Rachel Wilson (Harvard Medical School). The meeting provided an important clearinghouse
for ideas and approaches and helped scientists in the field obtain the most up-to-date information,
enabling them to meet, to network, and to establish collaborations. Based on the uniformly enthu-
siastic comments of the participants, the intensity of the oral and poster sessions, and the large
crowds that stayed up late every night at the bar to discuss science, the meeting was a great success.
A highlight of the meeting program was the inaugural Larry Katz Memorial Lecture, made pos-
sible by the generous donation of many colleagues in the field. Excellent nominations were received.
A committee composed of the three organizers and Liqun Luo selected one speaker: Christopher
Harvey, Princeton University. He gave a wonderful talk about his graduate and postdoctoral work.
K. Briggman, S. Lockery
247-304_Meetings_Annual Report_2009 template  7/8/11  12:23 PM  Page 253
PROGRAM
Circuits and Behavior
Chairperson: L. Luo, Stanford University, California
Connectomics/Vision
Chairperson: D. Chklovskii, HHMI Janiela Farm Research
Campus, Ashburn, Virginia
Cortex and Other Circuits
Chairperson: E.M. Callaway, Salk Institute for Biological Studies,
La Jolla, California
Methods/Chemosensation
Chairperson: S. Lockery, University of Oregon, Eugene
E. Callaway, D. Chklovskii, C. Bargmann
K. Kolkman, C. Root
254 Meetings
Q. Wen, I. Rabinowich
Chemosensation/Motor
Chairperson: C. Bargmann, The Rockefeller University, New
York
Neural Computations
Chairperson: M.-B. Moser, Norwegian University of Science and
Technology, Trondheim, Norway
Larry Katz Memorial Lecture
C.D. Harvey, Princeton University, New Jersey
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PTEN Pathways and Targets
March 16–20 129 Participants 
ARRANGED BY Suzanne Baker, St. Jude Children’s Research Hospital
Lewis Cantley, Beth Israel Deaconess Medical Center
Pier Paolo Pandolfi, Harvard Medical School
Ramon Parsons, Columbia University
This third meeting on PTEN pathways was enormously successful. The meeting brought together top
scientists studying the PTEN/PI-3 kinase pathway using biochemical and molecular approaches as
well as in vivo model systems. An exciting series of talks and poster
presentations addressed the complex regulation of this signal trans-
duction cascade and its critical role in normal development, cancer,
aging and metabolism, autism, and other pathological disease states.
The conference provided an opportunity for researchers of all levels
to get together to discuss their latest research findings and technical
approaches toward the analysis of the PTEN pathway. Particular
emphasis was placed on pathway regulation and cross-talk, human
cancer pathogenesis, disease models, and therapy.
A total of 76 investigators presented in the nine scientific ses-
sions, with 41 platform sessions and 35 poster presentations and
129 registered attendees. The seven platform and two poster ses-
sions were marked by dynamic and enthusiastic exchanges of new results. In the scientific sessions,
many audience members participated in the question and answer sessions, and the poster sessions
were well attended. 
Essential funding for the meeting was provided by the National Cancer Institute, a branch of
the National Institutes of Health. 
PROGRAM
255
Upstream of PTEN
Chairperson: R. Parsons, Columbia University, New York
Downstream from PTEN
Chairperson: L. Trotman, Cold Spring Harbor Laboratory
PTEN Regulation
Chairperson: P. Devreotes, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Development and Disease Models
Chairperson: H. Wu, University of California, Los Angeles
D. Guerin, B. Manning, R. Shaw
mTORC1 and Intersecting Pathways
Chairperson: B. Manning, Harvard School of Public Health,
Boston, Massachusetts
Therapy and Cancer Models
Chairperson: J. Engelman, Massachusetts General Hospital, Boston
Aging, Metabolism, and Cancer
Chairperson: A. Brunet, Stanford University, California
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Systems Biology: Global Regulation of Gene Expression
March 23–27 284 Participants
ARRANGED BY Brad Bernstein, Massachusetts General Hospital, Harvard Medical School, Broad Institute
Martha Bulyk, Brigham & Women’s Hospital, Harvard Medical School
Harmen Bussemaker, Columbia University
Marian Walhout, University of Massachusetts Medical School
Systems biology aims to understand the emergent properties of molecular networks
in cells by using systematic and global approaches. One of the most actively re-
searched areas of systems biology in recent years has been global regulation of gene
expression, which coordinates complex metabolic and developmental programs in
organisms. This seventh conference in the series, like the ones in previous years,
captured the continuing rapid progress and many new discoveries in this young
and exciting field. 
A total of 284 scientists attended the 4-day meeting, which featured 46 talks
and 109 poster presentations covering a broad range of topics. Two keynote
speeches were exciting highlights of the meeting. The first was presented by Dr.
Kevin Struhl, who has been a leader in the area of transcriptional regulation for
many years. Dr. Struhl presented a detailed story on the transcriptional and epige-
netic changes that accompany cellular transformation in a model of breast cancer.
The second keynote was presented by Dr. Steve Henikoff, a leader in the field of
epigenetics with a long history of creatively integrating systems approaches into
his research. Dr. Henikoff presented a global study of the role of histone variants
and histone exchange in the regulation of the Drosophila genome. 
Compared to previous conferences, five aspects featured prominently in this
year’s meeting: (1) Next-generation sequencing technologies—representing in-
creasingly standard means for data acquisition—are now being applied to study
transcription factor localization, nucleosome positioning, chromatin modifica-
tions, and higher-order genome organization; the large amounts of new data have
stimulated the generation of a plethora of new genomic methods, computational
algorithms, resources, and biological insights; (2) new imaging technologies are
allowing researchers to examine the dynamics of gene expression in vivo and in
real time, and in some cases, at a single-molecule level; (3) new resources on the
binding specificities of transcription factors and RNA-binding proteins continue to be created, pro-
viding opportunities for systematic analysis of gene regulatory networks in Drosophila and mammals;
(4) there is much excitement around the newly appreciated and emerging roles for different classes
of noncoding RNAs in genome regulation; and (5) new computational algorithms are being adopted
to analyze the gene regulatory networks. Generally, the speakers in these sessions were young, with
most being in the early stage of their careers. Finally, to help computational biologists and experiment
scientists better communicate with each other, this year’s meeting also included a premeeting work-
shop that was focused on introductory experimental and computational topics. 
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health, and the National Science Foundation.
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PROGRAM
Keynote Address: Mapping Genome-Wide Nucleosome 
Dynamics
S. Henikoff, Fred Hutchinson Cancer Research Center, Seattle,
Washington 
Keynote Address: An Epigenetic Switch That Links Inflamma-
tion to Cancer—Regulatory Circuits and Cancer Treatment
K. Struhl, Harvard Medical School, Boston, Massachusetts
Transcription
Chairperson: T. Hughes, University of Toronto, Canada
Transcriptional Regulatory Networks
Chairperson: X.S. Liu, Dana-Farber Cancer Institute, Boston,
Massachusetts
Chromatin
Chairperson: R. Morse, Wadsworth Center, Albany, New York
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Epigenetics
Chairperson: J. Stamatoyannopoulos, University of Washington,
Seattle
cis-Regulatory Logic
Chairperson: L. Mirny, Massachusetts Institute of Technology,
Cambridge
Posttranscriptional Regulation
Chairperson: M. Walhout, University of Massachusetts Medical
School, Worcester
Emerging Technology
Chairperson: B. Andrews, University of Toronto, Canada
Variation and Evolution
Chairperson: M. Bulyk, Brigham & Women’s Hospital, Harvard
Medical School, Boston, Massachusetts
R. Hardison, G. Bernardi L. Albert A. Gerber, J. Lieb
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RNA and Oligonucleotide Therapeutics
April 7–10 90 Participants
ARRANGED BY Ryszard Kole, AVI BioPharma
Adrian Krainer, Cold Spring Harbor Laboratory
Bruce Sullenger, Duke University
This first conference on RNA and oligonucleotide therapeutics was focused on clinical trials and the
development of oligonucleotides as drugs, but it brought together top scientists from academia and
industry interested in a variety of RNA-based therapeutics, not only oligonucleotides. The theme
“from the bench to the bedside” covered approaches ranging from an-
tisense oligonucleotides and aptamers through modulation of splicing,
targeting expanded triplet repeats, and immunostimulation to small
interfering RNAs (siRNAs) and microRNAs (miRNAs) as potential
drugs and targets. The all-important issue of RNA therapeutics de-
livery by a variety of methods was also covered. The applications of
these varied technologies included rare diseases, cancer, cardiovascular
diseases, and bacterial and viral infections. 
The participants came from 11 companies and from universities
and research institutions from the United States and abroad. The
seven scientific sessions featured 37 platform talks and 20 posters
and included 90 registered attendees. Animated and insightful ex-
changes during the sessions continued throughout. A number of
participants expressed interest in attending this conference next year.
The meeting opened with a keynote by Nobel laureate Dr. Sydney Altman and the sessions addressed
modulation of RNA splicing, antisense oligonucleotides, posttranscriptional control of gene expres-
sion, siRNA, miRNA and aptamers as therapeutics, delivery of RNA therapeutics, and im-
munomodulating oligonucleotides.
The topic of the meeting attracted funding from several companies including major funding
from AVI Biopharma.
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A. Krainer, R. Kole, B. Sullenger
Oligonucleotide Therapy
Chairperson: A. Krainer, Cold Spring Harbor Laboratory
Delivery of RNA Therapeutics
Chairperson: S. Dowdy, HHMI/University of California, San
Diego
Oligonucleotide-Induced Immunostimulation and Other
Mechanisms
Chairperson: S. Agrawal, IDERA Pharmaceuticals, Cambridge,
Massachusetts
PROGRAM
Keynote Address: RNA and Therapeutic Modes
S. Altman, Yale University, Connecticut
Exon Skipping Therapy
Chairperson: R. Kole, AVI BioPharma, Bothell, Washington
siRNA, miRNA, and Aptamers as Therapeutics
Chairperson: B. Sullenger, Duke University, Durham, North 
Carolina
Posttranscriptional Control of Gene Expression
Chairperson: C. Thornton, University of Rochester, New York
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Gene Expression and Signaling in the Immune System
April 21–25 327 Participants
ARRANGED BY Doreen Cantrell, University of Dundee, United Kingdom
Sankar Ghosh, Columbia University College of Physicians & Surgeons
Dan Littman, HHMI/New York University School of Medicine
Mark Schlissel, University of California, Berkeley
This meeting was held for the fifth time in 2010, taking place in the context of global travel restric-
tions due to the Icelandic volcano eruption. Although ~380 scientists registered for the meeting,
53 had to cancel due to flight cancellations in Europe. Nonetheless, ~25% of attendees were from
outside of the United States, 41% were women, and 53% were either graduate students or postdocs.
Although there are many immunology meetings, the unique aspect of this Cold Spring Harbor
meeting is its focus on molecular and biochemical aspects of the development and
function of the immune system. In addition, this meeting attracts a broad range of
scientists who utilize the immune system as a model to ferret out basic principles of
biological regulation. 
Talks were presented by a mix of invited speakers and investigators selected from
among a group of more than 200 submitted abstracts. Due to last-minute cancella-
tions, several investigators were asked to substitute for scheduled speakers and they
welcomed the opportunity. A significant number of women and junior investigators
were asked to give talks. Most speakers focused almost exclusively on their unpublished
work. A major new approach to the study of gene regulation permeated several talks—
ChIP-Seq analysis of specific chromosomal protein DNA interactions. Meinrad Bus-
slinger spoke about Pax5 and CTCF-binding sites in the IgHC locus that helped him
define an important new potential regulatory element in the V region of that complex
locus. David Schatz presented exciting new data on the genome wide binding of V(D)J recombinase
components to specifically modified histones as well as RSS elements. Cornelius (Kees) Murre (Uni-
versity of California, San Diego) presented an update to his three-dimensional model of interphase
structure of a complex genetic locus within nuclear space. The product of a collaboration with
physicists and mathematicians, this model based on fluorescent in situ hybridization data helps ex-
plain how more than 100 immunoglobulin V
H gene segments distributed over greater than a
megabase of DNA can recombine with DH segments at roughly similar frequencies. Young investi-
gator Greg Barton described the surprising discovery of how an enteric pathogen uses receptors
from the innate immune system to trigger the expression of its own pathogenicity genes. Finally, in
one of the last talks of the meeting, coorganizer Dan Littman revealed new details of how HIV in-
teracts with but does not infect dendritic cells. 
These talks highlighted the relevance of the data discussed at this meeting, not just to immunol-
ogy but to the broader scientific community. Oral presentations were supplemented by two after-
noon poster sessions that were extremely well-attended and provided a forum for all meeting
participants (including many graduate students and postdocs) to share their most recent data. In
addition, attendees took advantage of walking tours of the CSHL campus, a bountiful lobster ban-
quet, and an evening performance by the Yale-based music group “The Cellmates,” with dancing
extending into the early morning hours. 
Continuing support was obtained from the NIH/NIAID as well as from six corporate sponsors.
M. Schlissel
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Stem Cells and Early Developmental Decisions
Chairperson: S. Smale, University of California School of
Medicine, Los Angeles
Regulation of Immune Cell Development
Chairperson: M. Schlissel, University of California, Berkeley
Chromatin Structure and Epigenetics
Chairperson: H. Singh, HHMI/University of Chicago
Antigen Receptor Gene Assembly and Modification
Chairperson: F. Alt, HHMI/Children’s Hospital, Boston,
Massachusetts
Signaling
Chairperson: A. Weiss, HHMI/University of California, San
Francisco
Regulation of Immune Cell Function I
Chairperson: D. Littman, HHMI/New York University School of
Medicine
Regulation of Immune Cell Function II
Chairperson: D. Cantrell, University of Dundee, United
Kingdom
Innate Immunity
Chairperson: S. Ghosh, Columbia University College of
Physicians & Surgeons, New York
E. Chan, M. Krangel, H. Singh
G. Amarante-Mendes, T. Mak
K. Murphy, T. Zhang
S. Chatterjee, S. Volpi
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Vertebrate Organogenesis
April 27–May 1 138 Participants
ARRANGED BY Jonathan Epstein, University of Pennsylvania School of Medicine
Brigid Hogan, Duke University Medical Center
Guillermo Oliver, St. Jude Children’s Research Hospital
Recent advances in stem cell biology are impressive and have
strengthened our collective optimism that gene- and stem-cell-based
therapies may eventually become realistic approaches in the treat-
ment of many diseases, particularly those that have a significant
pathological effect on organs and specific organ systems. Central to
that goal is a clear understanding of the genes and mechanisms con-
trolling vertebrate organogenesis in health and disease. Accordingly,
the specific goals of this new conference was to bring together a di-
verse group of scientists working in various animal models and in-
terested in studying different molecular, cellular, and genetic aspects
of vertebrate organogenesis in basic and translational settings. 
Major topics (axis formation, nervous system, vascular system,
epithelial organs, heart development, genito-urinary formation, en-
dodermal organs, diabetes and cancer, and muscoskeletal forma-
tion) were chosen for detailed discussion, and these topics were all ultimately united by the use of
approaches that pursue answers to key biological questions. Presentations on these topics provided
C. Blanpain, B. Hogan
Poster session
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a general overview of key questions, common problems, and progress achieved by investigators
working in this field. The invited speakers were all leaders on each of the organs/tissues discussed.
The organizers made selection of material from the submitted abstracts for short oral presentations.
Two well-attended poster sessions were held during the conference. 
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health; the National Science Foundation; the Society for Developmental Biology; The
Company of Biologists; Genentech; March of Dimes; and Novartis.
B. Sosa-Pineda, L. Sussel, L. Iruela-Arispe
PROGRAM
Axis Formation
Chairperson: B. Hogan, Duke University, Durham, North
Carolina
Development of the Nervous System
Chairperson: G. Oliver, St. Jude Children’s Research Hospital,
Memphis, Tennessee
The Vascular System in Health and Disease
Chairperson: L. Iruela-Arispe, University of California, Los
Angeles
Epithelial Organ Morphogenesis
Chairperson: S. Pfaff, The Salk Institute, La Jolla, California
C. Miazga
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Developmental Mechanisms of Heart Development
Chairperson: J. Epstein, University of Pennsylvania School of
Medicine, Philadelphia
Myopathies and Muscoskeletal Formation
Chairperson: G. Karsenty, Columbia University, New York
Developmental Origin of Genito-Urinary Defects
Chairperson: A. McMahon, Harvard University, Cambridge,
Massachusetts
Endodermal-Derived Organs, Diabetes, and Cancer
Chairperson: K. Zaret, University of Pennsylvania School of
Medicine, Philadelphia
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Molecular Chaperones and Heat Shock Response
May 4–8 240 Participants
ARRANGED BY F. Ulrich Hartl,Max-Planck Institute for Biochemistry
David Ron, New York University School of Medicine
Jonathan Weisssman, HHMI/University of California, San Francisco 
This meeting continued the rich tradition of a forum where cutting-edge analysis of molecular
mechanisms of protein folding is presented in the context of its biological importance and health
relevance. The high attendance, large number of posters (94), and lively audience participation in
the sessions and in the informal activities that followed are testament to the success of the meeting
and to the successful balance of the sessions. The field of
chaperone research is evolving and this meeting is surely
evolving with it.
In addition to well-established biochemical and biophys-
ical methods for studying chaperone function, this meeting
featured presentations using single-molecule methods and ad-
vanced computational approaches to the study of signaling
networks involved in control of chaperone gene expression.
This year’s meeting also featured two new sessions: one on
Evolution and Regulation of Protein Folding Machines and
the other on Manipulating Chaperone Networks and Protein
Folding. The former provided a forum for work on the sys-
tems biology aspect of protein folding and the latter for work
of special relevance to the prospects of translating the basic
science to applications in health and biotechnology.
Among the cutting-edge themes explored were presentations of genetic interaction networks in
mammalian systems. Talks covered protein trafficking in the cell that emphasized the fluidity of sub-
cellular compartmentalization, intracellular protein turnover, connections between ribosomes and
chaperones, and novel signaling pathways involved in protein-folding homeostasis.
This meeting was funded in part by the National Institute on Aging; the National Heart, Lung,
and Blood Institute; the National Institute of General Medical Sciences; branches of the National
Institutes of Health; and Enzo Life Sciences, Inc.
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Chaperone Biochemistry and Protein Folding
Chairperson: J. Bardwell, HHMI/University of Michigan, 
Ann Arbor
Chaperone Function in Disease and Development
Chairperson: E. Deuerling, University of Konstanz, 
Germany
Evolution and Regulation of Protein-Folding Machines
Chairperson: J. Frydman, Stanford University, California
Manipulating Chaperone Networks and Protein-Folding
Pathways
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Y. Yanagitani P. Slade, J. Kim S. Quan
Chairperson: W. Balch, The Scripps Research Institute, La Jolla,
California
Chaperones and Proteolysis
Chairperson: B. Sauer, Massachusetts Institute of Technology,
Cambridge
Diseases of Protein Misfolding
Chairperson: A. Dillin, The Salk Institute, La Jolla, California
Quality Control and Protein Trafficking
Chairperson: R. Hegde, University of California,
San Francisco
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The Biology of Genomes
May 11–15 548 Participants
ARRANGED BY Susan Celniker, Lawrence Berkeley National Laboratory
Andrew Clark, Cornell University
Chris Ponting, UK Medical Research Council, University of Oxford
George Weinstock,Washington University
This annual meeting marked the 23rd annual gathering of genome scientists at Cold Spring Harbor
Laboratory. The meeting built upon the remarkable progress in the mapping, sequencing, annota-
tion, and analysis of genomes from many human individuals, “model
organisms,” other animals, and prokaryotes. New DNA-sequencing
technologies have caused a steep rise in the quantity of sequences being
generated, and the meeting reported many breakthroughs in our un-
derstanding of sequence variants that contribute to disease, including
cancer and complex disease, and to phenotypic traits. The new data are
also providing important insights into population structure for humans
and other species. In addition to those on genome sequence, there were
a number of reports of transcriptome and epigenomic profiling. Inves-
tigators from around the world attended the meeting, with more than
350 abstracts presented, describing a broad array of topics relating to
the production and analysis of genomes from diverse organisms.
There were numerous reports on progress in using the new sequenc-
ing technologies, with mounting expectation for further advances as these continue to be applied
widely. The keynote presentations were delivered by Cori Bargmann and Martin Blaser.
The ELSI (Ethical, Legal, and Social Implications) panel was chaired by Susan Wolf and the dis-
cussion topic was Returning Research Results to Participants in Large-Scale Genomics Studies.
Major sponsorship for this meeting was provided by Roche. Additional funding was provided
by Illumina, Inc. and the National Human Genome Research Institute, a branch of the National
Institutes of Health.
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G. Weinstock, J. Watson
PROGRAM
Functional and Cancer Genomics
Chairpersons: L. Ding, Washington University School of
Medicine, St. Louis, Missouri; P. Farnham, University of
California, Davis
Genetics of Complex Traits
Chairpersons: D. MacArthur, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; C. Ober, University of Chicago,
Illinois
High-Throughput Genomics and Genetics
Chairpersons: B. Graveley, University of Connecticut Health
Center, Farmington; J. Shendure, University of Washington,
Seattle
Computational Genomics
Chairpersons: L. Duret, CNRS, Université Lyon 1, Villeurbanne,
France; J. Wortman, University of Maryland School of
Medicine, Baltimore
ELSI Panel and Discussion: Returning Research Results to
Participants in Large-Scale Genomics Studies
Moderator: S.M. Wolf, J.D., University of Minnesota
Panelists: Y. Joly, D.C.L., McGill University, Canada; K.
Kato, Ph.D., Kyoto University, Japan; J. Kaye,
Ph.D., Oxford University, United Kingdom; I.
Kohane, M.D., Ph.D., Harvard Medical School,
Massachusetts
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Evolutionary Genomics
Chairpersons: L. Kruglyak, Princeton University, New Jersey; D.
Petrov, Stanford University, California
Population Genomic Variation
Chairpersons: D. Adams, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; R. Nielsen, University of
California, Berkeley
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Keynote Speakers 
C. Bargmann, The Rockefeller University, New York
Genetic Variation in Animal Behavior: Genes, Neurons, and
Maybe Some Principles
M. Blaser, New York University, New York
Genetics and Genomics of Nonhuman Species
Chairpersons: K. Pollard, Gladstone Institutes, San Francisco,
California; M. Purugganan, New York University, New York
M. Banck, A. Beutler, P. Berylein
H. Blocker D. Bentley, J. Mullikin
F. Casals, M. Zilversmit
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The Cell Cycle
May 18–22 301 Participants
ARRANGED BY Sue Biggins, Fred Hutchinson Cancer Research Center
Nicholas Dyson,Massachusetts General Hospital Cancer Center
Johannes Walter, Harvard Medical School
This biannual meeting is internationally recognized for its ability to bring together scientists who
study cell cycle regulation in eukaryotes ranging from yeast to humans. As usual, the meeting began
with a keynote talk from a leader in the field, and on this occasion, we were fortunate to have Dr.
Douglas Koshland, from the University of California, Berkeley, tell
us about the initial discovery of cohesin and the subsequent con-
tributions his lab has made to the field. After the keynote talk, the
evening session continued with five talks focused on key findings
about the regulation of cohesion. 
The remainder of the meeting was organized around seven lecture
sessions and two poster sessions, which focused on the major stages
of the cell division cycle, with an emphasis in each session on the
molecular mechanisms that govern cell cycle progression. Many of
these sessions focused on long-standing problems in cell cycle con-
trol, including the transcriptional mechanisms controlling entry in
the cell cycle, the mechanisms that initiate and control chromosome
duplication, the mechanisms that trigger the complex events of chro-
mosome segregation in mitosis, and the numerous checkpoint systems that ensure that cell cycle events
occur in the correct order. Cutting-edge techniques to address problems as well as talks that emphasized
modeling were represented. The meeting ended with a popular proteolysis session that brought together
different perspectives from investigators who study the role of proteolysis in a variety of cell cycle
processes. There were also a number of talks and posters about quiescence and other specialized states
of the cell cycle. 
The meeting also connected cell cycle regulation with cancer biology with reports about the func-
tions of oncogenes and tumor suppressors in cell cycle control. As always, major model systems for
cell cycle analysis were represented, and the striking phylogenetic conservation of cell cycle regulatory
mechanisms was readily evident. The meeting also served to demonstrate the impact of whole-
genome analysis on basic cell biology, and these achievements will no doubt continue to drive rapid
progress in this field. It was another landmark meeting for the cell cycle field, and the participants
continue to look forward to equally exciting meetings in future years.
PROGRAM
S. Biggins, N. Dyson, J. Walter
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G1 and CDK Regulation
Chairpersons: S. Haase, Duke University, Durham, North Carolina;
J. Lees, Massachusetts Institute of Technology, Cambridge
S Phase
Chairpersons: J. Diffley, Cancer Research UK London Research
Institute, United Kingdom; B. Duronio, University of North
Carolina, Chapel Hill
Keynote Address: Lessons Learned from Trying to Answer 
to a Higher Order
D. Koshland, University of California, Berkeley
Chromosome Cohesin and Condensation
Chairpersons: D. Morgan, University of California, San
Francisco; J.-M. Peters, Research Institute of Molecular
Pathology, Vienna, Austria
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The DNA-Damage Response
Chairpersons: D. Toczyski, University of California, San
Francisco; H. Piwnica-Worms, HHMI/Washington University,
St. Louis, Missouri
Cell Cycle Regulatory Pathways
Chairpersons: P. O’Farrell, University of California, San
Francisco; B. Edgar, Universität Heidelberg, Germany
Chromosome Segregation
Chairpersons: D. Pellman, Dana-Farber Cancer Institute,
Boston, Massachusetts; T. Kapoor, The Rockefeller University,
New York
B. Mardin, J. Keck B. Gomez-Escoda
K. Tschop, K. Engeland
268 Meetings
J. Witkowski, J. Watson R. Medema
Metaphase/Anaphase
Chairpersons: R. Medema, University Medical Centre
Utrecht, The Netherlands; T. Davis, University of
Washington, Seattle
Proteolysis
Chairpersons: B. Schulman, St. Jude Children’s Research
Hospital, Memphis, Tennessee; J. Pines, University of
Cambridge, United Kingdom
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Retroviruses
May 24–29 500 Participants
ARRANGED BY Christopher Aiken, Vanderbilt University
Jeremy Luban, University of Geneva
This was the 35th year of the Retroviruses Conference, and it coincided with the 35th anniversary
of the Nobel Prize awarded to Renato Dulbecco, David Baltimore, and Howard Temin, “for their
discoveries concerning the interaction between tumour viruses and the genetic material of the cell.”
Following tradition, the 13 sessions of the meeting (ten oral, three poster) focused on unpublished,
basic research concerning mechanisms of retroviral replication and interactions with nec-
essary host factors. HIV-1 took center stage, but there were presentations on other
lentiviruses, HTLV-1, FIV, MLV, RSV, yeast viruses, and endogenous elements. A new
area this year was XMRV, a new human retrovirus that has been associated with prostate
cancer and chronic fatigue syndrome. The invited keynote speakers were Drs. Sandra
Ruscetti and Ruslan Medzhitov. Dr. Ruscetti’s talk laid the foundation for the large num-
ber of XMRV talks and posters that followed. Dr. Medzhitov described work on the au-
toimmunity that results from the accumulation of cDNA from endogenous retroviruses
in the face of Trex1 deficiency and his work on novel mechanisms of intrinsic resistance
to disease that permit animals to survive challenge with pathogens. 
Some highlights of the submitted research presentations were the demonstration that
membrane microdomains have a role in virus capture and transfer by dendritic cells and
that viral incorporation of a specific ganglioside (GM3) is critical for this process; advances
in understanding the role of host factors TNPO3 and Nup358 in HIV infection, including
the demonstration that such factors control HIV-1 integration targeting preference; identification
of the first small-molecule inhibitor targeting the IN-LEDGF interaction; discovery and mechanism
of novel capsid-targeting HIV inhibitors; identification of the host protein Mov10 as an inhibitor
of retrovirus infection; demonstration of a positive role for the host factor ZASC1 in HIV Tat func-
tion; high-resolution X-ray structure of the HIV-1 CA pentamer; identification of host factors in-
269
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volved in epigenetic silencing of retroviruses; identification of a role of Rab11a in HIV-1 Env in-
corporation; mechanistic insights into Vpu and Nef conteraction of the host restriction factor BST-
2/Tetherin; and progress from several labs on the controversial role of XMRV in human disease. 
Stephen Hare from the Cerepanov lab reported on their landmark achievement of the cocrystal
structure of the a foamy virus integrase in complex with DNA, and Luban’s group reported evidence
that TRIM5 proteins can act as innate sensors for the retroviral capsid and participate in immune
signaling, suggesting that TRIM5 may function as a pattern recognition receptor akin to TLR3 and
RIG-I. Finally, Dan Littman presented exciting evidence that forcing HIV-1 to infected dendritic
cells in culture induces a type I interferon response that depends on interactions of cyclophilin A
with nascent Gag protein in the infected cell. Many other noteworthy advances were reported but
cannot be listed here due to space constraints.
On the final evening of the meeting, a special session celebrated the 35th anniversary of the
Nobel Prize awarded to the codiscoverers of reverse transcriptase, Dr. Howard Temin and Dr. David
Baltimore. Two invited speakers for the occasion, Dr. Rayla Temin and Dr. Baltimore, were intro-
duced by Dr. John Coffin and Dr. Stephen Goff, respectively. The legacies of Temin and Baltimore
were strongly evident during the session, not only from the historical descriptions of their monu-
mental achievements, but also owing to the fact that the majority of meeting attendees confirmed
that they received scientific training, either directly or indirectly, from one of these giants of the
field. Dr. James Watson was present to celebrate his fellow Nobel laureates.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, a
branch of the National Institutes of Health.
PROGRAM
Entry
Chairpersons: J. Mak, The Burnet Institute, Melbourne,
Australia; C. Berlioz-Torrent, INSERM U1016, Paris, 
France
RT and Trim5
Chairpersons: F. Diaz-Griffero, Albert Einstein College of
Medicine, Bronx, New York; W. Johnson, Harvard Medical
School, Boston, Massachusetts
Goin’ Nuclear
Chairpersons: M. Naghavi, University College Dublin, Ireland;
E. Bacharach, Tel Aviv University, Israel
Keynote Address
S. Ruscetti, National Cancer Institute, Frederick, Maryland
Understanding the Biological Effects of the Human Retrovirus
XMRV: Lessons Learned from Studying Murine Retroviruses
H. Taylor, O. Ciagoz S. Garforth, C. Lwatula
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Apobec
Chairpersons: V. Simon, Mount Sinai School of Medicine, New
York; Y.-H. Zheng, Michigan State University, East Lansing
Integration
Chairpersons: M. Roth, UMDNJ–Robert Wood Johnson Medical
School, Piscataway, New Jersey; P. Cherepanov, Imperial
College London, United Kingdom
RNA
Chairpersons: J.-C. Paillart, CNRS-Université de Strasbourg,
France; W.-S. Hu, National Cancer Institute, Frederick,
Maryland
Assembly
Chairpersons: F. Bouamr, NIAID, National Institutes of Health,
Bethesda, Maryland; A. Ono, University of Michigan Medical
School, Ann Arbor
Keynote Address
R. Medzhitov, HHMI/Yale University, Connecticut
Understanding the Biological Effects of the Human Retrovirus
XMRV: Lessons Learned from Studying Murine Retroviruses
Tetherin and XMRV
Chairpersons: S. Neil, King’s College London, United Kingdom:
I. Singh, University of Utah, Salt Lake City
Structure, Genome, and Defense
Chairpersons: F. Bushman, University of Pennsylvania,
Philadelphia; D. Unutmaz, New York University School of
Medicine
Special Celebration
35th anniversary of the Nobel Prize in Physiology or Medicine,
“for their discoveries concerning the interaction between
tumor viruses and the genetic material of the cell”
Introduction by John Coffin
R. Temin, University of Wisconsin, Madison
Introduction by Stephen Goff
D. Baltimore, California Institute of Technology
Tetherin and Pathogenesis
Chairpersons: D. Evans, Harvard Medical School, Boston,
Massachusetts; M. Pizzato, University of Geneva, Switzerland
T. Izumi, K. Sato
Retroviruses      271
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75 Years in Science: Biology, Society, and the Future
June 1 212 Participants
ARRANGED BY Jan Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Reginald Harris became the director of the Biological Laboratory at Cold Spring Harbor in 1924.
He set about revitalizing the Laboratory, making biophysics the new focus of research and, most
notably, established the Cold Spring Harbor Laboratory Symposia on Quantitative Biology. Their
goal, Harris wrote, was “to consider a given biological problem from its chemical, physical and
mathematical, as well as from its biological aspects.”
The first symposium was held in 1933 and they have been held annually ever since, with the ex-
ception of 1943–1945, surely making them one of the longest-lived series of meetings in the biological
sciences. The success of the Symposia was due not only to the quality of the science presentations,
but also to the very generous funding by two foundations, the Rockefeller Foundation and the
Carnegie Foundation. These together helped support the meetings from 1934 through 1960.
The Symposia topics have always been at the forefront of contemporary research. Prior to World
War II, biophysics research was the theme of the Symposia after the war; genetics came to dominate
the Symposia for more than 20 years, culminating in the 1996 Symposium, The Genetic Code.
Since then, Symposia topics have ranged over all aspects of ex-
perimental biology—DNA, RNA, and proteins; cell biology;
developmental biology; human genetics; cancer; neuroscience;
physiology; and immunology and virology. 
Such a storied history had to be celebrated and so a 1-day
meeting was held immediately before the start of the 75th
Symposium. We included two examples of the power of mo-
lecular genetics when applied to human beings—what is being
revealed of our origins and the use of DNA fingerprinting to
free the wrongly convicted. Molecular genetics was also the
foundation of two presentations on key areas of biomedical
research: cancer and neurodevelopmental disorders. Finally,
we looked deep into the crystal ball with a talk on synthetic
genomes. The banquet, always a lively event, was further en-
livened by Sydney Brenner who was the after-dinner speaker,
and he and Jim Watson cut a cake celebrating the occasion.
Reginald Harris left a legacy that has stimulated the generations of biologists who have come
each year to talk, argue, and gossip at the Symposium. Just as Harris promoted biophysics as the
key to a deep understanding of the nature of living organisms, so contemporary organizers promote
molecular approaches for the investigation of biological systems. As we celebrated the occasion of
the 75th Symposium, there was every reason to believe that the Symposia will continue to fulfill
Harris’s vision.
Generous financial support was provided equally by the Rockefeller Foundation and the Carnegie
Corporation of Washington. Additional support was provided through a personal gift from Dr.
Charles Weissmann.
S. Henikoff, J. Gall
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PROGRAM
Opening Remarks
B. Stillman, Cold Spring Harbor Laboratory
Chairperson: R. Tjian, Howard Hughes Medical Institute, Chevy
Chase
Devising Cancer Therapies
Chairperson: C. Sawyers, Memorial Sloan-Kettering Cancer
Center, New York
Commentary
T. Jacks, Massachusetts Institute of Technology, Cambridge
The Journey of Man: A Genetic Odyssey
S. Wells, National Geographic Society, Washington, District of
Columbia
Commentary
H.L. Gates, Jr., Harvard University, Cambridge, Massachusetts
75 Years in Science: Biology, Society, and the Future      273
E. Heard, J. Haber
Fulfilling the Promise of Molecular Medicine in a Develop-
mental Brain Disorder
M. Bear, Massachusetts Institute of Technology, Cambridge
Commentary
S. Landis, National Institute of Neurological Disorders & Stroke,
Bethesda, Maryland
The Wrongly Convicted: DNA and Justice
P. Neufeld, Innocence Project, New York
Commentary
J.C. Venter, J. Craig Venter Institute, Rockville, Maryland; R.
Roberts, New England BioLabs, Inc., Ipswich, Massachusetts
Closing Remarks
J.D. Watson, Cold Spring Harbor Laboratory
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Glia In Health and Disease
July 22–26 193 Participants
ARRANGED BY Beth Stevens, Children’s Hospital/Harvard Medical School
William Talbot, Stanford University
Glial cells constitute 90% of cells in the human nervous system, but their roles in the developing,
adult, and diseased brain are still poorly understood. In this summer’s meeting, students and scien-
tists from across the world gathered to discuss their recent progress. In the first part of the meeting,
sessions focused on understanding the normal roles of glia,
including sessions on the genetic analysis of glial function,
neural development, myelination, axon–glial interactions,
microglia function, and astrocyte function at synapses and
blood vessels. In the last half of the meeting, sessions focused
on recent progress on understanding the roles of glia in CNS
regenerative failure and disease processes, including glioma,
epilepsy, and multiple sclerosis. There was active discussion
related to the protective and destructive roles of “reactive glio-
sis” in CNS injury and neurodegenerative diseases including
ALS (Lou Gehrig’s disease) and glaucoma. 
One of the highlights of the meeting was an animated
roundtable discussion led by Ben Barres and Martin Raff on
key issues related to glial biology and life in science. Poster
sessions were well attended with active discussion. There was again a sense of excitement that our
understanding of the function of glia is quickly moving forward, with glia having central roles in
normal brain development, function, and disease. This excitement was reflected in the presence of
several top journal editors interested in enhancing their coverage of latest advances concerning glia.
This meeting was funded in part by the National Cancer Institute, a branch of the National In-
stitutes of Health.
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W. Talbot, B. Stevens
L. Goutebroze, J. Ness-Myers A. Agarwal A. Giangrande, M. Raff
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PROGRAM
Genetic Analysis of Glial Function
Chairpersons: B. Popko, University of Chicago, Illinois; M.
Freeman, University of Massachusetts Medical School,
Worcester
Myelinating Cells
Chairpersons: K. Jessen, University College London, United
Kingdom; P. Brophy, University of Edinburgh, United
Kingdom
Axon–Glial Interactions
Chairpersons: J. Chan, University of California, San Francisco;
E. Peles, Weizmann Institute of Science, Rehovot, Israel
Glial Function at Synapses
Chairpersons: D. Bergles, Johns Hopkins University, Baltimore,
Maryland; G. Corfas, Children’s Hospital, Boston,
Massachusetts
Microglia Function in Health and Disease
Chairpersons: A. Bessis, Ecole Normale Supérieure, Paris, France;
M. Carson, University of California, Riverside
Roundtable Discussion: Glia in Health and Disease—Open
Questions and Future Directions
Chairpersons: B. Barres, Stanford University School of Medicine,
California; M. Raff, University College London, United
Kingdom
Gliovascular Interactions and Astrocyte Function
Chairpersons: R. Daneman, University of California, San
Francisco; M. Nedegaard, University of Rochester, New 
York
CNS Injury and Disease
Chairpersons: M. Sofroniew, University of California School 
of Medicine, Los Angeles; H. Zong, University of Oregon,
Eugene
Glial Development and Epigenetic Mechanisms
Chairpersons: D. Rowitch, University of California, San
Francisco; P. Casaccia, Mount Sinai School of Medicine, 
New York
H. Colognato, D. Parkinson M.-L. Schmiedt
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Mechanisms and Models of Cancer
August 17–21 436 Participants
ARRANGED BY Dafna Bar-Sagi, New York University Medical Center
Jacqueline Lees, MIT Center for Cancer Research
Charles J. Sherr, HHMI/St. Jude Children’s Research Hospital
William Weiss, University of California, San Francisco
Molecular alterations affecting tumor suppressor genes and oncogenes have long been recognized to
spark the development of human cancers. During the last few years, steady advances in technological
developments have allowed a more exquisitely detailed dissection of signaling networks that are per-
turbed during different stages of tumor initiation and progression
and that determine the responses of cancers to both conventional
and targeted therapeutics. In addition, there has been the emerging
appreciation that interactions of tumor cells with their tissue mi-
croenvironment conjoin to alter tumor cell metabolism, affect the
manner by which a variety of host inflammatory and immune re-
sponses affect cancer progression, and determine properties of in-
vasion and metastasis. 
This third meeting convened an international group of inves-
tigators whose collective work focused on these themes. Oral and
poster presentations provided numerous examples of how new in-
sights have been gained from application of interdisciplinary ap-
proaches that utilize genetics, developmental biology, genomics
and proteomics, and model organisms (principally sophisticated
mouse models) to advance the development of rational therapeutics. A keynote address by Eileen
White illustrated the importance of autophagy (self-cannibalization) as a pathway to which cancer
cells show addiction and demonstrated its relevance for therapeutic targeting. There were eight oral
sessions and two poster sessions. The meeting will be held again in the summer of 2012.
This conference was funded in part by the National Cancer Institute, a branch of the National
Institutes of Health. 
PROGRAM
W. Weiss, J. Lees
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Apoptosis and Autophagy
Chairperson: E. White, Rutgers University, New Brunswick, 
New Jersey
Keynote Address
J. Brugge, Harvard Medical School, Massachusetts
Signaling Mechanisms I
Chairperson: R. Shaw, The Salk Institute for Biological Studies,
La Jolla, California
Mouse Models
Chairperson: C. Abate-Shen, Columbia University Medical
School, New York
Rb and p53 Networks
Chairperson: K. Vousden, Beatson Institute for Cancer Research,
Glasgow, United Kingdom
Microenvironment, Inflammation, and Metastases
Chairperson: L. Parada, University of Texas Southwestern
Medical Center, Dallas
Experimental Therapeutics
Chairperson: R. DePinho, Dana-Farber Cancer Institute,
Boston, Massachusetts
Genomics, Proteomics, Epigenetics
Chairperson: F. White, Massachusetts Institute of Technology,
Cambridge
Signaling Mechanisms II
Chairperson: M. Eilers, University of  Würzburg, Germany
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Molecular Genetics of Bacteria and Phages
August 24–28 169 Participants
ARRANGED BY James Hu, Texas A&M University
Petra Levin,Washington University
Malcolm Winkler, Indiana University Bloomington
This meeting featured 74 oral presentations and 82 poster presentations. Bacteria and phages con-
tinue to provide critical insights into diverse areas of biology, ranging from ecology, evolution, and
diversity, to gene expression and development, to infectious diseases. Exciting presentations covered
all of these topics and continued the historical strength of Phage meet-
ings in combining long-term themes of molecular microbiology with
cutting-edge approaches and exciting new research areas. A highlight
of the meeting was the keynote lecture by long-time participant Susan
Gottesman, who coupled a review of her career in bacterial molecular
biology with recognition of the 100th anniversary of the birth of
Jacques Monod. Another celebration was for the long, continuous par-
ticipation of Wisconsin’s Waclaw Szybalski, whose generous support
of the CSHL library was warmly recognized. 
The opening session focused on development, cell signaling, and
cell–cell interactions. Session chair Mike Laub touched on several re-
curring themes of the meeting in his description of how Caulobacter
uses the kinetics of phosphorylation and dephosphorylation of key
regulators to control its asymmetric cell division. Michelle Giglio pre-
sented an overview of the Human Microbiome Project and chaired the
second session with many other thought-provoking examples of how genomes and metagenomes
are opening new areas of biology. Ry Young chaired the session on Bacterial Cell Surfaces, and pre-
sented a talk on the discovery of spanin proteins that mediate the destruction of the inner membrane,
peptidoglycan, and outer membrane by phages of Gram-negative bacteria. 
Gail Christie spoke on the functions and evolutions of superantigen-encoding pathogenicity is-
lands that are mobilized by helper phages. Bryce Nichols’ talk concerned the detection of nanoRNAs
that can prime transcription initiation in vivo. Alan Wolfe spoke on the role of pathways that me-
diate the synthesis of acetyl phosphate and acetylation of target proteins. Robert Britton started his
session with a talk on the role of conserved GTPases in ribosome assembly. David Rudner, who
chaired the last session, talked about new proteins that regulate DNA replication during sporulation.
Regular talks and posters were presented by a mix of PIs, postdocs, and advanced graduate students,
whose high-quality presentations are a unique aspect of this meeting.
This meeting was funded in part by the National Institute of Allergy and Infectious Diseases, a
branch of the National Institutes of Health, and the National Science Foundation.
J. Hu, P. Levin
277
PROGRAM
Development, Cell Signaling, and Cell–Cell Interactions
Chairperson: M. Laub, HHMI/Massachusetts Institute of
Technology, Cambridge
Molecular Evolution, Systems Biology, and Genomics
Chairperson: M. Giglio, University of Maryland School
of Medicine, Baltimore
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Bacterial Cell Surfaces
Chairperson: R. Young, Texas A&M University, College 
Station
Bacteriophage Biology
Chairperson: G. Christie, Virginia Commonwealth University,
Richmond
Mechanism and Regulation of Transcription
Chairperson: B. Nickels, Rutgers University, Piscataway, New Jersey
Bacterial Metabolism and Physiology
Chairperson: A. Wolfe, Loyola University, Chicago, Illinois
Translation and Posttranscriptional Regulation
Chairperson: R. Britton, Michigan State University, East 
Lansing
Keynote Address: Beyond Transcription: Complex 
Regulatory Networks for Responding to Changing 
Environments
S. Gottesman, National Cancer Institute
DNA Replication, Recombination, and Transposition
Chairperson: D. Rudner, Harvard Medical School, Boston,
Massachusetts
278 Meetings
K. Potrykus, M. Cashel A. Labner-Oleson, D. Chattoraj F. Pouillot, H. Blois
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Nuclear Receptors and Disease
Aug. 31–Sept. 4 205 Participants
ARRANGED BY Keith Yamamoto, University of California, San Francisco
Ron Evans, Salk Institute Biological Studies
Jerrold M. Olefsky, University of California, San Diego
Forty-eight nuclear receptors are encoded in the human genome, and, collectively, they exert broad
control over most biological processes. The theme of this meeting was to bring together scientists
from different disciplines to exchange ideas and forge new in-
sights into the biology of nuclear receptors. Accordingly, the
meeting focused on the role of nuclear receptors in metabolism
and cancer. This represented the third time the nuclear receptor
community gathered at the Cold Spring Harbor Laboratory for
their biannual meeting.
The meeting brought together an enthusiastic group of par-
ticipants engendering lively discussions and debates, and an open
exchange of data and ideas. The invited Keynote talks were given
by David Mangelsdorf, Bruce Spiegelman, and Laurie Goodyear.
Other invited speakers included Johan Auwerx, Juleen Zierath,
Walter Wahli, Katja Lamia (The Salk Institute for Biological
Studies), Alan Saltiel (University of Michigan), DaYoung Oh
(University of California, San Diego), Philipp Scherer (University
of Texas Southwestern Medical Center), Michael Stallcup (University of Southern California), 
Susanne Mandrup (University of Southern Denmark), Bert O’Malley (Baylor College of Medicine),
Donald McDonnell (Duke University Medical Center), Myles Brown (Dana-Farber Cancer Insti-
tute), Vincent Giguere (McGill University), Mitchell Lazar (University of Pennsylvania School of
Medicine), Christopher Newgard (Duke University Medical Center), Christopher Glass (University
of California, San Diego), Gokhan Hotamisligil (Harvard School of Public Health), Laszlo Nagy
(University of Debrecen), W. Lee Kraus (University of Texas Southwestern Medical Center), Peter
Tontonoz (University of California, Los Angeles), and Gordon Hager (NCI, National Institutes of
Health). 
J. Olefsky, R. Evans, K. Yamamoto
PROGRAM
Keynote Addresses
D.J. Mangelsdorf, University of Texas Southwestern Medical
School, Dallas
Nuclear Receptor Modulators (NuRMs) in Worms
B. Spiegelman, Dana-Farber Cancer Institute, Boston,
Massachusetts 
PPARγ and the Antidiabetic PPARγ Ligands: A New Look at
an Old Friend
L. Goodyear, Joslin Diabetes Center, Boston, Massachusetts
Skeletal Muscle Metabolism: AMPK and Beyond
Physiology and Metabolism
Chairperson: A. Saltiel, University of Michigan, Ann Arbor
Inflammation and Metabolic Disease
Chairperson: B. Desvergne, University of Lausanne, 
Switzerland
Ligands and Cofactors
Chairperson: R.M. Evans, The Salk Institute, La Jolla,
California
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Cancer
Chairperson: C. Glass, University of California, San Diego
Mechanisms of Insulin Resistance and Adipogenesis
Chairperson: J.M. Olefsky, University of California, San 
Diego
D. Oh, E. Bae, K. Kemper
J. Judkins, D. Mangelsdorf K. Duszka, N. Herman-Kleiter
280 Meetings
M. Rozendaal, J. Nwachukwu
Inflammation II
Chairperson: S. Mandrup, University of Southern Denmark,
Odense
Chromatin and Transcription
Chairperson: M. Stallcup, University of Southern California, Los
Angeles
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Personal Genomes
September 9–12 197 Participants
ARRANGED BY George Church, Harvard University 
Paul Flicek, European Bioinformatics Institute
Richard Gibbs, Baylor College of Medicine
Elaine Mardis,Washington University School of Medicine
This special meeting on personal genomes acknowledges the increasing number of
personal genomes that are being sequenced in a clinical context, for identifying dis-
ease-causing mutations and, in some cases, for diagnosis and treatment. As the avail-
ability and use of next-generation, and soon third-generation, sequencing instruments
become more widespread, the critical questions that impact our understanding of
human biology and disease are more likely to be addressed by large and small labo-
ratories. 
The meeting provided an opportunity to explore a number of important themes
(see below). It featured a combination of talks and posters and included a keynote
talk and ethics panel discussion that addressed the societal and medical impacts of
the new sequencing technologies and their applications. The critical success and time-
liness of the meeting can be judged from the considerable enthusiasm of the audience
and the increased number of attendees from clinical disciplines, including several plenary speakers.
The collective decision was taken to hold the meeting for a third time at Cold Spring Harbor in
the fall of 2011.
This meeting was funded in part by Roche 454 Life Sciences and Illumina, Inc.
G. Church
L. White, G. Scott, A. Shah J. Kwan, S. Calvo
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Personal Genome Landscape
Chairpersons: D. Conrad, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; J. Wang, Beijing Genomics
Institute, Shenzhen, China
Keynote Addresses
E.D. Green, National Human Genome Research Institute,
Maryland
Genomics in 2K10 and Beyond: Charting a Course for
Genomic Medicine
L.E. Hood, Institute for Systems Biology, Seattle, Washington
Systems Genetics and Systems Biology
H. Greely, Stanford University, Stanford, California
Preparing for the Coming Tsunami of Clinical Genomic
Information
Ethics Panel: Teaching Genomics and Related Ethics to
Medical Professonals
Personal Cancer Genomes
Chairpersons: S. Grimmond, University of Queensland, St.
Lucia, Australia; S. Jones, BC Cancer Agency, Vancouver,
Canada
Personal Transcriptomes and Other Applications
Chairpersons: P. Laird, University of Southern California, Los
Angeles; R. Myers, HudsonAlpha Institute for Biotechnology,
Huntsville, Alabama
Inherited Diseases
Chairpersons: L. Jorde, University of Utah School of Medicine,
Salt Lake City; D. Altshuler, Broad Institute, Cambridge,
Massachusetts
Technologies for Personal Genomes
Chairperson: G. Church, Harvard Medical School, Boston,
Massachusetts
A. Dopazo, L. Brizuela
E. Green, H. Sussman
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Translational Control
September 13–17 411 Participants
ARRANGED BY Thomas Dever, National Institutes of Health
Paul Fox, The Cleveland Clinic
Alan Hinnebusch, National Institute of Child Health & Human Development, 
National Institutes of Health
Elisa Izaurralde,Max-Planck Institute for Developmental Biology
This meeting attracted participants from around the world, and included Jamie Cate, Rachel Green,
Eric Klann, and Paul Schimmel as keynote speakers, eight platform sessions and three poster sessions
that covered 337 abstracts. Novel findings on the mechanism of translation included the first high-
resolution crystal structure of the eukaryotic 80S ribosome, a 5.5
Å cryo-EM structure of the wheat ribosome, and multiparticle
cryo-EM analysis of translocating ribosomes that revealed new in-
termediate tRNA hybrid states. 
There were several breakthroughs regarding the mechanism of
initiation. Interaction of the eIF4G subunit of the mRNA cap-
binding complex with poly(A)-tail binding protein PABP was
found to be dispensable for initiation in yeast, being functionally
redundant with an RNA-binding domain in eIF4G. Among many
other findings, evidence was presented that ribosomes can circum-
vent proteins or oligonucleotides bound to the 5′UTR, presumably
by pathways independent of linear scanning. Important develop-
ments concerning elongation and termination included new find-
ings on yeast No-Go mRNA decay quality control. Several lines of
evidence suggest that the termination and ribosome recycling machineries are more closely related
than previously anticipated. New methods were described for monitoring the dynamics of translation
elongation in living cells, and ribosomal profiling by deep-sequencing of ribosome-protected mRNA
fragments. Pharmacological approaches to suppressing nonsense mutations were described as a new
C. Hellen, A. Hinnebusch
Wine and cheese party
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therapeutic approach to treating genetic diseases.
In the arena of translational control in disease, new results
show that a lack of rRNA modification impairs cell cycle arrest
in early oncogenesis by preventing a switch to IRES-mediated
translation of tumor suppressor p53. New insights into virus–
host interactions were obtained, and novel initiation mecha-
nisms were reported for plant positive-strand RNA viruses. In
calicivirus translational reinitiation, ribosomes can reach start
sites not only by direct positioning, but also by movement
along the viral RNA in a prokaryotic-like fashion. Regarding
translational control in development and the CNS, a novel
requirement for the eIF2 kinase PERK in regulating LTD was
demonstrated, which has important behavioral consequences
in un-learning previous associations. In Aplysia sensory neu-
rons, the effects of TOR in increasing cap-dependent translation were shown to be independent of
the major eIF4E- binding protein and S6 kinase. TORC2 was found to associate with polyribosomes
and cotranslationally phosphorylate AKT, regulating its stability. 
Finally, new insights into connections between translation and mRNA turnover were also re-
ported, including the fact that exon junction complexes (EJCs) are not deposited at all exon–exon
junctions. There is evidence that EJCs associate with the nonsense-mediated mRNA decay (NMD)
factors SMG1 and UPF1 in a way that is promoted by the cap-binding protein of the pioneer trans-
lation initiation complex and, subsequently, SMG6 by a mechanism that is inhibited by EJC asso-
ciation with the UPF3 NMD factor. This represents just a sampling of the many new findings
presented at the meeting, with vigorous discussion by graduate students, postdocs, and professors
at both oral sessions and poster sessions. The informality of the environment at Cold Spring Harbor
encourages intense and fruitful debate and discussion of novel ideas and approaches.
PROGRAM
Ribosome Structure and Function
Chairperson: J. Dinman, University of Maryland, College Park
Factors and Mechanisms
Chairperson: J. Lorsch, Stanford University, California
Viruses and Disease
Chairperson: G. Meyers, Bundesforschungsanstalt für
Viruskrankheiten der Tiere, Tübingen, Germany
mRNA Turnover
Chairperson: L. Maquat, University of Rochester Medical Center,
New York
Development, CNS, and Signaling
Chairperson: W. Sossin, McGill University, Montréal, Canada
Trans-Acting Regulators
Chairperson: P. Fox, The Cleveland Clinic, Ohio
Elongation and Termination
Chairperson: D. Bedwell, University of Alabama, Birmingham
RNA Regulatory Elements
Chairperson: S. Thompson, University of Alabama,
Birmingham
A. Contreras, A. Rodrigues, E. Bueno
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Axon Guidance, Synaptic Plasticity, and Regeneration
September 21–25 364 Participants
ARRANGED BY Graeme Davis, University of California, San Francisco
Alex Kolodkin, Johns Hopkins University
Carol Mason, Columbia University
The human brain has billions of nerve cells (neurons), and each neuron is typically connected to
hundreds of other neurons via synapses in a highly precise fashion. This complex neural wiring un-
derlies the ability of humans, and other animals, to interact with the outside world to learn and to
perform complex behaviors. Defects in the development of neu-
ral connections are being increasingly linked to the cause of neu-
rological disease. One of the major challenges for the field of
neuroscience is to understand how nerve connections are made
accurately and reliably. In the past decade, our understanding
of the mechanisms that control axon growth and guidance,
synaptogenesis, and the remodeling of neural circuits during de-
velopment has progressed rapidly from phenomenology to the
identification of specific molecular control mechanisms. 
This seventh meeting in the series focused on key issues in
axon guidance, circuit formation, synaptogenesis, and plasticity.
For the first time, it highlighted regeneration and included ses-
sions devoted to particular problems in the assembly, plasticity,
and repair of the nervous system. Speakers were chosen from among the participants submitting
abstracts by session chairs who are leaders in the field. The response of the field to the 2010 confer-
ence was one of overwhelming enthusiasm, with more than 360 participants, 257 of whom sub-
mitted abstracts; 49 abstracts were selected for talks, in seven sessions, the remaining abstracts being
presented as posters. Senior researchers, starting assistant professors, postdoctoral fellows, and grad-
uate students were well represented as speakers and participants. Session chairs at the meeting were
well-balanced between men and women and had a clear international presence with participants
from Europe and Asia. 
Many of the outstanding talks this year were by graduate students. All of the major areas of re-
search in the field were covered, as were all of the major approaches (cellular, physiological, anatom-
ical, molecular, dynamic imaging, biochemical, and genetic). In addition, there were three keynote
addresses. The first, by a speaker outside of the field of neural development, was given by Professor
Peter Devreotes and reviewed his work on the motility, polarization, and directional sensing during
chemotaxis of the single cell forms of Dictyostelium. The second and third keynote lectures were a
pairing of speakers who gave provocative talks on how specificity is achieved and the limits to exact
circuit formation and function. Tom Jessell focused on work that extends his findings regarding
transcriptional regulation of cell identity to the afferent–target interactions leading to motor output
in the vertebrate spinal cord. Eve Marder spoke on the physiological and computational aspects of
compensation in network performance, with the lobster CNS as her model. 
The meeting provided an important forum for ideas and approaches and helped scientists in the
field get the most up-to-date information, enabling them to meet, network, and establish collabo-
rations. As at the previous meeting, a need was identified for an additional poster session because
the number and quality of abstracts submitted for posters was so high. The three poster sessions
were extremely well attended. In addition, fewer talks were scheduled in the evening, and a talk ses-
S. Arber, G. Davis
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sion after the evening keynote was eliminated to allow time for discussion and attendee interactions.
Based on the enthusiastic comments of the participants, the intensity of the oral and poster sessions,
and the large crowds that stayed up late every night at the bar to discuss science, the meeting was a
great success. 
This meeting was funded in part by National Institute for Neurological Diseases and Stroke, a
branch of the National Institutes of Health.
PROGRAM
Axon to Synapse I
Chairpersons: K. Martin, University of California, Los Angeles;
Y. Zou, University of California, San Diego
Synapse to Circuit I
Chairpersons: M. Feller, University of California, Berkeley; A.
Chedotal, Institut de la Vision, INSERM, Paris, France
Special Lecture: The Cell’s Compass: Chemoattractant Bias
of an Excitable Network of Parallel Signaling Pathways
Directs Cell Migration
P. Devreotes, Johns Hopkins University School of Medicine,
Maryland
Stem Cells, Regeneration, and Disease I
Chairpersons: Y. Jin, HHMI/University of California, San
Diego; F. Bradke, Max-Planck Institute of Neurobiology,
Martinsried, Germany
Axon to Synapse II
Chairpersons: S. Arber, Biozentrum, Basel, Switzerland; B.
Sabatini, Harvard Medical School, Boston, Massachusetts
Synapse to Circuit II
Chairpersons: J. Kaplan, Massachusetts General Hospital,
Harvard Medical School, Boston; G. Turrigiano, Brandeis
University, Waltham, Massachusetts
Stem Cells, Regeneration, and Disease II
Chairpersons: Y. Zuo, University of California, Santa Cruz; S.
Temple, Albany Medical College, New York
Special Lectures
T. Jessell, HHMI/Columbia University, New York
The Neurons and Networks of Spinal Motor Control
E. Marder, Brandeis University, Massachusetts
Compensation in Robust Network Performance
Axon to Synapse III
Chairpersons: M. Halloran, University of Wisconsin, Madison; T.
Schwarz, Children’s Hospital, Boston, Massachusetts
286 Meetings
Relaxing on the lawn
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Molecular Genetics of Aging
Sept. 28–Oct. 2 289 Participants
ARRANGED BY Steven Austad, University of Texas Health Science Center, San Antonio 
Judith Campisi, Buck Institute for Age Research, Lawrence Berkeley 
National Laboratory
David Sinclair, Harvard University Medical School
Aging is the largest single risk factor for developing a panoply of diseases, ranging from neurode-
generation to cancer. In recent years, enormous progress has been made in understanding how ge-
netics and the environment collaborate to bring about the aging of organisms. Among the
remarkable findings is the identification of molecular pathways that control aging in diverse
species—from yeast to humans. This conference provided an intense forum for the latest results
and emerging ideas in aging research. 
The conference opened with a session on genetic variation—an exploration into why species,
and particularly individuals within a species, age at different rates. A related session discussed genetic
and epigenetic stability, which focused on the mechanisms that main-
tain the DNA sequence and its packaging (chromatin), how these en-
tities change during aging, and how such changes affect organismal
health and fitness. A subsequent session highlighted the role of mito-
chondria and energy metabolism in preserving organismal health and
longevity, and the molecules that are crucial for optimal energy pro-
duction and utilization. One session was devoted to cellular stress re-
sponses, and the intimate relationship between stress resistance and
longevity. The conference then featured a session on stem cells, which
emphasized recent findings on how these important sources of tissue
repair and regeneration change with age, and how aging alters the tis-
sue environment in which stem cells must function. Another session
discussed protein homeostasis—how protein aggregates (which drive
a number of age-related diseases) are formed and eliminated by spe-
cific genetic pathways. A session then focused on the power of genetic
manipulations of conserved pathways to alter the rates and outcome
of aging. The final session highlighted the latest findings on the role of nutrition and nutrient sensing
in aging and discussed interventional strategies that are currently being developed. 
The conference brought together scientists from diverse fields, mirroring the expanding multi-
disciplinarity of the field, and reflected the excitement and growing understanding of the processes
that drive aging and the possibilities for developing interventions into both the aging process and
the chronic diseases of aging. 
This meeting was funded in part by the National Institute on Aging, a branch of the National
Institutes of Health.
PROGRAM
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J. Sorrentino, C. Burd
Genetic Variation
Chairpersons: N. Barzilai, Albert Einstein College of Medicine,
Bronx, New York; R. Westendorp, Leiden University Medical
Center, The Netherlands
Genetic and Epigenetic Stability
Chairpersons: L. Donehower, Baylor College of Medicine,
Houston, Texas; J.P. Issa, University of Texas M.D. Anderson
Cancer Center, Houston
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Oral Presentations from Abstracts
Chairpersons: S. Austad, University of Texas Health Science
Center, San Antonio; J. Campisi, Lawrence Berkeley 
National Laboratory, Buck Institute for Age Research,
California; D. Sinclair, Harvard Medical School, 
Boston, Massachusetts
Metabolism and Bioenergetics
Chairpersons: C. Mobbs, Mount Sinai School of Medicine, New
York; R. De Cabo, NIA, National Institutes of Health,
Bethesda, Maryland
Cellular and Organismal Stress Responses
Chairpersons: D. Peeper, Netherlands Cancer Institute,
Amsterdam; S.-J. Lin, University of California, Davis
Tissue Maintenance/Stem Cells
Chairperson: G. Enikolopov, Cold Spring Harbor Laboratory
Protein Homeostasis
Chairpersons: N. Tavernakis, Foundation for Research and
Technology, Greece; R. Morimoto, Northwestern University,
Evanston, Illinois
Genetic Manipulations
Chairperson: G. Lithgow, Buck Institute for Age Research,
Novato, California
Nutrient Sensing and Interventions
Chairpersons: B. Kennedy, University of Washington, Seattle; A.
Dillin, Salk Institute, La Jolla, California
N. Hartman, L. Zidek M. Bonkowski, S. Gravina H. Siegfried
E. Jaehing, S.-J. Lin
288 Meetings
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Germ Cells
October 5–9 247 Participants
ARRANGED BY John Eppig, The Jackson Laboratory
Margaret Fuller, Stanford University School of Medicine
Phillip Newmark, HHMI/University of Illinois at Urbana, Champaign
The tone for this meeting was set in the first session, with five speakers focusing on issues of germ
cell specification, migration, and fate. As with all of the sessions, lively discussion followed each of
the talks. Likewise, the diversity in the model systems used for study, ranging from flies to worms,
sea urchin, fish, and mammals, highlighted deeply conserved emerging mechanisms. Session 2 fo-
cused on an area of particularly timely interest, Germ Line Stem Cells, a theme revisited with dif-
ferent emphasis throughout the meeting, particularly in Session 4, which focused on the switch
from mitotic to meiotic cell divisions. Evolving concepts about the nature of the germ cell niche
and the molecules driving stem cell dynamics provoked considerable discussion.
Poster Sessions (Sessions 3 and 6) presented studies on virtually all aspects of germ cell develop-
ment in diverse model species. There was even a presentation of ovarian development in the plains
viscacha with its unusual characteristics of absence of follicular
atresia and massive numbers of ovulated eggs. Sessions 7
through 9 reported rapid advancement of our understanding
of the regulation of meiosis and the oocyte-to-embryo transi-
tion. This was emphasized by studies on the role of small in-
terfering RNAs and other posttranscriptional control
mechanisms and the functions of maternal factors essential
for early embryonic development.
There has been remarkable progress since the last Germ Cells
meeting (in 2008). The evolution of new methods in molecular
and genetic analyses, as well as concepts in control mechanisms
such as small interfering RNA and molecular determinants of
pluripotency, have greatly advanced the field of germ cell biol-
ogy. Participants enjoyed breathtaking live-cell/organ imaging
that provided unique perspectives on germ cell behavior and
the possible functions of germ cell niches. The field looks forward to new applications of this exciting
technology that will help shape our views of germ cell development. An international cast, including
speakers from Japan, Australia, Taiwan, Germany, Switzerland, and the UK, participated in the meet-
ing. There was general excitement about continued advancements that will affect broad basic and clin-
ical fields of development, reproduction, and clinical sciences.
This meeting was funded in part by the National Institute of Child Health and Human Develop-
ment, a branch of the National Institutes of Health; the Lalor Foundation; and the March of Dimes.
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P. Lasko, L. Cooley
Germ Line Stem Cells
Chairperson: J. Kimble, HHMI/University of Wisconsin,
Madison
PROGRAM
Germ Cell Specification, Migration, and Fate
Chairperson: A. Spradling, HHMI/Carnegie Institution,
Baltimore, Maryland
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Germ Line Stem Cells, Gonocyte Proliferation, and the
Switch from Mitosis to Meiosis
Chairperson: B. Braun, The Jackson Laboratory, Bar Harbor,
Maine
Transcriptional Control and Epigenetic Programming
Chairperson: H. Lin, Yale University, New Haven, Connecticut
Posttranscriptional Control and Small RNAs in Gametogen-
esis and Early Embryos
Chairperson: R. Lehmann, HHMI/Skirball Institute, New York
University School of Medicine, New York
Meiosis
Chairperson: M.A. Handel, The Jackson Laboratory, Bar
Harbor, Maine
Cell Biology of Germ Cells
Chairperson: D. Page, HHMI/Massachusetts Institute of
Technology, Cambridge
Germ Line/Soma Communication and Sex Determination
Chairperson: E. Matunis, Johns Hopkins University School of
Medicine, Baltimore, Maryland
S. Hammond, M. Potok B. Braun, D. Licatolosi
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Mouse Development, Genetics, and Genomics
October 26–30 179 Participants
ARRANGED BY Kathryn Anderson,Memorial Sloan-Kettering Cancer Institute
Haruhiko Koseki, RIKEN Research Center for Allergy & Immunology
Michael Shen, Columbia University Medical Center
William Skarnes, Wellcome Trust Sanger Institute
This 23rd annual meeting attracted a diverse group of scientists studying
various molecular and genetic aspects of mammalian development. This
meeting provided a format for the exchange of ideas and information, to
discuss the latest research findings and technical advances toward the study
of mammalian development and disease. The annual Rosa Beddington Lec-
ture was given by Sally Dunwoodie on “Straightening out Notch,” and
Nobel laureate Mario Capecchi delivered a fascinating Keynote Lecture. 
The meeting included two poster sessions and eight oral sessions. The
growing emphasis on genetics/genomics and on human disease models, al-
ready noted in previous years, continues, reflecting the increasing impor-
tance of the mouse as a model to investigate disease mechanisms, and the
sophistication with which diseases can now be modeled and analyzed in this
organism. After a long and illustrious history at Cold Spring Harbor, the
Mouse meeting will now be moving elsewhere, in part a reflection of the
enormous success of the mouse community in making this the central model
for the study of human biology and disease, with sessions on mouse models at many of the other
Cold Spring Harbor meetings, from cancer to neurodegenerative diseases and aging.
This meeting was funded in part by the National Institute of Child Health and Human Devel-
opment, a branch of the National Institutes of Health, and the National Science Foundation.
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M. Skamagki, D. Maatouk
W. Skarnes, J. Lopez-Rios
M. Manley, L. Naiche
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PROGRAM
Human Disease and Cancer
Chairperson: G. Karsenty, Columbia University, New York
Organogenesis
Chairperson: K. Kaestner, University of Pennsylvania Medical
School, Philadelphia
Technology
Chairperson: A. Nagy, Samuel Lunenfeld Research Institute, Mt.
Sinai Hospital, Toronto, Canada
Patterning
Chairperson: P. Soriano, Mount Sinai School of Medicine, New
York
Keynote Address
Chairperson: M. Capecchi, University of Utah School of
Medicine
H. Zong, M. CapecchiF. Spitz, P. Tschopp
292 Meetings
Neurobiology
Chairperson: S. Pfaff, HHMI/The Salk Institute, La Jolla,
California
Epigenetics
Chairperson: T. Bestor, Columbia University College of
Physicians & Surgeons, New York
Genetics and Genomics
Chairperson: J. Baker, Stanford University, California
Rosa Beddington Lecture
Chairperson: S.L. Dunwoodie, Victor Chang Cardiac Research
Institute, Sydney, Australia
Germ Cells and Stem Cells
Chairperson: K. Hochedlinger, Massachusetts General Hospital,
Boston
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Pharmacogenomics and Personalized Therapy
November 17–21 137 Participants
ARRANGED BY Hiltrud Brauch, Ikp Stuttgart, Germany
Panagiotis Deloukas,Wellcome Trust Sanger Institute
Deanna Kroetz, University of California, San Francisco
Munir Pirmohamed, University of Liverpool
David Valle, Johns Hopkins University School of Medicine
Dick Weinshilboum,Mayo Medical School, Minnesota
This 8th annual meeting was a joint project of CSHL and the Wellcome Trust, funded in part by
the National Institute of General Medical Sciences (NIGMS), one of the National Institutes of
Health institutes. This series of meetings, held in alternating years on the Cold Spring Harbor Lab-
oratory and Wellcome Trust Genome campuses, is designed to bring together scientists from disci-
plines that range from basic genomics to clinical medicine who are studying the role of inheritance
in variation in drug response phenotypes, phenotypes that can range from life-threatening adverse
drug reactions to lack of the desired therapeutic drug effect.
As a result, pharmacogenomics represents a major component
of the movement toward “personalized” or “individualized”
medicine. The opening session at the meeting began with a
scientific presentation by Eric Green, director of NHGRI,
followed by a presentation from Michel Eichelbaum, former
director of the Dr. Margarete Fischer-Bosch Institute of Clin-
ical Pharmacology in Stuttgart, Germany. 
A major theme running through the meeting was the
widespread application of genome-wide association studies
and next-generation sequencing techniques to pharmacoge-
netic problems. The bottleneck posed by the explosive growth
in the amount of data that can be generated with new genom-
ic technologies was highlighted in sessions on translational
bioinformatics and next-generation sequencing approaches.
The importance of considering genetic variation in noncoding regions and structural variants was
discussed by Peter Donnelly of the Wellcome Trust Centre for Human Genetics. Novel approaches
to predicting the effects of genetic variation on protein function were presented in a session on ge-
netic control of expression, and epigenetics and functional genomic applications to pharmacoge-
nomics were also discussed as important areas for pharmacogenomics research. Pharmacoeconomic
barriers to the application of pharmacogenomics to patient care illustrated the need for increased
effort on the translation of pharmacogenomics findings. 
The major theme that emerged from the meeting was the importance of rapid adoption of new
genomic technologies and the need for increased translation of pharmacogenomics research findings
into clinical settings to facilitate the optimization of drug therapy.
This meeting was funded in part by the National Institutes of General Medical Sciences, a branch
of the National Institutes of Health.
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D. Weinshilboum, D. Valle
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PROGRAM
Opening Session
Translational Bioinformatics
Chairperson: E. Schadt, Pacific Biosciences, Menlo Park,
California
Next-Generation Sequencing Approaches in
Pharmacogenomics
Chairperson: D. Nickerson, University of Washington, Seattle
Genome-Wide Analyses and CNVs
Chairperson: P. Donnelly, Wellcome Trust Centre for Human
Genetics, Oxford, United Kingdom
A. Alfireule, P. Deloukas M. Radonjic, B. Drögemüller, G. Wright
A. Frauman
294 Meetings
Genetic Control of Expression
Chairperson: S. Brenner, University of California, Berkeley
Epigenetics and Functional Genomics
Chairperson: M. Esteller, Bellvitge Biomedical Research Institute,
Barcelona, Spain
ELSI, Pharmacoeconomic Issues, and Population-Based 
Pharmacogenetics
Chairperson: D. Veenstra, University of Washington, Seattle
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Neurodegenerative Diseases: Biology and Therapeutics
December 1–4 134 Participants
ARRANGED BY Sam Gandy,Mount Sinai School of Medicine
Virginia Lee, University of Pennsylvania School of Medicine
Jeffrey Rothstein, Johns Hopkins University School of Medicine
Up to one-half of those aged 85 years or older will develop debilitating degenerative disease of the
central nervous system. These various diseases include Alzheimer’s disease (AD), Parkinson’s disease
(PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS). Although these illnesses
appear most commonly in the absence of obvious heritability or identifiable genetic mutations, it
has been possible during the past 20 years to discover uncommon genetic mutations as well as risk-
modifying DNA changes in some examples and predictable causative changes in others. From these
findings, transgenic technology has rapidly led to the development of mouse, fruit fly, and nematode
model systems that partially recapitulate the clinical abnormalities of the human diseases as well as
some of the hallmark molecular and morphological pathology of the conditions.
In recent years, various molecular, biochemical, and cell-based screens have led to small-molecule
peptides and oligonucleotide compounds that show promise in neurodegenerative disease models.
Importantly, in the last year, the emergence of human cellular
models, based on iPS (stem cell) technology, has become one
of the most potentially important tools for disease pathogen-
esis and drug discovery. At this year’s meeting in the biannual
series, which started in 2000, numerous academic labs and
commercial drug discovery organizations presented data on
novel compounds, clinical trial results, and new druggable
pathways for AD, PD, HD, ALS, spinal muscular atrophy,
and spinocerebellar ataxia. As in previous years, the explicit
goal of the meeting focused on facilitating the translation of
“breakthrough” science into effective medicines.
For this meeting, platform sessions were organized around
common technological themes. Chairpersons, invited speakers,
and speakers selected from submitted abstracts were drawn
from the academic and pharma sectors. The discussion of new, unpublished data was emphasized.
Poster presentations also covered a wide range of neurodegenerative disease pathways, new animal and
insect models, and novel therapeutic insights. Posters were displayed for an extended period during
the meeting, and poster viewing was especially encouraged during the cocktail hours before the evening
meals.
Topics in the 2010 meeting included monoclonal antibody and protein therapeutics for AD and
ALS; biomarkers including imaging ligands and TDP-43 pathology; and RNA metabolism including
splicing pathology, antisense modification of splicing, and RNA mapping. A number of investigators
explored new intracellular trafficking pathways in AD models. The role of glial cells—oligoden-
droglia and astroglia—was highlighted including potential glial-centric therapeutics. New clinical
trial results in AD were reviewed. At the prior meeting in 2008, the first new data on TDP-43
pathology was discussed. Now 2 years on, an explosion of science has developed around this muta-
tion and large number of sporadic neurodegenerative diseases that appear to implicate TDP-43
pathogenesis, with in vitro and animal tools that may be useful for future drug discovery.
This meeting was funded in part by Merck Research Laboratories.
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Alzheimer’s Clinical Trials Update
Chairperson: S. Gandy, Mount Sinai School of Medicine, New
York
Biomarkers and Genetics
Chairperson: V. Lee, University of Pennsylvania School of
Medicine, Philadelphia
RNA Metabolism in Neurodegenerative Disease
Chairperson: J. Rothstein, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Submitted Abstracts
Chairperson: S. Gandy, Mount Sinai School of Medicine, New
York
R. Darnell
Protein Sorting and Vps10 Proteins in Neurodegeneration
Chairperson: V. Lee, University of Pennsylvania School of
Medicine, Philadelphia
Theme Stem Cells, Glia, and Synaptic Factors
Chairperson: J. Rothstein, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Drug Targets and Assays for Drugs
Chairperson: S. Gandy, Mount Sinai School of Medicine, New
York
A. Krainer, G. Schellenberg R. FisherI. de Jong
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Automated Imaging and High-Throughput Phenotyping
December 5–8 114 Participants
ARRANGED BY Philip Benfey, Duke University
Anne Carpenter, Broad Institute of Harvard and Massachusetts Institute of Technology 
Robert Waterston, University of Washington
Uwe Ohler, Duke University
This first meeting on Automated Imaging and High-Throughput Phenotyping was enormously
successful. A total of 42 investigators presented in the six scientific sessions, with nearly 32 platform
and poster presentations and 114 registered attendees. The six platform sessions and one poster ses-
sion were marked by dynamic and enthusiastic exchanges of new results. In the scientific sessions,
many audience members participated in the question and answer sessions, and the poster session
was well attended. 
Sessions at the meeting are listed below. Two additional sessions engaged the community in dis-
cussion: Future directions for the community as a whole, and Guidelines for databasing and pub-
lishing phenotyping data.
LemnaTec GmbH and Molecular Devices provided partial support for the meeting. 
PROGRAM
297
Cellular Phenotyping
Chairperson: R. Waterston, University of  Washington, 
Seattle
Imaging Technologies and Platforms
Chairperson: A. Carpenter, Broad Institute of Harvard and
Massachusetts Institute of Technology, Cambridge
Developmental Phenotyping
Chairperson: F. Piano, New York University, New York
Future Directions
A. Carpenter, P. Benfey
Stimulus/Response Phenotyping
Chairperson: U. Ohler, Duke University, Durham, North
Carolina
Image Databasing and Knowledge Representation
Chairperson: P. Benfey, Duke University, Durham, North
Carolina
Workshop on Databasing/Publication Guidelines
Organismal Phenotyping
Chairperson: S. Fraser, California Institute of Technology,
Pasadena
F. Piano, R. Waterston
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Blood Brain Barrier Physiology
December 8–11 88 Participants
ARRANGED BY Roland J. Bainton, University of California, San Francisco
Ben Barres, Stanford University
Richard Daneman, University of California, San Francisco
The second biotechnology conference addressed blood brain
barrier (BBB) physiology. The conference encouraged new
conceptual approaches and novel methods for our under-
standing of the neuroprotective physiologies of BBB struc-
tures, pairing genetics of model organism and associated
biological methods with recent insights into vertebrate BBB
physiology and development. 
The conference fostered cross-disciplinary exchange of
ideas and expertise between developmental and evolutionary
biologists, vascular and BBB physiologists, and disease-ori-
ented industry scientists interested in modifying or circum-
venting specific pathways of neuroprotection. Keynote talks
on different aspects of BBB physiology were given by Kwang
Sik Kim, Corey Nislow, and Guri Giaver. Topics addressed
by the conference included: pathogenesis at the BBB, cellular
constituents of the barrier, complexities of junctional complexes, xenobiotic protection, regulation
of barrier physiology, and screening methodologies targeting barrier functions. As is traditional at
Cold Spring Harbor meetings, selection of material for oral and poster presentation was made by
the organizers and individual session chairs on the basis of scientific merit.
PROGRAM
Modeling of the BBB
R. Bainton, B. Barres, R. Daneman
Chairpersons: E. Shusta, University of Wisconsin, Madison; M.
Jacobson, University of California, San Francisco
Model Organisms for BBB Analysis
Chairpersons: I. Blasig, Leibniz-Institut for Molekulare
Pharmakologie, Berlin, Germany; H. Gelbard, University of
Rochester Medical Center, New York
Keynote Address: Central Nervous System Infection and
Blood-Brain Barrier (BBB): Lessons Learned from E. coli
Translocation of the BBB
K.S. Kim, Johns Hopkins Children’s Center, Maryland
Cellular and Molecular Regulation of the BBB
Chairpersons: E. Dejana, Fondazione Ifom, Milano, Italy; A.
Reijerkerk, Vu University Medical Center, Amsterdam, The
Netherlands N. Saunders, S. Liddelow
298
247-304_Meetings_Annual Report_2009 template  7/8/11  12:23 PM  Page 298
Angiogenesis and BBB Development
Chairpersons: N. Saunders, University of Melbourne, Parkville,
Australia; C. Gu, Harvard Medical School, Boston,
Massachusetts
Disease States of the BBB
Chairpersons: K. Akassoglou, Gladstone Institutes/University of
California, San Francisco; A. Flugel, University Medical
Center Göttingen, Germany
Keynote Address
C. Nislow and G. Giaever, University of Toronto, Canada
Crossing Biological Barriers: Yeast and Worm Chemical
Biology
Mechanisms of BBB Crossing
Chairpersons: B. Engelhardt, University of Bern, Switzerland; X.
Nassif, Inserm U570, Hopital Necker Enfants Malades, Paris,
France
M. Rengarajan, B. Dauwalder
Blood Brain Barrier Physiology      299
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COLD SPRING HARBOR LABORATORY/
WELLCOME TRUST CONFERENCES
This year marked the final year of the joint Cold Spring Harbor Laboratory/Wellcome Trust con-
ference program at the Wellcome Trust Conference Centre in Hinxton, United Kingdom. Initiated
in 2001, more than 3500 scientists have attended meetings on topics as diverse as genome infor-
matics, host–pathogen interactions, and prion biology. The UK program also provided Cold Spring
Harbor Laboratory with the opportunity to develop a number of conferences that alternated between
the two sites, for example, the meeting on Pharmacogenomics that now alternates between the
United States and Europe. The Wellcome Trust Conference team have now developed the tools and
skills to manage the academic conference program independently, and we wish them well in their
endeavors.
Aerial view over Francis Crick Auditorium and the Genome campus Conference Hall
Wellcome Trust Conference Center; main center and Hinxton Hall
300
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Computational Cell Biology
February 10–14 63 Participants
ARRANGED BY Benjamin Geiger,Weizmann Institute
Edda Klipp,Max-Planck Institute for Molecular Genetics
Bela Novak, Oxford Centre for Integrative Systems Biology
The specific goal for this meeting was to foster fruitful and creative dialogue between experimental
cell biologists and mathematical–computational modelers with common interests in the regulation
of cell physiology. Emphasis was placed on areas of greatest current interest and importance, such
as cell signaling, motility, cell proliferation and death, calcium dynamics, microbial physiology, and
development. Sessions were also devoted to new experimental technologies and software develop-
ments.
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences at Hinxton are supported in
part with funding courtesy of The Wellcome Trust.
PROGRAM
Keynote Addresses
J. Ferrell, Stanford University, California
Cooperative Phosphorylation in the Regulation of Wee1A
B. Scheres, Utrecht University, The Netherlands
Multilevel Analysis of Plant Development
Intracellular Signaling
Chairperson: M. White, University of Liverpool, United
Kingdom
Tools and Software
Chairperson: N. Le Novère, EMBL-European Bioinformatics
Institute, Hinxton, United Kingdom
Software Demo and Poster Session I
Socializing at the meeting during coffee break
301
Self-Organization in Cells
Chairperson: B. Mulder, FOM Institute AMOLF, Amsterdam,
The Netherlands
Cell Motility
Chairperson: F. Nédélec, European Molecular Biology
Laboratory, Heidelberg, Germany
Software Demo and Poster Session II
Patterns in Development
Chairperson: J. Traas, École Normale Supérieure de Lyon, France
Cell Biophysics
Chairperson: K. Kruse, Universität des Saarlandes, Germany
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Systems Biology: Networks
August 11–15 108 Participants
ARRANGED BY Patrick Aloy, Institute for Research Biomedicine, Spain
Anne-Claude Gavin, EMBL, Germany
Trey Ideker, University of California, San Diego
Marian Walhout, University of Massachussetts Medical School
The 2010 conference was again held at the Wellcome Trust Conference Centre on the Wellcome
Trust Genome Campus in Hinxton, United Kingdom. Network Biology attempts to understand
biology from the point of view of global and local systems properties of molecular networks. The
conference addressed the structure, function, and dynamics of a variety of cellular networks such as
genetic, transcriptional, posttranscriptional gene regulatory, protein–protein interaction, signaling,
and metabolic networks. A central theme of the meeting was to understand how network properties
relate to phenotypes, including human disease. 
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences at Hinxton are supported in
part with funding courtesy of The Wellcome Trust.
PROGRAM
Gene Regulatory Networks I
Chairperson: L. Serrano, Centre for Genomic Regulation,
Barcelona, Spain
Keynote Addresses
C. Boone, University of Toronto, Toronto, Canada
The Genetic Landscape of a Cell
E.M. Marcotte, University of Texas, Austin
Deaf Plants, Bleeding Yeast, and Other Surprising Disease
Models from Deeply Conserved Gene Networks
Protein–Protein Interaction Networks
Chairperson: V. Cheung, University of Pennsylvania,
Philadelphia
Genetic Networks
Chairperson: H. Zhu, Johns Hopkins University, Baltimore,
Maryland
Network Medicine
Chairperson: P. Braun, Dana-Farber Cancer Institute, Boston,
Massachusetts
An animated discussion after one session
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Gene Regulatory Networks II
Chairperson: G. Superti-Furga, Austrian Academy of Sciences,
Vienna, Austria
Signaling Networks
Chairperson: A. Godzik, Burnham Institute for Medical
Research, La Jolla, California
Metabolic Networks
Chairperson: D. Pe’er, Columbia University, New York
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Infectious Disease Genomics and Global Health
September 12–15 86 Participants
ARRANGED BY Matthew Berriman,Wellcome Trust Sanger Institute
Jane Carlton, New York University
Julian Parkhill,Wellcome Trust Sanger Institute
George Weinstock,Washington University School of Medicine
This fourth conference was held at the Wellcome Trust Conference Centre on the Wellcome Trust
Genome Campus in Hinxton, United Kingdom. The meeting explored how the recent progress in
host, pathogen, and vector genome data and other large data sets is changing the way we think
about infectious diseases with an emphasis on global health issues.
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences at Hinxton are supported in
part with funding courtesy of The Wellcome Trust.
PROGRAM
Keynote Address
D. Kwiatkowski, Oxford University, Sanger Institute
Epidemiology and Public Health
Chairpersons: C. Arias, University of Texas Medical School,
Houston; P. Bejon, Kemri Wellcome Trust Research Program,
Kilifi, Kenya
Viruses I
Chairpersons: R. Heyderman, Malawi-Liverpool Wellcome Trust,
Blantyre, Malawi; P. Kellam, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Viruses II
Chairpersons: C. Simmons, Hospital for Tropical Diseases, Ho
Chi Minh City, Vietnam; L. Kramer, Wadsworth Center,
SUNY Albany, New York
Population Genomics
Chairpersons: D. Conway, Medical Research Council, The
Gambia; P. Keim, Northern Arizona University, Flagstaff
Bacteria
Chairpersons: N. Day, Mahidol Oxford Tropical Medicine
Research Unit (Moru), Bangkok, Thailand; J. Vinetz,
University of California, San Diego
Parasites and Vectors
Chairpersons: T. Anderson, Southwest Foundation for
Biomedical Research, San Antonio, Texas; A. Das, National
Institute of Malaria Research (ICMR), New Delhi, India
Coffee break
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247-304_Meetings_Annual Report_2009 template  7/8/11  12:23 PM  Page 303
Genome Informatics 
September 15–19 256 Participants
ARRANGED BY Inanc Birol, BC Cancer Agency, Canada
Michele Clamp, The Broad Institute of Harvard and Massachusetts Institute of Technology 
James Kent, University of California, Santa Cruz
This conference focuses on large-scale genome informatics. Biology is an experimental science that
is experiencing an explosion of new data. This requires biologists to increase the scale and sophisti-
cation in the information technology used for their research. The conference scope encompasses
the management and the analysis of these data, such as whole-genome comparisons within and
among species and strains, the analysis of results from high-throughput experiments to uncover cel-
lular pathways and molecular interactions, and the design of effective algorithms to identify regu-
latory sequence motifs. It was the tenth Cold Spring Harbor Laboratory/Wellcome Trust Conference
on Genome Informatics to be held at the Wellcome Trust Conference Centre on the Wellcome
Trust Genome Campus in Hinxton, United Kingdom.
Joint Cold Spring Harbor Laboratory/Wellcome Trust conferences at Hinxton are supported in
part with funding courtesy of The Wellcome Trust.
PROGRAM
Keynote Address: RNA Wikiproject—Community
Annotation of RNA Families
A. Bateman, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom
Sequencing Pipelines and Assembly
Chairpersons: Z. Torok, Astrid Research, Debrecen, Hungary; I.
Birol, BC Cancer Agency, Vancouver, Canada
Population and Statistical Genomics
Chairpersons: R. Durbin, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; E. Margulies, NIGRII, National
Institutes of Health, Bethesda, Maryland
Environmental and Medical Genomics
Chairpersons: T. Thorgeirsson, University of California, Santa
Cruz; M. Clamp, Bioteam, Middleton, Massachusetts
Databases, Data Mining, Visualization, and Curation
Chairpersons: D. Dooling, Washington University School of
Medicine, St. Louis, Missouri; M. Krzywinski, BC Cancer
Agency, Vancouver, Canada
Epigenomics and Gene Regulation
Chairpersons: W. Noble, University of Washington, Seattle; 
Z. Weng, University of Massachusetts Medical School,
Worcester
Comparative and Evolutionary Genomics
Chairpersons: S. Batzoglou, Stanford University, California; P.
Flicek, European Bioinformatics Institute, Hinxton, United
Kingdom
Sequencing and Gene Prediction
Chairpersons: A. Mortazavi, California Institute of Technology,
Pasadena; L. Pachter, University of California, Berkeley
Discussing and looking over posters
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities
do not adequately teach them. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into research in a particular
area. To ensure up-to-date coverage of current research work, we bring together course faculty from
many laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 7–20
INSTRUCTORS R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
M. Marr, Brandeis University, Waltham, Massachusetts
ASSISTANTS J. Cao, University of California, Los Angeles
M. Chambers, University of California, Los Angeles
R. Chumanov, University of Wisconsin, Madison
A. Esch, University of Wisconsin, Madison
Y.-U. Lee, M.D. Anderson Cancer Center, University of Texas, Houston
C. Olsen, Brandeis University, Waltham, Massachusetts
K. Pennington, Brandeis University, Waltham, Massachusetts
A. Ponce, University of California, Los Angeles
N. Thompson, University of Wisconsin, Madison
W. Turki-Judeh, University of California, Los Angeles
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This course was for scientists who were not familiar with techniques of protein isolation and char-
acterization. It was a rigorous program that included laboratory work all day and a lecture with dis-
cussion sessions every evening. Each student became familiar with each of the major techniques in
protein purification by actually performing four separate isolations including (1) a regulatory protein
from muscle tissue, (2) a sequence-specific DNA-binding protein, (3) a recombinant protein over-
expressed in Escherichia coli, and (4) a membrane-bound receptor. A variety of bulk fractionation,
electrophoretic, and chromatographic techniques included precipitation by salts, pH, and ionic
polymers; ion exchange, gel filtration, hydrophobic interaction, and reverse phase chromatography;
lectin affinity, ligand affinity, oligonucleotide affinity, and immunoaffinity chromatography; poly-
acrylamide gel electrophoresis, and electroblotting; and high-performance liquid chromatography.
Procedures were presented for solubilizing proteins from inclusion bodies and refolding them into
active monomeric forms. Methods of protein characterization were utilized to include immunolog-
ical and biochemical assays, peptide mapping, amino acid analysis, protein sequencing, and mass
spectrometry. Emphasis was placed on strategies of protein purification and characterization. Guest
lecturers discussed protein structure, modification of proteins, methodologies for protein purifica-
tion and characterization, and applications of protein biochemistry to cell and molecular biology
and oncology.
This course was supported with funds provided by the National Cancer Institute. 
PARTICIPANTS
Da Ros, M., M.Sc., University of Turku, Finland
Dantoft, T., M.S., Aarhus University, Faculty of Health
Science, Denmark
Du, J., Ph.D., Medical College of Wisconsin, Milwaukee
Flores, G., B.S., University of Puerto Rico, San Juan
Foeger, N., B.A., Washington University in St. Louis, Missouri 
Giniatullina, A., M.S., VU University Amsterdam, The
Netherlands
Girgis, H., Ph.D., Massachusetts General Hospital, Boston
Jin, J.-K., B.S., University of Texas M.D. Anderson Cancer
Center, Houston
Kalendova, A., M.S., Institute of Molecular Genetics AS CR,
Prague, Czech Republic
Li, D., B.S., Massachusetts Institute of Technology,
Cambridge
Lloyd, F., M.D., Indiana/Purdue University at Indianapolis,
Indianapolis
Mosebi, S., Ph.D., Research Scientist at Mintek, Randburg,
South Africa
Park, Y., Ph.D., University of Arkansas, Pine Bluff
Rak, R., B.S., Tel-Aviv University, Israel
Rincon, H., Ph.D., Fred Hutchinson Cancer Research Center,
Seattle, Washington 
Xu, J., Ph.D., University of California, Irvine
SEMINARS
Burgess, R., University of Wisconsin, Madison: Introduction
to protein purification; RNA polymerase–Sigma factor
interactions and use of LRET-based assays for drug discovery
and biochemistry.
Chumanov, R., University of Wisconsin, Madison: Halo tag
and purification of CARMI.
Courey, A., University of California, Los Angeles: System-wide
analyses of Groucho and SUMO in Drosophila development.
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Cadherin-11 in prostate cancer bone metastasis.
Marr, M., Brandeis University, Waltham, Massachusetts:
Transcriptional and translational cellular responses to stress.
Thompson, N., University of Wisconsin, Madison:
Immunoaffinity chromatography.
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Cell and Developmental Biology of Xenopus
April 9–20
INSTRUCTORS R. Keller, University of Virginia, Charlottesville
K. Kroll, Washington University School of Medicine, St. Louis, Missouri
CO-INSTRUCTORS A. Sater, University of Houston, Texas
G. Thomsen, Stony Brook University, Stony Brook, New York
ASSISTANTS B. Dzamba, University of Virginia, Charlottesville
T. Nakayama, University of Virginia, Charlottesville
K. Pfister, University of Virginia, Charlottesville
Xenopus is the leading vertebrate model for the study of gene function in development. The com-
bination of lineage analysis, gene-knockout strategies, experimental manipulation of the embryo,
and genomic/bioinformatic techniques makes it ideal for studies on the molecular control of embryo
patterning, morphogenesis, and organogenesis. The course combined intensive laboratory training
with daily lectures from recognized experts in the field. Students learned both emerging technologies
and classical techniques to study gene function in Xenopus development. An important element was
the informal interaction between students and course faculty. Technologies included oocyte and
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embryo culture, lineage analysis and experimental manipulation of embryos, time-lapse imaging of
morphogenesis, gain- and loss-of-function analyses using mRNAs and antisense oligos, whole-
mount in situ hybridization, immunocytochemistry, RT-PCR, genomic/bioinformatic techniques,
preparation of transgenic embryos, and use of Xenopus tropicalis for genetic analyses. This course
was designed for those new to the Xenopus field, as well as for those wanting a refresher course in
the emerging technologies. The course was open to investigators from all countries.
This course was supported with funds provided by the National Institute of Child Health and
Human Development, the National Science Foundation, and the Howard Hughes Medical Insti-
tute.
PARTICIPANTS
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Amin, N., Ph.D., University of North Carolina, Chapel Hill
Barnett, C., B.A., University of Alaska, Anchorage
Bertke, M., B.S., University of Notre Dame, Notre Dame,
Indiana
Charney, R., B.A., University of California, Irvine, California
Cheng, W.-C., B.Sc., Kings College, London, United
Kingdom
Gibb, N., B.Sc., University of Aberdeen, United Kingdom
Lloyd, R., Ph.D., Institute of Zoology, Zoological Society of
London, United Kingdom
Messina, A., M.A., University of Trento, Italy
Nedelkovska, H., B.S., University of Rochester Medical
Center, New York
Ploper, D., B.S., HHMI/University of California, Los Angeles
Riechert, S., M.S., Cancer Research, UK–London Research
Institute, United Kingdom
Schneider, I., M.Sc., University of Hohenheim, Stuttgart,
Germany
Stellabotte, F., Ph.D., House Ear Institute, Los Angeles,
California
Walentek, P., M.S., University of Hohenheim, Stuttgart,
Germany
SEMINARS
Christian, J., Oregon Health and Science University, Portland:
TGF-β superfamily signaling in early Xenopus development.
Grainger, R., University of Virginia, Charlottesville: Genomic
approaches for enhancer identification in Xenopus.
Harland, R., University of California, Berkeley: Biology of the
organizer.
Houston, D., University of Iowa, Iowa City: Roles of localized
maternal mRNAs in Xenopus axis formation.
Keller, R., University of Virginia, Charlottesville: Introduction
to Xenopus morphogenesis.
Khokha, M., Yale University School of Medicine, New Haven,
Connecticut: Introduction to Xenopus tropicalis.
Kintner, C., The Salk Institute, La Jolla, California: Cell
biological analysis of early development.
Nakayama, T., University of Virginia, Charlottesville:
Approaches for manipulating gene expression in 
Xenopus.
Vize, P., University of Calgary, Canada: Xenbase.
Zimmerman, L., National Institute for Medical Research,
London, United Kingdom: Genetics in Xenopus tropicalis.
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Workshop on Schizophrenia and Related Disorders
June 9–15
INSTRUCTORS A. Malhotra, Zucker Hillside Hospital, Glen Oaks, New York
A. Law, National Institute of Mental Health, NIH, Bethesda, Maryland
CO-INSTRUCTOR J. Hall, University of Edinburgh, United Kingdom
ASSISTANT P. DeRosse, Zucker Hillside Hospital, Glen Oaks, New York
This workshop provided students with the most current understanding of the molecular, cellular,
and neural systems underlying the disturbances in brain function in these devastating illnesses. Dur-
ing the 7-day workshop, students learned about the clinical aspects of schizophrenia, schizoaffective
disorder, and bipolar disorder, as well as explored in detail the genetic and neurobiological under-
pinnings of these complex psychiatric disorders. The Workshop included sessions focused on The
Clinical Syndrome, Basic Neurobiology, Cognitive Neuroscience, Neuroimaging, Genetics and Ge-
nomics, Endophenotypes, and Gene Expression and Gene Modulation. In addition to hearing about
the most recent research in these areas, controversial topics and challenges to basic assumptions in
the field were explored and discussed. A diverse faculty brought the most up-to-date results and
theories to the students, making this Workshop a valuable resource for young researchers starting
out in this fast-moving and expansive field. Not only did it help them build the foundation for their
future research, it also introduced them to many potential collaborators working to understand
schizophrenia and similar disorders from different perspectives.
This course was supported with funds provided by the Oliver Grace Fund.
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PARTICIPANTS
Balu, D., Ph.D., McLean Hospital, Belmont, Massachusetts
Becerril, K., B.S., Washington University, St. Louis, Missouri
Chang, W., B.S., University of California San Diego, La Jolla
Cui, X., Ph.D., Sigma Advanced Genetic Engineering (SAGE)
Labs, St. Louis, Missouri
Dowd, E., B.S., Washington University, St. Louis, Missouri
Gallego, J., Ph.D., Zucker Hillside Hospital, Glen Oaks, New
York
Kleinhaus, K., Ph.D., New York University School of
Medicine
Maher, B., Ph.D., University of Connecticut, Storrs
Malavasi, E., B.S., University of Edinburgh, United Kingdom
Morris, H., Ph.D., Johns Hopkins Medical Institution,
Baltimore, Maryland
Nucifora, F., Ph.D., Johns Hopkins School of Medicine,
Baltimore, Maryland
Radhakrishnan, R., Ph.D., Yale University School of
Medicine, New Haven, Connecticut
Smith, S., B.S., University of Missouri,  Saint Louis
Stilo, S., Ph.D., Psychosis Clinical Academic Group, London,
United Kingdom
Sussmann, J., Ph.D., Edinburgh University, Edinburgh,
United Kingdom
Wang, X., Ph.D., University of Southern California, Los
Angeles
Ward, K., B.S., Pfizer Global Research and Development,
Groton, Connecticut
Woods, G., B.S., University of California, Davis
Zhang, J., Ph.D., Zucker Hillside Hospital, Glen Oaks, New
York
Zhu, S., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
SEMINARS
Abi-Dargham, A., Columbia University, New York: PET
imaging in schizophrenia.
Akbarian, S., University of Massachusetts, Medical School,
Worcester: Epigenetics in schizophrenia.
Calicott, J., National Institute of Mental Health, NIH,
Bethesda, Maryland: Functional MR in schizophrenia.
Cornblatt, B., Zucker Hillside Hospital, Glen Oaks, New
York: Cognitive and psychosocial risk factors.
DeRosse, P., Zucker Hillside Hospital, Glen Oaks, New York:
Introduction to the clinical syndrome.
Fletcher, P., University of Cambridge, United Kingdom: A
cognitive neuroscientific model of the positive symptoms of
schizophrenia.
Hall, J., University of Edinburgh, United Kingdom: Cognition
of schizophrenia and imaging genomics.
Hyde, T., National Institute of Mental Health, NIH, Bethesda,
Maryland: Postmortem gene expression in
neurodevelopment.
Jarskog, F., Columbia University, New York: Treatment
strategies.
Law, A., National Institute of Mental Health, Bethesda,
Maryland: NRG/ErbB signaling and risk for schizophrenia:
The genetics of gene regulation and function.
Lawrie, S., University of Edinburgh, United Kingdom:
Structural imaging in schizophrenia.
Lewis, D., University of Pittsburgh, Pennsylvania: Cortical
GABA systems in schizophrenia.
Li, B., Cold Spring Harbor Laboratory: Glutamatergic synapse
and its receptors: From cognitive function to psychiatric
disorder.
Malhotra, A., Zucker Hillside Hospital, Glen Oaks, New
York: Pharmacogenomics in schizophrenia.
Moghaddam, B., University of Pittsburgh, Pennsylvania: The
glutamatergic system.
O’Donnell, P., University of Maryland, Baltimore: The
dopaminergic system.
O’Donovan, M., University of Wales, Cardiff, United
Kingdom: GWAS and candidate genes in schizophrenia.
Porteous, D., University of Edinburgh, United Kingdom:
Common and rare variants in schizophrenia: The DISC1
example.
Sebat, J., University of California, San Diego: Rare variants in
schizophrenia.
Song, H., Johns Hopkins University, Baltimore, Maryland:
Neurogenesis and iPS in schizophrenia.
Susser, E., Columbia University, New York: Epidemiology and
environmental risk factors.
Weinberger, D., National Institute of Mental Health,
Bethesda, Maryland: Intermediate phenotypes and
schizophrenia-associated genes.
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Advanced Bacterial Genetics
June 9–29
INSTRUCTORS J. Kirby, University of Iowa, Iowa City
S. Lovett, Brandeis University, Waltham, Massachusetts
A. Segall, San Diego State University, San Diego, California
ASSISTANTS K. Elliott, University of Georgia, Westminster, South Carolina
J. Rostron, University of Iowa, Iowa City
C. Weitzel, Brandeis University, Waltham, Massachusetts
J. Willett, University of Iowa, Iowa City
This course presented logic and methods used in the genetic dissection of complex biological
processes in diverse bacteria. Laboratory methods included classical mutagenesis using transposons,
mutator strains, and chemical and physical mutagens; detection and quantitation of gene expression
changes using various reporter genes and real-time PCR; the mapping of mutations using genetic
and physical techniques; modern approaches to the generation and analysis of targeted gene dis-
ruptions and fusions using PCR and cloning methods; epitope insertion mutagenesis; site-directed
mutagenesis; and fluorescence microscopy. Key components of the course were the use of sophisti-
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cated genetic methods in the analysis of model bacteria (including Escherichia coli, Salmonella, Bacil-
lus subtilis, and Myxococcus xanthus) and the use of the wealth of new genomic sequence information
to motivate these methods. Invited lecturers presented various genetic approaches to study bacterial
mechanisms of metabolism, development, and pathogenesis. 
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
312 Postgraduate Courses
Arnoldini, M., M.Sc., ETH Zurich, Switzerland
Barrett, E., B.S., Dartmouth College, Hanover, New
Hampshire
Brolund, A., M.Sc., Karolinska Institute, Stockholm, Sweden
Cady, K., B.S., Dartmouth Medical School, Lebanon, New
Hampshire
Carpino, J., B.S., Queens College and CUNY Graduate
Center, Flushing, New York
Hao, L., M.S., University of Wisconsin, Madison
Jun, S., B.Sc., Harvard University, Cambridge, Massachusetts
Kuehn, S., Ph.D., The Rockefeller University, New York
Lazova, M., M.Sc., FOM Institute AMOLF, Amsterdam, 
The Netherlands
Lewis, E., B.S., University of California, Irvine
Liu, X., Ph.D., Harvard Medical School, Boston,
Massachusetts
Rae, R., B.S., Max-Planck Institute for Developmental
Biology, Tuebingen, Germany
Rodriguez Esperon, M., B.S., Institute De Invest. Clemente
Estable, Montevideo, Uruguay
Sankararaman, S., Ph.D., University of California, Berkeley
Shanahan, E., B.Sc., Centenary Institute University of Sydney,
Camperdown, Australia
Viburiene, R., M.S., University of Oslo, Norway
SEMINARS
Edwards, R., San Diego State University, California: Using
genomics and metagenomics to understand the world 
around us.
Hughes, D., Uppsala University, Sweden: Bacterial mutants
selected to cope with stressful growth conditions.
Kirby, J., University of Iowa, Iowa City: Chemosensory
regulation of biofilm formation.
Laub, M., Massachusetts Institute of Technology/HHMI,
Cambridge: Specificity and evolution of bacterial signaling
pathways.
Lazazzera, B., University of California, Los Angeles:
Identifying pathways to control surface-adhered biofilm
formation.
Lovett, S., Brandeis University, Waltham, Massachusetts:
Replication gap repair.
Rohwer, F., San Diego State University, California: Human
virome.
Rudner, D., Harvard Medical School, Boston, Massachusetts:
Regulation of essential cell biological processes during
bacterial differentiator.
Segall, A., San Diego State University, California: Inhibitors of
DNA repair and the serendipity of science.
Storz, G., National Institute of Child Health and Human
Development, Bethesda, Maryland: The genes that were
missed.
Whitaker, R., University of Illinois, Urbana: Dynamics of
host–virus interactions across space and time.
Yildiz, F., University of California, Santa Cruz: Analysis of
biofilm formation in Vibrio cholerae.
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Ion Channel Physiology
June 9–29
INSTRUCTORS N. Golding, University of Texas, Austin
A. Lee, University of Iowa, Iowa City
M. Nolan, University of Edinburgh, United Kingdom
ASSISTANTS C. Bladen, University of Calgary, Alberta, Canada
K. Buchanan, University College London, United Kingdom
P. Dodson, University of Edinburgh, United Kingdom
A. Graves, Northwestern University, Evanston, Illinois
K. Hansen, Emory University, Atlanta, Georgia
P. Kammermeier, University of Rochester, New York
S. Khurana, University of Texas, Austin
L. Scott, University of Texas, Austin
K. Vance, Emory University, Atlanta, Georgia
The primary goal of this course was to investigate, through lectures and laboratory work, the prop-
erties of ion channels that allow neurons to carry out their unique physiological functions in a variety
of neural systems. Areas of particular interest included channels that (1) are activated by neuro-
transmitters at central and peripheral synapses, (2) are activated by voltage changes in axons and
dendrites, (3) respond to neuromodulators with changes in functional properties, or (4) are devel-
opmentally required and regulated. The research interests of guest lecturers reflected these areas of
emphasis.
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The laboratory component of the course introduced students to electrophysiological approaches
for the study of ion channels in their native environments. Hands-on exercises included patch-
clamp recording of ion channel activity in acutely isolated or cultured cells or neurons in brain slice
preparations. Different recording configurations were used (e.g., whole-cell, cell-free, and nucleated
patches) to examine macroscopic or single-channel activity. Similarly, various methods of ligand
and drug application were demonstrated. The advantages and disadvantages of each method, prepa-
ration, and recording technique were considered in relation to the specific scientific questions being
asked. Admissions priority was given to students and postdocs with a demonstrated interest and
specific plans, as well as a supportive environment to apply these techniques to a defined problem. 
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Altimimi, H., B.S., McGill University, Montreal, Canada
Gavin, C., B.A., The Scripps Research Insitute, Florida
Campus, Jupiter
Goodfellow, N., B.S., University of Toronto, Canada
Gutnisky, D., Ph.D., Janelia Farm-HHMI, Ashburn, 
Virginia
Kalia, J., M.S., National Institutes of Health, Bethesda,
Maryland
Kim, S.E., M.S., The Scripps Research Institute, La Jolla,
California
Kuo, C., Ph.D., Duke University Medical Center, Durham,
North Carolina
Madry, C., Ph.D., University College London, United
Kingdom
Moscato, E., B.A., University of Pennsylvania, Philadelphia
Schoonover, C., Ph.D., Columbia University, New York
Surmeli, G., B.S., Columbia University, New York
Tauchmann, M., B.A., Arizona State University, Tempe
SEMINARS
Deisseroth, K., Stanford University, Stanford, California:
Channel engineering.
Dolphin, A., University College London, United Kingdom:
Voltage-gated Ca2+ channels. The α2δ subunits of voltage-
gated calcium channels: Involvement in disease and target
site for drugs.
Dudman, J., Janelia Farm Research Campus, Ashburn,
Virginia: Hyperpolarization-activated channels.
Farrant, M., University College London, United Kingdom:
Inhibitory synaptic transmission and differential activation
of GABAA receptor subtypes.
Golding, N., University of Texas, Austin: Synaptic integration
and integrative properties for auditory temporal coding.
Jan, L., University of California, San Francisco: K+ channels
and Ca+-activated C1-channels.
Kaczmarek, L., Yale University School of Medicine, New
Haven, Connecticut: Ion channel modulation. Regulation 
of neuronal timing by short-term and long-term channel
modulation.
Larsson, P., University of Miami, Florida: Voltage-gated K+
channels and molecular mechanisms of voltage-gated proton
channels.
Raman, I., Northwestern University, Evanston, Illinois: Na
channels. Biophysics and physiology. Sodium currents
specializations in spontaneous spiking and cerebellar
signaling.
Sjostrom, J., University College London, United Kingdom:
Plasticity and LTP. Spike-timing-dependent plasticity in
neocortex.
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Molecular Embryology of the Mouse
June 9–29
INSTRUCTORS K. Hadjantonakis, Memorial Sloan-Kettering Cancer Institute, New York
L. Pevny, University of North Carolina, Chapel Hill
J. Rivera-Perez, University of Massachusetts Medical School, Worcester
ASSISTANTS D. Escalante-Alcalde, Institute of Cellular Physiology–UNAM, Distrito Federal, CP, Mexico
A. Ferrer-Vaquer, Memorial Sloan-Kettering Cancer Institute, New York
D. Matsushima, University of North Carolina, Chapel Hill
G. Tortelote, University of Massachusetts Medical School, Worcester
This intensive laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse development. Lectures provided the conceptual basis for contempo-
rary research in mouse embryogenesis and organogenesis, and laboratory practicals provided extensive
hands-on introduction to mouse embryo analysis. Experimental techniques covered included in vitro
culture and manipulation of pre- and postimplantation embryos, embryo transfer, culture and genetic
manipulation of embryonic stem cells, production of chimeras by embryo aggregation and by ES
cell injection, and transgenesis by pronuclear microinjection. In addition, this year’s practicals featured
increased emphasis on phenotypic analysis of mutants, including techniques of histology, in situ hy-
bridization, immunohistochemistry, skeletal preparation, organ culture, and tissue recombination.
The course also introduced the generation of iPS cells (induced pluripotent cells) and time-lapse mi-
croscopy of early gastrulation embryos and organ cultures (eye, kidney, and gut).
This course was supported with funds provided by the National Cancer Institute.
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PARTICIPANTS
Akinci, U., Ph.D., Erasmus Medical Center, Rotterdam, The
Netherlands
Aylor, D., Ph.D., University of North Carolina, Chapel Hill
Azzoni, E., M.S., H. San Raffaele–DIBIT, Milan, Italy
Bezzi, M., M.D., Institute of Molecular and Cell Biology,
Singapore
Chang, C., M.S., The Rockefeller University, New York
Cooper, L., Ph.D., University of Illinois, Urbana
Goetz, R., Dipl., University of Freiburg, Germany
Günesdogan, U., Dipl., Max-Planck Institute for Biophysical
Chemistry, Göttingen, Germany
Lim, C., Ph.D., Institute of Medical Biology, Singapore
Muta, Y., Ph.D., RIKEN, Kobe, Japan
Peyrot, S., Ph.D., University of Texas, Austin
Ryall, J., Ph.D., National Institutes of Health, Bethesda,
Maryland
Vagin, V., Ph.D., Cold Spring Harbor Laboratory
Wat, M., B.S., Baylor College of Medicine, Houston, 
Texas
SEMINARS
Anderson, K., Memorial Sloan-Kettering Cancer Institute,
New York: ENU screens and signaling pathways.
Behringer, R., The University of Texas/M.D. Anderson Cancer
Center: Transgenics and Evo-Devo.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Germ cells and the transcriptional network in the
gonad.
Chapman, D., University of Pittsburgh, Pennsylvania:
Somitogenesis.
Conlon, F., University of North Carolina, Chapel Hill: Heart
development.
Costantini, F., Columbia University, College of Physicians &
Surgeons, New York: Kidney development.
Dickinson, M., Baylor College of Medicine, Houston, Texas:
Cardiovascular function and imaging.
Eggenschwiler, J., Princeton University, New Jersey: Genetic
dissection of neural tube development.
Epstein, D., University of Pennsylvania, Philadelphia: Early
neural development.
Hadjantonakis, K., Memorial Sloan-Kettering Cancer
Institute, New York: Imaging early embryo morphogenesis.
Hochedlinger, K., Masschusetts General Hospital, Boston:
Nuclear reprogramming and iPS cells.
Hogan, B., Duke University Medical Center, Durham, North
Carolina: Lung development and progenitor cells.
Johnson, R., Anderson Cancer Center, Houston, Texas: Limb
development and hippo signaling.
Joyner, A., Memorial Sloan-Kettering Cancer Institute, New
York: Patterning and fate mapping of the neural system.
Lovell-Badge, R., MRC National Institute for Medical
Research, London, United Kingdom: Primary sex
orientation.
Magnuson, T., University of North Carolina, Chapel Hill:
Epigenetics.
Nagy, A., Samuel Lunenfeld Research Institute, Toronto,
Canada: ES cells, chimeras, and recombinases.
Papioannou, V., Columbia University, New York: The mouse
as a model system.
Pevny, L., University of North Carolina, Chapel Hill:
Transcriptional regulation of retinogenesis.
Rivera, J., University of Massachusetts Medical School,
Worcester: Lineage analysis and early postimplantation
development.
Robertson, E., University of Oxford, United Kingdom: Nodal
signaling and axial development.
Shen, M., Columbia Unversity Medical Center, New York:
Prostate development, stem cells, and cancer.
Solter, D., Institute of Medical Biology, Singapore, Singapore:
Preimplantation development.
Soriano, P., Mount Sinai School of Medicine, New York: Gene
trapping and signaling pathways.
Sussel, L., Columbia University, New York: Pancreas
development.
Takahashi, J., HHMI/University of Texas Southwestern
Medical Center, Dallas: Circadian rhythms.
Tam, P., Children’s Medical Research Institute, Westmead,
Sydney, Australia: Gastrulation.
Threadgill, D., North Carolina State University, Raleigh:
Mouse genetics.
Trainor, P., Stowers Institute for Medical Research, Kansas
City, Missouri: The neural crest in craniofacial development,
evolution, and disease.
Turnbull, D., New York University Medical Center, New York:
Imaging modailities and applications: Ultrasound and MRI.
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Integrative Statistical Analysis of Genome-Scale Data
June 16–29
INSTRUCTORS H. Bussemaker, Columbia University, New York
V. Carey, Harvard University, Boston, Massachusetts
M. Reimers, Virginia Commonwealth University, Richmond
ASSISTANTS N. Altman, Penn State, University Park
S. Bekiranov, University of Virginia, Charlottesville
M. Figueroa,Weill Cornell Medical College, New York
T. Guennel, Virginia Commonwealth University, Richmond
A. Lazarovici, Columbia University, New York
T. Riley, Columbia University, New York
Genome-scale data sets are a central feature of modern biological research. Experimental and com-
putational biologists who want to get the most from their data sets need to have a firm grasp of sta-
tistical and analytical methodology. This course was designed to build competence in quantitative
methods for the analysis of high-throughput molecular biology data. Detailed lectures and presen-
tations by guest speakers in the morning and evening were combined with hands-on computer tu-
torials in the afternoon, in which the methods covered in the lectures were applied to actual
high-throughput data for yeast and humans. Students were assumed to have a basic familiarity with
the R programming language at the start of the course.
This course was supported with funds provided by the National Cancer Institute.
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PARTICIPANTS
Bartonicek, N., B.S., European Molecular Biology
Laboratories, Cambridge, United Kingdom
Berko, E., B.A., Albert Einstein College of Medicine, Bronx,
New York
Cai, Y., M.S., Cold Spring Harbor Laboratory
Cho, M., M.D., Brigham & Women’s Hospital, Boston,
Massachusetts
Fendler, B., Ph.D., Cold Spring Harbor Laboratory
Fertig, E., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Grant, J., Ph.D., University of Alberta, Edmonton, Canada
Jonsson, P., M.S., University of Houston, Texas
Krupka, M., B.A., Albert Einstein College of Medicine,
Bronx, New York
Liang, W., Ph.D., Translational Genomics Research Institute,
Phoenix, Arizona
Mandal, A., B.Sc., Institute of Genomics & Integrative
Biology, Delhi, India
Matarin, M., B.S., ION/UCL, London, United Kingdom
Mayfield, J., Ph.D., Duke University, Durham, North
Carolina
Muller, J., M.S., A*Star, Singapore
Obholzer, N., B.S., Harvard Medical School, Boston,
Massachusetts
Pereira, J., Ph.D., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Rosenbloom, K., B.A., University of California, Santa Cruz
Ross, E., M.B.A., Howard Hughes Medical Institute, Salt Lake
City, Utah
Sorokin, E., B.A., University of Wisconsin, Madison
Stokowy, T., M.Sc., Silesian University of Technology, Gilwice,
Poland
Wang, C., M.S., Uppsala University, Sweden
Wee, C., B.Sc., Temasek Lifesciences Laboratory, Singapore
Yuen, R., B.Sc., Child & Family Research Institute,
Vancouver, Canada
Zhang, W., B.Sc., Roswell Park Cancer Institute, Buffalo, New
York
SEMINARS
Altman, N., Penn State, University Park: Multiple
comparisons: Concepts and methods and experimental
design and basic statistical ideas. Exploratory data analysis
and differential expression using RNA-Seq data.
Bekiranov, S., University of Virginia, Charlottesville: Physics
of hybridization. High-throughout sequencing technology.
Bravo Corrado, H., Johns Hopkins University, Baltimore,
Maryland: Base calling.
Bussemaker, H., Columbia University, New York: Gene-set
based analysis of functional genomics data. Representations
of protein-DNA-binding specificity I. Representations of
protein-DNA-binding specificity II. Algorithms for de novo
motif discovery. Linear modeling of transcriptional
regulation.
Carey, V., Harvard University, Boston, Massachusetts:
Bioconductor infrastructure for NGS.
Davis, S., National Institutes of Health, Bethesda, Maryland:
Methylation and copy-number methods and integrated
analysis of the NCI60.
Futcher, B., Stony Brook University, Stony Brook, New York:
Lessons learned from a successful microarray experiment.
Gottardo, R., Clinical Research Institute of Montreal, 
Quebec, Canada: ChIP-chip data analysis. Research 
seminar.
Horvath, S., University of California, Los Angeles: Cancer
classification. Research seminar. Cocorrelation analysis.
Liu, S., Harvard University, Cambridge, Massachusetts: 
ChlP-chip and ChlP-Seq analysis.
Lucito, R., Cold Spring Harbor Laboratory: Methylation 
and copy-number analysis.
Reimers, M., Virginia Commonwealth University, 
Richmond: Biases in RNA-Seq data. Integrated analysis 
of the NCI60.
Taub, M., Johns Hopkins University, Baltimore, Maryland:
Intro to RNA-Seq. Processing RNA-Seq data. Biases in
RNA-Seq data.
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Workshop on Circuit and Molecular Architecture
of the Vertebrate Brain
June 17–29
INSTRUCTORS Z.J. Huang, Cold Spring Harbor Laboratory
P. Mitra, Cold Spring Harbor Laboratory
K. Rockland, Massachusetts Institute of Technology, Cambridge and
RIKEN Brain Science Institute, Japan
ASSISTANTS J. Hahn, University of Southern California, Los Angeles
V. Pinskiy, Cold Spring Harbor Laboratory
N. Wall, Salk Institute for Biological Studies, La Jolla, California
H. Wang, Cold Spring Harbor Laboratory
In comparison with complete reference genomes now available for multiple species, our knowledge
about the neuronal and circuit architecture of the vertebrate nervous systems is relatively sparse.
However, this situation is rapidly changing, enabled by technical advances as well as resurgent and
widespread interest in the neuroscientific community in mapping out neural circuitry at unprece-
dented scales, ranging from the reconstruction of local microcircuits to the mapping of brain-wide
mesocircuits. This circuit architecture naturally and logically complements the molecular architecture
as delineated by the mapping of brain-wide gene expression patterns. Experimental efforts are under
way in multiple species, promising to advance our knowledge of the wiring logic of the vertebrate
brain. This fundamentally impacts on our understanding of brain function and evolution and also
has an essential role in understanding pathological changes in circuitry that underlie neurological
and neuropsychiatric disorders. 
This new workshop brought together classical neuroanatomical approaches along with the new
techniques that are enabling a new generation of neuroanatomical research into the circuit and mo-
lecular architecture of the vertebrate brain. The workshop had three main components: classical, mo-
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lecular, and computational neuroanatomy. An experimental component of the workshop involved
gross dissection (sheep brain); microscopic viewing of glass histology slides (sets of 20 slides per stu-
dent); and injection-based tract tracing in the mouse, using classical and viral tracer substances, in
wild-type and transgenic mice. Lectures covered classical (tracer injections, sectioning, histochemistry,
imaging) and molecular (genetic engineering of mice as well as viral tracers, optogenetic probing of
circuits) techniques. Material was presented by simultaneous viewing slides under light microscopy as
well as digital images, including an in-depth orientation to Internet resources. Anatomical topics in-
cluded specific circuits and pathways, molecular topics included development and cell-type specificity.
The computational component involved hands-on algorithmic analysis and interpretation of digital
neuroanatomical data sets, from both EM and light microscopy, and discussion of 3-0 brain morphing
and enregistering of disparate date sets to a common reference. Species covered included rodents and
human and nonhuman primates, with special lectures on other vertebrate lineages. 
The course was supported by funds provided through Cold Spring Harbor Laboratory.
PARTICIPANTS
320 Postgraduate Courses
Beier, K., B.S., Harvard Medical School, Boston,
Massachusetts
Bogart, L., B.S., Harvard University, Boston, Massachusetts
Bressan, D., M.Sc., Cold Spring Harbor Laboratory
Harrison, T., B.Sc., University of British Columbia,
Vancouver, Canada
Laramee, M.-E., M.S., Université du Québec á Trois-Riviéres,
Canada
McCarren, H., B.S., University of Pennsylvania, Philadelphia
Morgan, J., Ph.D., University of California, Davis,
Sacramento
Takashima, Y., Ph.D., Carnegie Mellon University, Pittsburgh,
Pennsylvania
Vannini, E., B.S., Scuola Normale Superiore, C.N.R., Pisa, Italy
Wolf, L., Ph.D., Tel-Aviv University, Israel
Yu, H.-H., Ph.D., Monash University, Clayton, Australia
Zhang, X., B.S., National Institutes of Biological Sciences,
Beijing, China
SEMINARS
Allman, J., California Institute of Technology, Pasdena: The
von economo Neurons (VENs) in fronto-insular and anterior
cingulate cortex in apes and humans.
Amaral, D., University of California, Davis: The organization
of the nonhuman primate and human hippocampal
formation.
Bohland, J., Boston University, Massachusetts: An overview of
image analysis challenges in high-throughput neuroanatomy.
Imaging processing tutorial.
Cardona, A., University of Zurich, Switzerland: Neuronal
reconstruction tutorial with Fiji open source software.
Chklovskii, D.B., HHMI/Janelia Farm, Ashburn, Virginia:
Wiring principles and/or EM reconstruction pipeline.
Deisseroth, K., Stanford University, California: Optogenetics:
development application.
Fischl, B., Martinos Center for Biomedical Imaging/MGH,
Boston, Massachusetts: Introduction to MRI: What you can
measure. Introduction to computational neuroanatomy using
MRI.
Greenspan, R., The Neurosciences Institute, La Jolla,
California: Invertebrate neuroanatomy.
Hawrylycz, M., Allen Institute for Brain Science, Seattle,
Washington: Computational neuroanatomy of gene
expression. Tutorial on Allen Institute tools.
Helmstaedter, M., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Dense circuit reconstruction from
blockface electron microscopy data. EM reconstruction tutorial.
Henkelman, M., University of Toronto, Canada: Magnetic
resonance imaging and computer analysis for mouse
neuroanatomy.
Huang, Z.J., Cold Spring Harbor Laboratory: Genetic
dissection of neural circuits in mouse brain. Introductory
remarks: Why is molecular genetics useful in systems
neuroscience.
Jeromin, A., Banyan Biomarkers, Inc., Alachua, Florida: High-
throughput brain mapping: Projects and approaches.
Neuroanatomy pipeline tour.
Karten, H., University of California, San Diego, La Jolla:
Evolutionary origins of mammalian neocortex.
Kleinfeld, D., and Karten, H., University of California, San
Diego, La Jolla: Introduction to wide-field and digital
imaging. Brain image databases. Optical sectioning and 3D
reconstruction.
Lee, J.H., University of California, Los Angeles: Optogenetic
stimulation and fMRI.
Li, B., Cold Spring Harbor Laboratory: Synapse, circuit, and
psychiatric disorders.
Martin, K., University of Zurich, Switzerland, Mapping the
matrix.
Mello, C., Oregon Health and Science University, Portland:
Gene expression in zebra finch.
Mitra, P., Cold Spring Harbor Laboratory: Course introduction.
Osten, P., Cold Spring Harbor Laboratory: Viral tracers.
Peterson, D., Rosalind Franklin University of Medicine and
305-366_courses_Annual Report_2009 template  7/8/11  12:24 PM  Page 320
Workshop on Circuit and Molecular Architecture of the Vertebrate Brain      321
Science, North Chicago, Illinois: Quantitative histology:
Introduction to design-based stereology.
Pinskiy, V., Cold Spring Harbor Laboratory and Jeromin, A.,
Banyan Biomarkers, Inc., Alachua, Florida: Neuroanatomy
pipeline tour. 
Rockland, K., Massachusetts Institute of Technology, and RIKEN
Brain Science Institute, Cambridge: Introduction to experi-
mental techniques (stains and example connections). Gross
neuroanatomy lab. Histology Lab I. Histology Lab II. PPT.
Rosa, M., Monash University, Victoria, Australia: Toward a
computational atlas of the primate cerebral cortex and its
connections.
Safdieh, J., Weill Cornell Medical College, New York: General
organization of the human central and peripheral nervous
system. Clinical case studies.
Saper, C., Harvard Medical School, Boston, Massachusetts:
Techniques using thermoregulation as a platform.
Sestan, N., Yale University, New Haven, Connecticut:
Molecular control of cortical projection neuron identity and
connectivity.
Swanson, L., University of Southern California, Los Angeles:
Studying long connections in the nervous system: Past,
present, and future.
Wall, N., Salk Institute for Biological Studies, La Jolla,
California: Modified rabies virus as a retrograde trans-
synaptic tracer and means for genetically targeting neuronal
circuits.
Witter, M., Norwegian University of Science and Technology,
Trondheim, Norway: Modern nueroanatomy applied to
study the entorhinal-hippocampal network.
Xiaoxia, C., Sigma Advanced Genetic Engineering (SAGE)
Labs, St. Louis, Missouri: Genetic engineering of the rat
genome using zinc finger nucleases.
Zeng, H., Allen Institute for Brain Science, Seattle,
Washington: Mouse genetic tool kit for a genetically based
connectional atlas.
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322
Computational Neuroscience: Vision
June 18–July 1
INSTRUCTORS G. Boynton, University of Washington, Seattle
G. Horwitz, University of Washington, Seattle
S. Treue, German Primate Center, Göttingen, Germany
ASSISTANTS M. Cohen, Harvard Medical School, Cambridge, Massachusetts
R. Kiani, HHMI/Stanford University School of Medicine, California
Computational approaches to neuroscience will produce important advances in our understanding
of neural processing. Prominent success will come in areas where strong inputs from neurobiological,
behavioral, and computational investigation can interact. The theme of the course was that an un-
derstanding of the computational problems, the constraints on solutions to these problems, and
the range of possible solutions can help guide research in neuroscience. Through a combination of
lectures and hands-on experience with MATLAB-based computer tutorials and projects, this in-
tensive course examined visual information processing from the retina to higher cortical areas, spatial
pattern analysis, motion analysis, neuronal coding and decoding, attention, and decision-making.
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Anton-Erxleben, K., Ph.D., New York University, New York
Cicmil, N., B.S., University of Oxford, United Kingdom
Czuba, T., B.S., University of Texas, Austin
Dold, H., B.S., Berlin Institute of Technology, Germany
Ernst, Z., B.S., University of Washington, Seattle
Freeman, J., B.S., New York University, New York
Heilbronner, S., B.S., Duke University Medical Center,
Durham, North Carolina
Jepson, L., B.S., Salk Institute for Biological Studies, La Jolla,
California
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Computational Neuroscience: Vision      323
Marshel, J., B.S., Salk Institute for Biological Studies, La Jolla,
California
Moeeny, A., Ph.D., National Institutes of Health, Bethesda,
Maryland
Morgenstern, Y., B.S., York University, Toronto, Canada
Ni, A., B.S., Harvard Medical School, Boston, 
Massachusetts
Putzeys, T., B.S., University of Leuven, Belgium
Said, C., B.S., Princeton University, New Jersey
Saproo, S., B.S., University of California, San Diego, La Jolla
Scharff, A., B.S., University of Washington, Seattle
Scholvinck, M., Ph.D., University College London, United
Kingdom 
Smolyanskaya, A., B.S., Harvard Medical School, Boston,
Massachusetts
Tan, C., B.S., Massachusetts Institute of Technology,
Cambridge
Twarog, N., B.S., Massachusetts Institute of Technology,
Cambridge
Wang, H., B.S., New York University, New York
Westendorff, S., B.S., German Primate Center, Goettingen,
Germany
SEMINARS
Adelson, T., Massachusetts Institute of Technology,
Cambridge: The elements of early vision.
Boynton, G., University of Washington, Seattle: Introduction
to Matlab tutorials and fMRI in the LGN and V1.
Brainard, D., University of Pennsylvania, Philadelphia: Color
vision.
Carrasco, M., New York University, New York: Attention:
Psychophysics and neuroimaging.
Chance, F., University of California, Irvine: Normalization
models II.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Retina I. Retina II.
Dan, Y., University of California, Berkeley: Early ventral
stream.
Geisler, W., University of Texas, Austin: Image statistics.
Heeger, D., New York University, New York: Normalization
models I.
Hirsch, J., University of Southern California, Los Angeles:
LGN/V1 anatomy and physiology.
Horwitz, G., University of Washington, Seattle: V1/white
noise analysis.
Movshon, J.A., New York University, New York: MT
physiology.
Reid, C., Harvard Medical School, Boston, Massachusetts: V1.
Rust, N., University of Pennsylvania, Philadelphia: Population
coding/decoding.
Shadlen, M., University of Washington, Seattle: Decision
making.
Simoncelli, E., New York University, New York: Linear
systems.
Snyder, L., Washington University School of Medicine, St.
Louis, Missouri: Higher dorsal stream.
Sommer, F., Redwood Center for Theoretical Neuroscience,
University of California, Berkeley: Models of LGN and V1.
Treue, S., German Primate Center, Goettingen, Germany:
Attention physiology.
Tsao, D., California Institute of Technology, Pasadena: Higher
ventral stream.
Webster, M., University of Nevada, Reno: High-level
adaptation.
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Computational Cell Biology
July 2–22 
INSTRUCTORS T. Elston, University of North Carolina, Chapel Hill
L. Loew, University of Connecticut Health Center, Farmington
G. Smith, College of William & Mary, Williamsburg, Virginia
J. Tyson, Virginia Tech, Blacksburg
ASSISTANTS S.A. Brown, University of Connecticut Health Center, Farmington
M. LaMar, College of William and Mary, Williamsburg, Virginia
E. Ramirez Hoyos, University of Connecticut Health Center, Farmington
D. Siegal-Gaskins, Ohio State University, Columbus
Computational cell biology is the field of study that applies the mathematics of dynamical systems
together with computer simulation techniques to the study of cellular processes. The field encom-
passes several topics that have been studied long enough to be well established in their own right,
such as calcium signaling, molecular motors and cell motility, the cell cycle, and gene expression dur-
ing development. In addition to providing a recognizable larger community for topics such as these,
this course provided a base for the development of newer areas of inquiry, for example, the dynamics
of intracellular second-messenger signaling, of programmed cell death, of mitotic chromosome move-
ments, and of synthetic gene networks. Unlike computational genomics or bioinformatics, compu-
tational cell biology focused on simulation of the molecular machinery (genes–proteins–metabolites)
that underlie the physiological behavior (input-output characteristics) of living cells.
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This 3-week course incorporated a series of didactic lectures on the mathematics of dynamical
systems, computational simulation techniques, cell biology, and molecular biology. Practicing the-
oreticians and experimentalists rotated for 1- to 3-day visits during the course to give lectures and
interact with the students. Midway through the course, students selected an area for independent
study, and the focus of the last week of the course largely on these projects, supplemented by con-
tinued visiting lecturers.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Computation Cell Biology      325
Alsing, A., M.S., Center for Models of Life, Denmark,
Copenhagen
Ay, A., Ph.D., Michigan State University, E. Lansing
Berthoumiel, S., M.Sc., INRIA, Montbonnot, France
Brody, Y., M.Sc., Bar-lian University, Ramat-Gan, Israel
Chettaoui, C., B.A., INRIA and INRA, Paris, France
Clowney, E., B.S., University of California, San Francisco
de Luis B., M.B.A., North Carolina State University, 
Raleigh
Diedrichs, D., M.S., University of Iowa, Iowa City
Ebisuya, M., Ph.D., Kyoto University, Japan 
Gresham, D., Ph.D., New York University, New York
Hoang-Trong, T., B.E., George Mason University, 
Manassas, Virginia
Jose, D., M.Sc., Max Delbruck Center for Molecular
Medicine, Berlin, Germany
Kamenz, J., Dipl., Friedrich Miescher Laboratory, Tubingen,
Germany
Keifenheim, D., B.S., University of Massachusetts Medical
School, Worcester
Korencic, A., M.A., University of Ljubljana, Slovenia
Long, B., Ph.D., Rice University, Houston, Texas 
Marriott, H., Ph.D., University of Sheffield, United Kingdom 
Pearce, S., B.S., Purdue University, W. Lafayette, Indiana
Tsui, R., B.A., University of California San Diego
SEMINARS
Blackwell, A., George Mason University Krasnow Institute,
Fairfax, Virginia: Signaling pathway in synaptic plasticity
and learning. Modeling the role of temporal pattern and
spatial localization in synaptic plasticity.
Civelekoglu, S.G., University of California, Davis:
Microtubule-based motility in the mitotic spindle and the
cilium.
Cytrynbaum, E., University of British Columbia, Vancouver,
Canada: Stochastic modeling of polymer dynamics.
Stochastic modeling with Matlab.
Hasty, J., University of California, San Diego: Gene 
networks.
Haugh, J., North Carolina State University, Raleigh: Signaling
RTKS.
Hucka, M., California Institute of Technology, Pasadena:
SBML + model databases and translation.
Iyengar, R., Mt. Sinai School of Medicine, New York:
Signaling models.
Keener, J., University of Utah, Salt Lake City: Models of
cardiac physiology. Cardiac exercises.
Loew, L., University of Connecticut Health Center,
Farmington: Virtual cell and ODEs. Virtual cell and ODEs
excerises. Virtual cell and spatial modeling. Virtual cell and
spatial/stochastic exercises. Dendritic nucleation.
Ma’ayan, A., Mount Sinai School of Medicine, New York:
Network analysis algorithms and datasets.
Mendes, P., University of Manchester, United Kingdom:
Copasi and parameter estimation.
Mogilner, A., University of California, Davis: Microtubule
dynamics and centering.
Phair, R., Integrative Bioinformatics, Los Altos, California:
Cell biology, metabolism, and tracers.
Sachs, K., Stanford University, California: Bayesian analysis of
reaction networks.
Samant, A., Mathworks, Natick, Massachusetts: Network
(ode) modeling with SimBiology. Matlab tutorial.
Sherman, A., NIH/National Institute of Diabetes, Digestive,
and Kidney Diseases, Bethesda, Maryland: Whole-cell
models. Cellular biophysics and ODEs. Reaction-diffusion
and advection. Markov chain models in cell biology. Waves.
Terman, D., Ohio State University, Columbus: Dynamical
systems. Introduction to XPP/setup and exercises.
Dynamical systems and XPP.
Tyson, J., Virginia Tech, Blacksburg: How do cells compute
network motifs and functional modules. Temporal
organization of the cell cycle. Design principles of
biochemical oscillators. XXP exercises. History of
computational cell biology XPP exercises.
You, L., Duke University, Durham, North Carolina: Cell
cycle. Modeling and engineering bacterial population
dynamics by cell–cell communication.
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Molecular Techniques in Plant Science
July 2–22
INSTRUCTORS S. Harmer, University of California, Davis
R. Last, Michigan State University, E. Lansing
J. Maloof, University of California, Davis
ASSISTANTS C. Ellison, University of California, Davis
M. Gaurav, Michigan State University, E. Lansing
A. Schilmiller, Michigan State University, E. Lansing
A. Schrager, University of California, Davis
This course provided an intensive overview of topics in plant physiology, biochemistry, and devel-
opment, focusing on molecular genetic and analytical approaches to understanding plant biology.
It emphasized recent results from Arabidopsis, maize, and a variety of other plants and provided an
introduction to current methods used in plant molecular biology. It is designed for scientists with
some experience in molecular techniques or in plant biology who wish to work with plants using
the latest technologies in genetics, molecular biology, and biochemistry. The course consisted of a
vigorous lecture series, a hands-on laboratory, and informal discussions. Discussions of important
topics in plant research were presented by the instructors and by invited speakers. Seminars included
plant morphology and anatomy; plant development (such as development of flowers, leaves, male
and female gametophytes, and roots); perception of light and photomorphogenesis; cell-wall biosyn-
thesis, function, and perception of hormones; and application of research results to addressing cur-
rent agronomic problems. Lectures describing bioinformatics tools available to the plant community,
and the resources provided by plant genome projects were also included. Speakers provided
overviews of their fields, followed by in-depth discussions of their own work. The laboratory sessions
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provided an introduction to important techniques currently used in plant research. These included
studies of plant development, mutant analysis, histochemical staining, transient gene expression,
gene silencing, applications of fluorescent protein fusions, protein interaction and detection, pro-
teomics approaches, several different approaches for quantifying metabolites, transient transforma-
tion, and techniques commonly used in genetic and physical mapping. The course also included
several short workshops on important themes in plant research.
This course was supported with funds provided by the National Science Foundation.
PARTICIPANTS
Molecular Techniques in Plant Science      327
Arias-Garzon, T., B.S., University of Missouri, Columbia
Casas, M., B.S., The Ohio State University, Columbus
Kosma, D., Ph.D., Michigan State University, E. Lansing
Lindh, I., M.Sc., Orebro University, Sweden 
Liu, B., M.S., Norwegian University of Science and
Technology, Trondheim, Norway
Markelz, R.J.C., B.Sc., Institute of Genomic Biology, Urbana,
Illinois 
McCarthy Suarez, I., Ph.D., IBMCP-CSIC, Valencia, Spain 
Muller, K., Ph.D., Simon Fraser University, Burnaby BC,
Canada 
Sasidharan, R., Ph.D., Utrecht University, The Netherlands
Sattely, E., Ph.D., Harvard Medical School, Boston,
Massachussetts 
Schopper, S., M.Sc., Lund University, Sweden
Stephan, A., B.S., The Johns Hopkins University, Baltimore,
Maryland
Wilkins, O., B.Sc., Dartmouth College, Hanover, New
Hampshire
SEMINARS
Bailey-Serres, J., University of California, Riverside: Plant
stress responses.
Birchler, J., University of Missouri, Columbia: Maize genetics.
Birnbaum, K., New York University, New York: Root
development.
Bomblies, K., Harvard University, Boston, Massachusetts:
Genetics of speciation.
Bowman, J., Monash University, Melbourne, VIC, Australia:
Evolution of plant development.
Brutnell, T., Boyce Thompson Institute, Ithaca, New York:
Plastids. Short read sequencing.
Coruzzi, G., New York University, New York: Plant systems
biology.
Grossniklaus, U., University of Zurich, Switzerland:
Gametophyte development.
Harmer, S., University of California, Davis: Circadian
rhythms.
He, S.Y., Medical College of Wisconsin, Milwaukee:
Plant/pathogen interactions.
Jackson, D., Cold Spring Harbor Laboratory: Shoot meristem
development.
Jander, G., Boyce Thompson Institute, Ithaca, New York:
Quantitative genetics.
Juntawong, P., University of California, Riverside:
Quantitative PCR.
Kellogg, E.T., University of Missouri, St. Louis: Phylogenetics.
Kerk, N., Yale University, New Haven, Connecticut:
Introduction to plant biology.
Kuhlemeier, C., University of Bern, Switzerland: Phyllotaxy.
Kutchan, T., Donald Danforth Plant Science Center, St. Louis,
Missouri: Bioactive plant metabolites.
Last, R., Michigan State University, E. Lansing: Secondary
metabolites.
Maloof, J., University of California, Davis: Light regulation of
plant development.
Oldroyd, G., John Innes Centre, Norwich, United Kingdom:
Rhizobial interactions/calcium signaling.
Pauly, M., University of California, Berkeley: Cell walls and
biofuels.
Poethig, S., University of Pennsylvania, Philadelphia:
Vegetative development.
Roossnick, M., University of Colorado, Denver: Plant/virus
interactions.
Schaller, G.E., Dartmouth College, Hanover, New
Hampshire: Cytokinin signaling.
Shukla, V., Dow Agro Sciences LLC, Indianapolis, Indiana:
Modification of plant genome.
Spadling, E., University of Wisconsin, Madison: Photosensory
signal transduction.
Sussex, I., Yale University, New Haven, Connecticut:
Introduction to plant biology.
Timmermans, M., Cold Spring Harbor Laboratory:
microRNA regulation.
Vision, T., University of North Carolina, Durham: Genome
evolution/speciation.
Walling, L., University of California, Riverside: Plant/pest
interactions.
Zheng, N., University of Washington, Seattle: Regulated
protein degradation and plant.
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Neurobiology of Drosophila
July 2–22
INSTRUCTORS R. Allada, Northwestern University, Evanston, Illinois
H. Broihier, Case Western Reserve University, Cleveland, Ohio
D. Featherstone, University of Illinois, Chicago
ASSISTANTS T. Andlauer, FU Berlin, Germany
K. Chen, University of Illinois, Chicago
V. Kilman, Northwestern University, Evanston, Illinois
C. Miller, Case Western Reserve University, Cleveland, Ohio
I. Nechipurenko, Case Western Reserve University, Cleveland, Ohio
D. Owald, Charite Berlin, Germany
This laboratory/lecture course was intended for researchers at all levels from beginning graduate
students through established primary investigators who want to use Drosophila as an experimental
system for nervous system investigation. The 3-week course was divided into the study of develop-
ment, physiology/function, and behavior. Daily seminars introduced students to a variety of research
topics and developed those topics by including recent experimental contributions and outstanding
questions in the field. Guest lecturers brought original preparations for viewing and discussion and
direct laboratory exercises and experiments in their area of interest. The course provided students
with hands-on experience using a variety of experimental preparations that are used in the investi-
gation of current neurobiological questions. The lectures and laboratories focused on both the de-
velopment of the nervous system and its role in controlling larval and adult behaviors. In addition
to an exposure to the molecular genetic approaches available in Drosophila, students learned a variety
of techniques including embryo in situ hybridization, labeling of identified neurons, electrophysi-
ology (intracellular recording and patch clamping), optical imaging of neuronal activity, and the
analysis of larval and adult behavior. Collectively, the course provided a comprehensive and practical
introduction to modern experimental methods for studying the Drosophila nervous system.
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This course was supported with funds provided by the National Institute of Mental Health and
the Howard Hughes Medical Institute.
Neurobiology of Drosophila 329
PARTICIPANTS
Aw, S., Ph.D., Duke–NUS Graduate Medical School,
Singapore
Bahl, A., Dipl., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Duncan, K., Ph.D., EMBL, Heidelberg, Germany
Gruber, M., M.A., Johannes Gutenberg-University Mainz,
Germany 
Halstead, J., M.Sc., Oxford University, United Kingdom
Keller, P., Dipl., HHMI/Janelia Farm Research Campus,
Ashburn, Virginia
Lee, L., B.S., Florida Atlantic University, Boca Raton
Ramdya, P., Ph.D., UNIL/EPFL, Lausanne, Switzerland
Robertson, D., Sc.B., University of California, San Francisco
Schweizer Burguete, A., Ph.D., University of Pennsylvania,
Philadelphia
Tschida, K., B.A., Duke University, Durham, North Carolina
Vanlandingham, P., Ph.D., University of Oklahoma, Norman
SEMINARS
Allada, R., Northwestern University, Evanston, Illinois:
Circadian rhythms and sleep.
Benton, R., University of Lausanne, Switzerland: Olfactory
signal processing and physiology/imaging of the olfactory
system.
Broihier, H., Case Western University, Cleveland, Ohio: Axon
Pathfinding. Genetic screens.
Dubnau, J., Cold Spring Harbor Laboratory: Learning and
memory.
Ejima, A., Kyoto University, Japan: Courtship.
Featherstone, D., University of Illinois, Chicago: Information
transfer in the nervous system and introduction to
electrophysiology.
Fouquet, W. and Andlauer, T.F., Freie Universitat Berlin,
Germany: Synpatic ultrastructure and live imaging of
fluorescently-tagged synaptic proteins.
Freeman, M., University of Massachusetts, Worcester: Glia.
Bioinformatics/web tools.
Goodwin, S., Glasgow University, United Kingdom; Jefferis,
G., University of Cambridge, United Kingdom: Mosaic
techniques. Adult brain anatomy.
Lee, C., NIH/National Institute of Child Health and Human
Development, Bethesda, Maryland: Visual system
development.
Levitan, E., University of Pittsburgh, Pennsylvania: Imaging,
peptide release/dense core vesicle trafficking.
Luo, L., Stanford University, California: Combined lecture
with advanced techniques in molecular neurobiology course.
O’Connor-Giles, K., University of Wisconsin, Madison: NMJ
structure and development.
Rothenfluh, A., University of Texas Southwestern, Dallas:
Ethanol/drugs.
Shen, P., University of Georgia, Athens: Larval feeding
behavior.
Skeath, J., Washington University School of Medicine, St.
Louis, Missouri: Neural stem cells.
Turner, G., Cold Spring Harbor Laboratory: CNS physiology
and imaging.
Verstreken, P., K.U. Leuven, Belgium: Vesicle cycling and
neurotransmitter release.
Waddell, S., University of Massachusetts, Worcester: Learning
and memory.
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Genetics of Complex Human Diseases
July 6–12
INSTRUCTORS A. Al-Chalabi, Kings College London, United Kingdom
L. Almasy, Southwest Foundation for Biomedical Research, San Antonio,
Complex diseases are conditions that are influenced by the actions of multiple genes, their interac-
tions with each other and with the environment. This lecture course considered the difficulties in
studying the genetic basis of complex disorders such as diabetes, cardiovascular disease, cancer,
Alzheimer’s disease, schizophrenia, and epilepsy. We discussed genetic–epidemiologic study designs,
including family and case/control studies, as well as methods for quantifying the strength of the ge-
netic influences on a disease. A major focus was the identification of specific gene effects using both
linkage and association analysis and their variants. We discussed the efficiency and robustness of
different designs for such analysis and how evidence from epidemiologic studies informs both the
design and interpretation of molecular genetic studies. Study design and methods for analysis of
quantitative risk factors related to complex diseases was covered as well as copy-number variation,
haplotype mapping, SNP tagging, meta-analysis, and gene–environment interaction. An overview
of next-generation sequencing was given to provide participants with insight into the applications
of these techniques. Illustrations were provided through discussion of results from ongoing studies
of a variety of complex diseases and related risk factors.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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Genetics of Complex Human Diseases      331
SEMINARS
Al-Chalabi, A., King’s College London, United Kingdom:
GWAS and principles of association.
Almasy, A., Southwest Foundation for Biomedical Research,
San Antonio, Texas: Introduction to linkage and quantitative
traits.
Borecki, I., Washington University School of Medicine, St.
Louis, Missouri: Genetic epidemiology.
de Bakker, P., Brigham & Women’s Hospital, Harvard
Medical School, Boston, Massachusetts: GWAS–Meta-
analysis.
Loos, R., Cambridge University, United Kingdom: GxE
interaction.
Neale, B., Massachusetts General Hospital, Boston: SNP
imputation.
Purcell, S., Massachusetts General Hospital, Boston: Analysis
of GWAS.
Rampersaud, E., University of Miami, Florida: Family-based
association.
Sham, P.-C., University of Hong Kong, China: Power
considerations.
Sinsheimer, J., David Geffen School of Medicine, Los Angeles,
California: Statistics 101.
Tobin, M., University of Leicester, United Kingdom: Copy-
number variation.
Trembath, R., King’s College London, United Kingdom:
Next-generation sequencing
PARTICIPANTS
Brisbin, A., B.S., Cornell University, Ithaca, New York
Byrne, S., Ph.D., Trinity College, Dublin, Dundalk, Ireland
Cropp, C., Ph.D., National Human Genome Research
Institute/NIH, Baltimore, Maryland
Demacq, C., Ph.D., State University of Campinas
(UNICAMP), Campinas, Brazil
Dunn, E., B.S., Harvard School of Public Health, Norwood,
Massachusetts
Hall, D., Ph.D., Rush University, Chicago, Illinois
Jiang, Y., B.S., Emory University, Atlanta, Georgia
Kepp, K., B.S., Estonian Biocentre and University of Tartu,
Estonia
Li, R., Ph.D., National Institutes of Health, Rockville,
Maryland
Losh, M., Ph.D., University of North Carolina, Chapel Hill
Manjarrez Orduño, N., Ph.D., The Feinstein Institute,
Manhasset, New York
McLaughlin, R., B.S., Trinity College, Dublin, Ireland
Melton, P., Ph.D., Southwest Foundation for Biomedical
Research, San Antonio, Texas
Moghraby, J., Ph.D., Kind Saud bin Abdul Aziz University-
Health Science, Riyadh, Saudi Arabia
Nielsen, K., B.S., Technical University of Denmark, Lyngby
Polsky, D., Ph.D., New York University Langone Medical
Center, New York
Reynolds, R., Ph.D., University of Alabama, Birmingham
Shulman, J., Ph.D., Brigham & Women’s Hospital, Boston,
Massachusetts
Tiwari, A., Ph.D., Center for Addiction & Mental Health,
Toronto, Canada
Wang, Y., B.S., Center for Integrative Genetics; Aas, Norway
Zhang, J., Ph.D., The Zucker Hillside Hospital, Glen Oaks,
New York
Zlojutro, M., Ph.D., Southwest Foundation for Biomedical
Research, San Antonio, Texas
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Advanced Techniques in Molecular Neuroscience
July 6–22
INSTRUCTORS C. Lai, Indiana University, Bloomington
R. Lansford, California Institute of Technology, Pasadena
B. Stevens, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts
ASSISTANTS S. Gattu, Indiana University, Bloomington
D. Huss, California Institute of Technology, Pasadena
E. Lehrman, Harvard University/Children’s Hospital, Boston, Massachusetts
K. Podorski, University of British Columbia, Vancouver, Canada
E. Robinson, Indiana University, Bloomington
A. Rosen, Harvard Medical School, Boston, Massachusetts
This course was designed to provide neuroscientists at all levels with a conceptual and practical un-
derstanding of several of the advanced techniques in molecular neuroscience. The course was geared
toward students who were familiar with the basic techniques of molecular biology.
The course curriculum was divided into three sections: an extensive and up-to-date set of labo-
ratory exercises, daily lectures on theoretical and practical aspects of advanced molecular biological
and imaging techniques, and a series of evening lectures given by invited speakers which served to
showcase the ways in which these molecular techniques have been used to advance specific areas of
neurobiology. The laboratory exercises were designed to provide each student with a working fa-
miliarity with these advanced techniques using proven protocols and reagents. The experiments and
protocols were chosen to provide the course participants with sufficient hands-on expertise so that
they may return to their home laboratories and, with a modicum of practice and perseverance, suc-
cessfully implement the use of these advanced technologies.
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Each laboratory exercise was preceded by a lecture that covered the purpose of the experiment
and included an in-depth presentation of the concepts, background, and theory. The participants
were guided through a step-by-step analysis of the actual protocol, which were provided both in
hard copy and on the course website. The laboratory portion of each course included gene delivery
systems including mammalian cell transfection, single-cell electroporation, the selection and use of
animal viral vectors, as well as the introduction of DNAs using in vivo electroporation in Xenopus
tadpoles, quail embryos, and rodents; loss-of-function approaches to study gene function using
RNAi approaches; the use of optogenetics to probe neural circuits within animals; the design and
manipulation of bacterial artificial chromosome (BAC) transgenic vectors and their use in achieving
cell-type-specific expression in animals; comparison of quantitative PCR, RNA-Seq, and microarray
analyses to profile gene expression; methods to identify gene expression in single cells and in sub-
cellular regions of single cells; and techniques to isolate, propogate, and analyze desired neural and
glial populations. As many of these advanced techniques also included the use of more standard
procedures to first modify and then “move” DNA fragments from one vector to another, the labo-
ratory exercises also provided training in these methods, which were essential to the successful exe-
cution of the more sophisticated approaches. Finally, course participants were introduced to
bioinformatics and a wide range of Internet resources that are available to molecular neuroscientists. 
This course was supported with funds provided by the National Institute of Mental Health and
the Howard Hughes Medical Institute.
PARTICIPANTS
Advanced Techniques in Molecular Neuroscience      333
Bajic, D., Ph.D., Children’s Hospital, Boston, Massachusetts
Barrett, R., B.A., University of California, Irvine
Brouwers, N., Ph.D., VIB and University of Antwerp, Belgium
Hayden, M., M.A., Stanford University Hospital and Clinics,
California
He, H., Ph.D., The Scripps Research Institute, La Jolla,
California
Heng, M., B.S., Vollum Institute, OHSU, Portland, Oregon
Heraud, J., B.Sci., Medical University of Vienna, Austria
Kirby, E., B.S., University of California, Berkeley
Klaus, A., M.Sc., National Institutes of Health, Bethesda,
Maryland
Lotfipour, S., Ph.D., University of California, Los Angeles
Nogaroli, L., Ph.D., Federal University of Rio de Janeiro,
Brazil
Sink, K., Ph.D., Emory University, Atlanta, Georgia
Stephenson-Jor, M., B.Sc., Karolinska Institutet, Stockholm,
Sweden
Toledo, A., M.S., Universidad de la Republica, Monvevideo,
Uruguay
Wheeler, T., B.S., University of Rochester, New York
Zong, C., Ph.D., Harvard University, Cambridge,
Massachusetts
SEMINARS
Barres, B., Stanford University School of Medicine, California:
Neuron–glial interactions in the CNS.
Cline, H., The Scripps Research Institute, La Jolla, California:
Distinguished Alumni Lecture. Molecular dissection of
neural circuit development.
Darnell, R., The Rockefeller University, New York: Decoding
RNA maps in the brain.
Eberwine, J., University of Pennsylvania Medical School,
Philadelphia: Metastability of the henome: Impact on
neuronal phenotype and dendritic biology.
Lichtman, J., Harvard University, Cambridge, Massachusetts:
Connectomics.
Lipscombe, D., Brown University, Providence, Rhode Island:
Neuronal calcium channels: Spliced for optimal function.
Liquin, L., Stanford University, California: Mapping olfaction
in the fly and mouse brain.
Lledo, P.M., Pasteur Institute, Paris, France: Development of
neural stem cells in the adult circuits.
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Workshop on Biology of Social Cognition
July 14–20 
INSTRUCTORS J. Mitchell, Harvard University, Cambridge, Massachusetts
D. Skuse, University College London Institute of Child Heath, United Kingdom
ASSISTANT D. Tamir, Harvard University, Cambridge, Massachusetts
The past few years have seen remarkable advances in our knowledge of the genetic, molecular, and
neural factors that contribute to social behavior. At the same time, sophisticated analytical and the-
oretical approaches have helped to make sense of the data. This week-long workshop sought to pro-
vide a comprehensive overview of these topics. Although the emphasis was on social cognition in
humans, there were also study days dedicated to state-of-the-art presentations on comparative ap-
proaches and evolutionary models. Finally, all themes were related to the clinical consequences of
dysfunctional social cognition and the role of translational research. The course included introduc-
tory seminars on key themes, offered every morning. There were afternoons devoted largely to prac-
tical sessions that provided hands-on experiments in consultation with seminar leaders, rounded
off by after-supper keynote lectures by leading scientists that reflect cutting-edge and future views
related to our theme for that day. 
This workshop was supported with funds provided by Autism Speaks; the INCORE Consortium;
Nancy Lurie Marks Family Foundation; and the Simons Foundation.
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Workshop on Biology of Social Cognition      335
PARTICIPANTS
Albo, Z., B.S., Baylor College of Medicine, Houston, Texas
Bartholomeusz, C., Ph.D., The University of Melbourne,
Carton South, Australia
Chevallier, C., Ph.D., King’s College London, United
Kingdom
Contreras, J., B.S., Harvard University, Cambridge,
Massachusetts
Cook, J., B.S., University College London, United Kingdom
Costa, R., B.S., University of Lisbon, Portugal, Lisboa
Diehl, M., B.S., University of Rochester, New York
Hillebrandt, H., B.S., University College London, United
Kingdom
Koelkebeck, K., Ph.D., University of Muenster, Germany
Kret, M., B.S., Tilburg University, The Netherlands
Lee, V., B.S., McMaster University, Hamilton, Canada
Light, S., B.S., University of Wisconsin, Madison
Menyhart, O., B.S., Cornell University, Ithaca, New York
Moore, L., B.S., University of California, Los Angeles
Moore III, W., B.S., University of Oregon, Eugene
Muralidharan, A., B.S., Emory University, Atlanta, Georgia
Paxton, R., B.S., Emory University, Atlanta, Georgia
Simmons, J., Ph.D., National Institutes of Health, Bethesda,
Maryland
Stjepanovic, D., B.S., The University of Queensland, St.
Lucia, Australia
Theodoridis, A., B.S., University of California, Berkeley
Troiani, V., B.S., University of Pennsylvania School of
Medicine, Philadelphia
Zaki, J., B.S., Columbia University, New York
SEMINARS
Amodio, A., New York University, New York: Social cognition
and emotion. 
Blair, J., National Institute of Mental Health, Bethesda,
Maryland: Psychopathy.
Blakemore, S., University College of London, United
Kingdom: Development of social cognition.
Bourgeron, T., Pasteur Institute, Paris, France: Autism
genetics.
Cahill, L., University of California, Irvine: Sex differences in
emotional processing.
Couzin, I., University of Princeton, New Jersey: Evolution of
collective behavior.
Cushman, F., Harvard University, Cambridge, Massahusetts:
The moral faculty: Domain specificity, neural circuitry, and
universality.
Dean, M., Brown University, Providence, Rhode Island:
Introduction to neuroeconomics.
Giedd, J., National Institute of Mental Health, Bethesda,
Maryland: Neuroimaging of the developing brain.
Haxby, J., Dartmouth College, Hanover, New Hampshire:
Face processing.
Huhman, K., Georgia State University, Atlanta: Conditioned
defeat in hamsters.
Matsuzawa, T., Kyoto University, Aichi, Japan: Social
cognition in primates.
Mitchell, J., Harvard University, Cambridge, Massachusetts:
Investigating theory of mind.
Murray, R., King’s College London, United Kingdom: Social
cognition and major mental illness.
Ochsner, K., Columbia University, New York: Regulation of
emotion and social cognition.
Phelps, E., New York University, New York: Emotion and
cognition.
Schultz, B., Children’s Hospital of Philadelphia, Pennsylvania:
The neural basis of autism.
Shaw, P., National Institutes of Mental Health, Bethesda,
Maryland: Genes, brain, and behavior.
Skuse, D., University College London, United Kingdom: The
biology of social cognition in autistic disorders. X-linked
genes and social cognition.
Wieben, E., Mayo Clinic, Rochester, Minnesota: Introduction
to genomics.
Young, L., Emory University, Atlanta, Georgia: Neuropeptides
and social cognition: From pair-bonding voles to autism.
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Brain Tumors
July 22–28
INSTRUCTORS D. Gutmann,Washington University School of Medicine, St. Louis, Missouri
E. Holland, Memorial Sloan-Kettering Cancer Center, New York
S. Majumder, University of Texas M.D. Anderson Cancer Center, Houston
ASSISTANT S. Singh, University of Texas M.D. Anderson Cancer Center, Houston
This one-week discussion course provided a clinical overview of brain tumors and emphasized mo-
lecular mechanisms involved in the growth and development of brain tumors with special emphasis
on neural differentiation, signaling mechanisms, DNA replication, chromatin modulation, stem
cells, mouse models, genomics, imaging techniques, genetically modified mouse techniques, nano-
technology, mechanism-based therapeutic strategies, biobanks, and ethical concerns. Attendees were
able to interact with senior investigators on a one-to-one basis in an informal environment. 
This course was supported with generous funding provided by the American Brain Tumor As-
sociation.
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PARTICIPANTS
Annibali, D., Ph.D., CNR, Toronto, Canada
Aref, D., B.S., University of Toronto, Canada
Dziurzynski, K., Ph.D., University of Texas M.D. Anderson
Cancer Center, Houston
Gajadhar, A., B.S., Hospital for Sick Children, University of
Toronto, Canada
Jones, T., Ph.D., University of Tennessee, Memphis
Kohli, L., B.S., University of Alabama, Birmingham
Kristoffersen, K., B.S., Copenhagen National University
Hospital, Denmark
Lathia, J., Ph.D., Cleveland Clinic Foundation, Ohio
Li, S., Ph.D., University of California, Los Angeles
McDevitt, M., Ph.D., Memorial Sloan-Kettering Cancer
Center, New York
Moiyadi, A., Ph.D., Tata Memorial Center, Mumbai, India
Panosyan, E., Ph.D., University of California, Los Angeles
Paolella, B., B.S., Dartmouth College, Lebanon, New
Hampshire
Põlajeva, J., B.S., Uppsala University, Sweden
Pollard, S., Ph.D., University College London, United
Kingdom
Read, R., Ph.D., The Salk Institute for Biological Studies, La
Jolla, California
Rich, B., Ph.D., Dana Farber Cancer Institute, Boston,
Massachusetts
Sathyan, P., Ph.D., M.D. Anderson Cancer Research Center,
Houston, Texas
Song, Y., Ph.D., National Cancer Institute, Frederick,
Maryland
Vanner, R., B.S., University of Toronto, Canada
Wells, E., Ph.D., Children’s National Medical Center,
Washington, D.C.
Zinn, P., Ph.D., Dana Farber Cancer Institute/Harvard
University, Boston, Massachusetts
SEMINARS
Aldape, K., University of Texas M.D. Anderson Cancer
Center, Houston: Molecular subgroups of gliomas and
prognostic markers.
Becher, O., Memorial Sloan-Kettering Cancer Center, New
York: Clinical aspects of pediatric brain tumors.
Bondy, M., M.D. Cancer Center, Houston, Texas: Genetic
and molecular epidemiology of brain tumors.
Brennan, C., Memorial Sloan-Kettering Cancer Center, New
York: Molecular subclasses of glioma and accessing The
Cancer Genome Atlas.
Eberhart, C., Johns Hopkins University School of Medicine,
Baltimore, Maryland: The role of Notch signaling in brain
tumor initiation and growth.
Enikolopov, G., Cold Spring Harbor Laboratory: Quiescence
and division of neural stem cells.
Fuller, G., M.D. Anderson Cancer Center, Houston, Texas:
Clinical overview of brain tumors: Neuroradiology and
neuropathology.
Gilbertson, R., St. Jude’s Children’s Research Hospital,
Memphis, Tennessee: Developmental neurobiology oncology.
Gladson, C., Cleveland Clinic, Ohio: Angiogenesis in
malignant glioma tumors: Can we effectively target it?
Gutmann, D., Washington University School of Medicine, St.
Louis, Missouri: Using neurofibromatosis-1 to understand
pediatric brain tumors.
Holland, E., Memorial Sloan-Kettering Cancer Center, New
York: Modeling proneural/PDGF gliomas in mice.
James, C.D., University of California, San Francisco:
Transplantable orthotopic tumor models for therapeutic
testing.
Kornblum, H., University of California Molecular and
Medical Pharmacology, Los Angeles: Methods and rationales
in evaluating neural and brain tumor stem cells.
Lang, Jr., F., M.D. Anderson Cancer Center, Houston, Texas:
Clinical management of brain tumors: The surgical
perspective.
Majumder, S., University of Texas M.D. Anderson Cancer
Center, Houston: Cellular flexibility determines both normal
brain development and brain tumors.
Pelroy, R., National Cancer Institute, Bethesda, Maryland:
Funding opportunities at the National Institutes of Health.
Pieper, R., University of California, San Francisco: The
multiple roles of ubiquitination in the development and
treatment of brain cancer.
Reilly, K., National Cancer Institute, Bethesda, Maryland:
Using mouse models of brain cancer to understand genetic
susceptibility factors.
Rich, J., Cleveland Clinic, Ohio: Brain tumor stem cells.
Roussel, M., St. Jude’s Children’s Research Hospital,
Memphis, Tennessee: Critical signaling pathways in
cerebellum development and cancer.
Rowitch, D., University of California, San Francisco:
Generation of mouse models of pediatric brain cancer.
Snyder, E., Burnham Institute, La Jolla, California: Using our
growing knowledge of fundamental stem cell biology to
understand brain tumor development and behavior.
Stiles, C., Dana Farber Cancer Institute, Boston,
Massachusetts: Separated at birth? Transcription factors in
normal and malignant neural progenitors.
Wechsler-Reya, R., Duke University Medical Center, Durham,
North Carolina: What mouse models teach us about
medulloblastoma biology.
Yung, W.K.A., M.D. Anderson Cancer Center, Houston,
Texas: Molecular targeted therapy in malignant gliomas.
Brain Tumors      337
305-366_courses_Annual Report_2009 template  7/8/11  12:25 PM  Page 337
Proteomics
July 22–August 4
INSTRUCTORS T. Andacht, Centers for Disease Control and Prevention, Atlanta, Georgia
J. Bruce, University of Washington, Seattle
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
D. Pappin, Cold Spring Harbor Laboratory
ASSISTANTS K. Bayyareddy, University of Georgia, Athens
C. Browne, Vanderbilt University School of Medicine, Nashville, Tennessee
C. Fu, Cold Spring Harbor Laboratory
P. Kirby, University of Georgia, Athens
S. Peacock, Cold Spring Harbor Laboratory
C. Ruse, Cold Spring Harbor Laboratory
P. Samir, Vanderbilt University School of Medicine, Nashville, Tennessee
B. Weindorf, Cold Spring Harbor Laboratory
C. Weisbrod, University of Washington, Seattle
This intensive laboratory and lecture course focused on cutting-edge proteomics approaches and
technologies. In the protein-profiling portion of the course, students gained hands-on experience
in several quantitative proteome analysis methods, including two-dimensional gel electrophoresis
and isotopic labeling strategies. Students were trained to use DIGE (differential in-gel electrophore-
sis) for gel-based protein quantification. Differentially expressed proteins were determined using
advanced gel analysis software and identified using MALDI mass spectrometry. Students were taught
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differential and quantitative mass spectrometry approaches to profile and identify changes in pro-
teomes and were trained in high-sensitivity microcapillary liquid chromatography coupled with
nanospray-ESI and tandem mass spectrometry. Both single dimension and multidimensional mi-
crocapillary liquid chromatography separations coupled to mass spectrometry were taught. Students
gained hands-on experience purifying and identifying protein complexes and posttranslational mod-
ifications using the latest technologies. This course also included discussion and application of mul-
tiple reaction monitoring (MRM) methods for targeted proteomics. Students developed and applied
MRM transitions and chromatographic methods to quantify targeted proteins in complex proteome
samples, such as serum or whole-cell lysates. A strong emphasis was placed on data analysis through-
out the course. The overall aim of the course was to provide students with the fundamental knowl-
edge and hands-on experience necessary to be able to perform and analyze proteomics experiments
and to learn to identify new opportunities in applying proteomics approaches to their own research.
This course was supported with funds provided by the National Cancer Institute and the Howard
Hughes Medical Institute.
Proteomics      339
PARTICIPANTS
Bellail, A., Ph.D., Emory University, Atlanta, Georgia
Cilia, M., Ph.D., USDA-ARS, Ithaca, New York
Gruninger, J., M.Sc., University of British Columbia,
Vancouver, Canada
Igel, U., M.A., Royal Institute of Technology, Stockholm,
Sweden
Kigar, S., B.A., University of Wisconsin, Madison
Kimura, M., Ph.D., Gifu University School of Medicine,
Japan
Leal, M., B.A., Federal University of Sao Paulo, Brazil
Mande, K., Ph.D., King Abdullah University of Science and
Technology, Jeddah, Saudi Arabia
McDonald, Z., B.Sc., University of Cape Town, South Africa
Møldrup, M., M.S., University of Copenhagen, Denmark
Moore, R., Ph.D., National Institute of Allergy & Infectious
Disease, Hamilton, Montana
Richlen, M., Ph.D., Woods Hole Oceanographic Institution,
Massachusetts
Roedkaer, S., B.A., University of Southern Denmark, Odense
M, Denmark
Seizl, M., Ph.D., Ludwig-Maximilians-Universistät, Munich,
Germany
Zarr, M., B.A., Johns Hopkins School of Medicine, Baltimore,
Maryland
Zou, J., B.S., Xavier University of Louisiana, New Orleans
SEMINARS
Andacht, T., Centers for Disease Control and Prevention,
Atlanta, Georgia: Fundamentals and applications of two-
dimensional DIGE in proteomics.
Bruce, J., University of Washington, Seattle: Fundamentals of
mass spectrometry and proteomics.
Chait, B., The Rockefeller University, New York: Proteomic
analysis of protein machines.
Chaurand, P., University of Montreal, Canada: Imaging mass
spectrometry of cells and tissue.
Clauser, K., Broad Institute of MIT and Harvard, Cambridge,
Massachusetts: De novo interpretation of tandem mass
spectra.
Cristea, I., Princeton University, New Jersey: Proteomic probes
of the living interactome.
Dufresne, C., Thermo Fisher Scientific, West Palm Beach,
Florida: Mass spectrometry approaches to identify and
quantify PTMs.
Eng, J., University of Washington, Seattle: Analysis of tandem
MS data using the transproteomic pipeline.
Friedman, D., Vanderbilt University, Nashville, Tennessee:
Variation and experimental design in proteomic analyses.
Kelleher, N., Northwestern University, Evanston, Illinois: Top-
down mass spectrometry.
MacCoss, M.J., University of Washington, Seattle: Targeted
proteomics for quantitative analysis and biomarker
validation.
Magee, M., Arizona State University, Tempe: Functional
proteomics: Protein microarrays.
Pappin, D., Cold Spring Harbor Laboratory: Quantitative
proteomics and iTRAQ.
Wolf-Yadlin, A., Harvard University, Cambridge,
Massachusetts: Enhanced phosphoproteomics in mammalian
systems.
Zhang, B., Vanderbilt University School of Medicine,
Nashville, Tennessee: Functional and network analysis of
proteomics data.
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Eukaryotic Gene Expression
July 27–August 16
INSTRUCTORS J. Espinosa, HHMI/University of Colorado, Boulder
W.L. Kraus, Cornell University, Ithaca, New York
A. Shilatifard, Stowers Institute for Medical Research, Kansas City, Missouri
D. Taatjes, University of Colorado, Boulder
ASSISTANTS M. Galbraith, University of Colorado, Boulder
M. Knuesel, University of Colorado, Boulder 
M. Mohan, Stowers Institute for Medical Research, Kansas City, Missouri
D. Ruhl, Cornell University, Ithaca, New York
This course was designed for students, postdocs, and principal investigators who have recently ven-
tured into the exciting area of gene regulation. The course focused on state-of-the-art strategies and
techniques used in the field. Emphasis was placed on both in vitro and in vivo protein–DNA in-
teractions and on novel methodologies to study gene regulation. Students made nuclear extracts,
performed in vitro transcription reactions, and measured RNA levels using primer extension. Char-
acterizations of the DNA-binding properties of site-specific transcription factors was carried out
using electrophoretic mobility shift and DNase I footprinting assays. In addition, students learned
techniques for the assembly and analysis of chromatin in vitro. This included transcription assays,
chromatin footprinting, and chromatin remodeling assays. During the past few years, the gene reg-
ulation field has developed in vivo approaches to study gene regulation. Students were exposed to
the chromatin immunoprecipitation technique. They also used RNAi for specific knock-down ex-
periments in mammalian cells. In addition, determining cellular gene expression profiles has been
accelerated tremendously by DNA microarray technology. Students received hands-on training in
performing and interpreting results from DNA microarrays.
This course was supported with funds provided by the National Cancer Institute.
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Eukaryotic Gene Expression      341
PARTICIPANTS
Bistulfi, G., B.S., Roswell Park Cancer Institute, Buffalo, New
York
Camp, J., B.S., University of North Carolina, Chapel Hill
Chatterjee, D., M.Sc., Cold Spring Harbor Laboratory
Chen, S., Ph.D., University of California, San Francisco
de Oliveira, K., B.S., Max Delbrück Center, Berlin, Germany
Duncan, A., M.S., University of Texas, Houston
Gehani, S., M.S., Biotech Research and Innovation Centre,
Copenhagen N, Denmark
Hoeg, F., Dipl., Gene Center at the University of Munich,
Germany
Klein, A., Ph.D., University of Texas Southwestern Medical
Center, Dallas
Kostromitskaia, J., M.S., Centre for Molecular Biology and
Neuroscience, Oslo, Norway
Mazumdar, S., M.S., Tufts University, Boston, Massachusetts
Migliori, V., M.D., Institute of Molecular and Cellular
Biology, Singapore 
Nichol, J., Ph.D., McGill University, Montreal, Canada
Sharma, N., M.S., University of Aarhus, Denmark
Treutlein, B., M.S., Ludwig-Maximilians University, Munich,
Germany
Zhang, X., Ph.D., Cornell University, Ithaca, New York
SEMINARS
Adelman, K., National Institute of Environmental Health
Sciences/NIH, Research Triangle Park, North Carolina:
Pausing of RNA polymerase II disrupts DNA-encoded
nucleosome organization to enable precise gene regulation.
Almouzni, G., Institut Curie, Paris, France: Variation on the
theme of chromatin assembly.
Carey, M., University of California School of Medicine, Los
Angeles: Biochemical mechanisms of chromatin
transcription.
Conaway, J., Stowers Institute for Medical Research, Kansas
City, Missouri: Introduction to the general transcription
machinery.
Cramer, P., LMU University of Munich, Germany: Structure-
function studies of eukaryotic transcription.
Gill, G., Tufts University School of Medicine, Boston,
Massachusetts: Regulation of chromatin structure and
transcription by Sp3 and SUMO.
Kadonaga, J., University of California, San Diego, La Jolla:
Secrets of the RNA polymerase II core promoter.
Kingston, R., Massachusetts General Hospital/Harvard
Medical School, Boston: In vivo biochemistry: Interrogating
nucleosomes and nucleosome-modifying complexes on the
genome.
Kurdistani, S., University of California, Los Angeles: Role of a
linker histone in regulating expression of gene family
clusters.
Levine, M., University of California, Berkeley: Whole-genome
analysis of transcriptional precision in the Drosophila
embryo.
Lieb, J., University of North Carolina, Chapel Hill: Genome-
wide measurement of transcription-factor-binding dynamics
by competition ChIP.
Luger, K., HHMI/Colorado State University, Fort Collins:
The expected, the unexpected, and the just plain weird:
Insights from new experimental approaches to study
nucleosome structure.
Pugh, F., Pennsylvania State University, University Park:
Genome-wide interplay of the transcription machinery and
chromatin.
Spector, D., Cold Spring Harbor Laboratory: Intranuclear
dynamics.
Washburn, M., Stowers Institute for Medical Research,
Kansas City, Missouri: Driving biological discovery with
quantitative shotgun proteomics.
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Imaging Structure and Function in the Nervous System
July 27–August 16
INSTRUCTORS S. Thompson, University of Maryland School of Medicine, Baltimore
W. Tyler, Arizona State University, Tempe
J. Waters, Northwestern University, Chicago, Illinois
ASSISTANTS O. KoHo, University College London, United Kingdom
A. Nimmerjahn, Stanford University, California
S. Page, University of Maryland School of Medicine, Baltimore
A. Scimemi, National Institute of Neurological Disorders and Stroke/NIH, Bethesda, Maryland
Advances in light microscopy, digital image processing, and the development of a variety of powerful
fluorescent probes present expanding opportunities for investigating the nervous system, from synap-
tic spines to networks in the brain. This intensive laboratory and lecture course provided participants
with the theoretical and practical knowledge to utilize emerging imaging technologies. The primary
emphasis of the course was on vital light microscopy. Students learned the principles of light mi-
croscopy, as well as use of different types of electronic cameras, laser-scanning systems, functional
fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of
cell function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated (caged) com-
pounds, exocytosis tracers, and optogenetic activators. Issues arising in the combination of imaging
with electrophysiological methods were covered. Particular weight was given to multiphoton laser-
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scanning microscopy and to newly available biological fluorophores, especially green-fluorescent
protein (GFP) and its variants. We used a spectrum of neural and cell biological systems, including
living animals, brain slices, and cultured cells. 
This course was supported with funds provided by the National Institute of Mental Health and
the Howard Hughes Medical Institute.
Russo, M., B.A., Columbia University, New York
Shobe, J., Ph.D., University of California, Los Angeles
Shuai, Y., Ph.D., Cold Spring Harbor Laboratory
Tremblay, M.-E., Ph.D., University of Rochester Medical
Center, New York
van Ham, T., Ph.D., Massachusetts General Hospital/Harvard
Medical School, Boston
Xu, S. (Pei), B.S., Washington University, St. Louis, Missouri
SEMINARS
Albeanu, F., Cold Spring Harbor Laboratory: Synapto-
phlourins and synaptic vesicle imaging,
Bruchez, M., Carnegie Mellon University, Pittsburgh,
Pennsylvania: New and future indicators.
Deisseroth, K., Stanford University, California: Advanced
optogenetics/optical probing of brain circuits.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Extended 2P imaging and block-face
EM.
DiGregorio, D., Universite Paris 5, France: Flash photolysis.
Emilani, V., CNRS, INSERM, University Paris Descartes,
France: Holography.
Engert, F., Harvard University, Cambridge, Massachusetts:
Shot noise. 2P microscopy.
George, N., Olympus America, Inc., Center Valley,
Pennsylvania: Objectives. BX51 optics.
Gould, T., Yale University School of Medicine, New Haven,
Connecticut: STED and PALM.
Griesbeck, O., Max-Planck Institute of Neurobiology,
Martinsried, Bayern, Germany: XFPs and genetically
encoded sensors.
Hirsch, J., Columbia University, New York: fMRI.
Huebener, M., Max-Planck Institute of Neurobiology,
Martinsried, Germany: Intrinsic imaging.
Kilborn, K., Intelligent Imaging Innovations, Inc., Santa
Monica, California: Deconvolution.
Lanni, F., Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Basic microscopy.
Lee, J., University of California, Los Angeles: Advanced
optogenetics.
Litchman, J., Harvard University, Cambridge, Masschusetts:
Confocal microscopy.
Mrsic-Flogel, T., University College London, United
Kingdom: Organic calcium indicators bulk loading.
Prakriya, M., Northwestern University, Evanston, Illinois:
Foerster resonance energy transfer.
Racca, C., Newcastle University, Newcastle upon Tyne, United
Kingdom: Electron microscopy.
Simpson, J., MBF Bioscience, San Diego, California: MBF,
sterology, and structure analysis.
Stutzmann, G., Rosalind Franklin University, N. Chicago,
Illinois: Two-photon imaging in AD mouse models.
Tsai, P., University of California, San Diego, La Jolla: Optics
bench lab exercises–Basics Koehler. Optics bench lab
exercises–Scanning. Scanning and fluorescence. Optics
bench lab exercises–Scanning. Optics bench lab exercises–
Confocal. CCD cameras.
Tyler, J., Arizona State University, Tempe: Image J and Fiji;
Ultrasound neuromodulation.
Waters, J., Northwestern University, Chicago, Illinois: Organic
calcium indicators. Single-cell Ca imaging in vivo. CCD
cameras; Homebrew microscope including laser safety.
Wilbrecht, L., University of California, San Francisco: GFP
applications spine morphology.
Witkowski, J., Cold Spring Harbor Laboratory: Ethics.
Zhang, F., Harvard University, Cambridge, Massachusetts:
Light-triggered activation/silencing.
PARTICIPANTS
Clancy, K., B.S., University of Berkeley, California
Cohen, L., Ph.D., The Hebrew University of Jerusalem, Israel
Ford, C., Ph.D., Oregon Health & Science University,
Portland
Gu, Y.I., B.S., Johns Hopkins University, Baltimore, Maryland
Kreile, A., M.S., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Nadif, K.N., Ph.D., CSHL/DCN, Radboud University, Cold
Spring Harbor
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Yeast Genetics and Genomics
July 27–August 16
INSTRUCTORS D. Burke, University of Virginia, Charlottesville
B. Errede, University of North Carolina, Chapel Hill
J. Smith, University of Virginia, Charlottesville
ASSISTANTS K. Gardner, University of North Carolina, Chapel Hill
J. McClure, University of Virginia, Charlottesville
M. Wells, University of Virginia, Charlottesville
This is a modern, state-of-the-art laboratory course designed to teach the students the full repertoire
of genetic approaches needed to dissect complex problems in the yeast Saccharomyces cerevisiae.
Combinations of classical genetic approaches are emphasized, including the isolation and charac-
terization of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular ge-
netic techniques, including various types of yeast transformation, gene replacement with plasmids
and PCR, construction and analysis of gene fusions, and generation of mutations in cloned genes,
were also emphasized. Students used classical and molecular approaches to gain experience in iden-
tifying and interpreting various kinds of genetic interactions including suppression and synthetic
lethality. Students were immersed in yeast genomics and performed and interpreted experiments
with DNA arrays. Students gained first-hand experience in modern cytological approaches such as
epitope tagging and imaging yeast cells using indirect immunofluorescence, GFP–protein fusions,
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SEMINARS
Bekiranov, S., University of Virginia, Charlottesville:
Analyzing Tag4 arrays.
Hinnebusch, A., National Institutes of Health, Bethesda,
Maryland: Nitogren regulation of gene expression.
Hollingsworth, N., State University of New York, Stony
Brook: Phosphorylation and the regulation of meiotic
recombination.
Kaeberlin, M., University of Washington, Seattle: Genetics of
aging.
Levin, D., Boston University, Massachusetts: Stress-induced
transcriptional regulation through a novel MAPK-driven
mechanism.
Lew, D., Duke University, Durham, North Carolina: Cell
polanity in yeast.
Yeast Genetics and Genomics      345
and a variety of fluorescent indicators for various subcellular organelles. Lectures on fundamental
aspects of yeast genetics were presented along with seminars given by outside speakers on topics of
current interest.
This course was supported with funds provided by the National Human Genome Research In-
stitute and the Howard Hughes Medical Institute.
PARTICIPANTS
Abeydeera, N.D., Ph.D., Texas A&M University, College
Station
Bohnert, M., Ph.D., University of Freiburg, Germany 
Bosman, J., Ph.D., University of Groningen, Haren, The
Netherlands
Bussemaker, H., Ph.D., Columbia University, New York
Chakravarty, A., M.Sc., Memorial Sloan-Kettering Cancer
Center, New York
Chang, M., Ph.D., Nanyang Technological University,
Singapore
De Haro, L., Ph.D., University of New Mexico, Albuquerque
Elfick, A., Ph.D., University of Edinburgh, United Kingdom
Goltermann, L., M.Sc., Copenhagen University, Denmark
Hofree, M., B.Sc., University of California, San Diego, La
Jolla 
Houser, J., B.S., University of North Carolina, Chapel Hill
Kogej, T., Ph.D., University of Ljubljana, Slovenia
Rosby, R., Ph.D., Brown University, Providence, Rhode Island
Srivas, R., Ph.D., University of California, San Diego, La Jolla
Stein, V., MS, University of Queensland, Brisbane, Australia
Waisberg, M., Ph.D., National Institutes of Health, Rockville,
Maryland
Ramanathan, S., Harvard University, Cambridge,
Massachusetts: Using Bayesian statistics to uncover
information about proteins and networks.
Rusche, L., Duke University, Durham, North Carolina:
Evolution of transcription silencing.
Strathern, J., National Cancer Institute, Frederick, Maryland:
Detection of transcription errors.
Thorner, J., University of California, Berkeley: A signaling
pathway for maintenance of plasma membrane lipid
homeostasis.
Troyanskaya, O., Princeton University, New Jersey: Integrating
large-scale data.
Whiteway, M., National Research Council of Canada,
Montreal, Quebec: Transcriptional rewiring in fungi.
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Stem Cells
July 30–August 8
INSTRUCTORS R. McKay, National Institutes of Health, Bethesda, Maryland
M. Shen, Columbia University Medical Center, New York
ASSISTANT J. Chenoweth, National Institute of Neurological Disorders and Stroke/NIH, 
Bethesda, Maryland
Stem cells construct organs and tissues in development. They sustain tissues in the adult and restore
them after injury. Because of these properties, isolating and manipulating stem cells has become a
major new element in biomedical science. This workshop course covered a series of biological sub-
jects relating to stem cells and regenerative medicine. Topics included embryology and development,
reprogramming, degenerative disease, cancer stem cells, and human genetics. 
This 10-day-long discussion course brought together leading researchers in the stem cell field
with a small group of international students. The purpose of the workshop was to provide partici-
pants with an opportunity to achieve an advanced understanding of the scientific and clinical im-
portance of stem cells. A major aim of the workshop was to discuss, in considerable detail, the
relationship between stem cells and disease. The significance of this relationship with respect to de-
veloping new approaches to treating and understanding human disease was explored.
This course was supported with funds provided by the Howard Hughes Medical Institute.
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Rich, J., Cleveland Institute, Ohio: The evolving under-
standing of cancer stem cells.
Robertson, E., University of Oxford, United Kingdom: Cell
lineage specification and patterning in the pre- and early
postimplantation embryo.
Shen, M., Columbia University Medical Center, New York:
Prostate development, stem cells, and cancer.
Studer, L., Memorial Sloan-Kettering Cancer Center, New
York: Modeling neural development and disease in human
pluripotent stem cells.
Tesar, P., Case Western University, Cleveland, Ohio: Derivation
and utilization of distinct pluripotent stem cell states.
Tlsty, T., University of California School of Medicine, San
Francisco: Mechanisms of epigenetic plasticity in stem cells
and cancer.
Xiao, A., Yale School of Medicine, New Haven, Connecticut:
Investigating chromatin structure in early embryonic
development.
Stem Cells      347
PARTICIPANTS
Baridi, A., B.S., Cambridge Research Institute, United
Kingdom
Beagle, B., B.S., University of Rochester Medical School, New
York
Bolanos, D., Ph.D., Universidad de los Andes, Bogota,
Colombia
Elewa, A., B.S., University of Massachusetts Medical School,
Worcester
Feinberg, A., Ph.D., Carnegie Mellon University, Pittsburgh,
Pennsylvania
Feng, Y., B.S., Center for Molecular and Vascular Biology,
Leuven, Belgium
Jaishankar, A., B.S., National Institutes of Health, Bethesda,
Maryland
Lorenzo, L., B.S., University of Maryland, Baltimore
Marrus, S., Ph.D., Washington University School of
Medicine, St. Louis, Missouri
Micali, N., Ph.D., National Institute of Neurological
Disorders and Stroke/NIH, Bethesda, Maryland
Schneider, J., Ph.D., Vanderbilt University Medical Center,
Nashville, Tennessee
Talchai, C., B.S., Columbia University, New York
Tang, T., Ph.D., National Institute of Mental Health/NIH,
Bethesda, Maryland
Tsang, S.N., Ph.D., Columbia University, New York
Turco, M., B.S., European Institute of Oncology (IFOM-IEO
Campus), Milano, Italy
Vicente-Dueñas, C., Ph.D., Instituto de Biología Molecular y
Celular del Cáncer, Salamanca, Spain
Yeung, M., B.S., Karolinska Institutet, Stockholm, Sweden
SEMINARS
Hadjantonakis, K., Memorial Sloan-Kettering Cancer Center,
New York: Live imaging cell dynamics in the early mouse
embryo.
Hochedlinger, K., Massachusetts General Hospital, Boston:
Equivalency of ESCs and iPSCs?
Johnston, L., Columbia University, New York: Social
interactions among growing cells: Promoting tissue fitness.
Lee, J., Massachusetts General Hospital, Boston: The X as a
model to study stem cell biology and reprogramming.
Lemischka, I., Mt. Sinai School of Medicine, New York:
Pursuing pluripotency from a systems biology perspective.
McKay, R., National Institutes of Health, Bethesda, Maryland:
Stem cells in development and disease.
Ohlstein, B., Columbia University Medical Center, New York:
Investigating the role of stem cells in tissue homeostasis and
organogenesis.
Reddien, P., Whitehead Institute, Cambridge, Massachusetts:
Planarians as a model for the study of stem cells and
regeneration.
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Caenorhabditis elegans
October 11–26
INSTRUCTORS B. Conradt, Dartmouth Medical School, Hanover, New Hampshire
E. Lambie, Dartmouth College, Hanover, New Hampshire
E. Miska, University of Cambridge, United Kingdom
M. Zhen, Samuel Lunenfeld Research Institute, Toronto, Canada
ASSISTANTS L. Barbier, Samuel Lunenfeld Research Institute, Toronto, Canada
M. Po, University of Toronto, Canada
S. Rolland, Dartmouth Medical School, Hanover, New Hampshire
A. Sapetschnig, University of Cambridge, United Kingdom
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome project.
The course was suited both for those who have a current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, as well as students with some prior
worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm pushing, C. elegans data-
bases and worm bioinformatics, anatomy and development, forward genetics, chemical and
transposon mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics,
construction and screening of deletion libraries, and RNA inactivation. The course was designed to
impart sufficient training to students in the most important attributes of the C. elegans system to en-
able students to embark on their own research projects after returning to their home institutions.
This course was supported with funds provided by the National Institute of Child Health and
Human Development.
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PARTICIPANTS
Baas, S., B.S., Vanderbilt University Medical Center,
Nashville, Tennessee 
Beets, I., M.S., K.U. Leuven, Belgium
Buzzi, L., B.Sc., Fundacion Instituto Leloir, Buenos Aires,
Argentina
Cottee, P., Ph.D., The University of Alabama, Birmingham
Farhadifar, R., Ph.D., Harvard University, Cambridge,
Massachusetts
Hermand, D., Ph.D., FUNDP, Namur, Belgium
Joyce, A., B.S., Washington University School of Medicine, St.
Louis, Missouri
Kemeny, S., Ph.D., Columbia University, New York
Lim, M., B.A., University of Pennsylvania/CHOP,
Philadelphia
Caenorhabditis elegans 349
Liu, Z., B.S., Chinese Academy of Science, Beijing, China
Marquis, B., M.S., National Institute of Standards &
Technology, Gaithersburg, Maryland
Mi-Mi, L., B.S., State University of New York Upstate
Medical University, Syracuse
Rayes, D., Ph.D., Instituto de Investigaciones Bioquimicas
(NIBIBB), Bahia Blanca, Argentina 
Roux, A., Ph.D., University of California, San Francisco
Tran, P., Ph.D., University of Pennyslvania, Philadelphia
van Zon, J., Ph.D., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Ausubel, F., Massachusetts General Hospital, Boston: The C.
elegans immune defense response.
Besseréau, J.-L., Ecole Normale Superieure-INSERM, Paris,
France: Deconstructing the C. elegans neuromuscular
junction (with the help of transposons).
Fraser, A., The Wellcome Trust Sanger Institute, Hinxton,
United Kingdom: RNAi screening in C. elegans.
Goodman, M., Stanford University, California: Using C.
elegans to deconstruct touch sensation.
Hall, D., Albert Einstein College of Medicine, Bronx, New
York: Introduction on C. elegans anatomy. Modern EM
methods for nematode.
Hobert, O., Columbia University College of Physicians &
Surgeons, New York: Of worm neurons and machines.
Hunter, C., Harvard University, Cambridge, Massachusetts:
The discovery and genetic analysis of systemic RNAi.
Jin, Y., University of California, San Diego, La Jolla: C. elegans
axon regeneration.
Koelle, M., Yale University School of Medicine, New Haven,
Connecticut: Chloride transporters that regulate inhibitory
neurotransmission in C. elegans.
Kornfeld, K., Washington University School of Medicine, St.
Louis, Missouri: C. elegans as a model for aging research.
Roy, P., Mt. Sinai-Samuel Lunenfeld Research Institute,
Toronto, Canada: C. elegans as a platform for chemical
biology.
Schafer, W., University of California, San Diego, La Jolla
Schedl, T., Washington University School of Medicine, St.
Louis, Missouri: The germline stem cell versus meiotic
development decision in C. elegans.
Schnabel, R., Institut fuer Genetik, Brainschweig, Germany:
A practical approach to multi-channel 4D microscopy.
Phainothes and pattern formation by cell focusing in the C.
elegans embryo.
Sommer, R., Max-Planck Institute for Developmental Biology,
Tubingen, Germany: Vulva development. Vulva induction in
C. elegans and Pristiochus pacificus: A mechanistic
comparison.
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Programming for Biology
October 11–26
INSTRUCTORS S. Lewis, Lawrence Berkeley National Laboratory, Berkeley, California
S. Prochnik, DOE–Joint Genome Institute/University of California, Berkeley
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS J. Chia, Cold Spring Harbor Laboratory
E. Lee, Lawrence Berkeley National Laboratory, Berkeley, California
J. Leipzig, DuPont Experimental Station, Wilmington, Delaware
D. Messina, Stockholm University, Sweden
S. Robb, University of Utah, Salt Lake City
J. Thomason, Cold Spring Harbor Laboratory
K. Youens-Clark, Cold Spring Harbor Laboratory
A computer is an indispensable tool for biological research, but the mere use of web-based tools
alone is not enough for today’s biologist who needs to work with data from myriad sources in dis-
parate formats. This need will become ever more important as new technologies accelerate the ex-
ponential rate of acquiring new growth biological data. Designed for students and researchers with
little or no prior programming experience, this 2-week course gave biologists the bioinformatics
skills necessary to exploit this abundance of biological data. 
The course is based around the Perl scripting language, because of its ease of learning and its in-
credible wealth of ready-built code modules (e.g., bioperl) designed to solve common biological
problems. Starting with introductory coding, and continuing with a survey of available biological
libraries and practical topics in bioinformatics, students end by learning how to construct and run
powerful and extensible analysis pipelines in a straightforward manner. The course combines formal
lectures with hands-on sessions in which students work to solve problem sets covering common
350
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scenarios in the acquisition, validation, integration, analysis, and visualization of biological data.
For their final projects, which run during the second week of the course, students posed problems
using their own data and worked with each other and the faculty to solve them. 
This course was supported with funds provided by the National Human Genome Research In-
stitute.
PARTICIPANTS
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Abu-Ali, G., Ph.D., U.S. Food & Drug Administration,
Laurel, Maryland
Akhtar-Zaidi, B., B.A., Case Western Reserve University,
Cleveland, Ohio
Ameres, S., Ph.D., University of Massachusetts Medical
School, Worcester
Cristancho, M., B.Sc., National Center for Coffee Research,
Chinchina, Columbia
David, D., Ph.D., University of California, San Francisco
Delgado Vega, A.M., M.D., Uppsala University, Sweden
Frank, M., B.A., Cornell University, Ithaca, New York
Hakhverdyan, Z., B.A., The Rockefeller University, New York
Hall, A., Ph.D., University of Liverpool, United Kingdom
Lopatina, A., B.S., Russian Academy of Sciences, Moscow,
Russia
Lowe, I., M.S., University of California, Davis
SEMINARS
Begovic, E., University of California, Berkeley: Molecular
evolution I. Molecular evolution II.
Cain, S., Ontario Institute for Cancer Research, Medina,
Ohio: Gbrowse.
Deschamps, S., Pioneer Hi-Bred International,Wilmington,
Delaware: Deep sequencing I.
Hide, W., Harvard University, Boston, Massachusetts: Gene
expression.
Leipzig, J., DuPont, Wilmington, Delaware: HTML. Deep
sequencing II. Deep sequencing and assembly. Introduction
to R.
Lewis, S., Lawrence Berkeley National Laboratory, California:
Gene ontologies.
McCombie, W., Cold Spring Harbor Laboratory: Genetic
variation and deep sequencing. DBI. 
McKay, S., University of Arizona, Tucson: Database design
and SQL. DBI. CGI.
Lowry, D., Ph.D., University of Texas, Austin
Ni, Z., Ph.D., Cornell University, Ithaca, New York
O’Donnell, A., Ph.D., Columbia University, New York
Onishi-Seebach, M., Ph.D., European Molecular Biology
Laboratory, Heidelberg, Germany
Polymenidou, M., Ph.D., University of California, San Diego
Robertson, L., Ph.D., U.S. Geological Survey, Kearneysville,
West Virginia 
Rohland, N., Ph.D., Harvard Medical School, Cambridge,
Massachusetts
Rynearson, S., B.S., Eccles Institute of Human Genetics, Salt
Lake City, Utah
Sandberg, J., M.Sc., Royal Institute of Technology, Stockholm,
Sweden
Schorn, A., Ph.D., Cold Spring Harbor Laboratory
Teng, G., Ph.D., Yale University, New Haven, Connecticut 
Messina, D., Stockholm Bioinformatics Centre, Sweden: Perl
VI, subroutines, and modules. Perl IV–References.
Pearson, W., University of Virginia, Charlottesville: BLAST
and sequence alignment. BLAST workshop.
Prochnik, S., DOE–Joint Genome Institute, Walnut Creek,
California: Perl VII (object-oriented programming). Perl
pipelines.
Robb, S., University of Utah, Salt Lake City: Bioperl I. Bioperl
II.
Thomas, P., SRI International, Menlo Park, California: Gene
expression.
Tisdall, J., DuPont Experimental Station, Wilmington,
Delaware: Perl I. Perl III (arrays, hashes). Scientific
computing. Perl V–Regular expressions.
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X-Ray Methods in Structural Biology
October 11–26
INSTRUCTORS W. Furey, V.A. Medical Center and University of Pittsburgh, Pennsylvania
G. Gilliland, Centocor, Inc., Radnor, Pennsylvania
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku Americas Corporation, The Woodlands, Texas
ASSISTANT G. Obmolova, Centocor, Inc., Radnor, Pennsylvania 
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through
other methods. This intensified laboratory/computational course focused on the major techniques
used to determine the three-dimensional structures of macromolecules. It was designed for scientists
with a working knowledge of protein structure and function, but who are new to macromolecular
crystallography. Topics covered included basic diffraction theory, crystallization (proteins, nucleic
acids, and complexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freez-
ing, data collection, data reduction, multiple isomorphous replacement, multiwavelength anomalous
diffraction, molecular replacement, solvent flattening, noncrystallographic symmetry averaging,
electron density interpretation, molecular graphics, structure refinement, structure validation, co-
ordinate deposition, and structure presentation. Participants learned through extensive hands-on
experiments. One or more proteins were crystallized and the structure(s) determined by several
methods, in parallel with lectures on theory and informal discussions behind the techniques. Ap-
plicants were familiar with the creation and editing of simple text files on Linux workstations using
a screen-based editor (either vi or emacs).
This course was supported with funds provided by the National Cancer Institute and the Howard
Hughes Medical Institute.
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PARTICIPANTS
Cheng, H.-C., B.S., University of California, San Francisco
Elmlund, D., M.S., Stanford University, Palo Alto, California
Engel, C., M.Sc., Ludwig-Maximilians–Universistät, Munich,
Germany
Fagan, C., B.S., Emory University, Atlanta, Georgia
Festin, G., B.S., University of California, Irvine
Gallagher, C., B.Sc., University of California/HHMI, San
Francisco
Hausmann, J., M.S., Netherlands Cancer Institute,
Amsterdam, The Netherlands
Koh, J., Ph.D., HHMI at The Rockefeller University, New
York
Lin, J., Ph.D., University of Nebraska, Lincoln 
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Mattle, D., M.Sc., Aarhus University, Denmark
Miller, A., B.A., Memorial Sloan-Kettering Cancer Center,
New York
Murray, L., Ph.D., Yale University, New Haven, Connecticut
Rothberg, B., Ph.D., Temple University School of Medicine,
Philadelphia, Pennsylvania 
Stevenson, H., B.S., University of Pittsburgh, Pennsylvania
Tumbale, P., Ph.D., National Institute of Environmental
Health Sciences/NIH, Research Triangle Park, North
Carolina
Wang, K., Ph.D., Oregon Health & Sciences University,
Portland
SEMINARS
Adams, P., Lawrence Berkeley Laboratory, California:
Introduction to PHENIX (and CNS). Structure refinement.
Cohen, A., Stanford Synchrotron Radiation Laboratory,
California: Remote synchrotron data collection.
Einspahr, H., IUCr Journals, Chester, United Kingdom: Acta
crystallographica F.
Emsley, P., University of York, United Kingdom: Model-
building tools in coot. 
Furey, W., V.A. Medical Center and University of Pittsburgh,
Pennsylvania: Anomalous data collection consideration.
Patterson group therapy. Isomorphous replacement and
anomalous scattering. Solvent flattening/phase combination,
Noncrystallographic symmetry averaging. MAD phasing: A
classical approach. Solving structures with BnP.
Furukawa, H., Cold Spring Harbor Laboratory: Structure and
function of NMDA receptors.
Gilliland, G., Centorcor Inc., Radnor, Pennsylvania: Course
overview: The structure determination of biological
macromolecules.
Joshua-Tor, L., Cold Spring Harbor Laboratory: DNA
translocation in a replicative hexameric helicase.
Kleywegt, G., EMBL-EBI, Cambridge, United Kingdom: 
Just because it’s in Nature, doesn’t mean it’s true…
(macromolecular structure validation).
McPherson, A., University of California, Irvine:
Crystallization of macromolecules I. Crystallization of
macromolecules II. Symmetry, periodicity, unit cells, space
groups, Miller planes, and lattices. Waves, vectors, and
complex numbers. Fundamental diffraction relationships
and Bragg’s law. Diffraction patterns, reciprocal space, and
Ewald’s sphere. Fourier transforms and the electron density
equation. Patterson methods. Crystal growth mechanisms.
Heavy atoms and anomalous scatterers.
Perrakis, A., Netherlands Cancer Institute, Amsterdam, The
Netherlands: Automated model building and refinement
with ARP/WARP.
Pflugrath, J., Rigaku Americas Corporation, The Woodlands,
Texas: Data collection: Design and setup. Cryocrystal-
lography. HKL2000 tutorial. Scaling and merging
synchrotron data. 
Read, R., University of Cambridge, United Kingdom: Using
SAD data in Phaser. Molecular replacement: New structures
from old.
Richardson, D., Duke University Medical Center, Durham,
North Carolina: Detection and repair of model errors using
MolProbity.
Richardson, J., Duke University Medical Center, Durham,
North Carolina: Structure presentation.
Schalch, T., Cold Spring Harbor Laboratory: Macromolecular
representation and animation using PyMOL/eMovie.
Sweet, R., Brookhaven National Laboratory, Upton, New
York: A slightly different view of fundamental crystal-
lography. X-ray sources and optics. Scaling and merging
synchrotron data.
Terwilliger, T., Los Alamos National Laboratory, New Mexico:
Automated structure solution and model building.
Tronrud, D., University of Oregon, Eugene: Macromolecular
refinement I. Macromolecular refinement II. Difference
electron density maps. CSI CSHL: Forensic crystallography.
Westbrook, J., Rutgers/The State University of New Jersey,
Piscataway: Automating PDB deposition.
Yeh, J., University of Pittsburgh, Pennsylvania: Approaches for
membrane protein crystallization.
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Advanced Sequencing Technologies and Applications
October 13–26
INSTRUCTORS E. Mardis,Washington University School of Medicine, St. Louis, Missouri
G. Marth, Boston College, Chestnut Hill, Massachusetts
W. McCombie, Cold Spring Harbor Laboratory
A. Quinlan, University of Virginia, Charlottesville
M. Zody, Broad Institute, Cambridge, Massachusetts
ASSISTANTS A. Farrell, Boston College, Chestnut Hill, Massachusetts
M. Kramer, Cold Spring Harbor Laboratory
V. Magrini,Washington University School of Medicine, St. Louis, Missouri
S. McGrath,Washington University School of Medicine, St. Louis, Missouri
J. Walker,Washington University School of Medicine, St. Louis, Missouri
During the last decade, large-scale DNA sequencing has markedly impacted the practice of modern
biology and is beginning to affect the practice of medicine. With the recent introduction of several
next-generation sequencing technologies, costs and timelines have been reduced by orders of mag-
nitude, facilitating investigators to conceptualize and perform sequencing-based projects that hereto-
fore were cost- and infrastructure-prohibitive. Furthermore, the application of these technologies
to answer questions previously not experimentally approachable is broadening their impact and ap-
plication.
This intensive 2-week course explored applications of next-generation sequencing technologies,
with a focus on commercially available platforms. Students were instructed in the detailed operation
of several next-generation and third-generation sequencing platforms, including sample preparation
procedures, general data handling through pipelines, and in-depth data analysis. A diverse range of
applications and analyses were explored, including RNA-Seq, de novo DNA sequencing, assembly
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of bacterial genomes, and human microbiome sample analysis, among others. Guest lecturers high-
lighted their own applications of these technologies and focused on the significant bioinformatics-
based analysis component of analyzing massively parallel sequencing-derived data sets. 
This course was supported with funds provided by the Applied Biosystems, Illumina, and 454
Life Sciences.
PARTICIPANTS
Advanced Sequencing Technologies and Applications      355
Ainsley, J., Ph.D., Tufts University, Boston, Massachusetts
Andersen, H., Ph.D., University of Southern Denmark,
Odense, Denmark
Bangarusamy, D., Ph.D., King Abdullah University of Science
and Technology, Thuwal, Saudi Arabia
Belton, J.-M., B.S., University of Massachusetts Medical
School, Worcester
Cui, Y., Ph.D., University of Kansas Medicine Center, Kansas
City
Harbst, K., M.Sc., Lund University, Sweden
Ingles, S., Ph.D., University of Southern California, Los
Angeles 
Joseph, V., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Karmin, M., M.Sc., University of Tartu and Estonian
Biocentre, Tartu, Estonia
Lagier-Tourenne, C., M.D., University of California, San
Diego, La Jolla
Liu, P., Ph.D., National Heart, Lung, and Blood Institute/
NIH, Bethesda, Maryland
Maestro, R., Ph.D., CRO Aviano National Cancer Institute,
Aviano (PN), Italy 
Mafofo, J., Ph.D., University of the Western Cape, Cape
Town, South Africa
Marie, C., Ph.D., University of Virginia, Charlottesville
Salomon, M., B.S., University of Florida, Gainesville
Zhidkov, I., M.Sc., Ben Gurion University of the Negev, Beer
Sheva, Israel
SEMINARS
Church, D., DHHS/NIH/NLM/NCBI, Bethesda, Maryland:
Status of the human and mouse reference genomes and the
short-read archive.
Eichler, E., University of Washington, Seattle: Structural
variation in human genomes and its association to genetic
disease.
Eid, J., Pacific Biosciences Incorporated, Menlo Park,
California: The Pacific biosciences platform.
Leamon, J., Ion Torrent, Guilford, Connecticut: The ion
torrent sequencing technology.
Mardis, E., Washington University School of Medicine, St.
Louis, Missouri: Next-generation cancer genomics.
McPherson, J., Ontario Institute for Cancer Research,
Toronto, Canada: Cancer genomics at the Ontario Institute
for Cancer Research.
Navin, N., Cold Spring Harbor Laboratory: Genomic
heterogeneity in breast cancer.
Schatz, M., Cold Spring Harbor Laboratory: Cloud
computing with next-generation sequencing data.
Weinstock, G., The Genome Center at Washington University
School of Medicine, St. Louis, Missouri: Metagenomics and
the human microbiome project.
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Immunocytochemistry, In Situ Hybridization, 
Super-Resolution, and Live Cell Imaging
October 13–26
INSTRUCTORS V. Allan, University of Manchester, United Kingdom
K. Hu, Indiana University, Bloomington
J. Murray, University School of Medicine, Philadelphia, Pennsylvania
CO-INSTRUCTOR J. Peng, Stanford University, California
ASSISTANTS Y.-C. Hwang, University of California, Santa Cruz
A. Oguro-ando, University of California, Los Angeles
This course focused on specialized techniques in microscopy, in situ hybridization, immunocyto-
chemistry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells as well
as protein and RNA dynamics in living cells. The course emphasized the use of the latest equipment
and techniques in fluorescence microscopy, including confocal laser-scanning microscopy; decon-
volution methods; several super-resolution methods including structured illumination, STORM,
and PALM; digital image processing; and time-lapse imaging of living specimens. The course was
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designed to present students with state-of-the-art technology and scientific expertise in the use of
light microscopy to address basic questions in cellular and molecular biology. The course was de-
signed for the molecular biologist who is in need of microscopic approaches and for the cell biologist
who is not familiar with the practical application of the advanced techniques presented in the course.
Among the methods presented were the preparation of tagged nucleic acid probes; fixation methods;
detection of multiple DNA sequences in single nuclei or chromosome spreads; cellular localization
of RNA; localization of nucleic acids and proteins in the same cells; use of a variety of reporter mol-
ecules and nonantibody fluorescent tags; indirect antibody labeling; detection of multiple proteins
in a single cell; labeling antibodies with two fluorophores for STORM; the use of GFP variants to
study protein expression in living cells by conventional microscopy and PALM; and use of photo-
activable and -switchable fluorescent proteins for studying localization and dynamics. In each
method, several experimental protocols were presented, allowing the students to access the relative
merits of each and relate them to their own research. Students were encouraged to bring their own
nucleic acid, protein, or antibody probes to the course, which were used in addition to those pro-
vided by the instructors. The laboratory exercises were supplemented with lectures given by invited
distinguished scientists, who presented up to the minute reports on current methods and research
using the techniques being presented.
This course was supported with funds provided by the National Cancer Institute.
Immunocytochemistry, In Situ Hybridization, Super-Resolution, and Live Cell Imaging      357
PARTICIPANTS
Albania, L., M.S., University of Padua, Padova, Italy
Aspalter, I., M.S., London Research Institute, United
Kingdom
Badding, M., B.S., University of Rochester Medical Center,
New York
Baluch, D., Ph.D., Arizona State University, Tempe
Chi, R., Ph.D., University of Miami, Florida
Cicotte, K., B.S., University of New Mexico, Albuquerque
Elsing, A., M.S., Abo Akademi University, Turku, Finland
Francis, D., B.A., Mount Sinai School of Medicine, New York
SEMINARS
Allan, V., University of Manchester, United Kingdom:
Immunocytochemistry.
Davidson, M., The Florida State University, Tallahassee: A
library of fluorescent proteins for live cell imaging.
Day, R., Indiana University School of Medicine, Indianapolis:
Visualizing protein interactions using FLIM and FRET.
Dernberg, A., University of California/HHMI Berkeley:
Chromosomes dynamics during meiosis.
Goodwin, P., Applied Precision, Inc., Issaquah, Washington:
Introduction to structured illumination methods.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Introduction to light and fluorescence
microscopy. Digital detectors and digital imaging
fundamentals. Microscopy of thick specimens.
Fu, X., Ph.D., Children’s National Medical Center,
Washington, D.C.
Kanaoka, M., Ph.D., Nagoya University, Japan
Paszek, P., Ph.D., University of Liverpool, United Kingdom
Pedersen, S., Ph.D., University of Copenhagen, Denmark
Rao, A., Ph.D., Carnegie Mellon University, Pittsburgh,
Pennsylvania
Singh, K., Ph.D., Cleveland Clinic, Ohio
Zhao, Y., Ph.D., UMDNJ–New Jersey Medical School,
Newark
North, A., The Rockfeller University, New York: Immuno-
cytochemistry on tissue sections: principles and practice.
Ried, T., National Cancer Institute/NIH, Bethesda, Maryland:
Mechanisms and consequences of chromosomal aberrations
in cancer cells.
Shroff, H., and York, A., National Institutes of Health,
Bethesda, Maryland: Super-resolution methods for cell
biology.
Spector, D., Cold Spring Harbor Laboratory: Visualizing gene
expression/silencing in living cells.
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Computational and Comparative Genomics
November 3–9
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
L. Stubbs, University of Illinois, Urbana
ASSISTANTS K. Nowick, Max-Planck Institute for Moelcular Genetics, Berlin, Germany
D. Triant, Louisana State University, Baton Rouge
This course presented a comprehensive overview of the theory and practice of computational meth-
ods for the identification and characterization of functional elements from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included alignment and analysis of short-read “next-gen”
sequencing data, identification of conserved signals in aligned and unaligned sequences, regulatory
element and motif recognition, and integration of genetic and sequence information in biological
databases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course made extensive use of
local WWW pages to present problem sets and the computing tools to solve them. Advanced pro-
gramming skills were not required. The course was designed for biologists seeking advanced training
in biological sequence and genome analysis, computational biology core resource directors and staff,
and scientists in other disciplines, such as computer science, who wish to survey current research
problems in biological sequence analysis.
This course was supported with funds provided by the National Human Genome Research In-
stitute.
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PARTICIPANTS
Computational and Comparative Genomics      359
Blech-Hermoni, Y., B.S., Cleveland Clinic Foundation, Ohio
Burge, C., Ph.D., Cornell University, Ithaca, New York
Cabrera, A., B.S., The Ohio State University, Wooster
Correa, A., Ph.D., Florida International University, N. Miami
Dey, N., B.A., University of California, San Francisco
Egan, J., Ph.D., Mayo Clinic, Scottsdale, Arizona
Farrar, M., B.S., Howard Hughes Medical Institute, Ashburn,
Virginia
Karki, A., B.S., South Dakota State University, Brookings
Kavanaugh, L., Ph.D., Syngenta Biotechnology, Inc., Research
Triangle Park, North Carolina
Kim, J., Ph.D., Asan Medical Center, Seoul, South Korea
Lim, H.-C., B.Env.S., University of Illinois, Urbana-
Champaign 
Madissoon, E., M.Sc., Karolinska Institute, Stockholm,
Sweden
Rea, T., M.S., University of Michigan, Ann Arbor
Singh, S., Ph.D., University of Minnesota, St. Paul
Stranneheim, H., M.S., SCiLifeLab-KTH, Stockholm,
Sweden
Summers, H., B.S., Cornell University, Ithaca, New York
Tincopa Marca, L.-R., M.S., International Potato Center,
Lima, Peru
Tripathi, P., M.S., South Dakota State University, Brookings
Tsoi, S., Ph.D., University of Alberta, Edmonton, Canada 
Tutaj, M., M.S., Medical College of Wisconsin, Milwaukee
Unckless, R., M.S., University of Rochester, New York
Wijeratne, A., Ph.D., Ohio State University, Wooster
Yap, E., D.Phil., DSO National Labs, Singapore
similarity searching. Similarity searching II–Strategies.
Suboptimal global alignments. Sensitive sequence
comparison, PSSMs, and HMMs.
Sinha, S., University of Illinois, Urbana-Champaign:
Identifying functional elements I. Functional elements II.
Stubbs, L., University of Illinois, Urbana: Introduction to
genome biology. Genome biology II.
Taylor, J., Emory University, Atlanta, Georgia: Galaxy for
high-throughput analysis.
Wold, B., California Institute of Technology, Pasadena: Next-
generation biology.
SEMINARS
Edwards, R., San Diego State University, California:
Metagenomics goals, strategies, and tools. Introduction to
metagenomics projects. Metagenomics II–Analysis pipelines.
Mackey, A., University of Virginia, Charlottesville: Analysis of
next-generation sequence data I. Introduction to genome
biology projects.
Overduin, B., EMBL–European Bioinformatics Institute,
Hinxton, Cambridge, United Kingdom: The ENSEMBL
database of genomes I. ENSEMBL/BioMart.
Pearson, W., University of Virginia, Charlottesville:
Introduction and overview. Protein evolution and sequence
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Phage Display of Proteins and Peptides
November 9–22
INSTRUCTORS C. Barbas, The Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, San Diego, La Jolla
ASSISTANTS F. Axelsson, Lund University, Sweden
S. Kacir, University of Pennsylvania, Philadelphia
K. Noren, New England BioLabs, Ipswich, Massachusetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow
for the rapid production of antibodies from immune and nonimmune sources. This intensive lab-
oratory/lecture course focused on the construction of combinatorial antibody libraries expressed on
the surface of phage and selection of desired antibodies from libraries. Students learned the theo-
retical and practical aspects of constructing combinatorial libraries from immune and nonimmune
sources as well as the construction of synthetic antibody libraries. Antibodies were selected from
the library by panning. Production, purification, and characterization of Fab fragments expressed
in Escherichia coli were also covered. Epitopes of a mouse monoclonal antibody were selected from
a peptide display library and characterized. 
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The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglob-
ulin genes, the biology of filamentous phage, the utility of surface expression libraries, expression
of antibodies in E. coli and mammalian cells, antibody structure and function, catalytic antibodies,
directed protein evolution, retroviral and cell display libraries, the immunobiology of the antibody
response, and recent results on the use of antibodies in therapy. The theory and practical implications
for selection from phage displayed libraries of random peptides, cDNA products, and semisynthetic
proteins was also explored.
This course was supported with funds provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Phage Display of Proteins and Peptides      361
Acharya, J., Ph.D., National Cancer Institute, Frederick,
Maryland
Batra, G., Ph.D., University of Turku, Finland
Ching, A., M.Sc., Butantan Institute, Sao Paulo, Brazil
Chiu, E., M.S., Mount Sinai Hospital, Toronto, Canada
Darris, C., B.S., Tennessee State University, Nashville
Derda, R., Ph.D., Harvard University, Cambridge,
Massachusetts
Dubiley, S., Ph.D., IBG RAS, Moscow, Russia
Hasan, A., M.D., Memorial Sloan-Kettering Cancer Center,
New York
Lew, S., Ph.D., Columbia University, New York
Lima, S., M.Sc., University of São Paulo, Brazil
Lindberg, H., M.Sc., KTH, Stockholm, Sweden
Mohr, A., M.Sc., University of Copenhagen, Denmark
Novinger, L., B.S., University of Vermont College of
Medicine, Burlington
Prudencio, C., Ph.D., University of São Paulo, Brazil
Qian, Y., Ph.D., University of North Carolina, Chapel Hill
Sanchez, A., M.S., Biokit, S.A., Barcelona, Spain
SEMINARS
Barbas, C.S., Scripps Research Institute, La Jolla, California:
Functional antibodies and instant immunity.
Dreier, B., University of Zurich, Switzerland: Ribosome
display libraries.
Ladner, R., Dyax Corporation, Ijamsville, Maryland: Phage
display of peptides and their development at therapeutics.
Noren, C., New Englands Biolabs, Ipswich, Massachusetts:
Functional peptide libraries.
Rader, C., National Institutes of Health, Bethesda, Maryland:
Toward better monoclonal antibodies for cancer therapy:
From antigen discovery to antibody engineering.
Siegel, D., University of Pennsylvania, Philadelphia: Cell-
surface selection of phage-displayed antibodies.
Sidhu, S., University of Toronto, Ontario, Canada: Phage
display of synthetic antibodies and SH2 domains.
Silverman, G., University of California, San Diego: Overview
of the adaptive immune system.
Stahl, S., Royal Institute of Technology, Stockholm, Sweden:
Phage display of affibodies. 
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The Genome Access Course
April 27–28, November 16–17
TRAINERS U. Hilgert, Cold Spring Harbor Laboratory
G. Howell, The Jackson Laboratory
B. King, Mount Desert Island Biological Laboratories
L. Reinholdt, The Jackson Laboratory
This course was an intensive 2-day introduction to bioinformatics that was held twice in 2010 and
trained almost 40 participants in total. The core of the course was designed to cover the manipula-
tion and analysis of sequence information. The course was broken into modules designed to give a
broad overview of a given topic, with ample time for examples chosen by the instructors. Each mod-
ule included three parts, consisting of a discussion of theory and methods, coverage of software and
web resources, and use of selected tools with examples (including those supplied by the students).
The modular design allowed the instructors to tailor the presentation to the interests of the students.
Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple Se-
quence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the course were
open to all on a first-come-first-served basis, subject to basic eligibility requirements. The course
was held at the Laboratory’s Genome Research Center at Woodbury located seven miles south of
the main Laboratory campus. Each student was provided with a PC laptop with wireless modem
for the duration of the course. Students were encouraged to supply problem sets and sequences of
interest to the trainers for possible incorporation as examples in the modules. Materials were made
available on the web and students continued to ask questions of the trainers as they applied what
they had learned in their individual endeavors. 
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The Genome Access Course      363
April 27–29
Chowanadisai, W., Marine Biological Laboratory, Woods
Hole, Massachusetts
Dolan, P.,  University of Rochester/University of Alabama,
Birmingham, New York
Ernst, P., Dartmouth Medical School, Hanover, New
Hampshire
Eswarakumar, V., Yale University, New Haven, Connecticut
Faucher, S., Public Health Agency of Canada, Ottawa 
Gebhardt, C., Harvard University, Cambridge, Massachusetts
Ghiban, E., Cold Spring Harbor Laboratory
Gierszewska, M., Cold Spring Harbor Laboratory
Glaser, R., Stevenson University, Maryland
Kucera, S., University of Tampa, Florida
Li, Z., The Rockefeller University, New York
Lu, S., Harvard University, Cambridge, Massachusetts
McFadden, S., Independent Scientific Research Advocates,
Bethesda, Maryland
Sattely, E., Harvard Medical School, Boston, Massachusetts
November 16–17
Ander, B., University of California, Davis M.I.N.D. Institute,
Sacramento
Boland, L., University of Richmond, Virginia
Bradley, B., Yale University, New Haven, Connecticut
Cruz, V., USDA, ARS, NCGRP, Fort Collins, Colorado
Dadras, S., University of Connecticut, Farmington
Dirk, M., Stony Brook University, New York
Dolezal, D., SUNY Upstate Medical University, Syracuse,
New York
Duman, E., Stony Brook University, New York
Fowler, T., Tufts University, Boston, Massachusetts
Franco, S,. Johns Hopkins University, Baltimore, Maryland
Jurkiewicz, S., SUNY Stony Brook, New York
Kung, V., Northwestern University, Chicago, Illinois
Logue, M., Boston University School of Medicine,
Massachusetts
Marko, M., Cleveland Clinic, Ohio
Ozer, E., Northwestern University, Chicago, Illinois
Panella, L., USDA, ARS, CRL, Fort Collins, Colorado
Patil, V., UMDNJ–New Jersey Medical School, Newark
Reilley, A., National Center for Genetic Resources
Preservation, Fort Collins, Colorado
Richards, C., National Center for Genetic Resources
Preservation, Fort Collins, Colorado
Romero, S., Yale University, New Haven, Connecticut
Stone, A., Arizona State University, Tempe
Szpara, M., Princeton University, New Jersey
Chaozhe, Y., University of Alabama, Birmingham
Zuo, L., Yale University, West Haven, Connecticut
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The Laboratory acknowledges the generosity of the following companies that loaned equipment and reagents
to the various courses:
364 Postgraduate Courses
454 Life Sciences
Accuri Cytometers Inc.
Advanced Spectral Imaging
Agilent Technologies Inc.
Andor Technology
Applied Biosystems
Applied Precision
Art Robbins Institute
Astro-Med Inc.
BD Biosciences
Berthold Technologies USA,
LLC
Bio-Rad Laboratories
Bioptechs Inc.
Bruker Daltonics Inc.
Carl Zeiss Inc.
Charles River Laboratories
Chroma Technology
Corporation
Coherent Laser
ConOptics
CoolLED
Corning Inc.
CrystaLaser
Dagan Corporation
David Kopf Instruments
Doric Lenses
Drummond Scientific
Company
Epicentre Technologies
Eppendorf North America
Fotodyne Inc.
GE Healthcare
Hamamatsu Photonic Systems
Hamilton Thorne Biosciences
Hampton Research
Harvard Apparatus Inc.
Heka
Illumina Inc.
Intelligent Imaging
Innovations Inc.
James A. Hill Instrument
Services
Kinetic Systems Inc.
Leica Microsystems Inc.
Life Technologies
LI-COR
Luigs & Neumann
MDS Analytical Technologies
Nalge Nunc International
Nanodrop Technologies
Narishige International USA
Inc.
Nasco
NeoBiosystems
New England Biolabs Inc.
Nikon Inc.
Olympus America Inc.
PerkinElmer Life and
Analytical Sciences
Photometrics
Photonic Instruments Inc.
Pierce
Promega Corporation
Qiagen Inc.
Q-Imaging Inc.
Roche Nimblegen
Scientifica Ltd.
SciGene
Sigma-Aldrich
Singer Instruments
Spectra-Physics Lasers Inc.
Stanford Photonics
Stanford Research Systems
Stratagene
Sutter Instruments
Tecan US, Inc.
The Jackson Laboratory
Thermo Fisher Scientific
Tokai Hit Co., Ltd..
VDS Vosskuhler GmbH
Warner Instruments
Waters Corporation
World Precision Instruments
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365
SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings. These weekly seminars keep the CSHL staff current on the latest scientific developments and
broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar speakers
for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in an in-
formal setting. 
Title Host
January
Dr. Eric Holland, Memorial Sloan-Kettering Brain tumor stem-like cells and where they live. Grisha Enikolopov
Cancer Center
Dr. Brian Chait, The Rockefeller University Proteomic and nanoengineering probes of Leemor Joshua-Tor
nucleocytoplasmic transport.
Dr. Steve Henikoff, Fred Hutchinson Cancer Histone variant dynamics and epigenetics. Chris Vakoc
Research Center
February
Dr. David Bartel, Whitehead Institute microRNAs and other small regulatory RNAs. Leemor Joshua-Tor
Dr. Philip Benfey, Duke University Development rooted in interwoven networks. Marja Timmermans
Dr. Amy Wagers, Harvard University Reversing dysfunction of aged stem cells. Terri Grodzicker
March
Dr. Hugo Bellen, Baylor College of Medicine A forward genetic approach to study neurodegeneration. Linda Van Aelst
Dr. Josh Sanes, Harvard University Synaptic specificity in the visual system. Josh Huang
Dr. Karl Deisseroth, Stanford University Optogenetics: New developments, new applications. Tony Zador
Dr. Lisa Coussens, University of California, Inflammation and cancer: Polarized immune Mikala Egeblad
San Francisco responses regulate cancer development.
April
Dr. Eric Nestler, Mount Sinai School of Transcriptional and epigenetic mechanisms of addiction. Grigori Enikolopov
Medicine
Dr. Gary Ruvkun, Harvard University Comprehensive identification of C. elegans small Leemor Joshua-Tor
RNA pathway genes.
Dr. David Tuveson, Cancer Research UK Modeling cancer biology and medicine. Lloyd Trotman
Dr. David Eisenberg, University of California, Structural studies of the amyloid state. Leemor Joshua-Tor
Los Angeles
May
Dr. Karel Svoboda, Howard Hughes Medical The neural circuits underlying somatosensation. Tony Zador
Institute
October
Dr. Irving Weissman, Stanford University Normal and neoplastic stem cells. Grigori Enikolopov
Dr. Manuel Serrano, Spanish National Cancer Tumor suppressors at the interface of cancer and Scott Lowe
Research Centre aging.
November
Dr. Angelika Amon, Massachusetts Institute The consequences of aneuploidy. Terri Grodzicker
of Technology
Dr. David Lewis, University of Pittsburgh Cortical E/I balance and cognitive dysfunction in Josh Huang
schizophrenia.
Dr. Mark Ptashne, Memorial Sloan-Kettering Chromatin architecture: What determines it and Alex Gann
Cancer Center what is its function?
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366 Seminars
December
Dr. James Surmeier, Northwestern University Calcium, mitochondrial oxidant stress and Pavel Osten
Medical School Parkinson’s disease.
Dr. Rachel Green, Johns Hopkins University Quality control during translation in bacteria and yeast. Leemor Joshua-Tor
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor Laboratory’s In-House Seminars were initiated to provide a semiformal avenue
for communication between the various research groups at the Laboratory. The seminars also afford
a necessary opportunity for the graduate students and postgraduate staff to develop their skills in
organizing, presenting, and defending their research.
Title
January
Mike Wigler A unified genetic model for autism.
Prem Premsrirut (Lowe Lab) SLowe mice no more: A rapid and efficient method to produce conditional transgenic 
mice using RNAi.
Mikel Zaratiegui (Martienssen Lab) Centromere-binding protein B preserves genome integrity at replication forks paused 
by retrotransposons.
Anthony Mazurek (Stillman Lab) Discovery of an essential role for the DEAD-box RNA helicase, DDX5, in cell cycle 
control and breast cancer development.
February
Florin Albeanu Understanding olfactory neuronal circuits in the mammalian brain.
Alexander Dobin (Gingeras Lab) STARgazing reveals novel UFTs.
Shane McCarthy (Sebat Lab) Rare structural variants: Insights into the genetics of schizophrenia.
March
Pavel Osten Search for neural circuit endophenotypes in mouse models of autism.
Hysell Oviedo (Zador Lab) Form follows function: Linking circuits, connectivity, and function in the auditory cortex.
Raffaella Sordella Molecular targeted cancer therapies:  Quo vadis?
April
Glenn Turner Population coding in the Drosophila mushroom body.
Michael Zhang Machine learning and learning machines.
Alea Mills Engineering the genome: Cancer, chromatin, and chronic behavior.
October
Chris Vakoc Epigenetics of malignant hematopoiesis.
Fritz Henn Toward a new pathophysiology of depression.
Mikala Egeblad Seeing tumors in context.
November 5
James Watson Judah Folkman, anti-angiogenesis and the curing of cancer.
Antoine Molaro and Emily Hodges DNA methylation dynamics across mammalian evolution and development.
(Hannon Lab)
Zhenxun Wang (Krainer Lab) Investigating the mechanism of pyruvate kinase-M mutually exclusive splicing.
December
Xianfeng (Morgan) Xu (Jackson Lab) Cell-to-cell trafficking of a plant stem cell regulator is mediated by chaperonins.
Josh Huang Toward a genetic dissection of neural circuits in cerebral cortex:  Chandeliers light up the 
path from epigenomes to cognition.
Shuang Ni (Stillman Lab) ORC subunits Orc2 and Orc3 are required for stable spindle attachment at human 
chromosome kinetochores during mitosis.
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The Banbury Center is now in its 33rd year and continues to be used intensively. In 2010, there
were 22 science-related meetings attended by 577 participants. In addition, the Center was made
available to community groups on five occasions. The Meetings and Courses Program held six
lecture courses during the summer months and the Watson School of Biological Sciences used the
Center for its two Topics in Biology courses.
Of the 577 participants, 486 (71%) were from the United States. They were drawn from 33
states, the geographical distribution reflecting the degree of biomedical research in the United States.
The 91 foreign participants came from 18 countries, the majority from the United Kingdom. The
ratio of male to female participants remains at 2:1.
The meeting topics were unusually wide-ranging, even for the Banbury Center. The Center has
always held meetings on policy issues, issues where biomedical research is relevant to matters of so-
cietal interest. The first of two such meetings in 2010 concerned
science and economic policy. The American Recovery and Rein-
vestment Act (ARRA) provided an extra $10.4 billion funding over
a 2-year period for the National Institutes of Health (NIH) to pro-
mote biomedical research through funding new projects, construc-
tion, and the purchase of equipment. However, although this has
been a great success, the question arises as to what will happen
when the ARRA funding comes to an end. How Can We Maintain
the Stability of Biomedical Research and Development at the End of
the ARRA? examined first how NIH spent the ARRA funding and
second how federal agencies, universities, research institutes, and
individual investigators can manage the ending of ARRA support.
Participants included officials from NIH, universities, research in-
stitutes, economists, and scientists. 
The second meeting, funded by the Ellison Medical Foundation, discussed Easeful Death: 21st
Century Perspectives on Assisted Suicide. End-of-life issues involve profound legal, moral, religious, and
biomedical questions and evoke intense passions. The Banbury Center is admirably suited to tackle
difficult topics, although these are more usually controversies in the interpretation of scientific data.
Discussions covered three broad areas. First, there was an extended discussion on whether there are
distinctions to be drawn between a physician acquiescing to a patient’s refusal of food and water, as-
sisting in suicide by making it possible through providing materials, and the physician actively taking
part in the suicide. Second, participants from Belgium and The Netherlands presented data on whether
the legalization of euthanasia and assisted suicide changes the behaviors of patients and physicians,
and whether the slippery slope argument carries any weight. Third, we discussed the changes in the
political and legal apparatus that will have to come about before there can be acceptance of easeful
death as a proper end to life. Participants included scientists, physicians, lawyers, philosophers, and
religious leaders of differing opinions and although no consensus was likely to have been reached, the
discussions were of remarkable quality and interest.
Turning to more typical Banbury Center topics, there were several meetings on cancer. Energy
Metabolism, the Cell Cycle, and Cancer explored an old hypothesis on the fundamental nature of
cancer in the light of modern molecular analysis. The Warburg Hypothesis was advanced by Otto
Warburg in 1924 when he found that tumor cells mainly generate energy anaerobically by glycolysis
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rather than by oxidative metabolism. Warburg believed that this was a fundamental characteristic
of cancer cells, a thesis that fell out of fashion with the discovery of oncogenes and a focus on the
genetic changes in cancer. However, in recent years links have been found between glycolysis and
oncogenes and participants in this meeting reviewed these findings. For example, one session was
devoted to cancer metabolism and the tumor suppressor protein p53. 
A second meeting on cancer, Tumor Microenvironment and Metastasis, reviewed the evidence that
the cancer cell is not a “renegade” cell, growing and multiplying without regard for its surroundings.
On the contrary, there is increasing evidence that the behavior of a cancer cell, particularly metastasis,
is influenced by its microenvironment, which includes other cells and the tumor-associated extra-
cellular matrix. Participants examined such questions as, Is all the information needed for a cell to
metastasize autonomous or does the tissue microenvironment have a role in determining this process?
Does disrupting the tumor microenvironment have a positive or negative impact on metastatic po-
tential of cancer cells? Can the microenvironment explain why many primary tumors favor secondary
tumor formation in specific organs? The meeting explored what constitutes the tumor microenvi-
ronment and examined its functional impact on metastasis with specific focus on new targets for
treatment of metastatic cancer.
Banbury Center has a long-standing interest in promoting research on psychiatric disorders, be-
ginning in the early 1990s when RFLP (restriction-fragment–length polymorphism) linkage map-
ping was being used to try to locate genes involved in schizophrenia and depression. These and later
genetic mapping strategies such as genome-wide association studies have proved disappointing and
thus, it was fascinating to hold a meeting—The Lateral Habenula: Its Role in Behavior and Psychiatric
Disorders—based on a well-defined, if poorly understood, anatomical feature of the brain. The start-
ing point for interest in the lateral habenula was the observation that deep-brain stimulation of the
area in a woman profoundly disabled by depression led to a remission that persisted as long as the
stimulation continued. This meeting began with the fundamental anatomy and functional connec-
tions of the habenula before progressing to its role in cognition and how it might have a role in
clinical depression.
A closely related meeting was Linguistic Phenotypes: Toward a Biological Understanding of Language
that explored the thesis that language can provide a window into mental function
which can be exploited for the study and understanding of neuropsychiatric dis-
orders. If linguistic performance reflects thought processes, quantitative measures
defined on the basis of linguistic performance might be useful in characterizing
phenotypic variability among individuals. Specific examples include autism, spe-
cific language impairment, and Williams syndrome. Schizophrenia, which in-
cludes thought disorder in its symptom list, may also be amenable to useful
linguistic phenotyping. Participants included linguists and psycholinguists in-
terested in human neurobiology and disease, as well as biologists working on
autism, schizophrenia, and other neuropsychiatric disorders. We were particu-
larly pleased that Noam Chomsky took part in the meeting.
There were two Banbury Center meetings relating to history. Mutations are
essential for genetic analysis and T.H. Morgan’s white-eyed Drosophilamutation
initiated the modern era of genetics. Mutations cause inherited disorders and
generate the variability on which natural selection acts. The first of our two his-
torical meetings, Mutagenesis: What It Means and How It Has Changed, examined
how genes and mutations were regarded in the early days of genetics and how those ideas changed
with the advent of molecular genetics in the 1950s and 1960s. There were also presentations on the
consequences of environmental sources of mutation: radiation and chemical carcinogens. We also
discussed contemporary research on mutations, such as copy-number variation, and mutation-like
phenomena in prions. 
N. Chomsky
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Lewis Lehrman (The Lehrman Institute) wishes to encourage the use of genetic and genomic
analyses to inform our knowledge of history and has established a program to foster interactions
between scientists and historians. Examples of the power of such interactions are evident in studies
tracking the movements of early human beings out of Africa and subsequent spread of populations
throughout the globe; where and how key events in domestication of plants and animals occurred;
and what DNA sequencing is telling us about our relationship with Neanderthals. Participants in
DNA, Genetics, and the History of Mankind reviewed these and other topics. The meeting closed
with a free-ranging discussion on how to promote interactions between historians and scientists and
on what topics should be covered in the follow-up meeting.
The Banbury Center could not operate at its high level without the hard work of many people.
The Center is especially fortunate in having Janice Tozzo and Susanne Igneri ensuring that the meet-
ings run smoothly, and Basia Polakowski making sure that participants are welcome in Robertson
House. Sonny Leute, Alvin Watson, and Fredy Vasquez look after the grounds, dealing with vast
amounts of leaves in the fall and, this year, vast amounts of snow in the winter. Jon Parsons is inde-
fatigable in handling AV requirements and Connie Brukin took the photographs which enliven the
report. Culinary Services feeds our participants and Housekeeping copes admirably with the rapid
turnover of guests.
Jan Witkowski
Executive Director
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Levine Lab Presentation #1
D. Carpizo: p53 allele-specific synthetic lethality.
Cordon-Cardo Lab Presentation #1 
O. Karni-Schmidt: New findings on p53 and its possible
roles in bladder cancer and development.
Prives Lab Presentation #1
S. Singer: Nup98, a potential tumor suppressor regulates
select p53 target gene expression by a novel mechanism.
Lowe Lab Presentation #1
C. Scuoppo: The polyamine–hypusine axis defines a tumor
suppressor network in human lymphoma.
PI PLANNING MEETING
Cordon-Cardo Lab Presentation #2
A. Jia: microRNAs in bladder cancer progression.
Levine Lab Presentation #2
H. Mizuno: Stem cell signatures in breast cancer with p53
mutations.
BANBURY CENTER MEETINGS
p53 Retreat
January 28–30
FUNDED BY          Columbia University, New York, New York
ARRANGED BY      C. Prives, Columbia University, New York, New York
                               S. Lowe, Cold Spring Harbor Laboratory, New York
The p53 protein first identified in 1979 and believed to be an oncoprotein was shown in 1989 to
be a tumor suppressor. It has a central role in cell cycle control, regulation of DNA repair, and the
initiation of apoptosis and is the gene most frequently mutated in cancers. p53 was named the 1993
“Molecule of the Year” by Science. It is not surprising then that p53 has been the subject of intensive
investigation, not least by research groups at Cold Spring Harbor Laboratory (Lowe), Princeton
(Levine), and Columbia (Prives and Cordon-Cardo). Members of these laboratories came to Banbury
Center to report on their work and to promote interactions between the groups.
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Prives Lab Presentation #2
W. Freed-Pastor: Mutant p53 prevents formation of
mammary acini in three-dimensional culture.
Lowe Lab Presentation #2
L. Dow: How to make a hairy mouse: New transgenic
shRNA technologies to allow reversible loss of function
phenotypes in adult mice.
Guest Lecturers
R. Parsons: PTEN regulation in cancer: What is the
contribution of p53 mutation?
J. Manley: mRNA processing and cancer: Roles for p53 and
other tumor suppressors and oncogenes.
Prives Lab Presentation #3
C. Priest: A novel Mdm2 mutant that degrades itself
preferentially over p53.
Lowe Lab Presentation #3
Z. Zhao: p53 affects self-renewal in AML.
Wrap-up Discussion
367-410_LAR_Banbury_Annual Report_2009 template  7/8/11  12:26 PM  Page 372
373
The Lateral Habenula: Its Role in Behavior and Psychiatric Disorders
February 28–March 3
FUNDED BY Marie Robertson Memorial Fund
ARRANGED BY F. Henn, Brookhaven National Laboratory, Upton, New York
B. Li, Cold Spring Harbor Laboratory, New York
Depression is the disorder that is predicted to cause the greatest morbidity in the world by 2020,
and a 2009 survey found 16% of Americans suffer from depression. Recently, deep-brain stimulation
has been suggested as a possible therapy for refractory cases, and data suggest that the target of this
stimulation is the lateral habenula. This is a relatively little-studied part of the brain, and given these
findings, this was the right time to critically review what is known of the function of this structure,
its connections, and how they function. Participants included anatomists, physiologists, neurophar-
macologists, and clinicians.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Background: J. Watson, Cold Spring Harbor Laboratory, New York
Introduction: F. Henn, Brookhaven National Laboratory, Upton, New York 
B. Li, Cold Spring Harbor Laboratory, New York
SESSION 1: The Lateral Habenula: Anatomical/Functional Connections and Cellular Biology
Chairperson: O. Hikosaka, National Eye Institute, Bethesda, Maryland
M. Herkenham, National Institute of Mental Health,
Bethesda, Maryland: The anatomical connections of the
habenula nuclei, with a historical perspective.
S. Sesack, University of Pittsburgh, Pennsylvania: Projections
from the lateral habenula to midbrain dopamine neurons:
indirect inhibitory control via the rostromedial mesopontine
tegmentum.
T. Jhou, National Institute on Drug Abuse, Baltimore, Maryland:
A convergence of aversion: Fear, disappointment, and
inhibition in the rostromedial tegmentum (RMTg), a 
habenula target.
S. Haber, University of Rochester Medical Center, New 
York: The place of habenula in the reward circuit.
P. Shepard, University of Maryland, Baltimore: Stimulation 
of the lateral habenula inhibits the activity of midbrain
dopamine neurons at the population level.
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SESSION 3: The Lateral Habenula and Cognitive Function
Chairperson: B. Moghaddam, University of Pittsburgh, Pennsylvania
SESSION 4: The Lateral Habenula and the Neural Mechanisms Underlying Clinical Depression
Chairperson: F.A. Henn, Brookhaven National Laboratory, Upton, New York
W. Drevets, University of Oklahoma-Tulsa University School
of Community Medicine: Abnormalities of habenular
structure and function in mood and anxiety disorders.
J. Roiser, University College London, United Kingdom: Role
of the habenula in psychiatric disorders.
A. Sartorius, Central Institute of Mental Health, Mannheim,
Germany: Lateral habenula and treatment-resistant
depression: Results of functional inhibition of the lateral
habenula in congenitally helpless rats and in a first patient.
G. Northoff, University of Ottawa, Ontario, Canada: 
Subcortical regions and their relevance in emotion processing
in depression.
F. Henn, Brookhaven National Laboratory, Upton, New York:
An animal model of depression: A key to understanding the
road to the habenula.
B. Li, Cold Spring Harbor Laboratory, New York: The
synaptic circuitry of lateral habenula and learned
helplessness. 
R. Malinow, University of California, San Diego: The synaptic
and cellular changes in the lateral habenula of learned
helplessness in rats.
G. Goelman, Hadassah Hebrew University Medical Center,
Jerusalem, Israel: Role of the habenula in depression that
accompanies Parkinson’s disease.
SESSION 5: The Lateral Habenula and Animal Models of Psychiatric Disorders
Chairperson: R. Dolan, University College London, United Kingdom
SESSION 2: The Lateral Habenula: Anatomical/Functional Connections, and Cellular Biology (Cont’d)
Chairperson: S. Haber, University of Rochester Medical Center, New York
R. Veh, Charité—Universitätsmedizin Berlin, Germany:
Intrinsic properties and connections of the lateral habenular
complex in the rat.
U. Kim, Pennsylvania State University College of Medicine,
Hershey: Morphological and electrophysiological properties
of the habenula.
R. Blakely, Vanderbilt School of Medicine, Nashville,
Tennessee: Ironing out a relationship between serotonin and
the habenula: Insights from a genetic reference mouse
population
H. Okamoto, RIKEN Brain Science Institute, Wako City,
Japan: Functional analysis of the dorsal habenula in zebra
fish, an equivalent structure to the mammalian medial
habenula.
E. Turner, Seattle Children’s Research Institute, Washington: A
gene regulatory program for habenula development.
O. Hikosaka, National Eye Institute, Bethesda, Maryland:
Role of the lateral habenula in value-based decision-making.
L. Lecourtier, Louis Pasteur University, Strasbourg, France:
Role of the habenula in cognitive processes, linked to its
regulatory role over many neurotransmitter systems.
H. Piggins, University of Manchester, United Kingdom: 
Role of the habenula in the temporal regulation of brain 
states and behavior.
M. Ullsperger, Radboud University Nijmegen, The Nether-
lands: Role of the habenula in performance monitoring and
cognitive control. Approaches in human and animal
research.
G. Yadid, Bar-Ilan University, Ramat-Gan, Israel: Electrical
stimulation of the lateral habenula for modulation of the
reward system: Application to depression and addiction.
J. Watson, R. Malinow B. Li, S. Sesack
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Epigenetic Reprogramming and Transgenerational Inheritance
March 7–10
FUNDED BY The Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R. Martienssen, Cold Spring Harbor Laboratory, New York
W. Reik, Babraham Institute, Cambridge, United Kingdom
It is becoming clear that in mammals, plants, and other organisms, epigenetic mechanisms interface
with genetic ones in regulating developmental decisions and pathways. Epigenetic reprogramming
in the germ line and in early embryos allows pluripotency and stem cell plasticity, whereas the re-
striction of developmental plasticity also involves epigenetic mechanisms. Erasure of epigenetic
marks in the germ line may be incomplete, leading to epigenetic inheritance of altered developmental
potential across generations. In plants, there is growing evidence for a parallel reprogramming event
in both the male and the female germ lines. In pollen, this results in transposon activation followed
by small RNA production and transport into gametes. This represents a mechanism for reinforce-
ment of transposon control in each generation.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: W. Reik, Babraham Institute, Cambridge, United Kingdom
SESSION 1: Developmental Decisions
Chairperson: M.A. Surani, University of Cambridge, United Kingdom
T. Hiiragi, Max-Planck Institut für Molekulare Biomedizin,
Muenster, Germany: Stochastic patterning in the
development of pluripotency in mouse embryo.
M.-E. Torres-Padilla, Institute de Génétique et de Biologie,
Strasbourg, France: Histone variants establish specialized
chromatin signatures during reprogramming.
K. Hochedlinger, Harvard Stem Cell Institute, Cambridge,
Massachusetts: Epigenetic similarities and differences between 
ES cells and iPS cells.
E. Heard, Institut Curie, Paris, France: Lessons from in vivo studies
on X-chromosome inactivation and reactivation in different
animals.
H. Blau, Stanford University School of Medicine, California:
Role of active DNA demethylation by AID in
reprogramming toward pluripotency.
P. Avner, Institut Pasteur, Paris, France: Developmental
regulation of X-chromosome inactivation.
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R. Martienssen, Cold Spring Harbor Laboratory, New York:
Heterochromatin reprogramming and small RNA silencing in
plant germ cells.
F. Berger, National University of Singapore: Reprogramming
histone modifications in Arabidopsis.
J. Walter, Saarland University, Saarbrücken, Germany:
Epigenetic reprogramming in the mouse zygote: Lessons
from bisulphate sequencing.
M. Surani, University of Cambridge, United Kingdom:
Resetting the epigenome in embryos and germ line in the
mouse.
R. Fischer, University of California, Berkeley: Reprogramming
the endosperm genome.
W. Reik, Babraham Institute, Cambridge, United Kingdom:
Reprogramming and programming of DNA methylation
patterns in the genome.
SESSION 3: Imprints and Inheritance
Chairperson: T. Bestor, Columbia University, New York, New York
H. Sasaki, Medical Institute of Bioregulation, Kyushu,
Fukuoka, Japan: Role of the PIWI pathway in DNA
methylation of the imprinted Rasgrf 1 locus in the male
mouse germline.
A. Ferguson-Smith, University of Cambridge, United
Kingdom: Genomic imprinting and the stability of the
epigenetic program in developmental processes.
V. Colot, Ecole Normale Superieure, Paris, France:
Transgenerational inheritance of epigenetic variation in
Arabidopsis: Mechanisms and phenotypic impact.
D. Bourc’his, Institut Curie, Paris, France: Dnmt3L-
independent way to methylate mammalian genomes.
W. Kelly, Emory University, Atlanta, Georgia: Epigenetic
inheritance and reprogramming through the germline in C.
elegans.
J. Paszkowski, University of Geneva, Switzerland: Stability of
transgenerational epigenetic inheritance.
SESSION 4: Environmental Effects and Evolution
Chairperson: J. Rafalski, Dupont Experimental Station, Wilmington, Delaware
N. Heintz, The Rockefeller University, New York, New York: 
The significance of 5-hydroxymethylctytosine in neuronal 
function.
A. Rao, Harvard Medical School, Boston, Massachusetts:
Biological functions of TET proteins, enzymes that convert
5 methylcytosine to hydroxymethylcytosine DNA.
D. Ruden, Wayne State University, Detroit, Michigan:
Epigenomic reprogramming of aggression in killer bees.
SESSION 2: Reprogramming and Reproduction
Chairperson: E. Heard, Institut Curie, Paris, France
376 Banbury Center
J. Finnegan, CSIRO, Black Mountain, Australia: Flicking the
switch on polycomb-regulated genes.
B. Hohn, Friedrich Miescher Institute of Biomedical Research,
Basel, Switzerland: Environmental influences on plant
genome dynamics.
U. Grossniklaus, Institute of Plant Biology, University of
Zurich, Switzerland: Role of epigenetic regulation in
evolution: The control of pollination syndromes.
SESSION 5: Methylation Mechanisms
Chairperson: H. Sasaki, Medical Institute of Bioregulation, Kyushu, 
Higashiaku, Japan
T. Bestor, Columbia University, New York, New York: How much
tissue-specific DNA methylation and how important?
Y. Zhang, HHMI, University of North Carolina, Chapel Hill: 
Could the DNA demethylase please stand up?
S. Jacobsen, University of California, Los Angeles: DNA 
methylation in Arabidopsis.
General Discussion: W. Reik, Babraham Institute, Cambridge, United
Kingdom
Concluding Remarks: R. Martienssen, Cold Spring Harbor Laboratory,
New York H. Blau, Y. Lazebnik
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The Second NIMH-Sponsored Brain Camp
March 13–16
FUNDED BY National Institute of Mental Health
ARRANGED BY M. Akil, National Institute of Mental Health, Bethesda, Maryland
T. Insel, National Institute of Mental Health, Bethesda, Maryland
We were very happy that the NIMH Brain Camp returned to Banbury in 2010 after its successful
inauguration in 2009. The goal of the Brain Camp is to identify areas of neuroscience that are of
interest and relevance to psychiatrists and to communicate these to a small group of outstanding
psychiatry residents and research fellows. Some of the most distinguished and thoughtful neurosci-
entists in the country contributed to the meeting. The outcome of the meeting will be the start of
a neuroscience curriculum that can eventually be shared with psychiatry training programs around
the country.
Introduction and Charge: M. Akil, National Institute of Mental Health, Bethesda, Maryland
Rethinking Mental Illness: T. Insel, National Institute of Mental Health, Bethesda, Maryland
SESSION 1: Circuitry Underlying Aggression/Circuitry of Emotional Learning
R. Yuste, Columbia University, New York, New York
D. Salzman, Columbia University, New York, New York
SESSION 4: Circuitry Underlying Fear, Anxiety, and Recovery
J. LeDoux, New York University, New York, New York
E. Phelps, New York University, New York, New York
Roundtable Discussion with All Speakers
SESSION 5: Translation: From Neurobiology to Treatments
K. Berman, National Institute of Mental Health, Bethesda,
Maryland
M. Bear, Massachusetts Institute of Technology, Cambridge
SESSION 2: How Circuits Develop
C. Nelson, Harvard University, Boston, Massachusetts
B.J. Casey, Cornell University, Ithaca, New York
Discussion with the Organizers: Teaching neuroscience in
medical school and during psychiatry training: What’s 
missing?
SESSION 3: Stress from Molecules to Circuits
H. Akil, University of Michigan, Ann Arbor
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How Can We Maintain the Stability of Biomedical Research
and Development at the End of the ARRA?
April 25–27
FUNDED BY Howard Hughes Medical Institute
Alfred P. Sloan Foundation
ARRANGED BY R. Freeman, NBER Science and Engineering Workforce Project, Harvard University, Cambridge, 
Massachusetts
P. Stephan, Andrew Young School of Policy Studies, Georgia State University, Atlanta
A. Wang, NBER Science and Engineering Workforce Project, Harvard University, Cambridge, 
Massachusetts
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
The American Recovery and Reinvestment Act (ARRA) has provided an extraordinary $8.2 billion
in extramural funding to the National Institutes of Health and $3 billion to the National Science
Foundation as well as sizable funds to other agencies. These funds have been used to promote re-
search, construct and renovate buildings and facilities, and purchase shared instrumentation. Bio-
medical research has benefited greatly from the ARRA, but there are increasing concerns about what
will happen when the program comes to an end. It is important that the young researchers whose
careers have been promoted through the support of the stimulus funds are not abandoned and that
promising projects initiated using ARRA funds are not delayed. This workshop was held to discuss
ways in which the government, universities, and other groups can “smooth” spending over time
and find other ways to avoid problems.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introduction: ARRA and NIH, and Government Support for Science
R. Freeman and A. Wang, NBER Science and Engineering Workforce Project, Harvard 
University, Cambridge, Massachusetts 
378
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SESSION 1: How NIH Spent the ARRA Funding and
Thoughts About Post-ARRA
Points to Consider
L. Tabak, National Institute of Dental and Craniofacial 
Research, Bethesda, Maryland
J. Niederhuber, National Cancer Institute, Bethesda, 
Maryland
P. Stephan, Andrew Young School of Policy Studies, Georgia 
State University, Atlanta
SESSION 2:What Is the Hard-Landing Scenario for Research
Careers? What Is the Best-Case Scenario?
Points to Consider 
M. Teitelbaum, The Alfred P. Sloan Foundation, New York, 
New York
J. Wiest, National Cancer Institute, Bethesda, Maryland
H. Garrison, Federation of American Societies for 
Experimental Biology, Bethesda, Maryland
SESSION 3: How Can Federal Agencies Manage the End of
ARRA?
Points to Consider
S. Turner, University of Virginia, Charlottesville
J. McGowan, National Institute of Allergy and Infectious 
Diseases, Bethesda, Maryland
D. Mowery, University of California, Berkeley
W. Schaffer G. Marschke, P. Stephan R. Freeman
SESSION 4: How Can Universities and Research Institutes
Manage the End of ARRA?
Points to Consider
D. Korn, Harvard University, Cambridge, Massachusetts
B. Stillman, Cold Spring Harbor Laboratory, New York
SESSION 5: How Can PIs Manage the End of ARRA?
Points to Consider 
G. Marschke, National Bureau of Economic Research, 
Cambridge, Massachusetts
R. Kolter, Harvard Medical School, Boston, Massachusetts
M. Carlson, Howard Hughes Medical Institute, Chevy 
Chase, Maryland
F. Murray, MIT Sloan School, Cambridge, Massachusetts
SESSION 6: Innovative Approaches to Managing Support for
Science
Points to Consider
W. Goldschmidts, Cold Spring Harbor Laboratory, New 
York 
D. Goroff, The Alfred P. Sloan Foundation, New York, New 
York 
W. Schaffer, National Institutes of Health, Bethesda, 
Maryland
Summary and Concluding Remarks
R. Freeman, NBER Science and Engineering Workforce 
Project, Harvard University, Cambridge, Massachusetts
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Linguistic Phenotypes: Toward a Biological Understanding
of Language
May 2–5
FUNDED BY The Simons Foundation
Université de Québec à Montréal
Oliver Grace Fund
ARRANGED BY R. Berwick, Massachusetts Institute of Technology, Cambridge
N. Chomsky, Massachusetts Institute of Technology, Cambridge
A. Di Sciullo, Université de Québec, Montréal, Canada
P. Mitra, Cold Spring Harbor Laboratory, New York
K. Wexler, Massachusetts Institute of Technology, Cambridge
The general idea of this meeting was that language provides a window into mental function that
can be exploited for the study and understanding of neuropsychiatric disorders. One of the out-
standing problems in the study of neuropsychiatric disorders is the relative paucity of objectively
defined phenotypic measures, which can be used for diagnoses and in psychiatric genetic studies.
Linguistic performance reflects thought processes, so the hypothesis is that quantitative measures
defined on the basis of linguistic performance could be used to characterize phenotypic variability
among individuals. Autism (which includes communication disorders), specific language impair-
ment, as well as Williams syndrome (where language seems to be a relative strength) are of particular
interest in this regard. Schizophrenia (which includes thought disorder in its symptom list) may
also be amenable to useful linguistic phenotyping. Participants included linguists and psycholinguists
interested in human neurobiology and disease, as well as biologists working on autism, schizophrenia,
and other neuropsychiatric disorders.
A major goal of the meeting was to bring together scientists who are doing linguistic phenotyping
with experts in the syndromes and geneticists, in an attempt to push along what we hope will be an
exciting field that can make major contributions to one of the most important scientific (theoretical
and applied) topics concerning humans.
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Introductory Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
INTRODUCTORY SESSION
Chairperson: R. Berwick, Massachusetts Institute of Technology, Cambridge
SESSION 1
Chairperson: A.-M. Di Sciullo, Université du Québec à Montréal, Canada
P. Mitra, Cold Spring Harbor Laboratory, New York:
Introduction.
N. Chomsky, Massachusetts Institute of Technology, 
Cambridge: Language as a biological organ: What is it? 
How does it develop? And why?
K. Wexler, Massachusetts Institute of Technology, Cambridge:
Optional infinitives: A worked-out model of a particular
linguistic characterization/phenotype.
S. Fisher, University of Oxford, United Kingdom: Building 
bridges between ge
nes, brains, and language.
A. Monaco, Wellcome Trust Centre for Human 
Genetics, Oxford, United Kingdom: Genetics of specific
language impairment.
N. Modyanova and K. Wexler, Massachusetts Institute of
Technology, Cambridge: Linguistic phenotypes of more
complex syntax: Phases and determiners in SLI, Williams
syndrome, and autism.
A. Perovic, University College London, United Kingdom:
Grammatical impairments in autism spectrum, Williams
syndrome, and Down syndrome.
L. Kovelman, University of Michigan, Ann Arbor: Optional
infinitive: Evidence of how adult brain processes grammatical
errors that are typical.
SESSION 2: 
Chairperson: K. Wexler, Massachusetts Institute of Technology, Cambridge, Massachusetts
L.-A. Petitto, University of Toronto, Canada: The phonetic,
genetic, and brain-based changes that give rise to early
language acquisition. Genes, brains, and cognition: 
space and language in Williams syndrome.
M.-T. Guasti, University of Milan-Biocca, Milan, Italy: SLI
and dyslexia: Differences between linguistic disorders in
children.
General Discussion
B. Landau, Johns Hopkins University School of Medicine,
Baltimore, Maryland
K. Wexler, Massachusetts Institute of Technology, Cambridge
P. Mitra, Cold Spring Harbor Laboratory, New York
Moderated Discussion: White Paper
SESSION 3 
Chairperson: P. Mitra, Cold Spring Harbor Laboratory, New York
D. Kimbrough Oller, University of Memphis, Tennessee and 
P. Niyogi, University of Chicago, Illinois: Vocal development
theory and the automated identification disorders including
autism.
P. Suppes, Stanford University, California: Brain
representations of linguistic constituents.
P. Freed, Columbia University, New York, New York:
Applications to clinical psychiatric practice.
N. Schiff, Weill Cornell Medical College, New York, New
York: Recovery of consciousness after severe brain injury.
Opportunities for linguistics to inform research.
D. Fox, Massachusetts Institute of Technology, Cambridge:
Logic, language, and modularity.
SESSION 4
Chairperson: N. Modyanova, Massachusetts Institute of Technology, Cambridge
L. Osborne, University of Toronto, Canada: Duplication of
genes on human chromosome 7q11.23 and their role in
speech and expressive language.
C. Mervis, University of Louisville, Kentucky: Speech and
language abilities of individuals with Williams syndrome.
S. Desiderio, Johns Hopkins School of Medicine, Baltimore,
Maryland: TFII-I, a target of genetic lesions associated with
the Williams–Beuren cognitive profile.
W. McCombie, Cold Spring Harbor Laboratory, New York:
Genetics becomes genomics.
Discussion: Future Planning
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Tumor Microenvironment and Metastasis
May 5–7
FUNDED BY Champalimaud Foundation and the Champalimaud Metastasis Programme
ARRANGED BY R. Kalluri, Harvard Medical School, Boston, Massachusetts
J. Massague, Memorial Sloan-Kettering Cancer Center, New York, New York
Approximately 80% of deaths related to cancer are associated with metastasis, and the central unan-
swered question remains the mechanism behind the systemic spread of cancer and secondary tumor
formation in distant organs. It is clear that the microenvironment of a cancer cell has a key role in
influencing its behavior and that this environment includes other cells and the tumor-associated
extracellular matrix. The question, then, is what role does the tumor microenvironment have in
metastasis? Is all the information needed for a cell to metastasize cell-autonomous or does the tissue
microenvironment have a role in determining this process? Does disrupting the tumor microenvi-
ronment have a positive or negative impact on metastatic potential of cancer cells? Can the mi-
croenvironment explain why many primary tumors favor secondary tumor formation in specific
organs? The meeting explored what constitutes the tumor microenvironment and examined its func-
tional impact on metastasis with specific focus on new targets for treatment of metastatic cancer. 
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: J. Watson, Cold Spring Harbor Laboratory, New York
SESSION 1
Chairperson: R. Kalluri, Harvard Medical School, Boston, Massachusetts
J. Massague, Memorial Sloan-Kettering Cancer Center, New York, New 
York: Surviving the microenvironment.
Z. Werb, University of California, San Francisco: Transcriptional 
regulation of metastasis.
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SESSION 2
Chairperson: Z. Werb, University of California, San Francisco
H. Dvorak, Beth Israel Deaconess Medical Center, Boston
Massachusetts: Angiogenesis: The wrong therapeutic target?
D. McDonald, University of California, San Francisco:
Angiogenesis inhibitors: Risk and return.
A. Harris, The Weatherall Institute of Molecular Medicine,
SESSION 3
Chairperson: K. Cichowski, Brigham & Women’s Hospital, Boston, Massachusetts
Oxford, United Kingdom: Role of notch signaling and anti-
VEGF therapy resistance.
H. Hurwitz, Duke University Medical Center, Durham, North
Carolina: Anti-angiogenesis therapy for cancer-expected and
unexpected outcomes.
M. Clarke, Stanford University, Palo Alto, California:
Regulation of self-renewal by the microenvironment in
normal epithelial stem cells and epithelial cancer cells or stem
cells and cancer, two faces.
R. Bjerkvig, University of Bergen, Norway: Cancer stem cells:
Can they be defined?
S. Haggarty, Massachusetts General Hospital, Boston: Patient-
specific stem cell modes for characterizing disease and
therapeutic discovery.
J. Chang, Baylor College of Medicine, Houston, Texas: Multi-
targeting of key self-renewal pathways.
SESSION 4
Chairperson: J. Massague, Memorial Sloan-Kettering Cancer Center, New York, New York
R. Kalluri, Harvard Medical School, Boston, Massachusetts:
Pericyte coverage of tumor vessels: An adaptive host response to
control tumor hypoxia?
J. Sleeman, University of Heidelberg, Germany: The
significance of lymphatic dissemination for metastasis: Blind
alley, highway, or beacon?
K. Cichowski, Brigham & Women’s Hospital, Boston,
Massachusetts: The inflammation, the microenvironment,
and prostate cancer metastasis.
D. Cheresh, University of California, San Diego, La Jolla:
microRNA-132 mediated loss of p120RasGAP activates
quiescent endothelium to facilitate pathological angiogenesis
and tumor growth.
SESSION 5
Chairperson: S. Mohla, National Cancer Institute, Bethesda, Maryland
S. Rafii, Weill Cornell Medical Center, New York, New York:
Contribution of the activated vascular niche to tumor growth.
D. Lyden, Weill Cornell Medical Center, New York, New
York: Early cellular molecular events for the information of
metastatic niche.
R. Hynes, Massachusetts Institute of Technology, Cambridge:
Extracellular matrices of tumors.
SESSION 6
Chairperson: Y. Kang, Princeton University, New Jersey
S. Dias, Portuguese Institute of Oncology, Lisbon, Portugal:
Metabolism and metastasis.
S. Muthuswamy, Ontario Cancer Institute, University of
Toronto, Canada: Cell polarity and cancer progression.
O. Casanovas, Catalan Institute of Oncology, Barcelona,
Spain: Tumor-adaptive responses to antiangiogenic therapies.
E. Sahai, Cancer Research UK, London, United Kingdom:
Cancer cell invasion in a complex environment.
R. Sordella, Cold Spring Harbor Laboratory, New York:
Intrinsic and extrinsic regulation of metastatic spread of
NSCLC.
SESSION 7
Chairperson: D. Lyden, Weill Cornell Medical College, New York
M. Skobe, Mount Sinai School of Medicine, New York, New
York: Role of lymphangiogenesis in tumor metastasis.
J. Condeelis, Albert Einstein College of Medicine, Bronx, New
York: Imaging of the tumor microenvironment of metastasis
and the cell types within.
Y. Kang, Princeton University, New Jersey: Tumor–stromal
interactions in bone metastasis: Novel targets for
therapeutic invention.
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Genetic Variation at a Single Locus for Prediction and
Prevention of Late-Onset Alzheimer’s Disease
May 9–10
FUNDED BY United Biomedical, Inc.
ARRANGED BY C. Finstad, United Biomedical, Inc., Hauppauge, New York
C. Wang, United Biomedical, Inc., Hauppauge, New York
Heterogeneity of response of individuals selected for clinical trials is a serious problem. Participants
in this workshop explored ways to incorporate “pharmacogenetics” as a tool in the selection of in-
dividuals with pre-Alzheimer’s disease for anti-Aβ peptide immunotherapy. There was also discussion
of how sequence variation is used to develop genome-wide association maps for determining how
genomes are organized and regulated and their role in disease.
Opening Remarks: J. Watson, Cold Spring Harbor Laboratory, New York
C. Wang, United Biomedical, Inc., Hauppauge, New York 
SESSION 1: Genetic Variation and Early Detection of Alzheimer’s Disease
A. Roses, Deane Drug Discovery Institute, Duke University
and Cabernet Pharmaceuticals, Durham, North Carolina:
Tomm40 variable-length polymorphism predicts the age of
late-onset Alzheimer’s disease (LOAD).
T. Gingeras, Cold Spring Harbor Laboratory, New York:
Origin of phenotypes: Genes and transcripts.
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SESSION 2: Immunotherapy and Immunoprevention of Alzheimer’s Disease
M. Weksler, Weill Cornell Medical College, New York, New
York: Role of a segmental immunodeficiency in age-
associated and trisomy 21-associated dementia: From
immunotherapy to immunoprevention.
N. Relkin, Weill Cornell Medical College, New York, New York:
Brain-imaging studies used in a phase II clinical study of
intravenous immunoglobulin (IVIg) in patients with
Alzheimer’s disease.
P. Szabo, Weill Cornell Medical College, New York, New York:
Amyloid-β peptide targets for immunotherapy of Alzheimer’s
disease.
C. Finstad, A. Walfield, F. Lin, K. Zhao, M.-J. Liao, C. Hung,
C. Wang, United Biomedical, Inc., Hauppauge, New York
and S. Lynn, B. Kuo, S.-N. Hsu, United Biomedical, Inc.,
Asia, Taiwan, Republic of China: Active immunization with
UBITh® amyloid-β1-14 synthetic peptide vaccine (UB311):
Design, development, and phase I clinical study.
SESSION 3: Discussion and Summary
A. Roses, D. Crenshaw, D. Burns, Duke University School of
Medicine, Durham, North Carolina and I. Grossman, T.W.
Swanson, Cabernet Pharmaceuticals, Durham, North
Carolina: Use of “Pharmacogenetics” in study design as a
tool to maximize the benefit/risk profile of a compound in
development, particularly at “proof of concept.” Suitable
biomarkers for early detection of Alzheimer’s disease and
clinical trial design.
Discussion Topics
• Phase II clinical trial protocol for UBITh® Aβ1-14 vaccine 
(UB311) in individuals with mild Alzheimer’s disease
• Phase II clinical trial protocol for UBITh® Aβ1-14 vaccine
(UB311) in individuals with mild cognitive impairment
(MCI) selected through MCI enrichment screening (amnesia
testing and FDG-PET scan) with posthoc genotyping of
APOE and 523 locus in TOMM40
• Retrospective genotyping of APOE and 523 locus in
TOMM40 in normal and individuals with Alzheimer’s
disease in a Chinese population
• Experience with FDG-PET and PiB-PET for early diagnosis
of individuals with pre-Alzheimer’s disease
Robertson House patio
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Mutagenesis: What It Means and How It Has Changed
May 15–18
FUNDED BY Oliver Grace Cancer Fund
ARRANGED BY J. Drake, National Institute of Environmental Health, Research Triangle Park, North Carolina
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Mutation is, of course, an integral part of genetics, although what are considered mutations has
changed over the years as new techniques have led to new knowledge, leading to revisions of what
“mutation” encompasses. This discussion meeting reviewed the developing concepts of mutation
and understanding of the varied forms of mutation from the early days of Drosophila genetics to
the present. Although the theme of the meeting was the history of the concept of mutation, con-
temporary research was also included, for example, on copy-number variation.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: J. Watson, Cold Spring Harbor Laboratory, New York
SESSION 1
S. Mueller-Wille, University of Exeter, United Kingdom: The
taxonomic roots of mutation: Constant varieties, sports, and
pure lines.
E. Carlson, Bloomington, Indiana: Mutation and the gene in
H.J. Muller’s course, career, and influence. 
S. Brenner, Salk Institute for Biological Studies, San Diego,
California: Discovery of frame-shift mutants.
R. Falk, Hebrew University of Jerusalem, Israel: Mutagenesis as
a genetic research strategy.
L. Campos, Drew University, Madison, New Jersey: From
experimental evolution to genetic engineering: Mutation at
Cold Spring Harbor Laboratory.
W. Maas, New York University School of Medicine, New York,
New York: Role of serendipitous mutants in the elucidation
of gene action and its regulation.
Who Are They? Identifying Participants in the Cold Spring
Harbor Laboratory Symposia Photographs 
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SESSION 2
B. Bridges, Romsey, United Kingdom: From phenomenology
to molecular understanding: Early work with ionizing
radiation mutation.
A. Creager, Princeton University, New Jersey: Mutation in the
atomic age.
B. Ames, Children’s Hospital Oakland Research Institute,
California: Mutation, detecting mutagens, and cancer
prevention.
J. Drake, National Institute of Environmental Health,
Research Triangle Park, North Carolina: Artifacts of
mutation ascertainment.
J. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York: Cold Spring Harbor Laboratory’s
contribution to the Human Genome Project.
W. Maas, R. Maas, B. Ames S. Brenner, J. Witkowski
E. Friedberg, E. Witkin
L. Pollock, Cold Spring Harbor Laboratory, New York:
International data repository for the history of the Human
Genome Project.
B. Ames, Children’s Hospital Oakland Research Institute,
California: Delaying cancer and other age-related diseases
with micronutrients.
N. Fedoroff, U.S. Department of State, Washington, D.C.:
McClintock, mutations, and epimutations. 
E. Friedberg, University of Texas Southwestern Medical School,
Dallas: The molecular mechanism of DNA-damage-induced
mutagenesis: After the SOS phenomenon to the present.
Who Are They? Identifying Participants in the Cold Spring
Harbor Laboratory Symposia Photographs 
SESSION 3
P. Hanawalt, Stanford University, California: Role of
transcription in mutagenesis and genomic stability.
M. Lynch, Indiana University, Bloomington: Evolution of 
the mutation rate.
G. Montgomery, New York, New York: Changing views on
sequence and synthesis. 
G. Walker, Massachusetts Institute of Technology, Cambridge:
Positively-acting functions required for mutagenesis:
Function and control of translesion DNA polymerases.
C. Weissmann, Scripps Research Institute, Jupiter, Florida:
Mutation-like events during prion propagation.
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PopTech Science and Public Leadership Fellows Retreat
August 11–15
FUNDED BY PopTech Accelerator
ARRANGED BY L. Filderman, PopTech, Camden, Maine
O. Wilder, PopTech, Camden, Maine
The PopTech Science and Public Leadership Fellows Program aims to develop a corps of extremely
high potential, socially engaged working scientists who embody science as an essential way of think-
ing, discovering, understanding, and deciding, and who can communicate both their work and the
importance of their fields to the public at large. The program gives these scientists intensive, high-
quality training, a powerful social network, ongoing mentoring, and opportunities for public lead-
ership and engagement. The Banbury Center was delighted to host the Fellows for the first meeting
of the science and public leadership group.
Welcome and Introductions: J. Witkowski, Executive Director, Banbury Center, Cold Spring Harbor Laboratory, New York 
A. Zolli, Executive Director and Curator, PopTech, Camden, Maine
C. Heller, CEO, Heller Communication Design, Brooklyn,
New York: Communicating for engagement.
M. Moon, Communication Designer, New York, New York:
Art of the great presentation. 
S. Marsh, Theatre Arts, Stony Brook University, New York:
Improv for scientists—Robertson House.
M. Duenwald, Deputy Editor, Op-Ed Page, The New York
Times, New York, New York: Demystifying the Op-Ed page.
L. Witter, Chief Strategy Officer, Fenton, New York: Media
training.
H. Schneider, Dean, School of Journalism, Stony Brook
University, New York: Communicating science in a changing
media landscape.
Panel Discussion: The Journalists’ Perspective
L. Cuthbert, Director, Discovery News, New York, New York
B. Nissen, Senior Producer, NBC News-NBC Learn, New York.
M. Moyer, Senior Technology Editor Scientific American,
New York, New York and I. Oransky, Executive Editor,
Reuters Health: Science, New York, New York: The
journalist’s perspective.
M. Nisbet, Associate Professor, School of Communication,
American University, Washington, D.C. and R. Covey,
Senior Vice President, National Geographic Digital Media,
Washington, D.C.: Framing scientific issues to foster
engagement.
G. MacKenzie, Founder and President, Gillian MacKenzie
Agency, New York, New York; W. Murphy, Senior Editor,
Random House, New York, New York; T. Neillsen, CEO,
BrightSight Group, Princeton, New Jersey: Creating a
personal brand.
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Plant Development and Phenomics
September 19–22
FUNDED BY Cold Spring Harbor Laboratory/Pioneer–DuPont Joint Collaborative Research Program
ARRANGED BY D. Jackson, Cold Spring Harbor Laboratory, New York
H. Sakai, Pioneer–DuPont International, Johnston, Texas
Every year, the Cold Spring Harbor Laboratory–DuPont Pioneer Collaborative meets to review cur-
rent projects and to plan future projects. This year’s update focused on the area of phenomics and
its relation to plant development and included current research from outside the collaboration by
speakers working in this field.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: D. Jackson, Cold Spring Harbor Laboratory, New York
S. Tingey, DuPont Experimental Station, Wilmington, Delaware
SESSION 1: Informatics, Natural Variation, and Yield
Chairperson: Z. Lippman, Cold Spring Harbor Laboratory, New York
W. McCombie, Cold Spring Harbor Laboratory, New York:
Novel sequencing methodologies and results.
B. Fendler, Cold Spring Harbor Laboratory, New York:
Population genetics of microsatellites in humans.
D. Ware, Cold Spring Harbor Laboratory, New York: Profiling
maize using next-generation sequencing approaches.
Z. Lippman, Cold Spring Harbor Laboratory, New York:
Flowering, dosage, and yield.
R. Lafitte, Pioneer Hi-Bred International, Johnston, 
Iowa: Maize field phenotyping for transgene 
validation.
M. Williams, Dupont Experimental Station, Wilmington,
Delaware: Identifying maternal haploid-inducing QTL1 and
ENU-mutagenesis of maize.
SESSION 2: Development, Epigenetics, and Networks
Chairperson: M. Aukerman, Dupont Experimental Station, Wilmington, Delaware
P. Bommert, Cold Spring Harbor Laboratory, New York: Cloning
of compact Plant2 and update on other fasciated mutants.
M. Komatsu, DuPont Experimental Station, Wilmington,
Delaware: Inflorescence traits and hybrid production.
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M. Aukerman, Dupont Experimental Station, Wilmington,
Delaware: A putative silencing suppressor identified from an
NUE screen.
K. Creasey, Cold Spring Harbor Laboratory, New York:
Developmental interaction of DDM1 and RNAi.
J. Han, Cold Spring Harbor Laboratory, New York:
Identification of high-copy mutator insertions in MTM lines
by Illumina sequencing.
A. Eveland, Cold Spring Harbor Laboratory, New York:
Expression profiling of maize inflorescences.
C. MacAlister, Cold Spring Harbor Laboratory, New York: Control
of meristem size and identity at the transition to flowering in
tomato: Role of terminating flower and fasciated flower.
S. Kumari, Cold Spring Harbor Laboratory, New York:
Genome-wide computational predications of core promoter
elements in plant genomes.
E. Spalding, University of Wisconsin, Madison: Root 
phenomics.
T. Altmann, Leibniz Institute of Plant Genetics and Crop,
Gatersleben, Germany: Analysis of Arabidopsis natural
genetic variation and heterosis in biomass accumulation and
metabolism.
G. Li, Pioneer Hi-Bred International, Johnston, Iowa: HTP
greenhouse phenotyping: Challenges and promises.
Y. Eshed, Weizmann Institute of Science, Rehovot, Israel: Leaf
development.
M. Scanlon, Cornell University, Ithaca, New York: Maize
shoot apical meristem genomics.
SESSION 3: Phenomics and Shoot Development
Chairperson: R. Williams, DuPont Experimental Station, Wilmington, Delaware
SESSION 4: Reproductive and Root Development
Chairperson: D. Jackson, Cold Spring Harbor Laboratory, New York
J. Kyozuka, Tokyo University, Japan: Rice inflorescence
development. 
U. Grossniklaus, Institute of Plant Biology University of
Zurich, Switzerland: Genetic approaches toward the
engineering of apomixis.
D. Jackson, Cold Spring Harbor Laboratory, New York: Maize
inflorescence development.
G. Taramino, DuPont AgBiotechnology, Johnston, Iowa:
Toward understanding the genetic network controlling maize
root architecture. 
R. Martienssen, Cold Spring Harbor Laboratory, New York:
Heterochromatin reprogramming and germ cell fate.
S. Brady, University of California, Davis: Root networks.
SESSION 5: Epigenetics and General Discussion
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory, New York
A. Rafalski, Dupont Experimental Station, Wilmington,
Delaware: Update on epigenotyping method development at
Pioneer/Dupont.
M. Regulski, Cold Spring Harbor Laboratory, New York:
Epigenetic project.
J. Lu, Cold Spring Harbor Laboratory, New York: Epigenetic
project.
M. Dotto, Cold Spring Harbor Laboratory, New York:
AGO10-associated small RNAs and tasiRNA pathways in
maize.
K. Petsch, Cold Spring Harbor Laboratory, New York: Genetic
dissection of inbred-specific modifiers of the maize tasiRNA
pathway.
S. Tingey E. Spalding, S. Brady
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Fragile X Syndrome: Current Status, Future Prospects
September 26–29
FUNDED BY University of Illinois through a grant from National Institute of Mental Health with
additional support from the National Institute of Child Health and Human Development
ARRANGED BY K. Huber, University of Texas Southwestern Medical Center, Dallas
P. Vanderklish, Scripps Research Institute, La Jolla, California
The Banbury meetings on Fragile X syndrome have served as a major catalyst for the rapid advances
the field has made over the last decade. These include elucidation of the molecular functions of
FMRP; formation of the mGluR theory of Fragile X; expanded descriptions of behavioral pheno-
types present in humans and animal models; identification of FMRP targets that have led to novel
pathways for potential pharmacotherapy; and to several clinical trials. The present meeting was de-
voted to a critical review of where the field stands, an examination of the current debates about
mechanisms and treatments, and determination of the essential next steps.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Fragile X Portraits: K. Clapp, FRAXA Research Foundation, Newburyport, Massachusetts
SESSION 1: Clinical Trials and Outcome Measures
Chairperson: D. Nelson, Baylor College of Medicine, Houston, Texas
M. Tranfaglia, FRAXA Research Foundation, Newburyport,
Massachusetts: Psychopharmacology of Fragile X: Past,
present, and future.
R. Hagerman, University of California Davis Health System,
Sacramento: Arbaclofen trial: Seaside study. 
S. Webb, University of Washington, Seattle: Can EEG be used
to assess response to medication?
E. Berry-Kravis, Rush University Medical Center, Chicago,
Illinois: New outcome measures for clinical trials in FXS.
C. Erickson, Riley Hospital for Children, Indianapolis,
Indiana: Commercially available glutamatergic agents in
Fragile X syndrome: Pilot investigations. 
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D. Rojas, University of Colorado, Denver School of Medicine:
Gamma-band responses as potential biomarkers in autism
and FXS.
W. Gan, New York University Medical Center, New York,
New York: Abnormal experience-dependent dendritic spine
plasticity in a mouse model of Fragile X.
A. Contractor, Northwestern University, Chicago, Illinois:
Synapse development in the sensory cortex of FMR1
knockout mice.
M. Huntsman, Children’s National Medical Center,
Washington, D.C.: Inhibitory neurotransmission defects in
Fragile X syndrome.
L. Kaczmarek, Yale University School of Medicine, New
Haven, Connecticut: FMRP, ion channels, and the
regulation of neuronal timing.
B. Alger, University of Maryland School of Medicine,
Baltimore: Endocannabinoids and a mouse model of Fragile
X syndrome.
O. Manzoni, Neurocentre Magendie, Bordeaux, France:
Disorganization of the endocannabinoid perisynaptic
signaling machinery in FMR1–/– mice.
R. Wong, SUNY–Downstate Health Science Center,
Brooklyn, New York: Mechanism of mGLuR-mediated
plasticity.
D. NelsonF. Tassone
SESSION 3: Receptors to Ribosomes
Chairperson: P. Vanderklish, Scripps Research Institute, La Jolla, California
K. Huber, University of Texas Southwestern Medical Center,
Dallas: Mechanisms of mGluR5 dysfunction in Fmrl KO
mice.
F. Tassone, Mind Institute, Davis, California: Altered mTOR-
dependent signaling and differential mGluR expression
patterns in Fragile X syndrome.
S. Zukin, Albert Einstein College of Medicine, Bronx, New
York: FMRP acts via PIKE to regulate mTOR signaling.
G. Bassell, Emory University, Atlanta, Georgia: FMRP and
miRNAs: Partners for translation at the synapse.
SESSION 4: FMRP Isoforms and Their Manipulation in Brain
Chairperson: I.J. Weiler, University of Illinois, Urbana-Champaign
D. Venkitaramani, University of Illinois, Urbana-Champaign:
FMRP isoforms and restoration of function. Spatial,
temporal, and splice variations in FMRP function.
SESSION 2: Synapses, Circuits, and Rhythms
Chairperson: K. Huber, University of Texas Southwestern Medical Center, Dallas 
D. Nelson, Baylor College of Medicine, Houston, Texas:
FMR1 and FXRs.
SESSION 5: Targets and Model Systems
Chairperson: G. Bassell, Emory University, Atlanta, Georgia
C. Westmark, Waisman Center, Madison, Wisconsin: Reversal
of Fragile X phenotypes by manipulation of APP/Aβ levels.
R. Jope, University of Alabama, Birmingham: Therapeutic
effects of GSK3 inhibitors in Fragile X mice.
B. Oostra, Erasmus University, Rotterdam, The Netherlands:
Rescue of behavioral phenotype and neuronal protrusion
morphology in FMR1 KO mice.
S. Haggarty, Massachusetts General Hospital, Boston: Using
patient-specific iPS cells for modeling pathogenesis and
treatment of Fragile X syndrome.
P. Vanderklish, Scripps Research Institute, La Jolla, California:
Strategies for new target discovery and evaluation. Identifica-
tion and validation of new targets for the treatment of FXS.
General Discussion: F. Gasparini, Novartis Pharma AG, Basel,
Switzerland
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Genome-Era Pathology, Precision Diagnostics, and
Preemptive Care: A Stakeholder Summit
October 13–15
FUNDED BY Various institutions and individual participants
ARRANGED BY M. Boguski, Beth Israel Deaconess Medical Center, Boston, Massachusetts
J. Saffitz, Beth Israel Deaconess Medical Center, Boston, Massachusetts
P. Tonellato, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Historically, the discipline of pathology has had a central role to detect, classify, and interpret cellular
and molecular markers of disease to guide physicians in the care and management of their patients.
In recent years, many high-throughput technologies have been developed and used in research to
determine the molecular and genetic mechanisms underlying diseases, but the pathology community
has not responded systematically to the challenges and opportunities provided by these technological
innovations. The objective of this discussion workshop was to define these opportunities, identify
challenges and barriers to success, and formulate a call to action that will keep pathology at the fore-
front of modern medical care.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: The Issue and Objective
Welcome and Overview: J. Saffitz, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
Brief Background Presentations
J. Schamberg, College of American Pathologists, Waukesha,
Wisconsin: Pathology today: Challenges.
E. Green, National Human Genome Research Institute,
Bethesda, Maryland: Genome-era pathology.
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J. Saffitz, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts: Genome-era
pathology and preemptive care.
M. Boguski, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts
Discussion: Objectives of genome-era pathology
Objective: Define and refine primary objectives, open issues,
and potential action items
SESSION 2: Factors for Success
J. Crawford, North Shore LIJ Laboratories, Lake Success, New
York
Discussion: Obstacles and challenges
Objective: Identify and prioritize primary challenges and
identify potential solutions
P. Tonellato, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts and R. Haspel, Beth
Israel Deaconess Medical Center, Harvard Medical School,
Boston, Massachusetts
Discussion: Overcoming the obstacles and challenges.
Objective: Review current efforts designed to resolve
obstacles. 
Identify key stakeholders, approaches and methods to 
overcome barriers and funding options that may provide the 
resources and forums to act on solutions
J. Crawford, North Shore LIJ Laboratories, Lake Success, New
York, P. Tonellato, Beth Israel Deaconess Medical Center,
Harvard Medical School, Boston, Massachusetts, and M.
Boguski, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts
Discussion: Summarize objectives, action items, and next steps
Objective: Summarize main points and final action items
J. Saffitz, Beth Israel Deaconess Medical Center, Harvard
Medical School, Boston, Massachusetts
Discussion: The horizon view
SESSION 3: A Call to Action
S. Tomlins, F. Barr W. Rosenkrans, R. Jeter, H. Halvorson
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Stem Cells, Genetics, and RNA-Binding Proteins: Recent
Advances in ALS Research and Drug Discovery
October 17–19 
FUNDED BY The ALS Association Greater New York Chapter
ARRANGED BY L. Bruijn, The ALS Association, Washington, D.C.
T. Maniatis, Columbia University Medical Center, New York, New York
C. Svendsen, University of Wisconsin, Madison
During the past decade, significant progress has been made in understanding the mech-
anisms leading to ALS. The focus has shifted from a motor neuron centric view to a
recognition that the neighboring cells and in particular the glia have an integral role in
the disease process. The landscape for ALS is again changing, and this meeting brought
together leaders in diverse fields of ALS genetics, RNA processing, stem cells, and model
systems to discuss how to capitalize on the promising research advances in all these
fields and make an impact on ALS discoveries. Progress in developing new in vitro and
in vivo systems to better understand the disease and the development of new tools for
drug discovery were key topics of discussion at the workshop. The workshop provided
a unique opportunity for academic scientists, clinicians, and the industry to discuss
how better to understand the role of the new genes in ALS and how this impacts drug
discovery.
Introduction: L. Bruijn, The ALS Association, Washington, D.C.
Introductory Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
T. Maniatis
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Overview of FUS/TDP43 Genetics and Pathology
C. Shaw, Guy’s Hospital, London, United Kingdom
R. Brown, University of Massachusetts, North Worchester
Emerging Technologies in Genetics: Session Discussion
J. Hardy, Reta Lila Weston Institute of Neurological Studies,
University College London, United Kingdom
R. Myers, Hudson Alpha Institute for Biotechnology,
Huntsville, Alabama
SESSION 1: Genetics of ALS
Chairpersons: C. Shaw, Guy’s Hospital, London, United Kingdom and R. Brown, University of Massachusetts,
North Worchester
SESSION 2: Disease Mechanisms and ALS
Chairperson: A. Goldberg, Harvard Medical School, Boston, Massachusetts
Disease Mechanism and Lessons Learned from SODI
D. Cleveland, University of California, San Diego, La Jolla
Protein Misfolding and Cell Death: Apoptosis, Autophagy,
and Necrosis
A. Goldberg, Harvard Medical School, Boston, Massachusetts
J. Rothstein, D. Cleveland
D. Borchelt, University of Florida, Gainesville
Glial–Neuronal Interactions and Inflammation
J. Rothstein, Johns Hopkins University School of Medicine,
Baltimore, Maryland
B. Barres, Stanford University School of Medicine, California
SESSION 3: Animal Models
Chairperson: G. Cox, The Jackson Laboratory, Bar Harbor, Maine
R. Baloh, Washington University School of Medicine, St.
Louis, Missouri
D. Cleveland, University of California, San Diego, La Jolla
P. Wong, Johns Hopkins University, Baltimore, Maryland
N. Shneider, Columbia University, New York, New York
SESSION 4: TDP43/FUS and Disease Mechanism
Chairperson: T. Maniatis, Columbia University Medical Center, New York, New York
M. Moore, HHMI/University of Massachusetts Medical
School, Worcester
SESSION 5: Stem Cells
Chairperson: C. Svendsen, Cedar Sinai Medical Center, Los Angeles, California
V. Lee, University of Pennsylvania School of Medicine,
Philadelphia
IPS Technology
F. Soldner, Whitehead Institute, Massachusetts Institute of
Technology, Cambridge
IPS in ALS–Model Systems
C. Svendsen, Cedar Sinai Medical Center, Los Angeles,
California
K. Eggan, Harvard University, Cambridge, Massachusetts
Assay Development Using Stem Cells
H. Wichterle, Columbia University, New York, New York
D. Fischer, BioFocus DPI, Leiden, The Netherlands
S. Finkbeiner, University of California, San Francisco
SESSION 6: Closing Session
Chairperson: C. Svendsen, Cedar Sinai Medical Center, Los
Angeles, California
T. Maniatis, Columbia University Medical Center, New York,
New York
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The Calculus of Medicine: Treatment of Pancreatic
Cancer as a Prime Exemplar
October 20–22 
FUNDED BY Abraxis BioScience, Inc.
ARRANGED BY J. Fleshman, Pancreatic Cancer Action Network, Manhattan Beach, California
B. Mishra, Courant Institute, New York University, New York, New York
P. Soon-Shiong, Abraxis BioScience, Inc., Los Angeles, California
This meeting emphasized the importance of the integration of computer science, statistics, and
mathematics into biomedical research and clinical trials, focusing on a better understanding of can-
cer, with pancreatic cancer as the prime exemplar. Key leaders in oncology research and clinical ap-
plication discussed how to shape this exciting field (and community) with a particular focus on
genomics, proteomics, imaging, translational bioinformatics, systems biology, disease modeling, sin-
gle-cell analysis and nano-medicine.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: J.-P. Bizarri, Celgene, Summit, New Jersey
SESSION 1: The Biology of Pancreatic Cancer
Chairperson: D. Tuveson, CRUK Cambridge Research Institute, United Kingdom
R. Hruban, Johns Hopkins Medical Institutions, Baltimore,
Maryland: Genetics of pancreatic cancer.
D. Simeone, University of Michigan Health Systems, Ann
Arbor: Pancreatic stem cells.
D. Bar-Sagi, New York University, New York, New York: Inter-
and intra-cellular pathways in PDA.
D. Hedley, Ontario Cancer Institute, Toronto, Canada: Effects
of the tumor microenvironment on invasion and metastasis.
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D. Tuveson, CRUK Cambridge Research Institute, United
Kingdom: Stromal barriers in pancreatic cancer.
M. Lisanti, Kimmel Cancer Center, Philadelphia,
Pennsylvania: Warburg in reverse: The autophagic tumor
stroma model of cancer.
M. Lotze, University of Pittsburgh, Pennsylvania: Autophagy
as a target in pancreatic cancer.
SESSION 2: Clinical Developments in Pancreatic Cancer
Chairperson: M. Tempero, University of California, San Francisco
M. Tempero, University of California, San Francisco: New
paradigms for drug development.
J. Berlin, Vanderbilt-Ingram Cancer Center, Nashville,
Tennessee: New agents for treatment of pancreatic cancer.
M. Hidalgo, Centro National de Investigaciones Oncologicas,
Madrid, Spain: Targeting the stroma in pancreatic cancer.
P. Philip, Karmanos Cancer Institute, Detroit, Michigan:
Targeting IGF-IR in pancreatic cancer.
J. Clark, Massachusetts General Hospital, Boston: Modulating
KRAS as a target in pancreatic cancer.
W. Isacoff, University of California, San Francisco: Novel
chemotherapy schedules for pancreatic cancer.
SESSION 3: BioInformatics and BioMarkers in Pancreatic Cancer
Chairperson: B. Mishra, Courant Institute, New York University, New York, New York
C. Cantor, Sequenom Inc., San Diego, California: Cancer-
specific nucleic acid sequences.
J. Reed, University of California, Los Angeles: Nano
measurement approaches for characterizing single cells in
populations.
B. Mishra, Courant Institute, New York University, New York,
New York: Translational cancer bioinformatics.
J. Watson, L. Lisanti D. Bar-Sagi, D. Simeone
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Energy Metabolism, the Cell Cycle, and Cancer
October 31–November 3
FUNDED BY Oliver Grace Cancer Fund
ARRANGED BY D. Beach, Barts and London School of Medicine & Dentistry, United Kingdom
L. Cantley, Beth Israel Deaconess Medical Center, Boston, Massachusetts
B. Futcher, Stony Brook University, New York
In 1924, Otto Warburg drew attention to the fact that cancer cells generate energy largely through
glycolysis and he believed that this was the fundamental characteristic of cancer cells. In recent years,
there has been a renewal of interest in the Warburg effect, and this meeting focused on the general
idea that proliferating cells may require more energy than quiescent cells and that energy production
must therefore be coordinated with commitment to cell cycle entry. Specific topics included the
Warburg effect; TOR and AKT signaling; metabolites controlling gene expression, energy metabo-
lism, and the cell cycle; and effects of oxygen and reactive oxygen species. Although the meeting
concentrated on mammalian systems, recent results from model systems such as yeast showing link-
ages between energy metabolism and cell cycle were also discussed.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: C. Van Dang, Johns Hopkins Medical School, Baltimore, Maryland
SESSION 1: Glycolysis and Energy
Chairperson: J. Blenis, Harvard Medical School, Boston, Massachusetts
J. Chesney, University of Louisville, Kentucky: Fructose-2, 6-
bisphosphate couples glycolysis with proliferation.
C. Van Dang, Johns Hopkins Medical School, Baltimore,
Maryland: Oncogenic alterations of glucose and glutamine
metabolism.
M. Vander Heiden, Massachusetts Institute of Technology,
Cambridge: PKM2 and understanding the energetics of
cancer cell metabolism.
R. Shaw, Salk Institute for Biological Studies, La Jolla,
California: The LKB1/AMPK pathway: Tumor suppression
and central regulators of metabolism.
M. Pollak, SMBD Jewish General Hospital, Montreal,
Quebec, Canada: Host energy intake, cellular energy supply,
and tumor growth: Roles of insulin and AMPK. 
K. Struhl, Harvard Medical School, Boston, Massachusetts:
Metformin selectively kills cancer stem cells and acts together
with chemotherapy to prolong remission. 
399
367-410_LAR_Banbury_Annual Report_2009 template  7/8/11  12:26 PM  Page 399
400 Banbury Center
SESSION 2: Metabolic Regulation
Chairperson: J. Chesney, University of Louisville, Kentucky 
J. Brugge D. Schenkein A. Caudy
Y. Xiong, University of North Carolina, Chapel Hill: Metabolic
regulation in normal and tumor cells.
M. Lisanti, Kimmel Cancer Center, Philadelphia, Pennsylvania:
Warburg in reverse: The autophagic tumor stroma model of
cancer.
J. Brugge, Harvard Medical School, Boston, Massachusetts:
Regulation of metabolism by extracellular matrix on
oncogenes.
L. Cantley, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: PI3 kinase and cancer metabolism.
D. Schenkein, Agios Pharmaceuticals, Cambridge,
Massachusetts: Mutations in isocitrate dehydrogenase: Role
in disease pathogeneses and potential as a therapeutic target.
T. Mak, Campbell Family Institute for Breast Cancer Research
at PMH, UHN, Toronto, Ontario, Canada: Knock-in
mouse model for IDH1 mutations.
J. Blenis, Harvard Medical School, Boston, Massachusetts:
Amino acids, mTOR signaling, and metabolism.
B. Manning, Harvard University, Boston, Massachusetts:
mTOR activation drives the metabolic reprogramming of
tumor cells.
M. Tyers, University of Edinburgh, United Kingdom:
Metabolic and growth control by TOR effectors in yeast.
B. Futcher, Stony Brook University, New York: Introductory
remarks.
B. Tu, University of Texas Southwestern Medical Center,
Dallas: Metabolic signals that drive cell growth and
proliferation.
A. Caudy, Princeton University, New Jersey: The
sedoheptulose bisphosphatase SHB17 shunts carbon from
glycolysis to the pentose phosphate pathway for riboneo-
genesis in yeast.
J. Broach, Princeton University, New Jersey: Direct control of
metabolism by nutrient signaling pathways in yeast.
B. Futcher, Stony Brook University, New York: cAMP,
liquidation of storage carbohydrates, and commitment to
the cell cycle.
S. Kohlwein, Karl-Franzens-Universitat Graz, Austria: Lipid
requirements during the cell cycle.
E. White, Cancer Institute of New Jersey, New Brunswick:
Role of autophagy in cancer metabolism.
K. Vousden, Beatson Institute for Cancer Research, Bearsden,
Glasgow: The regulation of metabolism by p53.
A. Levine, Institute for Advanced Study, Princeton, New
Jersey: Role of p53 in regulating metabolic pathways.
L. Cantley, Beth Israel Deaconess Medical Center, Boston,
Massachusetts: Concluding remarks and general discussion.
SESSION 3: PI3 Kinase, Isocitrate Dehydrogenase, TOR
Chairperson: L. Cantley, Beth Israel Deaconess Medical Center, Boston, Massachusetts
SESSION 4: Connections between Metabolism and Cell Cycle in Yeast
Chairperson: M. Tyers, University of Edinburgh, United Kingdom
SESSION 5: Cancer Metabolism and p53
Chairperson: L. Cantley, Beth Israel Deaconess Medical Center, Boston, Massachusetts
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Easeful Death: 21st Century Perspectives on Assisted Suicide
November 3–5
FUNDED BY The Ellison Medical Foundation
ORGANIZED BY M. Battin, University of Utah, Salt Lake City
E. MacDonald, Guy’s and St. Thomas Hospital, London, United Kingdom
T. Murray, The Hastings Center, Garrison, New York, New York
M. Raff, University College London, United Kingdom
J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Because of advances in medical care, the proportion of the elderly in the population is increasing.
And as a consequence, the number of individuals suffering from Alzheimer’s, Parkinson’s, and motor
neuron diseases, as well as other age-related degenerative disorders, is increasing. Individuals suffering
from these disorders place an extraordinary burden on their caregivers, who are often also elderly
and who may be unable to cope. End-of-life issues involve profound legal, moral, religious, and
biomedical questions and evoke such intense passions that calm discourse is hard to achieve. The
Banbury Center provided a venue for calm discussions of topics, which included what are the data
on assisted suicide and how (and why) do interpretations of the data differ? What is the evidence
for abuse, what is its incidence and how might it be prevented? How can end-of-life decisions be
made in cases of psychiatric illness (and perhaps dementia)? Participants included scientists, physi-
cians, philosophers, lawyers, and religious leaders and included experts on euthanasia and assisted
suicide in Europe.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: M. Raff, University College London, United Kingdom
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SESSION 1
Chairperson: T. Murray,The Hastings Center, Garrison, New York
D. Orentlicher, University of Iowa, Iowa City: Drawing lines
at the end of death: Where can we draw meaningful lines
among treatment withdrawal, assisted suicide, and
euthanasia?
B. Onwuteaka-Philipsen, VU Medical Center, Amsterdam,
The Netherlands: The influence of regulation on the practice
of assisted suicide in The Netherlands.
L. Deliens, Vrije Universiteit, Brussels, Belgium: Belgian data
on euthanasia.
L. Cohen, Baystate Medical Center, Northampton,
Massachusetts: Accusations and investigations of euthanasia
and PAS directed at American palliative medicine physicians.
Matters arising from Day 1
J. Prey, M. Raff L. Deliens, T. Murray
Z. Schostak, B. Gert
SESSION 2
Chairperson: E. MacDonald, Guy’s and St. Thomas Hospital, London, United Kingdom
SESSION 3
Chairperson: R. Payne, Duke Divinity School, Durham, North Carolina
C. Baron, Boston College, Newton, Massachusetts: Law at the
end of life: Have we come of age?
J. Lynn, Colorado Foundation for Medical Care, Chevy Chase,
Maryland: Political realities and strategies: Improving care in
the “death panel” era.
General Discussion: What is the 21st perspective on assisted
suicide?
M. Battin, University of Utah, Salt Lake City: Discussion.
B. Gert, Dartmouth College, Hanover, New Hampshire:
Refusal of hydration and nutrition as an alternative to
physician-assisted suicide.
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Microbial Forensics in the Era of Genomics
November 7–10
FUNDED BY The U.S. Department of Homeland Security and individual participants
ARRANGED BY B. Budowle, University of North Texas Health Science Center, Fort Worth
T. Pals, U.S. Department of Homeland Security, Washington, D.C.
S. Schutzer, University of Medicine and Dentistry–New Jersey Medical School, Newark
This workshop brought experts in metagenomics together with experts from the field of microbial
forensics and bioterrorism to consider the implications of whole-genome sequencing for investigations
of bioterrorism. It is likely that whole-genome sequencing will become the method of choice to char-
acterize a microbe and compare it with a reference sample. However, there are issues when considering
strategic planning and implementation of genome-wide analyses for forensic attribution purposes.
These include the development of reference databases for making inferences about the significance
of an observation; the need to establish criteria to guide decision makers and scientists on performance
and expectations; how to deal with degraded and trace evidence; how to improve analytical and sam-
pling strategies for maximum extraction of information from large data sets; and cost.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1: Overview 
Chairperson: S. Schutzer, University of Medicine and Dentistry–New Jersey Medical Center, Newark
B. Budowle, University of North Texas Health Science Center,
Fort Worth: Microbial forensics in the era of genomics:
Setting the stage.
R. Murch, Virginia Tech–National Capital Region, Alexandria:
Overview of needs.
T. Pals, U.S. Department of Homeland Security, Washington,
D.C.: Bioforensics basic research R&D program.
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Discussion
Leaders:
N. Bergman, National Biodefense Analysis and
Countermeasures Center, Frederick, Maryland and A.
Phillippy, Battelle National Biodefense Institute, Frederick,
Maryland: Current analytical and bioinformatic tools
available to meet the national mandate for characterization of
microbial forensic evidence.
SESSION 2: Lessons from Case Studies
Chairperson: B. Budowle, University of North Texas Health Science Center, Fort Worth
R. Bull, Federal Bureau of Investigation, Frederick, Maryland:
Lessons learned from anthrax attack and other cases.
D. Rock and W. Laegreid, College of Veterinary Medicine,
Urbana, Illinois: Lessons not learned from animal agriculture
cases.
T. Cebula, Johns Hopkins University, Baltimore, Maryland:
Lessons learned from human food outbreaks.
SESSION 3: Technology: What Do We Currently Have and What Do We Need? If Money Is No Object;
Philosophy/Fantasy
Chairperson: P. Pesenti, U.S. Department of Homeland Security, Washington, D.C.
P. Keim, Northern Arizona University, Flagstaff: Whole-
genome sequencing, targeted genotyping, and the value of
databases for investigation of plague infections.
W. Nierman, J. Craig Venter Institute, Rockville, Maryland:
Forensic sequencing project accuracy with current sequencing
production platforms and assembly and analysis tools.
J. Ravel, Institute of Genome Sciences, University of
Maryland, Baltimore: Real-time or targeted marker typing
capabilities.
C. Fraser-Liggett, University of Maryland School of Medicine,
Baltimore: Current technologies and wish list.
W. McCombie, Cold Spring Harbor Laboratory, New York:
Overview of bioinformatic capabilities.
B. Budowle, A. van Daal, J. Smith, S. Schutzer, T. Cebula
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SESSION 5: Other Technologies Including Proteomics
Chairperson: S. Morse, Centers for Disease Control & Prevention, Atlanta, Georgia
S. Velsko, Lawrence Livermore National Laboratory,
California: Nongenetic technologies.
T. Angel, Pacific Northwest National Laboratory, Richland,
Washington: Proteomic complements to genomics.
R. Bull, Federal Bureau of Investigation, Frederick, Maryland:
Potential host forensic signatures.
SESSION 6: Metagenomics 
Chairperson: C. Fraser-Liggett, University of Maryland School of Medicine, Baltimore
G. Weinstock, Washington University School of Medicine, St.
Louis, Missouri: Metagenomics for surveillance.
J. Ravel, Institute for Genomic Research, University of
Maryland, Baltimore: Human microbiome.
Y. Fofanov, University of Houston, Texas: Software and 
analytical tools.
A. van Daal, Bond University, Gold Coast, Australia: Example
of specific platform (Illumina HiSeq) capabilities to meet
needs of microbial forensics.
SESSION 7: Bioinformatics
Chairperson: P. Keim, Northern Arizona University, Flagstaff
S. Velsko, Lawrence Livermore National Laboratory,
California: What questions need to be answered?
J. Tiedje, Michigan State University, East Lansing: Population
genetics issues.
R. Chakraborty, University of North Texas Health Science,
Fort Worth: Statistical interpretation issues: Comparison to
forensic human DNA.
T. Leighton, Children’s Hospital, Oakland Research Institute,
California: Next-generation DNA sequencing analysis of
clonal variants, manipulated populations, and production
process trace-back. 
S. Velsko, Lawrence Livermore National Laboratory, California:
Genetic inference on disease transmission networks.
SESSION 8: Data Sharing
Chairperson: D. Rock, College of Veterinary Medicine, Urbana, Illinois
T. Slezak, Lawrence Livermore National Laboratory,
California: Forensic uses of microarrays or databases for
sharing forensic data.
B. Budowle, University of North Texas Health Science Center,
Fort Worth: Archives and database needs.
SESSION 4: Quality of Sample of Necessary Technology
Chairperson: J. Burans, U.S. Department of Homeland Security, Frederick, Maryland
M. Eshoo, Ibis Biosciences, Inc. Carlsbad, California:
Extraction capabilities, DNA repair, and whole-genome
amplification and analysis of trace unculturable specimens.
wrap-up, strategies, and what we would like conveyed to the
community, stakeholders, policy makers, and summary for
manuscript.
J. Smith, Penn State University, Pennsylvania; BioForensic
Consulting, LLC, Edgewood, Maryland: Data exchange
requirements and policies for sharing.
C. Cooke Jr., WINPAC, Washington, D.C.: Quality assurance
for data generation.
SESSION 9: Summary
Chairperson: S. Schutzer, University of Medicine and Dentistry–New Jersey Medical School, Newark
B. Budowle, University of North Texas Health Science Center,
Fort Worth and Traci Pals, U.S. Department of Homeland
Security, Washington, D.C.: Prioritization of needs, recap,
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Signaling through Ubiquitin
November 14–17 
FUNDED BY The Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY R. Deshaies, California Institute of Technology, Pasadena
V. Dixit, Genentech, South San Francisco, California
W. Tansey, Vanderbilt University Medical Center, Nashville, Tennessee
The object of this meeting was to analyze and discuss how protein ubiquitylation exerts its myriad
biological effects within the cell. Although ubiquitin has traditionally been studied within the context
of protein turnover, it is now clear that ubiquitylation refers to a complex set of posttranslational
modifications that are interpreted by the cellular machinery to impact a broad range of biological
processes, just one of which is proteolysis. Participants in the meeting discussed the spectrum of ubiq-
uitin and related modifications, how they are recognized, and what they do. Discussions drew on ex-
perts in biochemistry, cell biology, computational biology, structural biology, genetics, and patho-
physiology to identify common emerging themes in how ubiquitin and related proteins work.
Introductory and Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
Introductory Remarks: W. Tansey, Vanderbilt University Medical Center, Nashville, Tennessee
SESSION 1: Signaling via Ubiquitin Chain Diversity and Recognition
Chairperson: T. Hunter, The Salk Institute, La Jolla, California 
R. Cohen, Colorado State University, Fort Collins:
Recognition of polyubiquitin chains.
K. Hofmann, Miltenyi Biotec GmbH, Gladbach, Germany:
UBL receptors: At the crossroads of UPS and autophagy. 
S. Polo, Institute of Molecular Oncology Foundation, Milan,
Italy: Specificity in chain formation and recognition.
Z. Chen, University of Texas Southwestern Medical Center,
Dallas: Ubiquitin signaling in the RIG-I antiviral pathway. 
I. Dikic, Johann Wolfgang Goethe University Medical School,
Frankfurt, Germany: Ubiquitin signaling networks.
K. Iwai, Osaka University, Japan: Linear polyubiquitination: A
new regulator of NF-κB signaling.
J. Peng, Emory University School of Medicine, Atlanta,
Georgia: Exploring ubiquitin pathways by quantitative
proteomics.
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SESSION 2: Signaling via Ub-Like Proteins
Chairperson: M. Hochstrasser, Yale University, New Haven, Connecticut
R. Hay, Sir James Black Centre, University of Dundee, United
Kingdom: SUMO targeted ubiquitin ligases.
J. Huibregtse, University of Texas, Austin: The mechanism and
function of ISG15 conjugation. 
T. Hunter, The Salk Institute, La Jolla, California: Ubiquitin-
SUMO cross-talk.
C. Lima, Memorial Sloan-Kettering Cancer Institute, New
York, New York: Structure and mechanism in the SUMO
conjugation pathway.
Y. Ohsumi, Frontier Research Center, Tokyo Institute of
Technology, Yokohama, Japan: Two ubiquitin-like
conjugation reactions essential for autophagy.
A. Huang, Sanofi-Aventis, Cambridge, Massachusetts:
Regulation of axin stability through poly-ADP ribosylation:
Linking Wnt pathway signaling activity, ubiquitination, and
poly-ADP-ribosylation.
SESSION 3: Signaling to the Proteasome
Chairperson: J. Huibregtse, University of Texas, Austin
D. Finley, Harvard Medical School, Boston, Massachusetts:
Editing of ubiquitin at the proteasome.
M. Glickman, Technion-Israel Institute of Technology, Haifa,
Israel: Coordination of ubiquitin-processing factors at the
proteasome.
M. Hochstrasser, Yale University, New Haven, Connecticut:
Proteases of the ubiquitin system.
R. Kopito, Stanford University, California: Why do ubiquitin
chains accumulate in neurodegenerative disease?
S. Murata, The University of Tokyo, Japan: Proteasome 
diversity.
R. Deshaies, California Institute of Technology, Pasadena: 
Nedd8 links active Cullin-RING ligases to p97 substrate
processing machinery.
SESSION 4: Ubiquitin–Proteasome Signaling in the Nucleus
Chairperson: R. Hay, Sir James Centre, University of Dundee, United Kingdom 
G. Rosenfeld, University of California, San Diego, La Jolla:
Ubiquitylation, SUMOylation, methylation, and strategies
in regulated transcriptional programs.
W. Tansey, Vanderbilt University Medical Center, Nashville,
Tennessee: Ubiquitin and transcription.
H. Ulrich, Cancer Research UK, London Research Institute,
Herts, United Kingdom: Ubiquitin and replication stress.
SESSION 5: Ubiquitin Signaling in Disease States
Chairperson: R. Kopito, Stanford University, California
A. D’Andrea, Dana-Farber Cancer Institute, Boston,
Massachusetts: Regulation of the Fanconi anemia pathway to
deubiquitination.
R. Youle, National Institute of Health, Bethesda, Maryland:
Mechanisms of Parkin-mediated mitophagy.
SESSION 6: Ub-Ligases, Isopeptidases, and Their Substrates
Chairperson: C. Lima, Memorial Sloan-Kettering Cancer Center, New York, New York
V. Dixit, Genentech, South San Francisco, California:
Ubiquitin modification in cancer.
W. Harper, Harvard Medical School, Boston, Massachusetts:
Signaling through the ubiquitin–proteasome pathway.
M. Pagano, New York University School of Medicine, New
York, New York: SCF ubiquitin ligases and cell proliferation.
P. Kaiser, University of California, Irvine: Interpretation of
ubiquitin signal.
P. Matthias, ETH Zurich, Institute of Biochemistry,
Switzerland: Regulation and substrates of Cullin-based E-3
ligases.
M. Rape, University of California, Berkeley: Role of lysine 11-
linked ubiquitin chains in cell cycle control.
B. Schulman, St. Jude Children’s Research Hospital,
Memphis, Tennessee: Structural studies of Cullin-RING
ligases.
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DNA, Genetics, and the History of Mankind
November 28–30 
FUNDED BY The Lehrman Institute
ARRANGED BY J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
The impact of molecular genetic studies has spread beyond the immediate discipline of biology,
and as the study of genetic variation is essentially an historical study, DNA analysis has been applied
to historical problems in related disciplines. For example, conclusions on the movements of early
human populations based on linguistic and archeological data have been reinforced or modified by
DNA analysis. Domestication of animals and plants marked one of the great transitions in human
history, and genetic analysis is revealing how and where domestication took place. Genetic analysis
may provide reliable information on personal relationships and identification that has been the sub-
ject of speculation, for example, Thomas Jefferson’s family and identifying the bodies of the Tsar’s
family. Participants in this workshop discussed how genetic and DNA analysis can further our un-
derstanding of the history of human beings, and how to promote such studies.
Welcoming Remarks: J. Witkowski, Banbury Center, Cold Spring Harbor Laboratory, New York
SESSION 1
Chairperson: M. Thomas, University College London, United Kingdom
K. Dobney, University of Aberdeen, United Kingdom and J.-
D. Vigne, Muséum National d’Histoire Naturelle, Paris,
France: Mammals to microbes: Role of genetics in exploring
past bio-cultural dynamics using the fossil vertebrae record.
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E. Willerslev, Natural History Museum of Denmark,
Copenhagen: Early peopling of the New World and
extinction of the megafauna.
M. Richards, University of Leeds, United Kingdom:
Archaeogenetics and modern human dispersals.
C. Bustamante, Stanford School of Medicine, California:
Sequencing admixed genomes and what the thousand
genomes data are telling us.
A. Chakravarti, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Admixture: What it means for
studying human populations.
B. Shapiro, Pennsylvania State University, University Park:
Appropriately incorporating spatial and temporal
information into genealogical analysis.
W. McCombie, Cold Spring Harbor Laboratory, New York:
Human genetics in the era of “next-generation” sequencing.
SESSION 2
Chairperson: J. Buikstra, Center for Bioarchaeological Research, Arizona State University, Tempe
S. Pääbo, Max-Planck Institute for Evolutionary Anthropology,
Leipzig, Germany: The contributions of DNA studies: What
we would not, and could not, have gained from other sources.
D. Reich, Harvard Medical School, Boston, Massachusetts:
Evidence for gene flow from neanderthals into modern humans.
J. Hawks, University of Wisconsin, Madison: Natural selection,
population growth, and human migrations in the early
holocene.
M. Crawford, University of Kansas, Lawrence: The sequelae of
Russian contact in the Aleutian archipelago: Molecular
perspectives.
M. Zeder, National Museum of Natural History, Washington,
D.C.: Documenting domestication: The intersection of
archaeology and genetics.
A. Stone, Arizona State University, Tempe: The origins and
spread of human tuberculosis. 
SESSION 3
Chairperson: L. Madrigal, University of South Florida, Tampa
N. Wade, The New York Times, New York, New York: The
evolution of human races and economic systems.
D. O’Rourke, University of Utah, Salt Lake City:
Consultation and consent: Cultural concerns in human
population genetic research.
SESSION 4: Future Developments
J.-D. Vigne, Muséum National d’Histoire Naturelle, Paris,
France: The Archaeozoology and Genetics (A&G) Working
Group of International Council for Archaeozoology (ICAZ).
D. O’Rourke, University of Utah, Salt Lake City: The
American Association of Physical Anthropologists.
J. Witkowski, Banbury Center, Cold Spring Harbor
Laboratory, New York
Discussion Points
• What might be done to foster cross-disciplinary
interactions in these fields?
• What topics should be covered in a Banbury Center
meeting in 2011?
• Any other points for discussion?
D. Micklos, S. Pääbo, D. Reich, B. Shapiro
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Preparing students and families to thrive in the gene age
ADMINISTRATION INSTRUCTION BIOMEDIA
Lauren Correri Jennifer Aiello Anthony Biondo
Mary Lamont Elna Carrasco Cornel Ghiban
Valerie Meszaros Jennifer Galasso Uwe Hilgert
David Micklos Natalia Hanson Eun-Sook Jeong
Karen Orzel Amanda McBrien Mohammed Khalfan
Carolyn Reid Erin McKechnie Susan Lauter
Bruce Nash Amy Nisselle
Ileana Rios Todd Rocheford
Tedi Setton Jason Williams
Jermel Watkins Chun-hua Yang
Just as a unique pattern of bars in a universal product code (UPC) identifies each item for sale in a
store, a DNA barcode is a DNA sequence that uniquely identifies each living species. This simple
premise was galvanized into action during meetings held in 2003 at Cold Spring Harbor Labora-
tory’s (CSHL) Banbury Center and funded by the Alfred P. Sloan Foundation. At these meetings,
scientists agreed to use short, standard DNA sequences to classify all living species and launched the
International Barcode of Life Project (iBOL).
Operating under the iBOL banner, collaborators from more than 150 countries are involved in
“campaigns” to census diversity in different plant, fungal, and animal groups, including ants, bees,
butterflies, fish, birds, mammals, fungi, and flowering plants, and within ecosystems, including the
seas, poles, rainforests, and coral reefs. The 10-year Census of Marine Life announced in October
the first comprehensive list of more than 190,000 marine species, involving 2700 scientists and
identifying 6000 potentially new species.
DNA barcoding is also important in detecting food fraud and products taken from conserved
species. In advance of formal DNA barcoding, in 1996, Rob DeSalle of the American Museum of
Natural History (AMNH) used related methods to find that five of 23 samples of caviar purchased
in New York City (NYC) were mislabeled and included three samples from threatened sturgeon
species. The Congressional Research Service recognizes that more than a dozen commercial fish are
often mislabeled, passing off cheaper fish for expensive varieties. In 2008, Trinity High School stu-
dents worked with Mark Stoeckle of The Rockefeller University and George Amato of the AMNH
to show the pervasiveness of fish fraud in NYC. They found that 25% of 60 seafood items pur-
chased in grocery stores and restaurants were mislabeled as more expensive species. One mislabeled
fish was an endangered species, the Acadian redfish.
Urban Barcode Project
DNA barcoding came full circle to New York, when in December we received a $300,000 grant from
the Sloan Foundation for the Urban Barcode Project, a science competition spanning the five bor-
oughs of NYC. Student research teams will use DNA barcoding to explore biodiversity in the city
environment, including: 
• Sampling biodiversity in a park, garden, office, or school.
• Checking for invasive plant or animal species. 
DNA LEARNING CENTER
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• Monitoring animal movements or migrations.
• Identifying exotic or endangered food products in markets.
• Detecting food or product fraud.
The competition is open to NYC high school students enrolled in grades 9–12. Teams of two to
four students will work with a teacher sponsor to submit a project proposal for a June or October
2011 deadline. Proposals will be judged for originality, creativity, relevance, plausibility, and scien-
tific merit. The top 100 teams will be invited to compete in the Urban Barcode Project. Teams must
complete their projects by the spring of 2012 and will present their work at a project symposium.
The best overall project will win the Grand Prize of $10,000, and an additional $10,000 in runner-
up prizes will be awarded.
Sponsoring teachers must participate in a 6-hour training session, which will dovetail with our
existing training program sponsored by the Howard Hughes Medical Institute (HHMI). Each suc-
cessful team will have free access to everything needed for their DNA barcode experiments, includ-
ing equipment, protocols, and reagents. Five equipment footlockers will be available for use by
individual schools or for groups of nearby schools to share. During the term of the project, we ex-
pect to process ~10,000 DNA sequences. Teams may work on their projects at summer workshops
and Open Lab days at designated locations.
Teams will be assigned a mentor from a NYC university, museum, or other scientific institution
to answer technical questions and provide advice. Many mentors will be drawn from five NYC in-
stitutions that are collaborating on the project: AMNH, New York Academy of Sciences, New York
Botanical Garden, Prospect Park Zoo, and The Rockefeller University. The project’s scientific ad-
visor, Mark Stoeckle, is a member of The Rockefeller Program for the Human Environment. In ad-
dition to demonstrating the educational promise of DNA barcoding, Dr. Stoeckle was one of the
organizers of the 2003 Banbury meeting that launched the field of DNA barcoding and serves on
iBOL’s Scientific Steering Committee.
A dedicated Internet microsite (www.urbanbarcodeproject.org) supports all phases of the proj-
ect. This “online lab notebook” includes a video introduction to the barcode experiment, down-
loadable PDF lab protocols, teacher preparation, bioinformatics tools, and multimedia resources.
Video interviews with scientists, animations, and video podcasts (vodcasts) describe the science and
applications of DNA barcoding, and an active news feed and a link to Dr. Stoeckle’s Barcode Blog
provide up-to-date perspectives on DNA barcoding. Student DNA sequences are automatically up-
loaded to the “Blue Line” of DNA Subway, an online tool for DNA barcode and phylogenetic analy-
sis developed as part of the National Science Foundation (NSF)-funded iPlant Collaborative. A
Google Maps utility will track biodiversity discovered by student experiments, and students will
highlight their projects through the social networking website, Facebook.
414 DNA Learning Center
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Student DNA Sequencing
A decade ago, the DNALC developed a similar program—with simplified biochemistry and a bioin-
formatics work flow—to allow students to analyze a portion of their own mitochondrial (mt) chro-
mosome. Using a kit distributed by Carolina Biological Supply Company, students isolate DNA
from cheek cells and then use polymerase chain reaction (PCR) to amplify the mitochondrial con-
trol region. Student samples are sent by overnight mail to the DNALC, where student interns pre-
pare them for sequencing. The processed samples are then sent to the CSHL Sequencing Facility in
Woodbury, and finished DNA sequences are uploaded to the Sequence Server database at our
BioServers website. There, students visualize their sequences and use software to align them with
mitochondrial sequences from modern humans and extinct hominids to explore human genetic di-
versity and evolution.
The donation of sequencing reagents by Applied Biosystems of Foster City, California has made
it possible to provide students this Sequencing Service free of charge. Since 1998, a total of 49,217
student DNA samples have been sequenced, and 1.3 million students and teachers have used the sup-
porting Bioservers website. We continued the Sequence Service in 2010, processing 7128 student
DNA samples received from 93 high schools and 57 colleges and universities. 
The cost of commercial sequencing, however, has decreased so dramatically during the last year
that in December, we ceased sequencing on site and shifted all sequencing to Genewiz, a global con-
tract research organization with expertise in sequencing. We negotiated a much-reduced price of
$3.00 per sample, which is less than our cost of sequencing with free reagents and student labor! This
arrangement anticipates the increased volume of sequencing demanded by our Urban Barcode Proj-
ect, as well as growing interest in using DNA sequencing in education. Student sequences are up-
loaded to our server within 48 hours of receipt by Genewiz, a dramatic improvement over the 2-week
turnaround we were previously able to provide.
iPlant Collaborative
The iPlant Collaborative is a consortium headed by the University of Arizona and CSHL to develop
a computer (cyber) infrastructure to support plant research. iPlant aims to develop tools and inter-
faces that will provide scientists with easy access to large-scale plant data sets and high-powered in-
formatics tools. Working Groups composed of iPlant staff and plant community members are
currently building “discovery environments” to help plant scientists solve two “grand challenges”:
(1) produce an iPlant Tree of Life (iPToL) encompassing ~500,000 plant species and (2) explore the
genotype-to-phenotype continuum in plants (iPG2P). 
Education, outreach, and training (EOT) is integral to iPlant’s mission of helping plant scien-
tists make the best use of computer infrastructure to solve biological problems. During the first 2
years of the project, EOT worked in parallel with the Grand Challenge teams to create an educa-
tional Discovery Environment that allows students and teachers to work with the same data and use
the same tools at the same time as high-level plant researchers. This
culminated in the release in March of DNA Subway, a student-cen-
tered platform for gene annotation and comparison.
DNA Subway uses the metaphor of a subway map as an appeal-
ing interface to sophisticated informatics tools. “Riding” on either
of the initial lines, students can predict and annotate genes in up to
150 kb of DNA (Red Line) or identify homologous, or related, se-
quences in whole genomes (Yellow Line). By year’s end, a third “Blue
Line” to analyze DNA barcodes and other short DNA sequences
was mostly complete. This line offers the types of sequence analysis
that precedes the massive tree construction envisioned by the iPToL DNA Subway’s Blue Line
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Grand Challenge, simplifying sequence alignment and construction of phylogenetic trees. The Blue
Line will support the Urban Barcode Project in NYC and a nationwide iPlant program to encour-
age students to identify plants using the barcode region of the rbcl gene found in chloroplasts. Thus,
DNA Subway provides opportunities for students to discover basic principles of genome biology
while embarking on independent research. By December 2010, the site had 742 registered users
and had received 14,535 unique visits.
Acting on recommendations of an NSF site visit in 2010, EOT began to expand its role and be-
came a Working Group analogous to those within the iPToL and iPG2P Grand Challenges. The
EOT Working Group (EOTWG) includes core iPlant staff, collaborators, and community mem-
bers from each of the Grand Challenge areas. The EOT Working Group also aims to increase the
number of scientists who use and contribute to iPlant Discovery Environments and tools. Toward
this goal, we are extending our successful workshop program to high-level researchers and are en-
couraging participants to bring their own data to analyze at workshops. This collaborative effort
will help us to develop case studies of interesting research questions that can be addressed with
iPlant Discovery Environments. 
As part of this expanded role, EOT multimedia staff at the DNALC took on the task of re-
designing the iPlant website to increase its appeal and utility (www.iplantcollaborative.org). This in-
cluded the development of podcasts that introduce
iPlant and the significance of the two Grand Chal-
lenges. The podcasts are available at the iPlant and
DNALC websites and on YouTube. In the coming
year, we will develop intuitive interfaces to data sets
and simplified work flows that make iPlant cyberin-
frastructure available to a wide range of users. One
project will repackage the iPG2P work flow for high-
throughput sequencing as a “Green Line” on DNA
Subway, allowing analysis of RNA data, including
transcriptome and RNA-Seq data. We will also de-
velop an Orphan Data interface that will match un-
derworked data sets with students and faculty who
would like to contribute to original research.
Harlem DNA Lab
Genetics and biotechnology occupy major parts of required science courses and exams taken by vir-
tually all NYC students in the eighth through tenth grades. However, teachers have received little
training and few resources to deliver hands-on labs that could make these topics come alive for stu-
dents. Thus, the objective of our HHMI program is to use our expertise to prepare NYC teachers
to teach a set of six labs that target key genetics and biotechnology concepts: DNA Structure and Iso-
lation, Variability and Inheritance, Bacterial Transformation, Protein Isolation, DNA Analysis and
Forensics, and Analysis of Human DNA Variations by PCR.
The lab program is supported by an Internet microsite, Lab Center, which is a virtual classroom
into which a DNALC staff member enters to make a video introduction for each lab. By clicking
on various objects on the whiteboard and desk, students can access (1) interactive and PDF versions
of the experiment, (2) follow-up activities, (3) scientist interviews, (4) animations, and (5) selected
links. In 2010, we began development of the final element of Lab Center: a series of vodcasts to
highlight how each of the target labs relates to research done at New York–area institutions. Each
New York Story will be largely produced by a team of NYC students. The initial vodcast, on green
fluorescent protein (GFP) and bacterial transformation, was developed by a six-student team from
Brooklyn International School and organized by HHMI Teacher Fellow and Assistant Principal
iPlant Collaborative redesigned homepage
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Kathleen Rucker and science teacher David Conneely. In parallel with a
DNALC videographer, students used flip cameras to record in their school
and at locations at Columbia University, where they interviewed Nobel
laureate Martin Chalfie.
During the year, we also implemented an important new element of in-
school support for NYC teachers. A grant from the Lounsbery Founda-
tion supported the purchase of equipment to outfit 15 biotechnology
footlockers that contain all of the equipment and expendable supplies
needed to teach each target lab. The kits are available to any teacher who
has undergone HHMI training. At $50 per class of 32 students, each foot-
locker is less than half the cost of a commercial kit. In their inaugural year,
the kits extended lab experiences to 1455 students, about half the num-
ber accommodated in field trips to the Harlem DNA Lab. To accelerate
footlocker use, we waived the restocking fee for most schools and pro-
vided free footlocker shipping. To further support teachers as they imple-
ment the labs, we recruited a part-time instructor at year’s end to accompany footlockers to schools
and help set up the equipment or coteach the lab activities. 
We also tore a page out of the DNALC’s own play book when we created a Charter Membership
Program for Harlem DNA Lab. The DNALC was started in 1985 with multiyear memberships from
local Long Island school districts. Adopting this model in the spring, we welcomed Trinity School and
The Chapin School as Charter Members of our Manhattan operation. Each school receives an ex-
clusive set of benefits to develop a sequenced program of accelerated science opportunities for students.
The program launched in June, with in-school Fun with DNA, DNA Science, and Human Genomics
workshops taught by DNALC instructors. The collaboration continued through the academic year
with focused faculty development, field trips to the DNALC, and assistance with student research. 
Although Harlem DNA Lab prospered in the face of the recession, we became increasingly con-
cerned with the continued devolvement of the NYC Department of Education (DOE). In the spring,
the DOE quietly disbanded its entire science supervisory de-
partment, with whom we and other organizations collabo-
rated to enrich science programs. It has also reassigned key
science discretionary funds to English and math, for which
student test scores are closely tracked for federal aid. The ad-
ministration has pushed responsibility for science advance-
ment onto loosely allied networks of schools, expecting them
to self-organize without access to funds. This explains why it
is difficult for teachers to find even the modest funds needed
to take a field trip to the Harlem DNA Lab or to restock
reagents for a footlocker kit that they can borrow from us.
Our host school, the John S. Roberts Educational Com-
plex, is emblematic of the instability faced by many schools
in NYC. It has been adversely affected by administrative
shuffling, with two schools phased out and two schools
phased in during our tenancy. Simple tasks, such as securing resources and teacher cooperation, have
become more difficult. Student discipline and security have become major concerns as enrollment in-
creases in each of the tenant schools. These situations impact the field trip experience for our visitors.
Reaching Underrepresented Minorities
It is a sad fact that Hispanic and African Americans perform poorly in science and are underrepre-
sented in scientific fields when compared with Caucasians. Hispanic and African Americans perform
Student at Harlem DNA Lab
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~20% lower in science than Caucasians on the International Assessment of Education Progress, a
respected benchmark for student achievement. This disparity holds true in grades 4, 8, and 12. Ac-
cording to the National Science Board, these groups are underrepresented in postsecondary science
education and science careers compared to their proportion of the overall U.S. population (24%).
Underrepresented minorities received 17% of bachelor’s degrees, 13% of master’s degrees, and 7%
of doctorates in science and engineering fields in 2007. They accounted for only 10% of college-
educated persons employed in science and engineering occupations and received salaries that aver-
aged 25% less than those of Caucasian workers.
The National Science Education Standards and other studies emphasize that students need to be
engaged in the process of science, asking questions, forming hypotheses, designing experiments,
collecting data, analyzing results, and forming conclusions. Underrepresented minorities—who are
concentrated in low-achieving schools and who may receive less science “boosting” at home—have
less access to hands-on experiences that help them to learn about science in the same way as scien-
tists. 
The DNALC takes seriously the challenge of increasing minority representation in science. The
Urban Barcode Project and our Harlem DNA Lab were established for the express purpose of pro-
viding minority and disadvantaged students—and their teachers—the same opportunities for lab-
oratory-based learning as those offered students in wealthy suburban school districts. Statistics for
2010 show that our Manhattan operation is reaching this target audience. Hispanic and African
Americans made up 69% of students visiting the Harlem DNA Lab and 41% of teachers trained
under our HHMI program. The strong Harlem numbers, combined with a policy of conducting
many teacher-training workshops at institutions serving minorities, maintained underrepresented
minorities at 25% of 696 teachers trained at 1–10-day workshops.
Doing the best job in science education for underrepresented minorities also requires that an in-
stitution practice what it preaches—and provide role models for students to emulate. Thus, dur-
ing the last several years, the DNALC has hired four exemplary African American and Latino
educators, who now compose 33% of the instructional staff. Jermel Watkins, Ph.D., began his sci-
ence career as a DNALC intern and completed his graduate training at Stony Brook University.
Jason Williams moved into education after research stints in two CSHL laboratories. Ileana Rios,
Ph.D., attended elementary school several blocks away from the Harlem DNA Lab and completed
her graduate training at City University of New York. Our newest staff member, Kerri-Ann
Matthews, brings experience as an informal science educator with the New York Hall of Science
and other science exhibitions.
Internet Strategies and Visitation
The September issue of Wired magazine ran the full-page headline, “The Web is Dead.” The lead
article made the point that the World Wide Web (WWW)—navigated by browsers such as Ex-
plorer, Firefox, Safari, and Chrome—now accounts for less than 25% of total Internet traffic. The
vast majority of Internet bandwidth is consumed by other types of communication, notably, e-mail,
virtual private networks (VPNs), voice-over Internet, music and video sharing, and active gaming.
The article also referred, metaphorically, to the struggle between the chaotic, “everything-all-the-time
(from-everyone)” world of websites—dominated by search engines such as Google—and the “what-
you-need-when-you need-it (from-someone-you-trust)” world of cell phone applications (apps) and
social media—dominated by sharing software such as Facebook and Apple iTunes. The DNALC
now finds itself in this struggle to adapt to the changing Internet landscape.
The DNALC benefited from its early entry into the Internet world. At a time when there were
only 10–25 million active websites on the Internet, websites we developed in the late 1990s and early
2000s rapidly built audiences. Overall visitation increased steadily, peaking at 7.1 million in 2007.
However, our visitation declined and then leveled at ~6 million in 2008–2009. In less than 5 years,
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the web had grown to more than 100 million active sites; the DNALC and other small-content
providers now found it increasingly difficult to build and maintain audiences.
In the face of an exponentially crowded web, search engines such as Google became the primary
arbiters of website visitation. We therefore embarked on an ambitious program to redesign our older
websites to make them more “visible” to search engines, a process called search engine optimization
(SEO). DNALC.org, the home site from which all other DNALC websites are reached, was the
first to be revamped according to SEO principals. Relaunched in September 2009, it saw a 24% in-
crease in visitation in 2010. DNA from the Beginning, our first major website, is now undergoing an
even more extensive SEO makeover, and we anticipate a similar bump in visitation when it is re-
launched in spring 2011.
In parallel with SEO, we have turned to other channels—applications for handheld devices
(“apps”) and social media—to broaden the audience for our multimedia products. Our 3D Brain—
a detailed rendering of the human brain that can be rotated and explored in three dimensions—pro-
vides a remarkable example of the way in which rechanneling content can increase viewership.
Originally developed as part of the website Genes to Cognition (G2C) Online, which debuted in spring
2009, 3D Brain was later launched as a stand-alone iPhone, iPod, and iPad application. It rose to num-
ber seven of 7,100 education apps and number one among 250 iPad apps. In 2010, the web version
of 3D Brain received 54,868 visits, and the app version had 413,874 downloads! Feedback on the
iTunes site shows, as one would expect, strong use by college students and faculty. However, it is also
used by medical professionals: “Excellent! I use this with clients to help them see where some of their
PTSD (posttraumatic stress disorder) symptoms are coming from. Has been very helpful for them.”
During the year, we continued an aggressive program to develop a DNALC channel on YouTube,
the site where most people find and share videos. Visitation surged following the addition of nearly
100 new videos, including a collection of three-dimensional molecular animations created for the
DNA Interactive website by 2010 McArthur Prize–winner Drew Berry. Our collection of 184 videos
received 280,503 views in 2010. Blogs, supporting each of our major content sites, generated an ad-
ditional 283,843 web visits.
As a result of the SEO makeover for the DNALC homepage plus aggressive moves into apps,
YouTube, and blogs, Internet visitation rose 14% to 7.1 million in 2010, equaling the 2007 peak.
App downloads, YouTube views, and blog views contributed 933,220 visits, or 13% of total Inter-
net traffic. The amount of data served by DNALC websites surged 35% in 2010, to 6669 gigabytes
(GB), or 6.5 terabytes (TB). DNALC.org accounted for 43% of all data served.
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Visitation was also augmented by a grant from Google AdWords, through which we receive free
“sponsored” links on Google searches. The AdWords account contains a set of keywords for each
DNALC website. When someone searches for one of the keywords, an ad for the related DNALC
site is displayed and logged as an “impression”; a “click-through” is logged when the link is fol-
lowed. (Each click results in a visit to one of our websites.) AdWords generated 20,185,997 im-
pressions of DNALC ads, resulting in 133,034 website visits. This advertising is valued at $99,438.
G2C Online is our most successful AdWords campaign, with two-thirds of 62,952 click-throughs
resulting from searches for “brain.” 
Teacher Training
Since trekking from New York to California in our mobile Vector Van in the summer of 1986, the
DNALC has maintained a unique ability to provide sophisticated lab and computer training at es-
sentially any site around the world. The year 2010 was the zenith of off-site training, with 940 high
school and college faculty participating in professional development activities conducted at 27 sites
across the United States and Canada. (For a complete list of training activities and host sites, see the
tables at the back of this report: “2010 Workshops, Meetings, and Collaborations.”)
With funding from HHMI, and in collaboration with the NYC Department of Education, 290
teachers participated in 52 workshops conducted at the Harlem DNA Lab. Ease of scheduling and
quick completion of P-Credits (graduate equivalent) and Professional Development hours (required
to maintain a New York State teaching license) made the summer workshops more popular than
those held during the academic year. 
In our role as education lead of the iPlant Collaborative, we introduced DNA Subway to 187 col-
lege teachers at 10 2-day workshops hosted at academic institutions around the country. An addi-
tional 188 educators learned about DNA Subway at short courses and demonstrations at the meetings
of the American Society of Plant Biologists, Botanical Society of America, DOE’s Joint Genome In-
stitute, iPlant Collaborative, National Association of Biology Teachers, and USDA Plant and Ani-
mal Genome research program.
With funding from NSF’s Course, Curriculum, and Laboratory Improvement (CCLI) program,
we continued our effort to bring compelling RNA interference (RNAi) experiments into college
classrooms via an experiment- and bioinformatics-rich curriculum. In 2010, 54 faculty attended
follow-up workshops designed to increase confidence with our RNAi curriculum and update par-
ticipants on new developments in the field. The training program is supported by the Silencing
Genomes website that includes all experiments and reagent recipes, and a free biological library, that
includes all needed bacterial and C. elegans strains and more than 100 vectors developed by work-
shop participants to silence worm homologs of human genes. To date, more than 1500 strain or-
ders have been filled and have been used with a reported 12,500 students. Two stand-alone kits
derived from the program have been released by Carolina Biological Supply Company, with a third
to be released early in 2011.
With support from the National Institutes of Health (NIH) Science Education Partnership Award
(SEPA) and the Hewlett Foundation, we continued to disseminate two large-scale Internet sites at
1- to 2-day workshops. Under the SEPA program, 71 high school and college faculty attended five
workshops to learn how to use the Inside Cancer website to enhance teaching of cancer cell biology
in health, general biology, and advanced biology classes. In addition, 18 Regional Fellows taught 228
educators at 22 second-round workshops. Five workshops on our Hewlett-sponsored website, G2C
Online, drew 88 high school and college educators.
Continuing our long-term relationship with the Singapore Ministry of Education, two Singa-
porean biology teachers participated in HHMI Leadership training in July. Then, in the fall, we
hosted four primary school teachers (grades 4–6). During their 2-week attachment, they observed
and cotaught student field trips and in-school programs. They were also immersed in the Fun with
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DNA and World of Enzymes curricula during small workshop sessions with DNALC instructors.
Each of the teachers developed a plan for sharing their new knowledge when they returned home.
Program Evaluation
In 2010, we initiated nationwide experimental studies to evaluate how two of our websites con-
tribute to science instruction in the classroom. The Inside Cancer website explores the molecular
basis of cancer. The evaluation study, funded by an NIH SEPA Phase II grant, involved four teach-
ers who used the website to teach topics such as the cell cycle, mutations, and genetic disease to 199
students in Illinois, Missouri, and Maryland. The G2C Online website explores the molecular basis
of brain function and dysfunction. In the evaluation, funded by the Dana and Hewlett Foundations,
five teachers used G2C Online to teach nervous system function and psychiatric disorders to 146 stu-
dents in Missouri, Minnesota, New York, and North Carolina. (An additional 12 teachers and more
than 900 students will participate in both studies in 2011.)
Pre- and posttest surveys—used by students across all study sites—measure changes in basic ge-
netics literacy and attitudes toward science. Content tests, developed locally by each teacher, meas-
ure specific knowledge gained. To control for differences between teachers and students, we used a
repeated measures study design, where a participating faculty member teaches the same topic to
two different classes—one class receives classroom instruction only (control) and the other receives
classroom instruction plus supplementary use of the website (treatment). For a second topic, the
classes switch roles as treatment and control. Students were also asked questions to determine
whether they prefer to explore information as network-related items or follow a suggested linear
“story.”
Considerable effort has focused on evaluating Silencing Genomes. With a response rate of 75%,
follow-up surveys show that the majority of 262 college faculty who received workshop training
completed Silencing Genome labs in their classrooms, reaching 3926 students and sharing them with
156 other teachers. An in-school study is matching experimental classes that do RNAi laboratories
with control classes that learn equivalent topics without labs. Pre- and posttests measure changes in
student attitudes, genetic literacy, and detailed knowledge of RNAi. To date, six teachers and 76 stu-
dents have participated, with an additional 10 teachers and more than 400 students expected in
2011. Preliminary analyses are encouraging, with experimental students showing significant gains
in knowledge of RNAi (12.0%, p = .0003).
Student Programs
In 2010, we continued to be the world’s largest provider of hands-on learning in genetics and mo-
lecular biology. Twenty thousand students performed experiments at the Dolan DNALC, DNALC
West, and the Harlem DNA Lab, and 10,856 students received in-school instruction by DNALC
staff. High school students composed 31% of lab visitors (9417). Most of the 21,442 middle school
visitors participated in our Genetics as a Model For Whole Learning Program. A grant from the
William Townsend Porter Foundation provided scholarships for 1057 Hispanic and African Amer-
ica students to attend labs at Harlem DNA Lab. Grants from Bank of America, TD Bank, and Na-
tional Grid provided lab visits and in-school instruction for 2349 students from underserved schools
in Queens and on Long Island.
Summer camps drew 908 students to the Dolan DNALC, DNALC West, and Harlem DNA Lab,
and to The Trinity and Chapin Schools, with two new workshops proving to be popular. DNALC
staff member Jen Aiello drew on her recent undergraduate degree in forensic science to develop
Forensic Detectives. This intermediate-level course for eighth and ninth graders includes labs on fin-
gerprinting, forensic anthropology, toxicology, ballistics, and criminalistics. Silencing Genomes is a
spin-off of the NSF teacher-training program of the same name, initiated by DNALC instructor
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Participants in a World of Enzymes
summer camp
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Bruce Nash. This course introduces the Nobel Prize–winning technology of RNAi in the model or-
ganism Caenorhabditis elegans.
Great Moments in DNA Science Honors Seminars, conducted in the spring, drew 211 top high
school students from Long Island for three in-depth presentations of current biological research. Dr.
Chih-Shan Jason Chen of Memorial Sloan-Kettering Cancer Center presented his research on the ge-
netics of Dermatofibrosarcoma protuberans (DFSP), an aggressive soft tissue tumor that often relapses
after treatment. Dr. Damon Love of Weill Cornell College of Medicine discussed his work with a
protein called Chibby, which is required for proper lung development in the fetus. Dr. Zuzana Zachar
of Stony Brook University discussed recent discoveries in cancer cell metabolism and introduced
“thioctans,” a new class of chemotherapeutic agents that target cancer cells while sparing healthy ones.
The Harlem DNA Lab participated in several science education events around NYC. Children
and parents extracted DNA from bananas at our booth at the World Science Festival in Washing-
ton Square Park and at the Morningside Area Alliance 2010 STEM Expo in Harlem. With support
from the Porter Foundation, high school students from the Mentoring in Medicine program attended
a week-long DNA Science camp. Founded by Dr. Lynne Holden, the program seeks to improve di-
versity in medicine by providing academic opportunities to underrepresented minority students. 
Saturday DNA! drew 203 participants to monthly events held during the fall, winter, and spring.
Two-hour sessions were offered at two age levels: one for children ages 10–13 with an accompany-
ing adult and one for ages 14 and above. Topics presented by the DNALC’s education and scien-
tific staff covered such diverse topics as DNA barcoding and the genetic basis of smell.
Partnerships and Graduate Training
In the spring, we graduated our fourth class of Genome Science, our partnership with Cold Spring
Harbor High School (CSHHS). Coinstructed by DNALC staff and CSHHS biology teacher Mar-
tin Glynn, this college-level course brings students to the DNALC for their final two class periods
each day. As in previous years, the course emphasized critical thinking and included experiments and
independent projects across a range of biological systems. One unit looked for evidence of genetic
modification in common foods and annotated newly sequenced genes in rice. Another unit used stu-
dents’ own DNA to explore the molecular basis of simple traits and trace human origins. The final
unit used RNAi to turn off genes in the roundworm C. elegans and study worm equivalents of genes
involved in human diseases.
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In the fall, the fifth year of Genome Science began under the tutelage of DNALC staff along with
a new CSHHS staff member, Jaak Raudsepp. This was a comfortable change because Jaak is a grad-
uate of our former Leadership Institute, the rigorous 3-week program for the nation’s best biology
teachers. Always a proving ground for our latest experiments, the CSHHS students were the first to
use DNA barcoding to identify plants collected in the local area. In preparing essays on modern par-
allels to the eugenics movement of the early 20th century, students also visited the CSHL Research
Archives to examine historical documents remaining from the former Eugenics Record Office.
As part of a reinvigorated collaboration with the Center for Science and Mathematics Education
(CESAME) at Stony Brook University, CSHHS students completed a module on protein model-
ing. Using methods developed by Tim Herman at the Milwaukee School of Engineering, students
developed three-dimensional molecular models to illuminate how chemotherapeutic drugs interact
with protein receptors on the surface of cancer cells. Using data from primary research papers, stu-
dents identified important parts of the drugs and receptors. They then used three-dimensional mod-
eling software to highlight key atoms involved in molecular interactions. The modified structure files
were sent to CESAME, where detailed atomic resolution models of the proteins were manufactured
on state-of-the-art prototyping printers. (These machines are essentially laser printers that layer
droplets of polymer resin in three dimensions.) Students will present their models and explanatory
posters at the spring 2011 CSHL meeting, “The Biology of Cancer.”
During their second semester, graduate students at the CSHL Watson School of Biological Sci-
ences work under the guidance of experienced DNALC instructors. The graduate students work in
pairs during 12 half-day sessions, learning from and leaning on one another as they develop effec-
tive teaching techniques. During the first phase of training, students observe a DNALC staff mem-
ber teaching a laboratory class and then organize a lesson plan that integrates their own perspectives.
During the second phase, students join the DNALC staff member to coteach parts of a laboratory
class. After critiques of their lesson plans and coteaching experience, the students move on to inde-
pendently teach an entire lesson. After completing rotations with middle- and high-school-level ex-
periments, students deliver three additional lessons to demonstrate mastery of teaching and class
management skills.
In October, we began a collaboration with the New York Academy of Sciences (NYAS), one of
the oldest scientific institutions in the United States and a leading organizer of scientific meetings.
The NYAS developed a new science mentoring program in which graduate students and postdoc-
toral researchers from NYC research institutions present science activities to students in grades K–
12. DNALC instructors trained 22 mentors in effective strategies to deliver hands-on genetics
activities in after-school settings. 
Staff and Interns
We were sad when Dr. John Connolly left in February to evaluate clinical trials at the Center for Ap-
plied Genomics, Children’s Hospital of Philadelphia. After receiving a Ph.D. in neuropsychology
at Trinity College, Dublin, John came to the DNALC in 2005 to develop our innovative website
G2C Online, for which he interviewed more than 80 scientists. As Multimedia Coordinator, he be-
came indispensable in managing many aspects of our Internet venture—developing the Landeau
Multimedia Studio and launching regular blogs for each of our major content sites. Notably, he
moved us into the world of apps with his spectacularly successful 3D Brain. We will miss his Irish
brogue, which often lightened the office atmosphere.
The multimedia staff returned to full force in November, with the arrival from “down under” of
Multimedia and Evaluation Manager Dr. Amy Nisselle. After attending the DNALC’s presentation
at the 19th International Congress on Human Genetics in Melbourne in 2003, Amy decided to pur-
sue her Ph.D. in multimedia genetics education. In 2008, she spent 3 months at the DNALC, eval-
uating the G2C Online website as part of her thesis research. In addition to managing multimedia
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projects, Amy will also increase our academic profile in the world of
science and technology education. 
Our growing involvement in the iPlant Collaborative led to the
recruitment in November of Computer Programmer Mohammed
Khalfan. After receiving a B.S. degree from the University of Toronto,
he received a Master’s degree in bioinformatics and computational
biology at the University of Newcastle upon Tyne, United Kingdom.
His initial projects include building the “Blue Line” (phylogenetics)
of DNA Subway and redeveloping the iPlant website in Drupal, an
open source content management system (CMS). 
Our multimedia group also benefited from fresh ideas from young
people. In the fall, we welcomed Todd Rocheford as Design Assistant
and Videographer. Todd has an undergraduate degree in video pro-
duction from the University of Canberra, Australia. We met Todd
through his father, Torbert, a Purdue geneticist who developed vita-
min-A-fortified corn. After filming a documentary on his father’s work in Africa, Todd realized that
he wanted to develop educational videos, leading to his position at the DNALC. Undergraduate in-
tern Tony Biondo was promoted to Junior Programmer, based largely on the initiative that he took
in developing an Android version of our 3D Brain app. Tony is a sophomore majoring in computer
science at Stony Brook University. An active supporter of open-source software, he won the Student
Cluster Competition of the 2009 International Conference on High-Performance Computing at
Portland, Oregon. Chris Weidler (Farmingdale State College) continues to support the BioMedia
Group and was especially productive on the DNA from the Beginning upgrade.
Our internship program continued to draw some of Long Island’s most talented high school and
college students, engaging them in science research and providing practical laboratory experience.
We were pleased to accept several new high school interns this year: Devika Gupta (Farmingdale),
Jueng Woen Kim (Hauppauge), Yasin Muhammad (Lawrence Woodmere Academy), H. Alan
Phipps (Portledge School), David Streitman (Syosset), and Young Joon Suh (John Glenn). The new
hires joined a dedicated group of returning interns: Laura Bergsten (Cold Spring Harbor), George
Economou (Syosset), Jack Greenfield (Oyster Bay), Lindsay Hochberg (Oyster Bay), Max Vaysman
(Commack), and Pamela Wax (Harborfields). We bid farewell to a number of high school interns
as they left for their freshman year at college: Anouva Kalra-Lall (Case Western Reserve University),
Emily Troge (Brandeis University), Sara Wienclaw (University of Delaware), and Kevin Wu (New
York University).
In addition to regular prep duties, college interns help to fulfill requests from faculty nationwide
for student DNA sequencing and RNAi targeting vectors. Three former high school interns re-
turned to assist with summer workshops: Kaitlin Watrud (Gettysburg College), Arielle Scardino
(City College of New York), and Seth Shortz (Emory University). New college interns starting in
2010 were David Dopfel (Stony Brook), Sarah Justvig (Georgetown), Sulaiman Usman (New York
Institute of Technology), Lina-Mari Varghese (Stony Brook), and Katherine Villalon (John Jay).
Annie Laurie Benzie (Adelphi University) left the DNALC for an internship at Bellevue Hospital.
Many of our high school interns are involved in science research and compete in state and na-
tionwide science competitions. Anouva Kalra-Lall was an Intel semifinalist and a top-four finalist
for the Neuroscience Research Prize. Young Joon Suh took first place in chemistry at the New York
State Science and Engineering Fair. Laura Bergsten was accepted into the CSHL Partners for the Fu-
ture Program. 
Additionally, DNALC staff served as mentors to local high school students working on inde-
pendent projects. Elliot Horlick (Cold Spring Harbor) worked on two projects with Dr. Jermel
Watkins: sunblock (SPF) protection against UV-induced DNA damage in yeast and the protein
complement (proteome) of squamous cell carcinoma. Daniel Krumholz (Oyster Bay) worked with
Mohammed Khalfan and 
Amy Nisselle.
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Dr. Bruce Nash to use RNAi to “knock down” genes in C. elegans that are homologous to human
genes involved in serotonin signaling.
Expert Advisors and Corporate Support
We are fortunate to have high-level support from two advisory bodies: the DNALC Committee
and the Corporate Advisory Board (CAB). The DNALC Committee consists of community lead-
ers and members of CSHL senior management and the Board of Trustees, who oversee strategic de-
velopment including capital funding and the evolution of satellite locations in North America and
beyond. The CAB provides liaison to the Long Island and NYC business communities; its annual
fund campaign and golf tournament contributed $155,000 in 2010.
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2010 Workshops, Meetings, and Collaborations
January 5 Site visit by William Mak, Hong Kong Biotechnology Education Resource Center and Mobile Lab, Hong Kong 
University, Pokfulam
January 12 Site visit by Denise Philpotts, Trinity School, Harlem DNA Lab
January 14 NSF Plant Collaborative, Genotype 2 Phenotype Steering Committee Meeting, San Diego, California
HHMI Professional Development Workshop, “PCR and Human DNA Variations, Part 2,” Harlem DNA Lab
January 16 HHMI Professional Development Workshop, “PCR and Human DNA Variations, Part 2,” Harlem DNA Lab
January 22 Site visit by Hans Bosch and Laura Savini, WLIW, New York
January 23 Saturday DNA! “Express Yourself!” DNALC
January 29 Site visit by Marilyn Parks, Life Technologies Foundation, Carlsbad, California, and Randi Spatz, Invitrogen, 
Carlsbad, California
February 24 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
February 27 Saturday DNA! “Composting 101,” DNALC
HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
March 3 Site visit to Carolina Biological Supply Company, Burlington, North Carolina
March 10 Oyster Bay Rotary Club Meeting Luncheon presenting DNALC programs and events, Oyster Bay, New York
March 12 G2C Online Workshop, Santa Clara University, Santa Clara, California
March 13 NIH Inside Cancer Workshop, Santa Clara University, Santa Clara, California
March 17 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
March 20 Saturday DNA! “Explore the Realm of Your DNA,” DNALC
HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
March 20–21 National Science Teachers Association National Conference, “Exploring Gene Function in C. elegans: Mutations 
and RNA Interference,” “Genomic Science,” and “Silencing Genomes,” Philadelphia, Pennsylvania
March 24–26 Joint Genome Institute User Meeting, Walnut Creek, California
March 26 G2C Online Workshop, Oklahoma City Community College, Oklahoma City
March 27 NIH Inside Cancer Workshop, Oklahoma City Community College, Oklahoma City
April 7 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
April 9 Site visit by graduate students from Molloy College, Rockville Centre, New York
April 10 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
April 11–14 NIH SEPA Principal Investigators Meeting, Birmingham, Alabama
April 13 Great Moments in DNA Science Honors Seminar: “Dead End? Not Anymore! Molecular Targeted Therapy for 
Skin Cancer,” Dr. Chih-Shan Jason Chen, Memorial Sloan-Kettering Cancer Center, New York
April 16 G2C Online Workshop, iBio Institute, Harold Washington College, Chicago, Illinois
April 17 NIH Inside Cancer Workshop, iBio Institute, Harold Washington College, Chicago, Illinois
April 17 Saturday DNA! “The Insomniac’s Guide to Wildlife,” DNALC
April 20 Site visit by Debby Hirshman, Victor Centers for Jewish Genetic Diseases, Philadelphia, Pennsylvania
April 21 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
April 23 CSHL Association Directors, viewing of “Naturally Obsessed: The Making of a Scientist,” DNALC
April 23–24 NSF iPlant Collaborative Genomics in Education Workshop, Spelman College, Atlanta, Georgia
April 24 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
April 26 Site visit by Kevin Shine, Verizon Communications, New York
April 29 G2C Online Workshop, Biogen Idec, Cambridge, Massachusetts
Great Moments in DNA Science Honors Seminar: “The Role of Wnt/β-catenin Antagonist chibby in Lung 
Development,” Dr. Damon Love, Weill Cornell College of Medicine, New York
Site visit by Jackie Dorrance, Beckman Foundation, Irvine, California
Site visit by Robert Isaksen and Lorraine Aycock, Bank of America Long Island, Melville, New York
Site visit by Judy Calabrese and Maureen Laness, CSHL Directors, Harlem DNA Lab
April 30 NIH Inside Cancer Workshop, Biogen Idec, Cambridge, Massachusetts
May 3 Meeting with Minister of Higher Education, Sheikh Nahyan binMubarak Al Nahyan, Abu Dhubai, United 
Arab Emirates
May 7–8 NSF iPlant Collaborative Genomics in Education Workshop, University of Texas, Austin
May 8 HHMI Professional Development Workshop “DNA Isolation, Inheritance, and Variability,” Harlem DNA Lab
May 12 Site visit by Roland Jimenez, Community Bank, Hauppauge, New York
May 14–15 HHMI Professional Development Workshop, “PCR, Part 1,” Harlem DNA Lab
May 15 Saturday DNA! “Walking Whales and Genetic Tales,” DNALC
May 17 Site visit by Srinivasa Rao, Indian Institute of Biotechnology, Hyderabad, India
May 18 Great Moments in DNA Science Honors Seminar: “Thioctans: A Novel Approach to Cancer Chemotherapy,” 
Dr. Zuzana Zachar, Stony Brook University, New York
May 21 HHMI Professional Development Workshop, “PCR, Part 2,” Harlem DNA Lab
G2C Online Workshop, University of Colorado, Aurora
426 DNA Learning Center
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May 21–22 NSF iPlant Collaborative Genomics in Education Workshop, Lawrence Berkeley National Laboratory, 
Berkeley, California
May 22 NIH Inside Cancer Workshop, University of Colorado, Aurora
May 22 HHMI Professional Development Workshop, “PCR, Part 2,” Harlem DNA Lab
May 22 2010 S.T.E.M. Expo sponsored by Morningside Area Alliance, “DNA Extraction,” Harlem, New York
May 24–26 NSF iPlant Collaborative 2010 Conference, Las Vegas, Nevada
May 26 NSF iPlant Collaborative, DNA Subway Workshop, Las Vegas, Nevada
June 4 Site visit by Kidgie Williams, Hospitality Committee for United Nations Delegations, Inc., and United Nations 
delegates’ family members, New York
June 4–5 NSF Silencing Genomes Follow-up Workshop, St. Louis Science Center, Missouri
June 6 World Science Festival, “Banana DNA Extraction,” New York
June 8 17th Annual Golf Outing, Piping Rock Club, Locust Valley, New York
June 11–12 NSF iPlant Collaborative Genomics in Education Workshop, Howard University, Washington, D.C.
NSF Silencing Genomes Follow-up Workshop, Rust College, Holly Springs, Mississippi
June 12 Saturday DNA! “Solved! The Mystery of Anastasia Romanov,” DNALC
June 14–18 DNA Science Workshop, Harlem DNA Lab
DNA Science Workshop, Trinity School, New York
Fun with DNA Workshop, Trinity School, New York
June 17–18 NSF Silencing Genomes Follow-up Workshop, North Carolina Agricultural & Technical State University, Greensboro
June 18 Site visit by Mike Scanlon, Cornell University, Ithaca, New York
June 20–25 Milwaukee School of Engineering Workshop, SMART protein modeling training, New York
June 21–22 Charter Membership High School Professional Development Workshop, The Chapin School, “Human Genomics,” 
New York
June 21–25 Fun with DNA Workshop, The Chapin School, New York
Human Genomics Workshop, The Chapin School, New York
June 22 Site visit by Theresa Chilianis, Michael Lardner, and Phil Summers, MSG Varsity, Woodbury, New York
June 23–24 Charter Membership Middle School Professional Development Workshop, The Chapin School, “Fun with DNA,” 
New York
June 24–25 NSF Silencing Genomes Follow-up Workshop, Pasadena City College, California
June 25–26 NSF iPlant Collaborative Genomics in Education Workshop, The Rockefeller University, New York
June 28 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
June 28–July 2 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Fun with DNA Workshop, DNALC West
June 29 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
June 29–30 NSF Silencing Genomes Follow-up Workshop, Howard University, Washington, D.C.
June 30 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1” Harlem DNA Lab
July 1 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
July 6 HHMI Professional Development Workshop, “DNA Structure and Isolation,” Harlem DNA Lab
July 6–9 Green Genes Workshop, DNALC
Plant Genomics Workshop, DNALC
World of Enzymes Workshop, DNALC West
July 7 HHMI Professional Development Workshop, “Variability and Inheritance,” Harlem DNA Lab
July 8 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
July 8–9 NSF iPlant Collaborative Genomics in Education Workshop, University of Chicago, Illinois
July 9 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
July 12 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
July 12–16 DNA Science Workshop, DNALC
Human Genomics Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC West
July 13 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
July 14 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
July 15 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
Site visit by Suzi Lewis, University of California, Berkeley
July 16 HHMI Professional Development Workshop, “Genetically Modified Foods,” Harlem DNA Lab
July 19–23 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
Silencing Genomes Workshop, DNALC
Green Genes Workshop, DNALC West
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July 19–30 HHMI New York Leadership Symposium, Harlem DNA Lab
July 20 Site visit by Rafael Palacios, Universidad Nacional Autónoma de México, Cuernavaca Center for Genomic 
Sciences, Cuernavaca, Mexico
July 26–30 DNA Science Workshop, DNALC
Genetic Horizons Workshop, DNALC
World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC West
July 29 Site visit by Mort Slater, Gateway to Higher Education, New York, and Arthur Registre, Uniondale High School, 
New York
July 31 Botanical Society of America, DNA Subway Hands-on Workshop, Providence, Rhode Island
July 31–Aug. 4 American Society of Plant Biologists Annual Conference, DNA Subway Demonstrations and Poster, Montreal, Canada
August 2 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
August 2–6 Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
Human Genomics Workshop, DNALC
Fun with DNA Workshop, DNALC West
August 3 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
August 4 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
August 5 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
August 6 HHMI Professional Development Workshop, “Genetically Modified Foods,” Harlem DNA Lab
August 9 HHMI Professional Development Workshop, “DNA Transformation and Protein Isolation,” Harlem DNA Lab
August 9–13 DNA Science Workshop, DNALC
Genetic Horizons Workshop, DNALC
World of Enzymes Workshop, DNALC
World of Enzymes Workshop, DNALC West
August 10 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
August 11 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
August 12 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
August 16–20 Forensic Detectives Workshop, DNALC
Fun with DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC West
DNA Science Workshop, Mentors in Medicine, Harlem DNA Lab
August 17 Site visit by Esther Baena, Harvard Medical School, Cambridge, Massachusetts
August 18 Site visit by Ted Scovell and Mark Stoeckle, The Rockefeller University, New York
August 19–20 NSF Silencing Genomes Follow-up Workshop, Houston Community College, Texas
August 23–27 DNA Science Workshop, DNALC
Fun with DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Human Genomics Workshop, DNALC West
Aug. 30–Sept. 3 DNA Science Workshop, DNALC
Green Genes Workshop, DNALC
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC West
September 2 Site visit by Pauline Charman, University of Western Australia, Perth
September 14 Eugenics Exhibit, Holocaust Memorial and Tolerance Center, Glen Cove, New York
September 15 Site visit by Torbert Rocheford, Purdue University, West Lafayette, Indiana
September 16–17 NSF iPlant Collaborative Genomics in Education Workshop, University of Washington, Seattle
September 17 Site visit by Anne and Walter Meier, The Robertson Foundation for Government, Juno Beach, Florida
September 25 HHMI Professional Development Workshop, “DNA Structure and Isolation, Part 2,” Harlem DNA Lab
October 5 Site visit by Denise Smith, Vincent Torti, and Rick Garrett, Saint Dominic’s Church and Schools, Oyster Bay, 
New York
October 15 HHMI Professional Development Workshop, “Inheritance and Variability,” Harlem DNA Lab
October 16 HHMI Professional Development Workshop, “Inheritance and Variability,” Harlem DNA Lab
New York Academy of Sciences Graduate Training, New York
Saturday DNA! “Classify Me!” DNALC
October 18–19 NIH SEPA Grant Review, Bethesda, Maryland
October 22 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
October 23 HHMI Professional Development Workshop, “Bacterial Transformation and Protein Isolation,” Harlem DNA Lab
November 2–3 NSF iPlant Collaborative Genomics in Education Workshop, University of Minnesota, Saint Paul
November 3–6 National Association of Biology Teachers Conference, “Orphaned Data,” “Frontiers in Genomics,” “DNA 
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Subway,” “RNAi/CBSC,” “Iceman,” “CSI,” “LabCenter,” Minneapolis, Minnesota
November 4 Site visit by Paula Olsiewski, Alfred P. Sloan Foundation, Harlem DNA Lab
November 5 Site visit by Verizon Fios One MYLITV for filming 
November 8 iPlant Collaborative NSF site visit, Tucson, Arizona
November 8–9 Science Teachers Association of New York State Conference, presentations on DNALC family of websites, 
Rochester, New York
November 12 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
November 13 HHMI Professional Development Workshop, “DNA Analysis and Forensics,” Harlem DNA Lab
Saturday DNA! “DNA Barcoding,” DNALC
November 22 Baruch College, “iPlant Collaborative, DNA Subway,” New York
Marcus Foundation “Gene Screen,” Victor Centers for Jewish Genetic Diseases, Albert Einstein Medical Center, 
Philadelphia, Pennsylvania
Nov. 29–Dec. 11 Singapore Primary Teachers Attachment, DNALC
December 3 Site visit by Mohammad Alshehri, King Saud University, and Talal Al-Malki, Taif University, Saudi Arabia
HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
December 4 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 1,” Harlem DNA Lab
December 9 Site visit by Suzanne Sunshine, S. Sunshine & Associates, New York
December 11 HHMI Professional Development Workshop, “PCR and Human DNA Variation, Part 2,” Harlem DNA Lab
Saturday DNA! “What Does Your Nose Know?” DNALC
December 14–15 Site visit by Steve Goff and Eric Lyons, iPlant Collaborative, Tucson, Arizona
December 15–16 NSF iPlant Collaborative Genomics in Education Workshop, University of Texas, Brownsville and Texas 
Southmost College, Brownsville
December 16 Site visit by James Jorasch and Megan Kingery, Science House, Harlem DNA Lab
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Sites of Major Faculty Workshops 1985–2010
Key: Middle School High School College
ALABAMA University of Alabama, Tuscaloosa 1987–1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Arizona State University, Tempe 2009
Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA California State University, Dominguez Hills 2009
California State University, Fullerton 2000
California Institute of Technology, Pasadena 2007
Cañada College, Redwood City 1997
City College of San Francisco 2006
Contra Costa County Office of Education, Pleasant Hill 2002, 2009
Foothill College, Los Altos Hills 1997
Harbor–UCLA Research & Education Institute, Torrance 2003
Los Angeles Biomedical Research Institute (LA Biomed), Torrance 2006
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Oxnard Community College, Oxnard 2009
Pasadena City College, Pasadena 2010
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001, 2008
San Francisco State University 1991
San Jose State University 2005
Santa Clara University 2010
University of California, Berkeley 2010
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Aspen Science Center 2006
Colorado College, Colorado Springs 1994, 2007
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998, 2009, 2010
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA Armwood Senior High School, Tampa 1991
Florida Agricultural & Mechanical University, Tallahassee 2007–2008
North Miami Beach Senior High School 1991
University of Miami School of Medicine 2000
University of Western Florida, Pensacola 1991
GEORGIA Fernbank Science Center, Atlanta 1989, 2007
Morehouse College, Atlanta 1991, 1996, 1997
Spelman College, Atlanta 2010
HAWAII Kamehameha Secondary School, Honolulu 1990
IDAHO University of Idaho, Moscow 1994
ILLINOIS Argonne National Laboratory 1986–1987
iBio Institute/Harold Washington College, Chicago 2010
Illinois Institute of Technology, Chicago 2009
University of Chicago 1992, 1997, 2010
INDIANA Butler University, Indianapolis 1987
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence 1995
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Bossier Parish Community College 2009
Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
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MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990–1992
National Center for Biotechnology Information, Bethesda 2002
St. John’s College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
MASSACHUSETTS Beverly High School 1986
Biogen Idec, Cambridge 2002, 2010
Boston University 1994, 1996
CityLab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
The Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MINNESOTA Minneapolis Community and Technical College 2009
University of Minnesota, St. Paul 2005
University of Minnesota, St. Paul 2010
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990–1991
Rust College, Holly Springs 2006–2008, 2010
MISSOURI St. Louis Science Center, St. Louis 2008–2009, 2010
Stowers Institute for Medical Research, Kansas City 2002, 2008
Washington University, St. Louis 1989, 1997
NEVADA University of Nevada, Reno 1992
NEW HAMPSHIRE Great Bay Community College, Portsmouth 2009
New Hampshire Community Technical College, Portsmouth 1999
St. Paul’s School, Concord 1986–1987
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
Raritan Valley Community College, Somerville 2009
NEW MEXICO Biolink Southwest Regional Meeting, Albuquerque 2008
NEW YORK Albany High School 1987
American Museum of Natural History 2007
Bronx High School of Science 1987
Canisius College, Buffalo 2007
Cold Spring Harbor High School 1985, 1987
Columbia University 1993
Cornell University, Ithaca 2005
DeWitt Middle School, Ithaca 1991, 1993
Dolan DNA Learning Center 1988–1995, 
2001–2004, 
2006–2009
Dolan DNA Learning Center 1990, 1992,
1995, 2000
Dolan DNA Learning Center 1990–1992
DNALC West 2005
Fostertown School, Newburgh 1991
Harlem DNA Lab, East Harlem 2008–2009
Huntington High School 1986
Irvington High School 1986
John Jay College of Criminal Justice 2009
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine 1997
New York City Department of Education 2007
New York Institute of Technology 2006
New York Institute of Technology 2006
Orchard Park Junior High School 1991
Plainview–Old Bethpage Middle School 1991
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State University of New York, Purchase 1989
State University of New York, Stony Brook 1987–1990
Stuyvesant High School 1998–1999
The Rockefeller University 2003
The Rockefeller University 2010
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Lake Saranac 2001
Union College, Schenectady 2004
United States Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina Agricultural & Technical State University, Greensboro 2006–2007, 
2009–2010
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
Langston University, Langston 2008
North Westerville High School 1990
OKLAHOMA Tulsa Community College, Tulsa 2009
Oklahoma City Community College 2000
Oklahoma City Community College 2006–2007, 2010
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
Kimmel Cancer Center, Philadelphia 2008
RHODE ISLAND Botanical Society of America, Providence 2010
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TENNESSEE NABT Professional Development Conference, Memphis 2008
TEXAS Austin Community College–Rio Grande Campus 2000
Austin Community College–Eastview Campus 2007–2009
Houston Community College Northwest, Houston 2009, 2010
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Midland College, Midland 2008
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Texas A&M, AG Research and Extension Center, Weslaco 2007
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004, 2010
University of Texas, Brownsville 2010
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
Utah Valley State College, Orem 2007
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
Virginia Polytechnic Institute and State University, Blacksburg 2005, 2008–2009
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001, 2008
University of Washington, Seattle 1993, 1998, 2010
WASHINGTON, D.C Howard University 1992, 1996, 
2009–2010
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
432 DNA Learning Center
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Madison Area Technical College 1999, 2009
Marquette University, Milwaukee 1986–1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
AUSTRIA Vienna Open Lab 2007
CANADA Red River Community College, Winnipeg, Manitoba 1989
CHINA Ho Yu College, Hong Kong 2009
GERMANY Urania Science Center, Berlin 2008
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
MEXICO ASPB Plant Biology, Merida 2008
PANAMA University of Panama, Panama City 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001–2005
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University, Uppsala 2000
THE NETHERLANDS International Chromosome Conference, Amsterdam 2007
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Serials
Genes & Development, Vol. 24 (www.genesdev.org)
Genome Research, Vol. 20 (www.genome.org)
Learning & Memory, Vol. 17 (www.learnmem.org)
RNA, Vol. 16 (www.rnajournal.org)
Cold Spring Harbor Symposia on Quantitative Biology, Vol. 74:
Evolution: The Molecular Landscape, edited by Bruce 
Stillman, David Stewart, and Jan Witkowski
Cold Spring Harbor Protocols (www.cshprotocols.org)
Cold Spring Harbor Perspectives in Biology
(www.cshperspectives.org)
Laboratory Manuals
Emerging Model Organisms: A Laboratory Manual, Volume 2
Drosophila Neurobiology: A Laboratory Manual, edited by 
Bing Zhang, Marc R. Freeman, and Scott Waddell
Imaging: A Laboratory Manual, edited by Rafael Yuste
Imaging in Developmental Biology: A Laboratory Manual,
edited by James Sharpe and Rachel O. Wong; Series 
Editor Rafael Yuste
RNA: A Laboratory Manual, by Donald C. Rio, Manuel Ares Jr.,
Gregory J. Hannon, and Timothy W. Nilsen
Handbooks
At the Helm: Leading Your Laboratory, Second Edition, by Kathy
Barker
Career Opportunities in Clinical Drug Research, by Rebecca J. 
Anderson
Advanced Textbooks
Guide to the Human Genome, by Stewart Scherer (online and/or
print)
Means to an End: Apoptosis and Other Cell Death Mechanisms, by
Douglas R. Green
RNA Worlds: From Life’s Origins to Diversity in Gene Regulation, 
by John F. Atkins, Raymond F. Gesteland, and Thomas R.
Cech
Monographs (Perspectives in Biology
Topic Collections)
Generation and Interpretation of Morphogen Gradients, edited by
James Briscoe, Peter A. Lawrence, and Jean-Paul Vincent
Cell–Cell Junctions, edited by W. James Nelson and Elaine Fuchs
Symmetry Breaking in Biology, edited by Rong Li and Bruce 
Bowerman
NF-κB: A Network Hub Controlling Immunity, Inflammation, 
and Cancer, edited by Michael Karin and Louis M. Staudt
The Origins of Life, edited by David Deamer and Jack W. Szostak
The p53 Family, edited by Arnold J. Levine and David P. Lane
The Nucleus, edited by Tom Misteli and David L. Spector
Auxin Signaling: From Synthesis to Systems Biology, edited by 
Mark Estelle, Dolf Weijers, Karin Ljung, and 
Ottoline Leyser
Neuronal Guidance: The Biology of Brain Wiring, edited by Marc
Tessier-Lavigne and Alex L. Kolodkin
Immunoreceptor Signaling, edited by Lawrence E. Samelson and
Andrey Shaw
Cell Biology of Bacteria, edited by Lucy Shapiro and Richard M.
Losick 
Science and Society
Speaking of Genetics: A Collection of Interviews, by Jane Gitschier
Sydney Brenner: A Biography, by Errol C. Friedberg
The Honest Look, by Jennifer L. Rohn
Other
Neurobiology of the Leech, edited by Kenneth J. Muller, John G.
Nicholls, and Gunther S. Stent (reissue of 1981 title)
CSHL Annual Report 2009, Yearbook Edition
CSHL Annual Report 2009
Banbury Center Annual Report 2009
Watson School of Biological Sciences Annual Report 2009
Websites
http://cshmonographs.org/index.php/monographs; Cold Spring
Harbor Monographs Archive Online 
http://www.cshl.symposium.org; Symposia, Vol. 74 added to
online Symposia website
http://www.humangenomeguide.org
2010 PRESS PUBLICATIONS
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Cold Spring Harbor Laboratory’s research activities are complemented by the creation of journals,
books, and electronic media that extend the professional education of scientists around the world.
With a tradition of excellence originating in the 1930s, Cold Spring Harbor Laboratory Press is
continuing to redefine its role as a publisher in the digital age. Although distribution channels for
scientific information continue to evolve and diversify, the mission of the Press remains to identify
innovative research, technologies, and scientists, to amplify their effectiveness by selecting, aggre-
gating, and curating information that research communities can use, and to deliver the information
when, where, and how the communities want it. The task is complex and in 2010, there were sig-
nificant achievements. More than 10 million research articles were downloaded internationally from
our journals, over 3000 electronic subscriptions were delivered to academic institutions worldwide,
and 35,000 copies of print books were shipped from our warehouses in the United States and Eu-
rope. The publication program encompasses six research journals, two of them among the most
highly ranked in biology; authoritative laboratory manuals; and best-selling primers on professional
skill development for scientists. Their distribution makes a significant contribution to the Labora-
tory’s broad educational mission and strengthens Cold Spring Harbor’s association with excellence. 
Financially, the established journals performed strongly in 2010. The start-up costs of a new journal
were written off. Sales of print books were weakened by lower backlist orders and delayed publication
of some new titles. To improve the book program’s future financial performance, substantial expense
savings were made through procedural changes and by staff reduction at the year’s end. 
Journals
Journal publishing remains the largest contributor of revenue and is vital to the financial sustain-
ability of the publishing program. Journal subscriptions did well in what continued to be a chal-
lenging market, as academic libraries continued to come to terms with reduced budgets.
Nevertheless, total subscription revenue for all five established journal titles increased by more than
5%. Despite continued merger activity within the laboratory supplies sector that reduces the po-
tential client base, advertising revenue across the journals met its goals, with a continued but still
gradual shift in the relative proportion of income from print and online sales. 
Genes & Development completed a satisfactory year with, for the first time, a single center of ed-
itorial operations that provided authors with faster and more consistent decisions. Both Genes &
Development and Genome Research continued to rank among the most important publications in
genetics and cell and developmental biology, attracting more submissions, maintaining impressive
impact factors, and, through article downloads, finding intense use in academic centers worldwide.
RNA maintained its status as the premier specialist journal in the burgeoning field of RNA biology
and a new 5-year publishing contract was signed with its owner, The RNA Society. Learning &
Memory remains a source of specialized work in the molecular analysis of nervous system plasticity. 
The subscription base of Cold Spring Harbor Protocols made solid gains and its usage continued
to grow. The new journal Cold Spring Harbor Perspectives in Biology, with content of exceptional
quality, found remarkable usage during an 18-month free trial period, a result that augurs well for
subscription growth. The journal’s unique feature is the publication of collections of articles that
have each been commissioned to provide an in-depth, coherent survey of a single topic. A large
number of subject collections from cell and molecular biology are in the publication pipeline, and
each collection has commissioning editors with outstanding international reputations. Each article
COLD SPRING HARBOR LABORATORY PRESS
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is being published individually in an issue of the journal, but when complete, the collections will
be available separately. The response from scientists to the Perspectives concept has been so positive
that a sister publication, Cold Spring Harbor Perspectives in Medicine, is being planned as a source of
research information for physicians and scientists working in cancer, neuropathies, psychiatric illness,
infectious disease, metabolic syndrome, and other disorders.
The type of content in both Perspectives and Protocols was previously published only in printed
book form. In a digital journal context, it is now discoverable in biomedical science’s most important
bibliographic database, PubMed, enhancing its prestige and value to the research community. Nev-
ertheless, the content is still publishable in print as topic-specific books. Of the 26 books published
by the Press in 2010, 12 originated in the Perspectives journal and can be printed on demand from
online content. In this way, unpredictable markets for print publications can be served with infor-
mation that also has a digital, subscription-based business model. 
A multichannel approach to content distribution is also seen in the Guide to the Human Genome,
a unique, richly linked online resource that is structured like a book, but published online as well
as in print. Online users can use search tools to explore the human genome through direct links to
the reference sequence and compare human sequences with those from other species. The Guide’s
low-cost hosting, an ordering system allowing individual and institutional customers to purchase
and immediately access the online content, and print-on-demand capability together may provide
a publishing solution for future Press titles with both print and online markets. 
Other Electronic Publications
Many forms of publishing have been transformed in the past 2 years by the explosion in sales of
handheld devices like smartphones, tablet computers such as the iPad, and e-readers like the Kindle.
The use of software applications on these devices for information access and reuse is growing expo-
nentially. Like all publishers, the Press is closely monitoring these changes and the choices being
made by the consumers of information, but we remain cautious about investing in these avenues
Cold Spring Harbor Laboratory bookstore
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for the distribution of our content. A limited number of our book titles are available for the Kindle
reader on a case-by-case basis, and sales, predictably, were low while the device remained expensive.
But with the availability of new models at lower prices, and now that Kindle software can run on
many different devices, there may be a larger audience in the future. There is no doubt that Cold
Spring Harbor’s book content must find its way into digital media and our biographies, histories,
and novels will find part of their audience on digital reading devices. But these are a small part of
our output, and much thought, discussion, and exploration are being devoted to the more important
consideration of what working professionals need and the choices of digital media they will make.
The experience of producing and marketing electronic books has been valuable and so has the cre-
ation of an iPhone application for our journal Genome Research that allows abstracts of papers to be
read everywhere and full text to be accessed when the phone is connected to a subscribing institu-
tion’s network. Our goal remains to make our content available in as many ways as readers require,
and we will continue to explore the options available. 
Books in Print
The year’s crop of new books included five manuals of techniques, a traditionally strong component
of our publishing program. Molecular biology has been transformed by the discovery of new species
of RNA molecule that regulate gene function in vivo and in vitro and RNA: A Laboratory Manual
is a uniquely authoritative source of expertise in working with these molecules. Imaging technologies
are also transforming the way experimental biology is done, and two new manuals provided instruc-
tion in both general and more specific approaches to the use of these methods. 
Our widely praised list of professional development handbooks was enhanced by a new book
about career opportunities in industry and the second edition of At the Helm, Kathy Barker’s enor-
mously successful source of advice and counsel for principal investigators. 
As knowledge in biology becomes denser and more detailed, it is harder to write short, inform-
ative, thought-provoking books on specific topics. Yet Douglas Green has achieved this distinction
with Means to an End, a personal account of how cells die that has been widely praised. Inspiration
for young scientists of a different but still potent kind is found in Errol Friedberg’s account of the
notable life and work of Sydney Brenner and in a collection of insightful interviews conducted by
Jane Gitschier with a variety of people in and around science (Speaking of Genetics). And in The
Honest Look, a second novel by the cell biologist Jennifer Rohn, readers can find a human drama
based in a realistic portrayal of the scientific enterprise and the men and women engaged in it. A
complete list of the year’s new titles can be found at the beginning of this report.
The year’s best-sellers included Molecular Cloning, At the Bench, Symposium 74: Evolution, Sta-
tistics at the Bench, Epigenetics, Live Cell Imaging, At the Helm; and RNA: A Laboratory Manual. New
translation contracts included Japanese translations of Statistics at the Bench and At the Helm; and
Chinese translations of Live Cell Imaging and Transcriptional Regulation in Eukaryotes.
The generation of book sales worldwide continues to rely heavily on a monthly electronic newslet-
ter. Our websites continue to be cornerstones of our presence in the information landscape and our
long relationship with Amazon remains essential to the sale of our books in the United States. In-
ternationally, we benefit greatly from the local expertise of commission-based sales agents in Ger-
many and several associated European countries, China, Japan, India, and South America.
Warehousing, order processing, and book distribution outside the United States continue to be han-
dled by a company in the United Kingdom. 
Staff
During the year, we said farewell to Ingrid Benirschke, Ann Boyle, Mary Cozza, Joan Ebert, Maria
Fairchild, Lauren Heller, Kaaren Kockenmeister, Kathryn LaForgia, Christina Lo, Katherine MacDon-
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ald, Nora Ruth, and Patricia Serpe. We welcomed Antonella Caiazza, Marie Cotter, Joanne McFadden,
and Hashi Wijayatilake.
A complete list of staff members of the Press at the end of December 2010 is printed elsewhere
in this volume. The Press and the Laboratory are fortunate to have the service of such capable and
dedicated individuals. Special thanks are due to those who during the year had the responsibility of
leadership in the diverse departments and projects of the Press: Jan Argentine, David Crotty, Alex
Gann, Terri Grodzicker, Christina Lo, Geraldine Jaitin, Bill Keen, Wayne Manos, Richard Sever,
Marcie Siconolfi, Hillary Sussman, Linda Sussman, and Denise Weiss. 
John R. Inglis
Executive Director
and Publisher
440 Cold Spring Harbor Laboratory Press
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2010
(with comparative financial information as of December 31, 2009)
  2010 2009
Assets:
Cash and cash equivalents $    60,766,362 65,950,558 
Grants receivable 7,725,659 6,200,398 
Contributions receivable, net 104,272,591 119,740,185 
Publications inventory 3,555,193 4,570,278 
Investments 276,424,730 241,595,564 
Restricted use assets 2,580,471 2,111,090 
Other assets 9,922,097 10,398,213 
Land, buildings, and equipment, net 238,777,879 237,791,406 
Total assets $  704,024,982 688,357,692 
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $    25,635,009  26,475,011 
Deferred revenue 8,210,668 5,640,029 
Bonds payable 97,200,000 97,200,000 
Total liabilities 131,045,677 129,315,040 
Net assets:
Unrestricted 227,854,292 235,125,827 
Temporarily restricted 242,589,902 142,357,714 
Permanently restricted 102,535,111 181,559,111 
Total net assets 572,979,305 559,042,652 
Total liabilities and net assets $  704,024,982 688,357,692
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2010
(with summarized financial information for the year ended December 31, 2009)
                                                                                                      Temporarily       Permanently              2010                    2009
                                                                        Unrestricted            Restricted          Restricted                Total                     Total
Revenue and other support:
Public support–contributions and 
non-federal grant awards $     13,624,936 30,685,893 1,109,499 45,420,328 67,103,796 
Federal grant awards 35,405,944 – – 35,405,944 29,648,968 
Indirect cost allowances 25,973,354 – – 25,973,354 21,016,585 
Investment return utilized 18,309,184  – – 18,309,184 18,216,748 
Program fees 6,971,358 – – 6,971,358 5,484,810 
Publications sales 9,251,441 – – 9,251,441 9,136,188 
Dining services 4,319,847 – – 4,319,847 4,103,820 
Rooms and apartments 3,556,328 – – 3,556,328 3,255,480 
Miscellaneous 2,126,513 – – 2,126,513 1,962,873 
Net assets released from restrictions 34,646,285          (34,646,285) – – –
Total revenue and other support 154,185,190 (3,960,392) 1,109,499 151,334,297 159,929,268 
Expenses:
Research 86,810,119 – – 86,810,119 74,005,657 
Educational programs 17,121,875 – – 17,121,875 14,964,908 
Publications 10,877,055 – – 10,877,055 9,032,225 
Banbury Center conferences 1,370,778 – – 1,370,778 1,069,044 
Dolan DNA Learning Center 
programs 1,406,339 – – 1,406,339 1,467,947 
Watson School of Biological Sciences
programs 3,535,758 – – 3,535,758 3,595,810 
General and administrative 14,746,870 – – 14,746,870 13,903,883 
Dining services 5,137,648 – – 5,137,648 4,712,901 
Total expenses 141,006,442 – – 141,006,442 122,752,375 
Excess (deficiency) of revenue and other
support over (under) expenses  13,178,748 (3,960,392) 1,109,499 10,327,855 37,176,893 
Other changes in net assets:
Investment (loss) return excluding amount
utilized (428,497) 9,028,095 – 8,599,598 24,463,751 
Change in fair value of interest-rate swap (4,990,800) – – (4,990,800) 24,524,899 
Release of temporarily restricted capital
funds 4,527,558 (4,527,558) – – –
Net asset reclassification based on change
in law/interpretation (19,558,544) 99,692,043 (80,133,499) – –
(Decrease) increase in net assets (7,271,535) 100,232,188 (79,024,000) 13,936,653 86,165,543 
Net assets at beginning of year 235,125,827 142,357,714 181,559,111 559,042,652 472,877,109 
Net assets at end of year $   227,854,292 242,589,902 102,535,111 572,979,305 559,042,652 
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CONSOLIDATED STATEMENT OF CASH FLOWS
Year ended December 31, 2010
(with comparative financial information for the year ended December 31, 2009)
     2010 2009
Cash flows from operating activities:
Increase in net assets $    13,936,653 86,165,543 
Adjustments to reconcile increase in net assets
to net cash provided by operating activities:
Change in fair value of interest rate swap 4,990,800 (24,524,897)
Depreciation and amortization 15,443,523 9,282,371 
Net appreciation in fair value of investments (23,724,939) (36,992,017)
Contributions restricted for long-term investment (1,712,498) (9,121,400)
Changes in assets and liabilities:
Grants receivable (1,525,261) 2,397,001 
Contributions receivable, net of financing activities 11,309,672 (18,458,455)
Publications inventory 1,015,085 (644,311)
Other assets 929,237 (611,026)
Restricted use assets (469,381) 1,456,592 
Accounts payable and accrued expenses, net of financing activities (2,521,650) 32,680 
Deferred revenue 2,570,639 1,678,029 
Net cash provided by operating activities 20,241,880 10,660,110 
Cash flows from investing activities:
Capital expenditures (16,429,996) (48,389,574)
Proceeds from sales and maturities of investments 36,404,485 140,454,706 
Purchases of investments (47,508,712) (131,634,094)
Net change in investment in employee residences (453,121) 440,775 
Net cash used in investing activities (27,987,344) (39,128,187)
Cash flows from financing activities:
Permanently restricted contributions 1,109,499 2,255,040 
Contributions restricted for investment in land, buildings,
and equipment 602,999 6,866,360 
Decrease in contributions receivable 4,157,922 3,399,927 
Decrease in deposits with bond trustee – 11,886,744 
(Decrease) increase in accounts payable relating to capital
expenditures (3,309,152) 403,725 
Decrease in deposits with swap counterparty – 17,380,247 
Net cash provided by financing activities 2,561,268 42,192,043 
Net (decrease) increase in cash and cash equivalents (5,184,196) 13,723,966 
Cash and cash equivalents at beginning of year 65,950,558 52,226,592 
Cash and cash equivalents at end of year $    60,766,362 65,950,558 
Supplemental disclosure:
Interest paid $      3,652,690 3,180,748 
Noncash investing and financing activities:
Contributed property $           57,475      98,085 
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a
substantial portion of their funding through grants from the federal government and through grants,
capital gifts, and annual contributions from New York State, private foundations, corporations, and
individuals. The following section summarizes funding that occurred during 2010.
GRANTS January 1–December 31, 2010
COLD SPRING HARBOR LABORATORY
Grantor Program/Principal Investigator Duration of Grant 2010 Funding1
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Support Dr. Pappin 05/13/10 05/12/11 $    851,656 *2
Program Project and Center Support Drs. Hannon/Krainer/Lowe/Spector/Stillman 01/01/07 12/31/11 4,743,330 
Dr. Stillman–Cancer Center Core 08/15/05 07/31/11 4,236,444 
Dr. Stillman–Cancer Center Core 09/30/09 03/31/11 59,081 2
Dr. Zador–Faculty Recruitment 09/30/09 08/31/11 538,683 2
Cooperative Research Agreement Support3 Drs. Gingeras/Hannon 09/27/07 06/30/11 1,899,018 
Dr. Huang 09/08/06 08/31/11 201,418 
Drs. Lowe/Hannon/Hicks/Powers 09/01/10 08/31/11 871,519 *
Contract Support Drs. Hannon/Lowe 12/31/09 12/31/11 999,999 
Research Support Dr. Churchland 09/01/10 08/31/13 248,999 *
Dr. Dubnau 09/15/09 08/31/14 430,650 
Dr. Furukawa 03/01/10 02/28/15 435,000 *
Dr. Hannon 09/01/09 08/31/13 353,133 
Drs. Hannon/Gingeras/McCombie 09/30/09 08/31/11 1,506,827 2
Drs. Hannon/Gingeras/McCombie 09/30/09 08/31/11 1,103,288 2
Drs. Hannon/Gingeras/McCombie 09/30/09 08/31/11 1,491,492 2
Dr. Huang 04/16/09 04/30/11 210,000 
Dr. Huang 09/30/09 08/31/11 513,667 2
Dr. Joshua-Tor 07/01/07 06/30/12 307,561 
Dr. Joshua-Tor 02/01/06 01/31/11 105,597 
Dr. Koulakov 02/01/08 01/31/12 415,800 
Drs. Koulakov/Enikolopov 07/15/10 04/30/14 348,000 *
Dr. Krainer 09/21/07 08/31/11 656,937 
Dr. Li 07/01/10 03/31/15 526,630 *
Dr. Lowe 09/15/09 08/31/14 353,133 
Dr. Martienssen 08/01/07 07/31/11 419,760 
Dr. Martienssen 09/29/09 08/31/11 348,000 2
Dr. McCombie 07/23/10 04/30/15 1,135,298 *
Dr. Mills 12/26/07 11/30/12 359,805 
Dr. Mitra 09/30/09 05/31/14 648,174 
Dr. Mitra 09/30/09 08/31/11 499,997 2
1Includes direct and indirect costs
2Award issued under the American Recovery and Reinvestment Act of 2009
3Cooperative research agreement funding amounts include only CSHL portion of award
*New grants awarded in 2010 445
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Dr. Mitra 08/01/10 05/31/13 $   399,317 *
Dr. Muthuswamy 02/01/09 12/31/13 389,393 
Drs. Powers/Lowe/Krasnitz/Sordella 09/29/09 08/31/11 2,374,043 2
Dr. Powers 12/02/06 11/30/11 456,045 
Dr. D. Spector 04/01/90 03/31/11 676,357 
Dr. Stenlund 02/01/08 01/31/12 430,650 
Dr. Stillman 06/01/08 05/31/12 644,890 
Dr. Tonks 07/01/10 04/30/15 712,640 *
Dr. Tonks 01/11/10 12/31/13 408,900 *
Dr. Trotman 04/01/10 01/31/14 288,840 *
Dr. Turner 07/15/10 06/30/15 361,000 *
Dr. Van Aelst 07/01/08 03/31/13 391,500 
Dr. Van Aelst 01/01/09 12/31/13 361,050 
Drs. Wigler/McCombie 09/30/09 08/31/11 1,395,339 2
Dr. Zador 09/18/08 07/31/13 366,053 
Dr. Zador 09/24/09 08/31/11 93,017 2
Dr. Zador 09/27/10 05/31/15 435,000 *
Dr. Zhong 06/01/10 05/31/13 348,000 *
Research Subcontracts
NIH/Allen Institute for Brain Science Dr. Mitra 09/15/09 08/31/11 229,681 
Consortium Agreement
NIH/Angion Biomedica Corp. Dr. Enikolopov 09/30/09 08/31/11 278,368 
Consortium Agreement
NIH/Brookhaven National Laboratory Dr. Stillman 09/01/06 08/31/11 38,421 
Consortium Agreement
NIH/Carnegie Mellon University Dr. Osten 09/15/10 07/31/11 134,000 *
Consortium Agreement            
NIH/Columbia University Consortium Dr. Lowe 08/18/06 07/31/11 402,398 
Agreement
NIH/Cornell University Consortium Dr. Mitra 04/03/08 01/31/11 55,118 
Agreement
NIH/Georgia Institute of Technology Dr. D. Spector 09/30/06 07/31/11 297,852 
Consortium Agreement
NIH/Northwestern University Dr. Osten 09/15/09 08/31/11 33,600 
Consortium Agreement
NIH/Paratek Pharmaceuticals, Inc. Dr. Krainer 01/05/09 12/31/10 168,931 
Consortium Agreement
NIH/Princeton University Consortium Dr. Zador 05/01/10 04/30/11 43,500 *
Agreement
NIH/University of California, San Dr. Egeblad 09/01/09 08/31/14 178,984 
Francisco Consortium Agreement
NIH/University of California, Berkeley Dr. Gingeras 05/04/07 03/31/11 655,799 
National Laboratory Consortium 
Agreement
NIH/University of Southern California Dr. Hannon 07/01/10 06/30/14 121,800 *
Consortium Agreement
NIH/University of Southern California Drs. Lowe/Sordella 09/28/09 07/31/14 370,000 
Consortium Agreement
NIH/University of Texas, Dallas Drs. Krainer/McCombie/M. Zhang 08/01/10 07/31/11 291,888 *
Consortium Agreement
Fellowship Support Dr. Borges 08/16/09 08/15/12 52,154 
M. Lazarus 07/15/09 07/14/10 25,380 
446 Finance
1Includes direct and indirect costs
2Award issued under the American Recovery and Reinvestment Act of 2009
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Graduate Training Support Dr. Joshua-Tor, Watson School of Biological 07/01/07 06/30/12 $    207,432 
Sciences
Dr. Joshua-Tor, Watson School of Biological 09/01/09 08/31/11 41,266 2
Sciences
Course Support Immunocytochemistry, In Situ Hybridization, 09/01/10 08/31/15 78,167 *
Super-Resolution, and Live Cell Imaging
Advanced Techniques in Molecular Neuroscience 07/01/01 06/30/12 74,678 
Caenorhabditis elegans 08/01/98 08/31/11 81,739 
Cell and Developmental Biology of Xenopus 04/01/09 03/31/14 60,918 
Computational and Comparative Genomics 06/06/91 07/31/13 50,282 
Eukaryotic Gene Expression 01/01/83 03/31/11 108,929 
Imaging Structure and Function in the Nervous 07/01/01 06/30/12 87,131 
System 
Integrated Data Analysis for High-Throughput 09/01/07 04/30/12 79,188 
Biology 
Molecular Embryology of the Mouse 01/01/83 03/31/11 108,369 
Neurobiology of Drosophila 07/01/01 06/30/12 68,010 
Programming for Biology 07/07/00 08/31/14 61,800 
Protein Purification and Characterization 01/01/83 03/31/11 86,303 
Proteomics 07/01/03 06/30/11 80,080 
X-Ray Methods in Structural Biology 07/01/07 06/30/12 77,056 
Yeast Genetics and Genomics 09/18/10 06/30/13 51,905 *
Meeting Support Axon Guidance, Synaptic Plasticity, and 08/01/10 07/31/11 10,000 *
Regeneration 
The Biology of Genomes 04/01/08 03/31/13 38,193 
The Cell Cycle 03/01/06 02/28/11 4,000 
Gene Expression and Signaling in the Immune 04/01/08 03/31/13 10,000 
System 
Molecular Genetics of Aging 03/01/08 02/28/13 30,030 
Germ Cells 07/01/08 06/30/13 6,000 
Glia in Health and Disease 07/01/10 06/30/11 24,989 *
Mechanisms and Models of Cancer 08/01/08 07/31/13 6,000 
Molecular Chaperones and Heat Shock Response 05/01/10 04/30/13 20,000 *
Molecular Genetics of Bacteria and Phages 07/01/10 06/30/11 18,500 *
Mouse Development, Genetics, and Genomics 08/01/10 07/31/11 8,500 *
Pharmacogenomics and Personalized Therapy 09/30/10 08/31/15 15,000 *
PTEN Pathways  and Targets 03/01/06 02/28/11 7,000 
75th Symposium: Nuclear Organization and 04/01/10 03/31/11 10,000 *
Function
Systems Biology: Global Regulation of Gene 03/01/10 02/28/15 5,000 *
Expression
Telomeres and Telomerase 09/30/10 08/31/11 30,625 *
Vertebrate Organogenesis 04/01/10 03/31/15 12,000 *
HEALTH RESOURCES AND SERVICES ADMINISTRATION
Equipment Support Dr. D. Spector 08/01/10 07/31/12 495,000 *
NATIONAL SCIENCE FOUNDATION
Multiple Project Award Support Dr. Jackson 10/01/10 09/30/15 1,120,694 *
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Drs. McCombie/Martienssen/Ware 08/01/10 07/31/12 $ 2,499,992 *
Dr. Ware 10/01/07 09/30/11 1,757,922 
Research Support Dr. Jackson 09/01/10 08/31/13 200,000 *
Dr. Jackson 07/01/09 06/30/11 78,072 
Dr. Lippman 09/15/09 08/31/12 166,841 
Dr. Timmermans 08/15/10 07/31/13 200,000 *
Dr. Ware 06/15/08 05/31/11 263,886 
Research Subcontracts
NSF/Cornell University Consortium Drs. Timmermans/Micklos 09/01/08 08/31/12 408,333 
Agreement
NSF/New York University Consortium Drs. McCombie/Martienssen 08/01/10 07/31/14 384,900 *
Agreement
NSF/University of Arizona Consortium Dr. Ware 08/15/10 07/31/14 542,429 *
Agreement
NSF/University of Arizona Consortium Drs. Stein/Martienssen/Micklos/Ware 02/01/08 01/31/13 2,101,833 
Agreement
NSF/University of California, Berkeley Dr. Jackson 08/01/06 07/31/11 228,512 
Consortium Agreement
NSF/University of California, Davis Dr. Ware 09/01/08 08/31/11 214,214 
Consortium Agreement
NSF/Washington University Consortium Dr. Ware 03/01/10 02/28/11 312,400 *
Agreement
Fellowship Support K. Liberatore 06/01/10 05/31/13 40,500 *
Undergraduate Training Support Dr. Lippman 03/01/09 02/29/12 69,420 
Course Support Advanced Bacterial Genetics 07/01/09 06/30/14 90,953 
Computational Cell Biology 04/15/08 03/31/11 96,338 
Molecular Techniques in Plant Science 07/01/10 06/30/11 96,680 *
Meeting Support Molecular Genetics of Bacteria and Phages 08/01/10 07/31/11 7,000 *
7th International Conference on Plasmodesmata 03/01/10 02/28/11 15,000 *
Systems Biology: Global Regulation of Gene 
Expression 06/01/10 05/31/11 7,000 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/08 08/31/11 133,795 
Dr. McCombie 09/11/09 09/10/14 113,436 
UNITED STATES DEPARTMENT OF ENERGY
Research Support Dr. Martienssen 09/03/10 09/02/12 852,567 *
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 09/01/08 08/31/13 658,118 
Drs. Lucito/Tonks 07/01/10 06/30/12 434,000 *
Dr. Trotman 08/15/09 08/14/12 162,162 
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Drs. Wigler/Hicks/Krasnitz 09/01/09 08/31/11 $ 2,151,000 
Dr. Zhong 06/15/10 06/14/13 285,477 *
Fellowship Support Dr. B. Zhang 03/15/10 03/14/11 61,772 *
MISCELLANEOUS SOURCES OF FUNDING
Equipment Support
F.M. Kirby Foundation Dr. Egeblad 05/01/10 04/30/11 100,000 *
Eleanor Schwartz Charitable Foundation Dr. McCombie 06/01/10 05/31/11 200,000 *
Program Project Support
The Leukemia & Lymphoma Society Dr. Lowe 10/01/08 09/30/13 1,250,000 
Pioneer Hi-Bred International, Inc. Drs. Jackson/Lippman/Martienssen/ 07/01/07 06/30/12 1,600,000 
Timmermans/Ware
The Simons Foundation/Autism Dr. Wigler 07/01/08 06/30/11 6,664,189 
The Simons Foundation/Center for Dr. Wigler 09/01/08 08/31/11 1,500,000 
Quantitative Biology
Theodore R. and Vada S. Stanley Drs. Watson/McCombie 07/01/07 06/30/12 5,000,000 
Research Support
Paul G. Allen Family Foundation Dr. Zador 10/01/10 09/30/13 611,100 *
Alpern Family Foundation Inc. Dr. Egeblad 12/15/10 12/14/11 2,500 *
Alzheimer’s Association Dr. Furukawa 03/01/10 02/28/12 49,969 *
American Cancer Society Dr. Wigler 01/01/10 12/31/10 10,000 *
Dr. Wigler 01/01/06 12/31/10 60,000 
Anonymous Dr. Osten 09/01/09 08/31/11 248,492 
The A&P Foundation Dr. Egeblad 06/01/10 05/31/11 20,000 *
The Breast Cancer Research Foundation Dr. Wigler 10/01/10 09/30/11 223,000 *
Brookhaven National Laboratory/New Dr. Enikolopov 03/01/10 04/30/10 16,202 *
York State Department of Health 
Carnegie Mellon University/Anonymous Dr. Osten 01/01/10 11/30/11 25,000 *
Mr. and Mrs. Edward Chernoff in honor Dr. Egeblad 07/01/10 06/30/11 1,000 *
of Fred and Marika Fogelman
Mr. and Mrs. Edward Chernoff in Dr. Furukawa 08/15/10 08/14/11 500 *
memory of James J. Kehoe
Clear Channel Worldwide (WALK 97.5 Dr. Egeblad 04/01/10 03/31/11 4,000 *
FM)
Damon Runyon Cancer Research Dr. Sordella 01/01/10 12/31/12 150,000 *
Foundation
The Dana Foundation Dr. Li 10/01/09 09/30/12 63,844 
Dr. Li 01/01/09 12/31/11 200,000 
Dart Neuroscience LLC Dr. Dubnau 05/01/10 04/30/11 250,000 *
Dr. Zhong 06/01/10 05/31/11 125,000 *
The Kathryn W. Davis Foundation Dr. Hannon 01/15/07 01/14/11 1,005,660 
Deer Park High School Dr. Egeblad 12/01/10 11/30/11 500 *
In memory of Raymond Donovan Dr. Trotman 08/01/10 07/31/11 360 *
The Ellison Medical Foundation Dr. Enikolopov 09/09/09 09/08/13 252,000 
Entertainment Industry Foundation Dr. Hannon 11/01/10 10/31/11 250,000 *
Charitable Lead Annuity Trust under Dr. Osten 12/29/10 12/28/11 25,000 *
the Will of Louis Feil
Brian Fox through United Way of Dr. Lowe 03/01/10 02/28/11 2,000 *
New York City
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The Joni Gladowsky Breast Cancer Dr. Egeblad 12/01/10 11/30/11 $      30,000 *
Foundation
GlaxoSmithKline Dr. Powers 09/20/06 03/20/11 259,599 
Richard and Mindy Gordon Dr. Egeblad 01/01/10 12/31/10 3,000 *
Dr. Lazebnik 01/01/10 12/31/10 2,000 *
Greenwich Breast Cancer Alliance Inc. Dr. Egeblad 01/01/10 12/31/11 62,500 *
The Irving A. Hansen Memorial Dr. Tonks 07/01/10 06/30/11 20,000 *
Foundation
Jo-Ellen and Ira Hazan Dr. Enikolopov 12/01/10 11/30/11 20,000 *
Dr. Osten 12/01/10 11/30/11 180,000 *
Hearts for Cancer Dr. Egeblad 04/01/10 03/31/11 8,455 *
The International Human Frontier Dr. Lippman 07/01/09 06/30/12 100,000 
Science
Isis Pharmaceuticals, Inc. Dr. Krainer 11/01/08 10/31/11 125,000 
Islip Breast Cancer Coalition Inc. Dr. Egeblad 05/01/10 04/30/11 5,000 *
Knott Family Foundation Drs. Tonks/Pappin 09/01/10 08/31/11 15,000 *
The Susan G. Komen Breast Cancer Dr. Egeblad 04/13/10 04/12/13 150,000 *
Foundation, Inc.
Charles Henry Leach II Foundation Dr. Enikolopov 06/01/10 05/31/11 2,000 *
Mara and Thomas Lehrman Charitable Dr. Erlich 08/01/10 07/31/11 40,000 *
Fund
The George Link, Jr. Foundation, Inc. Dr. Sordella 12/01/10 11/30/11 50,000 *
The Long Island 2-Day Walk to Fight Dr. Egeblad 08/15/10 08/14/11 31,000 *
Breast Cancer
The Lustgarten Foundation Drs. Hannon/Lowe 01/01/10 12/31/12 1,048,204 *
Drs. Powers/Lowe/Van Aelst 02/01/10 01/31/12 424,723 *
Carol Marcincuk Fund Dr. Tonks 01/01/10 12/31/10 3,872 *
In honor of Carissa Maringo Dr. Egeblad 10/01/10 09/30/11 4,540 *
The G. Harold and Leila Y. Mathers Dr. Mitra 09/01/10 08/31/13 204,135 *
Charitable Foundation
Breast Cancer Awareness Day in memory Dr. Wigler 01/01/10 12/31/11 72,305 *
of Elizabeth McFarland
The McKnight Endowment Fund for Dr. Osten 08/01/09 07/31/11 100,000 
Neuroscience
The John Merck Fund Dr. Kepecs 06/01/10 05/31/14 75,000 *
The Don Monti Memorial Research Dr. Lowe 03/01/10 02/28/11 300,000 *
Foundation
Louis Morin Charitable Trust Dr. Joshua-Tor 12/01/10 11/30/11 70,000 *
The Neuberger Berman Foundation Dr. Egeblad 02/01/10 01/31/11 20,000 *
New York State Department of Health– Drs. Enikolopov/Koulakov 01/01/09 12/31/11 360,000 
New York Stem Cell Science Dr. Timmermans 01/01/09 12/31/10 119,900 
(NYSTEM)
Paratek Pharmaceuticals, Inc. Dr. Krainer 01/01/10 12/31/10 37,800 *
Philips Research North America Drs. Lucito/Wigler 04/01/09 03/31/11 636,518 
Dr. Zhang 01/01/09 12/31/10 227,527 
V. Kann Rasmussen Foundation Dr. Trotman 09/01/07 08/31/12 50,000 
Christina Renna Foundation, Inc. Dr. Van Aelst 01/01/08 12/31/11 15,000 
Diane Emdin Sachs Memorial Fund Dr. Sordella 09/01/10 08/31/11 13,315 *
Judi Shesh Memorial Foundation Dr. Egeblad 08/01/10 07/31/11 10,000 *
The Simons Foundation Dr. Henn 09/01/10 08/31/12 294,030 *
Dr. Henn 09/01/10 08/31/11 500,978 *
Dr. Mills 01/01/10 10/31/10 289,633 *
Dr. Mills 07/01/10 06/30/13 350,000 *
Dr. Mitra 09/01/09 08/31/11 150,000 
Dr. Osten 07/01/09 06/30/11 150,107 
450 Finance
1Includes direct and indirect costs
*New grants awarded in 2010
441-472_LAR_Finance_Annual Report_2009 template  7/8/11  12:29 PM  Page 450
Grantor Program/Principal Investigator Duration of Grant 2010 Funding1
Mary F. Smith Family Foundation Dr. Egeblad 11/01/10 10/31/11 $        5,000 *
Mr. and Mrs. Douglas S. Soref Drs. Tonks/Pappin 09/01/10 08/31/11 15,000 *
Starr Cancer Consortium Dr. Egeblad 08/01/09 07/31/11 150,000 
Dr. Krainer 11/01/10 10/31/11 240,000 *
Dr. Lazebnik 08/01/09 07/31/11 180,000 
Drs. Lowe/Vakoc 08/01/10 07/31/12 167,500 *
Drs. Lucito/Tonks 08/01/09 07/31/11 491,076 
Dr. McCombie 08/01/09 07/31/11 180,000 
Dr. Powers 08/01/09 07/31/11 180,000 
Drs. Sordella/Van Aelst 08/01/10 07/31/12 809,381 *
Dr. Trotman 08/01/09 07/31/11 150,000 
Dr. Wigler 08/01/09 07/31/11 854,942 
Drs. M. Zhang/Atwal 08/01/09 07/31/11 240,000 
The Sandra and Howard Tytel Family Drs. Tonks/Pappin 09/01/10 08/31/11 15,000 *
Foundation, Inc.
University of California, Los Angeles/ Dr. Hannon 10/01/09 09/30/12 828,568 
Entertainment Industry Foundation
U.S.–Israel Binational Agricultural Dr. Lippman 06/01/10 05/31/13 41,000 *
Research and Development Fund
Dr. Krainer 10/01/10 09/30/14 10,000 *
Dr. Zador 10/01/10 09/30/14 5,750 *
The V Foundation Drs. Powers/Sordella 11/01/08 10/31/11 200,000 
West Islip Breast Cancer Coalition for Dr. Egeblad 11/01/10 10/31/11 10,000 *
Long Island Inc.
Whitehall Foundation, Inc. Dr. Kepecs 06/01/08 05/31/11 75,000 
Ms. Evelyn Willard Dr. Churchland 12/21/10 12/20/11 50,000 *
Women’s Partnership Lectures Dr. Sordella 12/01/10 11/30/11 1,350 *
Fellowship Support
Australian Government National Health Dr. Bolden 04/01/10 03/31/12 76,230 *
and Medical Research Council Dr. Dow 02/01/09 01/31/11 45,478 
Terri Brodeur Breast Cancer Foundation Dr. Bialucha 01/01/09 12/31/10 50,000 
Canadian Institutes of Health Research Dr. Aznarez 07/01/09 12/31/11 43,044 
Cashin Family Fund Watson School of Biological Sciences 09/01/09 08/31/11 80,000 
The Jane Coffin Childs Memorial Fund Dr. Kuhn 03/29/10 01/31/12 39,475 *
for Medical Research
CSHL Association Fellowship New Investigator Support 01/01/10 12/31/10 280,000 *
Deutsche Forschungsgesellschaft Dr. Ahrens 06/01/10 05/31/12 43,296 *
Engelhorn Scholarship Program Watson School of Biological Sciences 01/01/10 12/31/10 49,980 *
Genentech Foundation Watson School of Biological Sciences 07/01/09 06/30/12 57,157 
The Fred C. Gloeckner Foundation, Inc. J. Calarco 08/01/10 07/31/11 8,100 *
The Allen and Lola Goldring Foundation Dr. Stillman 09/01/10 08/31/11 75,000 *
Lita Annenberg Hazen Foundation Watson School of Biological Sciences 05/01/08 04/30/18 10,000 
Hope Funds for Cancer Research Dr. Sawey 07/01/09 06/30/11 44,500 
Human Frontier Science Program Dr. Canela 05/01/09 04/30/11 53,640 
Dr. Kvitsiani 09/01/08 08/31/11 47,150 
Dr. Skopelitis 04/01/09 03/31/12 51,720 
International Rett Syndrome Foundation Dr. Krishnan 10/01/10 09/30/12 50,000 *
Dr. Lin 01/01/09 12/31/10 50,000 
Dr. Paul 10/01/09 09/30/11 50,000 
Annette Kade Charitable Trust Watson School of Biological Sciences 04/01/10 03/31/11 50,000 *
Harvey L Karp Foundation Dr. Ipsaro 09/01/10 08/31/11 50,000 *
The Esther A. & Joseph Klingenstein Dr. Kepecs 07/01/09 06/30/12 50,000 
Fund Inc. Dr. Shea 07/01/10 06/30/13 50,000 *
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The Susan G. Komen Breast Cancer Dr. Anczukow 06/04/09 06/03/12 $     60,000 
Foundation, Inc.
Life Sciences Research Foundation Dr. Xu 11/01/09 10/31/12 56,000 
NARSAD Dr. Karakas 01/01/10 12/31/11 30,000 *
Dr. Taniguchi 01/01/10 12/31/11 30,000 *
National Cancer Center Dr. Mao 07/01/10 06/30/12 40,000 *
The Robert Leet and Clara Guthrie Dr. Lu 01/15/09 01/14/11 46,000 
Patterson Trust
Mr. and Mrs. John C. Phelan Watson School of Biological Sciences 09/01/10 08/31/11 100,000 *
Marie Robertson Memorial Fund New Investigator Support 01/01/10 12/31/11 137,500 *
The Seligson Foundation Dr. Zuber 01/01/10 12/31/10 75,000 *
Alfred P. Sloan Foundation Dr. Kepecs 09/16/09 09/15/11 25,000 
Lauri Strauss Leukemia Foundation Dr. Chien 06/01/10 05/31/11 10,000 *
The Swartz Foundation Dr. Zador 01/01/10 12/31/10 100,000 *
Drs. Koulakov/Kolterman 01/01/10 12/31/10 55,000 *
Drs. Zador/Reid 01/01/10 12/31/10 55,000 *
Dr. Zador 01/01/10 12/31/10 7,500 *
Training Support
Howard Hughes Medical Institute Undergraduate Research Program 06/01/10 05/31/11 4,500 *
Research Foundation of the City Undergraduate Research Program 06/01/10 05/31/11 7,000 *
University of New York 
Steamboat Foundation Undergraduate Research Program 05/01/10 04/30/11 12,000 *
William Townsend Porter Foundation Undergraduate Research Program 04/01/10 03/31/11 10,010 *
Course Support
American Brain Tumor Association Brain Tumors 01/01/10 12/31/10 45,000 *
American Express Foundation Leadership in Bioscience Workshop 01/01/10 12/31/10 95,000 *
Applied Biosystems Advanced Sequencing Technologies and 07/01/10 06/30/11 30,000 *
Applications
Autism Speaks, Inc. Workshop on Biology of Social Cognition 05/01/07 04/30/11 15,000 
Howard Hughes Medical Institute Neurobiology Course Support 01/01/07 12/31/11 750,000 
Illumina, Inc. Advanced Sequencing Technologies and 07/01/10 06/30/11 30,000 *
Applications
The Nancy Lurie Marks Family Workshop on Biology of Social Cognition 05/01/07 04/30/11 15,000 
Foundation
Roche Diagnostics Corporation Advanced Sequencing Technologies and 07/01/10 06/30/11 30,000 *
Applications 
Workshop on Circuit and Molecular 07/01/10 06/30/11 40,000 *
Architecture
The Simons Foundation Workshop on Biology of Social Cognition 05/01/07 04/30/11 15,000 
Meeting Support
Alnylam US, Inc. RNA and Oligonucleotide Therapeutics 04/01/10 03/31/11 1,000 *
Amgen Inc. Gene Expression and Signaling in the Immune 10/01/09 09/30/10 5,000 
System
AVI BioPharma, Inc. RNA and Oligonucleotide Therapeutics 04/01/10 03/31/11 25,000 *
Blake Industries Protein Data Bank 40th Anniversary 12/01/10 11/30/11 1,000 *
Boehringer Ingelheim Pharmaceuticals Gene Expression and Signaling in the Immune 10/01/09 09/30/10 2,500 
Inc. System
Cambridge Isotope Laboratories, Inc. Protein Data Bank 40th Anniversary 12/01/10 11/30/11 1,000 *
Genentech, Inc. Vertebrate Organogenesis 09/01/09 08/31/10 3,500 
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Genentech, Inc. Gene Expression and Signaling in the Immune 10/01/09 09/30/10 $     2,500 
System
Helixis, Inc. The Biology of Genomes 04/01/10 03/31/11 7,500 *
Illumina, Inc. Personal Genomes 09/14/09 09/13/10 3,750 
The Biology of Genomes 04/01/10 03/31/11 11,000 *
Isis Pharmaceuticals, Inc. RNA and Oligonucleotide Therapeutics 04/01/10 03/31/11 3,000 *
The March of Dimes Foundation Vertebrate Organogenesis 03/01/10 08/31/10 5,000 *
Merck Serono S.A. Gene Expression and Signaling in the Immune 10/01/09 09/30/10 10,000 
System
Molecular Devices, Inc. Automated Imaging and High-Throughput 11/01/10 10/31/11 5,000 *
Phenotyping
New England BioLabs, Inc. Infectious Disease Genomics and Global Health 08/01/10 07/31/11 1,500 *
Openeye Scientific Software, Inc. Protein Data Bank 40th Anniversary 12/01/10 11/30/11 2,000 *
Penn State University Galaxy Developers 04/01/10 03/31/11 35,050 *
Pfizer Inc. RNA and Oligonucleotide Therapeutics 04/01/10 03/31/11 3,000 *
Roche Diagnostics Corporation Personal Genomes 03/01/10 02/28/11 49,466 *
Schrodinger Protein Data Bank 40th Anniversary 12/01/10 11/30/11 1,000 *
Shigemi Inc. Protein Data Bank 40th Anniversary 12/01/10 11/30/11 500 *
Alfred P. Sloan Foundation New Faculty Investigator Conference 12/01/10 06/01/11 20,000 *
Library Support
Ellen Brenner Memorial Fund 12/22/10 12/21/11 2,000 *
New York University School of Medicine 01/26/10 04/30/10 1,000 *
The State of New York 07/01/09 06/30/10 3,850 
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Bay Shore Union Free School District $  6,000
Bellmore Union Free School District 3,500
Bellmore–Merrick Central HS District 8,000
Commack Union Free School District 6,700
Copiague Union Free School District 1,200
Eastern Middle School, Greenwich, CT 3,000
East Meadow Union Free School District 5,550
East Williston Union Free School District 2,800
Elwood Union Free School District 4,500
Floral Park–Bellerose Union Free School District 6,250
Friends Academy, Locust Valley 2,800
Garden City Union Free School District 11,500
Great Neck Union Free School District 16,550
Half Hollow Hills Central School District 7,625
Herricks Union Free School District 3,150
Holy Child Academy, Westbury 6,500
Huntington Union Free School District 6,700
Island Park Union Free School District 1,350
Jericho Union Free School District 7,875
Kings Park Central School District 1,950
Lawrence Union Free School District 7,100
Locust Valley Central School District $  9,989
Merrick Union Free School District 2,250
MS 447–The Math and Science Exploratory School, NYC 3,000
North Bellmore Union Free School District 1,600
Northport–East Northport Union Free School District 1,025
North Shore Central School District 1,500
Oceanside Union Free School District 1,500
Oyster Bay–East Norwich Central School District 3,050
Palisades Middle School, PA 1,800
Rockville Centre Union Free School District 2,400
Roslyn Union Free School District 3,599
Scarsdale Union Free School District 10,500
Smithtown Central School District 1,400
Saint Dominic Elementary School, Oyster Bay 4,050
St. Edward the Confessor School, Syosset 2,025
Syosset Central School District 32,500
Three Village Central School District 1,500
Valley Stream 13 Union Free School District 2,400
Yeshiva Darchei Torah School 1,600
Yeshiva of Flatbush 1,800
The following schools and school districts each contributed $1000 or more for participation in the Genetics as a Model for Whole Learning Program:
Northport–East Northport Union Free School District $  2,000
Oyster Bay–East Norwich School District 1,500
Plainview–Old Bethpage Central School District 1,500
Portledge School 1,500
Roslyn Union Free School District 1,500
Syosset Central School District 1,500
The Green Vale School 1,500
Yeshiva University High School for Girls 1,500
DNA LEARNING CENTER GRANTS
Duration 2010 
Grantor Program of Grant Funding†
FEDERAL GRANTS
National Institutes of Health Science Education Partnership Award (SEPA): Nationwide  8/08–7/11 $   52,701
Dissemination of Inside Cancer Internet Site 
National Science Foundation Course, Curriculum, and Laboratory Instruction (CCLI) Program: 9/07–8/11 87,245
Nationwide Dissemination of RNAi Curriculum
National Science Foundation, Weed to Wonder Internet Site Development: Educational Outreach for 9/08–8/11 74,732
Cornell University Functional Genomics of the Maize Shoot Apical Meristem
National Science Foundation, Educational Outreach for iPlant: A Cyberinfrastructure for 2/08–1/13 720,501
University of Arizona Plant Sciences
NONFEDERAL GRANTS
Bank of America Scholarships for Minority and Underserved Students on Long Island 2010 25,000
Dana Foundation Harlem DNA Lab Operating Support 3/09–2/12 129,334
Hewlett Foundation Genes to Cognition Online Internet Site Dissemination and Evaluation 10/08–4/11 37,190
Howard Hughes Medical  Pre-College Science Education Initiative: NYC Teacher Professional 9/07–8/12 142,476
Institute Development
Lounsbery Foundation Biotechnology Footlocker Program at Harlem DNA Lab 11/09–10/10 21,546
National Grid Foundation Scholarships for Minority and Underserved Students in the 10/10–10/11 15,000
Brentwood Union Free School District
North Shore–LIJ Health System DNALC West Operating Support 2010 50,000
William Townsend Porter Scholarships for Minority and Underserved Students at Harlem 3/10–3/11 35,035
Foundation DNA Lab
Bellmore–Merrick Central High School District $  3,000
Bethpage Union Free School District 1,500
East Meadow Union Free School District 1,500
Great Neck Union Free School District 1,500
Harborfields Central School District 1,500
Herricks Union Free School District 1,500
Long Beach City School District 1,500
Massapequa Union Free School District 1,500
†Includes direct and indirect costs
The following schools and school districts each contributed $1000 or more for participation in the Curriculum Study Program:
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BANBURY CENTER GRANTS
Duration 2010 
Grantor Program of Grant Funding
FEDERAL SUPPORT
NIH–National Institute of Mental The Second NIMH-Sponsored Brain Camp 2010 $ 44,465
Health
The U.S. Department of Homeland Microbial Forensics in the Era of Genomics 2010 23,433
Security
NONFEDERAL SUPPORT
Abraxis Bioscience, Inc. The Calculus of Medicine: Treatment of Pancreatic Cancer as a 2010 41,955
Prime Exemplar
Alfred P. Sloan Foundation How Can We Maintain the Stability of Biomedical Research and 2010 9,891
Development at the End of the ARRA?
The ALS Association Stem Cells, Genetics, and RNA-Binding Proteins: Recent 2010 32,231
Advances in ALS Research and Drug Discovery
Champalimaud Foundation and the Tumor Microenvironment and Metastasis 2010 35,407
Champalimaud Metastasis Programme
Cold Spring Harbor Laboratory Epigenetic Reprogramming and Transgenerational Inheritance 2010 52,673
Corporate Sponsor Program
Cold Spring Harbor Laboratory Signaling through Ubiquitin 2010 45,994
Corporate Sponsor Program
Cold Spring Harbor–Pioneer Plant Development and Phenomics 2010 54,394
Collaborative Research Program
Columbia University p53 Retreat 2010 10,870
The Ellison Medical Foundation Easeful Death: 21st Century Perspectives on Assisted Suicide 2010 25,374
Howard Hughes Medical Institute How Can We Maintain the Stability of Biomedical Research and 2010 10,000
Development at the End of the ARRA?
The Lehrman Institute DNA, Genetics, and the History of Mankind 2010 29,755
Marie Robertson Research Fund The Lateral Habenula: Its Role in Behavior and Psychiatric 2010 40,000
Disorders
Oliver Grace Fund Linguistic Phenotypes: Toward a Biological Understanding of 2010 31,472
Language
Oliver Grace Cancer Fund Mutagenesis: What It Means and How It Has Changed 2010 39,357
Oliver Grace Cancer Fund Energy Metabolism, the Cell Cycle, and Cancer 2010 40,912
PopTech Accelerator PopTech Science and Public Leadership Fellows Retreat 2010 42,000
The Simons Foundation Linguistic Phenotypes: Toward a Biological Understanding of 2010 10,000
Language
United Biomedical, Inc. Genetic Variation at a Single Locus for Prediction and Prevention 2010 14,275
of Late-Onset Alzheimer’s Disease
Université de Québec Linguistic Phenotypes: Toward a Biological Understanding of 2010 3,000
Language
University of Illinois Fragile X Syndrome: Current Status, Future Prospects 2010 48,306
Various institutions and individuals Genome-Era Pathology, Precision Diagnostics, and 2010 22,260
Preemptive Care: A Stakeholder’s Summit
Banbury Center Grants      455
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CORPORATE SPONSOR PROGRAM 
FOR MEETINGS SUPPORT
The Corporate Sponsor Program continues to provide critical funding for the vigorous meetings pro-
gram held at Cold Spring Harbor Laboratory, whether at Grace Auditorium on the main Laboratory
campus or at the Banbury Center. Without the strong foundation provided by the Program, we could
neither plan with confidence for the year’s meetings nor introduce new and unusual topics.
We are especially grateful to the companies that joined us in 2010 as the economic difficulties
began to take effect. The year 2011 is going to be especially challenging as the number of companies
shrinks through takeovers, and companies and foundations adopt austerity measures.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for eight representatives of the Corporate Sponsors at our meetings. Three
scientists from Sponsors may attend meetings at the Banbury Center, where attendance is otherwise
only by invitation of the organizers. Member companies also receive gratis copies of Cold Spring
Harbor Laboratory Press publications, including the journals Genes & Development, Learning &
Memory, Protein Science, Genome Research, and RNA. 
We acknowledge our Sponsors in all relevant publications, including the books of abstracts given
to each of the 7000 participants who come to the meetings each year. The names of the sponsoring
companies are listed on the poster describing the meetings, and this is mailed to approximately 17,000
scientists throughout the world. In addition, the companies are listed on the Cold Spring Harbor
Laboratory website on the Meetings Office and Banbury Center pages. Members in 2010 were the
following:
FOUNDATION
Hudson-Alpha Institute for Biotechnology
PLANT CORPORATE SPONSORS
Monsanto Company
Pioneer Hi-Bred International, Inc.
CORPORATE SPONSORS
Agilent Technologies, Inc.
AstraZeneca UK Ltd.
BioVentures, Inc.
Bristol-Myers Squibb Company
Genentech, Inc.
GlaxoSmithKline
Life Technologies
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Sanofi-Aventis
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DEVELOPMENT
The completion of the $200 million campaign in 2009 brought many new fund-raising challenges and opportunities.
Hiring of faculty to fill the new space became a top priority as did the need for additional resources for recruiting, staffing,
and equipping the buildings. We once again turned to our Board of Directors, closest friends, and local community
groups to ensure that the Laboratory continued its tradition of bringing the best and brightest young minds here. 
In 2010, the Laboratory lost two very good friends, Charlie Harris and George “Butch” Cutting. Charlie was a
former Trustee and an early member and Co-Chair of our President's Council. Ironically, his passion for nanotech-
nology was the inspiration for the 2010 President's Council meeting. Butch was a former Trustee, Honorary CSHL
Association member, and longtime supporter. It was never a surprise to see him at the Laboratory’s many dinners,
concerts, lectures, and fund-raising events. Both Charlie and Butch were great advocates and staunch supporters of
the Laboratory during many years and they will be missed deeply.
The Double Helix Medals Dinner continues to be a source of pride for the
Laboratory as we recognize some of the most influential scientists, community
leaders, and business executives in the biomedical field. This year’s event hon-
ored Evelyn Lauder, John Nash, and Mary-Claire King for their enormous
achievements. It also raised more than $3 million in important unrestricted
funding for the Laboratory. 
On a personal note, I would like to thank Eduardo Mestre for his 6 years
of dedicated service as Chairman of the Board. Under his leadership, the Lab-
oratory has grown in every way, and most importantly, our researchers continue
to produce some of the world’s most outstanding science. There is no doubt
that Jamie Nicholls will take over right where Eduardo left off in leading the
Laboratory’s efforts in science and discovery. I look forward to working closely with her in this endeavor.
We at the Laboratory remain eternally grateful for the support we receive from our community, advocates, sup-
porters, and friends. Thank you for helping us to strengthen and expand our science and educational programs not
only on Long Island, but all across the United States and the world.
Charles V. Prizzi, Vice President for Development
Cold Spring Harbor Laboratory is a nonprofit research and educational institution chartered by the State of New
York. Less than half of the Laboratory’s annual revenues are derived from federal grants and contracts, and thus,
it relies heavily upon support from the private sector: foundations, corporations, and individuals. CSHL takes this
occasion to sincerely thank each and every donor whose generous contributions have made possible the discoveries
we report in this publication. There are a variety of ways to give to the Laboratory:  
2010 Double Helix Medals honorees John Nash,
Mary-Claire King, and Evelyn Lauder
Capital and Endowment Campaign Support: Dona-
tions help secure the financial stability of the Laboratory,
increase the speed that genetic discoveries are translated
into diagnostic tests and therapeutics, and expand the
Lab’s facilities and staff. 
Annual Fund: Donations provide funding for some of
the most determined and innovative young researchers
in science today and constitute an important investment
in innovative research in cancer, neuroscience, plant bi-
ology, and bioinformatics. 
Science Education: Donations support programs at the
DNA Learning Center and the Watson School of Bio-
logical Sciences, where the next generation of citizens
learns about genetics in an exciting and interactive en-
vironment. 
Planned and Estate Gifts: Individuals who inform us
of their intention to make a gift to CSHL from their es-
tate are invited to become members of The Harbor So-
ciety. Estate gifts help to ensure that CSHL will con-
tinue to pursue its mission for many years to come.
For additional information, please contact Charlie Prizzi, Vice President for Development, Cold Spring Harbor Laboratory, One Bungtown
Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6961.
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Dr. Marcia Kramer Mayer and Mr.
Michael Eisenbud
Mr. and Mrs. Robert A. Gay
Dr. Leo Guthart
Mr. Matthew Haines–The Marc Haas
Foundation
Mr. and Mrs. Charles E. Harris II 
Mr. and Mrs. Ira Hazan
Mr. Harvey Karp 
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. David M. Knott
Mr. David H. Koch
Dr. Laurie J. Landeau
Dr. Betsy and Mr. Bryan H. Lawrence 
Mr. and Mrs. Richard Leeds
Mr. and Mrs. Thomas D. Lehrman
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
Mrs. Nancy Abeles Marks
Dr. Gillian and Mr. Eduardo Mestre
Mr. and Mrs. Howard L. Morgan
Mr. and Mrs. Douglas P. Morris
Mr. and Mrs. John C. Phelan
Mr. and Mrs. Arthur J. Saladino
Mr. and Mrs. Alan Seligson 
Drs. Marilyn and James Simons
Mr. and Mrs. Erwin P. Staller
Mr. and Mrs. Theodore Stanley
Mr. and Mrs. James F. Stebbins
Dr. and Mrs. Charles L. Stone, Jr.
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz
Mr. Paul J. Taubman
Mrs. Robert W. Tilney
Mr. and Mrs. Howard J. Tytel
Dr. and Mrs. James D. Watson
Mr. and Mrs. Stephen F. Wiggins
Mr. Roy J. Zuckerberg
President’s Council
The 2010 President’s Council topic, “Tiny Treatments: The Science of Nanotechnology,” featured talks on na-
notech investment, potential treatments for brain trauma, new approaches for diagnostics and drug delivery, and
safety concerns. Members enjoyed the April reception in New York hosted by long-time Lab friends Nathalie and
Bill Comfort in their spacious penthouse with breathtaking views. Co-chairs of the council this year were Thomas
Lehrman, Cynthia Stebbins, and Jim Stone. The October meeting was held for the first time on our new Hillside
Campus and included talks by nanotech luminaries Bob Langer and George Whitesides.  
The increasingly timely topic of nanotechnology was chosen in part as a tribute to Charles E. Harris, the late
CSHL Trustee and founding member and former Chairman of the President’s Council. Charlie, founder of Harris
& Harris Group, a publicly traded nanotech venture firm, was among the Lab’s most beloved friends. After learning
of his incurable cancer in March 2009, Charlie began to write a blog about dying—and living—written with the
warmth, eloquence, and insight so characteristic of him. Charlie, who worked behind the scenes to shape this year’s
particularly dynamic meeting, died the day before it took place. We look forward to the release of Incurable: A Life
after Diagnosis, a publication of his blog to be released this spring by CSHL Press.
President
Dr. Bruce Stillman
Chairpersons
Thomas D. Lehrman
Cynthia R. Stebbins
James M. Stone
Members
Ms. Amy Anthony
Ms. Jamie Nicholls, and Mr. Fran Biondi
Mr. and Mrs. Hans E.R. Bosch
Ms. Louise Parent and Mr. John Casaly
Dr. Gerald Chan
Mr. and Mrs. Edward Chernoff
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Yves C. de Balmann 
Mr. and Mrs. Geoffrey de Lesseps
Susan Harris and Nathalie Comfort at the Spring President’s Coun-
cil reception.
Isaac Cheng, Howard Morgan, Charles Prizzi, and Ginny Knott at
the President’s Council October meeting.
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Cold Spring Harbor Laboratory Association (CSHLA)
With nearly 1000 members, the CSHLA and its directors continue to increase awareness of CSHL. This year,
nearly $5,000,000 in unrestricted support was raised for the Laboratory. Events and benefits spearheaded by di-
rectors of the Association and members of the Board of Trustees included the Double Helix Medals dinner in New
York City, Symposium dinner parties, a regional junior chess tournament, dinners and luncheons highlighting the
accomplishments of our female scientists, and a variety of receptions and dinners to introduce new friends to the
exceptionally talented young scientists who devote their lives to improving human health.  
Early in 2010, we lost George “Butch” Cutting. Butch was an enthusiastic champion of the Laboratory for
many decades as Association director, president, honorary director, and member of the Board of Trustees and the
Laboratory’s President’s Council. He helped to shape the Laboratory Association board of directors in its early
days and put the “fun” into fund-raising for scientific research. He was genuinely interested in the research process
and enjoyed numerous enduring friendships with scientists, a great asset in his quest to help demystify molecular
biology to friends from Cold Spring Harbor to Alaska where he was always just a phone call away from the Lab’s
development department each summer. We are grateful to him for his true interest and for continuing with gusto
the tradition of neighborly support that is unique to Cold Spring Harbor Laboratory.
Special thanks go to Tim Broadbent for his thoughtful leadership as Association President for the last 2 years
and for his and his wife Lisa’s success for the past 7 years raising friends and funds at numerous special events with
creativity and elegance.
Lauryl Palatnick
David Peikon
Whitney F. Posillico
Scott J. Ratner, M.D.
Tracey DeMatties Serko
Debra Parmet Sondock
Cathy Cyphers Soref
Heather Lane Spehr
Pearl F. Staller
James A. Woods
Joseph V. Amella
Hans E.R. Bosch
Michele Munn Celestino
Linda Ferrante
Charles B. Goodwin, M.D.
Lynn M. Gray
Carolyn Gulotta
Nancy Lippman Israeli, M.D.
Virginia Knott
Maureen G. Leness
Directors
Executive Committee
Timothy S. Broadbent, 
President
Frank O’Keefe, Vice President
Sandy Tytel, Vice President
C. Fifield Whitman, Treasurer
Suzanne DiMaio, Secretary
CSHLA Members Sandy Pearson (left) with Robin and Paul Vermylen Ashley O’Keefe (left) with CSHLA Directors Suzanne DiMaio and
Michele Celestino
Honorary Directors
George W. Cutting, Jr.
Mary D. Lindsay
Anne R. Meier
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DNA Learning Center Advisory Boards
We are lucky to have high-level support from two advisory bodies: the Education Committee and the
Corporate Advisory Board (CAB). The Education Committee formulates policy and assists with strate-
gic planning, whereas the CAB provides liaison to the Long Island and New York City business com-
munity. The CAB also conducts an annual golf tournament and the annual fund campaign. These are
the DNALC’s major sources of unrestricted funding. In 2010, more than $200,000 was raised through
these events. 
Edward Chernoff
Lola Grace
Lori Homer
Suzanne Kleinknecht
Suzanne Leeds
Peter Quick
Lawrence Scherr, M.D.
Adele Smithers
DNALC Education Committee
Chairperson: Laurie Landeau, VMD
Arthur Spiro 
Peter Tilles
Edward Travaglianti
Marianne Dolan Weber
Corporate Advisory Board
Chairman: Edward A. Chernoff, Motors & Armatures Inc.
CSHL Trustee Liaison: Laurie Landeau, VMD
CAB member Pat Petersen (second from left) with Daniel Gale Sotheby In-
ternational Realty colleagues during the DNALC Annual Golf Tournament
at the Piping Rock Country Club
CAB member Dan Decker (standing, middle) and his colleagues from
Eppendorf North America at the 2010 Golf Tournament
Michael Aboff, Aboff’s Inc.
Paul Amoruso, Oxford & Simpson Realty
Rocco S. Barrese, Dilworth & Barrese
Edward Blaskey, TD Bank
Thomas J. Calabrese, Daniel Gale Sothebys
International Realty
Jeffrey Carstens
Richard A. Catalano, KPMG, LLP
Marian Conway, New York Community
Bank Foundation
James Chinitz, Population Diagnostics
Dan Decker, Eppendorf North America
Robert Dickstein, Ph.D., Pall Corporation
David Epstein, Ph.D., OSI Pharmaceu-
ticals, Inc.
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis, Mallet-
Prevost, Colt & Mosle LLP
Mary Jane Helenek, Luitpold Pharma-
ceuticals
Arthur D. Herman, Herman Develop-
ment Corporation
Diana Hoadley, JP Morgan
Robert Isaksen, Bank of America
Neil M. Kaufman, Davidoff, Malito &
Hutcher
John C. Kean III, Kean Development
Corporation
Norman Kelker, Enzo Life Sciences
Robert Keller, National Grid Foundation
James E. Mattutat, Ingleside Investors, Inc.
John Molloy, H2M
John Passarelli, M.D.
Patricia Petersen, Daniel Gale Sothebys
Real Estate
Christiaan B. Reynolds
William D. Roche
Raju Sarwal, M.D.
Charles R. Schueler, Cablevision
Lee Shuett, Nikon Instruments
Kurt Timmel, Marsh USA
Jeffrey K. Tupper, U.S. Trust Company of
New York
Robert Van Nostrand
Hans Zobel
441-472_LAR_Finance_Annual Report_2009 template  7/8/11  12:29 PM  Page 460
Contributions of $5,000,000+ lifetime
American Cancer Society
Anonymous
The Donald Everett Axinn Trust
Arnold and Mabel Beckman Foundation
Mr. and Mrs. Landon T. Clay
The Dana Foundation
Dart Neuroscience LLC
Kathryn W. Davis
Diana Davis Spencer Foundation (formerly
The Kathryn W. Davis Foundation)
The DeMatteis Family Foundation
Mr. and Mrs. Charles F. Dolan–The Dolan
Family Foundation
The William Stamps Farish Foundation
Hazen Polsky Foundation (formerly The
Lita Annenberg Hazen Foundation)
Howard Hughes Medical Institute
W.M. Keck Foundation
David H. Koch
The Leukemia & Lymphoma Society
Lucille P. Markey Charitable Trust
Nancy Abeles Marks
The Don Monti Memorial Research
Foundation
GEN*NY*sis grant from the New York
State Dormitory Authority
New York State Empire State Development
Corporation
Pioneer Hi-Bred International, Inc.
The Quick Family
The Robertson Family–Banbury Fund
The Simons Foundation
Mr. and Mrs. Theodore R. Stanley–The
Stanley Medical Research Institute
The Starr Foundation
Mr. and Mrs. Henry Wendt III
Contributions of $100,000 in 2010 or
$1,000,000+ lifetime
Paul G. Allen Family Foundation
Angel Foundation
Anonymous
BioBay of Suzhou Venture Capital Group
Jamie C. Nicholls and O. Francis Biondi, Jr.
The Breast Cancer Research Foundation
Bristol-Myers Squibb Company
Terri Brodeur Breast Cancer Foundation
Burroughs Wellcome Fund
The Mary K. Chapman Foundation
Mr. and Mrs. Edward A. Chernoff–Motors
& Armatures, Inc.
Dr. and Mrs. Bayard Delafield Clarkson
Lester Crown
Mr. and Mrs. Roderick H. Cushman
Mr. and Mrs. Norris Darrell, Jr.
Mr. and Mrs. Michel David-Weill
Ira W. DeCamp Foundation
The Ellison Medical Foundation
Entertainment Industry Foundation
The Samuel Freeman Trust
Coleman Fung Foundation
Mr. and Mrs. Robert A. Gay
Genentech, Inc.
Kenyon Gillespie
GlaxoSmithKline
Jacob D. Goldfield
The Allen & Lola Goldring Foundation
Florence Gould Foundation
The Grace Family
Greenwich Breast Cancer Alliance, Inc.
Leo A. Guthart
The Harrison Foundation and The Mary
Anderson Harrison Foundation
The Thomas Hartman Foundation for
Parkinson’s Research
Janet Strauss and Jeff Hawkins
Jo-Ellen and Ira Hazan
William Randolph Hearst Foundation
Human Frontier Science Program
International Rett Syndrome Foundation
Isis Pharmaceuticals, Inc.
The Karches Foundation
F.M. Kirby Foundation, Inc.
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. John Klingenstein–The Esther
A. & Joseph Klingenstein Fund, Inc.
Mr. and Mrs. Townsend J. Knight
Susan G. Komen for the Cure
Laurie Landeau Foundation LLC
The Forrest C. & Frances H. Lattner
Foundation
The Lehrman Institute
Mr. and Mrs. Stephen M. Lessing
The Fay J. Lindner Foundation
Mr. and Mrs. Robert D. Lindsay and
Family
Mary D. Lindsay
The Litchfield Charitable Trust
Estate of Elisabeth Sloan Livingston
Louis Morin Charitable Trust
Mr. and Mrs. David L. Luke III
The Lustgarten Foundation
Josiah Macy, Jr. Foundation
The G. Harold & Leila Y. Mathers
Charitable Foundation
The McKnight Endowment Fund for
Neuroscience
Gillian and Eduardo Mestre
Universidad Nacional Autónoma de
México
Mr. and Mrs. William R. Miller
Mr. and Mrs. Howard Morgan
Muscular Dystrophy Association
New York State Dormitory Authority
OSI Pharmaceuticals Foundation
Louise Parent and John Casaly
The Pew Charitable Trusts
Mr. and Mrs. John C. Phelan
Philips Research North America
William and Maude Pritchard Charitable
Trust
V. Kann Rasmussen Foundation
The Robertson Foundation
Mr. and Mrs. David M. Rubenstein
Damon Runyon Cancer Research 
Foundation
Eleanor Schwartz Charitable Foundation
Edith and Alan Seligson
Mr. and Mrs. Herbert J. Siegel
Alfred P. Sloan Foundation
Mr. and Mrs. Howard Solomon
St. Giles Foundation
Dr. and Mrs. James M. Stone
Dr. Jerome Swartz–Swartz Charitable
Foundation
Honor Roll of Donors
CSHL Trustee Jim Stone with Terry Lindsay (left)
and Cynthia Stebbins at the President’s Council
Spring Reception held at the home of Nathalie
and Bill Comfort
CSHL Chairman-Elect Jamie Nicholls (center) with (from left to right) Dan Loeb,
Fran Biondi, Hartley Rogers, Amy Falls, and Judy Cormier at the Double Helix
Medals Dinner held on November 10, 2010 at the Mandarin Oriental in New York
Honor Roll of Donors      461
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Waclaw T. Szybalski, D.Sc.
Paul J. Taubman
Doris M. and Peter S. Tilles Foundation
The V Foundation for Cancer Research
Dr. and Mrs. James D. Watson
Whitehall Foundation, Inc.
The Roy J. Zuckerberg Family 
Foundation
Contributions of $50,000+
American Express Foundation
Mr. and Mrs. Hans E.R. Bosch
Cashin Family Fund
Mr.* and Mrs. George W. Cutting Jr.
Genentech Foundation
Mr. and Mrs. John S. Grace–Gifted
Learning Institute
Annette Kade Charitable Trust
The Karp Foundation
Mr. and Mrs. David M. Knott–Knott
Family Foundation
Mara and Thomas Lehrman
Life Sciences Research Foundation
The George Link, Jr. Foundation
The Manhasset Women’s Coalition Against
Breast Cancer
Breast Cancer Awareness Day in memory
of Elizabeth McFarland
The John Merck Fund
Mirus Bio LLC
NARSAD
University of Notre Dame
Pall Corporation
Mr. and Mrs. Henry P. Davison II–The
Perkin Fund
Roche Diagnostics Corporation
Melissa Kerr and Stephen Wiggins
Evelyn W. Willard
Wodecroft Foundation
Contributions of $25,000+
Alzheimer’s Association
American Brain Tumor Association
Anonymous 
Amy Anthony
Applied Biosystems
Astellas USA Foundation
AVI BioPharma, Inc.
Bank of America Charitable Foundation,
Inc.
Mr. and Mrs. David Boies–Boies, Schiller
& Flexner LLP
The Breast Cancer Project
Mr. and Mrs. George W. Carmany III
Dr. Gerald Chan–The Morningside
Foundation
The Jane Coffin Childs Memorial Fund for
Medical Research
Mr. and Mrs. Yves C. de Balmann
Mr. and Mrs. Geoffrey de Lesseps–Alpha
Omega Charitable Foundation, Inc.
Marcia Kramer Mayer and Michael
Eisenbud
The Estee Lauder Companies Inc.
F.A.C.T. (Find A Cure Today)
Charitable Lead Annuity Trust Under the
Will of Louis Feil
Matthew Haines–The Marc Haas
Foundation
Mr.* and Mrs. Charles E. Harris
The Hastings Foundation, Inc.
Hope Funds for Cancer Research
Illumina, Inc.
Joni Gladowsky Breast Cancer 
Foundation
Betsy and Hunt Lawrence
Mr. and Mrs. Richard Leeds
Long Island 2-Day Walk to Fight Breast
Cancer, Inc.
Nancy Lurie Marks Family Foundation
Mr. and Mrs. Douglas P. Morris
Paratek Pharmaceuticals
The Robert Leet and Clara Guthrie 
Patterson Trust
Penn State University
William Townsend Porter Foundation
Patricia Quick
Thomas C. Quick
Andrew W. Solomon and John Habich
Solomon
Pearl F. and Erwin P. Staller
Cynthia R. and James F. Stebbins
Joan P. Tilney
Sandy and Howard Tytel
Contributions of $10,000+
The A&P Foundation
Anonymous
Autism Speaks, Inc.
The Bahnik Foundation, Inc.
Frank Brunckhorst
John K. Castle
The Cutler Family
Martin Elias and Family
Eppendorf North America
Fortunato Sons Contracting, Inc.
William F. Gerry–Gerry Corbett 
Foundation
Mr. and Mrs. William H. Goodwin, Jr.
Michael J. Griffin
The Irving A. Hansen Memorial
Foundation
Mr. and Mrs. J. Tomilson Hill III–The
Hill Family Foundation
Dr. Nancy Lippman Israeli and Dr. Ron
Israeli
Mr. and Mrs. Thomas Campbell Jackson
Judi Shesh Memorial Foundation
Drs. Marsha and Henry Laufer
Life Technologies
Long Island Radio Group
Bridget and John Macaskill
Mr. and Mrs.* Edward E. Matthews
Merck Serono S.A.
National Grid Foundation
Neuberger Berman Foundation
Nichols Foundation, Inc.
Ashley and Frank O’Keefe
Wendy O’Neill
John G. Passarelli, M.D.
Patricia Petersen–Daniel Gale Sotheby’s
International Realty
Mr. and Mrs. John R. Reese
Christina Renna Foundation, Inc.
Diane Emdin Sachs Memorial Walk
Laura and Harry Slatkin
Deborah K. Solbert
Mr. and Mrs. Douglas S. Soref
Mr. and Mrs. Allen Sperry
*Deceased in 2010
CSHL Trustees John Phelan (left) and Roy Zuckerberg with Melva Bucksbaum and Amy Phelan at
the Double Helix Medals Dinner
CSHLA Director Fife Whitman (left), Heather
Whitman, CSHLA Director Heather Spehr, and
Rich Spehr
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Steamboat Foundation
TD Charitable Foundation
Textor Family Foundation
The Lauri Strauss Leukemia Foundation
West Islip Breast Cancer Coalition for
Long Island
Dr. and Mrs. Michael Wigler
Mr. and Mrs. Richard H. Witmer, Jr.
Ann Eden Woodward Foundation
Contributions of $5,000+
Mr. and Mrs. Lee S. Ainslie III
Amgen, Inc.
Mr. and Mrs. W. Dillaway Ayres, Jr.
Bank of New York Mellon
Lisa and Tim Broadbent
Helen M. Brooks
Mr. and Mrs. James J. Celestino
Samara Cohen
Credit Agricole Corporate Investment 
Bank
Mr. and Mrs. Richard T. Cunniff–Cunniff
Family Fund
Deutsche Bank
Dilworth & Barrese, LLP
Suzanne and Michael DiMaio
Bob and Diane Fagiola
The Fortin Foundation of Florida
Richard Gelfond
The Deane A. and John D. Gilliam
Foundation
The Fred C. Gloeckner Foundation, Inc.
Mr. and Mrs. Austen T. Gray, Jr.
H2M Group
The Randall and Mary Hack Foundation
Robin T. Hadley
The Emma Alyson & Kate Hance Family
Foundation
Helixis, Inc.
Diana Hoadley
Dr. Mark Hoffman
Islip Breast Cancer Coalition
Jason Dennis Francis Inc.
Kapp Family Foundation
Kean Development Company
Andrea B. and Peter D. Klein
The Edward and Kinga Lampert
Foundation
Mr. and Mrs. Anthony V. Leness
Luitpold Pharmaceuticals, Inc.
Mrs. David J. Mahoney
March of Dimes
Masthead Cove Yacht Club–Carol
Marcincuk Fund
Robert L. Marcus
Anjali and Prakash Melwani
Molecular Devices, Inc.
New York Community Bank Foundation
Nikon Instruments, Inc.
Susanne Olin
Mr. and Mrs. George D. O’Neill–Abby
and George O’Neill Trust
Lauryl and Robert Palatnick
David P. Pearson
Mr. and Mrs. Simon Pharr
Dr. and Mrs. John E. Postley, Jr.–New York
Physicians Foundation, Inc.
Mrs. Richardson Pratt, Jr.
Mr. and Mrs. Enrique F. Senior
Mary F. Smith Family Foundation
Lee Steinberg
Dr. and Mrs. Bruce W. Stillman
Sally Susman–Pfizer, Inc.
Leonard Litwin
The Thompson Family Foundation, Inc.
Mr. and Mrs. Remy W. Trafelet
Mr. and Mrs. Edward Travaglianti
Robin and Paul Vermylen
Mrs. Philip R. von Stade
Ralph Worthington
Contributions of $2,500+
Allison Abbott
Aboff’s Inc.
Advantage Title Agency, Inc.
Aireco Real Estate
All Pro Carpet Co., Inc.
Alpern Family Foundation
Mr. and Mrs. Robert H.B. Baldwin
Cristina Mariani-May–The Banfi Vintners
Foundation
Liz and Rod Berens
Judy and Howard Berkowitz
Gail A. Binderman
Bliss Pest Protection Services, LLC
Boehringer Ingelheim Pharmaceuticals
Dr. Steven Brenner
Mr. and Mrs. Thomas J. Calabrese, Jr.
Mr. and Mrs. William J. Candee III
Mrs. Robert L. Clarkson, Jr.
Clear Channel Communications–
WALK 97.5
Crest Hollow Country Club at 
Woodbury, Inc.
Mr. and Mrs. Joseph T. Donohue
Dvirka and Bartilucci Consulting
Engineers
Michael L. Focazio–Carissa Maringo Fund
G & M Earth Moving, Inc.
The Geier Foundation
Cosby George
Glencore International
Mr. and Mrs. Lawrence G. Graev
Bernadette Castro Guida and Peter 
Guida, M.D.
Mr. Arthur D. Herman–Herman
Development Corporation
James Hicks, Ph.D.
Lori and Chris Homer
Ron Howard and Brian Grazer
Joan M. Hutchins
The Stanley R. and Elisabeth G. Jacobs
Foundation
Mr. and Mrs. Barclay G. Jones III
Mr. and Mrs. Richard Kleinknecht
Laureen and Ragnar M. Knutsen
Melva Bucksbaum and Raymond Learsy
Georgie W. Lewis
The MacLean Family Trust
Mr. and Mrs. William A. Marino
OSI Pharmaceuticals
Oxford & Simpson Realty Svcs., Inc.
Scott J. Paternoster Family
Terry and Howard Phipps
Whitney Posillico
Nicole and Charlie Prizzi
Drs. Marjorie van de Stouwe and Scott
Ratner
Anne and Bernard Reynolds
Dr. and Mrs. Gerald M. Rubin
Debra Parmet Sondock and Clifford B.
Sondock
Drs. Mona and David Spector
Heather and Richard Spehr
TD Bank
Nikki Tippins
Mr. and Mrs. Stanley S. Trotman, Jr.
United Healthcare
Universal Studios
Heather and Fifield Whitman
The Diane and Howard Wohl Family
Foundation, Inc.
Wolfensohn Family Foundation
Craig Wulff, Fidelity Investments
On December 20, 2010, The Manhasset Women’s Coalition Against Breast Cancer presented Dr. Mikala
Egeblad (third from left, front row) with a check for $50,000 to support her breast cancer research.
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Contributions of $1,000+
Mr. and Mrs. Robert J. Adams
Alnylam U.S., Inc.
Americana Manhasset and Wheatley Plaza
Lisa and Doug Arthur
Audio Command Systems, Inc.
Mary and Paul Auersperg
Mr. and Mrs. Richard Aurelio–The Aurelio
Family Charitable Foundation
Erica and Henry Babcock
Pam and Gene Bernstein–PGJM
Foundation
Dr. and Mrs. Giuseppe Bertani
Mr. and Mrs. Xerxes K. Bhote
Blake Industries
Elizabeth B. Borden–Katharine Bradford
Foundation
Renee A. Fitts and David Botstein
Dr. William Braden III–Porter Braden
Endowment Fund
Mr. and Mrs. Michael Brennan
Bresnan International Aviation, LLC
John Britton
The Eli and Edythe Broad Foundation
Cambridge Isotope Laboratories, Inc.
Peter B. Cannell
Muffy Carlstrom
Centerbrook Architects and Planners, LLC
Jane H. Choate
Mr. and Mrs. David C. Clark
Rita M. Cleary
Mr. and Mrs. Jonathan Connors
Cortel Business Solutions, Inc.
Cosel-Pieper Family Foundation
Rebecca Creavin
Curtis, Mallet-Prevost, Colt & Mosle LLP
Curtis Cushman
Davidoff Malito & Hutcher LLP
Mr. and Mrs. Guy L. de Chazal
Robert de Rothschild
Mr. and Mrs. David H. Deming
Meleanor and Donald Deming
Nevenka Dimitrova
Thomas J. Dowling Jr., M.D.
Dr. Lester Dubnick
Electronix Systems Central Station Alarms
Enzo Life Sciences
Lisa and Johnston Evans
Mary and Donald Eversoll
Farrell Fritz, P.C.
Dr. Robert and Marjorie Feeney
Mr. and Mrs. Frank Feinberg
Mr. and Mrs. Michael G. Ferrel
Brian Fox
Christine and Douglas Fox
E. Maxwell Geddes, Jr.
Mr. and Mrs. Thomas S.T. Gimbel
Jessica and Lawrence Glassman
Mr. and Mrs. William H. Grover
Amy M. Hagedorn
Danielle and Mark Hamer 
The Reverend Linda P. Hancock
Mr. and Mrs. Gordon S. Hargraves
Hearts for Cancer
Sheila and Gil Henoch
W.A. Herzog
Mr. and Mrs. Joseph Heyenoort
Mrs. John S. Hilson
R. Stewart Honeyman, Jr.
Mrs. Bruce Duff Hooton
A.C. Israel
J. Crew
Walter B. James Fund No. 2
Johnston Family Foundation
Susan Karches
Mr. and Mrs. Clarke Keough–Donald and
Marilyn Keough Foundation
Paul Knight
Natasha and Stephen Koll
KPMG, LLC
Mr. and Mrs. James Large
Charles Henry Leach, II Foundation
Shirley and Eugene Levitt
Arthur L. Loeb
The Honorable and Mrs. Earle I. Mack
François Maisonrouge
Mr. and Mrs. Gerard Manolovici
Neil T. McGoldrick
Mercer Health & Benefits LLC
Meriwether Foundation
MetLife
Mr. and Mrs. Clarence F. Michalis
Dana and David Micklos
Dr. Jeffrey H. Miller
Leo Model Foundation, Inc.
Frances and Keith M. Moffat
Kathleen A. Mooney
Morey Family Foundation
Mr. and Mrs. Stephen P. Munn
Mr. and Mrs. Stephen V. Murphy
Richard P. and Faye Nespola Charitable
Foundation
New England BioLabs, Inc.
Larry Norton, M.D.
JoAnne Olian
William C. and Joyce C. O’Neil Charitable
Trust
Openeye Scientific Software, Inc.
Mr. and Mrs. Richard S. Overton
Philip A. Bonnadonna–PABCO
Construction Corporation
Mr. and Mrs. Jeffrey Pash
Mr. and Mrs. Nicholas B. Paumgarten
Mr. and Mrs. David Peikon
Joyce and John Phelan
Dr. and Mrs. Anthony F. Piazza
Cecile Pickart Student Travel Award
Louise S. Pickart
Mr. and Mrs. Robert A. Pilkington
Mr. and Mrs. Robert S. Pitts
Lucy Gordon and Mark Ptashne
Mr. and Mrs. Thomas L. Pulling
Road and Heavy Construction Laborers
Local Union 1298
George A. Roche
Mr. and Mrs. Arthur M. Rogers, Jr.
Miriam K. Rothenberg
Mr. and Mrs. J. Wright Rumbough, Jr.
Mr. and Mrs. Henry E. Salzhauer
Mr. and Mrs. Oleg J. Samilenko
Raju Sarwal, M.D.
Mr. and Mrs. Peter G. Schiff
Seawanhaka Corinthian Yacht Club
Mr. and Mrs. Trevor A. Smith
Mr. and Mrs. Ian Kendall Wheeler Snow
The Jerry and Emily Spiegel Family
Foundation, Inc.
Mr. and Mrs. James L. Spingarn
Joan and Arthur M. Spiro
Mr. and Mrs. Tom Stacey
Marcia and Myron Stein
Sterling North America
Judith and Irwin Tantleff
Pamela M. Thye
Mr. and Mrs. Bart T. Tiernan
Lynn and Pat Tone
Mr. and Mrs. John W. Ussery
John B. Vermylen
Helene P. Victor
Dr. Pamela Rosman and Dr. Philip R.
Vulliet
Mr. and Mrs. Douglas A. Warner III
Lloyd P. Wells
Mr. and Mrs. John A. Werwaiss
Neil Westreich
Gerald I. White
Eunice Johnson Winslow
Marilyn Monter and Wilfried Witthuhn
Mayer Wolf
Womens Council of LIBOR
Ingrid and John Wright
Zeitz Foundation
Richard Monti, Co-chairman of the Board, and
Caroline Monti Saladino, President, of The Don
Monti Memorial Research Foundation, avid
supporters of cancer research
CSHL Vice Chairman-Elect Marilyn Simons
(right) with Dennis Choi and Jim Simons at the
Double Helix Medals Dinner
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Aetna Foundation, Inc.
American Express Charitable Fund
American Express PAC Match Program
Amgen
Bank of America Matching Gifts
Bristol-Myers Squibb Foundation
Credit Agricole Corporate Investment 
Bank
FBR Capital Markets Charitable
Foundation
Honeywell Matching Gift Program
iStar Financial, Inc.
The J.P. Morgan Chase Foundation
Jeffries and Company
The Henry Luce Foundation, Inc.
McKinsey & Company, Inc.
The Millipore Foundation
Pfizer Foundation Matching Gifts
Program
Select Equity Group Foundation
United Way of New York City
Verizon Foundation
Wells Fargo Foundation
XL Global Services, Inc.
CORPORATE AND FOUNDATION MATCHING GIFT CONTRIBUTORS
Sophie and Dill Ayres
Mr. and Mrs. Fred Berg
Alexandria Boyatt
Lisa and Dick Cashin
Antonio Cavallero
Edward Chernoff
Susan P. Connors
John Eastman
Spence Evans
Jennifer Figorito
Marika Nyman and Fred Fogelman
Drew Friedman
Mary Goldberg
Dario and Avan Hassankhani
Arthur Herman
Rhona and Louis Herman
Jill Hirsch
Vivien and Julie Huang
Ben Israeli
Anne Just
Donald A. Koch, Jr.
Laurie Landeau and Robert Maze
Rebecca and Mark Lane
Evelyn Lauder
Patricia Licata
Mary D. Lindsay
Cathryn MacInnes
Marianna Cuomo Maier
Marty’s 101st Birthday
Marcia Kramer Mayer
Mr. and Mrs. H. Orenstein
Louise and Stan Pickart
Justin Rosati
Joshua Rubin
Dr. Gregory Sabino
Mr. and Mrs. Steve Shuster
Marty Slatkin
Erwin Staller
Dr. Bruce Stillman
Leo Takemaru
Sandy Tytel
Elizabeth Watson
Henry and Charles Whitman
David Zarowin
IN HONOR OF
Virginia Armentrout
Donald E. Axinn
Herb Baum
Enes Bongarzone
Silvana Radman Brady
Thomas Brennan
Ellen Brenner
John Caliendo
John Paul Cleary
Carol Ann Coscia
Anna Cracchiolo
George Cutting
John D’Alessandro
Danny Davison
Paul F. DeLaney
Sylvia Delmonte
Philip H. Director
Raymond Donovan
Leona Dubnick
Diane Emdin
Ardell Bierman Fox
Lilian Frisch
Nancy Slaughter Gay
Dr. Alan Gewirtz
Joni Gladowsky
Dr. Christopher G. Goff
Veronica Guadagno
Lorraine S. Gurinskas
Jorun Gunnlaug Hansen
Charles E. Harris
Marian Heavey
Tracy Hedberg
Jerome D. Kaleko
Abe Kantor
Dr. Andy Kaplan
Mr.  James J. Kehoe
Ethel Killeen
Kathleen Koerner
Doris and Mel Kuhn
Marie Lastig
Lisa MacInnes
Carol Marcincuk
Carissa Maringo
Elizabeth McFarland
Sarah Meyer
Tita and Joe Monti
Rose M. Mooney
Monica Mowery
Gloria Jeanne Hamilton Noble
Howard Olian
Gerald David Olin
Eddi Painter
Dr. Cecile Pickart
G. Jeffrey Poletti
Dr. James Streeter Potter
Lydia and Christopher Reeves
Christina Renna
Susan Rose
Harriet C. Roth
Gregory Russell
Diane Edmin Sachs
Joel Schechter
Charles T. Schiavoni
Ambassador Felix Schnyder
Martha Seidel
Andrew Seligson
Gloria Shultz
Susan Leslie Stuckey
Sunny and Shelly Tobin
Yoko Toshishige
Lynn Ann Welles
Alfons Wetzl
Rita Wilcox
Suzy Geller Wolf
Dr. Mark Zoller
IN MEMORY OF
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LABORATORY MANAGEMENT
Bruce W. Stillman, President
James D. Watson, Chancellor Emeritus
W. Dillaway Ayres Jr., Chief Operating Officer
RESEARCH 
David L. Spector
Director of Research
Sydney Gary
Director, Research Operations
Walter L. Goldschmidts
Executive Director, Sponsored
Programs
Professors
Thomas Gingeras, Professor and
Head, Functional Genomics
Gregory Hannon,* Program
Chair, Bioinformatics and 
Genetics
Z. Josh Huang
David Jackson
Leemor Joshua-Tor*
Adrian Krainer
Yuri Lazebnik
Scott Lowe,* Program Chair,
Cancer and Molecular Biology
Robert Martienssen
W. Richard McCombie
Partha Mitra
Lincoln Stein
Marja Timmermans
Nicholas Tonks, Deputy
Director, Cancer Shared
Resources
Linda Van Aelst
Michael Wigler
Anthony Zador, Program Chair,
Neuroscience
Yi Zhong
Associate Professors
Joshua Dubnau
Grigori Enikolopov
Alexei Koulakov
Alea Mills
Senthil Muthuswamy
Pavel Osten
Darryl Pappin
Scott Powers
Arne Stenlund
*Employee of the Howard Hughes Medical Institute
Assistant Professors
Dinu Albeanu
Gurinder Atwal
Anne Churchland
Mikala Egeblad
Hiroyasu Furukawa
Christopher Hammell
Adam Kepecs
Alexander Krasnitz
Bo Li
Zachary Lippman
Robert Lucito
Michael Schatz
Stephen Shea
Raffaella Sordella
Lloyd Trotman
Glenn Turner
Hongwu Zheng
Research Professor
James Hicks
Research Assistant Professor
Molly Hammell
Senior Computer Scientists
Dan Levy
Boris Yamrom
Quantitative Biology Fellows
Ivan Iossifov
Justin Kinney
Clinical Fellow
Christoph Miething
Cold Spring Harbor Fellow
Christopher Vakoc
Research Investigators
Joan Alexander
Kenneth Chang
Carrie Davis
Diane Esposito
Xuecui Guo
Emily Hodges
Yimin Hua
Yoon-Ha Lee
Weijun Luo
Shane Edward McCarthy
Tatyana Michurina
Nicholas Navin
Youngkyu Park
Natalia Peunova
Michael Regulski
Michael Ronemus
Cristian Ruse
Eric Sawey
Thomas Schalch
Yi-Jun Sheu
Mona Spector
David Wah*
Adjunct Professors
Timothy Tully
Michael Zhang
Adjunct Associate Professors
Anil Malhotra
Doreen Ware, USDA Adjunct
Associate Professor
Adjunct Assistant Professor
Lars Zender
Visiting Professors
Matthew Ridley
Kathleen Rockland
Visiting Scientists/
Collaborative Scientists
Nevenka Dimitrova
Bhubaneswar Mishra
Sophie Rengarajan
Research Specialist I
Beicong Ma*
Manager, Gene Targeting
Shared Resources
Sang Yong Kim
Database Manager,
Genomics
Christopher Zaleski
Postdoctoral Fellows
Sandra Ahrens
Martin Akerman
Olga Anczukow-Camarda
Isabel Aznarez DaSilva
Jan Bergmann
Jennifer Beshel
Benjamin Boettner
Benoit Boivin
Jessica Bolden
Peter Bommert
Katharine Borges
Alexander Campbell
Andres Canela Rodriguez
Gang Cao
Maia Chanrion
Santanu Chattopadhyay
Chong Chen
Muhan Chen
Sung Wook Chi
Agustin Chicas
Yu-Chen Chien
Katie Creasey
Stacy DeBlasio
Heike Demmer
Camila Dos Santos
Marcela Dotto
Lukas Dow
Cheryl Eifert
Elad Elkayam*
Andrea Eveland
Christopher Faehnle
Delphine Fagegaltier
Gaofeng Fan
Michael Feigin
Bernard Fendler
Cristina Fernandez Marco
Alexander Goldshmidt
Hong Goo Chae
Pascal Grange
Xinglong Gu
Astrid Desiree Haase
Balazs Hangya
Toshihide Hige
Guy Horev
Manzar Hossain
Tomas Hromadka
Michael Huebner
Aman Husbands
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Ingrid Ibarra
Jonathan Ipsaro
Yannick Jacob
Jaclyn Jansen
Santiago Jaramillo Escobar
Marie Javelle
Mads Aaboe Jensen
Ke Jiang
Lolahon Kadiri
Erkan Karakas
Fedor Karginov
Mamoru Kato
Hironori Kawakami
Tim Kees
Yongsoo Kim
Thomas Kitzing
Akiko Kobayashi
Brian Kolterman
Kannan Krishnamurthy
Keerthi Krishnan
Navasona Krishnan
Claus-Dieter Kuhn
Jayant Kulkarni
Duda Kvitsiani
Tali Lavy*
Seung-Jae Lee*
Young Koung Lee
Darrin Lewis
Haohong Li
Jinyu Li
Li Li
Ying Lin
Yilei Liu
Yu Liu
Mukesh Lodha
Jiangteng Lu
Amaya Lujambio Goizueta
Cora MacAlister
Yuntao Mao
Toma Marinov
Anthony Mazurek
Martine Mirrione
Sylvain Mitelheiser
Adaobi Mofunanya
Adam Mohamed Naguib
Swagatam Mukhopadhyay
Shuang Ni
Christos Noutsos
Jaclyn Novatt
Dawid Nowak
Hysell Oviedo
Sundaramurthy Pandurangan
Jae-Hyun Park
June Hee Park
Soonju Park
Jennifer Parla
Anirban Paul
Shilpi Paul
Katherine Petsch
Hyun Jae Pi
Lisa Prazak
Jonathan Preall
Hongtao Qin
Ileng Ramachandran
Sachin Ranade
Clare Rebbeck
Smitha Reddy
Ashlan Reid
Jie Ren
Kate Revill
Francesc Roca
Adam Rosebrock
Marlies Rossmann
Anna Saborowski
Michael Saborowski
Kentaro Sahashi
Andrea Schorn
Ulla Schwertassek
Serif Senturk
Stephanie Shaw
Yichun Shuai
Puja Singh
Rahul Sinha
Damianos Skopelitis
FNU Sneh Lata
Yilin Tai
Naoki Takada
Chunlao Tang
Man-Hung Eric Tang
Hiroki Taniguchi
Milos Tanurdzic
Julian Taranda
Ante Tocilj
Vasily Vagin
Frederic Van Ex
Emma Vernersson Lindahl
Chia-Lin Wang
Minghui Wang
Zihua Wang
Yi Wei
Kazimierz Wrzeszczynski
Qiaojie Xiong
Xianfeng Xu
Fang Yang
Jianchao Yao
Zhan Yao
Miguel Zaratiegui Biurrun
Huiqing Zhan
Bin Zhang
Zhen Zhao
Zhu Zhu
Graduate Students
Pedro Alexandre Garcia Da
Silva
Arkarup Bandyopadhyay
Timour Baslan
Philippe Batut
Mitchell Bekritsky
Kimberly Bell
Fatma Bezirci
Megan Bodnar
Dario Bressan
Robert Bronstein
Ralph Burgess
Ying Cai
Joseph Calarco
Matthew Camiolo
Colleen Carlston
Stephane Castel
Sudipto Chakrabortty
An-Yun Chang
Deblina Chatterjee
Fauzia Chaudhary
Sihem Cheloufi
Hyejin Cho
Carrie Clendaniel
Miriam Cohen
Michael Cressy
Noelle Cutter
Benjamin Czech
Shipra Das
Kristen Delevich
Saya Ebbesen
Melanie Eckersley-Maslin
Christof Fellmann
Xin Feng
Silvia Fenoglio
Patrick Finigan
Oliver Fregoso
Yu Fu
Wee Siong Goh
Eyal Gruntman
Paloma Guzzardo Tamargo
Jong Jin Han
Anna Hangyane Benkovics
Aftabul Haque
Miao He
Kyle Honegger
Chun-Hao Huang
Wen Huang
Dong-Woo Hwang
Stephanie Izzi
Liang Jin
Nihan Kara
Matthew Koh
Sang-Geol Koh
Lisa Krug
Marek Kudla
Canan Kuscu
Matthew Lazarus
Wangzhi Li
Wanhe Li
Willey Liao
Katie Liberatore
Guang Lin
Yu Liu
Zhijie Liu
Binyan Lu
Elena Lum
Fred Marbach
Ozlem Mert
Yifan Mo
Antoine Molaro
Felix Muerdter
Elizabeth Nakasone
David Nunes Raposo
Mark Orcholski
Hassana Oyibo
Michael Pautler
Ian Peikon
Zinaida Perova
Maria Pineda
Vadim Pinskiy
Yevgeniy Plavskin
Prem Premsrirut
Huan Qi
Megha Rajaram
Mathangi Ramesh
Amy Rappaport
Morten Rasch
Frederick Rollins
Joshua Sanders
Johann Schlesinger
Claudio Scuoppo
John Sheppard
Junwei Shi
Suyash Shringarpure
Areekul Sodsiri
Yi Su
Guoli Sun
Eric Szelenyi
Nilgun Tasdemir
Matthew Titmus
Elena Tonin
Jason Tucciarone
Ruei-Ying Tzeng
Assaf Vestin
Elvin Wagenblast
Jack Walleshauser
Zhenxun Wang
Kaja Wasik
Susann Weissmueller
Jie Wu
Chunsu Xu
Bin Xue
Shuqi Yan
Ming Yang
Yu-Ting Yang
Jia-Ray Yu
Cinthya Zepeda Mendoza
Siwei Zhang
Rui Zhao
Yanhong Zhao
Xin Zhou
Petr Znamenskiy
*Employee of the Howard Hughes Medical Institute
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Scientific Informatics
Peter Andrews
Jer-Ming Chia
Aaron Chuah
Alexander Dobin
Osama El Demerdash
Evan Ernst
Assaf Gordon
Gregor Havkin
Sonali Jha
Jude Kendall
Melissa Kramer
Sunita Kumari
Anthony Leotta
Wei Lin
Zhenyuan Lu
Steven Marks
Marcela Monaco
Andrew Olson
Martin Paradesi
Shiran Pasternak
Kith Pradhan
Kandasamy Ravi
Joshua Stein
Vishal Thapar
James Thomason
Kannan Umadevi 
Venkataraju
Liya Wang
Xuehong Wei
Charles Youens-Clark
Research Associates
Carmelita Bautista
Barry Burbach
Hilary Cox
Jorg Drenkow
Carla Gauss
Zsolt Lazar
Lisa Manche
Linda Rodgers
Patricia Wendel
Caizhi Wu
Xiaoqun Zhang
Laboratory Facility Managers
Sabrina Boettcher*
Nancy Dawkins-Pisani
Stephanie Goldsmith*
Stephen Hearn
Christopher Johns
Philip Mercurio
Pamela Moody
Timothy Mulligan
Joseph Simorowski
Spencer Teplin
Jennifer Troge
Ming Wang
Scientific Administrators
Paloma Anderson
Sadie Arana
Christine Bedell
Patricia Bird
Lynn Boss*
Maria Chapelle
Becky Dong
Irene Gill
Carol Gundersen
Jo Leonardo*
Idee Mallardi
Barbara Matusik
Sandra Michelsen
Stephanie Peragallo
Dorothy Tsang Hu
Madeline Wisnewski
Laboratory Technicians
Sai Dipikaa Akshinthala
Chandni Ashar
Michael Baer
Deanna Bahel*
Yanghuan Bao
Jacqueline Cappellani
Yon Chang
Gloria Cheang
Xin Cheng
Joshua Cohen
Martin Davis
Margaret Falkowski
Meagan Fastuca
Michael Gallo
Robert Gerdes
Elena Ghiban
Magdalena Gierszewska
Zachary Glass
Danielle Grace
Inessa Hakker
Emily Harrison
Chao He
Fangle Hu
Jiahao Huang
Justyna Janas
Jamie Jones
Asif Karim
So Young Kim
Dana King
Chantal LeBlanc
Alana Lelo
Jingjing Li
Trine Lindsted
Laura Lintault*
Shichong Liu
Ying Hsiu Liu
Arti Manohar
John Marchica
Krista Marran
Senem Mavruk
Jean McIndoo
Joseph Milazzo
Patricia Mocombe
Maria Mosquera
Stephanie Muller
Ronnie Packer
Rae Hum Paik
Ramesh Palaniswamy
Samantha Peacock
Kimberly Persaud
Christine Peterson
David Pevzner
Christopher Pratt
Jing Qiu
Umamaheswari Ramu
Christian Refakis
Michael Riggs
Julie Rosenbaum
David Sau*
Kasim Sayed
Scott Sayers
Stephen Schuck
Lei Hoon See
Aditya Shroff
Janelle Simon*
Noriko Simorowski
Rebecca Solomon
Young-Eun Son
Vaishali Sridhar
Maya Strahl
Grace Melanie Sucaldito
Meredith Taylor
Pamela Tello
Kui Tian
Alexander Tolpygo
Kevin Tranchina
Amy Valentine
Michele Vigliotti
Eric Wang
Huaien Wang
Jing Wang
Benjamin Weindorf
Jessica White
Scilla Wu
YoungJoo Yang
Allison Yu
Tara Zadrozny
Haley Zamer
Martha Zeeman
Lifang Zhang
Media Makers/Laboratory
Aides
Nabil Azamy
Nancy Bolanos
Patricia Brady
Florinda Chaves
Terrance Chisum
Paul Hanlon
Qiaoling He
Salvador Henriquez
Adriana Hincapie
Kelly Ann Holfester
Amy Ji
Melissa Leonardo
Vincent Meschan
Hong Jie Shen
Margaret Wallace
Research Administration
Maureen Bell
EDUCATION
Banbury Center
Jan A. Witkowski,
Executive Director
Susanne Igneri
Barbara Polakowski
Janice Tozzo
CSHL Press
John R. Inglis,
Executive Director
Barbara Acosta
Janet Argentine
Cynthia Blaut
Carol Brown
Kathleen Bubbeo
Margaret Calicchia
Jane Carter
Kathleen Cirone
Laureen Connell
Heather Cosel-Pieper
Marie Cotter
David Crotty
Judith Cuddihy
Maryliz Dickerson
Corrisa Farmer
Alexander Gann
Bibiane Garite
Pauline Henick
Nancy Hodson
Geraldine Jaitin
Kaaren Janssen
William Keen
Catherine Kelly
Delia King
Robert Majovski
Victor Manchiso
Wayne Manos
Jacqueline Matura
Mala Mazzullo
Joanne McFadden
Mary Mulligan
Stephanie Novara
*Employee of the Howard Hughes Medical Institute
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Meetings and Courses
David J. Stewart,
Executive Director
Alfred Baman
Mark Beavers
Edward Campodonico
Joseph Carrieri
Reginald Cayo
Katiria Ceballos
Maoyen Chi
Wendy Crowley
William Dickerson
Bradley Frey
Constance Hallaran
Andrew Mendelsohn
Nicholas Moore
Maureen Morrow
Michele Navarro
Andrea Newell
Kenneth Orff
Valerie Pakaluk
Jonathan Parsons
Lauren Postyn
Rebecca Schwartz
Mary Smith
Margaret Stellabotte
Andrea Stephenson
James Whitaker
Barbara Zane
Watson School of Biological
Sciences
Leemor Joshua-Tor, Dean
Kimberley Geer
Keisha John
Alyson Kass-Eisler
Dawn Pologruto
Terri I. Grodzicker, Dean of
Academic Affairs
ADMINISTRATIVE
DEPARTMENTS
Comptrollers Office and
Accounting
Lari C. Russo, Vice President,
Finance and Comptroller
Nicole Balazs
Sharon Bense
Karine Boyce
Damian Desiderio
Maryanne Detweiler
Karen Filasky
Mary Ellen Goldstein
Elizabeth Janow
Karen Jones
Patricia Maroney
Alison McDermott
Mary Ann Miceli
Patricia Penner
Kristine Romano
Patricia Urena
Katherine Valle
Ann Williams
Central Administration
Maureen Berejka
Katharine Colgate
Carol Link
Denise Roberts
Judith Smith
Culinary Services
James Hope, Director
Andres Alarcon
Jeannette Amato
Ingrid Amaya
Yamic Ambra
Jaime Bonilla
Francis Bowdren
Maryam Brinkwart
Elmer Canales
Giuditta Carino
William Carmona
Julio Carrasco
Marvin Chavez
Julie Ehrlich
Suzanne Esposito
Yesenia Fuentes
Wilson Garciaguirre
Andres Gonzalez
Silvia Gonzalez
Barbara Gordon
Jennifer Gordon
William Herrera
Pierre Jean-Baptiste
Jose Lizama
Jesus Magana
Juan Magana
Thomas McIlvaine
Jessica Miller
Laurie Moller
Frederik Munter
Jorge Ramirez
Jose Reyes
Susana Roman
Marlenis Romero
Faustino Vargas
Jose Velasquez
Maria Villatoro
Maria Vilorio
Laura Wade
Dennis Zelaya
Jennifer Ziegler
Daycare Center
Deborah Keller, Director
Denise Aiello
Danielle Arleo
Rita Beetham
Aisheia Brooks
Suzanne Chitwood
Stephanie Dennis
Serena Dowd
Karen Flore
Nasrin Huda
Cynthia Lyon
Vivian Mathews
Deirdre McDermott
Paula Messinger
Lauren Milroy
Christina Potter
Meryl Rosen-Wells
Theresa Treffeisen
Development
Charles V. Prizzi, Vice President
Jean DeForest
Diane Fagiola
Carolyn Laing
Karen Orzel
Wendy Schneps
Paula Smith
Bailey Stark
Jill Stone
Facilities
Arthur Brings, Vice President,
Chief Facilities Officer
Richard Abreu
Alexander Aguilera
Robert Albinson
Brian Allen
Leslie Allen
Mayra Amundaray
Edward Anderson
Peter Anderson
Jose Araujo-Sandoval
Jerry Armstrong
Dillion Baptiste
Damir Begonja
Santo Bellino
Fred Bencivenga
Edwin Bennett
John Benson
Lisa Bianco
Matthew Bird
William Bishop
Thomas Blume
Reinaldo Bonilla
Margaret Brock
Keith Brown
Kelly Brunk
Oral Bryan
Keriaki Pollakis
Elizabeth Powers
Theodore Roeder
Nora Ruth
Mary Sabala
Susan Schaefer
Richard Sever
Inez Sialiano
Marcie Siconolfi
Maria Smit
Ann Smith
Rena Steuer
Sharon Story
Hillary Sussman
Linda Sussman
Christopher Vacca
Denise Weiss
Hashanthi Wijayatilake
Dolan DNA Learning Center
David A. Micklos,
Executive Director
Jennifer Aiello
Elna Carrasco
Lauren Correri
Jennifer Galasso
Cornel Ghiban
Natalia Hanson
Uwe Hilgert
Eun-Sook Jeong
Mary Lamont
Susan Lauter
Amanda McBrien
Colleen McKechnie
Valerie Meszaros
Eric Nash
Amy Nisselle
Carolyn Reid
Ileana Rios
Todd Rocheford
Tedhar Setton
Jermel Watkins
Jason Williams
Chun-hua Yang
Library and Archives
Ludmila T. Pollock,
Executive Director
Paula Abisognio
Thomas Adams
Yow-Ning Chang
Clare Clark
Angela Cornwell
Helena Johnson
Gail Sherman
Rhonda Veros
Carlos Viteri
Judith Wieber
Claudia Zago
John Zarrillo
Laboratory Management      469
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Amy Burrows
Michael Cahn
Frank Carberry
Dessie Carter
Andrew Caulfield
Ming-Kai Chan
Daniel Chapman
Ryan Cherry
Christopher Clark
Jodi Coblentz
Timothy Collery
Robert Collins
Drew Comer
Michael Cook
Kristin Cox
Gabriela Cruz
Peter Dale
Matthew D'Amico
Charlene DePoto
James Decker
Robert Dickerson
Nicholas DiLollo
Glen DiMaria
Steven Dlugolonski
Kevin Donohue
Jared Downing
Wesley Dreusike
Eileen Earl
Paul Edwards
Robert Eifert
Susan Esposito
Rafael Estrella
Yolanda Figueroa
Devin Fitzgerald
Nelson Flores Giron
Timothy Foley
Robert Fowles
Jed Francis
Angela Garcia
Wilman Garcia
Robert Gensel
Jeffrey Goldblum
Robert Gorney
Erick Greene
Leo Greene
Stephen Gregorovic
Kim Gronachan
Wilman Gutierrez
Jill Habel
Wayne Hamilton
Birgit Hanson
Evan Harmon
Ariel Hermele
Gerard Holler
Denise Hoppe
Joseph Houser
Matthew Hoyer
Craig Hubbs
Christopher Hubert
Louis Hunter
Michael Hutchinson
William Jantzen
Randal Jones
Daniel Jusino
Jeffrey Klaverweiden
Oscar Lastra
Walter Leute
Jian Lin
Trinidad Lopez Chacon
Charles Mandell
Patricia McAdams
Christopher McEvoy
Tahid McCoy
David McGovern
John Meyer
Daniel Miller
Guido Mosquera
Louis Muno
Mary Muno
Gustavo Munoz
Michael Murphy
Kenneth Nastri
George Newell
Michael Noone
Aigoul Nourjanova
Eugene Pacifico
Wayne Pav
Jason Pellegrini
Jose Pena Corvera
John Pisciotta
David Pollock
Raisa Puzis
Manuel Ramones
Wilson Ramones
Steven Randall
Carla Rivas
Ronald Romani
Marlene Rubino
Israel Rubio
Frank Russo
Steven Sardone
John Schindler
Claudia Schmid
Stanley Schwarz
Peter Schwind
Cesar Sisalima
Lane Smith
Michael Spichalsky
Peter Stahl
Dennis Stanford
John Sundman
Clifford Sutkevich
Matthew Sweeney
Steven Tang
Michael Taravella
Yew Teo
Paul Thelen
Matthew Treffeisen
Albaro Trinidad
Leigh Tyrrel
James Van Wie
Fredy Vasquez
Benjamin Veneable
Fidelia Vilorio
Alvin Watson
Leslie Wenzel
Graham Wildt
Curtis Williams
Dorothy Williams
Jenna Williams
Daniel Zimmer
Human Resources
Katherine G. Raftery,
Vice President
Kerry Birnstill
Camille Cava-Belluscio
Patricia Crawford
Lesley Inglis
Kathryn LaForgia
Jennifer Molignano
Marjorie Ryan
Sheri Schlicher
Patricia Schoeffler
Rashmi Sinha
Jessica Toner
Rita Wienclaw
Information Technology
Hans Erik Aronson, Director
James Bense
Melissa Bruggemann
William Burns
Ron Calderon
Roy Reeves Crowe
Peter DiLauro
Gregg Evans
Frank Falco
Kelvin Flores
Jeffrey Goldschrafe
Todd Heywood
Alex Jerez
Thomas Karow
Sean Kelly
Daniel Liebster
Johnny Lindahl
Michael Malave
Louis Malfi
Nicholas Mau
Gerald McCloskey
Bhargavkumar Patel
Barbara Peters
Leila Sawicki
Salvatore Serafino
Michael Skuthan
David Trimboli
Peter Van Buren
Steven Zielinski
Procurement
Philip Lembo, Director
Deborah Aufiero
Kimberly Bronson
Carol Brower
Susan DeAngelo
Jeffrey DuPree
Bruce Fahlbusch
Christopher Oravitz
Barbara Purcell
Krystyna Rzonca
Theresa Saia
Leonard Sposato
Public Affairs
Dagnia Zeidlickis, Vice
President, Communications
Hema Bashyam
Margot Bennett
James Duffy
Catherine Eberstark
Jessica Giordano
Deborah Gordon
Philip Renna
Peter Tarr
Sponsored Programs
Walter L. Goldschmidts,
Executive Director
Maureen Davies
Paola DiMarzio
Dolores Doxey
Carol DuPree
Diane Errico
Donna Gavin
Jill Hemish
Joanne Janelli
Ruta Ledins
Stacy Leotta
Kathleen Wall-Rooney
Technology Transfer
John P. Maroney, Vice President
and In-House Counsel
Elizabeth Cherian-Samuel
Vladimir Drozdoff
Lorraine McInerny
Limin Wen
RESEARCH STAFF
DEPARTURES DURING 2010
Adjunct Professors
Hollis Cline
Roberto Malinow
Karel Svoboda
William Tansey
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Adjunct Associate Professors
Carlos Brody
Zachary Mainen
Jonathan Sebat
Adjunct Assistant Professors
Mirjana Maletic-Savatic
Lakshmi Muthuswamy
Research Assistant Professor
Matthew Vaughn
Visiting Scientists/ 
Collaborative Scientists
Benoit Arcangioli
Carmen Berasain
Natalya Bondar
Peter Chuang
Michelle Cook
Poppy Crum
Tasman Daish
Yuda Fang
Paulo Ferreira
Lia Frenkel
Fernando Goes
Nathalie Harder
James Jarvis
Nataliya Kudryavtseva
Inigo Lasa
Olgica Milenkovic
Giao Ngoc Nguyen
Lucy Park
Jerry Pelletier
Joaquin Piriz
Nicholas Wall
Yalin Wang
Clinical Fellow
Johannes Zuber
Research Investigator
Sheldon McKay
Postdoctoral Fellows
Uli Bialucha
Chunlin Cai
Iver Hansen
Danielle Irvine
Valery Krizhanovsky
Dheeraj Malhotra
Louis Manganas
Nael Nadif Kasri
Michaela Oswald-Pisarski
Mario Pagani
Rajesh Prakash
Vladimir Vacic
Daniel Valente
Haibin Wang
Michael Wittinger
Zhiguang Yuchi
Lixing Zhan
Zhihua Zhang
Scientific Informatics
Abhishek Bhandari
John Colagioia
Sohail Khan
Vladimir Makarov
Liya Ren
Chenghai Xue
Seungtai Yoon
Research Associate
Cexiong Fu
Laboratory Management      471
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